Citrus Sinensis ID: 008026
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 580 | 2.2.26 [Sep-21-2011] | |||||||
| P43298 | 942 | Probable receptor protein | yes | no | 0.974 | 0.599 | 0.722 | 0.0 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.465 | 0.375 | 0.386 | 3e-52 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.929 | 0.446 | 0.291 | 2e-51 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.929 | 0.446 | 0.291 | 3e-51 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.365 | 0.298 | 0.445 | 6e-51 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.656 | 0.434 | 0.310 | 3e-50 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.455 | 0.372 | 0.409 | 4e-50 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.458 | 0.349 | 0.424 | 3e-49 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.465 | 0.376 | 0.364 | 6e-49 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.437 | 0.308 | 0.392 | 1e-48 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 819 bits (2116), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/574 (72%), Positives = 478/574 (83%), Gaps = 9/574 (1%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L G LP S +GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG
Sbjct: 198 LEGELPMSLAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSG 253
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+K+LESLSLRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+F
Sbjct: 254 LKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSF 313
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
CL SPG CDPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM
Sbjct: 314 CLSSPGECDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKME 373
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA 243
LTGTISPEF + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN
Sbjct: 374 LTGTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNV 433
Query: 244 IVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGA 302
+VNT+GNPDIGK+KSS S G+GSG N G+K SS I +I+ V+GG
Sbjct: 434 VVNTNGNPDIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGL 492
Query: 303 FVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAIS 362
I L G+LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS
Sbjct: 493 LSIFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGIS 551
Query: 363 ETHTVP-SSEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT 420
+T+T+P +SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGT
Sbjct: 552 DTYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGT 611
Query: 421 KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480
KIAVKRME GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTL
Sbjct: 612 KIAVKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTL 671
Query: 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540
SRH+F W+EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA
Sbjct: 672 SRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 731
Query: 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA
Sbjct: 732 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 765
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 207 bits (526), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 116/300 (38%), Positives = 173/300 (57%), Gaps = 30/300 (10%)
Query: 298 VIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHS------------------ 339
+ G +++L GV+ L ++K+KR + + + HP S
Sbjct: 251 AVAGFAIMALIGVVF--LVRRKKKRNIDSYNHSQYLPHPNFSVKSDGFLYGQDPGKGYSS 308
Query: 340 ---GS--ENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT 394
GS NS+ + ++ S + G H + SS D +L +G S + L +T
Sbjct: 309 GPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEIT 368
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
F+ +NILG GGFG VYKG L DG +AVK+++AG SG+G EFK+E+ ++++V HRH
Sbjct: 369 QGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAG--SGQGDREFKAEVEIISRVHHRH 426
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
LV+L+G+C+ +LL++EY+ TL H+ +GL LEW++R+ IA+ A+G+ YL
Sbjct: 427 LVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG---KGLPVLEWSKRVRIAIGSAKGLAYL 483
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
H H IHRD+K +NILL D+ A+VADFGL RL + + TR+ GTFGYLAPEYA
Sbjct: 484 HEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYA 543
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (518), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 188/645 (29%), Positives = 303/645 (46%), Gaps = 106/645 (16%)
Query: 4 LIGGLPASF-SGSQIQSL--WVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP 59
L G +P+S S S+++ L W+N +L G I + + +L+ + L N +GP+P
Sbjct: 463 LTGSIPSSLGSLSKLKDLILWLN------QLSGEIPQELMYLQALENLILDFNDLTGPIP 516
Query: 60 -DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMA 117
S +L +SL +N +G +P SL +L +L I+ + NN + G +P E SL
Sbjct: 517 ASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWL 576
Query: 118 KGSNNFCLPSPGACDPRLN--------ALLS--------------------VVKLMGYPQ 149
+ NF G+ P L ALL+ +++ G Q
Sbjct: 577 DLNTNFL---NGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQ 633
Query: 150 RFAENWKGNDPCS---DWIGVTCT----KGNITVINFQKMNLTGTISPEFASFKSLQRLI 202
+ PC+ + G+T G++ ++ L G+I E + L L
Sbjct: 634 EQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILN 693
Query: 203 LADNNLSGMIPE------------------------GLSVLGALKELDVSNNQLYGKIPS 238
L N+LSGMIP+ L+ L L E+D+SNN L G IP
Sbjct: 694 LGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPE 753
Query: 239 FKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTG-SGNASSTENGVKNSSALITVILFC 297
D PD + ++S G P P +G +A+ + + ++L +
Sbjct: 754 SAP-----FDTFPDY-RFANNSLCGYPLPLPCSSGPKSDANQHQKSHRRQASLAGSVAMG 807
Query: 298 VIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVS 357
++ F I G+++ + KK++R M H HS + NS + K T A +S
Sbjct: 808 LLFSLFCI--FGLIIVAIETKKRRRKKEAALEAYMDGH-SHSATANS-AWKFTSAREALS 863
Query: 358 VGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELH 417
+ ++ E ++ L TN F ++++G GGFG VYK +L
Sbjct: 864 I---------------NLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLK 908
Query: 418 DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477
DG+ +A+K++ +SG+G EF +E+ + K++HR+LV LLG+C G E+LLV+EYM
Sbjct: 909 DGSVVAIKKLIH--VSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKY 966
Query: 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537
G+L + + + G+K L W R IA+ ARG+ +LH IHRD+K SN+LL ++
Sbjct: 967 GSLEDVLHDRKKTGIK-LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDEN 1025
Query: 538 MRAKVADFGLVRL--APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580
+ A+V+DFG+ RL A + S+ T +AGT GY+ PEY +F S
Sbjct: 1026 LEARVSDFGMARLMSAMDTHLSVST-LAGTPGYVPPEYYQSFRCS 1069
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 188/645 (29%), Positives = 303/645 (46%), Gaps = 106/645 (16%)
Query: 4 LIGGLPASF-SGSQIQSL--WVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP 59
L G +P+S S S+++ L W+N +L G I + + +L+ + L N +GP+P
Sbjct: 463 LTGSIPSSLGSLSKLKDLILWLN------QLSGEIPQELMYLQALENLILDFNDLTGPIP 516
Query: 60 -DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMA 117
S +L +SL +N +G +P SL +L +L I+ + NN + G +P E SL
Sbjct: 517 ASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWL 576
Query: 118 KGSNNFCLPSPGACDPRLN--------ALLS--------------------VVKLMGYPQ 149
+ NF G+ P L ALL+ +++ G Q
Sbjct: 577 DLNTNFL---NGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQ 633
Query: 150 RFAENWKGNDPCS---DWIGVTCT----KGNITVINFQKMNLTGTISPEFASFKSLQRLI 202
+ PC+ + G+T G++ ++ L G+I E + L L
Sbjct: 634 EQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILN 693
Query: 203 LADNNLSGMIPE------------------------GLSVLGALKELDVSNNQLYGKIPS 238
L N+LSGMIP+ L+ L L E+D+SNN L G IP
Sbjct: 694 LGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPE 753
Query: 239 FKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTG-SGNASSTENGVKNSSALITVILFC 297
D PD + ++S G P P +G +A+ + + ++L +
Sbjct: 754 SAP-----FDTFPDY-RFANNSLCGYPLPIPCSSGPKSDANQHQKSHRRQASLAGSVAMG 807
Query: 298 VIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVS 357
++ F I G+++ + KK++R M H HS + NS + K T A +S
Sbjct: 808 LLFSLFCI--FGLIIVAIETKKRRRKKEAALEAYMDGH-SHSATANS-AWKFTSAREALS 863
Query: 358 VGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELH 417
+ ++ E ++ L TN F ++++G GGFG VYK +L
Sbjct: 864 I---------------NLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLK 908
Query: 418 DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477
DG+ +A+K++ +SG+G EF +E+ + K++HR+LV LLG+C G E+LLV+EYM
Sbjct: 909 DGSVVAIKKLIH--VSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKY 966
Query: 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537
G+L + + + G+K L W R IA+ ARG+ +LH IHRD+K SN+LL ++
Sbjct: 967 GSLEDVLHDRKKIGIK-LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDEN 1025
Query: 538 MRAKVADFGLVRL--APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580
+ A+V+DFG+ RL A + S+ T +AGT GY+ PEY +F S
Sbjct: 1026 LEARVSDFGMARLMSAMDTHLSVST-LAGTPGYVPPEYYQSFRCS 1069
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (514), Expect = 6e-51, Method: Compositional matrix adjust.
Identities = 99/222 (44%), Positives = 146/222 (65%), Gaps = 10/222 (4%)
Query: 353 GSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVY 412
GS G + + + P D ++ +G + + L ++T FS+ NILG GGFG VY
Sbjct: 314 GSQRGGGGYTRSGSAP-----DSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVY 368
Query: 413 KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472
KG+L+DG +AVK+++ G SG+G EFK+E+ ++++V HRHLV+L+G+C+ +E+LL++
Sbjct: 369 KGKLNDGKLVAVKQLKVG--SGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIY 426
Query: 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 532
EY+P TL H+ +G LEW RR+ IA+ A+G+ YLH H IHRD+K +NI
Sbjct: 427 EYVPNQTLEHHLHG---KGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANI 483
Query: 533 LLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
LL D+ A+VADFGL +L + + TR+ GTFGYLAPEYA
Sbjct: 484 LLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYA 525
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 200 bits (508), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 142/458 (31%), Positives = 219/458 (47%), Gaps = 77/458 (16%)
Query: 125 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS----DWIGVTCTKGNITVINFQ 180
LP ++A++++ + G +R +W+G DPC+ W G+ C+ N
Sbjct: 353 LPQLDTYQDEVSAMMNIKTIYGLSKR--SSWQG-DPCAPELYRWEGLNCSYPNFAPPQII 409
Query: 181 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--- 237
+NL+G+ NLSG I +S L L+ELD+SNN L G IP
Sbjct: 410 SLNLSGS-------------------NLSGTITSDISKLTHLRELDLSNNDLSGDIPFVF 450
Query: 238 -SFKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILF 296
K+ ++N GN ++ + + Q S E G KNS+ ++ +
Sbjct: 451 SDMKNLTLINLSGNKNLNRSVPETLQKR-----IDNKSLTLIRDETG-KNSTNVVAIA-- 502
Query: 297 CVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNV 356
+ F + + +VF + +KKQ R + P +
Sbjct: 503 ASVASVFAVLVILAIVFVVIRKKQ-RTNEASGPRSFT----------------------- 538
Query: 357 SVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGEL 416
T TV S + + + +T NF E +LG+GGFGTVY G L
Sbjct: 539 -------TGTVKSDARSSSSSIITKERKFTYSEVLKMTKNF--ERVLGKGGFGTVYHGNL 589
Query: 417 HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476
D T++AVK + S +G EFK+E+ +L +V HRHLV L+G+C DG+ L++EYM
Sbjct: 590 -DDTQVAVKMLSHS--SAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYME 646
Query: 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 536
+G L ++ + + L W R+ IA++ A+G+EYLH +HRD+KP+NILL +
Sbjct: 647 KGDLRENMS--GKHSVNVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTNILLNE 704
Query: 537 DMRAKVADFGLVRLAP-EGKGSIETRIAGTFGYLAPEY 573
+AK+ADFGL R P +G+ + T +AGT GYL PEY
Sbjct: 705 RSQAKLADFGLSRSFPVDGESHVMTVVAGTPGYLDPEY 742
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 4e-50, Method: Compositional matrix adjust.
Identities = 117/286 (40%), Positives = 169/286 (59%), Gaps = 22/286 (7%)
Query: 293 VILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQ----SPNAMVIHPRHSGSENSESVK 348
V+ V V +L G+ V+CL +K++KR S V +P+ M S + S+S
Sbjct: 281 VVGISVAVALVVFTLFGIFVWCL-RKREKRLSAVSGGDVTPSPM------SSTARSDSAF 333
Query: 349 ITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGF 408
+ S+ VGA + + S G L + S + L TN FS+EN+LG GGF
Sbjct: 334 FRMQ-SSAPVGASKRSGSYQSQSGG----LGNSKALFSYEELVKATNGFSQENLLGEGGF 388
Query: 409 GTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468
G VYKG L DG +AVK+++ G G+G EFK+E+ L+++ HRHLV+++GHC+ G+ +
Sbjct: 389 GCVYKGILPDGRVVAVKQLKIG--GGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRR 446
Query: 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 528
LL+++Y+ L H+ E+ + L+W R+ IA ARG+ YLH H IHRD+K
Sbjct: 447 LLIYDYVSNNDLYFHLH--GEKSV--LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 502
Query: 529 PSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
SNILL D+ A+V+DFGL RLA + I TR+ GTFGY+APEYA
Sbjct: 503 SSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYA 548
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 196 bits (499), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 118/278 (42%), Positives = 164/278 (58%), Gaps = 12/278 (4%)
Query: 299 IGGAFVI-SLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVS 357
IG A V+ +L GV+V CL KK++KR S + M P S S S+S + S
Sbjct: 335 IGVALVLLTLIGVVVCCL-KKRKKRLSTIGGGYVMPT-PMESSSPRSDSALLKTQSSAPL 392
Query: 358 VGAISETHTVPS-SEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGEL 416
VG S T S SEPG + S + L TN FS+EN+LG GGFG VYKG L
Sbjct: 393 VGNRSSNRTYLSQSEPGGFGQ---SRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 417 HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476
D +AVK+++ G G+G EFK+E+ +++V HR+L++++G+C+ N +LL+++Y+P
Sbjct: 450 PDERVVAVKQLKIG--GGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVP 507
Query: 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 536
L H+ GL +W R+ IA ARG+ YLH H IHRD+K SNILL +
Sbjct: 508 NNNLYFHLHAAGTPGL---DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEN 564
Query: 537 DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
+ A V+DFGL +LA + I TR+ GTFGY+APEYA
Sbjct: 565 NFHALVSDFGLAKLALDCNTHITTRVMGTFGYMAPEYA 602
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 196 bits (497), Expect = 6e-49, Method: Compositional matrix adjust.
Identities = 110/302 (36%), Positives = 169/302 (55%), Gaps = 32/302 (10%)
Query: 298 VIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVK--------- 348
IGG FV+ + L+F LCKKK++R + ++P A + + G + + +
Sbjct: 232 AIGGGFVLLVALALIFFLCKKKRRRDN--EAPPAPIDGVPYGGQQQQNASRRSDHVVMSV 289
Query: 349 ----------------ITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRN 392
++ S S+ +P PG L + + L
Sbjct: 290 PPPKSPSSAPPRPPHFMSSGSSGDYDSNYSDQSVLPPPSPGLALGLGIYQGTFNYEELSR 349
Query: 393 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
TN FSE N+LG+GGFG V+KG L +G ++AVK+++ G S +G EF++E+ ++++V H
Sbjct: 350 ATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEG--SSQGEREFQAEVGIISRVHH 407
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
RHLVAL+G+C+ ++LLV+E++P TL H+ +G +EW+ RL IA+ A+G+
Sbjct: 408 RHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHG---KGRPTMEWSSRLKIAVGSAKGLS 464
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
YLH + IHRD+K SNIL+ AKVADFGL ++A + + TR+ GTFGYLAPE
Sbjct: 465 YLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPE 524
Query: 573 YA 574
YA
Sbjct: 525 YA 526
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (494), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 112/285 (39%), Positives = 162/285 (56%), Gaps = 31/285 (10%)
Query: 290 LITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKI 349
++ +++ V+GG +SL + V CLC++K + +R R GS NS + +
Sbjct: 407 VVWIVVGSVLGGFVFLSLFFLSVLCLCRRKNNK-TRSSESTGWTPLRRFRGSSNSRTTER 465
Query: 350 TVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFG 409
TV+ S HT + IS L++ TNNF ++G GGFG
Sbjct: 466 TVSSSGY--------HT----------------LRISFAELQSGTNNFDRSLVIGVGGFG 501
Query: 410 TVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469
V++G L D TK+AVKR G S +GL EF SEI +L+K+RHRHLV+L+G+C + +E +
Sbjct: 502 MVFRGSLKDNTKVAVKRGSPG--SRQGLPEFLSEITILSKIRHRHLVSLVGYCEEQSEMI 559
Query: 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 529
LV+EYM +G L H++ PL W +RL + + ARG+ YLH + Q IHRD+K
Sbjct: 560 LVYEYMDKGPLKSHLYGSTN---PPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDIKS 616
Query: 530 SNILLGDDMRAKVADFGLVRLAP-EGKGSIETRIAGTFGYLAPEY 573
+NILL ++ AKVADFGL R P + + T + G+FGYL PEY
Sbjct: 617 TNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEY 661
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 580 | ||||||
| 224069210 | 945 | predicted protein [Populus trichocarpa] | 0.975 | 0.598 | 0.783 | 0.0 | |
| 255585572 | 951 | receptor protein kinase, putative [Ricin | 0.984 | 0.600 | 0.759 | 0.0 | |
| 359476563 | 889 | PREDICTED: probable receptor protein kin | 0.941 | 0.614 | 0.760 | 0.0 | |
| 449445063 | 953 | PREDICTED: probable receptor protein kin | 0.982 | 0.598 | 0.751 | 0.0 | |
| 224077350 | 946 | predicted protein [Populus trichocarpa] | 0.975 | 0.598 | 0.757 | 0.0 | |
| 351727489 | 941 | NAK-type protein kinase precursor [Glyci | 0.986 | 0.607 | 0.733 | 0.0 | |
| 357491853 | 945 | Kinase-like protein [Medicago truncatula | 0.979 | 0.601 | 0.717 | 0.0 | |
| 29824403 | 942 | putative receptor protein kinase (TMK1) | 0.974 | 0.599 | 0.722 | 0.0 | |
| 15218941 | 942 | putative receptor protein kinase TMK1 [A | 0.974 | 0.599 | 0.722 | 0.0 | |
| 224589461 | 942 | leucine-rich repeat receptor-like protei | 0.974 | 0.599 | 0.722 | 0.0 |
| >gi|224069210|ref|XP_002302927.1| predicted protein [Populus trichocarpa] gi|222844653|gb|EEE82200.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2330), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/573 (78%), Positives = 502/573 (87%), Gaps = 7/573 (1%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L G LPASFSGSQ+QSLW+NGQ KL GGIDVIQNMT L+E+WLHSN FSGPLPDFSG
Sbjct: 203 LEGELPASFSGSQVQSLWLNGQ----KLSGGIDVIQNMTLLREVWLHSNGFSGPLPDFSG 258
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+K LESLSLRDN FTG VP+SLV LESLK VN++NNLLQGP+P F SVS+DM K SN F
Sbjct: 259 LKDLESLSLRDNSFTGLVPESLVNLESLKFVNLSNNLLQGPMPVFKSSVSVDMVKDSNRF 318
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
CLP+P CD R+N LLS+VK M YPQR A++WKGNDPC+DWIG+TC GNITV+NF+KM
Sbjct: 319 CLPTPDLCDSRVNTLLSIVKSMDYPQRLADSWKGNDPCADWIGITCNNGNITVVNFEKMG 378
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA 243
LTG+ISP+FAS KSL+RL+LA+NNL+G IP+ ++ L LK LDVSNN LYG++P+F SN
Sbjct: 379 LTGSISPDFASVKSLERLVLANNNLTGSIPQEITTLPGLKVLDVSNNHLYGRVPAFTSNV 438
Query: 244 IVNTDGNPDIGKEKS--SSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGG 301
IVNT+GNP+IGK+ + +S + + TGSG+ S+ K SS LI VI+F VIGG
Sbjct: 439 IVNTNGNPNIGKDVNISTSSESPSASPSANTGSGSGGSSRKSGKKSSTLIVVIIFSVIGG 498
Query: 302 AFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAI 361
F++SL G+LVFCL KKKQKRFSRVQSPN MVIHPRHSGS+N ESVKITVAGS++SVGAI
Sbjct: 499 VFLLSLIGLLVFCLYKKKQKRFSRVQSPNEMVIHPRHSGSDN-ESVKITVAGSSISVGAI 557
Query: 362 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 421
SETHT+P+SE GDIQM+EAGNMVISIQVLRNVTNNFSEENILG GGFG VYKGELHDGTK
Sbjct: 558 SETHTIPASEQGDIQMVEAGNMVISIQVLRNVTNNFSEENILGWGGFGVVYKGELHDGTK 617
Query: 422 IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 481
IAVKRME+GVISGKGLTEFKSEIAVLTKVRHRHLVALLG+CLDGNEKLLV+EYMPQGTLS
Sbjct: 618 IAVKRMESGVISGKGLTEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTLS 677
Query: 482 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541
RHIFNWAEEGLKPLEW RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK
Sbjct: 678 RHIFNWAEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 737
Query: 542 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA
Sbjct: 738 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 770
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585572|ref|XP_002533475.1| receptor protein kinase, putative [Ricinus communis] gi|223526668|gb|EEF28907.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 893 bits (2308), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/573 (75%), Positives = 499/573 (87%), Gaps = 2/573 (0%)
Query: 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 62
+L GGLP +FSGSQIQSLW+NGQ KL GGIDVI+NMT LK++WLHSN FSGPLPDFS
Sbjct: 204 ELQGGLPGTFSGSQIQSLWLNGQTSKGKLTGGIDVIKNMTLLKDVWLHSNGFSGPLPDFS 263
Query: 63 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNN 122
G+K LE LS+RDN FTGP+P SL L SLK VN++NNL QGP+P F R VS+D+ SN+
Sbjct: 264 GLKDLEVLSIRDNSFTGPIPLSLTALASLKAVNLSNNLFQGPMPVFKRLVSVDLTADSNS 323
Query: 123 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM 182
FCLPSPG CD R+ LL + K +GYPQRFAE+WKGNDPC+DW+G+TCT GNITV+NFQKM
Sbjct: 324 FCLPSPGDCDSRVKTLLLIAKSVGYPQRFAESWKGNDPCADWVGITCTGGNITVVNFQKM 383
Query: 183 NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 242
LTGT++PEFA SLQRL+L +NNL+G IP+ L+ L ALK+LDVSNNQ+ GKIP+FKSN
Sbjct: 384 GLTGTVAPEFAMLLSLQRLVLDNNNLTGSIPQELTTLPALKQLDVSNNQISGKIPTFKSN 443
Query: 243 AIVNTDGNPDIGKE-KSSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGG 301
+VNT+GNPDIGK+ +S+ GSPSG+ + ++ NG K SS+ I VILF VIGG
Sbjct: 444 VMVNTNGNPDIGKDVNTSTTPGSPSGATMAGTGSGSGNSGNGGKKSSSNIGVILFSVIGG 503
Query: 302 AFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAI 361
FVISL G+L+FC+ KKKQKRFS+VQSPNAMVIHPRHSGS+N ESVKITVAGS+VSVGAI
Sbjct: 504 VFVISLIGLLIFCIYKKKQKRFSKVQSPNAMVIHPRHSGSDN-ESVKITVAGSSVSVGAI 562
Query: 362 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 421
SETHT P+SE GDIQM+E+GNMVISIQVLRNVTNNFSE+N+LG+GGFG VYKGELHDGTK
Sbjct: 563 SETHTFPASEQGDIQMVESGNMVISIQVLRNVTNNFSEDNLLGQGGFGKVYKGELHDGTK 622
Query: 422 IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 481
IAVKRME+GVISGKGL EFKSEIAVL KVRHRHLVALLG+CLDGNEKLLV+E+MPQG LS
Sbjct: 623 IAVKRMESGVISGKGLAEFKSEIAVLNKVRHRHLVALLGYCLDGNEKLLVYEFMPQGALS 682
Query: 482 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541
RH+F+WA++GLKPLEW RRL IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK
Sbjct: 683 RHLFHWADDGLKPLEWTRRLIIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 742
Query: 542 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
VADFGLVRLAP+GKGSIETRIAGTFGYLAPEYA
Sbjct: 743 VADFGLVRLAPDGKGSIETRIAGTFGYLAPEYA 775
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476563|ref|XP_002265087.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2298), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/571 (76%), Positives = 485/571 (84%), Gaps = 25/571 (4%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L+GGLP++ SGS I+SLWVNGQ KL G IDVIQNMTSLKE+WLHSNAFSGPLPDFSG
Sbjct: 167 LVGGLPSALSGSLIESLWVNGQMSEEKLSGTIDVIQNMTSLKEVWLHSNAFSGPLPDFSG 226
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+K L+SLSLRDN FTG VP SLV L SL+ VN+TNN LQGPVPEF SV++DM N+F
Sbjct: 227 LKDLQSLSLRDNLFTGVVPVSLVNLGSLEAVNLTNNFLQGPVPEFKNSVAVDMTPDGNSF 286
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
CLP PG CDPR+N LLS+VK GYP +FA+NWKGNDPC++W G+TC GNITV+NFQKM
Sbjct: 287 CLPKPGECDPRVNILLSIVKSFGYPTKFAKNWKGNDPCTEWFGITCNNGNITVVNFQKMG 346
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA 243
LTGTIS F+S SLQ+L+LADNN++G IP+ L+ L AL +LDVSNNQLYGKIPSFK N
Sbjct: 347 LTGTISSNFSSLISLQKLVLADNNITGSIPKELTTLPALTQLDVSNNQLYGKIPSFKGNV 406
Query: 244 IVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAF 303
+VN +G+ D G S+ NG K SS+LI +I+F VIGG F
Sbjct: 407 LVNANGSQDSG------------------------SSMNGGKKSSSLIGIIVFSVIGGVF 442
Query: 304 VISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISE 363
VI L G+LVFCL K+KQKRF+RVQSPNAMVIHPRHSGS+N +SVKITVAGS+VSVGAISE
Sbjct: 443 VIFLIGLLVFCLYKRKQKRFTRVQSPNAMVIHPRHSGSDN-DSVKITVAGSSVSVGAISE 501
Query: 364 THTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIA 423
THT PSSEP DIQM+EAGNMVISIQVLRNVTNNFSEENILG+GGFGTVY+GELHDGTKIA
Sbjct: 502 THTHPSSEPNDIQMVEAGNMVISIQVLRNVTNNFSEENILGQGGFGTVYRGELHDGTKIA 561
Query: 424 VKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRH 483
VKRME+GVI+GKGL EFKSEIAVLTKVRHRHLVALLG+CLDGNEKLLV+EYMPQGTLSRH
Sbjct: 562 VKRMESGVITGKGLAEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTLSRH 621
Query: 484 IFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 543
+F+W EEG+KPLEW RRL IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA
Sbjct: 622 LFSWPEEGIKPLEWTRRLAIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 681
Query: 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
DFGLVRLAPEGKGSIETRIAGTFGYLAPEYA
Sbjct: 682 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 712
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445063|ref|XP_004140293.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] gi|449479894|ref|XP_004155738.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2279), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/576 (75%), Positives = 487/576 (84%), Gaps = 6/576 (1%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L GGLP+SFSGSQ++SLWVNGQN KL G IDV+QNMTSL E+WLHSN+FSGPLPDFS
Sbjct: 203 LEGGLPSSFSGSQLESLWVNGQNSADKLSGSIDVLQNMTSLIEVWLHSNSFSGPLPDFSR 262
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+K L++LSLRDN FTGPVP SLV SLK+VN+TNNLLQGP+P F V +DM SN+F
Sbjct: 263 LKDLQALSLRDNKFTGPVPSSLVNSPSLKVVNLTNNLLQGPIPLFKTGVVVDMTNDSNSF 322
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
CL PG CD R+N LLS+VK MGYPQRFAENWKGNDPC++WIG++C +IT++NFQKM
Sbjct: 323 CLQDPGECDSRVNTLLSIVKFMGYPQRFAENWKGNDPCAEWIGISCRNQSITIVNFQKMG 382
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA 243
L+G ISPEFAS K L+RL+LADN+L+G IPE L+ L L ELDVSNNQL GKIP F+SN
Sbjct: 383 LSGMISPEFASLKGLERLVLADNHLTGSIPEELTTLPFLTELDVSNNQLSGKIPKFRSNV 442
Query: 244 IVNTDGNPDIGKEK--SSSFQGSPSGSPTGTGSGNASSTENGV---KNSSALITVILFCV 298
++ GNPDIGKEK SSS SPS S T ++ N K S+++ VI+ V
Sbjct: 443 MMTITGNPDIGKEKTDSSSNGASPSASSNDTKEAGSNGGGNSGDGEKKPSSMVGVIVLSV 502
Query: 299 IGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSV 358
+GG FV+ L G++V C+ K KQKRFS+VQSPNAMVIHPRHSGS+N ESVKITVAGS+V V
Sbjct: 503 VGGVFVLFLIGLVVLCVYKMKQKRFSQVQSPNAMVIHPRHSGSDN-ESVKITVAGSSVRV 561
Query: 359 GAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHD 418
GAISET SSE GDIQM+EAGNMVISIQVL+NVTNNFSEENILG+GGFGTVYKGELHD
Sbjct: 562 GAISETQNGASSETGDIQMVEAGNMVISIQVLKNVTNNFSEENILGQGGFGTVYKGELHD 621
Query: 419 GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478
GTKIAVKRME+GVI GKGLTEFKSEIAVLTKVRHRHLVALLG+CLDGNEKLLV+EYMPQG
Sbjct: 622 GTKIAVKRMESGVIKGKGLTEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQG 681
Query: 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 538
TLSRH+FNW EEGLKPLEW +RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM
Sbjct: 682 TLSRHLFNWPEEGLKPLEWTKRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 741
Query: 539 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA
Sbjct: 742 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 777
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224077350|ref|XP_002305223.1| predicted protein [Populus trichocarpa] gi|222848187|gb|EEE85734.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2253), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/573 (75%), Positives = 493/573 (86%), Gaps = 7/573 (1%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L G LPASFSG Q+QSLW+NGQ KL G I VIQNMT L+E+WL SN FSGPLPDFSG
Sbjct: 203 LEGELPASFSGLQVQSLWLNGQ----KLSGSIYVIQNMTLLREVWLQSNGFSGPLPDFSG 258
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+K LESL+LRDN FTGPVP+SLV LESLK+VN++NNLLQGP+P F SVS+D+ K SN F
Sbjct: 259 LKDLESLNLRDNSFTGPVPESLVNLESLKVVNLSNNLLQGPMPVFKSSVSVDVVKDSNRF 318
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
CL +PG CD R+N LLS+VK M YP R A+ WKGNDPC+DW G+TC KGNITV+NF+KM
Sbjct: 319 CLSTPGPCDSRVNTLLSIVKSMYYPHRLADGWKGNDPCADWFGITCNKGNITVVNFEKMG 378
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA 243
LTG+ISP+FAS KSL+RL+LA+NNL+G+IP+ ++ L LK LDVSNNQ+YGK+P+F +N
Sbjct: 379 LTGSISPDFASLKSLERLVLANNNLTGLIPQEITTLPRLKALDVSNNQIYGKVPAFTNNV 438
Query: 244 IVNTDGNPDIGKE--KSSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGG 301
IVNT+GNP IGK+ S+S + TGSG+ ++ K SSA I VI+F V+GG
Sbjct: 439 IVNTNGNPRIGKDVNSSTSPGSPSASPSANTGSGSGGNSGKSGKKSSAFIGVIVFSVVGG 498
Query: 302 AFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAI 361
F++ L G++VFCL KKKQKRFSRVQSPN MVIHPRHS S+N ESVKITVAGS+VSVGAI
Sbjct: 499 VFLLFLIGLVVFCLYKKKQKRFSRVQSPNEMVIHPRHSVSDN-ESVKITVAGSSVSVGAI 557
Query: 362 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 421
SETHT+P+SE GDIQM EAGNMVISIQVLRNVTNNFSEENILG+GGFG VYKGELHDGTK
Sbjct: 558 SETHTIPTSEQGDIQMGEAGNMVISIQVLRNVTNNFSEENILGQGGFGVVYKGELHDGTK 617
Query: 422 IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 481
IAVKRM +GVIS KGL EFKSEIAVLTKVRHRHLVALLG+CLDGNEKLLV+EYMPQGTLS
Sbjct: 618 IAVKRMGSGVISSKGLNEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTLS 677
Query: 482 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541
RH+FNWAEEGLKP+EW RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK
Sbjct: 678 RHLFNWAEEGLKPMEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 737
Query: 542 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
V+DFGLVRLAPEGKGSIETRIAGTFGYLAPEYA
Sbjct: 738 VSDFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 770
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727489|ref|NP_001238698.1| NAK-type protein kinase precursor [Glycine max] gi|223452361|gb|ACM89508.1| NAK-type protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/577 (73%), Positives = 486/577 (84%), Gaps = 5/577 (0%)
Query: 1 MLQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD 60
M L G LP SFSGSQIQSLW+NGQ KLGG ++V+QNMT L ++WL SNAF+GPLPD
Sbjct: 190 MNNLEGTLPLSFSGSQIQSLWLNGQKSVNKLGGSVEVLQNMTFLTDVWLQSNAFTGPLPD 249
Query: 61 FSGVKQLESLSLRDNFFTGPVP-DSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 119
SG+K L LSLRDN FTGPVP S V L++LK+VN+TNNL QGP+P F V +D K
Sbjct: 250 LSGLKSLRDLSLRDNRFTGPVPVASFVGLKTLKVVNLTNNLFQGPMPVFGDGVVVDNVKD 309
Query: 120 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 179
SN+FCLPSPG CDPR++ LLSVV +MGYP RFAE+WKGNDPC+ WIG+TC+ G ITV+NF
Sbjct: 310 SNSFCLPSPGDCDPRVDVLLSVVGVMGYPPRFAESWKGNDPCAYWIGITCSNGYITVVNF 369
Query: 180 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 239
QKM L+G ISPEFA KSLQR++LADNNL+G IPE L+ L AL +L+V+NNQLYGK+PSF
Sbjct: 370 QKMELSGVISPEFAKLKSLQRIVLADNNLTGSIPEELATLPALTQLNVANNQLYGKVPSF 429
Query: 240 KSNAIVNTDGNPDIGKEKSS-SFQG-SPSGSPTGTGSGNASSTENGVKNSSALITVILFC 297
+ N +V+T+GN DIGK+KSS S QG P +P G S G K SS+ + VI+F
Sbjct: 430 RKNVVVSTNGNTDIGKDKSSLSPQGLVPPMAPNAKGDSGGVSGIGG-KKSSSHVGVIVFS 488
Query: 298 VIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVS 357
VIG FV+S+ G LVFCL + KQK+ SRVQSPNA+VIHPRHSGS+N ESVKITVAGS+VS
Sbjct: 489 VIGAVFVVSMIGFLVFCLFRMKQKKLSRVQSPNALVIHPRHSGSDN-ESVKITVAGSSVS 547
Query: 358 VGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELH 417
VGA SET TVP SE DIQM+EAGNMVISIQVL+NVT+NFSE+N+LG+GGFGTVY+GELH
Sbjct: 548 VGAASETRTVPGSEASDIQMVEAGNMVISIQVLKNVTDNFSEKNVLGQGGFGTVYRGELH 607
Query: 418 DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477
DGT+IAVKRME G I+GKG EFKSEIAVLTKVRHRHLV+LLG+CLDGNEKLLV+EYMPQ
Sbjct: 608 DGTRIAVKRMECGAIAGKGAAEFKSEIAVLTKVRHRHLVSLLGYCLDGNEKLLVYEYMPQ 667
Query: 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537
GTLSRH+F+W EEGL+PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD
Sbjct: 668 GTLSRHLFDWPEEGLEPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 727
Query: 538 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
MRAKVADFGLVRLAPEGK SIETRIAGTFGYLAPEYA
Sbjct: 728 MRAKVADFGLVRLAPEGKASIETRIAGTFGYLAPEYA 764
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357491853|ref|XP_003616214.1| Kinase-like protein [Medicago truncatula] gi|355517549|gb|AES99172.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2124), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/574 (71%), Positives = 476/574 (82%), Gaps = 6/574 (1%)
Query: 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 62
+L G LP F+G +++SLW+NGQ + KL G + V+QNMTSL E+WL SN F+GPLPD
Sbjct: 200 KLEGVLPKGFNGLKVESLWLNGQKSDVKLSGSVQVLQNMTSLTEVWLQSNGFNGPLPDLG 259
Query: 63 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNN 122
G+K LE LSLRDN FTG VP SLV +SLK+VN+TNN QGPVP F V +D K SN+
Sbjct: 260 GLKNLEVLSLRDNSFTGVVPSSLVGFKSLKVVNLTNNKFQGPVPVFGAGVKVDNIKDSNS 319
Query: 123 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM 182
FCLPSPG CDPR+N LLSVV MGYP RFAE+WKGNDPC+DWIG+TC+ GNI+V+NFQK+
Sbjct: 320 FCLPSPGDCDPRVNVLLSVVGGMGYPLRFAESWKGNDPCADWIGITCSNGNISVVNFQKL 379
Query: 183 NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 242
LTG ISP+FA KSLQRLIL+DNNL+G+IP L+ L L +L+VSNN L+GK+PSF+SN
Sbjct: 380 GLTGVISPDFAKLKSLQRLILSDNNLTGLIPNELTTLPMLTQLNVSNNHLFGKVPSFRSN 439
Query: 243 AIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSGNASSTENGV--KNSSALITVILFCVIG 300
IV T GN DIGK+KSS SPS SP GT + + + + SS+ + +I+ VIG
Sbjct: 440 VIVITSGNIDIGKDKSSL---SPSVSPNGTNASGGNGGSSENGDRKSSSHVGLIVLAVIG 496
Query: 301 GAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGA 360
FV SL G+LVFCL + +QK+ SRVQSPNA+VIHPRHSGS+N ESVKITVAGS+VSVG
Sbjct: 497 TVFVASLIGLLVFCLFRMRQKKLSRVQSPNALVIHPRHSGSDN-ESVKITVAGSSVSVGG 555
Query: 361 ISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT 420
+SE HTVP+SE GDIQM+EAGNMVISIQVLR+VTNNFSE+NILG+GGFGTVYKGELHDGT
Sbjct: 556 VSEAHTVPNSEMGDIQMVEAGNMVISIQVLRSVTNNFSEKNILGQGGFGTVYKGELHDGT 615
Query: 421 KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480
+IAVKRM G I GKG EF+SEIAVLTKVRHRHLVALLG+CLDGNEKLLV+EYMPQGTL
Sbjct: 616 RIAVKRMMCGAIVGKGAAEFQSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTL 675
Query: 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540
SR+IFNW EEGL+PL WN+RL IALDVARGVEYLH LAHQSFIHRDLKPSNILLGDDMRA
Sbjct: 676 SRYIFNWPEEGLEPLGWNKRLVIALDVARGVEYLHSLAHQSFIHRDLKPSNILLGDDMRA 735
Query: 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
KVADFGLVRLAPEGK SIETRIAGTFGYLAPEYA
Sbjct: 736 KVADFGLVRLAPEGKASIETRIAGTFGYLAPEYA 769
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|29824403|gb|AAP04161.1| putative receptor protein kinase (TMK1) [Arabidopsis thaliana] gi|110737237|dbj|BAF00566.1| putative receptor protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/574 (72%), Positives = 478/574 (83%), Gaps = 9/574 (1%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L G LP S +GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG
Sbjct: 198 LEGELPMSLAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSG 253
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+K+LESLSLRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+F
Sbjct: 254 LKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSF 313
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
CL SPG CDPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM
Sbjct: 314 CLSSPGECDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKME 373
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA 243
LTGTISPEF + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN
Sbjct: 374 LTGTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNV 433
Query: 244 IVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGA 302
+VNT+GNPDIGK+KSS S G+GSG N G+K SS I +I+ V+GG
Sbjct: 434 VVNTNGNPDIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGL 492
Query: 303 FVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAIS 362
I L G+LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS
Sbjct: 493 LSIFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGIS 551
Query: 363 ETHTVP-SSEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT 420
+T+T+P +SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGT
Sbjct: 552 DTYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGT 611
Query: 421 KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480
KIAVKRME GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTL
Sbjct: 612 KIAVKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTL 671
Query: 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540
SRH+F W+EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA
Sbjct: 672 SRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 731
Query: 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA
Sbjct: 732 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 765
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15218941|ref|NP_176789.1| putative receptor protein kinase TMK1 [Arabidopsis thaliana] gi|1174718|sp|P43298.1|TMK1_ARATH RecName: Full=Probable receptor protein kinase TMK1; Flags: Precursor gi|12322608|gb|AAG51302.1|AC026480_9 receptor protein kinase (TMK1), putative [Arabidopsis thaliana] gi|166888|gb|AAA32876.1| protein kinase [Arabidopsis thaliana] gi|332196347|gb|AEE34468.1| putative receptor protein kinase TMK1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 819 bits (2116), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/574 (72%), Positives = 478/574 (83%), Gaps = 9/574 (1%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L G LP S +GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG
Sbjct: 198 LEGELPMSLAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSG 253
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+K+LESLSLRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+F
Sbjct: 254 LKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSF 313
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
CL SPG CDPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM
Sbjct: 314 CLSSPGECDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKME 373
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA 243
LTGTISPEF + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN
Sbjct: 374 LTGTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNV 433
Query: 244 IVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGA 302
+VNT+GNPDIGK+KSS S G+GSG N G+K SS I +I+ V+GG
Sbjct: 434 VVNTNGNPDIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGL 492
Query: 303 FVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAIS 362
I L G+LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS
Sbjct: 493 LSIFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGIS 551
Query: 363 ETHTVP-SSEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT 420
+T+T+P +SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGT
Sbjct: 552 DTYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGT 611
Query: 421 KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480
KIAVKRME GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTL
Sbjct: 612 KIAVKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTL 671
Query: 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540
SRH+F W+EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA
Sbjct: 672 SRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 731
Query: 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA
Sbjct: 732 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 765
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224589461|gb|ACN59264.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 819 bits (2116), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/574 (72%), Positives = 478/574 (83%), Gaps = 9/574 (1%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L G LP S +GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG
Sbjct: 198 LEGELPMSLAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSG 253
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+K+LESLSLRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+F
Sbjct: 254 LKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSF 313
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
CL SPG CDPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM
Sbjct: 314 CLSSPGECDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKME 373
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA 243
LTGTISPEF + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN
Sbjct: 374 LTGTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNV 433
Query: 244 IVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGA 302
+VNT+GNPDIGK+KSS S G+GSG N G+K SS I +I+ V+GG
Sbjct: 434 VVNTNGNPDIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGL 492
Query: 303 FVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAIS 362
I L G+LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS
Sbjct: 493 LSIFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGIS 551
Query: 363 ETHTVP-SSEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT 420
+T+T+P +SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGT
Sbjct: 552 DTYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGT 611
Query: 421 KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480
KIAVKRME GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTL
Sbjct: 612 KIAVKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTL 671
Query: 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540
SRH+F W+EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA
Sbjct: 672 SRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 731
Query: 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA
Sbjct: 732 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 765
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 580 | ||||||
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.975 | 0.600 | 0.706 | 1.1e-215 | |
| TAIR|locus:2059703 | 943 | AT2G01820 [Arabidopsis thalian | 0.967 | 0.594 | 0.599 | 1.4e-176 | |
| TAIR|locus:2024016 | 886 | AT1G24650 [Arabidopsis thalian | 0.458 | 0.300 | 0.671 | 4.2e-158 | |
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.956 | 0.598 | 0.475 | 2.2e-130 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.322 | 0.197 | 0.476 | 3.1e-60 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.325 | 0.299 | 0.434 | 2.1e-57 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.348 | 0.192 | 0.454 | 2.9e-56 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.320 | 0.180 | 0.455 | 9.1e-56 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.341 | 0.207 | 0.442 | 7.8e-55 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.337 | 0.164 | 0.447 | 2.4e-54 |
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2084 (738.7 bits), Expect = 1.1e-215, P = 1.1e-215
Identities = 405/573 (70%), Positives = 466/573 (81%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L G LP S +GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG
Sbjct: 198 LEGELPMSLAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSG 253
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+K+LESLSLRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+F
Sbjct: 254 LKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSF 313
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
CL SPG CDPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM
Sbjct: 314 CLSSPGECDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKME 373
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA 243
LTGTISPEF + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN
Sbjct: 374 LTGTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNV 433
Query: 244 IVNTDGNPDIGKEKXXXXXXXXXXXXXXXXXXXXXXXXXXVKNSSALITVILFCVIGGAF 303
+VNT+GNPDIGK+K SS I +I+ V+GG
Sbjct: 434 VVNTNGNPDIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMKSSTFIGIIVGSVLGGLL 493
Query: 304 VISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISE 363
I L G+LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS+
Sbjct: 494 SIFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGISD 552
Query: 364 THTVP-SSEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 421
T+T+P +SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGTK
Sbjct: 553 TYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTK 612
Query: 422 IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 481
IAVKRME GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTLS
Sbjct: 613 IAVKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLS 672
Query: 482 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541
RH+F W+EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK
Sbjct: 673 RHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 732
Query: 542 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA
Sbjct: 733 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 765
|
|
| TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1715 (608.8 bits), Expect = 1.4e-176, P = 1.4e-176
Identities = 344/574 (59%), Positives = 422/574 (73%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
L G LP SF+G+ IQSL++NGQ KL G I V+ NMTSL E+ L N FSGP+PD SG
Sbjct: 199 LEGELPMSFAGTSIQSLFLNGQ----KLNGSISVLGNMTSLVEVSLQGNQFSGPIPDLSG 254
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+ L ++R+N TG VP SLV L SL VN+TNN LQGP P F +SV +D+ N+F
Sbjct: 255 LVSLRVFNVRENQLTGVVPQSLVSLSSLTTVNLTNNYLQGPTPLFGKSVGVDIVNNMNSF 314
Query: 124 CLPSPG-ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM 182
C G ACDPR++ L+SV + GYP + AE+WKGN+PC +W+G+TC+ GNITV+N +K
Sbjct: 315 CTNVAGEACDPRVDTLVSVAESFGYPVKLAESWKGNNPCVNWVGITCSGGNITVVNMRKQ 374
Query: 183 NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 242
+L+GTISP A SL+ + LADN LSG IP+ L+ L L+ LDVSNN YG P F+
Sbjct: 375 DLSGTISPSLAKLTSLETINLADNKLSGHIPDELTTLSKLRLLDVSNNDFYGIPPKFRDT 434
Query: 243 AIVNTDGNPDIGKEKXXXXXXXXXXXXXXXXXXXXXXXXXXVKNSSALITVILFCVIGGA 302
+ T+GN ++GK K+S+ I V V+GG
Sbjct: 435 VTLVTEGNANMGKNGPNKTSDAPGASPGSKPSGGSDGSETSKKSSNVKIIVP---VVGGV 491
Query: 303 F-VISLTGVLVFCLCKKKQKRFSRVQSPNA-MVIHPRHSGSENSESVKITVAGSNVSVGA 360
+ L G+ V CL KK+KR +RVQSP++ MVIHP HSG +++ +K+TVA S+++ G
Sbjct: 492 VGALCLVGLGV-CLYAKKRKRPARVQSPSSNMVIHPHHSG--DNDDIKLTVAASSLNSGG 548
Query: 361 ISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT 420
S++++ S DI ++EAGN+VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT
Sbjct: 549 GSDSYSHSGSAASDIHVVEAGNLVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT 608
Query: 421 KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480
KIAVKRME+ V+S KGLTEFKSEI VLTK+RHRHLVALLG+CLDGNE+LLV+EYMPQGTL
Sbjct: 609 KIAVKRMESSVVSDKGLTEFKSEITVLTKMRHRHLVALLGYCLDGNERLLVYEYMPQGTL 668
Query: 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540
S+H+F+W EEG KPL+W RRL IALDVARGVEYLH LAHQSFIHRDLKPSNILLGDDMRA
Sbjct: 669 SQHLFHWKEEGRKPLDWTRRLAIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMRA 728
Query: 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
KV+DFGLVRLAP+GK SIETR+AGTFGYLAPEYA
Sbjct: 729 KVSDFGLVRLAPDGKYSIETRVAGTFGYLAPEYA 762
|
|
| TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 4.2e-158, Sum P(2) = 4.2e-158
Identities = 184/274 (67%), Positives = 212/274 (77%)
Query: 301 GAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGA 360
G V S+ G+L+ L F + +HP+ S+ ++ KIT+ N+ G
Sbjct: 459 GKIVGSVIGILLALLLIGVAIFFLVKKKMQYHKMHPQQQSSDQ-DAFKITI--ENLCTG- 514
Query: 361 ISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT 420
+SE+ D + EAGN+VISIQVLR+ T NF E+NILGRGGFG VYKGELHDGT
Sbjct: 515 VSES----GFSGNDAHLGEAGNIVISIQVLRDATYNFDEKNILGRGGFGIVYKGELHDGT 570
Query: 421 KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480
KIAVKRME+ +ISGKGL EFKSEIAVLT+VRHR+LV L G+CL+GNE+LLV++YMPQGTL
Sbjct: 571 KIAVKRMESSIISGKGLDEFKSEIAVLTRVRHRNLVVLHGYCLEGNERLLVYQYMPQGTL 630
Query: 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540
SRHIF W EEGL+PLEW RRL IALDVARGVEYLH LAHQSFIHRDLKPSNILLGDDM A
Sbjct: 631 SRHIFYWKEEGLRPLEWTRRLIIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMHA 690
Query: 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
KVADFGLVRLAPEG SIET+IAGTFGYLAPEYA
Sbjct: 691 KVADFGLVRLAPEGTQSIETKIAGTFGYLAPEYA 724
|
|
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
Identities = 275/578 (47%), Positives = 363/578 (62%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
+ G LP S S IQ+LW+N Q+ + G I+V+ +MTSL + WLH N F GP+PD S
Sbjct: 194 ITGVLPPSLGKSSIQNLWINNQD--LGMSGTIEVLSSMTSLSQAWLHKNHFFGPIPDLSK 251
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 123
+ L L LRDN TG VP +L+ L SLK +++ NN QGP+P F V + + N F
Sbjct: 252 SENLFDLQLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPEVKVTI--DHNVF 309
Query: 124 CLPSPG-ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG--NITVINFQ 180
C G +C P++ LL+V +GYP AE+W+G+D CS W V+C N+ +N
Sbjct: 310 CTTKAGQSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCDSAGKNVVTLNLG 369
Query: 181 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK 240
K TG ISP A+ SL+ L L N+L+G+IP+ L+ + +L+ +DVSNN L G+IP F
Sbjct: 370 KHGFTGFISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVSNNNLRGEIPKFP 429
Query: 241 SNAIVN-TDGNPDIGKEKXXXXXXXXXXXXXXXXXXXXXXXXXXVKNSSALITVILFCVI 299
+ + GN +G ++ V++F I
Sbjct: 430 ATVKFSYKPGNALLGTNGGDGSSPGTGGASGGPGGSSGGGGSKVGVIVGVIVAVLVFLAI 489
Query: 300 GGAFVISLTGVLVFCLCKKKQKRFSRV--QSPNAMVIHPRHSGSENSESVKITVAGSNVS 357
G FV V F + K+K RF+R + +++ S + G+N +
Sbjct: 490 LG-FV-----VYKFVM-KRKYGRFNRTDPEKVGKILVSDAVSNGGSGNGGYANGHGAN-N 541
Query: 358 VGAISETHTVPSS-EPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGEL 416
A++ PSS + D +LE G++ I ++VLR VTNNFSE+NILGRGGFG VY GEL
Sbjct: 542 FNALNS----PSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGEL 597
Query: 417 HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476
HDGTK AVKRME + KG++EF++EIAVLTKVRHRHLVALLG+C++GNE+LLV+EYMP
Sbjct: 598 HDGTKTAVKRMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMP 657
Query: 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 536
QG L +H+F W+E G PL W +R++IALDVARGVEYLH LA QSFIHRDLKPSNILLGD
Sbjct: 658 QGNLGQHLFEWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGD 717
Query: 537 DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
DMRAKVADFGLV+ AP+GK S+ETR+AGTFGYLAPEYA
Sbjct: 718 DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 755
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 439 (159.6 bits), Expect = 3.1e-60, Sum P(2) = 3.1e-60
Identities = 93/195 (47%), Positives = 128/195 (65%)
Query: 381 GNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEF 440
G + + L TNNFS+ N +G GG+G VYKG L +G IA+KR + G S +G EF
Sbjct: 618 GTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQG--SMQGAFEF 675
Query: 441 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 500
K+EI +L++V H+++V LLG C D E++LV+EY+P G+L + + G+K L+W RR
Sbjct: 676 KTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSG--KNGVK-LDWTRR 732
Query: 501 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA--PEGKGSI 558
L IAL +G+ YLH LA IHRD+K +NILL + + AKVADFGL +L PE K +
Sbjct: 733 LKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPE-KAHV 791
Query: 559 ETRIAGTFGYLAPEY 573
T++ GT GYL PEY
Sbjct: 792 TTQVKGTMGYLDPEY 806
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 2.1e-57, Sum P(2) = 2.1e-57
Identities = 83/191 (43%), Positives = 121/191 (63%)
Query: 390 LRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
LR+ TN+F+ +NILGRGG+G VYKG L+DGT +AVKR++ I+G G +F++E+ ++
Sbjct: 294 LRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAG-GEVQFQTEVETISL 352
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
HR+L+ L G C E++LV+ YMP G+++ + + G L+W+RR IA+ AR
Sbjct: 353 ALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIR-GEPALDWSRRKKIAVGTAR 411
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
G+ YLH IHRD+K +NILL +D A V DFGL +L + T + GT G++
Sbjct: 412 GLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 471
Query: 570 APEYAGNFGSS 580
APEY SS
Sbjct: 472 APEYLSTGQSS 482
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 2.9e-56, Sum P(2) = 2.9e-56
Identities = 94/207 (45%), Positives = 132/207 (63%)
Query: 368 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM 427
P ++ +I ++ + L+N T +F N LG GGFG VYKG L+DG ++AVK++
Sbjct: 681 PYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQL 740
Query: 428 EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW 487
G GKG +F +EI ++ V HR+LV L G C +G+ +LLV+EY+P G+L + +F
Sbjct: 741 SIGSRQGKG--QFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFG- 797
Query: 488 AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
++ L L+W+ R I L VARG+ YLH A IHRD+K SNILL ++ KV+DFGL
Sbjct: 798 -DKSLH-LDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGL 855
Query: 548 VRLAPEGKGSIETRIAGTFGYLAPEYA 574
+L + K I TR+AGT GYLAPEYA
Sbjct: 856 AKLYDDKKTHISTRVAGTIGYLAPEYA 882
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 428 (155.7 bits), Expect = 9.1e-56, Sum P(3) = 9.1e-56
Identities = 87/191 (45%), Positives = 122/191 (63%)
Query: 384 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE 443
+ + L++ T +F N LG GGFG VYKG L+DG +AVK + G GKG +F +E
Sbjct: 681 IFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKG--QFVAE 738
Query: 444 IAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 503
I ++ V HR+LV L G C +G ++LV+EY+P G+L + +F ++ L L+W+ R I
Sbjct: 739 IVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFG--DKTLH-LDWSTRYEI 795
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 563
L VARG+ YLH A +HRD+K SNILL + +++DFGL +L + K I TR+A
Sbjct: 796 CLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVA 855
Query: 564 GTFGYLAPEYA 574
GT GYLAPEYA
Sbjct: 856 GTIGYLAPEYA 866
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 7.8e-55, Sum P(2) = 7.8e-55
Identities = 89/201 (44%), Positives = 128/201 (63%)
Query: 374 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS 433
D + LE S++ ++ TNNF N +G GGFG VYKG+L DGT IAVK++ G S
Sbjct: 601 DFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTG--S 658
Query: 434 GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLK 493
+G EF +EI +++ + H +LV L G C++G + LLV+E++ +L+R +F E L+
Sbjct: 659 KQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLR 718
Query: 494 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553
L+W R I + VARG+ YLH + +HRD+K +N+LL + K++DFGL +L E
Sbjct: 719 -LDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEE 777
Query: 554 GKGSIETRIAGTFGYLAPEYA 574
I TRIAGTFGY+APEYA
Sbjct: 778 DSTHISTRIAGTFGYMAPEYA 798
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 2.4e-54, Sum P(2) = 2.4e-54
Identities = 90/201 (44%), Positives = 124/201 (61%)
Query: 374 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS 433
+I M E + + + + T++FS++NI+G GGFGTVYK L +AVK++
Sbjct: 894 NIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQ 953
Query: 434 GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-L 492
G EF +E+ L KV+H +LV+LLG+C EKLLV+EYM G+L + N + G L
Sbjct: 954 GN--REFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRN--QTGML 1009
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552
+ L+W++RL IA+ ARG+ +LH IHRD+K SNILL D KVADFGL RL
Sbjct: 1010 EVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLIS 1069
Query: 553 EGKGSIETRIAGTFGYLAPEY 573
+ + T IAGTFGY+ PEY
Sbjct: 1070 ACESHVSTVIAGTFGYIPPEY 1090
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43298 | TMK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7229 | 0.9741 | 0.5997 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 580 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 5e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.003 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.003 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 4e-44
Identities = 69/172 (40%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
LG GGFGTVY G K+A+K ++ S L E EI +L K+ H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED-SSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
D N LV EY G+L + L + L I L + G+EYLH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 522 FIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
IHRDLKP NILL D+ + K+ADFGL +L K S+ I GT Y+APE
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-42
Identities = 63/172 (36%), Positives = 87/172 (50%), Gaps = 10/172 (5%)
Query: 402 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
LG G FGTVYK + G +AVK ++ K + EI +L ++ H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
D + LV EY G L ++ PL + IAL + RG+EYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
IHRDLKP NILL ++ K+ADFGL + + S+ T GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 1e-39
Identities = 56/177 (31%), Positives = 79/177 (44%), Gaps = 12/177 (6%)
Query: 397 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
+ LG G FG VY + G +A+K ++ I EI +L K++H ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNI 59
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
V L D ++ LV EY G L + L + + +EYLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-----GRLSEDEARFYLRQILSALEYLH 114
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ +HRDLKP NILL +D K+ADFGL R G+ T GT Y+APE
Sbjct: 115 S---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 62/192 (32%), Positives = 90/192 (46%), Gaps = 39/192 (20%)
Query: 401 NILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG G FG VYKG+L T++AVK ++ + +F E V+ K+ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVV 59
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTL------SRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
LLG C + LV EYM G L SR +F L L+ A+ +A+G
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFP--SPEKSTLSLKDLLSFAIQIAKG 117
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--------------------L 550
+EYL + F+HRDL N L+G+D+ K++DFGL R +
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 551 APEGKGSIETRI 562
APE S++ I
Sbjct: 175 APE---SLKDGI 183
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 400 ENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
LG G FG VYKG+L ++AVK ++ S + + EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V LLG C + +V EYM G L ++ + L + L+ AL +ARG+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
++FIHRDL N L+G+++ K++DFGL R +
Sbjct: 119 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 57/161 (35%), Positives = 87/161 (54%), Gaps = 12/161 (7%)
Query: 400 ENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
LG G FG VYKG L ++AVK ++ S + + EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V LLG C + ++V EYMP G L ++ + K L + L+ AL +ARG+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
++FIHRDL N L+G+++ K++DFGL R +
Sbjct: 120 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 58/178 (32%), Positives = 87/178 (48%), Gaps = 16/178 (8%)
Query: 401 NILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+LGRG FG+VY D G +AVK +E S + L + EI +L+ ++H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 460 GHCLDGNEK-LLVF-EYMPQGTLSRHIFNWAEEGLKPLEWN--RRLTIALDVARGVEYLH 515
G D + L +F EY+ G+LS + + L R+ T + G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTR--QILEGLAYLH 118
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPE 572
+HRD+K +NIL+ D K+ADFG RL G + GT ++APE
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 57/153 (37%), Positives = 84/153 (54%), Gaps = 13/153 (8%)
Query: 403 LGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457
LG G FG VYKG L TK+AVK ++ G S + EF E +++ K+ H ++V
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-SEEEREEFLEEASIMKKLSHPNIVR 65
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
LLG C G +V EYMP G L + + + L L +AL +A+G+EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLES- 120
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
++F+HRDL N L+ +++ K++DFGL R
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRD 151
|
Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 57/154 (37%), Positives = 84/154 (54%), Gaps = 24/154 (15%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
+G+G FG V G+ G K+AVK ++ F +E +V+T +RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 463 LDGNEKLLVFEYMPQGTL-------SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
L GN +V EYM +G+L R + A+ +L ALDV G+EYL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ----------QLGFALDVCEGMEYLE 119
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
++F+HRDL N+L+ +D+ AKV+DFGL +
Sbjct: 120 E---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 26/178 (14%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
+G+GGFG VYK G ++A+K ++ + S + + +EI +L K +H ++V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYLH 515
L +E +V E+ G+L + + N+ LT + ++ +G+EYLH
Sbjct: 66 YLKKDELWIVMEFCSGGSL-KDLLK---------STNQTLTESQIAYVCKELLKGLEYLH 115
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPE 572
IHRD+K +NILL D K+ DFGL +L+ + GT ++APE
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 61/175 (34%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 403 LGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEF-KSEIAVLTKVRHRHLVALLG 460
LG+G FG V + G A+K ++ I + E +E +L+++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 461 HC-LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
H EKL LV EY P G L H+ ++EG E R A ++ +EYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF--YAAEIVLALEYLHS-- 111
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
I+RDLKP NILL D K+ DFGL + T GT YLAPE
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEV 164
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 58/184 (31%), Positives = 91/184 (49%), Gaps = 22/184 (11%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
N+ +++GRG FG VYKG L G +A+K++ I + L EI +L ++H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGLKPLEWNRRLTIALDVA---R 509
+V +G + ++ EY G+L + I F E L +A+ V +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL----------VAVYVYQVLQ 110
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGY 568
G+ YLH Q IHRD+K +NIL D K+ADFG+ +L K + + GT +
Sbjct: 111 GLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYW 165
Query: 569 LAPE 572
+APE
Sbjct: 166 MAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 403 LGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG G FG V+ GE +D +AVK ++ S +F+ E +LT +H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSR-------HIFNWAEEGLKPLEWNRR--LTIALDV 507
G C +G+ ++VFEYM G L++ E L IA+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
A G+ Y LA Q F+HRDL N L+G D+ K+ DFG+ R
Sbjct: 132 ASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 56/173 (32%), Positives = 90/173 (52%), Gaps = 14/173 (8%)
Query: 402 ILGRGGFGTVYKGELH--DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457
ILG G FG+V +G+L DG+ K+AVK M+ + + + EF SE A + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 458 LLGHCLDGNEK------LLVFEYMPQGTLSRHIF-NWAEEGLKPLEWNRRLTIALDVARG 510
L+G C + + +++ +M G L + + + L L +D+A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 563
+EYL ++++FIHRDL N +L +DM VADFGL + G + RIA
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 56/157 (35%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 397 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
F+ E LG G FG V++G + ++A+K +++ +F+ E+ L ++RH+HL+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLI 65
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
+L C G ++ E M +G+L F + EG + L + +A VA G+ YL
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEG-QVLPVASLIDMACQVAEGMAYLE- 121
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553
Q+ IHRDL NIL+G+D+ KVADFGL RL E
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 9/148 (6%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG G FG V+ G + TK+AVK ++ G +S F E ++ K+RH LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 522
+ +V EYM +G+L + + EG K L + + +A +A G+ YL +++
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKS--GEG-KKLRLPQLVDMAAQIAEGMAYLE---SRNY 124
Query: 523 IHRDLKPSNILLGDDMRAKVADFGLVRL 550
IHRDL NIL+G+++ K+ADFGL RL
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARL 152
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (258), Expect = 5e-24
Identities = 59/178 (33%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRH-RHLVALLG 460
LG G FG VY D +A+K + + S E F EI +L + H ++V L
Sbjct: 8 LGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
D LV EY+ G+L + PL + L I + +EYLH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKK--IGRKGPLSESEALFILAQILSALEYLH---SK 120
Query: 521 SFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETR-----IAGTFGYLAPE 572
IHRD+KP NILL D K+ DFGL +L P+ + GT GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/173 (33%), Positives = 86/173 (49%), Gaps = 27/173 (15%)
Query: 397 FSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
F EE LG G FG VYKGEL T +A+K ++ K EF+ E +++ +
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDL 65
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF-------------NWAEEGLKPLEW 497
+H ++V LLG C ++FEY+ G L H F + E L+
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDL--HEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 498 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
+ L IA+ +A G+EY L+ F+HRDL N L+G+ + K++DFGL R
Sbjct: 124 SDFLHIAIQIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 401 NILGRGGFGTVYKGE---LHDGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
LG G FG V L D T ++AVK + + ++F+ EI +L + H ++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHENI 68
Query: 456 VALLGHCLD--GNEKLLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVARGVE 512
V G C G L+ EY+P G+L ++ + + LK L L + + +G++
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMD 123
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556
YL Q +IHRDL NIL+ + K++DFGL ++ PE K
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 56/163 (34%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 403 LGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG G FG V+ E H D +AVK ++ S + +F+ E +LT ++H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR--QDFQREAELLTVLQHQHIV 70
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSR---------HIFNWAE-EGLKPLEWNRRLTIALD 506
G C +G L+VFEYM G L+R I E L + L IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 507 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+A G+ YL L F+HRDL N L+G + K+ DFG+ R
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 403 LGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
+G G G V+K + G +A+K++ + G + EI L +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
G+ +LV EYMP LS + + E L + + L +GV Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD-EERPLPEAQ-VKSYMRML--LKGVAYMHAN---G 119
Query: 522 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+HRDLKP+N+L+ D K+ADFGL RL E + + + T Y APE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 52/148 (35%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
+G G FG V+ G + K+A+K + G +S + +F E V+ K+ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 522
+ + LVFE+M G LS ++ A+ G L + LDV G+ YL +
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL--RAQRGK--FSQETLLGMCLDVCEGMAYLE---SSNV 121
Query: 523 IHRDLKPSNILLGDDMRAKVADFGLVRL 550
IHRDL N L+G++ KV+DFG+ R
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRF 149
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 63/191 (32%), Positives = 96/191 (50%), Gaps = 23/191 (12%)
Query: 386 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIA 445
SIQ+LR LG G FG V++G ++ T +AVK ++ G + K +F +E
Sbjct: 7 SIQLLRK----------LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQ 53
Query: 446 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
++ K+RH L+ L C +V E M G+L ++ + L+ + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAA 110
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 565
VA G+ YL Q++IHRDL N+L+G++ KVADFGL R+ E E R
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI--YEAREGAK 165
Query: 566 F--GYLAPEYA 574
F + APE A
Sbjct: 166 FPIKWTAPEAA 176
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 4e-22
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 16/183 (8%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ +G+G FG VY DG +K ++ +S K + +E+ +L K+ H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP-----LEWNRRLTIALDVAR 509
++ + + +V EY G LS+ I +EG L+W +L +AL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK--- 117
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
YLH + +HRD+KP NI L + K+ DFG+ ++ +T + GT YL
Sbjct: 118 ---YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYL 170
Query: 570 APE 572
+PE
Sbjct: 171 SPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 53/147 (36%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG G FG V+ G+ +A+K + G +S +F E V+ K+ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 522
+V EYM G L + +G EW L + DV +EYL F
Sbjct: 69 TKQRPIFIVTEYMANGCLLN--YLRERKGKLGTEW--LLDMCSDVCEAMEYLE---SNGF 121
Query: 523 IHRDLKPSNILLGDDMRAKVADFGLVR 549
IHRDL N L+G+D KV+DFGL R
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 54/185 (29%), Positives = 79/185 (42%), Gaps = 38/185 (20%)
Query: 403 LGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAV----LTKVRHRHLV 456
LG+G G VYK H T A+K I G EF+ ++ L ++V
Sbjct: 9 LGQGSSGVVYKV-RHKPTGKIYALK-----KIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
G E +V EYM G+L+ + + E L IA + +G++Y
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA--------YIARQILKGLDY 114
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA------GTFG 567
LH H IHRD+KPSN+L+ K+ADFG+ +E + GT
Sbjct: 115 LHTKRHI--IHRDIKPSNLLINSKGEVKIADFGI-------SKVLENTLDQCNTFVGTVT 165
Query: 568 YLAPE 572
Y++PE
Sbjct: 166 YMSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 3e-21
Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 397 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS----EIAVLTKVR 451
+ + LG G +G VYK + G +A+K++ S EI++L +++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR----LDNEEEGIPSTALREISLLKELK 56
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
H ++V LL + LVFEY L +++ ++ PL N +I + RG+
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRGL 111
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
Y H +HRDLKP NIL+ D K+ADFGL R
Sbjct: 112 AYCH---SHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+G+G FG V G+ + G K+AVK ++ + F +E +V+T++RH +LV LL
Sbjct: 11 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 65
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
G ++ L +V EYM +G+L ++ G L + L +LDV +EYL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEA-- 120
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551
+F+HRDL N+L+ +D AKV+DFGL + A
Sbjct: 121 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 60/178 (33%), Positives = 96/178 (53%), Gaps = 8/178 (4%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+F LG+G +G+VYK + L D A+K ++ G +S K + +EI +L V H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+++ LDGN+ +V EY P G LS+ I ++ K + I + + RG++ L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQAL 119
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
H Q +HRDLK +NILL + K+ D G+ ++ K +T+I GT Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 5e-21
Identities = 60/153 (39%), Positives = 84/153 (54%), Gaps = 12/153 (7%)
Query: 402 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
I+G G FG V +GE + G K+AVK ++ V + F E AV+TK+ H++LV LLG
Sbjct: 13 IIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
L N +V E M +G L + G + + L +LDVA G+EYL +
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 522 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554
+HRDL NIL+ +D AKV+DFGL R+ G
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 62/169 (36%), Positives = 93/169 (55%), Gaps = 28/169 (16%)
Query: 397 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRM-----EAGV-ISGKGLTEFKSEIAVLTK 449
+ E +G G +GTVYK +L+ G +A+K++ E G+ +S EIA+L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS------TLREIALLKQ 54
Query: 450 VR---HRHLVALL----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 501
+ H ++V LL G D KL LVFE++ Q L+ ++ + GL P E + L
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP-ETIKDL 112
Query: 502 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
L RGV++LH +H +HRDLKP NIL+ D + K+ADFGL R+
Sbjct: 113 MRQL--LRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 67/183 (36%), Positives = 95/183 (51%), Gaps = 12/183 (6%)
Query: 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 454
F + +LG+GGFG V ++ G A KR+E I KG + +E +L KV +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 455 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
+V L + + + L LV M G L HI+N G E R L A ++ G+E
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---EEERALFYAAEILCGLED 117
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
LH ++ ++RDLKP NILL D +++D GL PEG+ SI R+ GT GY+APE
Sbjct: 118 LH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRV-GTVGYMAPEV 172
Query: 574 AGN 576
N
Sbjct: 173 LNN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 18/178 (10%)
Query: 400 ENILGRGGFGTVYKG--ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457
++ LG G +G VY+G + + T +AVK ++ + + EF E AV+ +++H +LV
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQ 66
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
LLG C ++ E+M G L ++ + + + L +A ++ +EYL
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE-- 121
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPE 572
++FIHRDL N L+G++ KVADFGL RL G T AG + APE
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE 175
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 65/183 (35%), Positives = 97/183 (53%), Gaps = 12/183 (6%)
Query: 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 454
F + +LG+GGFG V ++ G A K++E I KG + +E +L KV R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 455 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
+V+L + + + L LV M G L HI++ E G E R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF---EEGRAVFYAAEICCGLED 117
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
LH + ++RDLKP NILL D +++D GL PEG+ +I+ R+ GT GY+APE
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRV-GTVGYMAPEV 172
Query: 574 AGN 576
N
Sbjct: 173 VKN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 22/164 (13%)
Query: 403 LGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG G FG V+ E + D +AVK ++ ++ + +F+ E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL-----KPLEWN------RRLTIAL 505
G C DG+ ++VFEYM G L++ + + + +P + + L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+A G+ Y LA Q F+HRDL N L+G ++ K+ DFG+ R
Sbjct: 131 QIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 59/178 (33%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 395 NNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
NN +G+G FG V++ T +AVK ++ S +F+ E A++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 63
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLK------------ 493
+ H ++V LLG C G L+FEYM G L+ RH A+ L
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 494 --PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
PL +L IA VA G+ YL + + F+HRDL N L+G++M K+ADFGL R
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 19/161 (11%)
Query: 403 LGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG G FG V+ E + D +AVK ++ S +F E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIV 70
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA------EEGLKPLEW--NRRLTIALDVA 508
G C++G+ ++VFEYM G L++ + EG +P E ++ L IA +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
G+ Y LA Q F+HRDL N L+G+++ K+ DFG+ R
Sbjct: 131 AGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 57/164 (34%), Positives = 81/164 (49%), Gaps = 27/164 (16%)
Query: 403 LGRGGFGTV--YKGE-LHDGTK--IAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLV 456
LG G FG V Y + +DGT +AVK ++ G+ T +K EI +L + H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIV 69
Query: 457 ALLGHCLDGNEK--LLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
G C + K L+ EY+P G+L +H N A+ L A + G
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ----------LLLFAQQICEG 119
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554
+ YLH Q +IHRDL N+LL +D K+ DFGL + PEG
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 22/185 (11%)
Query: 394 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
+ +G G G VYK + G ++A+K+M + + +EI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVA 508
++V L G+E +V EYM G+L +++ E + + +V
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA--------YVCREVL 126
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFG 567
+G+EYLH Q+ IHRD+K NILL D K+ADFG +L E S + GT
Sbjct: 127 QGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--KSKRNSVVGTPY 181
Query: 568 YLAPE 572
++APE
Sbjct: 182 WMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 62/170 (36%), Positives = 88/170 (51%), Gaps = 19/170 (11%)
Query: 395 NNFSEENILGRGGFGTVYKGELH-DGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKV- 450
N+ ++++G G FG V K + DG ++ A+KRM+ S +F E+ VL K+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 65
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL------SRHI-----FNWAEEGLKPLEWNR 499
H +++ LLG C L EY P G L SR + F A L +
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L A DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 126 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 53/185 (28%), Positives = 76/185 (41%), Gaps = 31/185 (16%)
Query: 401 NILGRGGFGTVYKGE-LHDGTKIAVKRM------EAGVISGKGLTEFKSEIAVLTKVRHR 453
+G G +G VYK G +A+K++ E I+ EI +L K+RH
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT------AIREIKLLQKLRHP 58
Query: 454 HLVALLGHCLD--GNEKLLVFEYMP---QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
++V L +VFEYM G L + E +K +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK--------CYMKQLL 110
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFG 567
G++YLH +HRD+K SNIL+ +D K+ADFGL R R+ T
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLW 166
Query: 568 YLAPE 572
Y PE
Sbjct: 167 YRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 403 LGRGGFGTVYKGELHDGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
LG G FG V +GE +AVK +++ +S + +F E A++ + H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRL 61
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
G L + V E P G+L ++ L + A+ +A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLD---RLRKDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+ FIHRDL NILL D + K+ DFGL+R P+ +
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 28/188 (14%)
Query: 403 LGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG+G FG VY+G T++A+K + + + EF +E +V+ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
LLG G L+V E M +G L SR GL P + + +A ++A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-------PEGKGSIETRIAG 564
YL F+HRDL N ++ +D+ K+ DFG+ R GKG + R
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 565 TFGYLAPE 572
++APE
Sbjct: 187 ---WMAPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 61/181 (33%), Positives = 82/181 (45%), Gaps = 22/181 (12%)
Query: 401 NILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
N +G G FG VY L G +AVK + K + E E+ VL ++H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 460 G---HCLDGNEKLLVF-EYMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVEYL 514
G H EK+ +F EY GTL E G + R T+ L G+ YL
Sbjct: 66 GVEVH----REKVYIFMEYCSGGTLEE----LLEHGRILDEHVIRVYTLQL--LEGLAYL 115
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGK--GSIETRIAGTFGYLAP 571
H +HRD+KP+NI L + K+ DFG V+L G +AGT Y+AP
Sbjct: 116 H---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 572 E 572
E
Sbjct: 173 E 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 64/193 (33%), Positives = 89/193 (46%), Gaps = 31/193 (16%)
Query: 401 NILGRGGFGTVYKG----ELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
N LG G FG VY+G L G+ ++AVK + G + EF E +++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHP 59
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP--LEWNRRLTIALDVARGV 511
++V LLG CL + ++ E M G L ++ + E P L L I LDVA+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 512 EYLHGLAHQSFIHRDLKPSNILL----GDDMR-AKVADFGLVR-------LAPEGKGSIE 559
YL + FIHRDL N L+ D R K+ DFGL R EG+G +
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 560 TRIAGTFGYLAPE 572
R ++APE
Sbjct: 177 VR------WMAPE 183
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 7e-19
Identities = 58/173 (33%), Positives = 96/173 (55%), Gaps = 12/173 (6%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG+G FG V+ G + T++A+K ++ G +S + F E V+ K+RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 68
Query: 463 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
+ E + +V EYM +G+L F E G K L + + +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLD--FLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 522 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 60/182 (32%), Positives = 91/182 (50%), Gaps = 20/182 (10%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVK--RMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
+G+G FG VYKG L T++AVK R + +F E +L + H ++V L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRST---LPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
C+ +V E +P G+L + L + L ++LD A G+EYL +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLES---K 112
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT----FGYLAPEYAGN 576
+ IHRDL N L+G++ K++DFG+ R E +G I T G + APE A N
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPE-ALN 168
Query: 577 FG 578
+G
Sbjct: 169 YG 170
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 54/147 (36%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG G FG V G+ +A+K ++ G +S EF E V+ K+ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 522
+V EYM G L N+ E K + ++ L + DV G+ YL + Q F
Sbjct: 69 TKQRPIYIVTEYMSNGCL----LNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--SKQ-F 121
Query: 523 IHRDLKPSNILLGDDMRAKVADFGLVR 549
IHRDL N L+ D KV+DFGL R
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 26/157 (16%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS--------EIAVLTKV-RH 452
LG G FG+VY G +A+K+M+ +F S E+ L K+ H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLRKLNEH 57
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
++V L + +E VFEYM +G L + + + KP + +I + +G+
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYM-EGNLYQLM---KDRKGKPFSESVIRSIIYQILQGLA 113
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
++H F HRDLKP N+L+ K+ADFGL R
Sbjct: 114 HIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 60/180 (33%), Positives = 94/180 (52%), Gaps = 20/180 (11%)
Query: 403 LGRGGFGTVYK---GELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457
LG+G FG+V L D T +AVK+++ + + L +F+ EI +L ++H ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVK 69
Query: 458 LLGHCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
G C G L LV EY+P G+L ++ E L+ + L A + +G+EYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYL- 124
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG---TFGYLAPE 572
+ ++HRDL NIL+ + R K+ DFGL ++ P+ K + R G F Y APE
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APE 181
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 19/183 (10%)
Query: 401 NILGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+G+G FGTV K DG + K ++ G ++ K + SE+ +L +++H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 460 GHCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLE----WN--RRLTIALDVARGV 511
+D N+ L +V EY G L++ I +E K +E W +L +AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALY----- 119
Query: 512 EYLHGLAH--QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
H + + +HRDLKP+NI L + K+ DFGL ++ S GT Y+
Sbjct: 120 -ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYM 177
Query: 570 APE 572
+PE
Sbjct: 178 SPE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 60/173 (34%), Positives = 94/173 (54%), Gaps = 12/173 (6%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG G FG V+ G + TK+AVK ++ G +S + E E ++ K+RH LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQL--YA 68
Query: 463 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
+ E + +V EYM +G+L F EG + L+ + +A VA G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLL--DFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 522 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
+IHRDL+ +NIL+GD + K+ADFGL RL + + + + APE A
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 403 LGRGGFGTVYKGELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
LG G FG+V +G+L+ K+AVK M+ + + + +F SE + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 460 GHCLDGNEK------LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL--DVARGV 511
G CL E +++ +M G L + ++ G P ++ + D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 563
EYL + +SFIHRDL N +L ++M VADFGL + G + RIA
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 12/179 (6%)
Query: 396 NFSEENILGRGGFGTVYKGELHDGTKI-AVKRM-EAGVISGKGLTEFKSEIAVLTKVRHR 453
+F ++G+G FG V + D K+ A+K M + + + +E +L ++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
LV L D LV + + G L H+ + +K E + I ++ +EY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWIC-EIVLALEY 115
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
LH + IHRD+KP NILL + + DF + + T +GT GY+APE
Sbjct: 116 LH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 15/185 (8%)
Query: 394 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVR 451
NF E +G+G F VYK L DG +A+K+++ ++ K + EI +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
H +++ L ++ NE +V E G LSR I ++ ++ + + + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLCSAL 119
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA----GTFG 567
E++H + +HRD+KP+N+ + K+ D GL R S +T A GT
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPY 171
Query: 568 YLAPE 572
Y++PE
Sbjct: 172 YMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 62/183 (33%), Positives = 92/183 (50%), Gaps = 12/183 (6%)
Query: 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 454
F +LG+GGFG V ++ G A K++E I KG +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 455 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
+V+L + + + L LV M G L HI+N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---DEQRAIFYAAELCCGLED 117
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
L + ++RDLKP NILL D +++D GL PEG+ ++ R+ GT GY+APE
Sbjct: 118 LQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRV-GTVGYMAPEV 172
Query: 574 AGN 576
N
Sbjct: 173 INN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 4e-18
Identities = 56/174 (32%), Positives = 98/174 (56%), Gaps = 14/174 (8%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG+G FG V+ G + TK+A+K ++ G + + F E ++ K+RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPL--YA 68
Query: 463 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGL-KPLEWNRRLTIALDVARGVEYLHGLAHQ 520
+ E + +V E+M +G+L ++ +EG K L+ + + +A +A G+ Y+ +
Sbjct: 69 VVSEEPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM--- 121
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
++IHRDL+ +NIL+GD++ K+ADFGL RL + + + + APE A
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 56/178 (31%), Positives = 99/178 (55%), Gaps = 13/178 (7%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG G FG V+ G + TK+A+K ++ G +S + F +E ++ +++H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLVRL--YA 68
Query: 463 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
+ E + ++ EYM G+L F EG+K L N+ + +A +A G+ ++ ++
Sbjct: 69 VVTQEPIYIITEYMENGSLVD--FLKTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 522 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579
+IHRDL+ +NIL+ + + K+ADFGL RL + + + + APE A N+G+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE-AINYGT 179
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 32/161 (19%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISG--KGL--TEFKSEIAVLTKVRHRHLVA 457
LG G + VYK G +A+K+++ G G+ T + EI +L +++H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 458 LL---GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVA 508
LL GH N LVFE+M L + I + + LT L
Sbjct: 67 LLDVFGH--KSNIN-LVFEFME-TDLEKVIKD----------KSIVLTPADIKSYMLMTL 112
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
RG+EYLH +HRDLKP+N+L+ D K+ADFGL R
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 51/147 (34%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG G FG V+ G+ K+A+K + G +S + +F E V+ K+ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 522
+V E+M G L N+ + L + L++ DV G+EYL SF
Sbjct: 69 TQQKPLYIVTEFMENGCL----LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSF 121
Query: 523 IHRDLKPSNILLGDDMRAKVADFGLVR 549
IHRDL N L+ KV+DFG+ R
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 64/183 (34%), Positives = 94/183 (51%), Gaps = 12/183 (6%)
Query: 397 FSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 454
F +LG+GGFG V ++ K+ A K++E I KG +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 455 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
+V+L + + + L LV M G L HI+N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF---DEERAVFYAAEITCGLED 117
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
LH + ++RDLKP NILL D +++D GL PEG+ +I R+ GT GY+APE
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRV-GTVGYMAPEV 172
Query: 574 AGN 576
N
Sbjct: 173 VKN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 397 FSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
F LG G +G+VYK +H G +A+K + + L E EI++L + +
Sbjct: 5 FDILEKLGEGSYGSVYKA-IHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPY 59
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V G + +V EY G++S I + L E I +G+EYL
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMKITNKTLTEEEIA---AILYQTLKGLEYL 115
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
H IHRD+K NILL ++ +AK+ADFG+ + T I GT ++APE
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 52/155 (33%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 401 NILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
++G+G FG VY G L D AVK + + + + +F E ++ H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-ITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 457 ALLGHCLDGN-EKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEYL 514
+LLG CL L+V YM G L I + +K L + L VA+G+EYL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
A + F+HRDL N +L + KVADFGL R
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 26/190 (13%)
Query: 403 LGRGGFGTVYKG--ELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
LG G FG+V KG + G ++ AVK ++ I+ G EF E +V+ ++ H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLREASVMAQLDHPCIVRL 61
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAE-EGLKPLEWNRRLTIALDVARGVEYLHGL 517
+G C G +LV E P G L +++ E E A VA G+ YL
Sbjct: 62 IGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES- 113
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG-----YLAPE 572
+ F+HRDL N+LL + +AK++DFG+ R G GS R A T G + APE
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYR-ATTAGRWPLKWYAPE 168
Query: 573 --YAGNFGSS 580
G F S
Sbjct: 169 CINYGKFSSK 178
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 53/160 (33%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 402 ILGRGGFGTVYKG---ELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
+LG G FGTVYKG + KI A+K + S K E E V+ V H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYL 514
LLG CL ++ L+ + MP G L ++ N + L W + +A+G+ YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 515 --HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552
L +HRDL N+L+ K+ DFGL +L
Sbjct: 126 EEKRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 38/199 (19%)
Query: 397 FSEENILGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGKGLTEFKS---EIAVLTKV 450
+ E +GRG +G VYK DG + A+K+ + G+++ S EIA+L ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ--SACREIALLREL 59
Query: 451 RHRHLVALLGHCLDGNEKL--LVFEYMPQGTLSRHIFNWAEEG---------LKPLEWNR 499
+H ++V+L+ L+ +K L+F+Y I + + +K L W
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPPSMVKSLLWQ- 116
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDM---RAKVADFGLVRL--APE 553
+ GV YLH +HRDLKP+NIL+ G+ K+ D GL RL AP
Sbjct: 117 -------ILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 554 GKGSIETRIAGTFGYLAPE 572
+ + T Y APE
Sbjct: 167 KPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 59/173 (34%), Positives = 89/173 (51%), Gaps = 12/173 (6%)
Query: 403 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRHLVALLG 460
LG+GGFG V ++ K+ A K+++ + + G +E +L KV R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 461 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
+ + + L LV M G L HI+N E G R + A + G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPE---ARAIFYAAQIICGLEHLH---Q 113
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ ++RDLKP N+LL D +++D GL GK I+ R AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGR-AGTPGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 54/166 (32%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 402 ILGRGGFGTVYKGEL-----HDGT-KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRH 454
LG G FG V K E + T +AVK M + K L++ SE+ ++ + +H++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLT------I 503
++ LLG C +V EY G L +R P LT
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
A VARG+E+L A + IHRDL N+L+ +D K+ADFGL R
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 53/166 (31%), Positives = 88/166 (53%), Gaps = 18/166 (10%)
Query: 397 FSEENILGRGGFGTVYKGEL--HDGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
F+ +LG+G FG+V + +L DG+ K+AVK ++A + S + EF E A + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 453 RHLVALLGHCLDGNEK------LLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTI-- 503
+++ L+G L K +++ +M G L H F G +P + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+D+A G+EYL + ++FIHRDL N +L ++M VADFGL +
Sbjct: 119 MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 56/209 (26%), Positives = 81/209 (38%), Gaps = 48/209 (22%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKV-R 451
++F I+G G F TV E + A+K ++ +I K + K E VLT++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 452 HRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR- 509
H ++ L D E L V EY P G L ++I + ++ R
Sbjct: 61 HPGIIKLYYTFQD-EENLYFVLEYAPNGELLQYI-------------RKYGSLDEKCTRF 106
Query: 510 -------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 562
+EYLH IHRDLKP NILL DM K+ DFG ++ +
Sbjct: 107 YAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 563 A-------------------GTFGYLAPE 572
GT Y++PE
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPE 192
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 59/177 (33%), Positives = 89/177 (50%), Gaps = 20/177 (11%)
Query: 403 LGRGGFGTV------YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG+GGFG V G+++ K+ KR++ SG+ + + EI L KV +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK--SGEKMALLEKEI--LEKVNSPFIV 56
Query: 457 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
L + + L LV M G L HI+N E GL E R + + + G+ +LH
Sbjct: 57 NL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL---EMERVIHYSAQITCGILHLH 112
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ ++RD+KP N+LL D +++D GL +GK T+ AGT GY+APE
Sbjct: 113 SM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 54/177 (30%), Positives = 94/177 (53%), Gaps = 10/177 (5%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG G FG V+ G ++ TK+AVK ++ G +S + F E ++ ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 522
++ EYM +G+L F ++EG K + + + + +A G+ Y+ +++
Sbjct: 71 TKEEPIYIITEYMAKGSLLD--FLKSDEGGK-VLLPKLIDFSAQIAEGMAYIE---RKNY 124
Query: 523 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579
IHRDL+ +N+L+ + + K+ADFGL R+ + + + + APE A NFGS
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE-AINFGS 180
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 57/177 (32%), Positives = 89/177 (50%), Gaps = 9/177 (5%)
Query: 402 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
+LG+G FG V+KG L D T +AVK + + + +F SE +L + H ++V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
C +V E +P G + +E L+ + + ALD A G+ YL ++
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLES---KN 113
Query: 522 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578
IHRDL N L+G++ K++DFG+ R +G S + APE A N+G
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNYG 169
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 51/183 (27%), Positives = 77/183 (42%), Gaps = 17/183 (9%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTK 449
N + ++G G +G V K G +A+K+ + + L E+ VL +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+RH ++V L LVFEY+ + L + + GL P + R L +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPP-DAVRSYIWQL--LQ 111
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
+ Y H + IHRD+KP NIL+ + K+ DFG R S T T Y
Sbjct: 112 AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168
Query: 570 APE 572
APE
Sbjct: 169 APE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 28/181 (15%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLVAL 458
LG G FG+VY+G L DG AVK + G + + + EIA+L+K++H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 459 LGHCLDGNEKLLVF-EYMPQGTLSRHI--FNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
LG + + L +F E +P G+L++ + + E + L + R++ + G+EYLH
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQILL------GLEYLH 119
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA----GTFGYLAP 571
++ +HRD+K +NIL+ + K+ADFG+ K +E A G+ ++AP
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGM------AKQVVEFSFAKSFKGSPYWMAP 170
Query: 572 E 572
E
Sbjct: 171 E 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 59/181 (32%), Positives = 89/181 (49%), Gaps = 27/181 (14%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVAL 458
+G G +G VYK ++ G +A+K VI G + EI++L + RH ++VA
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL---DVARGVEYLH 515
G L ++ +V EY G+L I+ PL L IA + +G+ YLH
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQ-DIYQ---VTRGPLS---ELQIAYVCRETLKGLAYLH 118
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEY 573
IHRD+K +NILL +D K+ADFG ++ + +I R GT ++APE
Sbjct: 119 ---ETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 574 A 574
A
Sbjct: 173 A 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 65/193 (33%), Positives = 90/193 (46%), Gaps = 25/193 (12%)
Query: 389 VLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RM--EAGVISGKGLTEFKSE 443
R+VT F + N +G G +G VY+ + G +A+K RM E I L E
Sbjct: 2 RCRSVTE-FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL----RE 56
Query: 444 IAVLTKVRHRHLVALL----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 499
I +L +RH ++V L G LD LV EY Q L+ + N P ++
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQ-DLASLLDNMP----TPFSESQ 109
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 559
+ L + RG++YLH IHRDLK SN+LL D K+ADFGL R +
Sbjct: 110 VKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 560 TRIAGTFGYLAPE 572
++ T Y APE
Sbjct: 167 PKVV-TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 15/160 (9%)
Query: 401 NILGRGGFGTVYKGEL----HDGTKIAVK-RMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
LG G FG VY+G D ++ V + S + ++F E +++K H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
V L+G + + ++ E M G L R E L L A DVA+G +
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERP-SSLTMKDLLFCARDVAKGCK 130
Query: 513 YLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 549
YL FIHRD+ N LL G AK+ADFG+ R
Sbjct: 131 YLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 76/243 (31%), Positives = 120/243 (49%), Gaps = 26/243 (10%)
Query: 3 QLIGGLPASFSGSQIQSL-WVNGQNGNAKLGGGIDV-IQNMTSLKEIWLHSNAFSGPLP- 59
QL+G +P Q++SL W+ G L G I I +TSL + L N +GP+P
Sbjct: 199 QLVGQIPRELG--QMKSLKWI--YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
Query: 60 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV-SLDMAK 118
+K L+ L L N +GP+P S+ L+ L +++++N L G +PE + +L++
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILH 314
Query: 119 -GSNNFCLPSPGACD--PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175
SNNF P A PRL L Q ++ + G P + +G N+T
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVL----------QLWSNKFSGEIPKN--LG---KHNNLT 359
Query: 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 235
V++ NLTG I S +L +LIL N+L G IP+ L +L+ + + +N G+
Sbjct: 360 VLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419
Query: 236 IPS 238
+PS
Sbjct: 420 LPS 422
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 44/166 (26%), Positives = 85/166 (51%), Gaps = 12/166 (7%)
Query: 400 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
E ++G G FG V +G L K +A+K ++AG S K +F +E +++ + H ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNI 67
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
+ L G +++ EYM G+L + + + + + + +A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYL- 122
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 561
+ +++HRDL NIL+ ++ KV+DFGL R + + + T+
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 55/164 (33%), Positives = 83/164 (50%), Gaps = 17/164 (10%)
Query: 400 ENILGRGGFGTVYKGELH-DGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLV 456
E+++G G FG V + + DG K+ A +M S +F E+ VL K+ H +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTL------SRHI-----FNWAEEGLKPLEWNRRLTIAL 505
LLG C + + EY P G L SR + F L + L A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
DVA G++YL + + FIHRDL N+L+G+++ +K+ADFGL R
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 21/169 (12%)
Query: 397 FSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
F EE LG FG +YKG L+ D ++ + + + + EF+ E +++ ++ H
Sbjct: 9 FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA----------EEGL--KPLEWNRR 500
++V LLG ++FEY+ QG L + + E+G L+
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 501 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L IA+ +A G+EYL + F+H+DL NIL+G+ + K++D GL R
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-16
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 40 NMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 98
N+ +L+ ++L+ N SGP+P +++L SL L DN +G +P+ +++L++L+I+++ +
Sbjct: 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317
Query: 99 NLLQGPVPEFDRSV-SLDMAK-GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 156
N G +P S+ L + + SN F P N L+V+ L N
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN--LTVLDLS------TNNLT 369
Query: 157 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 216
G P C+ GN+ + +L G I + +SL+R+ L DN+ SG +P
Sbjct: 370 GEIPEG-----LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
Query: 217 SVLGALKELDVSNNQLYGKIPSFK 240
+ L + LD+SNN L G+I S K
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRK 448
|
Length = 968 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 59/191 (30%), Positives = 82/191 (42%), Gaps = 36/191 (18%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
++F LG G FG V K A+K + A ++ K + +E +L +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--- 509
LV L G D + LV EY+P G L F+ L + R VAR
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSH-------LRKSGRFP--EPVARFYA 107
Query: 510 -----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--- 561
+EYLH ++RDLKP N+LL D K+ DFG + ++ R
Sbjct: 108 AQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-------VKGRTYT 157
Query: 562 IAGTFGYLAPE 572
+ GT YLAPE
Sbjct: 158 LCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 55/191 (28%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 403 LGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALL 459
+ +G +G V+ + T A+K ++ + K + +E +L++ + ++V L
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSR--HIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
+ G + L LV EY+P G L+ +E + R+ IA ++ +EYLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA------RIYIA-EIVLALEYLHS 111
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLV------RLAPEGKGSIET-RIAGTFGYL 569
IHRDLKP NIL+ + K+ DFGL R E RI GT Y+
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 570 APEYAGNFGSS 580
APE G S
Sbjct: 169 APEVILGQGHS 179
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 17/181 (9%)
Query: 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAG----VISGKGLTEFKSEIAVLTKVRHRHLV 456
+LG+G +GTVY G + G IAVK++E + + K + + E+ +L ++H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
LG CLD N + E++P G++S + + G P + T + GV YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRF---GPLPEPVFCKYT--KQILDGVAYLH- 119
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPEG----KGSIETRIAGTFGYLAP 571
+ +HRD+K +N++L + K+ DFG RLA G ++ + GT ++AP
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 572 E 572
E
Sbjct: 178 E 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 60/178 (33%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 403 LGRGGFGTVY------KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG+GGFG V G+L+ K+ KR++ KG E +L KV R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK----KRKGYEGAMVEKRILAKVHSRFIV 56
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
+L + LV M G L HI+N EE R + G+E+LH
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-PGFPEPRACFYTAQIISGLEHLH- 114
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETR-IAGTFGYLAPE 572
+ I+RDLKP N+LL +D +++D GL V L G +T+ AGT G++APE
Sbjct: 115 --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK---DGQSKTKGYAGTPGFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKV 450
N+ +LG+G FG VY ++ G ++AVK++ S K + + EI +L +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 451 RHRHLVALLGHCLDGNEKLLVF-EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+H +V G CL +E L +F EYMP G++ + + L +
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILE 115
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RL-APEGKGSIETRIAGTFG 567
GVEYLH +HRD+K +NIL K+ DFG RL G+ + GT
Sbjct: 116 GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 568 YLAPE 572
+++PE
Sbjct: 173 WMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 28/180 (15%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457
+G G +G VYK + G +A+K++ E+ I L E K L ++ H +++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKL----LKELNHPNIIK 62
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY--LH 515
LL + LVFE+M + L L +R+ + + + Y L
Sbjct: 63 LLDVFRHKGDLYLVFEFM-------------DTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109
Query: 516 GLAH---QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
GLA +HRDLKP N+L+ + K+ADFGL R T T Y APE
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPE 168
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 7/148 (4%)
Query: 403 LGRGGFGTVYKGELHDGTKIA---VKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+G G FG V GE H G A VK + A + L F E+ ++ H +++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FLQEVQPYRELNHPNVLQCL 61
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
G C++ LLV E+ P G L ++ + + + + +A +VA G+ +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGL 547
FIH DL N L D+ K+ D+GL
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 54/171 (31%), Positives = 80/171 (46%), Gaps = 16/171 (9%)
Query: 405 RGGFGTVYKGELH-DGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
+G FG+VY + G A+K + ++ +I+ +T K+E A++ VA L +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 463 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
+ L LV EY+ G + I G P +W + +V GVE LH +
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQ---RG 117
Query: 522 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
IHRD+KP N+L+ K+ DFGL R G + GT YLAPE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 29/177 (16%)
Query: 396 NFSEENILGRGGFGTVYKGELHDGTKI-----------------AVKRMEAGVISGKGLT 438
NF E+ LG G FG V+ E AVK +
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN-ARE 64
Query: 439 EFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIF--NWAEEGL 492
+F E+ +L+++ ++ LLG C ++ EYM G L +H+ +
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
K L ++ L +A +A G+ YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 28/188 (14%)
Query: 403 LGRGGFGTVY----KGELHDG--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG+G FG VY KG + D T++A+K + S + EF +E +V+ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 72
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGV 511
LLG G L++ E M +G L ++ + E P + + +A ++A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-------GKGSIETRIAG 564
YL+ F+HRDL N ++ +D K+ DFG+ R E GKG + R
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 565 TFGYLAPE 572
+++PE
Sbjct: 187 ---WMSPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 23/157 (14%)
Query: 397 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI----SGKGLTEFKSEIAVLTKVR 451
F+ +G+G FG VYK + +A+K VI + + + + EI L++ R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIK-----VIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP--LEWNRRLTIALDVAR 509
++ G L G++ ++ EY G+ + LKP L+ I +V
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCL--------DLLKPGKLDETYIAFILREVLL 109
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546
G+EYLH + IHRD+K +NILL ++ K+ADFG
Sbjct: 110 GLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFG 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 29/173 (16%)
Query: 402 ILGRGGFGTVYKGE------LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
LG G FG V K T +AVK ++ S + L + SE +L +V H H+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQVNHPHV 65
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTL-------------------SRHIFNWAEEGLKPLE 496
+ L G C LL+ EY G+L +R+ + L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 497 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
++ A ++RG++YL A +HRDL N+L+ + + K++DFGL R
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 59/182 (32%), Positives = 98/182 (53%), Gaps = 15/182 (8%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
E LG G FG V+ + TK+AVK M+ G +S + F +E V+ ++H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL- 66
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLK-PLEWNRRLTIALDVARGVEYLHGL 517
H + E + ++ E+M +G+L F ++EG K PL + + + +A G+ ++
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE-- 119
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577
+++IHRDL+ +NIL+ + K+ADFGL R+ + + + + APE A NF
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE-AINF 177
Query: 578 GS 579
GS
Sbjct: 178 GS 179
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 38/171 (22%)
Query: 397 FSEENILGRGGFGTVYKG-ELHDGTKI----AVKRMEAGVISGKGLTEFKSEIAVLTKVR 451
F + +LG G FGTVYKG + +G K+ A+K + S K E E V+ V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTL------------SRHIFNWAEEGLKPLEWNR 499
+ H+ LLG CL +L+ + MP G L S+++ NW
Sbjct: 68 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWC----------- 115
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
+ +A+G+ YL + +HRDL N+L+ K+ DFGL +L
Sbjct: 116 -----VQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 23/183 (12%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG G F + Y+ ++ GT +AVK++ + + + EI ++ ++ H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 457 ALLGH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
+LG C D + L V E+M G++S + + + + + RG+ YLH
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLH 120
Query: 516 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFG-LVRLAPE--GKGSIETRIAGTFGYL 569
IHRD+K +N+L+ G +R +ADFG RLA + G G + ++ GT ++
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 570 APE 572
APE
Sbjct: 176 APE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 394 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
+ E +LG+G +G VY +L +IA+K + + + EIA+ + ++H
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKH 64
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-WAEEGLKPLEWNRRLTIAL---DVA 508
R++V LG + + E +P G+LS + + W PL+ N + TI +
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG-----PLKDNEQ-TIIFYTKQIL 118
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLV-RLAPEGKGSIETRIAGTF 566
G++YLH +HRD+K N+L+ K++DFG RLA G GT
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTL 173
Query: 567 GYLAPE 572
Y+APE
Sbjct: 174 QYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 28/197 (14%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEA-GVISGKGLTEFKSEIAVLT 448
R V F +G G +G VYK D G +A+K++ G +T + EI +L
Sbjct: 4 RCVDK-FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILR 61
Query: 449 KVRHRHLVALLGHCLDGNEKL----------LVFEYMPQ---GTLSRHIFNWAEEGLKPL 495
++ HR++V L D + L LVFEYM G L + +++E+ +K
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121
Query: 496 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
++L L+ G+ Y H ++F+HRD+K SNILL + + K+ADFGL RL +
Sbjct: 122 M--KQL---LE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 556 GSIETRIAGTFGYLAPE 572
T T Y PE
Sbjct: 171 SRPYTNKVITLWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 16/179 (8%)
Query: 401 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
++G G VY L + K+A+KR++ + E + E+ +++ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 460 GHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
+ G+E LV Y+ G+L + + L+ T+ +V +G+EYLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPR-----GGLDEAIIATVLKEVLKGLEYLHS 120
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETR--IAGTFGYLAPE 572
IHRD+K NILLG+D K+ADFG+ LA G + + R GT ++APE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 33/177 (18%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGL----------------TEFKSEIAV 446
LG G FG V+ E+ + + + V G+ L +F E+ +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 447 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEG---------L 492
L++++ +++ LLG C+D + ++ EYM G L S H+ + E G L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ ++ L +AL +A G++YL L +F+HRDL N L+G+++ K+ADFG+ R
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 55/172 (31%), Positives = 77/172 (44%), Gaps = 33/172 (19%)
Query: 419 GTKIAVKRMEAGVISGKGL-TEFKSEIAVLTKVRHRHLVALL--GHCLDGNEKLL--VFE 473
G ++A+K + + F+ E A+ ++ H ++VALL G G LL VFE
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG---LLFAVFE 59
Query: 474 YMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVEYLHGLAH---QSFIHRDLKP 529
Y+P TL + A +G L E R + LD LA Q +HRDLKP
Sbjct: 60 YVPGRTLREVL---AADGALPAGETGRLMLQVLD---------ALACAHNQGIVHRDLKP 107
Query: 530 SNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIA------GTFGYLAPE 572
NI++ G AKV DFG+ L P + + + GT Y APE
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 58/188 (30%), Positives = 87/188 (46%), Gaps = 28/188 (14%)
Query: 403 LGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
LG+G FG VY+G D T++AVK + S + EF +E +V+ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 72
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGV 511
LLG G L+V E M G L ++ + E G P + +A ++A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-------GKGSIETRIAG 564
YL+ + F+HRDL N ++ D K+ DFG+ R E GKG + R
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 565 TFGYLAPE 572
++APE
Sbjct: 187 ---WMAPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
NF + LG G + TVYKG G +A+K + G T + EI+++ +++H +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V L N+ +LVFEYM + L +++ G L+ N + + +G+ +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRG--ALDPNTVKSFTYQLLKGIAFC 116
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
H +HRDLKP N+L+ K+ADFGL R
Sbjct: 117 H---ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 51/167 (30%), Positives = 85/167 (50%), Gaps = 24/167 (14%)
Query: 403 LGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 453
LG G FG V E + TK+AVK +++ + K L++ SE+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHK 84
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 502
+++ LLG C ++ EY +G L ++ +N + + L + ++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 58/163 (35%), Positives = 81/163 (49%), Gaps = 17/163 (10%)
Query: 401 NILGRGGFGTVYKGELH-DGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVA 457
+++G G FG V K + DG ++ A + S +F E+ VL K+ H +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 458 LLGHCLDGNEKLLVFEYMPQGTL------SRHI-----FNWAEEGLKPLEWNRRLTIALD 506
LLG C L EY P G L SR + F A L + L A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 507 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
VARG++YL + + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 51/190 (26%), Positives = 95/190 (50%), Gaps = 26/190 (13%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
++ +++ ++G G FG V++G L + +A+K ++ G + K +F SE +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQF 63
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
H +++ L G +++ EYM G L +++ + E + L +A G
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLR---GIAAG 119
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---PEGK-----GSIETRI 562
++YL + +++HRDL NIL+ ++ KV+DFGL R+ PEG G I R
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR- 175
Query: 563 AGTFGYLAPE 572
+ APE
Sbjct: 176 -----WTAPE 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 396 NFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
N E LGRG FG V+ + T + VK ++ +EF+ E+ + K
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRK 64
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRH--IFNWAEEGLK--PLEWNRRLTIAL 505
+ H+++V LLG C + ++ EY G L + +E LK PL +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+A G+++ L++ F+HRDL N L+ KV+ L +
Sbjct: 125 QIALGMDH---LSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 10/173 (5%)
Query: 402 ILGRGGFG--TVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+LG+G FG T+Y+ D + + K + +S K + +EI +L+ ++H +++A
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
H +D N L+ EY GTL I + + E L + V Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+HRD+K NI L K+ DFG+ ++ ET + GT Y++PE
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 403 LGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 453
LG G FG V E + +AVK ++ + K L++ SE+ ++ + +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHK 81
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 502
+++ LLG C ++ EY +G L ++ ++ A + + + ++
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
VARG+EYL A Q IHRDL N+L+ ++ K+ADFGL R
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 56/177 (31%), Positives = 90/177 (50%), Gaps = 15/177 (8%)
Query: 402 ILGRGGFGTVYKGELHDGT---KI-AVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHL 455
+LG+GG+G V++ G KI A+K ++ I + K K+E +L V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
V L+ G + L+ EY+ G L H+ EG+ +E ++ +++ +E+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIF-MEDTACFYLS-EISLALEHLH 117
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
Q I+RDLKP NILL K+ DFGL + + G++ GT Y+APE
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHTFCGTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 24/167 (14%)
Query: 403 LGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 453
LG G FG V E + +AVK ++ + K L++ SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHK 78
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 502
+++ LLG C ++ EY +G L ++ F+ + + L + ++
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
A VARG+EYL A Q IHRDL N+L+ +D K+ADFGL R
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 52/175 (29%), Positives = 79/175 (45%), Gaps = 19/175 (10%)
Query: 403 LGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFK---SEIAVLTKVRHRHLVA 457
LG G G V K LH G +AVK + + K E+ +L K ++V
Sbjct: 9 LGAGNSGVVSKV-LHRPTGKIMAVKTIRLEINE----AIQKQILRELDILHKCNSPYIVG 63
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
G + + + EYM G+L + I + + P ++ +A V +G+ YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRI-PERILGKIAVA--VLKGLTYLHEK 119
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
IHRD+KPSNIL+ + K+ DFG+ + S+ GT Y+APE
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 30/220 (13%)
Query: 28 NAKLGGGI--DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSL 85
N +L G I D+ +SL+ + L +N F+G +P S + LE+L L +N +G +P+ +
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS-IPNLETLDLSNNMLSGEIPNDI 160
Query: 86 VKLESLKIVNMTNNLLQGPVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSV 141
SLK++++ N+L G +P +++ L +A SN G L + S+
Sbjct: 161 GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA--SNQLV----GQIPRELGQMKSL 214
Query: 142 VKL-MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM---NLTGTISPEFASFKS 197
+ +GY N G P G +T +N + NLTG I + K+
Sbjct: 215 KWIYLGY-----NNLSGEIPYE--------IGGLTSLNHLDLVYNNLTGPIPSSLGNLKN 261
Query: 198 LQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237
LQ L L N LSG IP + L L LD+S+N L G+IP
Sbjct: 262 LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 17/174 (9%)
Query: 403 LGRGGFGTVYKGELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
LG G FG VYK + H T + A K ++ S + L +F EI +L++ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQ-HKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
N+ ++ E+ G L + E + L + + + + +LH
Sbjct: 70 AYFYENKLWILIEFCDGGALD----SIMLELERGLTEPQIRYVCRQMLEALNFLH---SH 122
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPE 572
IHRDLK NILL D K+ADFG ++ + K +++ R GT ++APE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 402 ILGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVA 457
+LG G FGTVYKG + KI V +G K EF E ++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
LLG CL +L V + MP G L ++ E + L + +A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCL----LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-- 126
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
+ +HRDL N+L+ K+ DFGL RL
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 374 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 432
D ++LE ++S+ + ++ +G+G GTVY ++ G ++A+K+M
Sbjct: 1 DEEILEKLRTIVSVG---DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ 57
Query: 433 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA-EEG 491
K L +EI V+ + +H ++V L L G+E +V EY+ G+L+ + +EG
Sbjct: 58 PKKEL--IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 115
Query: 492 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRL 550
+ + + + +E+LH IHRD+K NILLG D K+ DFG ++
Sbjct: 116 -------QIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165
Query: 551 APEGKGSIETRIAGTFGYLAPE 572
PE S + + GT ++APE
Sbjct: 166 TPE--QSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 54/184 (29%), Positives = 92/184 (50%), Gaps = 24/184 (13%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISG------KGLTE-FKSEIAVLTKVRH 452
++G+G +G VY + G +AVK++E I+G K + + +SEI L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 453 RHLVALLGHCLDGNEKLLVF-EYMPQGTLSRHIFNWA--EEGLKPLEWNRRLTIALDVAR 509
++V LG E L +F EY+P G++ + + EE L R T V
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV-----RFFT--EQVLE 119
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGY 568
G+ YLH + +HRDLK N+L+ D K++DFG+ + + + + + + G+ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 569 LAPE 572
+APE
Sbjct: 177 MAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 54/184 (29%), Positives = 80/184 (43%), Gaps = 26/184 (14%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
+G G FG V+ + A+K M VI K +E VL +V H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYL 514
D ++ EY+P G L F++ L + R + A ++ +EYL
Sbjct: 69 TEHDQRFLYMLMEYVPGGEL----FSY-------LRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
H ++RDLKP NILL + K+ DFG A + + T + GT YLAPE
Sbjct: 118 HSK---EIVYRDLKPENILLDKEGHIKLTDFG---FAKKLRDRTWT-LCGTPEYLAPEVI 170
Query: 575 GNFG 578
+ G
Sbjct: 171 QSKG 174
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 54/175 (30%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE----FKSEIAVLTKVRHRHLVA 457
+G G FG VY ++ +A+K+M SGK E E+ L ++RH + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
G L + LV EY G+ S + E KPL+ I +G+ YLH
Sbjct: 80 YKGCYLREHTAWLVMEYC-LGSASDIL----EVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
IHRD+K NILL + K+ADFG L + GT ++APE
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 25/186 (13%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKG-------LTEFKSEIAVLTKVRHR 453
++G G FG+VY G G +AVK++E +S L EIA+L +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA--EEGLKPLEWNRRLTIALDVARGV 511
++V LG LD + + EY+P G+++ + N+ EE L + +G+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-------NFVRQILKGL 119
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----LAPEGKGSIETRIAGTF 566
YLH ++ IHRD+K +NIL+ + K++DFG+ + + G+
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 567 GYLAPE 572
++APE
Sbjct: 177 FWMAPE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 16/179 (8%)
Query: 397 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
F++ +G+G FG VYKG + +A+K ++ + + + + EI VL++ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP--LEWNRRLTIALDVARGVEY 513
G L G + ++ EY+ G+ A + LKP LE TI ++ +G++Y
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGS--------ALDLLKPGPLEETYIATILREILKGLDY 116
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
LH + IHRD+K +N+LL + K+ADFG+ + + T + F ++APE
Sbjct: 117 LHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 59/191 (30%), Positives = 86/191 (45%), Gaps = 38/191 (19%)
Query: 396 NFSE---ENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKG----LTEFKSEIAV 446
+ SE N +G G GTVYK +H T A+K VI G + EI +
Sbjct: 72 SLSELERVNRIGSGAGGTVYK-VIHRPTGRLYALK-----VIYGNHEDTVRRQICREIEI 125
Query: 447 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS-RHIFNWAEEGLKPLEWNRRLTIAL 505
L V H ++V E ++ E+M G+L HI E+ L
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI--ADEQFLA------------ 171
Query: 506 DVAR----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 561
DVAR G+ YLH + +HRD+KPSN+L+ K+ADFG+ R+ + +
Sbjct: 172 DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228
Query: 562 IAGTFGYLAPE 572
+ GT Y++PE
Sbjct: 229 V-GTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 403 LGRGGFGTVYKGELHDGTK--------IAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 453
LG G FG V + E + K +AVK ++ + K L + SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHK 78
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 502
+++ LLG C ++ EY +G L + F+ + + L + ++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
A VARG+EYL + IHRDL N+L+ +D K+ADFGL R
Sbjct: 139 CAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 22/155 (14%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLTKVRHRHLV 456
+G G +G VYK + G +A+K R+E GV S T + EI++L ++ H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS----TAIR-EISLLKELNHPNIV 61
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL--TIALDVARGVEYL 514
LL N+ LVFE++ L +++ + GL + L + + +G+ Y
Sbjct: 62 RLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGL-----DPPLIKSYLYQLLQGIAYC 115
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
H H+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 116 HS--HR-VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 403 LGRGGFGTV----YKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457
LG G FG V Y E + G ++AVK ++ G + + K EI +L + H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVK 70
Query: 458 LLGHCLD--GNEKLLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
G C + GN L+ E++P G+L ++ N + LK L A+ + +G++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQ-----LKYAVQICKGMDYL 125
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556
+ ++HRDL N+L+ + + K+ DFGL + K
Sbjct: 126 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 58/179 (32%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 402 ILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTE-FKSEIAVL---TKVRHRHLV 456
+LGRG FG V E G A+K ++ G I + E E + RH LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 457 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
L C + + V EY G L HI + +P R + A V G++YLH
Sbjct: 66 NLFA-CFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEP----RAVFYAACVVLGLQYLH 118
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET--RIAGTFGYLAPE 572
++RDLK N+LL + K+ADFGL + EG G + GT +LAPE
Sbjct: 119 ---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPE 171
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 20/177 (11%)
Query: 402 ILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKS----EIAVLTKVRHRHLV 456
++G G +G V K + + G +A+K+ + + K EI +L ++RH +LV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
L+ LVFE++ + + E+ L+ +R + RG+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH- 117
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 572
+ IHRD+KP NIL+ K+ DFG R LA G + T T Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEVYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 37/196 (18%)
Query: 43 SLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101
SL+ + L N+FSG LP +F+ + + L + +N G + + SL+++++ N
Sbjct: 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464
Query: 102 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 161
G +P+ S L+ S N GA +L +L +++L + +EN
Sbjct: 465 FGGLPDSFGSKRLENLDLSRN---QFSGAVPRKLGSLSELMQL-----KLSEN------- 509
Query: 162 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 221
L+G I E +S K L L L+ N LSG IP S +
Sbjct: 510 ---------------------KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548
Query: 222 LKELDVSNNQLYGKIP 237
L +LD+S NQL G+IP
Sbjct: 549 LSQLDLSQNQLSGEIP 564
|
Length = 968 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 14/162 (8%)
Query: 395 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
NN S LG G FG V + + K+AVK ++ S + SE+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER-EALMSELKIMS 93
Query: 449 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 507
+ H ++V LLG C G L++ EY G L + E L L+ + V
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQV 150
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
A+G+ +L A ++ IHRDL N+LL K+ DFGL R
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 402 ILGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRHLVA 457
+LG G FGTV+KG D KI V SG+ E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
LLG C G LV + P G+L H+ + L P R L + +A+G+ YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHV-RQHRDSLDP---QRLLNWCVQIAKGMYYLE-- 126
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552
+HR+L NILL D ++ADFG+ L
Sbjct: 127 -EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVIS---GKGLTE-------FKSEIAVLTK-VR 451
LG G FG VYK + + + E V + GK E SE+ ++ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE---WNRRLTIALDVA 508
H ++V L+ + +V + + L H + E+ + E WN + + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 568
+ YLH + +HRDL P+NI+LG+D + + DFGL + + S T + GT Y
Sbjct: 125 -ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179
Query: 569 LAPE 572
PE
Sbjct: 180 SCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 58/186 (31%), Positives = 94/186 (50%), Gaps = 25/186 (13%)
Query: 403 LGRGGFGTVYKGELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+GRG +G VYK + DG + A+K++E IS EIA+L +++H +++AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVIALQ 64
Query: 460 GHCLDGNEK--LLVFEYMPQGTLSRHIFNW---AEEGLKPLEWNRRLTIAL--DVARGVE 512
L +++ L+F+Y HI + ++ KP++ R + +L + G+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 513 YLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APEGKGSIETRIAGTF 566
YLH +HRDLKP+NIL+ + R K+AD G RL +P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 567 GYLAPE 572
Y APE
Sbjct: 180 WYRAPE 185
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 36/169 (21%)
Query: 401 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKS-------------EIAV 446
LG G +G V K G +A+K+++ IS +T+ + E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEIS-NDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 447 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---- 502
+ +++H +++ L+ ++G+ LV + M L K ++ RLT
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLK-----------KVVDRKIRLTESQV 121
Query: 503 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
I L + G+ LH F+HRDL P+NI + K+ADFGL R
Sbjct: 122 KCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 52/152 (34%), Positives = 79/152 (51%), Gaps = 18/152 (11%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
LG G + TVYKG G +A+K R+E G T + E ++L ++H ++V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIR-EASLLKDLKHANIVTL- 68
Query: 460 GHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
H + +K L VFEY+ L +++ + GL N RL + + RG+ Y H
Sbjct: 69 -HDIIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMH--NVRLFL-FQLLRGLAYCH-- 120
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 60/191 (31%), Positives = 90/191 (47%), Gaps = 18/191 (9%)
Query: 390 LRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
LR+ F ++G G +G VYKG + G A+K M+ ++G E K EI +L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLK 57
Query: 449 KV-RHRHLVALLGHCLDGN------EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 501
K HR++ G + N + LV E+ G+++ I N LK EW
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EW--IA 114
Query: 502 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 561
I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG+ G T
Sbjct: 115 YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171
Query: 562 IAGTFGYLAPE 572
I GT ++APE
Sbjct: 172 I-GTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 55/174 (31%), Positives = 77/174 (44%), Gaps = 16/174 (9%)
Query: 403 LGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 460
LG GGFG V ++ A+K ++ I G E SE +L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 461 HCLDGNEKLLVF--EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+ ++K + EY G L I + GL E+ R IA V EYLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGEL-WTILR--DRGLFD-EYTARFYIAC-VVLAFEYLH--- 110
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++ I+RDLKP N+LL + K+ DFG + G GT Y+APE
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 26/169 (15%)
Query: 403 LGRGGFGTVYKGEL---------------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVL 447
LG G FG V+ E +AVK + A V +F EI ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-TARNDFLKEIKIM 71
Query: 448 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS-----RHIFNW--AEEGLKPLEWNRR 500
+++++ +++ LLG C+ + ++ EYM G L+ R I + + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 501 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L +A+ +A G++YL L +F+HRDL N L+G+ K+ADFG+ R
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 37/197 (18%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKR--MEAGVISGKGLTEFKSEIAVL 447
R+V + + + N + G +G VY+ + G +A+K+ ME G +T + EI +L
Sbjct: 2 RSV-DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLR-EINIL 58
Query: 448 TKVRHRHLVAL----LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL--EWNRRL 501
K++H ++V + +G LD + +V EY+ E LK L +
Sbjct: 59 LKLQHPNIVTVKEVVVGSNLD--KIYMVMEYV-------------EHDLKSLMETMKQPF 103
Query: 502 TIA------LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+ L + GV +LH +HRDLK SN+LL + K+ DFGL R
Sbjct: 104 LQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160
Query: 556 GSIETRIAGTFGYLAPE 572
T++ T Y APE
Sbjct: 161 KPY-TQLVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 18/160 (11%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-----AGVISGKGLTEFKSEIAVLTK 449
NF + +G G +G VYK G +A+K++ GV S T + EI++L +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS----TAIR-EISLLKE 55
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+ H ++V LL N+ LVFE++ Q L + + G+ PL + L +
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGI-PLPLIKSYLFQL--LQ 111
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
G+ + H +H+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 112 GLAFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 8/178 (4%)
Query: 396 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+F N +G+G FG V+K D A+K+++ ++ + E E VL K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
++ LD + +V EY G L H + G +PL ++ + + G+ +L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRG-RPLPEDQVWRFFIQILLGLAHL 117
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
H + +HRD+K N+ L K+ D G+ +L + T I GT YL+PE
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 28/197 (14%)
Query: 390 LRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
L + T F ++G G +G VYK G +A+K M+ I E K E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILR 57
Query: 449 KV-RHRHLVALLG------HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 501
K H ++ G + ++ LV E G+++ + +GL+ +RL
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKK--GKRL 110
Query: 502 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
I + RG+ YLH ++ IHRD+K NILL + K+ DFG+
Sbjct: 111 KEEWIAYILRETLRGLAYLH--ENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167
Query: 556 GSIETRIAGTFGYLAPE 572
G T I GT ++APE
Sbjct: 168 GRRNTFI-GTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 69/230 (30%), Positives = 104/230 (45%), Gaps = 50/230 (21%)
Query: 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSL 72
S++ S+ ++G+N + K+ I + ++ I L +N SGP+PD F+ L L+L
Sbjct: 69 SRVVSIDLSGKNISGKISS---AIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 73 RDNFFTGPVPD-SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 131
+N FTG +P S+ LE+L +++NN+L G +P D+ S+ L G
Sbjct: 126 SNNNFTGSIPRGSIPNLETL---DLSNNMLSGEIP-------NDIGSFSSLKVLDLGG-- 173
Query: 132 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM---NLTGTI 188
N L+ G P S N+T + F + L G I
Sbjct: 174 ----NVLV-----------------GKIPNS--------LTNLTSLEFLTLASNQLVGQI 204
Query: 189 SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
E KSL+ + L NNLSG IP + L +L LD+ N L G IPS
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 51/180 (28%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVRHR 453
NF E +GRG F VY+ L DG +A+K+++ ++ K + EI +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVE 512
+++ ++ NE +V E G LSR I ++ ++ L P + + + L A +E
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++H + +HRD+KP+N+ + K+ D GL R K + + GT Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 41/164 (25%)
Query: 403 LGRGGFGTVYKGELHD-GTKIAVKRM-----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
+G G +GTV+K + + +A+KR+ + GV S EI +L +++H+++V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-----LREICLLKELKHKNIV 62
Query: 457 ALLGHCLDGNEKL-LVFEYMPQ----------GTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
L L ++KL LVFEY Q G + I +
Sbjct: 63 RLY-DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK---------------SFMF 106
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ +G+ + H + +HRDLKP N+L+ + K+ADFGL R
Sbjct: 107 QLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 403 LGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+G G FG V GE++ G ++ VK + S + +F E ++H +L+ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
G C + LLV E+ P G L ++ + E + P + +A ++A G+ +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLH--- 117
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGL 547
+FIH DL N LL D+ K+ D+GL
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 16/182 (8%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ + ++GRG FG V+ D + +K++ ++ ++E VL + H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP---LEWNRRLTIALDVARGV 511
++ + L+ ++V EY P GTL+ +I L L + ++ +A
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 570
LH + + +HRDLK NILL M K+ DFG+ ++ S + GT Y++
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYIS 169
Query: 571 PE 572
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 40/152 (26%), Positives = 65/152 (42%), Gaps = 11/152 (7%)
Query: 402 ILGRGGFGTVYKGELHD--GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 458
+G G FG VY+G KIAV + + E F E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+G + N +V E P G L ++ L+ + + ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYLES-- 125
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
+ F+HRD+ N+L+ K+ DFGL R
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 28/188 (14%)
Query: 393 VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVL 447
+TN + + +G G FG V + G +A+K++ V++ + E K +L
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LL 63
Query: 448 TKVRHRHLVALLGHCLDGNEKL-LVFEYMPQGT-LSRHIFNWAEEGLKPLEWNRRLTIAL 505
+RH ++++L + E + V E + GT L R + + +PLE
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTS------RPLEKQFIQYFLY 115
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAG 564
+ RG++Y+H +HRDLKPSNIL+ ++ K+ DFGL R+ P+ G + TR
Sbjct: 116 QILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-- 170
Query: 565 TFGYLAPE 572
Y APE
Sbjct: 171 ---YRAPE 175
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 60/177 (33%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 402 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFK---SEIAVLTK-VRHRHLV 456
++G+G FG V + DG AVK ++ I K E K +E VL K V+H LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK--KEQKHIMAERNVLLKNVKHPFLV 59
Query: 457 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
L + +KL V +Y+ G L H+ + + R A ++A + YLH
Sbjct: 60 GL-HYSFQTADKLYFVLDYVNGGELFFHL-----QRERSFPEPRARFYAAEIASALGYLH 113
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
L + I+RDLKP NILL + DFGL + E + T GT YLAPE
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 14/154 (9%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKI----AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
+LG G FGTVYKG + DG + A+K + S K E E V+ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
LLG CL +L V + MP G L ++ E + L + +A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
+ +HRDL N+L+ K+ DFGL RL
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 54/201 (26%), Positives = 80/201 (39%), Gaps = 38/201 (18%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
++GRG FG V+ + G A+K + ++ +I + ++E +L +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
D LV EYMP G L + + + P E R L +A ++ +H L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIR---KDVFPEETARFYIAELVLA--LDSVHKLG- 121
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGL------------------VRLAPEGKGSIETR 561
FIHRD+KP NIL+ D K+ADFGL L +
Sbjct: 122 --FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 562 ----------IAGTFGYLAPE 572
GT Y+APE
Sbjct: 180 HKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 49/180 (27%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVRHR 453
NF E +GRG F VY+ D +A+K+++ ++ K + EI +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL-TIALDVARGVE 512
+++ L ++ NE +V E G LS+ I + ++ K L R + + + VE
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVE 120
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++H + +HRD+KP+N+ + K+ D GL R K + + GT Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 25/178 (14%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLVALL 459
LG G FG VYK + + +A A VI K L ++ EI +L H ++V LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAA----AKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---IALDVARGVEYLHG 516
G + ++ E+ P G + + LE +R LT I + + +E L
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIM----------LELDRGLTEPQIQVICRQMLEALQY 125
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPE 572
L IHRDLK N+LL D K+ADFG ++ + +++ R GT ++APE
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 61/175 (34%), Positives = 84/175 (48%), Gaps = 14/175 (8%)
Query: 402 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTK-VRHRHLVAL 458
++G+G FG V + DG+ AVK ++ I K +E VL K ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 459 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
+ EKL V +Y+ G L H+ L+P R A +VA + YLH L
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHL-QRERCFLEP----RARFYAAEVASAIGYLHSL 115
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLKP NILL + DFGL + E + + T GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 33/164 (20%)
Query: 401 NILGRGGFGTVYKGE-LHDGTKIAVKRME---AGVISGKGLTEFKSEIAVLTKVRHRHLV 456
+G G +G V G K+A+K++ +I K + EI +L +RH +++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR---EIKLLRHLRHENII 62
Query: 457 ALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IAL 505
LL D N+ +V E M + L + I + + LT
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKS-----------PQPLTDDHIQYFLY 110
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ RG++YLH A+ IHRDLKPSNIL+ + K+ DFGL R
Sbjct: 111 QILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 68/239 (28%), Positives = 100/239 (41%), Gaps = 46/239 (19%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFS 62
L+G +P S + + SL N +G + M SLK I+L N SG +P +
Sbjct: 176 LVGKIPNSLT--NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233
Query: 63 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP----EFDRSVSLDMAK 118
G+ L L L N TGP+P SL L++L+ + + N L GP+P + +SLD++
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293
Query: 119 GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVIN 178
S + +P V++L N+ +++
Sbjct: 294 NSLSGEIPE------------LVIQLQ---------------------------NLEILH 314
Query: 179 FQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237
N TG I S LQ L L N SG IP+ L L LD+S N L G+IP
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 57/186 (30%), Positives = 92/186 (49%), Gaps = 25/186 (13%)
Query: 403 LGRGGFGTVYKGELHDGTK---IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+GRG +G VYK + DG A+K++E IS EIA+L +++H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 64
Query: 460 GHCLDGNEK--LLVFEYMPQGTLSRHIFNW---AEEGLKPLEWNRRLTIAL--DVARGVE 512
L ++ L+F+Y HI + ++ KP++ R + +L + G+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 513 YLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APEGKGSIETRIAGTF 566
YLH +HRDLKP+NIL+ + R K+AD G RL +P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 567 GYLAPE 572
Y APE
Sbjct: 180 WYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 376 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISG 434
Q A +V+S R ++F + +G G G V E H G ++AVK+M+
Sbjct: 6 QFRAALQLVVSPGDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR 62
Query: 435 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN--WAEEGL 492
+ L +E+ ++ H ++V + L G+E +V E++ G L+ + + EE +
Sbjct: 63 REL--LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 120
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV---- 548
T+ L V R + YLH +Q IHRD+K +ILL D R K++DFG
Sbjct: 121 A--------TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169
Query: 549 RLAPEGKGSIETRIAGTFGYLAPE 572
+ P+ K + GT ++APE
Sbjct: 170 KEVPKRKS-----LVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 55/174 (31%), Positives = 81/174 (46%), Gaps = 18/174 (10%)
Query: 403 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALLG 460
+G+GG+G V+ + D +I A+KRM+ ++ + +E +LT + LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
D L EY+P G R + N L E + R +A V+ LH L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLN-NLGVLS--EDHARFYMAEMFE-AVDALHELG-- 121
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE--TRIAGTFGYLAPE 572
+IHRDLKP N L+ K+ DFGL KG + + G+ Y+APE
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGL------SKGIVTYANSVVGSPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 53/149 (35%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
LG G + TVYKG +G +A+K + G T + E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 462 CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
+ E L VFEYM L++++ GL P +N RL + + RG+ Y+H Q
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQ-HPGGLHP--YNVRLFM-FQLLRGLAYIH---GQ 122
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+HRDLKP N+L+ K+ADFGL R
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 14/160 (8%)
Query: 400 ENILGRGGFGTVYKGEL-HDGTK---IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
E ++G G FG V +G L G + +A+K +++G + K +F SE +++ + H ++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVEYL 514
+ L G +++ E+M G L F +G ++ + + +A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDS--FLRQNDGQFTVIQL---VGMLRGIAAGMKYL 122
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554
+ +++HRDL NIL+ ++ KV+DFGL R +
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 43/201 (21%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM---EAGVISGKGLTEFKSEIAVL 447
+V + + +G G +G V G K+A+K++ E + L E K +L
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 448 TKVRHRHLVALL-----GHCLDGNEKLLVFEYMP---------QGTLSRHIFNWAEEGLK 493
+ +H +++ +L N+ +V E M Q + HI + + L
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL- 116
Query: 494 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-P 552
RG++Y+H + +HRDLKPSN+LL + K+ DFGL R+A P
Sbjct: 117 ---------------RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158
Query: 553 EGKGSIE-TRIAGTFGYLAPE 572
E + T T Y APE
Sbjct: 159 EHDHTGFLTEYVATRWYRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 12/150 (8%)
Query: 403 LGRGGFGTVYKGELHDGTKIA---VKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+G G FG V E++ T +A VK ++A S K EF + ++H +++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFN--WAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
G C++ LLVFEY G L ++ W + L R +A ++A GV ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHKH 118
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
+F+H DL N L D+ KV D+G+
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 374 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 432
D ++LE ++S+ + F + +G+G GTVY ++ G ++A+++M
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 433 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 492
K L +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 59 PKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---- 112
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 551
++ + + + + +E+LH IHRD+K NILLG D K+ DFG ++
Sbjct: 113 --MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 552 PEGKGSIETRIAGTFGYLAPE 572
PE S + + GT ++APE
Sbjct: 168 PE--QSKRSTMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 46/169 (27%), Positives = 72/169 (42%), Gaps = 25/169 (14%)
Query: 394 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKR-MEAGVISGKGLTEFKSEIAVLTKVR 451
++ LG G FG VYK ++ G +A+K+ + G +T + EI +L K++
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLK 65
Query: 452 HRHLVALL--------GHCLDGNEKLLVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRR 500
H ++V L+ +V YM G L E +K
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK------- 118
Query: 501 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L + G+ YLH +HRD+K +NIL+ + K+ADFGL R
Sbjct: 119 -CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 54/193 (27%), Positives = 80/193 (41%), Gaps = 35/193 (18%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKS----EIAVLTKV 450
E + LG G G+V K L + I + I+ + + E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALK----TITTDPNPDLQKQILRELEINKSC 56
Query: 451 RHRHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIF-----NWAEEGLKPLEWNRRLTI 503
+ ++V G LD + + EY G+L I+ G K L I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVL-----GKI 110
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 563
A V +G+ YLH + IHRD+KPSNILL + K+ DFG+ G + +A
Sbjct: 111 AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV-------SGELVNSLA 160
Query: 564 GTFG----YLAPE 572
GTF Y+APE
Sbjct: 161 GTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 29/176 (16%)
Query: 397 FSEENILGRGGFGTVYKGE---LHDGTK--------------IAVKRMEAGVISGKGLTE 439
F E+ LG G FG V+ E + +AVK + + +
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARND 65
Query: 440 FKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIF--NWAEEGLK 493
F EI ++++++ +++ LL C+ + ++ EYM G L SRH + +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 494 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ ++ + +A +A G++YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 18/196 (9%)
Query: 385 ISIQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSE 443
I + LR+ F ++G G +G VYKG + G A+K M+ ++ E K E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLE 62
Query: 444 IAVLTKV-RHRHLVALLGHCL------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 496
I +L K HR++ G + ++ LV E+ G+++ + N LK +
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-D 121
Query: 497 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556
W I ++ RG+ +LH AH+ IHRD+K N+LL ++ K+ DFG+ G
Sbjct: 122 W--IAYICREILRGLAHLH--AHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 557 SIETRIAGTFGYLAPE 572
T I GT ++APE
Sbjct: 177 RRNTFI-GTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 374 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 432
D ++LE ++S+ + F + +G+G GTVY ++ G ++A+K+M
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ 57
Query: 433 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 492
K L +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 58 PKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---- 111
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 551
++ + + + + +++LH IHRD+K NILLG D K+ DFG ++
Sbjct: 112 --MDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 552 PEGKGSIETRIAGTFGYLAPE 572
PE S + + GT ++APE
Sbjct: 167 PE--QSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 61/181 (33%), Positives = 95/181 (52%), Gaps = 21/181 (11%)
Query: 403 LGRGGFGTVYKG-ELHDGTK-IAVKRMEAGVIS-GKGLTEFKSEIAVLTKVR---HRHLV 456
+G G +G V+K +L +G + +A+KR+ G L+ + E+AVL + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 457 ALLGHCL----DGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
L C D KL LVFE++ Q L+ ++ E G+ P E + + L RG+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQL--LRGL 123
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
++LH +H+ +HRDLKP NIL+ + K+ADFGL R+ T + T Y AP
Sbjct: 124 DFLH--SHR-VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAP 178
Query: 572 E 572
E
Sbjct: 179 E 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 26/179 (14%)
Query: 403 LGRGGFGTVYKGELHD-GTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457
+G G +G V+K + G +A+K+ + VI L EI +L +++H +LV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPNLVN 64
Query: 458 LLGHCLDGNEKL-LVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
L+ KL LVFEY L ++ E +K + W + V +
Sbjct: 65 LI-EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQAVNF 115
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
H H IHRD+KP NIL+ + K+ DFG R+ G G T T Y APE
Sbjct: 116 CH--KHNC-IHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 46/176 (26%), Positives = 87/176 (49%), Gaps = 10/176 (5%)
Query: 397 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
F++ +G+G FG V+KG + K+ ++ + + + + EI VL++ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
G L + ++ EY+ G+ + E G PL+ + TI ++ +G++YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPG--PLDETQIATILREILKGLDYLHS 119
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ IHRD+K +N+LL + K+ADFG+ + + GT ++APE
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 52/188 (27%), Positives = 95/188 (50%), Gaps = 16/188 (8%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
RN +F +G G +G VYK ++ G A+K ++ + G+ + EI ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKD 62
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+H ++VA G L ++ + E+ G+L + I++ PL ++ ++ + +
Sbjct: 63 CKHSNIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVT----GPLSESQIAYVSRETLQ 117
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFG 567
G+ YLH + +HRD+K +NILL D+ K+ADFG ++ + +I R GT
Sbjct: 118 GLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPY 171
Query: 568 YLAPEYAG 575
++APE A
Sbjct: 172 WMAPEVAA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 16/188 (8%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
RN +++ +G G +G VYK LH G AVK ++ + G + + EI ++ +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKE 62
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+H ++VA G L + + EY G+L + I++ PL + + + +
Sbjct: 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVT----GPLSELQIAYVCRETLQ 117
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFG 567
G+ YLH +HRD+K +NILL D+ K+ADFG +A + +I R GT
Sbjct: 118 GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPY 171
Query: 568 YLAPEYAG 575
++APE A
Sbjct: 172 WMAPEVAA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 22/188 (11%)
Query: 396 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME---AGVISGKGLTEFKSEIAVLTKVR 451
N+ +LGRG FG VY + G ++AVK++ + K + + EI +L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 452 HRHLVALLGHCLDGNE--KLLVF-EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
H +V G CL E KL +F EYMP G++ + + G RR T +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYT--RQIL 116
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR----LAPEGKGSIETRIAG 564
+GV YLH +HRD+K +NIL K+ DFG + + G G I++ + G
Sbjct: 117 QGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG-IKS-VTG 171
Query: 565 TFGYLAPE 572
T +++PE
Sbjct: 172 TPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 35/203 (17%)
Query: 384 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEF--- 440
I LR +F ++GRG FG V ++ + V + K L++F
Sbjct: 32 AEKITKLRMKAEDFDVIKVIGRGAFGEV---------QLVRHKSSKQVYAMKLLSKFEMI 82
Query: 441 -KSEIAVLTKVRH-------RHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEE 490
+S+ A + R +V L H ++K L V EYMP G L + N+
Sbjct: 83 KRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-- 138
Query: 491 GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VR 549
P +W R T A V L + FIHRD+KP N+LL K+ADFG ++
Sbjct: 139 --IPEKWARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 550 LAPEGKGSIETRIAGTFGYLAPE 572
+ G +T + GT Y++PE
Sbjct: 192 MDANGMVRCDTAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 23/191 (12%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM-----EAGVISGKGLTEFKSEIAVLT 448
+ + + +G G +G VYK + + G +A+K+ E G+ T + EI++L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPP----TALR-EISLLQ 55
Query: 449 KVRHR-HLVALLG--HCLDGNEKL---LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 502
+ ++V LL H + N K LVFEY+ L + + + +PL +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPEGKGSIETR 561
+ +GV + H +HRDLKP N+L+ K+AD GL R S
Sbjct: 115 FMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 562 IAGTFGYLAPE 572
I T Y APE
Sbjct: 172 IV-TLWYRAPE 181
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 7e-11
Identities = 52/149 (34%), Positives = 81/149 (54%), Gaps = 12/149 (8%)
Query: 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
LG G + TVYKG+ +G +A+K + G T + E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 462 CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
+ E L LVFEY+ L +++ + GL P N +L + + RG+ Y+H +
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPE--NVKLFL-FQLLRGLSYIH---QR 122
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+HRDLKP N+L+ D K+ADFGL R
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 7e-11
Identities = 47/178 (26%), Positives = 93/178 (52%), Gaps = 14/178 (7%)
Query: 397 FSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
F++ +G+G FG V+KG + + T+ +A+K ++ + + + + EI VL++ +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPY 63
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+ G L G + ++ EY+ G+ + G P + + T+ ++ +G++YL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAG--PFDEFQIATMLKEILKGLDYL 117
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
H + IHRD+K +N+LL + K+ADFG+ + + T + GT ++APE
Sbjct: 118 HS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 17/188 (9%)
Query: 400 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
+ ++G+G +G V + H G K+A+K++ T EI +L +RH +V +
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 459 LGHCL-----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
L + + +VFE M H A + L P L L R ++Y
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQLL---RALKY 118
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSI-ETRIAGTFGYLAP 571
+H + HRDLKP NIL D + K+ DFGL R+A + +I T T Y AP
Sbjct: 119 IHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 572 EYAGNFGS 579
E G+F S
Sbjct: 176 ELCGSFFS 183
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 20/159 (12%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFKSEIAVLTKVR---HRHLV 456
+G G +GTVYK + H G +A+K R++ G L+ + E+A+L ++ H ++V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 457 ALLGHC----LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
L+ C D K+ LVFE++ Q L ++ GL P E + L RG+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGL-PAETIKDLMRQF--LRGL 121
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
++LH +HRDLKP NIL+ + K+ADFGL R+
Sbjct: 122 DFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 376 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISG 434
Q A +V+ R+ +NF + +G G G V + G ++AVK+M+
Sbjct: 3 QFRAALQLVVDPGDPRSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR 59
Query: 435 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGL 492
+ L +E+ ++ +H ++V + L G+E +V E++ G L+ + EE +
Sbjct: 60 REL--LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 117
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552
T+ L V + + +LH Q IHRD+K +ILL D R K++DFG
Sbjct: 118 A--------TVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFC---- 162
Query: 553 EGKGSIET----RIAGTFGYLAPE 572
+ S E + GT ++APE
Sbjct: 163 -AQVSKEVPRRKSLVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/197 (30%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 396 NFSEENILGRGGFGTV----YKGELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKV 450
+F+ LG G FG V YK E D +A+KR E + +I K + SE +L +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 504
H V L G D + LV E++ G E L N+R A
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGG-----------EFFTFLRRNKRFPNDVGCFYA 137
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--- 561
+ EYL L + ++RDLKP N+LL D K+ DFG ++ ++TR
Sbjct: 138 AQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYT 187
Query: 562 IAGTFGYLAPEYAGNFG 578
+ GT Y+APE N G
Sbjct: 188 LCGTPEYIAPEILLNVG 204
|
Length = 340 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 57/205 (27%)
Query: 393 VTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKS--------- 442
V + + + +G G +G V G K+A+K++ F+S
Sbjct: 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---------SRPFQSAIHAKRTYR 63
Query: 443 EIAVLTKVRHRHLVALLG--HCLDGNEKL----LVFEYMPQ--GTLSRHIFNWAEEGLKP 494
E+ +L + H +++ LL E LV M + +
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC----------- 112
Query: 495 LEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548
++L+ + + RG++Y+H A IHRDLKPSNI + +D K+ DFGL
Sbjct: 113 ----QKLSDDHIQFLVYQILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLA 165
Query: 549 RLAP-EGKGSIETRIAGTFGYLAPE 572
R E G + TR Y APE
Sbjct: 166 RHTDDEMTGYVATR-----WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 397 FSEENILGRGGFGTVY-KGELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRH 454
F++ +G G FG VY ++ +A+K+M +G S + + E+ L +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+ G L + LV EY G+ S + E KPL+ I +G+ YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSAS----DLLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
H + IHRD+K NILL + + K+ADFG +A S GT ++APE
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 2e-10
Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 374 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 432
D +++E ++SI + ++ +G+G GTV+ ++ G ++A+K++
Sbjct: 1 DEEIMEKLRTIVSIG---DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ 57
Query: 433 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 492
K L +EI V+ ++++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 58 PKKEL--IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC---- 111
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 551
++ + + + + +E+LH IHRD+K N+LLG D K+ DFG ++
Sbjct: 112 --MDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166
Query: 552 PEGKGSIETRIAGTFGYLAPE 572
PE S + + GT ++APE
Sbjct: 167 PE--QSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 17/153 (11%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRM-----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
+G G +G VYKG G +A+K++ E GV S T + EI++L +++H ++V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS----TAIR-EISLLKELQHPNIV 62
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
L + + L+FE++ L +++ + + E + + +G+ + H
Sbjct: 63 CLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYL--YQILQGILFCH- 118
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 397 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRH 454
FS+ +G G FG VY ++ + +A+K+M +G S + + E+ L K+RH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+ G L + LV EY G+ S + E KPL+ + +G+ YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSAS----DLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
H + IHRD+K NILL + K+ DFG + + GT ++APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 22/160 (13%)
Query: 400 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
E ++G G FG V G L K +A+K ++AG + K +F SE +++ + H ++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL-----DVARG 510
+ L G ++V EYM G+L F +G + I L +A G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDA--FLRKHDG-------QFTVIQLVGMLRGIASG 118
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
++YL + ++HRDL NIL+ ++ KV+DFGL R+
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 56/175 (32%), Positives = 78/175 (44%), Gaps = 21/175 (12%)
Query: 403 LGRGGFGTVY-KGELHDGTKIAVKRMEAGVISGKGLTE----FKSEIAVLTKVRHRHLVA 457
+G G FG VY H +AVK+M SGK E E+ L +++H + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS---YSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
G L + LV EY G+ S + E KPL+ I +G+ YLH
Sbjct: 86 YKGCYLKEHTAWLVMEYC-LGSAS----DLLEVHKKPLQEVEIAAITHGALQGLAYLHS- 139
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ IHRD+K NILL + + K+ADFG K S GT ++APE
Sbjct: 140 --HNMIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 16/151 (10%)
Query: 403 LGRGGFGTVYKG--ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
LG G + TVYKG +L D +A+K + G T + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL-- 69
Query: 461 HCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
H + EK LVFEY L + + + ++ + + + RG+ Y H
Sbjct: 70 HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 31/68 (45%), Positives = 39/68 (57%), Gaps = 7/68 (10%)
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE----TRIAG 564
+ ++Y+H + IHRDLKPSNILL D R K+ADFGL R E + + E T
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 565 TFGYLAPE 572
T Y APE
Sbjct: 175 TRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
LG G G+V K + + GT +A K + G S + E+ ++ + R ++V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-SVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
L+ N + E+M G+L R I+ + P+ IA+ V G+ YL+ +
Sbjct: 72 FLNENNICMCMEFMDCGSLDR-IY----KKGGPIPVEILGKIAVAVVEGLTYLYNVHR-- 124
Query: 522 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+HRD+KPSNIL+ + K+ DFG ++ E SI GT Y++PE
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFG---VSGELINSIADTFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 13/189 (6%)
Query: 387 IQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAG--VISGKGLTEFKSEI 444
I+ LR ++ ++GRG FG V K+ ++ + +I F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 445 AVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 504
++ +V L D +V EYMP G L + N+ P +W R T
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAE 150
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIA 563
+ +A L + FIHRD+KP N+LL K+ADFG +++ EG +T +
Sbjct: 151 VVLA-----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 564 GTFGYLAPE 572
GT Y++PE
Sbjct: 205 GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 26/186 (13%)
Query: 399 EENILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHR 453
ENI G G +G V + G K+A+K++ + ++ + L E K +L +H
Sbjct: 10 IENI-GSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHD 64
Query: 454 HLVALLGHCL----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+++A+ D + +V + M + L I +PL + R
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIH-----SDQPLTEEHIRYFLYQLLR 118
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---PEGKGSIETRIAGTF 566
G++Y+H + IHRDLKPSN+L+ +D ++ DFG+ R P T T
Sbjct: 119 GLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 567 GYLAPE 572
Y APE
Sbjct: 176 WYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 17/174 (9%)
Query: 400 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
+ ILG G GTVYK L +AVK + I+ + + SE+ +L K +++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
G N + E+M G+L + P R IA+ V +G+ YL L
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGR--IAVAVVKGLTYLWSL- 114
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+HRD+KPSN+L+ + K+ DFG+ + SI GT Y+APE
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 402 ILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFK-SEIAVLTKVRHRHLVALL 459
+LG+G FG V L G AVK ++ VI E +E +L+ R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 460 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
C ++L V E++ G L HI + + + R A ++ + +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLH--- 113
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 572
+ I+RDLK N+LL + K+ADFG+ + EG G + GT Y+APE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 45/125 (36%), Positives = 66/125 (52%), Gaps = 6/125 (4%)
Query: 28 NAKLGGGIDVIQ-NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLV 86
N L G I+ + +M SL+ + L N F G LPD G K+LE+L L N F+G VP L
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLG 496
Query: 87 KLESLKIVNMTNNLLQGPVPEFDRS----VSLDMAKGSNNFCLPSPGACDPRLNAL-LSV 141
L L + ++ N L G +P+ S VSLD++ + +P+ + P L+ L LS
Sbjct: 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQ 556
Query: 142 VKLMG 146
+L G
Sbjct: 557 NQLSG 561
|
Length = 968 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 11/184 (5%)
Query: 396 NFSEENILGRGGFGTVY--KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+ +G G FG +Y K + D +K ++ + K K E+ +L K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
++V + +V EY G L + I + G+ ++ L+ + ++ G+++
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINR--QRGVL-FSEDQILSWFVQISLGLKH 116
Query: 514 LHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+H + +HRD+K NI L + M AK+ DFG+ R + T GT YL+PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPE 172
Query: 573 YAGN 576
N
Sbjct: 173 ICQN 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 38/201 (18%)
Query: 402 ILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVA 457
++G+GG G VY +D ++A+K++ + L + F E + + H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 458 LLGHCLDGNEKLLVFEYMP--QGTLSRHIFN--WAEEGL-KPLEWNRR----LTIALDVA 508
+ C DG+ V+ MP +G + + W +E L K L L+I +
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL---VRLAPEGKGSIET----- 560
+EY+H + +HRDLKP NILLG + D+G +L E I+
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 561 ---------RIAGTFGYLAPE 572
+I GT Y+APE
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 393 VTNNFSEENILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 451
V + + + +G G +GTV + G K+A+K++ S E+ +L ++
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 452 HRHLVALLG-----HCLDG-NEKLLVFEYMPQ--GTLSRHIFNWAEEGLKPLEWNRRLTI 503
H +++ LL LD ++ LV +M G L +H + L +R +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---------EKLSEDRIQFL 123
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRI 562
+ +G++Y+H IHRDLKP N+ + +D K+ DFGL R E G + TR
Sbjct: 124 VYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR- 179
Query: 563 AGTFGYLAPE 572
Y APE
Sbjct: 180 ----WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 2/106 (1%)
Query: 135 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN-ITVINFQKMNLTGTISPEFA 193
L LLS + P ++ NW + W G+TC + + I+ N++G IS
Sbjct: 31 LELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIF 90
Query: 194 SFKSLQRLILADNNLSGMIPEGLSVLG-ALKELDVSNNQLYGKIPS 238
+Q + L++N LSG IP+ + +L+ L++SNN G IP
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136
|
Length = 968 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 56/177 (31%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVAL 458
+LG+G FG V EL ++ AVK ++ VI E +E VL +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 459 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
C ++L V EY+ G L HI + + R A ++ G+++LH
Sbjct: 62 HS-CFQTKDRLFFVMEYVNGGDLMFHI-----QRSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 572
+ I+RDLK N+LL + K+ADFG+ + EG G + GT Y+APE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 396 NFSEENILGRGGFGTVY----KGELHDGTKIAVKRMEAGVISGKGLT--EFKSEIAVLTK 449
NF +LG G +G V+ G G A+K ++ I K T ++E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 450 VRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIF---NWAEEGLKPLEWNRRLTIAL 505
VR + L + + KL L+ +Y+ G L H++ ++ E + R+ IA
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV-------RVYIA- 112
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 565
++ +++LH L I+RD+K NILL + + DFGL + + GT
Sbjct: 113 EIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 566 FGYLAPE 572
Y+APE
Sbjct: 170 IEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 54/160 (33%), Positives = 84/160 (52%), Gaps = 31/160 (19%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRM-----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
+G G +G VYK + IA+K++ + GV S T + EI++L +++H ++V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPS----TAIR-EISLLKEMQHGNIV 64
Query: 457 ALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL--TIALDVARGVE 512
L + +EK LVFEY+ L +H+ + + N RL T + RG+
Sbjct: 65 RL--QDVVHSEKRLYLVFEYLDL-DLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIA 116
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRA---KVADFGLVR 549
Y H +H+ +HRDLKP N+L+ D R K+ADFGL R
Sbjct: 117 YCH--SHR-VLHRDLKPQNLLI--DRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 28/204 (13%)
Query: 376 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISG 434
Q A MV+ R++ N+ + +G G G V E H G ++AVK M+
Sbjct: 5 QFKAALRMVVDQGDPRSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR 61
Query: 435 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGL 492
+ L +E+ ++ +H+++V + L G E ++ E++ G L+ + EE +
Sbjct: 62 REL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI 119
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LV 548
T+ V + + YLH Q IHRD+K +ILL D R K++DFG +
Sbjct: 120 A--------TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168
Query: 549 RLAPEGKGSIETRIAGTFGYLAPE 572
+ P+ K + GT ++APE
Sbjct: 169 KDVPKRKS-----LVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 16/176 (9%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFK-SEIAVLTKVRHRHLVALL 459
+LG+G FG V EL ++ A+K ++ VI + +E +L + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 460 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
C ++L V EY+ G L I + + + R A +V + +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQI-----QRSRKFDEPRSRFYAAEVTLALMFLH--- 113
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 572
I+RDLK NILL + K+ADFG+ + EG G T GT Y+APE
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 28/182 (15%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
+LG+G FG V EL + A+K ++ V+ L + E ++ R ++AL
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVV----LEDDDVECTMV----ERRVLALAW 53
Query: 461 HC---------LDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
E L V EY+ G L HI + + R A ++ G
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGRFDEARARFYAAEIICG 108
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 570
+++LH + I+RDLK N+LL D K+ADFG+ + G+G T GT Y+A
Sbjct: 109 LQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164
Query: 571 PE 572
PE
Sbjct: 165 PE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 23/179 (12%)
Query: 402 ILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRH---RHLV 456
++GRG +G VY+G H T +A+K + +++ + E+A+L+++R ++
Sbjct: 8 LIGRGAYGAVYRG-KHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNIT 65
Query: 457 ALLGHCLDGNEKLLVFEYMPQG---TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
G L G ++ EY G TL + P+ I +V ++Y
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMK---------AGPIAEKYISVIIREVLVALKY 116
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+H IHRD+K +NIL+ + K+ DFG+ L + T GT ++APE
Sbjct: 117 IH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPE 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 66/259 (25%), Positives = 109/259 (42%), Gaps = 37/259 (14%)
Query: 3 QLIGGLPASFSGSQIQSLWVNGQNGN--AKLGGG-------IDVIQNM------------ 41
QL G +P + ++N N N + G +D+ NM
Sbjct: 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSF 163
Query: 42 TSLKEIWLHSNAFSGPLPDFSG-VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
+SLK + L N G +P+ + LE L+L N G +P L +++SLK + + N
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223
Query: 101 LQGPVP-EFDRSVSLD-MAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 158
L G +P E SL+ + NN P P L L ++ L Y + + G
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIP----SSLGNLKNLQYLFLYQNKLS----GP 275
Query: 159 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 218
P S + + + ++ +L+G I ++L+ L L NN +G IP L+
Sbjct: 276 IPPSIF-SLQ----KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 219 LGALKELDVSNNQLYGKIP 237
L L+ L + +N+ G+IP
Sbjct: 331 LPRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 41/198 (20%)
Query: 44 LKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 102
L ++ L SN+ G +P + L + L+DN F+G +P KL + ++++NN LQ
Sbjct: 382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ 441
Query: 103 GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMG-YPQRFAENWKGNDP 160
G + S DM P L L L+ K G P F
Sbjct: 442 GRI----NSRKWDM----------------PSLQMLSLARNKFFGGLPDSFGSK------ 475
Query: 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 220
+ ++ + +G + + S L +L L++N LSG IP+ LS
Sbjct: 476 ------------RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK 523
Query: 221 ALKELDVSNNQLYGKIPS 238
L LD+S+NQL G+IP+
Sbjct: 524 KLVSLDLSHNQLSGQIPA 541
|
Length = 968 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 29/176 (16%)
Query: 394 TNNFSEENILGRGGFGTVYKGELHDGT------KIAVKRMEAGVISGKGLTEFKSEIAVL 447
T F EE LG FG VYKG L +A+K ++ G EFK E +
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMR 62
Query: 448 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF--------------NWAEEGLK 493
++++H ++V LLG ++F Y L + + L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 494 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
P ++ + I +A G+E+L + +H+DL N+L+ D + K++D GL R
Sbjct: 123 PADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 396 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR 451
N+ +LG+G FG VY ++ G ++A K+++ S K ++ + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 452 HRHLVALLGHCLDGNEKLLV--FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
H +V G D EK L EYMP G++ + + G R+ T +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY---GALTESVTRKYT--RQILE 117
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIAGT 565
G+ YLH +HRD+K +NIL K+ DFG L + G G + GT
Sbjct: 118 GMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI--RSVTGT 172
Query: 566 FGYLAPE 572
+++PE
Sbjct: 173 PYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 400 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
E ILG G FG + +G L +K +A+ + AG S K F +E L + H ++
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNI 68
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
V L G GN ++V EYM G L F EG L + + + +A G++Y
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEG--QLVAGQLMGMLPGLASGMKY-- 122
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL--APE 572
L+ ++H+ L +L+ D+ K++ F RL + +I T ++G L APE
Sbjct: 123 -LSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPE 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 25/178 (14%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLVALL 459
LG G FG VYK + + +A A VI K L ++ EI +L H ++V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA----AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---IALDVARGVEYLHG 516
N ++ E+ G + + LE R LT I + + +E L+
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVM----------LELERPLTEPQIRVVCKQTLEALNY 118
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPE 572
L IHRDLK NIL D K+ADFG ++ + +I+ R GT ++APE
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 20/187 (10%)
Query: 396 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR 451
N+ +LG+G FG VY + G ++AVK+++ S K + + EI +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 452 HRHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
H +V G D E+ L E+MP G++ + ++ G R+ T +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYT--RQILE 117
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIAGT 565
GV YLH +HRD+K +NIL K+ DFG L + G G + GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGT 172
Query: 566 FGYLAPE 572
+++PE
Sbjct: 173 PYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/174 (32%), Positives = 80/174 (45%), Gaps = 12/174 (6%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEA-GVISGKGLTEFKSEIAVLTK-VRHRHLVAL 458
++G+G FG V K AVK ++ ++ K SE VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
++ V +Y+ G L H+ L+P R A ++A + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEP----RARFYAAEIASALGYLHSL- 115
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ ++RDLKP NILL + DFGL + E G+ T GT YLAPE
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 399 EENILGRGGFGTVYKGE-LHDGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
EEN++ RG G YKG+ + +G + VK + + I SEIA + K++H ++V
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIV 746
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
L+G C L+ EY+ LS E L+ L W RR IA+ +A+ + +LH
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLS--------EVLRNLSWERRRKIAIGIAKALRFLHC 798
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ + +L P I++ D +RL+ G +T+ + Y+APE
Sbjct: 799 RCSPAVVVGNLSPEKIII------DGKDEPHLRLSLPGLLCTDTKCFISSAYVAPE 848
|
Length = 968 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
+GRG FG V+ G L D T +AVK + +F E +L + H ++V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 521
C +V E + G + EG + L+ + + + A G+EYL +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRT---EGPR-LKVKELIQMVENAAAGMEYLES---KH 114
Query: 522 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554
IHRDL N L+ + K++DFG+ R +G
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 17/185 (9%)
Query: 396 NFSEENILGRGGFGTVY---KGELHDGTKI-AVKRMEAGVISGKGLT--EFKSEIAVLTK 449
NF +LG G +G V+ K HD K+ A+K ++ I K T ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 450 VRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL-DV 507
+R + L + + KL L+ +Y+ G L H+ E K E + I ++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ--RERFKEQE----VQIYSGEI 114
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 567
+E+LH L I+RD+K NILL + + DFGL + E + GT
Sbjct: 115 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 568 YLAPE 572
Y+AP+
Sbjct: 172 YMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 452
++F ++GRG FG V + D I A+K++ + K ++E +L + +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQG---TL--SRHIFNWAEEGLKPLEWNRRLTIALDV 507
+V L D N L+ EY+P G TL + F EE R IA +
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF--TEEE-------TRFYIA-ET 110
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
++ +H L +IHRD+KP N+LL K++DFGL
Sbjct: 111 ILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
LG G + TV+KG +A+K + G T + E+++L ++H ++V L H
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTL--H 69
Query: 462 CLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
+ E+ LVFEY+ L +++ N + + + RG+ Y H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---K 121
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 17/184 (9%)
Query: 395 NNFSEENILGRGGFGTVY-KGELHDGTKIAVKRMEAGVISGKGLTEF-KSEIAVLTKVRH 452
+F ++++GRG FG V E G A+K M+ V+ + F + E +L+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVA 508
+ L D + LV EY P G L +R+ + E+ +A
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDED-----------MAQFYLA 109
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 568
V +H + ++HRD+KP N+L+ K+ADFG K GT Y
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 569 LAPE 572
+APE
Sbjct: 170 IAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 402 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALL 459
+LG+G FG V E G A+K + VI K + +E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+ +++L V EY G L F+ + E + R ++ +EYLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL---FFHLSRE--RVFTEERARFYGAEIVSALEYLHS-- 113
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ ++RD+K N++L D K+ DFGL + +++T GT YLAPE
Sbjct: 114 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 59/177 (33%), Positives = 85/177 (48%), Gaps = 18/177 (10%)
Query: 402 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTK-VRHRHLVAL 458
++G+G FG V + DG AVK ++ ++ + K +E VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 459 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
+ EKL V +++ G L F+ E P E R A ++A + YLH +
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFP-EPRARFYAA-EIASALGYLHSI 115
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 572
+ ++RDLKP NILL + DFGL + EG + T GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 59/173 (34%), Positives = 81/173 (46%), Gaps = 13/173 (7%)
Query: 403 LGRGGFGTVYKGELHDGTKI-AVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
+G+G FG V + D +I A+K + +A ++S +T +E VL +V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 461 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
EKL LV ++ G L H+ EG L R T L A +E LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCA--LENLHKF-- 112
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLKP NILL + DFGL +L + T GT YLAPE
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 42/199 (21%)
Query: 393 VTNNFSEENILGRGGFGTVYKGELHD--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTK- 449
+ + +GRG FGTV K LH GT +AVKR+ + V K ++ V+ +
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRS 59
Query: 450 ------VRHRHLVALLGHC------LDGN-EKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 496
V+ + G C +D + +K + Y + + EE L
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL----KSVIP--EEILG--- 110
Query: 497 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK- 555
IA+ + + YL IHRD+KPSNILL + K+ DFG+ G+
Sbjct: 111 -----KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI-----SGQL 158
Query: 556 -GSI-ETRIAGTFGYLAPE 572
SI +TR AG Y+APE
Sbjct: 159 VDSIAKTRDAGCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 42/128 (32%), Positives = 59/128 (46%), Gaps = 17/128 (13%)
Query: 137 ALLSVVKLMGYPQRFAENWKGNDPCSD----WIGVTC----TKGN--ITVINFQKMNLTG 186
AL ++ +G P RF W G DPC W G C TKG I + L G
Sbjct: 376 ALQTLKSSLGLPLRFG--WNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRG 432
Query: 187 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSN 242
I + + + LQ + L+ N++ G IP L + +L+ LD+S N G IP S
Sbjct: 433 FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492
Query: 243 AIVNTDGN 250
I+N +GN
Sbjct: 493 RILNLNGN 500
|
Length = 623 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-09
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 405 RGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLGHC 462
RG FG VY G + +K+ AVK ++ + K + ++E L + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 463 LDGNEKLLVFEYMPQGTLSR--HIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
N LV EY+ G + HI+ + +E + I+ +VA ++YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA------VKYIS-EVALALDYLH---RH 123
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
IHRDLKP N+L+ ++ K+ DFGL ++
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 58/217 (26%), Positives = 84/217 (38%), Gaps = 74/217 (34%)
Query: 400 ENILGRGGFGTVYKGELHDGTK------IAVKRMEAGVISGKGLTEFK---SEIAVLTKV 450
LGRG FG V + K +AVK ++ G + +E+K +E+ +L +
Sbjct: 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA----SEYKALMTELKILIHI 67
Query: 451 -RHRHLVALLGHCLDGNEKLLVF-EYMPQGTLS------RHIF----------------- 485
H ++V LLG C L+V EY G LS R F
Sbjct: 68 GHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127
Query: 486 ------------------NWAEE-GLKPLE--------WNRRLTI------ALDVARGVE 512
+ E+ L +E + LT+ + VARG+E
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 188 FL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 52/187 (27%), Positives = 86/187 (45%), Gaps = 21/187 (11%)
Query: 396 NFSEENILGRGGFGTVY---KGELHDGTKI---AVKRMEAGVISGKGLTEFKSEIAVLTK 449
NF +LG G +G V+ K HD K+ V + A V K + ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 450 VRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIF---NWAEEGLKPLEWNRRLTIAL 505
VR + L + KL L+ +Y+ G + H++ N++E+ ++ ++ + +AL
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF--YSGEIILAL 118
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 565
E+LH L ++RD+K NILL + + DFGL + + GT
Sbjct: 119 ------EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169
Query: 566 FGYLAPE 572
Y+APE
Sbjct: 170 IEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 53/174 (30%), Positives = 85/174 (48%), Gaps = 12/174 (6%)
Query: 402 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALL 459
+LG+G FG V E G A+K ++ VI K + +E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+ +++L V EY G L F+ + E + +R ++ ++YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL---FFHLSRE--RVFSEDRARFYGAEIVSALDYLH--S 113
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++ ++RDLK N++L D K+ DFGL + + +++T GT YLAPE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 30/187 (16%)
Query: 396 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLT--EFKS--------EIA 445
+F + LG G G V K V +G+I + L E K E+
Sbjct: 2 DFEKLGELGAGNGGVVTK----------VLHRPSGLIMARKLIHLEIKPAIRNQIIRELK 51
Query: 446 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
VL + ++V G E + E+M G+L + + + G P +++IA
Sbjct: 52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIA- 107
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 565
V RG+ YL +HRD+KPSNIL+ K+ DFG ++ + S+ GT
Sbjct: 108 -VLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGT 161
Query: 566 FGYLAPE 572
Y++PE
Sbjct: 162 RSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 56/191 (29%), Positives = 81/191 (42%), Gaps = 38/191 (19%)
Query: 396 NFSEENILGRGGFGTVYKGELHDGT------KIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
+F LG G FG V + H GT K KR ++ K + E ++L +
Sbjct: 19 DFEMGETLGTGSFGRVRIAK-HKGTGEYYAIKCLKKRE---ILKMKQVQHVAQEKSILME 74
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+ H +V ++ D N + E++ G L H+ + G P N DVA+
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFP---N-------DVAK 121
Query: 510 --------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 561
EYLH I+RDLKP N+LL + KV DFG + P+ +
Sbjct: 122 FYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT---- 174
Query: 562 IAGTFGYLAPE 572
+ GT YLAPE
Sbjct: 175 LCGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 403 LGRGGFGTVYKG--ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
LG G + TV+KG +L + +A+K + G T + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
LVFEY L + + + ++ + + + RG+ Y H +
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RR 123
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+HRDLKP N+L+ + K+ADFGL R
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 52/174 (29%), Positives = 76/174 (43%), Gaps = 12/174 (6%)
Query: 402 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL 459
+LG+G FG V+ EL A+K ++ V+ E E VL+ + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 460 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
E L V EY+ G L HI + + R A ++ G+++LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQFLHS-- 114
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ ++RDLK NILL D K+ADFG+ + G T GT Y+APE
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 11/173 (6%)
Query: 402 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALL 459
+LG+G FG V E G A+K ++ VI K + +E VL RH L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
+ V EY+ G L F+ + E + +R ++ ++YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL---FFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS--- 113
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++RDLK N++L D K+ DFGL + +++T GT YLAPE
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 14/151 (9%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG 460
+G G F V K G A+K M+ S + + EI L ++ H +++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 461 HCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
D +L LVFE M +++ + +PL R + + + ++++H
Sbjct: 66 VLFDRKTGRLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-- 118
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ F HRD+KP NIL+ DD K+ADFG R
Sbjct: 119 NGIF-HRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 401 NILGRGGFGTVYKG-ELHDGTKIAVKR--MEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457
+G+G FG V+K +A+K+ ME G +T + EI +L ++H ++V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALR-EIKILQLLKHENVVN 75
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-------- 509
L+ C + Y L +F + E L L N+ + L +
Sbjct: 76 LIEIC--RTKATPYNRYKGSFYL---VFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPEGKGSIETRIAGTF 566
G+ Y+H +HRD+K +NIL+ D K+ADFGL R L+ K + T T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 567 GYLAPE 572
Y PE
Sbjct: 188 WYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 26/163 (15%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKG-LTEFKSEIAVLTKVRH 452
+F ++G+G FG V + D KI A+K + + K L K+E VL +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--- 509
+V+L D L+ E++P G L + + T + DV R
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD-------------TFSEDVTRFYM 107
Query: 510 -----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
+E +H L FIHRD+KP NIL+ K++DFGL
Sbjct: 108 AECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 34/147 (23%), Positives = 62/147 (42%), Gaps = 13/147 (8%)
Query: 402 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
+ K + T +AVK++ S + L + EI +++H +++ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL---DVARGVEYLHGLA 518
+ +E +V M G+ + EGL L IA DV ++Y+H
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNALDYIH--- 118
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADF 545
+ FIHR +K S+ILL D + ++
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 12/175 (6%)
Query: 403 LGRGGFGTVY-----KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457
LG+G FGTVY K + K+ +K + G ++ + E +L+K+ H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
L+ + ++ EY L + G K L N+ + + GV Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVHYMH-- 123
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ +HRDLK NI L +++ K+ DFG+ RL G + T GT Y++PE
Sbjct: 124 -QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 57/180 (31%), Positives = 81/180 (45%), Gaps = 25/180 (13%)
Query: 402 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLTKVRHRHL 455
+LG+G FG V E G A+K ++ VI K LTE + VL RH L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR----VLQNTRHPFL 57
Query: 456 VALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
AL + +++L V EY G L H+ + E + +R ++ + YL
Sbjct: 58 TAL-KYSFQTHDRLCFVMEYANGGELFFHL---SRERV--FSEDRARFYGAEIVSALGYL 111
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 572
H ++RDLK N++L D K+ DFGL + EG G+ GT YLAPE
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 402 ILGRGGFGTVY-----KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
+LG+G FG V+ G G A+K ++ + + K E +L +V H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 457 ALLGHCLDGNEKL-LVFEYMPQGT----LSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
L + KL L+ +++ G LS+ + + EE +K + L +ALD
Sbjct: 62 KL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVK--FYLAELALALD----- 112
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
+LH L I+RDLKP NILL ++ K+ DFGL + + + + + GT Y+AP
Sbjct: 113 -HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 167
Query: 572 E 572
E
Sbjct: 168 E 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 403 LGRGGFGTVYKGELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
LG+G +G+VYK LH T + A+K + + K + E+ +L K ++V G
Sbjct: 9 LGKGNYGSVYKV-LHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
+ EYM G+L + P + RR+T A V +G+++L
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLK--EEH 122
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA----GTFGYLAPE 572
+ IHRD+KP+N+L+ + + K+ DFG+ G++ +A G Y+APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGV-------SGNLVASLAKTNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 23/183 (12%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
+G G +G+V + G ++AVK++ S E+ +L ++H +++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 82
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYLH 515
D E L H+ L + ++LT + + RG++Y+H
Sbjct: 83 --DVFTPARSLEEFNDVYLVTHLMG---ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPEYA 574
IHRDLKPSN+ + +D K+ DFGL R E G + TR Y APE
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 189
Query: 575 GNF 577
N+
Sbjct: 190 LNW 192
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 16/176 (9%)
Query: 403 LGRGGFGTVYKGELHDGTK---IAVKRMEAGVISGKGLT-EFKSEIAVLTKVRHRHLVAL 458
LG G FG V KG K +A+K ++ + K + E E ++ ++ + ++V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+G C + +LV E G L++ + +E + + + + V+ G++YL G
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLEG-- 113
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLAPE 572
++F+HRDL N+LL + AK++DFGL + + R AG + + APE
Sbjct: 114 -KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 46/152 (30%), Positives = 68/152 (44%), Gaps = 20/152 (13%)
Query: 403 LGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
+G G FG V D + A+K + A V+ K+E +L + + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 461 HCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
D + V +Y+P G + IF EE L R IA ++ +E +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIF---EEDLA------RFYIA-ELTCAIESVH 118
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
+ FIHRD+KP NIL+ D K+ DFGL
Sbjct: 119 KMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 53/174 (30%), Positives = 77/174 (44%), Gaps = 12/174 (6%)
Query: 402 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL 459
+LG+G FG V EL G AVK ++ V+ E E VL + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 460 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
E L V E++ G L HI ++G + R A ++ G+++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHI---QDKG--RFDLYRATFYAAEIVCGLQFLHS-- 114
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLK N++L D K+ADFG+ + G T GT Y+APE
Sbjct: 115 -KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 403 LGRGGFGTVYKG--ELHDGTK-IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
LG G FGTV KG ++ K +AVK ++ E E V+ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEY 513
G C + +LV E G L+ K L+ N+ +T + V+ G++Y
Sbjct: 63 GIC-EAESWMLVMELAELGPLN-----------KFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
L +F+HRDL N+LL AK++DFGL
Sbjct: 111 LE---ETNFVHRDLAARNVLLVTQHYAKISDFGL 141
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRH--LVA 457
I+GRGGFG VY D K+ A+K ++ I K G T +E +L+ V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 458 LLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
+ + +KL + + M G L H+ K + + A ++ G+E++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMH- 114
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++ ++RDLKP+NILL + +++D GL + K GT GY+APE
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 28/164 (17%)
Query: 403 LGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
LG G G V+ D ++AVK++ + + + EI ++ ++ H ++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIV--LTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 462 CLDGNEKL--------------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 507
L +V EYM + L+ + E+G E R L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL----EQGPLSEEHARLFMYQL-- 123
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRL 550
RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL R+
Sbjct: 124 LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 16/176 (9%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRH--LVA 457
I+GRGGFG VY D K+ A+K ++ I K G T +E +L+ V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 458 LLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
+ + +KL + + M G L H+ ++ G+ E R A ++ G+E++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFS-EAEMRF-YAAEIILGLEHMH- 114
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++ ++RDLKP+NILL + +++D GL + K GT GY+APE
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 403 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRH---LVA 457
+G+G FG VY+ D +I A+K + I + K + E +L + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
L ++ LV +YM G L H+ +EG E + IA ++ +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFS-EDRAKFYIA-ELVLALEHLH-- 113
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++RDLKP NILL + DFGL + A GT YLAPE
Sbjct: 114 -KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 25/64 (39%), Positives = 36/64 (56%), Gaps = 3/64 (4%)
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 568
RG++YLH A +HRD+KP N+L+ + K+ DFGL R+ + T+ T Y
Sbjct: 114 RGLKYLHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 569 LAPE 572
APE
Sbjct: 171 RAPE 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 28/204 (13%)
Query: 376 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISG 434
Q A MV+ R +NF + +G G G V + G +AVK+M+
Sbjct: 4 QFRAALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR 60
Query: 435 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN--WAEEGL 492
+ L +E+ ++ +H ++V + L G+E +V E++ G L+ + + EE +
Sbjct: 61 REL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV---- 548
+ L V + + LH Q IHRD+K +ILL D R K++DFG
Sbjct: 119 A--------AVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167
Query: 549 RLAPEGKGSIETRIAGTFGYLAPE 572
+ P K + GT ++APE
Sbjct: 168 KEVPRRKS-----LVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 29/64 (45%), Positives = 37/64 (57%), Gaps = 4/64 (6%)
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 568
RG++Y+H + +HRDLKPSN+LL + K+ DFGL R E KG T T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-KGDFMTEYVVTRWY 174
Query: 569 LAPE 572
APE
Sbjct: 175 RAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 30/75 (40%), Positives = 44/75 (58%), Gaps = 14/75 (18%)
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LV-RLAPEGKGS 557
IA+ + + +EYLH + S IHRD+KPSN+L+ + + K+ DFG LV +A
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA------ 159
Query: 558 IETRIAGTFGYLAPE 572
+T AG Y+APE
Sbjct: 160 -KTIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 21/185 (11%)
Query: 396 NFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRHR 453
+F ++GRG FG V +L + K+ A+K + + + T F+ E VL ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVAR 509
+ L D N LV +Y G L + + E P + R + IA+D
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAID--- 116
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGKGSIETRIA-GTFG 567
V LH ++HRD+KP NIL+ + ++ADFG ++L + G++++ +A GT
Sbjct: 117 SVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED--GTVQSSVAVGTPD 168
Query: 568 YLAPE 572
Y++PE
Sbjct: 169 YISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 5/63 (7%)
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
G+++LH IHRDLKPSNI++ D K+ DFGL R A G + T T Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 184
Query: 570 APE 572
APE
Sbjct: 185 APE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 13/193 (6%)
Query: 383 MVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAG--VISGKGLTEF 440
+V I+ L+ ++ ++GRG FG V K+ ++ + +I F
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 441 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 500
E ++ +V L D +V EYMP G L + N+ P +W +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKF 146
Query: 501 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIE 559
T +V ++ +H + IHRD+KP N+LL K+ADFG +++ G +
Sbjct: 147 YTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 560 TRIAGTFGYLAPE 572
T + GT Y++PE
Sbjct: 202 TAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 18/180 (10%)
Query: 403 LGRGGFG-TVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
+G G FG + DG + +K + +S K E + E+AVL+ ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFN-----WAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
+ +V +Y G L + I + E+ + L+W ++ +AL +++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFVQICLAL------KHVH- 118
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576
+ +HRD+K NI L D K+ DFG+ R+ T I GT YL+PE N
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICEN 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 48/195 (24%), Positives = 78/195 (40%), Gaps = 41/195 (21%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKS----EIAVLT 448
N F ++G G +G V K H TK +A+K+ + + E K E+ +L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCR-HKETKEIVAIKKFK----DSEENEEVKETTLRELKMLR 55
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEY-----------MPQGTLSRHIFNWAEEGLKPLEW 497
++ ++V L + LVFEY MP G + ++ + +K + W
Sbjct: 56 TLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 498 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557
+ I +HRD+KP N+L+ + K+ DFG R EG +
Sbjct: 116 CHKNDI-------------------VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156
Query: 558 IETRIAGTFGYLAPE 572
T T Y +PE
Sbjct: 157 NYTEYVATRWYRSPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 53/208 (25%), Positives = 76/208 (36%), Gaps = 52/208 (25%)
Query: 403 LGRGGFGTVYKGELHD-GTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
LG+G G V+ L G A+K ++ +I + +E +L + H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVE 512
LV +Y P G L R L + + L+ +VAR +E
Sbjct: 69 SFQTETYLCLVMDYCPGGELFR---------LLQRQPGKCLSE--EVARFYAAEVLLALE 117
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEG----------------- 554
YLH L ++RDLKP NILL + ++DF L + E
Sbjct: 118 YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 555 KGSIETRIA----------GTFGYLAPE 572
ET GT Y+APE
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 11/181 (6%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 452
++F ++GRG FG V ++ +I A+K + + + T F+ E VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+ + L D N LV +Y G L + + E P + R +A V
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF--EDRLPEDMAR-----FYIAEMVL 113
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA-GTFGYLAP 571
+H + ++HRD+KP N+LL + ++ADFG L G++++ +A GT Y++P
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYISP 172
Query: 572 E 572
E
Sbjct: 173 E 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 38/161 (23%), Positives = 73/161 (45%), Gaps = 19/161 (11%)
Query: 401 NILGRGGFGTVYKGELHDGT-----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
++L G FG ++ G L D ++ VK ++ S +T E +L + H+++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNI 70
Query: 456 VALLGHCLDGNEKLLV-FEYMPQGTL------SRHIFNWAEEGLKPLEWNRRLTIALDVA 508
+ +L C++ E V + YM G L R + L + + +A+ +A
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG---EANNPQALSTQQLVHMAIQIA 127
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
G+ YLH IH+D+ N ++ ++++ K+ D L R
Sbjct: 128 CGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 41/162 (25%), Positives = 82/162 (50%), Gaps = 21/162 (12%)
Query: 403 LGRGGFGTVYKG---ELHDG-----TKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHR 453
LG+G F ++KG E+ D T++ +K ++ S + +E F ++++++ H+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHK 59
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
HLV G C+ G+E ++V EY+ G+L ++ + L + W L+VA+ + +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK--NKNLINISWK------LEVAKQLAW 111
Query: 514 -LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554
LH L + H ++ N+LL + K + ++L+ G
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 26/184 (14%)
Query: 403 LGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGKGLTEFK-SEIAVLTKVR-HRHLVA 457
LG+G +G V E + +A+K++ V S K L + E+ +L R H+++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 458 LLGHCLDG------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
L +D NE L E M + L + I +PL + + G+
Sbjct: 67 LYD--MDIVFPGNFNELYLYEELM-EADLHQII-----RSGQPLTDAHFQSFIYQILCGL 118
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG---TFGY 568
+Y+H + +HRDLKP N+L+ D K+ DFGL R E G + T Y
Sbjct: 119 KYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 569 LAPE 572
APE
Sbjct: 176 RAPE 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 396 NFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFK-SEIAVLTKVRH 452
+F+ +LG+G FG V E GT A+K ++ VI E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
+ L C ++L V EY+ G L HI + + + + A ++A G+
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGL 114
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
+LH + I+RDLK N++L + K+ADFG+ + G + T GT Y+AP
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAP 170
Query: 572 E 572
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 39/207 (18%)
Query: 384 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT-KIAVKRMEAGVISGKGLTEFKS 442
+I + R+ ++ NI+G G FG VY+ D + K+A+K++ ++K+
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKN 107
Query: 443 -EIAVLTKVRHRHLVALLGH----CLDGNEKLL----VFEYMPQGTLSRHIFNWAEEGLK 493
E+ ++ + H +++ L + C NEK + V E++PQ T+ +++ ++A
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN--- 163
Query: 494 PLEWNRRLTIAL------DVARGVEYLHGLAHQSFI-HRDLKPSNILLGDDMRA-KVADF 545
N L + L + R + Y+H FI HRDLKP N+L+ + K+ DF
Sbjct: 164 ----NHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDF 215
Query: 546 GLVRLAPEGKGSIETRIAGTFGYLAPE 572
G + G+ S+ + I F Y APE
Sbjct: 216 GSAKNLLAGQRSV-SYICSRF-YRAPE 240
|
Length = 440 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 26/179 (14%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL-- 459
+G G +G+V + G K+A+K++ S E+ +L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 460 ---GHCLDGNEKL-LVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
D + LV YM Q L + + +E+ ++ L + + G++Y+
Sbjct: 83 FTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYLVYQ--------MLCGLKYI 133
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAGTFGYLAPE 572
H IHRDLKP N+ + +D K+ DFGL R A E G + TR Y APE
Sbjct: 134 HS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 27/185 (14%)
Query: 403 LGRGGFGTV---YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+G G +G+V Y L K+AVK++ S E+ +L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 460 ------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
+ NE LV M G +I + + +++ + + RG++Y
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKY 133
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAGTFGYLAPE 572
+H IHRDLKPSN+ + +D ++ DFGL R A E G + TR Y APE
Sbjct: 134 IHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPE 185
Query: 573 YAGNF 577
N+
Sbjct: 186 IMLNW 190
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 31/81 (38%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 28 NAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSL 85
N L G I + I + L+ I L N+ G +P + LE L L N F G +P+SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 86 VKLESLKIVNMTNNLLQGPVP 106
+L SL+I+N+ N L G VP
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 10/170 (5%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
LG G G V K + I +++ I + E+ VL + ++V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 522
E + E+M G+L + + E P E +++IA V RG+ YL HQ
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIA--VLRGLAYLRE-KHQ-I 125
Query: 523 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+HRD+KPSNIL+ K+ DFG ++ + S+ GT Y++PE
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 24/53 (45%), Positives = 30/53 (56%), Gaps = 2/53 (3%)
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
IHRD+KPSNILL K+ DFG+ + K +TR AG Y+APE
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 402 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
++G+G +G V DG + +K++ S + + E +L++++H ++VA
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY-R 65
Query: 461 HCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+G + LL V + G L + E+ K L N+ + + +A ++YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKL---KEQKGKLLPENQVVEWFVQIAMALQYLH--- 119
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576
+ +HRDLK N+ L KV D G+ R+ E + + + + GT Y++PE N
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSN 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 40/131 (30%), Positives = 68/131 (51%), Gaps = 10/131 (7%)
Query: 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLPD-FSG 63
GGLP SF ++++L ++ +N + G + + +++ L ++ L N SG +PD S
Sbjct: 466 GGLPDSFGSKRLENLDLS-RN---QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS 521
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNN 122
K+L SL L N +G +P S ++ L ++++ N L G +P+ SL S+N
Sbjct: 522 CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN 581
Query: 123 F---CLPSPGA 130
LPS GA
Sbjct: 582 HLHGSLPSTGA 592
|
Length = 968 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRM--EAGVISGKGLTEFKSEIAVLTKVRH 452
++F ++GRG FG V + D I ++ +A ++ + + ++E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+V + D L+ E++P G + + ++ L E + IA + ++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLS--EEATQFYIA-ETVLAID 115
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
+H L FIHRD+KP N+LL K++DFGL
Sbjct: 116 AIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 13/175 (7%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALL 459
++GRG FG V ++ + ++ A+K + + + T F+ E VL R + L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
D N LV +Y G L + + E+ L P + R +A V + +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRL-PEDMAR-----FYLAEMVLAIDSVHQ 120
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGKGSIETRIA-GTFGYLAPE 572
++HRD+KP N+LL + ++ADFG +RL + G++++ +A GT Y++PE
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD--GTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 10/178 (5%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
++F + + LG G G V+K I +++ I + E+ VL + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V G E + E+M G+L + + + G P + +++IA V +G+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA--VIKGLTYL 119
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+HRD+KPSNIL+ K+ DFG ++ + S+ GT Y++PE
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 40/140 (28%), Positives = 61/140 (43%), Gaps = 27/140 (19%)
Query: 443 EIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 502
E+ ++ V H+++++LL + PQ +L + L + +
Sbjct: 66 ELVLMKCVNHKNIISLLN------------VFTPQKSLEEFQDVYLVMELMDANLCQVIQ 113
Query: 503 IALDVAR----------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552
+ LD R G+++LH IHRDLKPSNI++ D K+ DFGL R A
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 169
Query: 553 EGKGSIETRIAGTFGYLAPE 572
G + T T Y APE
Sbjct: 170 -GTSFMMTPYVVTRYYRAPE 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 12/174 (6%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALL 459
++GRG + V L +I A+K ++ ++ + + ++E V + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
C +L LV EY+ G L +F+ + P E R A ++ + +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHAR--FYAAEICIALNFLH--- 113
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLK N+LL D K+ D+G+ + G G + GT Y+APE
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 16/176 (9%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVALL 459
++GRG + V L +I A+K ++ +++ + + ++E V + + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 460 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
C +L V EY+ G L +F+ + P E R + + +A + YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--LNYLH--- 113
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLK N+LL + K+ D+G+ + L P G + GT Y+APE
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GDTTSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 396 NFSEENILGRGGFGTVYKGELHD-GTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHR 453
+F ++GRG FG V + D G A+K + +A ++ + + ++E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
+V + D L+ E++P G + + ++ L E + IA + ++
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLT--EEETQFYIA-ETVLAIDS 116
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
+H L FIHRD+KP N+LL K++DFGL
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 10/153 (6%)
Query: 397 FSEENILGRGGFGTVYKGELHD-GTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRH 454
F + LG G FG V D A+K + + V+ + K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V L D + V +Y+P G + + G+ P + R L A VE +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCA--VESV 117
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
H + FIHRD+KP NIL+ D K+ DFGL
Sbjct: 118 HKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 12/180 (6%)
Query: 396 NFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFKS-EIAVLTKVRHR 453
+F+ +LG+G FG V E ++ A+K ++ V+ E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 454 HLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+ L C ++L V EY+ G L HI + + + + + A +++ G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVGLF 115
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+LH + I+RDLK N++L + K+ADFG+ + G GT Y+APE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 24/60 (40%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 490 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
E PL+ + L + VA+G+++L A ++ IHRD+ N+LL D AK+ DFGL R
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 397 FSEENILGRGGFGTV-YKGELHDGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRH 454
F + LG G FG V ++ A+K + + V++ + K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V L D + V +Y+P G + + + P E R IA ++ +E +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---EVFP-EVLARFYIA-ELTLAIESV 117
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
H + FIHRD+KP NIL+ D K+ DFGL
Sbjct: 118 HKMG---FIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 28/83 (33%), Positives = 39/83 (46%), Gaps = 11/83 (13%)
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-- 550
+PL ++ L I + G+ YLH Q IHRD+K NI + D + + D G +
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 551 -APEGKGSIETRIAGTFGYLAPE 572
AP G +AGT APE
Sbjct: 209 VAPAFLG-----LAGTVETNAPE 226
|
Length = 357 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 5/63 (7%)
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
G+++LH IHRDLKPSNI++ D K+ DFGL R A G + T T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 570 APE 572
APE
Sbjct: 193 APE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 39/120 (32%), Positives = 56/120 (46%), Gaps = 28/120 (23%)
Query: 470 LVFEYMPQG---TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 526
+V EY+ G TL ++I G P++ R + A V +EYLH +HRD
Sbjct: 78 MVMEYVEGGDCATLLKNI------GALPVDMAR-MYFAETVL-ALEYLHNYG---IVHRD 126
Query: 527 LKPSNILLGDDMRAKVADFGLVRLA--------PEGKGSIETR------IAGTFGYLAPE 572
LKP N+L+ K+ DFGL ++ EG +TR + GT Y+APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 23/57 (40%), Positives = 32/57 (56%), Gaps = 3/57 (5%)
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
K L + + VA+G+E+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 24/58 (41%), Positives = 32/58 (55%), Gaps = 3/58 (5%)
Query: 492 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
PL + + VARG+E+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 17/139 (12%)
Query: 419 GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG-----HCLDGNEKL-LVF 472
G +AVK++ + E+ +L V H+++++LL L+ + + LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 532
E M N + L+ R + + G+++LH IHRDLKPSNI
Sbjct: 106 ELMDA--------NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 154
Query: 533 LLGDDMRAKVADFGLVRLA 551
++ D K+ DFGL R A
Sbjct: 155 VVKSDCTLKILDFGLARTA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 20/178 (11%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVIS-GKGLTEFKSEIAVL-TKVRHRHLVAL 458
++GRG + V EL +I A+K ++ +++ + + ++E V T H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 459 LGH-CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
H C +L V E++ G L +F+ + P E R + + +A L+
Sbjct: 62 --HSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA-----LNF 111
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 572
L + I+RDLK N+LL + K+ D+G+ + EG G + GT Y+APE
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-05
Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 173 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 231
N+ ++ LT I F +L+ L L+ NNL+ + PE S L +L+ LD+S N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 232 L 232
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 21/105 (20%), Positives = 31/105 (29%), Gaps = 9/105 (8%)
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
R L L H + L + L R + + +R + +
Sbjct: 99 ARLLARL--HSVPPEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLA-- 154
Query: 512 EYLHGLAHQS---FIHRDLKPSNILLGDDMR-AKVADFGLVRLAP 552
L L +H DL P N+L+ R V DF L
Sbjct: 155 -ALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGD 198
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 27/95 (28%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 440 FKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 499
F +++++V H HL + G C+ G+E ++V E++ G L + E+G P+ W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD--VCLRKEKGRVPVAW-- 118
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534
++T+A +A + YL ++ +H ++ NILL
Sbjct: 119 KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 14/181 (7%)
Query: 402 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL-- 458
+LG G GTV + DG AVK ++ +S ++E+ L +V
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 459 -LGHCLDGNEKL-----LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
N + LV +Y G L + I + A+ + + + + V V
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN-RTFREHEAGLLFIQVLLAVH 157
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APEGKGSIETRIAGTFGYLAP 571
++H + IHRD+K +NILL + K+ DFG ++ A + GT Y+AP
Sbjct: 158 HVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 572 E 572
E
Sbjct: 215 E 215
|
Length = 496 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 43/202 (21%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEA----GVISGKGLTEFKS-----EIAVLTKVRHR 453
+G G FG V+ + KR + IS +GL E + E+ V+ +++H+
Sbjct: 21 IGNGRFGEVFL--------VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 454 HLVALLGHCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
++V + L+ N+KL ++ E+ G LSR+I + +E + + I + +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI-QKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 512 EYLHGLAH----QSFIHRDLKPSNILLGDDMR-----------------AKVADFGLVRL 550
Y H L + +HRDLKP NI L +R AK+ DFGL +
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 551 APEGKGSIETRIAGTFGYLAPE 572
G S+ GT Y +PE
Sbjct: 192 I--GIESMAHSCVGTPYYWSPE 211
|
Length = 1021 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 29/204 (14%)
Query: 383 MVISIQVLRNVTNNFSEENILGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFK 441
++ ++ L + T+ + +G+G +G VYK DG+ AVK ++ IS E +
Sbjct: 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP--ISDVD-EEIE 66
Query: 442 SEIAVLTKV-RHRHLVALLG------HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP 494
+E +L + H ++V G + G + LV E G+++ + +GL
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLV-GGQLWLVLELCNGGSVTELV-----KGL-- 118
Query: 495 LEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548
L +RL I G+++LH + IHRD+K +NILL + K+ DFG+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
Query: 549 RLAPEGKGSIETRIAGTFGYLAPE 572
+ T + GT ++APE
Sbjct: 176 AQLTSTRLRRNTSV-GTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 12/174 (6%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL 459
+LG+G FG V E ++ A+K ++ V+ E E VL + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
C ++L V EY+ G L I + + + + A ++A G+ +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFLHS-- 119
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLK N++L + K+ADFG+ + G GT Y+APE
Sbjct: 120 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 402 ILGRGGFGT--VYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
++G G FG + + D K A+K + S + + + E +L K++H ++VA
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF- 63
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFN-----WAEEGLKPLEWNRRLTIALDVARGVEY 513
+ + L +V EY G L + I + E+ + L+W ++ + GV++
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQWFVQMCL------GVQH 115
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+H + +HRD+K NI L + + K+ DFG RL G+ GT Y+ PE
Sbjct: 116 IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPYYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 3/62 (4%)
Query: 488 AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
+++G + L L+ VARG+E+L A ++ +HRDL N+LL K+ DFGL
Sbjct: 227 SDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGL 283
Query: 548 VR 549
R
Sbjct: 284 AR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 501 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 2/66 (3%)
Query: 177 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 236
+N N TG+I +L+ L L++N LSG IP + +LK LD+ N L GKI
Sbjct: 123 LNLSNNNFTGSIPRGSIP--NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 237 PSFKSN 242
P+ +N
Sbjct: 181 PNSLTN 186
|
Length = 968 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 16/84 (19%)
Query: 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 523
D + K +V EY+ L + ++ I V + LH +
Sbjct: 68 DPDNKTIVMEYIEGKPLK--------DVIEEGNDELLREIGRLVGK----LHKA---GIV 112
Query: 524 HRDLKPSNILLGDDMRAKVADFGL 547
H DL SNI++ DD + + DFGL
Sbjct: 113 HGDLTTSNIIVRDD-KLYLIDFGL 135
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 43 SLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
+LK + L +N + +PD F G+ L+ L L N T P++ L SL+ ++++ N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 101 L 101
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 34/129 (26%), Positives = 56/129 (43%), Gaps = 16/129 (12%)
Query: 418 DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477
K+ VK ++G EI +L + HR ++ L+ + +V MP+
Sbjct: 118 QRKKVIVK-----AVTGGKTPG--REIDILKTISHRAIINLIHAYRWKSTVCMV---MPK 167
Query: 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537
+F + + PL + +TI + + YLHG + IHRD+K NI L +
Sbjct: 168 YKCD--LFTYVD-RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEP 221
Query: 538 MRAKVADFG 546
A + DFG
Sbjct: 222 ENAVLGDFG 230
|
Length = 392 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 403 LGRGGFGTVYKGELHD--GTKIAVKRMEAGVI------SGKGLTEFKSEIAVLTKVRHRH 454
LG+G F +YKG L I E V+ + F ++++++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
LV L G C+ +E ++V EY+ G L +F E+ L W +L +A +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLD--VFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 515 HGLAHQSFIHRDLKPSNILL---GDDMR----AKVADFGLVRLAPEGKGSIETRIAGTFG 567
+ +H ++ NIL+ G + K++D G + + + RI
Sbjct: 118 E---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-IPITVLSREERVERIP---- 169
Query: 568 YLAPEYAGNFGSS 580
++APE N +S
Sbjct: 170 WIAPECIRNGQAS 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 27/84 (32%), Positives = 34/84 (40%), Gaps = 16/84 (19%)
Query: 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 523
D + L+V EY+ G L LK R + +V R V LH +
Sbjct: 70 DPDNGLIVMEYIE-GEL-----------LKDALEEARPDLLREVGRLVGKLH---KAGIV 114
Query: 524 HRDLKPSNILLGDDMRAKVADFGL 547
H DL SNI+L R DFGL
Sbjct: 115 HGDLTTSNIILSGG-RIYFIDFGL 137
|
Length = 204 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 25/116 (21%), Positives = 41/116 (35%), Gaps = 14/116 (12%)
Query: 440 FKSEIAVLTKVRHRHLVA--LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEW 497
+ E+A+L + + L +L L+ E++ TL +
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD------------EVSE 85
Query: 498 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553
+ IA +A + LH L H DL P NIL+ D + D+ P
Sbjct: 86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 19/60 (31%), Positives = 35/60 (58%), Gaps = 1/60 (1%)
Query: 49 LHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 107
L + G +P D S ++ L+S++L N G +P SL + SL++++++ N G +PE
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
|
Length = 623 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 36/133 (27%), Positives = 59/133 (44%), Gaps = 5/133 (3%)
Query: 441 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 500
+SE+ L H +V ++ LL+ EY G L++ I +E L E+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 501 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIE 559
L + + ++ +H + +HRDLK +NI L K+ DFG + + +
Sbjct: 173 L-LFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 560 TRIAGTFGYLAPE 572
+ GT YLAPE
Sbjct: 229 SSFCGTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 403 LGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG 460
+G+G +G V+K +G+K AVK ++ + E ++E +L + H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSDHPNVVKFYG 82
Query: 461 -----HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
+G++ LV E G+++ + + LK E IA + + L
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
L IHRD+K +NILL + K+ DFG+ + T + GT ++APE
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPE 194
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 32/126 (25%), Positives = 50/126 (39%), Gaps = 20/126 (15%)
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA---EEGLKPLEWNRRLTIALDVARG 510
++V L + + + LV ++ G L HI + EE +K W + +ALD
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK--RWAAEMVVALD---- 99
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGKGSIETRIAGTFGYL 569
L + + RDL P+NILL D ++ F + G + Y
Sbjct: 100 -----ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 570 APEYAG 575
APE G
Sbjct: 150 APEVGG 155
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 580 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.95 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.95 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.95 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.95 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.94 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.94 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.94 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.94 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.94 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.94 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.94 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.93 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.93 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.93 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.93 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.93 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.93 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.93 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.93 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.93 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.93 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.93 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.93 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.93 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.93 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.93 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.93 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.93 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.93 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.93 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.93 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.92 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.92 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.92 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.92 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.92 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.92 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.92 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.92 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.92 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.92 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.92 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.92 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.92 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.92 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.92 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.92 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.92 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.92 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.92 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.92 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.92 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.92 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.92 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.92 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.92 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.92 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.92 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.92 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.92 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.92 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.91 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.91 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.91 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.91 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.91 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.91 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.91 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.91 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.91 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.91 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.91 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.91 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.91 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.91 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.91 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.91 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.9 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.9 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.9 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.9 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.9 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.9 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.9 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.9 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.9 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.9 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.9 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.9 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.9 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.9 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.9 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.89 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.89 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.89 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.88 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.88 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.88 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.88 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.88 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.87 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.86 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.86 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.86 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.85 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.84 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.83 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.83 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.83 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.8 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.8 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.79 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.71 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.61 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.6 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.58 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.58 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.5 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.49 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.47 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.45 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.32 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.32 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.32 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.28 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.21 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.21 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.2 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.03 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.0 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.94 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.84 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.84 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.77 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.77 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.57 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.55 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.5 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.44 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.42 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.33 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.32 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.28 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=500.67 Aligned_cols=497 Identities=23% Similarity=0.352 Sum_probs=283.9
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++.|.+|..+ ..+..|+.++++.|++.+..|+.+..+++|+.|++++|.+.+.+| .+..+++|+.|+|++|++++.
T Consensus 342 n~l~~~~p~~l--~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~ 419 (968)
T PLN00113 342 NKFSGEIPKNL--GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419 (968)
T ss_pred CCCcCcCChHH--hCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence 56666777766 445666666666666666666666666666666666666666555 355566666666666666666
Q ss_pred CCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHH-----------HhhCCc
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVV-----------KLMGYP 148 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~-----------~~~~~~ 148 (580)
+|..|.++++|+.|+|++|++++.+|. +..+.+|+.|++++|.+....+..+. ...+..+. ..+..+
T Consensus 420 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l 498 (968)
T PLN00113 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSL 498 (968)
T ss_pred CChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhh
Confidence 666666666666666666666655553 34455555555555554433322210 00000000 000011
Q ss_pred cccccccCCCCCCC-CccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEc
Q 008026 149 QRFAENWKGNDPCS-DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 227 (580)
Q Consensus 149 ~~~~~~~~~~~~~~-~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~l 227 (580)
..+....++++... ..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|+++|.+|..+..++.|+.|++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 11122222222222 23444444555666666666666666666666666666666666666666666666666666666
Q ss_pred cCCcccccCCCCCCC---ceeecCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcceEEEEeeehhHHHH
Q 008026 228 SNNQLYGKIPSFKSN---AIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAFV 304 (580)
Q Consensus 228 s~N~l~g~~p~~~~~---~~~~~~~n~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~ 304 (580)
++|+++|.+|+.... ....+.||+..|+..... . ...+....+ ...+.++++++++++++
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~----------~-----~~~c~~~~~--~~~~~~~~~~~~~~~~~ 641 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS----------G-----LPPCKRVRK--TPSWWFYITCTLGAFLV 641 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCcccc----------C-----CCCCccccc--cceeeeehhHHHHHHHH
Confidence 666666666644221 123345666555422100 0 000000001 11122222222222222
Q ss_pred HHHhheeeEEEEeecccccccCCCCCcccccCCCCCCCCCcceeeeecCcccccccccCcccCCCCCCccchhhccCcee
Q 008026 305 ISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMV 384 (580)
Q Consensus 305 ~~l~~~l~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (580)
+++++++ +++++++++...+..... ... ... ..... . .
T Consensus 642 ~~~~~~~-~~~~~~~~~~~~~~~~~~----------~~~---~~~--------------------------~~~~~-~-~ 679 (968)
T PLN00113 642 LALVAFG-FVFIRGRNNLELKRVENE----------DGT---WEL--------------------------QFFDS-K-V 679 (968)
T ss_pred HHHHHHH-HHHHHhhhcccccccccc----------ccc---ccc--------------------------ccccc-c-c
Confidence 2222222 222222211100000000 000 000 00000 0 0
Q ss_pred eeHHHHHHhhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEE
Q 008026 385 ISIQVLRNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL 463 (580)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 463 (580)
............|...+.||+|+||.||+|+. .++..||+|++..... ....|++.+++++||||+++++++.
T Consensus 680 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~ 753 (968)
T PLN00113 680 SKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCR 753 (968)
T ss_pred chhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEE
Confidence 00011222334577788999999999999976 4789999998864221 1235688999999999999999999
Q ss_pred cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEE
Q 008026 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 543 (580)
Q Consensus 464 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 543 (580)
+.+..++||||+++|+|.++++ .++|.++.+|+.|++.||+|||+.+..+|+||||||+||+++.++.+++.
T Consensus 754 ~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~ 825 (968)
T PLN00113 754 SEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825 (968)
T ss_pred cCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence 9999999999999999999883 37899999999999999999996555799999999999999998888875
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
||.+...... ....||+.|||||++.+.+++
T Consensus 826 -~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~ 856 (968)
T PLN00113 826 -LSLPGLLCTD-----TKCFISSAYVAPETRETKDIT 856 (968)
T ss_pred -eccccccccC-----CCccccccccCcccccCCCCC
Confidence 6665443221 123689999999999877653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.41 Aligned_cols=177 Identities=32% Similarity=0.486 Sum_probs=159.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..+|.+.+.||+|+||+||+|+++ ++..||||.+.++....+..+-+..|+++|+.++|||||.++++++.++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888999999999999999876 6899999999987777778888999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC------CcEEEEeec
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------MRAKVADFG 546 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfg 546 (580)
|||.||||.+|++. .+.+++..++.++.|++.||++||+ ++||||||||.|||++.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999955 2478999999999999999999998 899999999999999754 458999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+|+....+ ....+.+|+|.|||||+++.+.|+
T Consensus 161 fAR~L~~~--~~a~tlcGSplYMAPEV~~~~~Yd 192 (429)
T KOG0595|consen 161 FARFLQPG--SMAETLCGSPLYMAPEVIMSQQYD 192 (429)
T ss_pred hhhhCCch--hHHHHhhCCccccCHHHHHhcccc
Confidence 99998654 345668999999999999988874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.75 Aligned_cols=191 Identities=51% Similarity=0.873 Sum_probs=165.3
Q ss_pred CceeeeHHHHHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceee
Q 008026 381 GNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460 (580)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 460 (580)
....+++.+++.++++|.....||+|+||.||+|...++..||||++....... ..+|.+|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 345789999999999999999999999999999999988999999876533221 456999999999999999999999
Q ss_pred EEEcCC-eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 461 HCLDGN-EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 461 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
||.+.+ ..++|+||+++|+|.++++.... . .++|.++++||.++|+||+|||+.+...||||||||+|||+|++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~--~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKG--E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCC--C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999998 49999999999999999965221 1 7899999999999999999999977678999999999999999999
Q ss_pred EEEEeeccccccCC-CCCCccccc-cccCCccCccccCCCC
Q 008026 540 AKVADFGLVRLAPE-GKGSIETRI-AGTFGYLAPEYAGNFG 578 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~-~~~~~~~~~-~Gt~~y~APE~~~~~~ 578 (580)
+||+|||+|+.... ... .... .||.+|+|||++..+.
T Consensus 216 aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~ 254 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGK 254 (361)
T ss_pred EEccCccCcccCCccccc--eeeecCCCCccCChhhhccCC
Confidence 99999999976654 221 1112 7999999999997653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=290.21 Aligned_cols=178 Identities=28% Similarity=0.450 Sum_probs=158.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.++||+|+||+||.++.+ +++.+|+|+++++.+. ..+.+....|..++.+++||+||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 367999999999999999999665 6899999999887654 34677889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
+||+.||.|..++.+ ...+++..+..++..|+.||.|||+ ++||||||||+|||+|.+|.++|+|||+|+..
T Consensus 104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999998843 3579999999999999999999998 89999999999999999999999999999965
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... ....+++||+.|||||++.+.+|+
T Consensus 176 ~~~~-~~t~tfcGT~eYmAPEil~~~gy~ 203 (357)
T KOG0598|consen 176 LKDG-DATRTFCGTPEYMAPEILLGKGYD 203 (357)
T ss_pred ccCC-CccccccCCccccChHHHhcCCCC
Confidence 4443 344558999999999999999885
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=287.58 Aligned_cols=174 Identities=29% Similarity=0.430 Sum_probs=155.2
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-eeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-EKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 473 (580)
+.+..+.||+|..|+||+++++ +++.+|+|++.. ..+....+++.+|++++++++||+||++||.|...+ ...++||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3455688999999999999876 789999999954 345667789999999999999999999999999998 5999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||++|+|++++.. .+.+++...-+|+.+|++||.|||+ ..+||||||||+|||++..|++||||||.++...+
T Consensus 159 YMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999998844 2568999999999999999999996 37899999999999999999999999999998766
Q ss_pred CCCCccccccccCCccCccccCCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
. ...+++||..|||||.+++..|+
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~Ys 255 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGESYS 255 (364)
T ss_pred h---hcccccccccccChhhhcCCcCC
Confidence 4 45678999999999999998875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=283.80 Aligned_cols=184 Identities=27% Similarity=0.465 Sum_probs=161.7
Q ss_pred cCCcccceeeccCcEEEEEEE-EcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceee-EEEcCCe-eEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG-HCLDGNE-KLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 471 (580)
.+|++.+.||+|+||+||++. ..+|..||.|.+.-+..+.+.++++..|+.+|++++|||||++++ .+.+.+. .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468899999999999999995 458999999999877778888999999999999999999999999 4555555 7899
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCC-CCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH-QSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||++|||.++++.+.+. .+.+++..+++++.|++.||.++|+..+ .-|+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999876554 4689999999999999999999997432 2388999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+.... .....++|||+||+||.+.+.+||
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~ 206 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYN 206 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCC
Confidence 86544 455668999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=287.37 Aligned_cols=177 Identities=31% Similarity=0.489 Sum_probs=153.0
Q ss_pred hhcCCcccceeeccCcEEEEEEE-EcCCcEEEEEEeeccccChh-----hHHHHHHHHHHHHhcCCCcccceeeEEEcCC
Q 008026 393 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGK-----GLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 466 (580)
+.+.|.+.+.||+|+||.|-+|. .++|+.||||++.+...... ......+|+++|++++||+||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678899999999999999994 45899999999987654321 2334679999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC---CcEEEE
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVA 543 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 543 (580)
..||||||++||+|.+.+.. .+.+.+.....+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999998843 3467777888999999999999998 899999999999999755 679999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|||+|+.... .....++||||.|.|||++.+.++
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~ 355 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGV 355 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCe
Confidence 9999998753 346677899999999999987764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=293.15 Aligned_cols=177 Identities=28% Similarity=0.476 Sum_probs=159.3
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.+|+..++||+|+|+.||.++. .+|+.||+|++.+... .....+.+.+||++.+.++|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999987 7899999999987543 4556788999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
|+|+.++|.++++ ..+++++.+++.+++||+.||.|||+ .+|||||||-.|++++++.++||+|||+|....
T Consensus 98 ELC~~~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999998884 33579999999999999999999998 889999999999999999999999999999887
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.+.. ...+.||||.|+|||++...++|
T Consensus 170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHs 196 (592)
T KOG0575|consen 170 YDGE-RKKTLCGTPNYIAPEVLNKSGHS 196 (592)
T ss_pred Cccc-ccceecCCCcccChhHhccCCCC
Confidence 5432 34557999999999999987764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=284.46 Aligned_cols=172 Identities=40% Similarity=0.631 Sum_probs=149.0
Q ss_pred cccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-eeEEEEEecC
Q 008026 398 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-EKLLVFEYMP 476 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~ 476 (580)
...+.+|+|+||+||+|.++....||||++..........++|.+|+.+|.+++|||||+++|++.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 445669999999999999985555999999876655555789999999999999999999999999887 7999999999
Q ss_pred CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC-cEecCCCCCCeEecCCC-cEEEEeeccccccCCC
Q 008026 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-FIHRDLKPSNILLGDDM-RAKVADFGLVRLAPEG 554 (580)
Q Consensus 477 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 554 (580)
+|+|.+++... ....+++..+++||.|||+||+|||+ .+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999653 34679999999999999999999998 56 99999999999999997 9999999999876543
Q ss_pred CCCccccccccCCccCccccCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
. ...+...||+.|||||++.+
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred c-ccccCCCCCccccChhhhcC
Confidence 2 12233679999999999994
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=262.69 Aligned_cols=174 Identities=30% Similarity=0.441 Sum_probs=155.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|+..+.||.|+||+|.+++.+ +|..+|+|++.+... .-+..+...+|..+|+.+.||+++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57888999999999999999776 689999999987543 3445667889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||++||.|..++++ .+++++..++.+|.||+.||+|||+ .+|++||+||+|||+|.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999843 4579999999999999999999998 899999999999999999999999999999875
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.. ..+.||||.|+|||+++..+|+
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~yn 219 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYN 219 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCC
Confidence 43 3457999999999999988874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=282.21 Aligned_cols=176 Identities=30% Similarity=0.447 Sum_probs=159.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+....+++.+.+.+|+++++.++||||+.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999654 78999999998876677788899999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+.| +|..++.. ...++++++..++.|++.||.|||+ .+|+|||+||.|||++..+.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9977 99988843 3579999999999999999999998 8999999999999999999999999999998765
Q ss_pred CCCCccccccccCCccCccccCCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.. ...+...|||.|||||++++++|+
T Consensus 153 ~t-~vltsikGtPlYmAPElv~e~pyd 178 (808)
T KOG0597|consen 153 NT-SVLTSIKGTPLYMAPELVEEQPYD 178 (808)
T ss_pred Cc-eeeeeccCcccccCHHHHcCCCcc
Confidence 43 455667899999999999999885
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=261.79 Aligned_cols=173 Identities=25% Similarity=0.358 Sum_probs=150.3
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.|+...++|+|+||.||+|+.+ +|+.||||++....-+....+-..+|++++++++|+|+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999876 69999999997654445556678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||+.--|. -+ +.....++...+.++..|++.|+.|+|+ +++|||||||+|||++..|.+||||||+|+....
T Consensus 82 ~~dhTvL~-eL----e~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLH-EL----ERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHH-HH----HhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99774443 33 2334568889999999999999999997 8999999999999999999999999999998874
Q ss_pred CCCCccccccccCCccCccccCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.+...+.++.|.+|.|||++-|
T Consensus 154 -pgd~YTDYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVG 175 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcc
Confidence 3346677899999999999887
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=275.57 Aligned_cols=177 Identities=27% Similarity=0.355 Sum_probs=154.2
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 470 (580)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++..+........-..+||.+|++++||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35688899999999999999954 5899999999987665666677889999999999999999999988876 68999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
|+|||+. ||.-++. ...-.+++.++..++.|++.||+|+|+ ++|+|||||.+|||||.+|.+||+|||+|++
T Consensus 196 VFeYMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEecccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 9999976 7876663 223468999999999999999999998 8999999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCccCccccCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+........+..+-|.+|.|||++.|..
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t 295 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGAT 295 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCc
Confidence 8766555556667799999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=249.78 Aligned_cols=175 Identities=29% Similarity=0.411 Sum_probs=152.3
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.+|...+.+|+|.||.||+|++ .+|+.||||+++.....+.......+|++.|+.++|+||+.++++|...+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688899999999999999965 589999999998865555555678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|++. +|+..+++ ....+...++..++.++++|++|+|+ +.|+||||||.|+|++++|.+||+|||+|+.+..
T Consensus 82 fm~t-dLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eccc-cHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9965 99888844 34578889999999999999999997 8999999999999999999999999999998876
Q ss_pred CCCCccccccccCCccCccccCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
....... .+-|.+|.|||++-|..
T Consensus 154 p~~~~~~-~V~TRWYRAPELLfGsr 177 (318)
T KOG0659|consen 154 PNRIQTH-QVVTRWYRAPELLFGSR 177 (318)
T ss_pred CCccccc-ceeeeeccChHHhccch
Confidence 5533332 35699999999887643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=274.74 Aligned_cols=179 Identities=31% Similarity=0.478 Sum_probs=154.6
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC---hhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCe
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNE 467 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 467 (580)
..+.|.+.+.||+|+||+|+.|... ++..||+|++.++... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3468999999999999999999654 7899999987764222 123456778999999999 9999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-CcEEEEeec
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 546 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg 546 (580)
.++||||+.||+|.+++.+ ..++.+..+.++++|++.|++|+|+ ++|+||||||+|||++.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999854 3578889999999999999999998 899999999999999998 999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCCC-CC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG-SS 580 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~~ 580 (580)
++.... .......+.+||+.|+|||++.+.+ |+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~ 200 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYS 200 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcC
Confidence 998774 2223445679999999999999977 63
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=271.99 Aligned_cols=181 Identities=30% Similarity=0.453 Sum_probs=155.9
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCe
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNE 467 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 467 (580)
.....+|.+.+.||+|+|++|++|+. .+++.||||++.+..+. +...+.+.+|-..|.+| .||.|++++..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34457899999999999999999955 47999999999876543 33345677899999999 79999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.|+|+||+++|+|.++|.+ .+.+++..++.++.+|+.||+|||+ +|||||||||+|||+|++|++||+|||.
T Consensus 149 LYFvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eEEEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccc
Confidence 9999999999999999955 3578999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCC------------ccccccccCCccCccccCCCCC
Q 008026 548 VRLAPEGKGS------------IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 548 a~~~~~~~~~------------~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+.+...... ....++||..|.+||++.+...
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~ 264 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA 264 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC
Confidence 9876543211 1144899999999999987653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=262.47 Aligned_cols=176 Identities=25% Similarity=0.422 Sum_probs=159.5
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
..+|++.+.||+|.||+|-+|.. ..|+.||||.|+++.+ ++.+.-.+++|+++|..++||||+.+|.+|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45789999999999999999954 5799999999987655 455677899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||..+|.|.+|+.+ .+.+++..+..+++||..|+.|+|. +++||||||.+|||+|+++++||+|||++..+
T Consensus 132 MEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999954 3578999999999999999999996 89999999999999999999999999999887
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ...+++||+|-|++||++.|.+|
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY 229 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPY 229 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCC
Confidence 654 35677999999999999999887
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=257.99 Aligned_cols=175 Identities=27% Similarity=0.448 Sum_probs=147.3
Q ss_pred HHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc--CCCcccceeeEEEcCC-
Q 008026 390 LRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV--RHRHLVALLGHCLDGN- 466 (580)
Q Consensus 390 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~- 466 (580)
-+.+..+..+.+.||+|+||+||+|+++ |+.||||++.. .+.+.+.+|.++++.. +|+||+.+++.-..++
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 3556677888999999999999999998 89999999864 3446778888888764 8999999998766543
Q ss_pred ---eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHh-----CCCCCcEecCCCCCCeEecCCC
Q 008026 467 ---EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG-----LAHQSFIHRDLKPSNILLGDDM 538 (580)
Q Consensus 467 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-----~~~~~ivH~Dlkp~NIll~~~~ 538 (580)
+.|+|++|.+.|+|.||+.+ ..++.+..++++..+|.||+|||. ++++.|.|||||+.|||+.+++
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 57999999999999999954 478889999999999999999993 4578899999999999999999
Q ss_pred cEEEEeeccccccCCCCCC---ccccccccCCccCccccCC
Q 008026 539 RAKVADFGLVRLAPEGKGS---IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~~~---~~~~~~Gt~~y~APE~~~~ 576 (580)
.+.|+|+|+|......... .....+||.+|||||++..
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 9999999999765544222 2234689999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=261.46 Aligned_cols=169 Identities=31% Similarity=0.522 Sum_probs=143.2
Q ss_pred CcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHh--cCCCcccceeeEEEcCC----eeEE
Q 008026 397 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK--VRHRHLVALLGHCLDGN----EKLL 470 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~l 470 (580)
.+..+++|+|+||.||+|.+. ++.||||++.. .+.+.+..|-++++. ++|+||++++++-.... ++++
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 445688999999999999886 69999998854 345678888777776 47999999999877655 7899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHh------CCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG------LAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~------~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
|+||.+.|+|.+++.. ..++|....+|+..+++||+|||+ +.+++|+|||||++||||..|+++.|+|
T Consensus 286 Vt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999954 578999999999999999999995 3457899999999999999999999999
Q ss_pred eccccccCCCCCC-ccccccccCCccCccccCCC
Q 008026 545 FGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 545 fg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~ 577 (580)
||+|..+..+... .....+||.+|||||+++|.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 9999877654322 12236899999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=267.24 Aligned_cols=175 Identities=28% Similarity=0.378 Sum_probs=151.9
Q ss_pred HhhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCC-ee
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN-EK 468 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~ 468 (580)
.+.++|.+.+.||.|.||.||+|+. .+++.||||+++++...-. .-.-.||+..|+++. ||||+++.+++.+.+ ..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3457899999999999999999954 5799999999998765532 233468999999998 999999999999888 89
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++|||||+ .+|.++++++ .+.+++..++.|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|
T Consensus 86 ~fVfE~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eeeHHhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccc
Confidence 99999995 4999998653 4689999999999999999999996 89999999999999998889999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+...... ..+.++.|.+|+|||++..-
T Consensus 158 Rev~Skp--PYTeYVSTRWYRAPEvLLrs 184 (538)
T KOG0661|consen 158 REVRSKP--PYTEYVSTRWYRAPEVLLRS 184 (538)
T ss_pred cccccCC--CcchhhhcccccchHHhhhc
Confidence 9876543 45678899999999997643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=262.39 Aligned_cols=151 Identities=25% Similarity=0.423 Sum_probs=135.8
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
+...++|+..+.||+|+||.||+|+.+ +|..+|+|++++... .....+.++.|-.+|...++|.||+++..|++.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 335679999999999999999999665 799999999987543 334456788899999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
|+||||++|||+..+|.+ .+.+++..+..++.+++.|++-||. .|+|||||||+|+|||..|++||+|||+|
T Consensus 217 YLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeecccccc
Confidence 999999999999999844 4679999999999999999999997 89999999999999999999999999998
Q ss_pred c
Q 008026 549 R 549 (580)
Q Consensus 549 ~ 549 (580)
+
T Consensus 289 ~ 289 (550)
T KOG0605|consen 289 T 289 (550)
T ss_pred c
Confidence 5
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=271.01 Aligned_cols=178 Identities=29% Similarity=0.436 Sum_probs=156.6
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 469 (580)
..++|.+.++||+|+||+|++++.+ +++.+|||++++..+ ...+.+....|.+++.... ||+++.++.+|++.++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4568999999999999999999876 688999999998764 4556778888988888875 999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
.||||+.||++..+. ..+.+++..+..+|..|+.||+|||+ ++|||||||-+|||+|.+|.+||+|||+|+
T Consensus 446 fvmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence 999999999964443 23579999999999999999999998 899999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
...... ....+++|||.|||||++.++.|+
T Consensus 517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt 546 (694)
T KOG0694|consen 517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYT 546 (694)
T ss_pred ccCCCC-CccccccCChhhcChhhhccCccc
Confidence 754332 356679999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=253.33 Aligned_cols=174 Identities=33% Similarity=0.526 Sum_probs=146.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC--eeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--EKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 471 (580)
.+|...+.||+|+||.||++... +|...|||.+.... ....+.+.+|+++|.+++|||||+++|...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45778899999999999999765 58999999987642 222677999999999999999999999855554 58899
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-CCcEEEEeeccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRL 550 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~ 550 (580)
|||+++|+|.+++.+. +. .+++..+.++++||++||+|||+ ++||||||||+|||++. ++.+||+|||+++.
T Consensus 95 mEy~~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeccCCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 9999999999998542 22 68999999999999999999998 89999999999999999 79999999999987
Q ss_pred cCC--CCCCccccccccCCccCccccCCC
Q 008026 551 APE--GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 551 ~~~--~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
... ........+.||+.|||||++.++
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g 196 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNG 196 (313)
T ss_pred cccccccccccccccCCccccCchhhcCC
Confidence 653 111223347899999999999853
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=252.56 Aligned_cols=174 Identities=25% Similarity=0.401 Sum_probs=152.3
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||.|..+.||+|+. ..++.||||++..+..+.. .+.+++|+..|+.++||||++++..|..+...|+||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 5799999999999999999965 4789999999988665544 7899999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||.+|++.+.++..... .+++..+..|.+++++||.|||. +|.||||||+.||||+++|.+||+|||.+..+..
T Consensus 105 fMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999775544 48899999999999999999997 8999999999999999999999999998655443
Q ss_pred CCCC--cc-ccccccCCccCccccC
Q 008026 554 GKGS--IE-TRIAGTFGYLAPEYAG 575 (580)
Q Consensus 554 ~~~~--~~-~~~~Gt~~y~APE~~~ 575 (580)
.... .. ..++||++|||||+++
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~ 203 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLM 203 (516)
T ss_pred cCceeeEeeccccCcccccChHHhh
Confidence 3221 11 4468999999999954
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=264.84 Aligned_cols=174 Identities=28% Similarity=0.472 Sum_probs=153.1
Q ss_pred hcCCcccceeeccCcEEEEEEE-EcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
...|...+.||+|+.|.||.|+ ..+++.||||++...... ..+-+.+|+.+|+..+|+|||.+++.|...++.|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3468888999999999999994 457899999999874432 3456789999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||++||+|.+.+.. ..+++.++..|+++++.||+|||. ++|+|||||.+|||++.+|.+||+|||+|..+.
T Consensus 350 Eym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999998843 358999999999999999999998 899999999999999999999999999998776
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....+|||+|||||++...+|
T Consensus 421 ~~~~-KR~TmVGTPYWMAPEVvtrk~Y 446 (550)
T KOG0578|consen 421 EEQS-KRSTMVGTPYWMAPEVVTRKPY 446 (550)
T ss_pred cccC-ccccccCCCCccchhhhhhccc
Confidence 5543 4556789999999999988666
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=247.78 Aligned_cols=175 Identities=28% Similarity=0.365 Sum_probs=148.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 471 (580)
+.|+..+.|++|.||.||+|+++ +++.||+|+++.+.....-.-...+||.++.+++|||||.+-.+.... +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46888899999999999999765 789999999987543333334568999999999999999998887643 578999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
||||+. ||..++.... +++...++..++.|+++|++|||. ..|+||||||+|+|+++.|.+||+|||+|+.+
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 999976 8888885432 478889999999999999999997 88999999999999999999999999999998
Q ss_pred CCCCCCccccccccCCccCccccCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
..... ..+..+-|.+|.|||++.|.+
T Consensus 228 gsp~k-~~T~lVVTLWYRaPELLLG~~ 253 (419)
T KOG0663|consen 228 GSPLK-PYTPLVVTLWYRAPELLLGAK 253 (419)
T ss_pred cCCcc-cCcceEEEeeecCHHHhcCCc
Confidence 77643 345566799999999998764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=239.52 Aligned_cols=178 Identities=30% Similarity=0.501 Sum_probs=155.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.... .....++.+|+++-+.++||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 367999999999999999999665 6788999999875543 33456899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
+||..+|.+...+.. .....+++.....++.|+|.||.|+|. ++||||||||+|+|++..+..||+|||.+...
T Consensus 101 lEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999888853 344568888999999999999999997 89999999999999999999999999988765
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.. ....+.+||.-|.|||..++.+++
T Consensus 175 p~---~kR~tlcgt~dyl~pEmv~~~~hd 200 (281)
T KOG0580|consen 175 PS---NKRKTLCGTLDYLPPEMVEGRGHD 200 (281)
T ss_pred CC---CCceeeecccccCCHhhcCCCCcc
Confidence 43 234567999999999999988764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=249.49 Aligned_cols=179 Identities=27% Similarity=0.379 Sum_probs=150.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCc-ccceeeEEEcCC-----
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH-LVALLGHCLDGN----- 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~----- 466 (580)
...|+..+.||+|.||+||+|+.. +|+.||+|++......+.......+|+.++++++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777888999999999999664 7899999999875443445567789999999999999 999999998877
Q ss_pred -eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 467 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 467 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
..++|+||++. +|..++....... ..++...+..+++||+.||+|||+ ++|+||||||.|||++++|.+||+||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeecc
Confidence 78899999954 9999885533221 356678899999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|+|+...-+.. ..+..++|..|.|||++.|..
T Consensus 165 GlAra~~ip~~-~yt~evvTlWYRaPEvLlGs~ 196 (323)
T KOG0594|consen 165 GLARAFSIPMR-TYTPEVVTLWYRAPEVLLGST 196 (323)
T ss_pred chHHHhcCCcc-cccccEEEeeccCHHHhcCCC
Confidence 99997654432 245567899999999998873
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=255.53 Aligned_cols=179 Identities=31% Similarity=0.472 Sum_probs=146.6
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChh------------hHHHHHHHHHHHHhcCCCcccc
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGK------------GLTEFKSEIAVLTKVRHRHLVA 457 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~ 457 (580)
+...+.|++.+.||+|.||.|-+|+.. +++.||||++.+...... ..+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445678999999999999999999765 789999999976432211 1357889999999999999999
Q ss_pred eeeEEEcC--CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec
Q 008026 458 LLGHCLDG--NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 535 (580)
Q Consensus 458 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 535 (580)
++.+..+. +..|||+|||..|.+...- .....+++.++++++++++.||+|||. ++||||||||+|+|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEc
Confidence 99998765 5789999999988875321 222238899999999999999999998 8999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCC----CccccccccCCccCccccCCC
Q 008026 536 DDMRAKVADFGLVRLAPEGKG----SIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 536 ~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~Gt~~y~APE~~~~~ 577 (580)
++|++||+|||.+.....+.. ......+|||.|||||...++
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~ 290 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG 290 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence 999999999999876633211 111236799999999998774
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=262.60 Aligned_cols=179 Identities=25% Similarity=0.396 Sum_probs=161.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe-eEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE-KLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 472 (580)
++|...+++|+|+||.++.++.+ ++..||+|++..........+...+|+.++++++|||||.+.+.|+.++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57899999999999999999665 67899999998877777777789999999999999999999999999888 89999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
+|++||++.+.+.+.. ...++++++..|+.|++.|+.|||+ ..|+|||||+.||++++++.+||+|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999997643 3468999999999999999999997 899999999999999999999999999999987
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... .....++||+.||.||++.+.+|+
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn 184 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDIPYN 184 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCCCCC
Confidence 655 245568899999999999999885
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=243.11 Aligned_cols=178 Identities=27% Similarity=0.418 Sum_probs=157.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.+.|++.+.||+|.|+.||++.. .+|+.+|+|++..+.......+++.+|+++.+.++||||+++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788999999999999999944 5799999999988877777889999999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a 548 (580)
+|++.|++|..-+..+ ..+++..+-..++||++||.|+|. ++|||||+||+|+++.. .--+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999998776542 357788889999999999999998 89999999999999963 345899999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... .+.....++|||+|||||+++..+|+
T Consensus 161 i~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~ 190 (355)
T KOG0033|consen 161 IEVN--DGEAWHGFAGTPGYLSPEVLKKDPYS 190 (355)
T ss_pred EEeC--CccccccccCCCcccCHHHhhcCCCC
Confidence 9887 33456678999999999999988875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=262.53 Aligned_cols=176 Identities=27% Similarity=0.404 Sum_probs=156.6
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeecc-ccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAG-VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.-|++++.||+|+.|.|..|++ .+|+.+|||++.+. .........+.+|+-+|+.+.|||++++|++++...++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4588999999999999999965 58999999999875 344555678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|.|.+++.+ .+++++.++.++++||+.|+.|+|. .+|+|||+||+|+|+|..+.+||+|||+|....
T Consensus 92 Eyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999999999854 3578899999999999999999997 799999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.+ ..-.+.||+|.|+|||++.|.+|.
T Consensus 164 ~g--klLeTSCGSPHYA~PEIV~G~pYd 189 (786)
T KOG0588|consen 164 PG--KLLETSCGSPHYAAPEIVSGRPYD 189 (786)
T ss_pred CC--ccccccCCCcccCCchhhcCCCCC
Confidence 44 344557999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=257.26 Aligned_cols=175 Identities=33% Similarity=0.509 Sum_probs=147.6
Q ss_pred CcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecC
Q 008026 397 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
++..+.||+|.||.||.|.++....||+|.++.... ..++|.+|+++|++++|++||+++++|..++..+||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 455688999999999999998778999999987533 34678899999999999999999999999889999999999
Q ss_pred CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC
Q 008026 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556 (580)
Q Consensus 477 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 556 (580)
.|+|.++++. .....+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+|+...++.-
T Consensus 285 ~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 285 KGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999965 334578888999999999999999998 8999999999999999999999999999995544321
Q ss_pred CccccccccCCccCccccCCCCCC
Q 008026 557 SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 557 ~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.......-...|.|||.+..+..|
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS 382 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFS 382 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcc
Confidence 111111124579999999876643
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-31 Score=246.58 Aligned_cols=172 Identities=30% Similarity=0.478 Sum_probs=152.4
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
|.+.++||+|+||.||+|.++ +|+.+|||.+.. +.+.+++.+|+.+|++++.|++|++||.|......|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 667889999999999999554 799999998865 346789999999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
..|+..+.++. +.+++.+.++..+.+.-++||+|||. ..-||||||+.|||++.+|.+||+|||.|..+.+..
T Consensus 111 GAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 111 GAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999998854 33579999999999999999999997 678999999999999999999999999998776544
Q ss_pred CCccccccccCCccCccccCCCCCC
Q 008026 556 GSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
. ...++.|||.|||||+++.-+|+
T Consensus 184 A-KRNTVIGTPFWMAPEVI~EIGY~ 207 (502)
T KOG0574|consen 184 A-KRNTVIGTPFWMAPEVIEEIGYD 207 (502)
T ss_pred H-hhCccccCcccccHHHHHHhccc
Confidence 2 34557899999999999877764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=258.76 Aligned_cols=178 Identities=24% Similarity=0.401 Sum_probs=149.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||+||+|+.. +++.||+|++.+... .......+.+|+.++.+++|++|+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999765 689999999976432 2333467888999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999998843 2468899999999999999999998 899999999999999999999999999987543
Q ss_pred CCCC----------------------------------CccccccccCCccCccccCCCCCC
Q 008026 553 EGKG----------------------------------SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~----------------------------------~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... ......+||+.|+|||++.+.+++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~ 214 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN 214 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC
Confidence 2110 001235799999999999877653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=259.03 Aligned_cols=180 Identities=24% Similarity=0.315 Sum_probs=151.5
Q ss_pred HHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC
Q 008026 389 VLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 466 (580)
Q Consensus 389 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 466 (580)
......++|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 33444578999999999999999999775 688999999875322 2334456788999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..|+||||+++|+|.+++.. ..+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecc
Confidence 99999999999999998843 247888999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+|+.............+||+.|||||++.+.
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhcc
Confidence 9987643322222346799999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=254.05 Aligned_cols=176 Identities=27% Similarity=0.441 Sum_probs=153.3
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
..|...+.||+|+||.||+|.+ .+++.||+|++.... .....+++++|+.+++.++++||.++|+.|..+...|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3577779999999999999965 478999999998753 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||.||++.+.+.. ...+++..+.-|++++..||.|+|+ .+.+|||||+.|||+..+|.+|++|||++.....
T Consensus 92 y~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999998832 2344777788899999999999998 8899999999999999999999999999987765
Q ss_pred CCCCccccccccCCccCccccCCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... ..+++|||+|||||+++..+|+
T Consensus 164 ~~~r-r~tfvGTPfwMAPEVI~~~~Y~ 189 (467)
T KOG0201|consen 164 TVKR-RKTFVGTPFWMAPEVIKQSGYD 189 (467)
T ss_pred hhhc-cccccccccccchhhhcccccc
Confidence 5433 3668999999999999987875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=255.04 Aligned_cols=181 Identities=30% Similarity=0.545 Sum_probs=153.8
Q ss_pred HHHHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 388 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 388 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
++.....+.+.+.+.||+|+||+||+|++. -.||||+++.........+.|++|+.++++-+|.||+-+.||+..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 455555667788899999999999999886 469999999887778889999999999999999999999999998877
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.||+.+|+|.+|..+++..+ ..++..+.+.||+||+.|+.|||. ++|||||||..||++.++++|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 99999999999999996533 358888999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCC-CccccccccCCccCccccCCCC
Q 008026 548 VRLAPEGKG-SIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 548 a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+.....-.. .......|..-|||||+++-++
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd 566 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQD 566 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcc
Confidence 864322111 1112235788899999998554
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=246.69 Aligned_cols=172 Identities=30% Similarity=0.483 Sum_probs=151.2
Q ss_pred cceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 400 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
.+.||+|.||+||-|.++ +|+.||||+|.+..+..+....+++|+.+|+.+.||.||.+.-.|+..+..++|||-+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 488999999999999665 8999999999988887777889999999999999999999999999999999999999 45
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC---CcEEEEeeccccccCCCC
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~ 555 (580)
+..+++... ...++++.....+..||+.||.|||. ++|||+||||+|||+.+. -.+||||||+|+.+.+.
T Consensus 648 DMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 648 DMLEMILSS---EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred hHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 776776542 33578888888899999999999997 899999999999999643 46999999999988653
Q ss_pred CCccccccccCCccCccccCCCCCC
Q 008026 556 GSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+....++|||.|.|||++++.+|+
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyN 744 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYN 744 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhcccc
Confidence 456678999999999999999885
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=256.97 Aligned_cols=178 Identities=24% Similarity=0.419 Sum_probs=149.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||||++..... .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999775 689999999976432 2334456788999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999998843 2358899999999999999999998 899999999999999999999999999987543
Q ss_pred CCCCC-------------------------------------ccccccccCCccCccccCCCCCC
Q 008026 553 EGKGS-------------------------------------IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~-------------------------------------~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... .....+||+.|+|||++.+.+++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 217 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC
Confidence 21100 01124699999999999877653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=257.44 Aligned_cols=148 Identities=26% Similarity=0.424 Sum_probs=131.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999664 789999999875432 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999988843 2467888999999999999999998 8999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=256.98 Aligned_cols=147 Identities=25% Similarity=0.384 Sum_probs=130.6
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.|++.+.||+|+||+||+|+.. +++.||+|++..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999664 688999999976432 33445678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 9999999988743 2457888899999999999999997 8999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=252.66 Aligned_cols=173 Identities=28% Similarity=0.458 Sum_probs=150.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999775 689999999976432 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999988843 2467888899999999999999998 899999999999999999999999999998664
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ....||+.|+|||++.+..+
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~ 192 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGH 192 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCC
Confidence 322 23579999999999987764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=243.17 Aligned_cols=170 Identities=28% Similarity=0.459 Sum_probs=139.8
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----eeE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 469 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 469 (580)
.|...+++|.|+||.||+|... +++.||||++-.+. +.-.+|+++|++++|||||++..+|.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4666799999999999999765 57999999886532 12357999999999999999988886532 235
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-CcEEEEeeccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLV 548 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a 548 (580)
+||||++. +|.++++.+...+ ..++...+.-++.||.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|
T Consensus 99 lVleymP~-tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 89999976 9999887644333 467778888999999999999998 899999999999999955 99999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+....+... ..+.-|.+|+|||.+.|..
T Consensus 174 K~L~~~epn--iSYicSRyYRaPELifga~ 201 (364)
T KOG0658|consen 174 KVLVKGEPN--ISYICSRYYRAPELIFGAT 201 (364)
T ss_pred eeeccCCCc--eeEEEeccccCHHHHcCcc
Confidence 988766543 4456799999999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=250.08 Aligned_cols=170 Identities=28% Similarity=0.385 Sum_probs=144.4
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
+.||+|+||.||+|+.. +++.||+|++..... .......+.+|++++++++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 789999999976432 2334566788999999999999999999999999999999999999
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 558 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 558 (580)
+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 151 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cc
Confidence 99888743 2468899999999999999999998 899999999999999999999999999987543222 12
Q ss_pred cccccccCCccCccccCCCCC
Q 008026 559 ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 559 ~~~~~Gt~~y~APE~~~~~~~ 579 (580)
....+||+.|+|||++.+.+|
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~ 172 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDY 172 (323)
T ss_pred ccceecCccccChhhhcCCCC
Confidence 234679999999999987765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=248.84 Aligned_cols=173 Identities=28% Similarity=0.391 Sum_probs=149.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999765 689999999875332 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999988843 2468888999999999999999998 899999999999999999999999999998664
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ....||+.|+|||++.+.++
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~~~ 175 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSKGH 175 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCCCC
Confidence 321 23568999999999987665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=251.56 Aligned_cols=173 Identities=29% Similarity=0.456 Sum_probs=149.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++...... ......+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999876 5899999999764322 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999998843 2467889999999999999999998 899999999999999999999999999997654
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. ......||+.|+|||++.+..+
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~ 175 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGY 175 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCC
Confidence 3 2234579999999999987765
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=239.61 Aligned_cols=149 Identities=31% Similarity=0.391 Sum_probs=133.7
Q ss_pred cCCcccceeeccCcEEEEEEEEcC-CcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|.-|+||+++.++ +..+|+|++.+.... .+...+.+.|-++|+.++||.++.+|+.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457788999999999999998874 589999999886543 445677889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
|||+||+|..+.++ +..+.+++..++.++..|+.||+|||- .|||+|||||+||||.++|++-|+||.++.
T Consensus 157 eyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred ecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999887644 445689999999999999999999997 899999999999999999999999999863
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=252.46 Aligned_cols=173 Identities=29% Similarity=0.411 Sum_probs=148.5
Q ss_pred cCCcccceeeccCcEEEEEEEEcC--CcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD--GTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
++|++.+.||+|+||.||+|.... +..||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 579999999999999999997543 36899999875432 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999988843 2468899999999999999999998 89999999999999999999999999999865
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... .....||+.|||||++.+..+
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~ 205 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGH 205 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCC
Confidence 432 234579999999999987654
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=255.62 Aligned_cols=147 Identities=26% Similarity=0.411 Sum_probs=129.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|++++++++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999764 689999999865322 2233466889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|.
T Consensus 81 E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 81 DYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 99999999998843 2457888899999999999999998 899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=262.90 Aligned_cols=182 Identities=30% Similarity=0.490 Sum_probs=149.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
.+.+..+.||+|+||+||+|+.. +...||||.++.. .+....++|++|+++++.++|||||+++|+|..++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 34556788999999999999753 3457999999874 3555788999999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhC---------CCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEG---------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
|||+|||..|||.+++....... ..+++..+.+.||.|||.|++||-+ +.+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 99999999999999997543211 2348889999999999999999997 78999999999999999999
Q ss_pred EEEEeeccccccCCCCCCccc-cccccCCccCccccCCCCCC
Q 008026 540 AKVADFGLVRLAPEGKGSIET-RIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~~~~~~-~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+|||+++.....+-.... ...=..+|||||.++.++++
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT 683 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT 683 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc
Confidence 999999999876443211111 11125689999999887764
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=255.93 Aligned_cols=147 Identities=26% Similarity=0.397 Sum_probs=130.0
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999764 688999999876432 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999999988743 2457888899999999999999998 8999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=251.14 Aligned_cols=177 Identities=24% Similarity=0.388 Sum_probs=159.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
...|.+.+.||+|.|+.|.+|++. ++..||+|.+++...+....+.+.+|+++|+.++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457899999999999999999765 7999999999988777777777999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+.+|.+.+++.. ...+.+..+..++.|+.+|++|+|+ +.|||||||++|||++.+..+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999954 2455568888999999999999998 899999999999999999999999999998886
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.+ ....+.+|++.|+|||++.|.+|+
T Consensus 207 ~~--~~lqt~cgsppyAaPEl~~g~~y~ 232 (596)
T KOG0586|consen 207 YG--LMLQTFCGSPPYAAPELFNGKKYD 232 (596)
T ss_pred cc--ccccccCCCCCccChHhhcCcccC
Confidence 43 345668999999999999998874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=243.74 Aligned_cols=176 Identities=34% Similarity=0.500 Sum_probs=148.6
Q ss_pred CcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 397 FSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
|+..+.||+|+||.||+|.. .+++.||+|.+...... ......+.+|++++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 77889999999999999976 47899999998764332 22334678899999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++|+|.+++.. .....+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~g~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 82 MNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred cCCCcHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999887743 222368899999999999999999998 89999999999999999999999999999875433
Q ss_pred CCCccccccccCCccCccccCCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
. ......||+.|+|||++.+..|+
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~ 179 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYT 179 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCC
Confidence 2 22335789999999999877653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=254.18 Aligned_cols=181 Identities=25% Similarity=0.319 Sum_probs=151.7
Q ss_pred HHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC
Q 008026 388 QVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 465 (580)
Q Consensus 388 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 465 (580)
...+...++|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|+.+++.++||||+++++++..+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 334445578999999999999999999775 688999999875322 233445678899999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999988743 247888889999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
|+++.............+||+.|||||++.+.
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 218 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhcc
Confidence 99987643322223346799999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=249.41 Aligned_cols=178 Identities=30% Similarity=0.464 Sum_probs=155.4
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCee
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEK 468 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 468 (580)
.....|++.+.||+|.||.||++..+ +|+.+|+|.+.+.... ......+.+|+.+|+++. ||||+.++++|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567899999999999999999766 5999999999876543 234678999999999998 99999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC----CcEEEEe
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVAD 544 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 544 (580)
++|||++.||.|.+.+... .+++..+..++.|++.|++|||+ .+|+|||+||+|+|+... +.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999998653 28999999999999999999998 899999999999999632 4799999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
||+|..... .......+||++|+|||++...+|+
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~ 216 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYG 216 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCC
Confidence 999998876 3345567899999999999876653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=248.53 Aligned_cols=175 Identities=23% Similarity=0.324 Sum_probs=148.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccc-cChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ........+.+|..++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999765 67899999987532 22333456788999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999988542 2367888999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
...........||+.|+|||++.+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhc
Confidence 433222233569999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=253.01 Aligned_cols=176 Identities=25% Similarity=0.329 Sum_probs=148.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
..++|++.+.||+|+||.||+|+.. ++..||+|++.+... .......+.+|+.+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999765 688999999975322 22334567889999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999988743 247788899999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
............+||+.|+|||++.+.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~ 218 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccC
Confidence 643322222345799999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=244.93 Aligned_cols=179 Identities=35% Similarity=0.488 Sum_probs=157.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.+.|..-++||+|+||.||-++.+ +|+-||.|++.++.+. ........+|-.++.++..+.||.+-..|++.+..|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 457888899999999999999665 7999999998776543 33445678899999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
+..|.||||.-+|.+ .+...+++..++.++.+|+.||++||. .+||+||+||+|||+|+.|+++|+|+|+|..+
T Consensus 264 LtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999988865 344679999999999999999999997 89999999999999999999999999999988
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..+.. .+..+||.+|||||++.++.|+
T Consensus 338 ~~g~~--~~~rvGT~GYMAPEvl~ne~Y~ 364 (591)
T KOG0986|consen 338 PEGKP--IRGRVGTVGYMAPEVLQNEVYD 364 (591)
T ss_pred CCCCc--cccccCcccccCHHHHcCCccc
Confidence 76553 3334899999999999998875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=247.49 Aligned_cols=170 Identities=28% Similarity=0.394 Sum_probs=143.8
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
+.||+|+||.||+++.. ++..||+|++..... .......+.+|+++++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999976432 2334566788999999999999999999999999999999999999
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 558 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 558 (580)
+|..++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 151 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cc
Confidence 99877733 2468899999999999999999998 899999999999999999999999999987543222 12
Q ss_pred cccccccCCccCccccCCCCC
Q 008026 559 ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 559 ~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.....||+.|+|||++.+..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~ 172 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDY 172 (323)
T ss_pred cccccCCcCcCCcccccCCCC
Confidence 233579999999999987765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=243.79 Aligned_cols=177 Identities=23% Similarity=0.341 Sum_probs=149.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999876 68899999997654444455678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|++++.+..+. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLE-----EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99987665433 122468889999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........||+.|+|||++.+.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~ 178 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPY 178 (287)
T ss_pred cccccccccccccccCCcHHHcCCCC
Confidence 33223334578999999999987665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=229.32 Aligned_cols=177 Identities=32% Similarity=0.473 Sum_probs=151.3
Q ss_pred HHHHhhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccC------hhhHHHHHHHHHHHHhcC-CCcccceee
Q 008026 389 VLRNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVR-HRHLVALLG 460 (580)
Q Consensus 389 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~niv~~~~ 460 (580)
.-..+.+.|...+.+|.|..+.|.++.. .+|..+|+|++...... ....++-.+|+.+++++. ||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 3445667888899999999999999854 47899999998643211 112345678999999985 999999999
Q ss_pred EEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcE
Q 008026 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540 (580)
Q Consensus 461 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 540 (580)
+|+++...++|+|.|+.|.|.+++.. .-.+++....+|++|+.+|++|||. .+|||||+||+|||++++.++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNI 162 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccce
Confidence 99999999999999999999999943 2368899999999999999999997 899999999999999999999
Q ss_pred EEEeeccccccCCCCCCccccccccCCccCccccC
Q 008026 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
||+|||+|..+..+. ..+..+|||+|.|||.+.
T Consensus 163 ~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtik 195 (411)
T KOG0599|consen 163 KISDFGFACQLEPGE--KLRELCGTPGYLAPETIK 195 (411)
T ss_pred EEeccceeeccCCch--hHHHhcCCCcccChhhee
Confidence 999999999887654 356689999999999875
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=251.21 Aligned_cols=178 Identities=24% Similarity=0.410 Sum_probs=149.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+.++..++||+|+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999765 689999999975332 2334567888999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999998843 2468889999999999999999998 899999999999999999999999999987542
Q ss_pred CCCC----------------------------------CccccccccCCccCccccCCCCCC
Q 008026 553 EGKG----------------------------------SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~----------------------------------~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... ......+||+.|+|||++.+.+++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~ 214 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN 214 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC
Confidence 2110 001235799999999999887653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=247.98 Aligned_cols=175 Identities=24% Similarity=0.355 Sum_probs=148.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccc-cChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999765 68999999997532 22334566888999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.+. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999988432 2457889999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
...........||+.|||||++.+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQA 177 (331)
T ss_pred CCCCccccceeccccccCHHHHhh
Confidence 433222233469999999999863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=253.31 Aligned_cols=167 Identities=31% Similarity=0.445 Sum_probs=141.8
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecc-ccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAG-VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.|...+.||.|+||.||.|++. +.+.||||++.-. ......-.++.+|++.|.+++|||++.+-|+|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3566778999999999999764 6789999998642 1223334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||- |+-.+.+. -..+++.+..+..|+.+.+.||+|||+ .+.||||||+.|||+++.|.|||+|||.|....+
T Consensus 107 YCl-GSAsDlle----VhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 107 YCL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHh-ccHHHHHH----HHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 995 47766662 233578888999999999999999998 7899999999999999999999999999976643
Q ss_pred CCCCccccccccCCccCccccC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
...++|||+|||||++.
T Consensus 179 -----AnsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVIL 195 (948)
T ss_pred -----hhcccCCccccchhHhe
Confidence 45689999999999976
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=247.82 Aligned_cols=175 Identities=25% Similarity=0.378 Sum_probs=149.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999765 689999999986533 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999988542 2468899999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
...........||+.|+|||++.+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred CCCceeeecccCCccccCHHHhcc
Confidence 443322333578999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=246.49 Aligned_cols=170 Identities=28% Similarity=0.401 Sum_probs=144.1
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
+.||+|+||.||+++.. +++.||+|++.+... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 689999999976432 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 558 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 558 (580)
+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 151 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-AT 151 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cc
Confidence 99877733 2468899999999999999999997 899999999999999999999999999987643222 12
Q ss_pred cccccccCCccCccccCCCCC
Q 008026 559 ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 559 ~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.....||+.|+|||++.+..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~ 172 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDY 172 (328)
T ss_pred cccccCCcCccChhhhcCCCC
Confidence 234579999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=236.92 Aligned_cols=176 Identities=30% Similarity=0.443 Sum_probs=149.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-----CC
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-----GN 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 466 (580)
+...|...+.||+|+||.|+.|... +|+.||||++..........++..+|+++++.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999664 79999999998666666778899999999999999999999998865 35
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
.+|+|+|+| +.+|...++. .+.++...+..++.|+++||.|+|+ .+|+|||+||+|++++.+..+||+|||
T Consensus 100 DvYiV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccc
Confidence 689999999 5689888843 3458999999999999999999998 899999999999999999999999999
Q ss_pred cccccCCC-CCCccccccccCCccCccccCCC
Q 008026 547 LVRLAPEG-KGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 547 ~a~~~~~~-~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+|+..... .....+.++-|.+|.|||++...
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~ 202 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNS 202 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhcc
Confidence 99987532 12233567889999999997643
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=245.23 Aligned_cols=172 Identities=28% Similarity=0.395 Sum_probs=143.9
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
+.||+|+||.||+++.. +++.||+|++..... .......+.+|+++++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 789999999976433 2234566788999999999999999999999999999999999999
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 558 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 558 (580)
+|.+++.. ...+++.++..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99887732 2468899999999999999999996 26899999999999999999999999999875432221 2
Q ss_pred cccccccCCccCccccCCCCCC
Q 008026 559 ETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 559 ~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.....||+.|+|||++.+..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYG 174 (325)
T ss_pred cccccCCcccCCHHHHccCCCC
Confidence 2335799999999999877653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=251.29 Aligned_cols=177 Identities=27% Similarity=0.416 Sum_probs=151.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++...... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999775 7899999999764332 244567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999988542 468899999999999999999998 899999999999999999999999999997654
Q ss_pred CCC----------------------------CCccccccccCCccCccccCCCCC
Q 008026 553 EGK----------------------------GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~----------------------------~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ........||+.|+|||++.+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY 207 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC
Confidence 332 011233569999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=246.90 Aligned_cols=174 Identities=25% Similarity=0.371 Sum_probs=146.8
Q ss_pred CCcccceeeccCcEEEEEEEEc----CCcEEEEEEeecccc--ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCee
Q 008026 396 NFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEK 468 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 468 (580)
+|++.+.||+|+||.||+++.. +++.||+|++.+... .....+.+.+|+.+++.++ |++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999653 578999999975332 1233456788999999995 99999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999988743 2458889999999999999999997 89999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+..............||+.|||||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 181 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGK 181 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCC
Confidence 86544333333346799999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=248.03 Aligned_cols=180 Identities=27% Similarity=0.426 Sum_probs=151.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..+...+.++||+|.||+|.+|+...+..||||+++... ......+|.+|+++|.+++||||++++|+|..++..++|+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 345677889999999999999999888999999998743 3445689999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.+... .........+|+.||+.|++||.+ .++||||+.+.|+|++.++++||+|||+++.+.
T Consensus 615 EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999965322 224556677899999999999998 899999999999999999999999999999665
Q ss_pred CCCCC-ccccccccCCccCccccCCCCC
Q 008026 553 EGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.+.-. .+.+.+=..+|||||.+..++.
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkF 716 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKF 716 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccc
Confidence 54322 2233445679999999876653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=244.54 Aligned_cols=169 Identities=28% Similarity=0.384 Sum_probs=143.6
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCCh
Q 008026 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 480 (580)
||+|+||.||+|+.. +++.||+|++.+... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999765 688999999975432 334456788999999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccc
Q 008026 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 560 (580)
Q Consensus 481 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 560 (580)
.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 988843 2468899999999999999999998 899999999999999999999999999997643322 2233
Q ss_pred cccccCCccCccccCCCCCC
Q 008026 561 RIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 561 ~~~Gt~~y~APE~~~~~~~~ 580 (580)
..+||+.|+|||++.+..++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~ 171 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYT 171 (312)
T ss_pred cccCCcccCCHHHHcCCCCC
Confidence 45799999999999877653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=248.41 Aligned_cols=182 Identities=28% Similarity=0.447 Sum_probs=145.3
Q ss_pred hcCCcccceeeccCcEEEEEEEE------cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCC
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 466 (580)
.++|++.+.||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 46799999999999999999964 235679999987532 333456789999999999 7999999999887654
Q ss_pred -eeEEEEEecCCCChhHHHHHHhhh-------------------------------------------------------
Q 008026 467 -EKLLVFEYMPQGTLSRHIFNWAEE------------------------------------------------------- 490 (580)
Q Consensus 467 -~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------- 490 (580)
..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999988642110
Q ss_pred --CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc-cccccccCC
Q 008026 491 --GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFG 567 (580)
Q Consensus 491 --~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~Gt~~ 567 (580)
....+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......... .....+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 01347788899999999999999998 899999999999999999999999999998654322211 122346788
Q ss_pred ccCccccCCCCC
Q 008026 568 YLAPEYAGNFGS 579 (580)
Q Consensus 568 y~APE~~~~~~~ 579 (580)
|+|||++.+..+
T Consensus 242 y~aPE~~~~~~~ 253 (338)
T cd05102 242 WMAPESIFDKVY 253 (338)
T ss_pred ccCcHHhhcCCC
Confidence 999999877654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=242.86 Aligned_cols=181 Identities=28% Similarity=0.465 Sum_probs=147.0
Q ss_pred cCCcccceeeccCcEEEEEEEEcC-----------------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccc
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD-----------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 457 (580)
++|++.+.||+|+||.||+|.+++ +..||+|.+.... ......++.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 578899999999999999997532 3469999887532 3344567899999999999999999
Q ss_pred eeeEEEcCCeeEEEEEecCCCChhHHHHHHhh--------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 008026 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAE--------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 523 (580)
Q Consensus 458 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iv 523 (580)
+++++...+..++||||+++++|.+++..... .....+++..+.+++.||+.||+|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 99999999999999999999999998854221 111346788899999999999999998 8999
Q ss_pred ecCCCCCCeEecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 524 HRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 524 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||||||+||++++++.+||+|||+++........ ......++..|||||++.++.+
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 217 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF 217 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence 9999999999999999999999999765433211 1122345788999999877654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=249.87 Aligned_cols=170 Identities=21% Similarity=0.245 Sum_probs=143.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..+|++.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++||||+++++++......++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 357999999999999999999764 689999996532 34678999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
|++. ++|..++.. ...+++.+++.++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+...
T Consensus 163 e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 9995 688777633 2457889999999999999999998 899999999999999999999999999997543
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
...........||+.|+|||++.+.+|+
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 261 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYG 261 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCC
Confidence 3222223345799999999999877653
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=243.84 Aligned_cols=175 Identities=27% Similarity=0.371 Sum_probs=146.2
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCC-CcccceeeEEEcCCeeEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 472 (580)
+|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+..|.++++.++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999765 578999999976432 23345678889999999976 46888999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999888743 2457889999999999999999997 899999999999999999999999999987532
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... .......||+.|+|||++.+..+
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~ 178 (324)
T cd05587 153 FGG-KTTRTFCGTPDYIAPEIIAYQPY 178 (324)
T ss_pred CCC-CceeeecCCccccChhhhcCCCC
Confidence 222 12234579999999999988765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=244.38 Aligned_cols=174 Identities=24% Similarity=0.344 Sum_probs=146.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+++.. +++.||+|++.+... .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999775 578899999865322 2233455788999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999988531 2357888999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
...........||+.|+|||++.
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred cCCcceecccccCccccCHHHHh
Confidence 33322223357999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=244.18 Aligned_cols=173 Identities=31% Similarity=0.433 Sum_probs=143.6
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHH---HhcCCCcccceeeEEEcCCeeEEE
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVL---TKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
|++.+.||+|+||.||+|... +++.||+|++++... .....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999765 689999999976432 223345666776655 566799999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|..++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999877632 468999999999999999999998 89999999999999999999999999998754
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .......||+.|+|||++.+..+
T Consensus 152 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~ 178 (324)
T cd05589 152 MGFG-DRTSTFCGTPEFLAPEVLTETSY 178 (324)
T ss_pred CCCC-CcccccccCccccCHhHhcCCCC
Confidence 3222 22334679999999999987664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=243.22 Aligned_cols=170 Identities=26% Similarity=0.392 Sum_probs=144.5
Q ss_pred ceeeccCcEEEEEEEE----cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecC
Q 008026 401 NILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
+.||+|+||.||+++. .+++.||+|++............+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 357899999998654433445667889999999999999999999999999999999999
Q ss_pred CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC
Q 008026 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556 (580)
Q Consensus 477 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 556 (580)
+++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999888743 2468899999999999999999998 8999999999999999999999999999986543322
Q ss_pred CccccccccCCccCccccCCCCC
Q 008026 557 SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 557 ~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......||+.|+|||++.+.++
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~ 175 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGH 175 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCC
Confidence 2234579999999999887654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=243.03 Aligned_cols=170 Identities=30% Similarity=0.476 Sum_probs=142.2
Q ss_pred ceeeccCcEEEEEEEE----cCCcEEEEEEeecccc--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 401 NILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+.||+|+||.||+++. .+++.||+|++..... .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 3578999999976432 223345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ...+.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999888743 2457788888999999999999998 89999999999999999999999999998754332
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. .......||+.|+|||++.+..+
T Consensus 154 ~-~~~~~~~gt~~y~aPE~~~~~~~ 177 (323)
T cd05584 154 G-TVTHTFCGTIEYMAPEILMRSGH 177 (323)
T ss_pred C-CcccccCCCccccChhhccCCCC
Confidence 2 22234579999999999987654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=231.33 Aligned_cols=178 Identities=28% Similarity=0.377 Sum_probs=155.1
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
..++|+..++||+|.||+|.+++- .+++.||+|++++..+. ......-..|-++++.++||.+..+-..|+..+..|.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 457899999999999999999965 48999999999887654 3344556789999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||..||.|.-++.+ .+.+++.....+...|+.||.|||+ ++||+||+|.+|.|+|++|++||+|||+++.
T Consensus 246 VMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999888733 3578999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..... ....+++|||.|.|||++....|
T Consensus 318 ~I~~g-~t~kTFCGTPEYLAPEVleDnDY 345 (516)
T KOG0690|consen 318 EIKYG-DTTKTFCGTPEYLAPEVLEDNDY 345 (516)
T ss_pred ccccc-ceeccccCChhhcCchhhccccc
Confidence 54333 34567899999999999987665
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=238.68 Aligned_cols=172 Identities=25% Similarity=0.389 Sum_probs=144.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|+.. ++..||+|++.... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 57999999999999999999765 68999999986532 22234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLDS-DLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCCc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 9975 88887743 22357888999999999999999998 8999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccCccccCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
... ......|++.|+|||++.+
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 156 PTK-TYSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred CCc-cccCceecccccChHHhcC
Confidence 322 2233468999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=241.65 Aligned_cols=176 Identities=26% Similarity=0.366 Sum_probs=150.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+++.. ++..||+|.+.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 368999999999999999999775 68889999987532 3344567999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999998843 2357888999999999999999997 2469999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... .....||+.|+|||++.+..++
T Consensus 156 ~~~---~~~~~g~~~y~aPE~~~~~~~~ 180 (331)
T cd06649 156 DSM---ANSFVGTRSYMSPERLQGTHYS 180 (331)
T ss_pred ccc---cccCCCCcCcCCHhHhcCCCCC
Confidence 322 2335689999999999877653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=242.77 Aligned_cols=170 Identities=23% Similarity=0.376 Sum_probs=143.6
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|++++.... ......+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999765 6889999999865332 33456688999999998 699999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~ 151 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-C
Confidence 999887733 2468999999999999999999997 899999999999999999999999999987532222 1
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......||+.|+|||++.+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~ 173 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDY 173 (329)
T ss_pred ccccccCCccccCHHHHcCCCC
Confidence 2334679999999999987765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=241.65 Aligned_cols=170 Identities=24% Similarity=0.381 Sum_probs=142.8
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|++.+.... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 6789999999865332 33455678899988877 799999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|..++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~ 151 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-C
Confidence 999877632 2468899999999999999999998 899999999999999999999999999987543222 1
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......||+.|+|||++.+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~ 173 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDY 173 (329)
T ss_pred ccccccCCccccCHHHHcCCCC
Confidence 2234579999999999987765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=246.25 Aligned_cols=182 Identities=29% Similarity=0.411 Sum_probs=148.9
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEcC--C--cE-EEEEEeecc-ccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELHD--G--TK-IAVKRMEAG-VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 464 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 464 (580)
+-..++....++||+|+||.||+|++.. + .. ||+|..+.. ........++.+|+++|+.++|||||++||++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3344556667999999999999997753 2 23 899988752 3556678899999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
....++|||+|.||+|.++++. ....++..+.+.++.+.|.||+|||+ +++|||||-++|+|++.++.+||+|
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k----~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKK----NKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999954 22368899999999999999999998 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
||+++........... ..-..+|+|||.+..+-||
T Consensus 306 FGLs~~~~~~~~~~~~-~klPirWLAPEtl~~~~~s 340 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFL-KKLPIRWLAPETLNTGIFS 340 (474)
T ss_pred cccccCCcceeecccc-ccCcceecChhhhccCccc
Confidence 9998765421111101 1124689999999887654
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=241.84 Aligned_cols=176 Identities=26% Similarity=0.344 Sum_probs=146.4
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 472 (580)
+|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+..|.+++..+. |++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999765 578999999986432 2233455677888888874 899999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999888743 2458889999999999999999998 899999999999999999999999999997543
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... .......||+.|+|||++.+.+++
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05616 153 WDG-VTTKTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred CCC-CccccCCCChhhcCHHHhcCCCCC
Confidence 222 122345799999999999887653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=241.02 Aligned_cols=170 Identities=29% Similarity=0.445 Sum_probs=140.7
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|+++.... .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 678999999976432 223345566677777654 799999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 999888743 2468889999999999999999998 899999999999999999999999999997653322 2
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.....+||+.|+|||++.+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~ 173 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKY 173 (316)
T ss_pred ccccccCCccccCHHHHcCCCC
Confidence 2334579999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=252.63 Aligned_cols=175 Identities=27% Similarity=0.479 Sum_probs=152.2
Q ss_pred CCcccceeeccCcEEEEEEEEcC----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
...+.++||.|.||+||+|+++. ...||||.++.. ..++...+|+.|+.+|.+++||||+++.|+......+.||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45788999999999999998762 357999999875 4667788999999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
+|||++|+|..+++. +...+++.+..-+.++|+.|++||-+ .++|||||.++|||++.+..+|++|||+++..
T Consensus 709 TEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999954 33569999999999999999999997 89999999999999999999999999999988
Q ss_pred CCCCCCccccccc--cCCccCccccCCCC
Q 008026 552 PEGKGSIETRIAG--TFGYLAPEYAGNFG 578 (580)
Q Consensus 552 ~~~~~~~~~~~~G--t~~y~APE~~~~~~ 578 (580)
.++.....+...| ..+|.|||.+....
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RK 810 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRK 810 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcc
Confidence 7665444444444 35899999986543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=252.59 Aligned_cols=178 Identities=21% Similarity=0.302 Sum_probs=149.1
Q ss_pred CCcccceeeccCcEEEEEEEEc-C-CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-D-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.|.+.+.||+|+||.||+|... + +..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 4888999999999999999654 4 678888876542 23344567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999998865332 23468889999999999999999998 8999999999999999999999999999987644
Q ss_pred CCC-CccccccccCCccCccccCCCCC
Q 008026 554 GKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......+||+.|+|||++.+..+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~ 248 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRY 248 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCC
Confidence 321 12334679999999999987765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=238.30 Aligned_cols=174 Identities=26% Similarity=0.378 Sum_probs=144.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 367999999999999999999775 689999999875332 223346778999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||++ ++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9995 577777633 23457888999999999999999998 899999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccCccccCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
... .......||+.|+|||++.+.
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~ 178 (303)
T cd07869 155 VPS-HTYSNEVVTLWYRPPDVLLGS 178 (303)
T ss_pred CCC-ccCCCCcccCCCCChHHHcCC
Confidence 322 122335689999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.97 Aligned_cols=170 Identities=29% Similarity=0.415 Sum_probs=142.2
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|++..... .......+..|.+++..+ +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 578999999976432 233445677889998876 699999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|..++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 151 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-V 151 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-c
Confidence 999887743 2467889999999999999999998 899999999999999999999999999987543322 2
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......||+.|+|||++.+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~ 173 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEY 173 (321)
T ss_pred cccccccCccccCHHHHcCCCC
Confidence 2334579999999999987665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.76 Aligned_cols=170 Identities=28% Similarity=0.418 Sum_probs=142.2
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|++.+... .......+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 688999999976432 233456677888888877 599999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~ 151 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-K 151 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-C
Confidence 999887743 2468889999999999999999997 899999999999999999999999999987543222 2
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......||+.|+|||++.+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~ 173 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLY 173 (320)
T ss_pred cccccccCccccCHHHHcCCCC
Confidence 2334579999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=240.62 Aligned_cols=175 Identities=26% Similarity=0.356 Sum_probs=145.6
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 472 (580)
+|+..+.||+|+||.||+|+.. +++.||+|++.+... .....+.+..|.++++.+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999765 689999999976432 2334456778899998886 577888999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999888743 2468899999999999999999998 899999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... .......||+.|+|||++.+..+
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~ 178 (323)
T cd05615 153 VDG-VTTRTFCGTPDYIAPEIIAYQPY 178 (323)
T ss_pred CCC-ccccCccCCccccCHHHHcCCCC
Confidence 222 12234569999999999987665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=245.07 Aligned_cols=171 Identities=29% Similarity=0.378 Sum_probs=148.0
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-C-----CcccceeeEEEcCCee
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-H-----RHLVALLGHCLDGNEK 468 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~ 468 (580)
+|++.+.||+|+||.|.+|.+. +++.||||+++.+ ..-..+...|+.+|..++ | -|+|+++++|..+++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 7999999999999999999654 7999999999863 334567788999999996 4 4899999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC--CcEEEEeec
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFG 546 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg 546 (580)
|||+|.+ ..+|.++++. .+...++...++.|+.||+.||.+||+ .+|||+||||+|||+.+. ..+||+|||
T Consensus 264 ciVfELL-~~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhh-hhhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999999 4599999965 455678999999999999999999997 899999999999999754 469999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.|....... ..++-+..|+|||++.|.+|+
T Consensus 337 SSc~~~q~v----ytYiQSRfYRAPEVILGlpY~ 366 (586)
T KOG0667|consen 337 SSCFESQRV----YTYIQSRFYRAPEVILGLPYD 366 (586)
T ss_pred cccccCCcc----eeeeeccccccchhhccCCCC
Confidence 998765432 256778999999999999985
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=240.12 Aligned_cols=170 Identities=31% Similarity=0.439 Sum_probs=139.8
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHH-HHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||+||+|... +++.||+|++...... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999775 6899999999764322 222344555554 56789999999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 999888743 2468889999999999999999998 899999999999999999999999999987543322 2
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......||+.|+|||++.+.++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~ 173 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPY 173 (323)
T ss_pred ccccccCChhhcChhhhcCCCC
Confidence 2334579999999999988765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=240.16 Aligned_cols=175 Identities=24% Similarity=0.363 Sum_probs=149.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 368999999999999999999776 68889999887642 3344567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+|||+++++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999998843 2357888899999999999999997 2479999999999999999999999999987653
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... .....||+.|+|||++.+..+
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~~~ 179 (333)
T cd06650 156 DSM---ANSFVGTRSYMSPERLQGTHY 179 (333)
T ss_pred hhc---cccCCCCccccCHHHhcCCCC
Confidence 321 233568999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=240.20 Aligned_cols=170 Identities=31% Similarity=0.433 Sum_probs=139.2
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHH-HHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 688999999976432 2223344555554 67889999999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|...+.. ...+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E 151 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence 999877632 2457888899999999999999998 899999999999999999999999999987543222 1
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......||+.|+|||++.+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~ 173 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPY 173 (321)
T ss_pred ccccccCCcccCCHHHhcCCCC
Confidence 2334579999999999987665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=253.08 Aligned_cols=184 Identities=24% Similarity=0.320 Sum_probs=153.2
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 466 (580)
..++|++.+.||+|+||.||+|+.. +++.||||++............+.+|+..+..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999654 7899999999876555566678899999999999999999988765432
Q ss_pred ---eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEE
Q 008026 467 ---EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 543 (580)
Q Consensus 467 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 543 (580)
..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 36799999999999998865332 23568899999999999999999998 899999999999999999999999
Q ss_pred eeccccccCCCCC-CccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+++....... .......||+.|+|||++.+..|+
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s 223 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCC
Confidence 9999986543221 122346799999999999887653
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=240.35 Aligned_cols=170 Identities=29% Similarity=0.433 Sum_probs=139.8
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHH-HHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||+||+|+.. +++.||+|++.+... .......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 789999999976432 2233345555654 56778999999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|..++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 151 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-D 151 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-C
Confidence 999877732 2468899999999999999999998 899999999999999999999999999987543222 1
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......||+.|+|||++.+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~ 173 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPY 173 (325)
T ss_pred CcccccCChhhCCHHHHcCCCC
Confidence 2234579999999999988765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=249.16 Aligned_cols=173 Identities=31% Similarity=0.462 Sum_probs=146.7
Q ss_pred CCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC------ee
Q 008026 396 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------EK 468 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 468 (580)
.|...+.||+|+||.||+++. .+|+.||||.++... .....++.-+|++++++++|+|||++++.-+... ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 355678899999999999985 489999999997743 4455678899999999999999999999866543 46
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec--CCCc--EEEEe
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMR--AKVAD 544 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~--~kl~D 544 (580)
.+|||||.+|||...+.+ .++...+++.+.+.+..+++.||.|||+ ++||||||||.||++- .+|+ -||+|
T Consensus 93 vlvmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred eEEEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeec
Confidence 899999999999998854 2344579999999999999999999997 8999999999999984 3343 69999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
||.|+...++. ....++||+.|.|||++..
T Consensus 168 fG~Arel~d~s--~~~S~vGT~~YLhPel~E~ 197 (732)
T KOG4250|consen 168 FGAARELDDNS--LFTSLVGTEEYLHPELYER 197 (732)
T ss_pred ccccccCCCCC--eeeeecCchhhcChHHHhh
Confidence 99999886654 4566899999999999985
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=234.75 Aligned_cols=173 Identities=31% Similarity=0.453 Sum_probs=144.4
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCCh
Q 008026 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 480 (580)
||+|+||+||++... +++.||+|++...... ....+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999765 7899999998764322 22345678899999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccc
Q 008026 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 560 (580)
Q Consensus 481 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 560 (580)
.+++..... ....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 887754222 23468899999999999999999998 8999999999999999999999999999976644332 223
Q ss_pred cccccCCccCccccCCCCCC
Q 008026 561 RIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 561 ~~~Gt~~y~APE~~~~~~~~ 580 (580)
...||+.|+|||++.+..++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~ 175 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYD 175 (280)
T ss_pred ccCCCcCccCHHHhcCCCCC
Confidence 35789999999999877653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=239.84 Aligned_cols=170 Identities=29% Similarity=0.406 Sum_probs=138.3
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHH-HHHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEI-AVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|++.+.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 6788999999764321 22233444444 456788999999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+.+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~ 151 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-G 151 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-C
Confidence 999888743 2357788888999999999999998 899999999999999999999999999997543322 1
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......||+.|+|||++.+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~ 173 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPY 173 (325)
T ss_pred CcccccCCccccCHHHHcCCCC
Confidence 2334679999999999987765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=233.97 Aligned_cols=176 Identities=35% Similarity=0.503 Sum_probs=147.9
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.|++.+.||+|+||.||++... +++.||+|++...... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999764 6899999999764332 2223457789999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999887743 222468899999999999999999998 8999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. ......|++.|+|||++.+..+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~ 178 (285)
T cd05605 155 GE--TIRGRVGTVGYMAPEVVKNERY 178 (285)
T ss_pred CC--ccccccCCCCccCcHHhcCCCC
Confidence 22 1233478999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=244.15 Aligned_cols=161 Identities=31% Similarity=0.503 Sum_probs=141.9
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCC
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 479 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 479 (580)
.+-||.|+.|.||+|+++ ++.||||+++. .-..+|+.|++++||||+.+.|+|.....+|||||||..|-
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 567999999999999997 78999998754 12467899999999999999999999999999999999999
Q ss_pred hhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCcc
Q 008026 480 LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 559 (580)
Q Consensus 480 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 559 (580)
|...++. ...++......|..+||.|+.|||. +.|||||||.-||||..+..+||+|||.++..... ...
T Consensus 199 L~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 199 LYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred HHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 9999843 3567778888999999999999998 78999999999999999999999999999876543 234
Q ss_pred ccccccCCccCccccCCCCCC
Q 008026 560 TRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 560 ~~~~Gt~~y~APE~~~~~~~~ 580 (580)
-.++||..|||||++++.+.|
T Consensus 269 MSFaGTVaWMAPEvIrnePcs 289 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCS 289 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcc
Confidence 458999999999999998864
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=239.61 Aligned_cols=171 Identities=24% Similarity=0.371 Sum_probs=143.9
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|++.+.... ....+.+.+|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 6789999999865332 33456688999999888 599999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 151 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-D 151 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-C
Confidence 999887732 2468999999999999999999998 899999999999999999999999999987532222 1
Q ss_pred ccccccccCCccCccccCCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.....+||+.|+|||++.+..++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~ 174 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYG 174 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCC
Confidence 22346799999999999887653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=256.72 Aligned_cols=183 Identities=25% Similarity=0.371 Sum_probs=150.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999765 6899999999764322 334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhh------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 473 EYMPQGTLSRHIFNWAEE------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
||++|++|.+++...... .....++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988653221 12345677889999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCC-----------------CccccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGKG-----------------SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~~-----------------~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+++....... ......+||+.|||||++.+.+++
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S 209 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC
Confidence 9976521100 011225699999999999887653
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=238.66 Aligned_cols=171 Identities=29% Similarity=0.450 Sum_probs=141.7
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. ++..||+|+++.... ..........|.+++... +||+|+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999775 688999999976432 123345667788888765 799999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 999888743 2467889999999999999999998 899999999999999999999999999987543222 1
Q ss_pred ccccccccCCccCccccCCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
......||+.|+|||++.+..++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYT 174 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCC
Confidence 23446799999999999877653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=241.62 Aligned_cols=172 Identities=29% Similarity=0.440 Sum_probs=141.9
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----eeE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 469 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 469 (580)
+|++.+.||+|+||.||+|... ++..||+|++...........++.+|++++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999764 6899999998754333344567889999999999999999999886432 479
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 688887732 2458899999999999999999998 899999999999999999999999999997
Q ss_pred ccCCCCC--CccccccccCCccCccccCC
Q 008026 550 LAPEGKG--SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 550 ~~~~~~~--~~~~~~~Gt~~y~APE~~~~ 576 (580)
....... .......||+.|+|||++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhc
Confidence 6432211 11234579999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=232.32 Aligned_cols=178 Identities=25% Similarity=0.371 Sum_probs=146.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|.+. .+..||+|.++... .......+.+|+..+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 46889999999999999999653 35689999987642 33445678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999988843 22468899999999999999999997 8999999999999999999999999998765
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.............++..|+|||.+.+..++
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCcc
Confidence 432211111123356789999998876653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=234.06 Aligned_cols=176 Identities=27% Similarity=0.374 Sum_probs=141.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc--CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc---CCCcccceeeEEEc-----
Q 008026 395 NNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLD----- 464 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----- 464 (580)
++|++.+.||+|+||.||+|+.. ++..||+|++............+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999763 468899999876443333344566777777766 69999999998852
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
....++||||++ ++|.+++... ....+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 346899999996 5888887432 22457889999999999999999998 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||+++...... ......||+.|+|||++.+..+
T Consensus 154 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 186 (290)
T cd07862 154 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSY 186 (290)
T ss_pred ccceEeccCCc--ccccccccccccChHHHhCCCC
Confidence 99998654332 2234568999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=237.21 Aligned_cols=171 Identities=29% Similarity=0.447 Sum_probs=141.4
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|+++.... ..........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999775 578999999976432 123345567788888764 899999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-A 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-C
Confidence 999988743 2457888999999999999999998 899999999999999999999999999987543222 1
Q ss_pred ccccccccCCccCccccCCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
......||+.|+|||++.+..++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYN 174 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCC
Confidence 22345799999999999877653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=250.91 Aligned_cols=176 Identities=30% Similarity=0.424 Sum_probs=144.9
Q ss_pred cCCcccceeeccCcEEEEEEEEcCC-cEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceee-EEEc------C
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDG-TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG-HCLD------G 465 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~------~ 465 (580)
.++++.+.|.+|||+.||.|....+ ..||+|++... ++...+.+.+|+++|++|+ |+|||.+++ .... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3567889999999999999987755 99999998764 6777889999999999998 999999999 3322 1
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
-++++.||||+||.|-+++..+... .+++.++++|+.|+++|+++||.+ +.+|||||||-+||||+.++..|||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 3568999999999999999765443 499999999999999999999985 578999999999999999999999999
Q ss_pred ccccccCCCCCCccc--------cccccCCccCccccCC
Q 008026 546 GLVRLAPEGKGSIET--------RIAGTFGYLAPEYAGN 576 (580)
Q Consensus 546 g~a~~~~~~~~~~~~--------~~~Gt~~y~APE~~~~ 576 (580)
|.|............ ...-|+.|+|||++.-
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl 229 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL 229 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh
Confidence 998654332211110 1235999999999863
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=234.81 Aligned_cols=177 Identities=25% Similarity=0.322 Sum_probs=157.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.-|.+.+.||+|-|+.|-+|++- +|..||||++.+...+......+.+|++.|+.++|||||++|.+.......|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45888899999999999999654 89999999999888887777889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-CCCcEEEEeeccccccC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAP 552 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~ 552 (580)
.-++|+|.+|+.... ..+.+..+.+++.||+.|+.|+|. ..+|||||||+||++- +-|-+||+|||++..+.
T Consensus 98 LGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999996633 358889999999999999999997 7899999999999874 67899999999998876
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++. ...+.+|+..|.|||++.|-.|+
T Consensus 171 PG~--kL~TsCGSLAYSAPEILLGDsYD 196 (864)
T KOG4717|consen 171 PGK--KLTTSCGSLAYSAPEILLGDSYD 196 (864)
T ss_pred Ccc--hhhcccchhhccCchhhhcCccC
Confidence 654 34567999999999999998774
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=242.57 Aligned_cols=173 Identities=27% Similarity=0.407 Sum_probs=144.8
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----eeE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 469 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 469 (580)
+|++.+.||+|+||.||+|... +++.||+|++..........+++.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999764 7899999998754333445567889999999999999999999998776 789
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+. ++|.+.+. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIV-----SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999996 57777663 23468899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
..............||+.|+|||++.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 179 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGS 179 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCC
Confidence 6544332233345689999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=242.55 Aligned_cols=167 Identities=28% Similarity=0.419 Sum_probs=140.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 35667889999999999999765 68999999986532 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+.. ..++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 153 ~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999986432 34567788899999999999998 8999999999999999999999999999987643
Q ss_pred CCCCccccccccCCccCccccC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
... ......||..|+|||++.
T Consensus 221 ~~~-~~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 221 TMD-PCNSSVGTIAYMSPERIN 241 (353)
T ss_pred ccc-cccccccCccccCccccc
Confidence 321 123357999999999874
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=243.29 Aligned_cols=182 Identities=29% Similarity=0.416 Sum_probs=146.8
Q ss_pred hcCCcccceeeccCcEEEEEEEE------cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCC
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 466 (580)
.++|++.+.||+|+||.||+|.. .++..||||+++... .....+.+.+|+++++.+ +||||+++++++...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34788999999999999999963 245689999986532 233456788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhh---------------------------------------------------------
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAE--------------------------------------------------------- 489 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 489 (580)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999998864211
Q ss_pred -------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC
Q 008026 490 -------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556 (580)
Q Consensus 490 -------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 556 (580)
.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 011247888999999999999999998 8999999999999999999999999999986643322
Q ss_pred Cc-cccccccCCccCccccCCCCC
Q 008026 557 SI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 557 ~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. .....++..|+|||++.+..+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~ 293 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVY 293 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCC
Confidence 11 112335678999999887654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=228.65 Aligned_cols=175 Identities=29% Similarity=0.426 Sum_probs=146.6
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||+++++++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4588889999999999999988878899999886532 2345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 81 MENGCLLNYLRQ----RQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 999999988743 12357899999999999999999997 89999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.........++..|+|||++.+.++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKY 178 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCcc
Confidence 2221222335678999999886654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=242.35 Aligned_cols=182 Identities=30% Similarity=0.469 Sum_probs=146.4
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 466 (580)
.++|++.+.||+|+||.||+|... ++..||+|++.... .......+.+|+++++.+ +|+||+++++++...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 357889999999999999998642 23579999997543 223456788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhh---------------------------------------------------------
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAE--------------------------------------------------------- 489 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 489 (580)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998854221
Q ss_pred --------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc-cc
Q 008026 490 --------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI-ET 560 (580)
Q Consensus 490 --------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 560 (580)
.....+++.++++++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 011247888899999999999999998 899999999999999999999999999997654332211 11
Q ss_pred cccccCCccCccccCCCCC
Q 008026 561 RIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 561 ~~~Gt~~y~APE~~~~~~~ 579 (580)
...++..|||||++.+..+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~ 291 (374)
T cd05106 273 NARLPVKWMAPESIFDCVY 291 (374)
T ss_pred CCCCccceeCHHHhcCCCC
Confidence 2235678999999877654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=246.08 Aligned_cols=171 Identities=28% Similarity=0.410 Sum_probs=145.3
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.|.++..||.|+||+||+|..+ ++-..|.|+|..+ .....+++.-||++|+.|+||+||++++.|+..+..||..|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 44677888999999999999665 4555677887653 45667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||+||-....+.+. ...+++.++..+++|++.||.|||+ ++|||||||+.|||++-+|.++|+|||.+.....
T Consensus 110 FC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred ecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh
Confidence 99999998877542 2578999999999999999999998 8999999999999999999999999998754332
Q ss_pred CCCCccccccccCCccCccccC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.. .....++|||+|||||+..
T Consensus 183 t~-qkRDsFIGTPYWMAPEVvm 203 (1187)
T KOG0579|consen 183 TR-QKRDSFIGTPYWMAPEVVM 203 (1187)
T ss_pred HH-hhhccccCCcccccchhee
Confidence 22 2334589999999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=259.29 Aligned_cols=185 Identities=24% Similarity=0.348 Sum_probs=158.7
Q ss_pred eHHHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEE
Q 008026 386 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCL 463 (580)
Q Consensus 386 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 463 (580)
.+..++--.++|.+.++||+|+||.|..++++ +++.||+|++.+-.. ......-|..|-.+|.....+-|+.++-.|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 44566667789999999999999999999875 688999999976332 2334566888889999999999999999999
Q ss_pred cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEE
Q 008026 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 543 (580)
Q Consensus 464 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 543 (580)
+..+.|+|||||+||||-.++.. ...+++..+..++..|+.||.-||+ .|+|||||||+|||+|..|++||+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk-----~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK-----FDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh-----cCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeec
Confidence 99999999999999999998843 3468999999999999999999997 899999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|||.|-.+..+..-.....+|||-|++||+++..+
T Consensus 218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~ 252 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQG 252 (1317)
T ss_pred cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhc
Confidence 99998777654433445568999999999987543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=235.46 Aligned_cols=171 Identities=30% Similarity=0.432 Sum_probs=142.9
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|.++++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 578999999986432 233456677899999888 699999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 151 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-V 151 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-C
Confidence 999887743 2368999999999999999999997 899999999999999999999999999987533222 1
Q ss_pred ccccccccCCccCccccCCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.....+||+.|+|||++.+..++
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~ 174 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYG 174 (318)
T ss_pred cccceecCccccCHHHhcCCCCC
Confidence 22335799999999999877653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=238.80 Aligned_cols=174 Identities=29% Similarity=0.391 Sum_probs=144.5
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 466 (580)
+.++|++.+.||+|+||.||+|... ++..||+|++............+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999764 6899999999765444455677889999999999999999999886543
Q ss_pred -eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 467 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 467 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
..|+||||+++ ++.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecC
Confidence 46999999965 5655542 247788899999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+++...... ......||+.|+|||++.+..+
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~ 199 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGY 199 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCC
Confidence 9997643322 2233578999999999987765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=239.74 Aligned_cols=182 Identities=27% Similarity=0.400 Sum_probs=147.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 466 (580)
.++|.+.+.||+|+||.||+|... .+..||||++... ......+.+.+|+++++++. ||||+++++++....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 457889999999999999999753 2347999998653 23344567899999999996 999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhhh--------------------------------------------------------
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEE-------------------------------------------------------- 490 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 490 (580)
..|+||||+++|+|.+++......
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999988653210
Q ss_pred -----------------------------------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec
Q 008026 491 -----------------------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 535 (580)
Q Consensus 491 -----------------------------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 535 (580)
....+++.++..++.||+.||+|||+ .+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 11347788889999999999999997 8999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 536 DDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 536 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+++.+||+|||+++........ ......+++.|+|||++.+..+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 316 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY 316 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC
Confidence 9999999999999865433221 1122356788999999877654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=204.37 Aligned_cols=175 Identities=25% Similarity=0.365 Sum_probs=149.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.+|...++||+|.||+||+|+.+ +++.||+|+++.+.-++.......+|+.+++.++|.|||++++....++..-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35777889999999999999654 68999999998766666667788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||+. +|..+. +.-...++.+.+..++.|+++||.|+|+ +++.|||+||.|.+|+.+|+.|++|||+|+-+..
T Consensus 82 ~cdq-dlkkyf----dslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 82 FCDQ-DLKKYF----DSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred HhhH-HHHHHH----HhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9954 776665 3344578889999999999999999998 7999999999999999999999999999998765
Q ss_pred CCCCccccccccCCccCccccCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+.... ...+-|..|.+|.++-|..
T Consensus 154 pvrcy-saevvtlwyrppdvlfgak 177 (292)
T KOG0662|consen 154 PVRCY-SAEVVTLWYRPPDVLFGAK 177 (292)
T ss_pred ceEee-eceeeeeeccCcceeeeee
Confidence 54322 2234599999999987653
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=227.24 Aligned_cols=176 Identities=25% Similarity=0.435 Sum_probs=148.7
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 5789999999999999999988888889999876532 2356789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++.....
T Consensus 83 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 83 MAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999988542 23457888899999999999999997 89999999999999999999999999999876543
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.........++..|+|||++.+..+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~ 181 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSF 181 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCC
Confidence 2222222345778999999876654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=227.73 Aligned_cols=176 Identities=35% Similarity=0.515 Sum_probs=147.5
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.|+..+.||+|+||.||+|... +++.||+|.+...... ......+.+|+.++++++|++|+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999765 6899999998764332 2233557789999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++... ....+++.++..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999887442 22458889999999999999999997 8999999999999999999999999999876543
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... .....|+..|+|||++.+..+
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~ 178 (285)
T cd05630 155 GQT--IKGRVGTVGYMAPEVVKNERY 178 (285)
T ss_pred Ccc--ccCCCCCccccChHHHcCCCC
Confidence 321 123468999999999987665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-28 Score=222.91 Aligned_cols=180 Identities=29% Similarity=0.392 Sum_probs=148.4
Q ss_pred cCCcccceeeccCcEEEEEEEE-cC----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-CCee
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 468 (580)
..|+....||+|.||.||+|.- ++ ...+|+|+++........-...-+|+.+++.++|||++.+..++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 4688999999999999999943 32 2379999997653222233556789999999999999999998887 7789
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC----CcEEEEe
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVAD 544 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 544 (580)
|+++||.+. +|.+.++-.+....+.++...+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 89888876555555678889999999999999999998 779999999999999876 8999999
Q ss_pred eccccccCCCCCCc--cccccccCCccCccccCCCC
Q 008026 545 FGLVRLAPEGKGSI--ETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 545 fg~a~~~~~~~~~~--~~~~~Gt~~y~APE~~~~~~ 578 (580)
||+|+.+...-... ...++-|.+|.|||++.|..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~ 215 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR 215 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccc
Confidence 99999887654332 23456799999999998865
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=227.24 Aligned_cols=175 Identities=36% Similarity=0.503 Sum_probs=147.2
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
|+..+.||+|+||+||+|... +++.||+|.+...... ......+.+|++++++++|++|+.+.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999764 6889999998764332 22345578899999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999887743 223468999999999999999999997 89999999999999999999999999998765432
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. ......|++.|+|||++.+..+
T Consensus 156 ~--~~~~~~g~~~~~aPE~~~~~~~ 178 (285)
T cd05632 156 E--SIRGRVGTVGYMAPEVLNNQRY 178 (285)
T ss_pred C--cccCCCCCcCccChHHhcCCCC
Confidence 2 1233568999999999987665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=227.22 Aligned_cols=169 Identities=32% Similarity=0.470 Sum_probs=141.2
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeeccccCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCCh
Q 008026 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 480 (580)
||+|+||.||+++.. +|+.||+|++....... .....+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999765 68999999987543322 2234556799999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccc
Q 008026 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 560 (580)
Q Consensus 481 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 560 (580)
.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYN---VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 887743 223457889999999999999999998 899999999999999999999999999987664432 223
Q ss_pred cccccCCccCccccCCCCC
Q 008026 561 RIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 561 ~~~Gt~~y~APE~~~~~~~ 579 (580)
...|++.|+|||++.+..+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~ 171 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPY 171 (277)
T ss_pred ccCCCCCccCHHHHccCCC
Confidence 3468999999999987665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=226.55 Aligned_cols=170 Identities=36% Similarity=0.560 Sum_probs=145.5
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
|++.+.||+|+||.||++... +++.||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999776 5678999999875444444444566999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
++++|.+++. ....+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred cccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999885 12468999999999999999999998 899999999999999999999999999987642211
Q ss_pred CCccccccccCCccCccccC
Q 008026 556 GSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~ 575 (580)
.......|+..|+|||++.
T Consensus 153 -~~~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 153 -ENFNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp -SEBSSSSSSGGGSCHHHHT
T ss_pred -ccccccccccccccccccc
Confidence 2334457899999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=237.23 Aligned_cols=175 Identities=27% Similarity=0.373 Sum_probs=145.2
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-----
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----- 465 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 465 (580)
...++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999764 688999999976544445567788999999999999999999988643
Q ss_pred -CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 466 -NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 466 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
...++||||+++ ++.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEee
Confidence 346999999965 6665552 247888899999999999999997 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||+++...... ......||+.|+|||++.+.++
T Consensus 163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~ 195 (355)
T cd07874 163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGY 195 (355)
T ss_pred CcccccCCCcc--ccCCccccCCccCHHHHcCCCC
Confidence 99998654322 2234578999999999987765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=247.39 Aligned_cols=186 Identities=19% Similarity=0.262 Sum_probs=141.2
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc--CCcEEEEEEe--------------ecc-ccChhhHHHHHHHHHHHHhcCCC
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRM--------------EAG-VISGKGLTEFKSEIAVLTKVRHR 453 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~--------------~~~-~~~~~~~~~~~~E~~~l~~l~h~ 453 (580)
..+.++|++.+.||+|+||+||+|..+ ++..++.|.+ .+. .........+.+|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345678999999999999999998654 2222222211 110 11122345688999999999999
Q ss_pred cccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeE
Q 008026 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533 (580)
Q Consensus 454 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 533 (580)
||+++++++...+..|+|+|++. +++.+++..............++..++.||+.||+|||+ ++||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 99999999999999999999995 577776643211111223456678899999999999998 89999999999999
Q ss_pred ecCCCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 534 LGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 534 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++.++.+||+|||+++..............||+.|+|||++.+.+|+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 346 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC 346 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC
Confidence 99999999999999987654433333346799999999999887663
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=222.47 Aligned_cols=177 Identities=25% Similarity=0.406 Sum_probs=152.6
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|.+.+.||+|++|.||+|... +++.|++|.+...........++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999765 689999999876555556677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++... ....+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999988542 23468889999999999999999997 89999999999999999999999999998876543
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. ......|++.|+|||++.+..+
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd08529 155 TN-FANTIVGTPYYLSPELCEDKPY 178 (256)
T ss_pred cc-hhhccccCccccCHHHhcCCCC
Confidence 32 2233568999999999887654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=234.35 Aligned_cols=166 Identities=27% Similarity=0.367 Sum_probs=136.3
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc---CCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
||+|+||.||+|+.. +++.||+|++.+... ..........|..++... +||+|+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999765 689999999875432 222334455677777665 699999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~ 151 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-K 151 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-C
Confidence 999887743 2468899999999999999999998 899999999999999999999999999987543322 1
Q ss_pred ccccccccCCccCccccCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~ 577 (580)
.....+||+.|+|||++.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~ 171 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDE 171 (330)
T ss_pred CccCccCCccccCHHHHcCC
Confidence 23346799999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=223.86 Aligned_cols=177 Identities=31% Similarity=0.449 Sum_probs=147.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|++|.||+|...++..||+|.++... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35688999999999999999988777889999987533 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++... ....+++.++..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999988542 12468899999999999999999997 8999999999999999999999999999987653
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........++..|+|||++.+..+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~ 181 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRF 181 (261)
T ss_pred CcccccCCCcCceeccCccccccCCC
Confidence 22111111223457999999876554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=234.91 Aligned_cols=172 Identities=28% Similarity=0.405 Sum_probs=143.9
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC----
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG---- 465 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 465 (580)
..+.++|++.+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999764 688999999876443334456678999999999999999999887543
Q ss_pred --CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEE
Q 008026 466 --NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 543 (580)
Q Consensus 466 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 543 (580)
...|+++|++ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEc
Confidence 3468999988 7788776632 468899999999999999999998 899999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
|||+++..... .....||+.|+|||++.+
T Consensus 161 Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 161 DFGLARQADDE----MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred CCccceecCCC----cCCccccccccCchHhcC
Confidence 99999865432 233578999999999876
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=223.97 Aligned_cols=180 Identities=26% Similarity=0.419 Sum_probs=150.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccc-cChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ........+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999765 78999999886532 23444567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988855332 23457888999999999999999997 899999999999999999999999999988764
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... ......|++.|+|||.+.+..+
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~ 183 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCC
Confidence 3321 1223468899999999876654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=235.75 Aligned_cols=174 Identities=27% Similarity=0.369 Sum_probs=144.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC------
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 465 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 465 (580)
..++|++.+.||+|+||.||+|... +++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999764 688999999976544445567788999999999999999999987543
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
...|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999965 6766652 247788899999999999999997 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+++...... ......||+.|+|||++.+.++
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~ 202 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGY 202 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCC
Confidence 9998654322 2234578999999999987765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=239.76 Aligned_cols=171 Identities=25% Similarity=0.316 Sum_probs=143.4
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
...|.+.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++|+||+++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 347999999999999999999765 578899995322 24578999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
|++. ++|.+++.. ....+++.+++.|+.|++.||+|||+ .+||||||||+|||++.++.+||+|||+++...
T Consensus 240 e~~~-~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKYR-SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EccC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 9995 688777643 22468999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCC-CccccccccCCccCccccCCCCCC
Q 008026 553 EGKG-SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~-~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... .......||+.|+|||++.+..++
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ 340 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCC
Confidence 3221 122335799999999999887653
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=229.83 Aligned_cols=173 Identities=24% Similarity=0.375 Sum_probs=143.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|.+.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 57899999999999999999765 678899999875432 2233467789999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLDK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 9975 78777633 22357888999999999999999998 8999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccCccccCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
... ......||+.|+|||++.+.
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~ 179 (309)
T cd07872 157 PTK-TYSNEVVTLWYRPPDVLLGS 179 (309)
T ss_pred Ccc-ccccccccccccCCHHHhCC
Confidence 322 22234689999999988653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=223.81 Aligned_cols=174 Identities=30% Similarity=0.445 Sum_probs=145.0
Q ss_pred CCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 396 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
+|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 5788899999999999999887778899999865332 2356788999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
++++|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++......
T Consensus 82 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 82 ANGCLLNYLRE----RKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999998843 12367899999999999999999998 899999999999999999999999999987654332
Q ss_pred CCccccccccCCccCccccCCCCC
Q 008026 556 GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
........++..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~ 178 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRF 178 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCC
Confidence 111111223457999999887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=224.06 Aligned_cols=175 Identities=30% Similarity=0.424 Sum_probs=146.0
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||+|+..++..||+|.+..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 46888999999999999999887777799998875332 246788999999999999999999999988889999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+.+++|.+++.. ....+++.+++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 81 MSNGCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999998743 12368899999999999999999997 89999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.........++..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~ 178 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKF 178 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcc
Confidence 2111112335678999999876554
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=226.74 Aligned_cols=181 Identities=30% Similarity=0.528 Sum_probs=147.8
Q ss_pred cCCcccceeeccCcEEEEEEEEcC------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......++.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468889999999999999997642 2579999886532 334456789999999999999999999999998999
Q ss_pred EEEEEecCCCChhHHHHHHhhhC-----------CCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEG-----------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 537 (580)
+++|||+++++|.+++....... ...+++..++.++.|++.||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 99999999999999986532111 1457888999999999999999998 899999999999999999
Q ss_pred CcEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 538 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 538 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+.+||+|||+++....... .......+++.|+|||++.+..+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF 203 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC
Confidence 9999999999976533221 11223456889999999877654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=232.60 Aligned_cols=175 Identities=25% Similarity=0.336 Sum_probs=148.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC------hhhHHHHHHHHHHHHhcC---CCcccceeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVR---HRHLVALLGHCL 463 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 463 (580)
..+|...+.+|+|+||.|+.|.++ ....|+||.|.+.++- .+..-.+-.|+.+|+.++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356899999999999999999775 4678999998775431 111223457999999997 999999999999
Q ss_pred cCCeeEEEEEec-CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 464 DGNEKLLVFEYM-PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 464 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
+++.+|++||-. ++.+|.+++ ...+.+++..+..|++||+.|+++||+ ++|||||||-+||.++.+|-+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I-----E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI-----EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh-----hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEE
Confidence 999999999976 456888888 334578999999999999999999998 89999999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+|||.|.....+. ...++||..|+|||++.|.+|
T Consensus 712 idfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y 745 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKY 745 (772)
T ss_pred eeccchhhhcCCC---cceeeeeccccchhhhCCCcc
Confidence 9999998776543 345789999999999999876
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=227.34 Aligned_cols=174 Identities=26% Similarity=0.356 Sum_probs=147.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||++... ++..||+|.+.... ......++.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36899999999999999999765 67889999886532 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 80 HMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999998843 2467889999999999999999997 35899999999999999999999999999876533
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. .....|++.|+|||++.+..+
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~ 175 (308)
T cd06615 153 SM---ANSFVGTRSYMSPERLQGTHY 175 (308)
T ss_pred cc---cccCCCCcCccChhHhcCCCC
Confidence 22 233578999999999877654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=250.66 Aligned_cols=183 Identities=23% Similarity=0.385 Sum_probs=148.8
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--Ce
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NE 467 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 467 (580)
....++|++.+.||+|+||.||+|... ++..||+|++............+..|+.+++.++||||++++++|... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999765 578899999876555555667889999999999999999999988653 56
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC----CCCcEecCCCCCCeEecCC------
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA----HQSFIHRDLKPSNILLGDD------ 537 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~----~~~ivH~Dlkp~NIll~~~------ 537 (580)
+|+||||+++++|.+++..... ....+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 8999999999999999865332 2246899999999999999999999732 1459999999999999642
Q ss_pred -----------CcEEEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 538 -----------MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 538 -----------~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+.+||+|||+++...... ......||+.|+|||++.+
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhc
Confidence 348999999998654322 2234579999999999854
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=229.83 Aligned_cols=176 Identities=28% Similarity=0.445 Sum_probs=143.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCc----EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
.+|++.+.||+|+||.||+|.+. ++. .||+|++... ......+++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46899999999999999999754 333 4899988643 2334556788999999999999999999998764 568
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 99999999999998853 22357888999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCcc-ccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSIE-TRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~~-~~~~Gt~~y~APE~~~~~~~ 579 (580)
.......... ....++..|+|||++.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 188 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIY 188 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCC
Confidence 7654332211 11234678999999877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=238.84 Aligned_cols=172 Identities=24% Similarity=0.373 Sum_probs=138.3
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC------
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 465 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 465 (580)
...+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3467999999999999999999764 68899999886421 2345799999999999999999887532
Q ss_pred --CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-CcEEE
Q 008026 466 --NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKV 542 (580)
Q Consensus 466 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl 542 (580)
...++||||+++ ++.+++..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence 246799999975 77777654322 33568899999999999999999998 899999999999999865 47999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccCCC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+|||+|+....... .....||+.|+|||++.+.
T Consensus 213 ~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 213 CDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGA 245 (440)
T ss_pred eccccchhccCCCC--cccCCCCcCccCHHHhcCC
Confidence 99999987644322 2335789999999998654
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-26 Score=225.33 Aligned_cols=173 Identities=32% Similarity=0.451 Sum_probs=149.3
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||++... +++.||+|++..... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999765 689999999875432 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||+|+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 99999999988743 2468889999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. .....|++.|+|||.+.+.++
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~ 175 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGY 175 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCC
Confidence 43 223468999999999877654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-26 Score=223.33 Aligned_cols=169 Identities=27% Similarity=0.383 Sum_probs=144.6
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......++.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3678889999999999999975 478899999987542 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999986432 46788889999999999999998 8999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. .....||..|+|||++.+..+
T Consensus 148 ~~---~~~~~~~~~y~aPE~~~~~~~ 170 (279)
T cd06619 148 SI---AKTYVGTNAYMAPERISGEQY 170 (279)
T ss_pred cc---ccCCCCChhhcCceeecCCCC
Confidence 22 233578999999999987654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=217.46 Aligned_cols=166 Identities=27% Similarity=0.425 Sum_probs=140.5
Q ss_pred cceeeccCcEEEEEE-EEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEEecCC
Q 008026 400 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
.+.||+|+|+.|.-+ ...+|..||||++.+. ....+.++.+|++++..++ |+||++++++|+++..+|+|||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 378999999999988 5678999999999874 4456788999999999997 99999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC---cEEEEeeccccccCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAPEG 554 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~ 554 (580)
|.|..++.+ ...+++.++.++..+|+.||.|||. ++|.|||+||+|||..+.. -+|||||.+..-+...
T Consensus 161 GplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 161 GPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred chHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 999998854 2468899999999999999999997 8999999999999997544 4899999886533221
Q ss_pred C------CCccccccccCCccCccccC
Q 008026 555 K------GSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 555 ~------~~~~~~~~Gt~~y~APE~~~ 575 (580)
. .....+.+|+..|||||+..
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHh
Confidence 1 11123367999999999875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=222.64 Aligned_cols=175 Identities=31% Similarity=0.475 Sum_probs=144.6
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||+|...+...||+|++..... ..+.+.+|++++++++||||+++++++. ....++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 56899999999999999999877667899999875332 2357889999999999999999999874 4567999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++... ....+++..+..++.|++.||+|+|+ .+++||||||+||++++++.+||+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 82 MSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999988542 22357889999999999999999998 89999999999999999999999999999766443
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.........++..|+|||+..+.++
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~ 180 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRF 180 (262)
T ss_pred ccccccCCcccceecCHhHhccCCC
Confidence 3222222346778999999876654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=225.53 Aligned_cols=175 Identities=29% Similarity=0.391 Sum_probs=140.2
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc---CCCcccceeeEEEc-----CC
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLD-----GN 466 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~ 466 (580)
+|++.+.||+|+||.||+|+.. +++.||+|.+............+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999765 689999999876433333334556777777665 69999999998864 24
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..++||||+++ +|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDK---VPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEccccc-CHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 57899999974 88877743 222458899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+++...... ......||+.|+|||++.+..+
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 184 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTY 184 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCCCC
Confidence 998664332 2233568999999999977654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-26 Score=221.90 Aligned_cols=177 Identities=25% Similarity=0.457 Sum_probs=146.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|.+. +...||+|.+.... ......++.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 57889999999999999999774 24579999886532 34455678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999998843 22368899999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 551 APEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
........ .....+++.|+|||.+.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~ 185 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCC
Confidence 65222111 112234678999999876554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=238.34 Aligned_cols=169 Identities=26% Similarity=0.439 Sum_probs=142.0
Q ss_pred cccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe--eEEEE
Q 008026 398 SEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE--KLLVF 472 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~ 472 (580)
+....||+|+|-+||+|.+. +|..||--.++.... .....++|..|+.+|+.|+||||+++|+++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44578999999999999654 688887655443322 34456899999999999999999999999988765 67999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-CCCcEEEEeecccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLA 551 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~ 551 (580)
|.+..|+|..|.+++ +.++...+..|++||++||.|||++ .++|||||||-+||+|+ ..|.|||+|+|+|+..
T Consensus 123 EL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999998653 4567788999999999999999986 47999999999999997 5689999999999987
Q ss_pred CCCCCCccccccccCCccCccccC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.... ...++|||.|||||++.
T Consensus 197 r~s~---aksvIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 197 RKSH---AKSVIGTPEFMAPEMYE 217 (632)
T ss_pred hccc---cceeccCccccChHHHh
Confidence 6543 34478999999999987
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=233.55 Aligned_cols=168 Identities=23% Similarity=0.319 Sum_probs=141.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..+|++.+.||+|+||.||+|... ++..||+|+.... ....|+.++++++||||+++++++......++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 357999999999999999999765 5788999975432 2356899999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+. ++|.+++.. ....+++..++.|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||.++...
T Consensus 137 e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 588777643 23468999999999999999999998 899999999999999999999999999997543
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......||+.|+|||++.+..+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~ 233 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKY 233 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCC
Confidence 221 2233569999999999987765
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=218.45 Aligned_cols=176 Identities=25% Similarity=0.371 Sum_probs=148.8
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|+||.||++... +++.||+|.+.... .....+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 5788999999999999999765 68999999986532 234556788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. .....+++..++.++.|++.||.|||+ .+|+|+||||+||++++++.++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999887743 223457889999999999999999997 89999999999999999999999999998766433
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. .......|++.|+|||++.+..+
T Consensus 154 ~-~~~~~~~~~~~~~aPE~~~~~~~ 177 (255)
T cd08219 154 G-AYACTYVGTPYYVPPEIWENMPY 177 (255)
T ss_pred c-cccccccCCccccCHHHHccCCc
Confidence 2 12234568999999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=224.29 Aligned_cols=164 Identities=16% Similarity=0.284 Sum_probs=138.5
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEc----CCeeEEEEEec
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLVFEYM 475 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 475 (580)
..|++|+++.||+|.+ +|+.||||++....... ...+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999987 58999999997643322 224678899999999999999999999877 34678999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
++|+|.+++.. ...+++.....++.|++.||.|||+ ..+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999998843 2467889999999999999999996 2478899999999999999999999999998654322
Q ss_pred CCccccccccCCccCccccCC
Q 008026 556 GSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~~ 576 (580)
....|+..|+|||++.+
T Consensus 178 ----~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLND 194 (283)
T ss_pred ----ccccCcccccCHHHhhh
Confidence 22468999999999875
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=220.72 Aligned_cols=180 Identities=26% Similarity=0.432 Sum_probs=152.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999776 789999998875322 3334678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++..... ....+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++...
T Consensus 82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999998855322 23457899999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... ......|++.|+|||++.+..+
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~ 183 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCC
Confidence 4322 1233468999999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=219.96 Aligned_cols=177 Identities=28% Similarity=0.433 Sum_probs=147.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|++|.||+|... +++.||+|.+...... ......+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46889999999999999999754 6899999998754322 2234578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||.++.
T Consensus 82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999988743 2357888899999999999999997 8999999999999999999999999999876
Q ss_pred cCCCCCCcc--ccccccCCccCccccCCCCC
Q 008026 551 APEGKGSIE--TRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~--~~~~Gt~~y~APE~~~~~~~ 579 (580)
......... ....|+..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCC
Confidence 543221111 23467889999999887653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-26 Score=221.58 Aligned_cols=176 Identities=30% Similarity=0.449 Sum_probs=146.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.+|.+.+.||+|+||.||+|... +++.||+|++... .....++.+|++++++++|+||+++++++...+..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 35788899999999999999765 5889999988653 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. .....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++....
T Consensus 83 ~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999998844 223457889999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........++..|+|||++.+..+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKF 182 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCC
Confidence 32211122234668999999877654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=218.92 Aligned_cols=177 Identities=25% Similarity=0.402 Sum_probs=151.8
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|+..+.||+|+||.||.++.. +++.+++|++...........++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999654 688999999876555556667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999988542 12467899999999999999999997 79999999999999999999999999999876443
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. ......|++.|+|||++.+..+
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~ 178 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKY 178 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCC
Confidence 32 2234568999999999877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=224.82 Aligned_cols=181 Identities=30% Similarity=0.523 Sum_probs=148.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
++|.+.+.||+|+||.||+|... ++..||+|.+.... .....+.+.+|++++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 46888899999999999999763 24789999987532 233457899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHh---------hhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 469 LLVFEYMPQGTLSRHIFNWA---------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
++||||+++++|.+++.... ......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999986532 1122457889999999999999999997 89999999999999999999
Q ss_pred EEEEeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 540 AKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+||+|||.++....... .......+++.|+|||++.++.+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF 201 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCc
Confidence 99999999875433221 11223346788999999987765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-26 Score=224.52 Aligned_cols=181 Identities=27% Similarity=0.456 Sum_probs=146.6
Q ss_pred cCCcccceeeccCcEEEEEEEE-----cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|.. .++..||+|.+.... .......+.+|++++++++||||+++++++..+...|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4688889999999999999974 246789999987532 3344567889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhh------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC
Q 008026 470 LVFEYMPQGTLSRHIFNWAE------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 537 (580)
+||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ ++|+||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 99999999999998853211 012347888999999999999999998 899999999999999999
Q ss_pred CcEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 538 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 538 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+.+||+|||+++....... .......++..|+|||++.+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF 203 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC
Confidence 9999999999976533221 11222345778999999876654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=218.33 Aligned_cols=171 Identities=31% Similarity=0.491 Sum_probs=141.7
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCCh
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 480 (580)
+.||+|+||.||+|...++..||+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999988888999999887532 333445788999999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccc
Q 008026 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 560 (580)
Q Consensus 481 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 560 (580)
.+++.. ....+++.++..++.|++.||.|+|+ .+++||||||+||++++++.+||+|||++............
T Consensus 80 ~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRK----KKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 888743 22357899999999999999999997 89999999999999999999999999998754433221112
Q ss_pred cccccCCccCccccCCCCC
Q 008026 561 RIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 561 ~~~Gt~~y~APE~~~~~~~ 579 (580)
...++..|+|||++.+..+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~ 171 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRY 171 (250)
T ss_pred CCCCcccccCHHHhccCCC
Confidence 2234677999999876654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-26 Score=233.65 Aligned_cols=181 Identities=26% Similarity=0.412 Sum_probs=146.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCe
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 467 (580)
++|.+.+.||+|+||.||+|+++ .+..||+|+++... .....+.+.+|++++.++. ||||+++++++...+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 45778899999999999999753 34689999997643 2333457889999999997 9999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhh----------------------------------------------------------
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAE---------------------------------------------------------- 489 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 489 (580)
.++||||+++|+|.+++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864311
Q ss_pred -----------------------------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 490 -----------------------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 490 -----------------------------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
.....+++.+++.++.|++.||+|||+ .+|+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 011246777889999999999999997 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 535 GDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
++++.+||+|||+++........ ......|++.|+|||++.+..+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 318 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC
Confidence 99999999999999865332211 1122457889999999887654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-26 Score=220.96 Aligned_cols=176 Identities=31% Similarity=0.492 Sum_probs=145.4
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++++++++++. ....+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 357889999999999999999888888899999876432 2457899999999999999999999875 456899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. .....+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999998854 223457899999999999999999998 8999999999999999999999999999976544
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........++..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~ 180 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRF 180 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCC
Confidence 32222222345668999999876543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=223.69 Aligned_cols=183 Identities=27% Similarity=0.438 Sum_probs=146.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 466 (580)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......++.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3467999999999999999998653 24679999886432 2234567889999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhhh-----CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEE
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 541 (580)
..++||||+++++|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 999999999999999988543211 12345778899999999999999998 8999999999999999999999
Q ss_pred EEeeccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 542 VADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 542 l~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+|||+++......... .....+++.|||||++.+..+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 198 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc
Confidence 99999987654322111 112245778999999877654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=218.08 Aligned_cols=177 Identities=23% Similarity=0.370 Sum_probs=148.9
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-CCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 473 (580)
+|++.+.||+|++|.||++... +++.||+|++..........+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999765 57899999997655455556778999999999999999999998764 446789999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. .....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~---~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999988854 223458899999999999999999997 8999999999999999999999999999986643
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......|++.|+|||++.+..+
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~ 179 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPY 179 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCC
Confidence 322 2234568999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=232.66 Aligned_cols=171 Identities=25% Similarity=0.309 Sum_probs=143.3
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
...+|++.+.||+|+||.||+|... .+..||+|.+... ....+|++++++++||||+++++++......+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3457999999999999999999653 3578999987542 23468999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+|||++. ++|.+++. ....+++.+++.++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++
T Consensus 163 lv~e~~~-~~l~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD-----RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEehhcC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 9999995 58877772 23468999999999999999999998 899999999999999999999999999997
Q ss_pred ccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
........ ......||+.|+|||++.+..|
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 264 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPY 264 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCC
Confidence 65443221 1234579999999999987765
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=222.27 Aligned_cols=171 Identities=27% Similarity=0.399 Sum_probs=136.3
Q ss_pred eeeccCcEEEEEEEEcC---CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 402 ILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 402 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
.||+|+||.||+|...+ ...+|+|.+... ........+.+|++.++.++|+||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999996543 356888876542 23344567889999999999999999999999999999999999999
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC-
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS- 557 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 557 (580)
+|.+++...........++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865433222345678889999999999999998 89999999999999999999999999998654322111
Q ss_pred ccccccccCCccCccccCC
Q 008026 558 IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~ 576 (580)
......+++.|+|||++..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEI 176 (269)
T ss_pred ccCCCCCcccccCHHHHhh
Confidence 1122345778999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=220.20 Aligned_cols=171 Identities=29% Similarity=0.458 Sum_probs=145.4
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35799999999999999999976 468899999987532 233456789999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+|+|||+||+||++++++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999988743 2357889999999999999999998 899999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccCccccC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.... ......|++.|+|||++.
T Consensus 158 ~~~~-~~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 158 ATIA-KRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred cccc-ccCccccCccccCHhHcc
Confidence 3221 122346899999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=220.14 Aligned_cols=176 Identities=27% Similarity=0.452 Sum_probs=146.4
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 457899999999999999999888889999999875432 3467889999999999999999999864 457899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. .....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 81 YMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999988743 223468889999999999999999997 8999999999999999999999999999976653
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........++..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~ 180 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTF 180 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCc
Confidence 32222223345778999999876543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=222.54 Aligned_cols=177 Identities=32% Similarity=0.496 Sum_probs=149.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
..+|++.+.||+|+||.||+|...++..+|+|.+.... .....++.+|+.+++.++|+||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45788999999999999999988888999999987632 2245678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++... ....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999998542 23467899999999999999999998 8999999999999999999999999999976644
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....++..|+|||++.+..+
T Consensus 157 ~~~~-~~~~~~~~~~~~PE~~~~~~~ 181 (261)
T cd05148 157 DVYL-SSDKKIPYKWTAPEAASHGTF 181 (261)
T ss_pred cccc-ccCCCCceEecCHHHHccCCC
Confidence 3221 122345778999999876654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=225.00 Aligned_cols=181 Identities=27% Similarity=0.440 Sum_probs=145.9
Q ss_pred cCCcccceeeccCcEEEEEEEEcC---------------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCccccee
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD---------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 459 (580)
++|++.+.||+|+||.||+|+... ...||+|.+... ........+.+|++++++++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 579999999999999999986532 235899998753 2334456789999999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCChhHHHHHHhh-------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCe
Q 008026 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAE-------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 532 (580)
Q Consensus 460 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI 532 (580)
+++...+..++||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 999999999999999999999998854211 111246888999999999999999998 8999999999999
Q ss_pred EecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 533 LLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 533 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
++++++.+||+|||+++........ ......++..|+|||++.++.+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 208 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF 208 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc
Confidence 9999999999999998765332211 1122345778999999876654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=220.44 Aligned_cols=172 Identities=27% Similarity=0.426 Sum_probs=139.0
Q ss_pred ceeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 35899999999999764 34679999886543 223345788899999999999999999999998999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++...........++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||.++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999865433233356677888999999999999998 89999999999999999999999999998754332211
Q ss_pred c-cccccccCCccCccccCC
Q 008026 558 I-ETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 558 ~-~~~~~Gt~~y~APE~~~~ 576 (580)
. .....|+..|+|||++.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDE 176 (269)
T ss_pred ecCCCcCCcccccCHhHhcc
Confidence 1 122457889999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=220.74 Aligned_cols=177 Identities=27% Similarity=0.435 Sum_probs=145.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-C---CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-D---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|... + +..+|+|.++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888999999999999999763 2 3479999886532 33445688999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999988843 22457889999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCCcccc--ccccCCccCccccCCCCC
Q 008026 551 APEGKGSIETR--IAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~~~--~~Gt~~y~APE~~~~~~~ 579 (580)
........... ..++..|+|||++.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 186 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCcc
Confidence 65432221111 223568999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=219.64 Aligned_cols=177 Identities=32% Similarity=0.530 Sum_probs=148.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|.+.+.||+|+||.||+|..+++..||+|.+..... ...++.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 467899999999999999999888788899999875332 34678899999999999999999999998889999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. .....+++.++..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||.++....
T Consensus 82 ~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999998854 222468899999999999999999997 8999999999999999999999999999886643
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........++..|+|||.+.+..+
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~ 181 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRF 181 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCc
Confidence 22111122234678999999876543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=223.00 Aligned_cols=180 Identities=30% Similarity=0.516 Sum_probs=146.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
++|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46888999999999999999642 3456899988653 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhh--------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcE
Q 008026 469 LLVFEYMPQGTLSRHIFNWAE--------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 540 (580)
++||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 999999999999998864321 122358999999999999999999997 899999999999999999999
Q ss_pred EEEeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 541 KVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||+|||+++....... .......+++.|+|||++.+..+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 199 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 199 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCC
Confidence 9999999976533221 11122345788999999887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=222.33 Aligned_cols=175 Identities=25% Similarity=0.383 Sum_probs=145.5
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|++|.||+|... ++..||+|++............+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788899999999999999765 689999999875433334456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
++ ++|.+++.... ....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 58887774321 22468899999999999999999997 89999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.. ......|++.|+|||++.+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd07861 155 VR-VYTHEVVTLWYRAPEVLLGS 176 (285)
T ss_pred cc-cccCCcccccccChHHhcCC
Confidence 21 22234578999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=228.90 Aligned_cols=181 Identities=28% Similarity=0.454 Sum_probs=144.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcC-C
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG-N 466 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 466 (580)
++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 57999999999999999999542 34789999987532 233456788899999999 799999999988654 5
Q ss_pred eeEEEEEecCCCChhHHHHHHhhh--------------------------------------------------------
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEE-------------------------------------------------------- 490 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 490 (580)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999888542110
Q ss_pred CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc-cccccccCCcc
Q 008026 491 GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYL 569 (580)
Q Consensus 491 ~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~ 569 (580)
....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 01367899999999999999999997 899999999999999999999999999998764332211 12234577899
Q ss_pred CccccCCCCC
Q 008026 570 APEYAGNFGS 579 (580)
Q Consensus 570 APE~~~~~~~ 579 (580)
|||++.+..+
T Consensus 243 aPE~~~~~~~ 252 (337)
T cd05054 243 APESIFDKVY 252 (337)
T ss_pred CcHHhcCCCC
Confidence 9999887765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=223.45 Aligned_cols=182 Identities=27% Similarity=0.412 Sum_probs=148.4
Q ss_pred hcCCcccceeeccCcEEEEEEEEcC-----------------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCccc
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHD-----------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 456 (580)
.++|++.+.||+|+||.||+|.... +..||+|.+.... .......+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578999999999999999986542 2458999887542 334567889999999999999999
Q ss_pred ceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhh------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 008026 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 530 (580)
Q Consensus 457 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~ 530 (580)
++++++...+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 9999999999999999999999999998653311 12368899999999999999999998 89999999999
Q ss_pred CeEecCCCcEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 531 NILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 531 NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||++++++.++|+|||+++....... .......+++.|+|||++.+..+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF 209 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC
Confidence 99999999999999999876533221 11223446788999999876543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=221.44 Aligned_cols=174 Identities=30% Similarity=0.438 Sum_probs=149.2
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|+||.||+|... ++..||+|++............+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4888999999999999999764 689999999987544444567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+ +++|.+++... ...+++.+++.++.||+.||+|||+ .+++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999887532 2468999999999999999999998 89999999999999999999999999998876543
Q ss_pred CCCccccccccCCccCccccCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.........|+..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGA 175 (286)
T ss_pred CCCccccccCcccccCceeeecc
Confidence 32223335689999999998653
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-27 Score=253.98 Aligned_cols=181 Identities=28% Similarity=0.396 Sum_probs=154.5
Q ss_pred HHHhhcCCcccceeeccCcEEEEEEE-EcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 390 LRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 390 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
+..++-+|+....||.|.||.||.|. ..+|+..|+|.++-.....+....+.+|+.++..++|||+|++||+-.+++..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34556688889999999999999994 56899999999987665666677889999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
+|.||||++|+|.+.+.. .+..++.....+..|++.|+.|||+ .+||||||||+||+++.+|.+|++|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccce
Confidence 999999999999998833 2345666677788999999999997 89999999999999999999999999999
Q ss_pred cccCCCCCC---ccccccccCCccCccccCCCC
Q 008026 549 RLAPEGKGS---IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 549 ~~~~~~~~~---~~~~~~Gt~~y~APE~~~~~~ 578 (580)
..+...... ......||+.|||||++.+..
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccc
Confidence 877654321 123467999999999998754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=235.58 Aligned_cols=177 Identities=25% Similarity=0.299 Sum_probs=138.8
Q ss_pred HHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCC------CcccceeeE
Q 008026 389 VLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH------RHLVALLGH 461 (580)
Q Consensus 389 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~ 461 (580)
++....++|++.+.||+|+||+||+|... +++.||||+++.. .........|+.+++.++| +++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 33445678999999999999999999764 6789999998642 1223455667777777654 458888888
Q ss_pred EEcC-CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC--
Q 008026 462 CLDG-NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 538 (580)
Q Consensus 462 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 538 (580)
+... ...|+|||++ +++|.+++.+ ...+++..+..|+.||+.||+|||+ +.+||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcc
Confidence 8765 5688999988 6788887743 2468899999999999999999996 25899999999999998665
Q ss_pred --------------cEEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 539 --------------RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 539 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.+||+|||.+..... .....+||+.|||||++.+.+|+
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~ 323 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWM 323 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCC
Confidence 499999998864322 22346799999999999887764
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=231.01 Aligned_cols=169 Identities=27% Similarity=0.442 Sum_probs=144.7
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 479 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 479 (580)
-+||+|.||+||.|++. +...+|||.+..+. ....+-+..||.+-++++|.|||+++|.+..++..-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 36999999999999775 56789999997643 3445678899999999999999999999999999999999999999
Q ss_pred hhHHHHHHhhhCCCCc--cHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-CCCcEEEEeeccccccCCCCC
Q 008026 480 LSRHIFNWAEEGLKPL--EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKG 556 (580)
Q Consensus 480 L~~~l~~~~~~~~~~~--~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~ 556 (580)
|.+++.. ..+++ .+.++-.+.+||++||.|||+ ..|||||||-.|||++ -.|.+||+|||.++....- .
T Consensus 659 LSsLLrs----kWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-n 730 (1226)
T KOG4279|consen 659 LSSLLRS----KWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-N 730 (1226)
T ss_pred HHHHHHh----ccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC-C
Confidence 9999854 33455 677888999999999999998 8999999999999997 5789999999999877533 3
Q ss_pred CccccccccCCccCccccCCCCC
Q 008026 557 SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 557 ~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
....++.||..|||||++..++.
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~R 753 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPR 753 (1226)
T ss_pred ccccccccchhhhChHhhccCCc
Confidence 44566889999999999987763
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=219.61 Aligned_cols=179 Identities=28% Similarity=0.459 Sum_probs=142.6
Q ss_pred cccceeeccCcEEEEEEEEcC-Cc--EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC------Cee
Q 008026 398 SEENILGRGGFGTVYKGELHD-GT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------NEK 468 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 468 (580)
.+.+.||+|+||.||+|...+ +. .||+|.++.........+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 457889999999999997753 32 689998876544555667889999999999999999999987532 246
Q ss_pred EEEEEecCCCChhHHHHHHhh-hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAE-EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
+++|||+++++|.+++..... .....+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988743221 223458899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 548 VRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 548 a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
++......... .....+++.|+|||+..+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 191 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY 191 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCc
Confidence 98764332111 112345778999999887654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=221.13 Aligned_cols=176 Identities=26% Similarity=0.503 Sum_probs=145.2
Q ss_pred CCcccceeeccCcEEEEEEEE-----cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--Cee
Q 008026 396 NFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 468 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 468 (580)
.|++.+.||+|+||.||+|.. .++..||+|.+.... .......+.+|++++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 468889999999999999964 257889999986532 334456799999999999999999999998775 567
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||+++++|.+++.. ....+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 899999999999988743 22357899999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCC--ccccccccCCccCccccCCCCC
Q 008026 549 RLAPEGKGS--IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 549 ~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+........ ......|+..|+|||++.+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 189 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF 189 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCC
Confidence 866443221 1123456778999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=246.60 Aligned_cols=179 Identities=29% Similarity=0.474 Sum_probs=142.6
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc------
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------ 464 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------ 464 (580)
+...+|+..++||+|+||.||+++.+ ||+.||||+|.... ..+....+.+|++.+++++|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34567888999999999999999877 89999999998765 56667889999999999999999999865321
Q ss_pred -------------------------------------------------C------------------------------
Q 008026 465 -------------------------------------------------G------------------------------ 465 (580)
Q Consensus 465 -------------------------------------------------~------------------------------ 465 (580)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHH
Q 008026 466 ----------------------------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511 (580)
Q Consensus 466 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL 511 (580)
...||-||||+...+.+++.+ +... -.....++++++|++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~---N~~~-~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR---NHFN-SQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh---cccc-hhhHHHHHHHHHHHHHH
Confidence 123677888888777666633 1111 13566889999999999
Q ss_pred HHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC------C----------C-CCCccccccccCCccCcccc
Q 008026 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP------E----------G-KGSIETRIAGTFGYLAPEYA 574 (580)
Q Consensus 512 ~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~------~----------~-~~~~~~~~~Gt~~y~APE~~ 574 (580)
.|+|+ ++||||||||.||++++++.|||+|||+|+... . + .....+..+||.-|+|||++
T Consensus 711 aYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 99998 899999999999999999999999999998621 0 0 11134567899999999999
Q ss_pred CCCC
Q 008026 575 GNFG 578 (580)
Q Consensus 575 ~~~~ 578 (580)
.+..
T Consensus 788 ~~~~ 791 (1351)
T KOG1035|consen 788 SDTS 791 (1351)
T ss_pred cccc
Confidence 8765
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=221.54 Aligned_cols=182 Identities=29% Similarity=0.451 Sum_probs=145.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
.++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 467999999999999999999643 24579999876432 22334567889999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhh-----CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
.++||||+++|+|.+++...... .....++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999998653221 12345677889999999999999997 89999999999999999999999
Q ss_pred EeeccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 543 ADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+|||+++......... .....++..|+|||.+.++.+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 198 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 198 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCC
Confidence 9999987653322111 112245678999999877654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=225.18 Aligned_cols=171 Identities=30% Similarity=0.412 Sum_probs=134.9
Q ss_pred cceeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--CCeeEEEEEe
Q 008026 400 ENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLVFEY 474 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 474 (580)
.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 467999999999999764 467899999865322 2456789999999999999999998864 4567899999
Q ss_pred cCCCChhHHHHHHhh----hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe----cCCCcEEEEeec
Q 008026 475 MPQGTLSRHIFNWAE----EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 546 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg 546 (580)
++ ++|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +..+.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 588777643211 112358889999999999999999998 899999999999999 456789999999
Q ss_pred cccccCCCCCC--ccccccccCCccCccccCCCC
Q 008026 547 LVRLAPEGKGS--IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 547 ~a~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+|+........ ......||+.|+|||++.+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 191 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 191 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCC
Confidence 99876433211 123457899999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=217.99 Aligned_cols=175 Identities=30% Similarity=0.466 Sum_probs=143.6
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4688899999999999999988777789999876532 23467889999999999999999998875 4568999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999988542 22357889999999999999999997 89999999999999999999999999999766433
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.........++..|+|||+..+..+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~ 180 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRF 180 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCc
Confidence 2222222346778999999876543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=216.41 Aligned_cols=171 Identities=27% Similarity=0.415 Sum_probs=139.9
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 479 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 479 (580)
+.||+|+||.||+|... +++.||+|.+... ........+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46899999999999764 7899999987643 233445678999999999999999999999999999999999999999
Q ss_pred hhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCcc
Q 008026 480 LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 559 (580)
Q Consensus 480 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 559 (580)
|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...........
T Consensus 80 L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRT----EGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9988743 22357899999999999999999997 8999999999999999999999999999876443211110
Q ss_pred -ccccccCCccCccccCCCCC
Q 008026 560 -TRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 560 -~~~~Gt~~y~APE~~~~~~~ 579 (580)
....++..|+|||++.++.+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~ 173 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRY 173 (252)
T ss_pred CCCCCCceeecCchhhcCCCC
Confidence 11123457999999877654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=217.75 Aligned_cols=176 Identities=30% Similarity=0.522 Sum_probs=147.3
Q ss_pred CCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccC----hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS----GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+|++.+.||+|+||.||+|...+++.+|+|.+...... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998878999999998754221 22345688999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++.+ ...+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999998843 2357888999999999999999997 78999999999999999999999999998754
Q ss_pred CCCC-----CCccccccccCCccCccccCCCCC
Q 008026 552 PEGK-----GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~-----~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... ........|+..|+|||++.+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 185 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCC
Confidence 3211 111123468999999999887654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=220.25 Aligned_cols=176 Identities=29% Similarity=0.521 Sum_probs=143.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--Ce
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 467 (580)
.+|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 46888999999999999999642 5789999998653 334456789999999999999999999987543 46
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 7899999999999998843 22358899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCCcc--ccccccCCccCccccCCCCC
Q 008026 548 VRLAPEGKGSIE--TRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 548 a~~~~~~~~~~~--~~~~Gt~~y~APE~~~~~~~ 579 (580)
++.......... ....++..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 188 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCc
Confidence 987644332111 11223456999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=220.22 Aligned_cols=173 Identities=25% Similarity=0.341 Sum_probs=146.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999876 68999999987543333334567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|++++.|..++. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 999988876652 22458899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
... ......++..|+|||++.+
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVG 174 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhC
Confidence 321 2233467889999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=219.05 Aligned_cols=180 Identities=26% Similarity=0.433 Sum_probs=150.8
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|.. .++..||+|.+..... ......++.+|+++++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999975 4789999998865322 3344567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++..... ....+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998854322 23468899999999999999999997 899999999999999999999999999987664
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... ......|+..|+|||++.+..+
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~ 183 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCc
Confidence 3322 2233568999999999876553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=217.05 Aligned_cols=176 Identities=26% Similarity=0.425 Sum_probs=146.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|...++..+|+|.+... ......+.+|++++++++|+||+++++++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4578999999999999999998777788999988653 2234678899999999999999999999887 77899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999988542 23457888999999999999999997 8999999999999999999999999999876644
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........++..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~ 180 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSF 180 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCc
Confidence 32222222345678999999876543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=219.53 Aligned_cols=170 Identities=28% Similarity=0.457 Sum_probs=145.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 47888999999999999999764 68899999987532 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 87 FCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999998743 2468899999999999999999998 7999999999999999999999999999876543
Q ss_pred CCCCccccccccCCccCccccC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
... ......|++.|+|||++.
T Consensus 159 ~~~-~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 159 TIA-KRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred ccc-ccccccCcccccChhhhc
Confidence 221 123357899999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=232.60 Aligned_cols=186 Identities=27% Similarity=0.425 Sum_probs=156.0
Q ss_pred eeeeHHHHHHhhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceee
Q 008026 383 MVISIQVLRNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG 460 (580)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~ 460 (580)
+...+..+...++.|++.+.||+|.+|.||+++. ++++.+|+|+.... ....++++.|.++++... |||++.+++
T Consensus 7 ~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg 83 (953)
T KOG0587|consen 7 MDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYG 83 (953)
T ss_pred cccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEE
Confidence 3445555666677899999999999999999954 47889999988653 334467788899998885 999999999
Q ss_pred EEEc-----CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec
Q 008026 461 HCLD-----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 535 (580)
Q Consensus 461 ~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 535 (580)
+|.. ++..|+|||||.+|+..++++... ...+.|..+..|++.++.|+.|||. ..++|||||-.|||++
T Consensus 84 ~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT 157 (953)
T KOG0587|consen 84 AFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLT 157 (953)
T ss_pred EEEEecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEe
Confidence 9864 568999999999999999998765 4578999999999999999999997 8899999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 536 DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 536 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.++.+||+|||++........ ...+.+|||.|||||++.-.+
T Consensus 158 ~e~~VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e 199 (953)
T KOG0587|consen 158 ENAEVKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDE 199 (953)
T ss_pred ccCcEEEeeeeeeeeeecccc-cccCcCCCcccccceeeeccc
Confidence 999999999999887655432 334578999999999986443
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=218.18 Aligned_cols=180 Identities=30% Similarity=0.472 Sum_probs=145.3
Q ss_pred CcccceeeccCcEEEEEEEEc-C---CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe-----
Q 008026 397 FSEENILGRGGFGTVYKGELH-D---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE----- 467 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 467 (580)
|++.+.||+|+||.||+|... + +..||+|+++...........+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999764 2 3679999997654455556789999999999999999999998876544
Q ss_pred -eEEEEEecCCCChhHHHHHHhh-hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 468 -KLLVFEYMPQGTLSRHIFNWAE-EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 468 -~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
.+++|||+++++|..++..... .....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 7899999999999988855322 123468899999999999999999997 89999999999999999999999999
Q ss_pred ccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 546 GLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 546 g~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+++......... .....++..|+|||++.+..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 192 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCC
Confidence 9998664332211 111235678999999876654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=223.41 Aligned_cols=182 Identities=27% Similarity=0.425 Sum_probs=147.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc--------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEc
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 464 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 464 (580)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 356888999999999999999641 2457999988653 2334567789999999999 79999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhh-----------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeE
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 533 (580)
....++||||+++++|.+++...... ....+++.+++.++.||+.||+|||+ .+|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 99999999999999999998653211 12357888899999999999999998 89999999999999
Q ss_pred ecCCCcEEEEeeccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 534 LGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 534 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+++++.+||+|||.++......... .....+++.|+|||++.+..+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 216 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY 216 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC
Confidence 9999999999999998664332111 122345678999999877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=227.47 Aligned_cols=182 Identities=27% Similarity=0.425 Sum_probs=143.6
Q ss_pred hcCCcccceeeccCcEEEEEEEE------cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcC-
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG- 465 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 465 (580)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35799999999999999999963 346889999997543 233456788999999999 589999999988654
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhh-------------------------------------------------------
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEE------------------------------------------------------- 490 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------- 490 (580)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4678999999999999988542100
Q ss_pred -------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc-cccc
Q 008026 491 -------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI-ETRI 562 (580)
Q Consensus 491 -------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~ 562 (580)
....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 01246788899999999999999997 899999999999999999999999999987653322111 1123
Q ss_pred cccCCccCccccCCCCC
Q 008026 563 AGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 563 ~Gt~~y~APE~~~~~~~ 579 (580)
.+++.|+|||++.+..+
T Consensus 242 ~~~~~y~aPE~~~~~~~ 258 (343)
T cd05103 242 RLPLKWMAPETIFDRVY 258 (343)
T ss_pred CCCcceECcHHhcCCCC
Confidence 35678999999876654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=216.91 Aligned_cols=177 Identities=27% Similarity=0.392 Sum_probs=144.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--Cee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 468 (580)
.+|++.+.||+|+||.||+|... ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999764 689999998864321 123456788999999999999999999988764 467
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+
T Consensus 82 ~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 899999999999988743 2357788899999999999999998 89999999999999999999999999998
Q ss_pred cccCCCCC--CccccccccCCccCccccCCCCC
Q 008026 549 RLAPEGKG--SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 549 ~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+....... .......|+..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCC
Confidence 75432111 11123458999999999877654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=220.33 Aligned_cols=182 Identities=29% Similarity=0.466 Sum_probs=148.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 357889999999999999999764 23689999986532 23345678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhh-----CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
.++||||+++++|.+++...... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 99999999999999998653221 12347888999999999999999997 89999999999999999999999
Q ss_pred EeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 543 ADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+|||+++....... .......++..|+|||.+.++.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 198 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC
Confidence 99999876543321 11223356789999999876554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=219.49 Aligned_cols=173 Identities=35% Similarity=0.583 Sum_probs=139.6
Q ss_pred ccceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 399 EENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 399 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.+.||.|.||.||+|.+. .+..|+||.+.. .......+.+.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4678999999999999876 357899999955 2344457889999999999999999999999998888999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++... ....+++.++..|+.||+.||.|||+ .+++|+||+++||++++++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999652 23568999999999999999999998 7899999999999999999999999999987632
Q ss_pred CCCC-ccccccccCCccCccccCCCC
Q 008026 554 GKGS-IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 554 ~~~~-~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.... ......+...|+|||.+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred cccccccccccccccccccccccccc
Confidence 2211 112234677899999986543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=221.10 Aligned_cols=175 Identities=26% Similarity=0.352 Sum_probs=148.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|... +++.||+|+++...........+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999775 68899999987654444456788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|++++.+..+.. ....+++.++..++.||+.||+|||+ .+++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEA-----SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 998866655442 22457899999999999999999998 8999999999999999999999999999987655
Q ss_pred CCCCccccccccCCccCccccCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
..........|+..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred CccccccCcccccCCcCCchhcCC
Confidence 433233446789999999998766
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=221.56 Aligned_cols=182 Identities=29% Similarity=0.433 Sum_probs=147.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 466 (580)
.++|++.+.||+|+||.||++... ....+|+|.+.... ......++.+|++++.++ +|+||+++++++...+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 357888999999999999999764 23679999887542 334456788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 535 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 535 (580)
..+++|||+++++|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 99999999999999999864321 223468899999999999999999997 8999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 536 DDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 536 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+++.+||+|||.++......... .....++..|+|||++.+..+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 211 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY 211 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc
Confidence 99999999999998664432111 111234678999999876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=223.02 Aligned_cols=179 Identities=34% Similarity=0.502 Sum_probs=142.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCc--EEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|.++ ++. .+|+|.+... ........+.+|++++.++ +|+||+++++++...+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 57889999999999999999765 444 4577766542 2334456788999999999 79999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 471 VFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
||||+++++|.+++..... .....+++.+++.++.|++.|++|||+ .+|+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999865321 112357899999999999999999997 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 540 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+||+|||+++...... ......++..|+|||++.+..+
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 200 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVY 200 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCC
Confidence 9999999986432111 1111234667999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=220.88 Aligned_cols=174 Identities=26% Similarity=0.434 Sum_probs=148.6
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..+|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 46799999999999999999976 4789999999875332 23466889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.+ ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||.+....
T Consensus 96 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 96 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred cccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999988743 357888999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... ......|++.|+|||++.+..+
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~ 192 (297)
T cd06656 167 PEQS-KRSTMVGTPYWMAPEVVTRKAY 192 (297)
T ss_pred CCcc-CcCcccCCccccCHHHHcCCCC
Confidence 3322 1223468999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=245.52 Aligned_cols=180 Identities=32% Similarity=0.515 Sum_probs=147.1
Q ss_pred CCcccceeeccCcEEEEEEEEcC--Cc----EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 396 NFSEENILGRGGFGTVYKGELHD--GT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
..+..+.||+|.||.||.|...+ +. .||+|.+++. .+.....+|.+|..+|++++||||++++|++.+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 45667899999999999997653 43 4899988763 35667789999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhh--CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
+++|||++|||..++++.+.. ....++..+.+.++.|||+|+.||++ +++|||||..+|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999764221 13467888999999999999999997 8999999999999999999999999999
Q ss_pred ccccCCCCCCccccc-cccCCccCccccCCCCC
Q 008026 548 VRLAPEGKGSIETRI-AGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 548 a~~~~~~~~~~~~~~-~Gt~~y~APE~~~~~~~ 579 (580)
|+.+....-...... .=..+|||||.+..+..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF 881 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF 881 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhccc
Confidence 995433221111111 11358999999987653
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=219.44 Aligned_cols=176 Identities=27% Similarity=0.408 Sum_probs=141.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCc----EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|.+. +++ .|++|.+... .......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 46888899999999999999764 444 4777776432 223345678888999999999999999998754 4578
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+++||+++|+|.+++.. ....+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||.++
T Consensus 85 ~i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 99999999999998853 22468899999999999999999998 889999999999999999999999999998
Q ss_pred ccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
........ ......|+..|+|||++.++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 188 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRY 188 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCc
Confidence 65433221 1223456788999999987665
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=204.20 Aligned_cols=178 Identities=28% Similarity=0.363 Sum_probs=146.7
Q ss_pred hcCCcccceeeccCcEEEEEEE-EcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----e
Q 008026 394 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----E 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 467 (580)
.++|++.+.+|+|+|+.||.++ ..++..||+|++.... .++.+..++|++..++++|||+++++++...+. .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3589999999999999999996 4578999999997643 456788999999999999999999998876433 4
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.|++++|+..|+|.+.+.....+ ...+++.+++.|+.+|++||++||+.. .++.||||||.||++.+++.+++.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 89999999999999999765443 357899999999999999999999842 4599999999999999999999999999
Q ss_pred ccccCCCCC--------CccccccccCCccCccccC
Q 008026 548 VRLAPEGKG--------SIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 548 a~~~~~~~~--------~~~~~~~Gt~~y~APE~~~ 575 (580)
++....... ........|..|.|||++.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~ 211 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFN 211 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchhee
Confidence 875432110 0011133589999999975
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=220.78 Aligned_cols=174 Identities=26% Similarity=0.434 Sum_probs=147.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..+|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++.+......++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 357999999999999999999754 688999999876432 23467889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred cccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999998743 357888999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... ......|++.|+|||++.+..+
T Consensus 168 ~~~~-~~~~~~~~~~y~aPE~~~~~~~ 193 (296)
T cd06654 168 PEQS-KRSTMVGTPYWMAPEVVTRKAY 193 (296)
T ss_pred cccc-ccCcccCCccccCHHHHcCCCC
Confidence 3321 1223468999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-25 Score=221.83 Aligned_cols=179 Identities=27% Similarity=0.380 Sum_probs=149.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999765 58999999997654332 34567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+.+++|.+++.. .....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999988743 222468899999999999999999998 899999999999999999999999999986543
Q ss_pred CCCCC----------------------------ccccccccCCccCccccCCCCC
Q 008026 553 EGKGS----------------------------IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~----------------------------~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..... ......||..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 209 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC
Confidence 22110 1112468999999999877654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=221.71 Aligned_cols=173 Identities=25% Similarity=0.389 Sum_probs=143.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc-ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57899999999999999999765 68899999987532 22234567789999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 997 588877743 22457888999999999999999998 8999999999999999999999999999876543
Q ss_pred CCCCccccccccCCccCccccCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
... ......+++.|+|||++.+.
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~ 179 (301)
T cd07873 157 PTK-TYSNEVVTLWYRPPDILLGS 179 (301)
T ss_pred CCC-cccccceeecccCcHHHhCC
Confidence 221 12234578999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=220.57 Aligned_cols=180 Identities=28% Similarity=0.443 Sum_probs=144.6
Q ss_pred CCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 396 NFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
+|++.+.||+|+||.||+|... ....+++|.+.... ......++.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999653 23568888876532 3344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhh-------------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 008026 470 LVFEYMPQGTLSRHIFNWAE-------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 530 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~ 530 (580)
+|+||+.+++|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 99999999999998854221 112357889999999999999999997 89999999999
Q ss_pred CeEecCCCcEEEEeeccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 531 NILLGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 531 NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||++++++.+||+|||+++......... .....++..|+|||++.+..+
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 206 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY 206 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc
Confidence 9999999999999999997653322111 122345678999999876544
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=223.03 Aligned_cols=181 Identities=29% Similarity=0.429 Sum_probs=145.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc--------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcC
Q 008026 395 NNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 465 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 465 (580)
++|.+.+.||+|+||.||+|+.. +...+|+|.+.... .......+.+|+++++++ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 56899999999999999999653 23469999987532 334456788899999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhh-----------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
+..++||||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 9999999999999999998653211 11357889999999999999999997 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 535 GDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
++++.+||+|||.++......... .....+++.|+|||++.+..+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 219 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC
Confidence 999999999999987654321111 111224568999999877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=214.64 Aligned_cols=171 Identities=36% Similarity=0.583 Sum_probs=146.1
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 57888999999999999999875 78999999876422 457889999999999999999999999998999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 82 MAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred cCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 9999999988542 22368899999999999999999998 89999999999999999999999999999876332
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. ...++..|+|||++.++.+
T Consensus 156 ~~----~~~~~~~~~ape~~~~~~~ 176 (256)
T cd05039 156 QD----SGKLPVKWTAPEALREKKF 176 (256)
T ss_pred cc----cCCCcccccCchhhcCCcC
Confidence 21 2234667999999876654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=221.29 Aligned_cols=178 Identities=29% Similarity=0.421 Sum_probs=146.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCe
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 467 (580)
++|.+.+.||+|+||.||+|... ++..||+|.++... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 56889999999999999999642 34579999887532 233456789999999999 79999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||+.+++|.+++.. .....+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.++++|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999998853 112347899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 548 VRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 548 a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
++........ ......++..|+|||++.+..+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 220 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY 220 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCC
Confidence 9865433221 1122346788999999876654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=211.23 Aligned_cols=173 Identities=27% Similarity=0.352 Sum_probs=140.9
Q ss_pred hhcCCccc-ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEc----C
Q 008026 393 VTNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD----G 465 (580)
Q Consensus 393 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~ 465 (580)
++++|.+. ++||-|-.|+|..+..+ +++.+|+|++.. ....++|+++--.. .|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 55677653 77999999999999654 799999998754 24567888876665 49999999998864 4
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEE
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 542 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 542 (580)
....+|||.++||.|...+.+ .+...+++.++-.|+.||+.|+.|||+ .+|.||||||+|+|... +..+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEe
Confidence 567899999999999888754 555689999999999999999999998 89999999999999964 456899
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+|||+|+....... ..+.+-||+|.|||++....|+
T Consensus 206 tDfGFAK~t~~~~~--L~TPc~TPyYvaPevlg~eKyd 241 (400)
T KOG0604|consen 206 TDFGFAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYD 241 (400)
T ss_pred cccccccccCCCcc--ccCCcccccccCHHHhCchhcC
Confidence 99999987654322 2334569999999999877763
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=214.52 Aligned_cols=177 Identities=24% Similarity=0.394 Sum_probs=149.7
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|+||.||++... +++.||+|++...........++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999664 689999999876544445567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+.+++|.+++.. .....+++.+++.++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999888743 222357888999999999999999998 89999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. ......|++.|+|||++.++.+
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~ 178 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPY 178 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCC
Confidence 21 1223468899999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=218.42 Aligned_cols=181 Identities=25% Similarity=0.409 Sum_probs=147.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+.... .......+.+|++++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 57888999999999999999764 24678999876532 222456789999999999999999999999998899
Q ss_pred EEEEEecCCCChhHHHHHHhhhC----CCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEG----LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
++||||+++++|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999985432111 1258899999999999999999997 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||+++..............++..|+|||.+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 195 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF 195 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCC
Confidence 99987543322222233456788999999876654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=223.34 Aligned_cols=172 Identities=19% Similarity=0.278 Sum_probs=140.6
Q ss_pred ccceeecc--CcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 399 EENILGRG--GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 399 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
+.++||+| +|++||++..+ +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 68999999664 7899999999765444445567888999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999885421 2358899999999999999999997 899999999999999999999999998654332111
Q ss_pred CC------ccccccccCCccCccccCC
Q 008026 556 GS------IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 556 ~~------~~~~~~Gt~~y~APE~~~~ 576 (580)
.. ......++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred ccccccccccccccceecccChHHhhc
Confidence 10 0112346788999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=221.10 Aligned_cols=180 Identities=24% Similarity=0.373 Sum_probs=145.2
Q ss_pred CCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 396 NFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
+|++.+.||+|+||.||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 5777899999999999999753 24789999987532 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC
Q 008026 470 LVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 538 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 538 (580)
+++||+++++|.+++..... .....+++..+..++.|++.||+|+|+ .+|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 99999999999998843210 112357888899999999999999997 8999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 539 RAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.+||+|||+++....... .......+++.|+|||++.++.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF 203 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC
Confidence 999999999876543221 11122346789999999876654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=197.13 Aligned_cols=176 Identities=27% Similarity=0.395 Sum_probs=145.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++......||+|++|.|-+-++. +|...|+|.+... ...+..++..+|+.+..+. .+|++|++||.+......|+.|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34455678999999999888664 7999999999874 4556678888999987777 5999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
|.|+ -+|..+-.+..+ ....+++...-+||..|.+||.|||+ +..+||||+||+|||++.+|.+|+||||++..+.
T Consensus 125 E~M~-tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHhh-hhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9995 477666544333 34678999999999999999999998 5899999999999999999999999999998876
Q ss_pred CCCCCccccccccCCccCccccCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+... .+...|-..|||||.+..+
T Consensus 201 dSiA--kt~daGCkpYmaPEri~~e 223 (282)
T KOG0984|consen 201 DSIA--KTMDAGCKPYMAPERINPE 223 (282)
T ss_pred hhhH--HHHhcCCCccCChhhcCcc
Confidence 5432 2224688899999998754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=221.56 Aligned_cols=173 Identities=24% Similarity=0.352 Sum_probs=144.3
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|+||.||+|+.. +|+.||+|++............+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999775 689999999876433333345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
++ ++|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 477776632 22468999999999999999999998 89999999999999999999999999999865433
Q ss_pred CCCccccccccCCccCccccCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
... .....+++.|+|||++.+.
T Consensus 153 ~~~-~~~~~~~~~y~aPE~~~~~ 174 (284)
T cd07839 153 VRC-YSAEVVTLWYRPPDVLFGA 174 (284)
T ss_pred CCC-cCCCccccCCcChHHHhCC
Confidence 221 2234578999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=219.51 Aligned_cols=175 Identities=23% Similarity=0.399 Sum_probs=147.3
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|... ++..||+|.+... ........+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36888999999999999999775 7899999988753 233445778899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++... .....+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||.+.....
T Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999998887431 112368999999999999999999996 25899999999999999999999999999876533
Q ss_pred CCCCccccccccCCccCccccCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.. .....|++.|+|||++.+.
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 156 SL---AKTNIGCQSYMAPERIKSG 176 (286)
T ss_pred Cc---cccCCCccCccCcchhcCC
Confidence 22 2234588899999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=219.57 Aligned_cols=184 Identities=24% Similarity=0.348 Sum_probs=148.9
Q ss_pred eeHHHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEE
Q 008026 385 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHC 462 (580)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 462 (580)
+.++.+....++|++.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 344555667789999999999999999999764 6789999987542 12235678899999999 699999999987
Q ss_pred E-----cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC
Q 008026 463 L-----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537 (580)
Q Consensus 463 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 537 (580)
. .++..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCC
Confidence 4 34568999999999999988754322 22467889999999999999999997 899999999999999999
Q ss_pred CcEEEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 538 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 538 ~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+.+||+|||+++....... ......|++.|+|||++.+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 198 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIAC 198 (286)
T ss_pred CCEEEccCCceeecccCCC-ccccccCCCcccChhhhch
Confidence 9999999999876543221 2233468999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-25 Score=218.11 Aligned_cols=173 Identities=29% Similarity=0.410 Sum_probs=146.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.+.|++.+.||+|+||.||+|+.. ++..|++|.+... .....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 357899999999999999999775 5889999998653 3445677889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|..++.+ ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 89 EFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred ecCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999877643 12458899999999999999999997 899999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccCccccCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.... ......|++.|+|||++.+
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~~ 184 (292)
T cd06644 162 KTLQ-RRDSFIGTPYWMAPEVVMC 184 (292)
T ss_pred cccc-ccceecCCccccCceeecc
Confidence 3221 1233468899999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-25 Score=214.56 Aligned_cols=182 Identities=26% Similarity=0.428 Sum_probs=150.8
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--CCeeEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLVF 472 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 472 (580)
+|++.+.||.|+||.||+|... ++..||+|++..........+++..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999654 68899999987655555566788999999999999999999998764 34678999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||+++++|.+++..... ....+++..++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999865432 2357899999999999999999999321 28999999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCccCccccCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
...... ......|++.|+|||++.+..+
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~ 187 (265)
T cd08217 160 LGHDSS-FAKTYVGTPYYMSPEQLNHMSY 187 (265)
T ss_pred ccCCcc-cccccccCCCccChhhhcCCCC
Confidence 654332 1233568999999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-25 Score=219.79 Aligned_cols=177 Identities=23% Similarity=0.390 Sum_probs=146.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||++... +++.||+|.+...... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999765 5789999998764322 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999998843 2468889999999999999999998 899999999999999999999999999986421
Q ss_pred CCC--------------CCccccccccCCccCccccCCCCC
Q 008026 553 EGK--------------GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~--------------~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ........|+..|+|||++.+.++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 193 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCC
Confidence 110 001112457889999999876554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=220.51 Aligned_cols=181 Identities=24% Similarity=0.426 Sum_probs=145.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-----------------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccc
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-----------------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 457 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 457 (580)
++|++.+.||+|+||.||+++.. ++..||+|++.... ......++.+|++++++++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 57999999999999999998532 23468999887532 3344568899999999999999999
Q ss_pred eeeEEEcCCeeEEEEEecCCCChhHHHHHHhhh------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 008026 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 531 (580)
Q Consensus 458 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N 531 (580)
+++++...+..++||||+++++|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 999999999999999999999999988653211 11347788899999999999999998 899999999999
Q ss_pred eEecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 532 ILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 532 Ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|++++++.++|+|||+++........ ......+++.|+|||...++.+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 209 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF 209 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc
Confidence 99999999999999999765432211 1122334678999998776554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=219.15 Aligned_cols=172 Identities=28% Similarity=0.413 Sum_probs=147.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 357899999999999999999765 6889999998653 3344567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 82 EFCDGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999988743 22468899999999999999999998 899999999999999999999999999887654
Q ss_pred CCCCCccccccccCCccCccccC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.... ......|++.|+|||++.
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 155 STLQ-KRDTFIGTPYWMAPEVVA 176 (280)
T ss_pred cccc-ccceeecchhhcCHHHHh
Confidence 3221 223356899999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-25 Score=216.57 Aligned_cols=169 Identities=28% Similarity=0.425 Sum_probs=143.3
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
|++.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 677889999999999999775 5788899988653 2345667889999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
++++|..++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 85 AGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999887643 22468899999999999999999998 899999999999999999999999999987653322
Q ss_pred CCccccccccCCccCccccC
Q 008026 556 GSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~ 575 (580)
. ......|++.|+|||++.
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 158 Q-RRDSFIGTPYWMAPEVVM 176 (282)
T ss_pred c-ccccccccccccCHhhcc
Confidence 1 223356899999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=220.73 Aligned_cols=173 Identities=27% Similarity=0.402 Sum_probs=146.3
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999875 58999999986643333345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.++... ...+++.+++.++.||+.||+|||+ .+++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999888766522 2358899999999999999999998 7999999999999999999999999999886544
Q ss_pred CCCCccccccccCCccCccccCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.. .......|+..|+|||++.+
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07846 153 PG-EVYTDYVATRWYRAPELLVG 174 (286)
T ss_pred Cc-cccCcccceeeccCcHHhcc
Confidence 33 22333568899999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=217.58 Aligned_cols=173 Identities=29% Similarity=0.456 Sum_probs=144.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcC-----
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG----- 465 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----- 465 (580)
..+.|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4567888999999999999999765 68899999986532 2345788999999998 699999999998753
Q ss_pred -CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 466 -NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 466 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
...|+||||+++++|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEcc
Confidence 457899999999999998854 223468899999999999999999998 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
||+++....... ......|++.|+|||++.
T Consensus 155 fg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 155 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred CCCceecccccc-cCCcccccccccCHhHhc
Confidence 999986543221 223456899999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-25 Score=218.18 Aligned_cols=173 Identities=29% Similarity=0.485 Sum_probs=140.9
Q ss_pred CcccceeeccCcEEEEEEEE-----cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeE
Q 008026 397 FSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKL 469 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 469 (580)
|++.+.||+|+||+||++.. .++..||+|.+.... .......+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 38889999999999988643 357889999987542 233456788999999999999999999988654 3578
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccc
Confidence 99999999999988843 358999999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCc--cccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSI--ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~--~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......... .....++..|+|||++.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 187 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCC
Confidence 664432211 112245677999999876553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=214.47 Aligned_cols=175 Identities=30% Similarity=0.479 Sum_probs=145.5
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ...++.+|++++++++||+++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 46788899999999999999877788999998875432 235688999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ....+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 81 MEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 999999888743 22357889999999999999999997 79999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.........++..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~ 178 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKY 178 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCc
Confidence 2111122335678999999876554
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-25 Score=214.44 Aligned_cols=169 Identities=27% Similarity=0.402 Sum_probs=138.4
Q ss_pred eeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 402 ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 402 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
.||+|+||.||+|.++ ++..+|+|++..........+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 5788999998765444455678899999999999999999999875 45678999999999
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 558 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 558 (580)
+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99988843 2358889999999999999999997 899999999999999999999999999998764433211
Q ss_pred --cccccccCCccCccccCCCCC
Q 008026 559 --ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 559 --~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.....++..|+|||.+.+..+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKF 175 (257)
T ss_pred eecCCCCCCccccCHhHhccCCc
Confidence 111234678999999876543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-25 Score=214.93 Aligned_cols=176 Identities=28% Similarity=0.514 Sum_probs=145.7
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh-------hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-------KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
+|.+.+.||+|++|.||+|... +++.||+|.+....... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999764 68899999886543221 123568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence 9999999999999998843 2457888999999999999999997 8999999999999999999999999999
Q ss_pred ccccCCCCC-----CccccccccCCccCccccCCCCC
Q 008026 548 VRLAPEGKG-----SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 548 a~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
++....... .......|+..|+|||++.+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 189 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY 189 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCC
Confidence 886642211 11122458899999999877654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-25 Score=218.18 Aligned_cols=173 Identities=25% Similarity=0.447 Sum_probs=147.8
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.+|++.+.||.|++|.||+|.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4689999999999999999965 478999999987532 2235678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 97 YLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred ecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999988742 357899999999999999999998 8999999999999999999999999999876543
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......|++.|+|||.+.+..+
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~ 192 (296)
T cd06655 168 EQS-KRSTMVGTPYWMAPEVVTRKAY 192 (296)
T ss_pred ccc-cCCCcCCCccccCcchhcCCCC
Confidence 322 1223468999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=216.13 Aligned_cols=177 Identities=25% Similarity=0.458 Sum_probs=144.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CC---cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|... ++ ..||+|.+... .......++..|+.+++.++||||+++++++......++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 35788999999999999999765 33 36999998653 234456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999988743 22457899999999999999999998 8999999999999999999999999999876
Q ss_pred cCCCCCCc--ccccc--ccCCccCccccCCCCC
Q 008026 551 APEGKGSI--ETRIA--GTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~--~~~~~--Gt~~y~APE~~~~~~~ 579 (580)
........ ..... ++..|+|||++.+.++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcc
Confidence 54332211 11111 2457999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=218.78 Aligned_cols=180 Identities=29% Similarity=0.488 Sum_probs=146.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
.+|.+.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 46888899999999999999643 3456888887642 233446788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC
Q 008026 469 LLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 537 (580)
++||||+++++|.+++..... .....+++..++.++.||+.||+|||+ ++|+||||||+||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 999999999999999854211 112347899999999999999999997 899999999999999999
Q ss_pred CcEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 538 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 538 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+.++|+|||+++....... .......|+..|+|||++.+..+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 202 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 202 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC
Confidence 9999999999976543221 11223456889999999877654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-25 Score=216.87 Aligned_cols=176 Identities=29% Similarity=0.421 Sum_probs=142.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCc----EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|.+. ++. .||+|++... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 57888999999999999999753 444 4899988653 233445678899999999999999999999875 4578
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+++||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCcee
Confidence 99999999999988743 23468899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......... .....+++.|+|||...+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRF 188 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCC
Confidence 764332211 111234678999999877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-25 Score=213.50 Aligned_cols=168 Identities=26% Similarity=0.426 Sum_probs=136.1
Q ss_pred eeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCC
Q 008026 403 LGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 479 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 479 (580)
||+|+||.||+|.+. ++..||+|++... ......+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 899999999999664 3567999988653 233445678999999999999999999998754 57899999999999
Q ss_pred hhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCcc
Q 008026 480 LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 559 (580)
Q Consensus 480 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 559 (580)
|.+++.. ....+++.++++++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 81 L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 9988743 23468899999999999999999997 8999999999999999999999999999976543322111
Q ss_pred cc--ccccCCccCccccCCCCC
Q 008026 560 TR--IAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 560 ~~--~~Gt~~y~APE~~~~~~~ 579 (580)
.. ..++..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKF 175 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCC
Confidence 11 123578999999876654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=213.02 Aligned_cols=173 Identities=29% Similarity=0.445 Sum_probs=148.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|... ++..+++|++.... ....+.+.+|++++++++||||+++++++...+..|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 57899999999999999999764 67889999987643 2255788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 81 YCGGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999988743 22468899999999999999999997 8999999999999999999999999999876543
Q ss_pred CCCCccccccccCCccCccccCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
... ......|+..|+|||++.+.
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 154 TIA-KRKSFIGTPYWMAPEVAAVE 176 (262)
T ss_pred hhh-ccccccCCccccCchhhccc
Confidence 221 22335689999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=221.17 Aligned_cols=181 Identities=28% Similarity=0.433 Sum_probs=145.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc--------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcC
Q 008026 395 NNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 465 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 465 (580)
++|.+.+.||+|+||.||+|... ....||+|.+.... .......+.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 56888999999999999999642 24568999887532 334456788999999999 599999999999999
Q ss_pred CeeEEEEEecCCCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
+..++||||+++++|.+++..... .....+++.++..++.|++.||+|||+ .+|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 999999999999999999865321 112358889999999999999999997 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 535 GDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
++++.+||+|||.++......... .....++..|||||++.+..+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY 213 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc
Confidence 999999999999998654322111 111234567999999877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=216.86 Aligned_cols=175 Identities=28% Similarity=0.403 Sum_probs=141.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHH-HHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAV-LTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|... +|+.||+|++...... ....++..|+.. ++..+||||+++++++...+..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 47889999999999999999765 6899999998764322 233455566665 56668999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||++ ++|.+++...... ...+++..+..++.||+.||+|||+ +.+++||||||+||+++.++.+||+|||.++...
T Consensus 80 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 6888877553322 2568999999999999999999997 2389999999999999999999999999988654
Q ss_pred CCCCCccccccccCCccCccccCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
... ......|+..|+|||++.+
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 156 DSV--AKTIDAGCKPYMAPERINP 177 (283)
T ss_pred ccc--ccccccCCccccChhhcCC
Confidence 322 1223468899999998864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=213.52 Aligned_cols=177 Identities=27% Similarity=0.427 Sum_probs=144.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--Cee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 468 (580)
.+|+..+.||+|+||.||+|... ++..||+|++...... ......+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999764 6899999988654322 23446788999999999999999999988753 567
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++++||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 899999999999988843 2357888899999999999999997 89999999999999999999999999998
Q ss_pred cccCCCC--CCccccccccCCccCccccCCCCC
Q 008026 549 RLAPEGK--GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 549 ~~~~~~~--~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+...... ........|+..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCC
Confidence 7553211 111123458899999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=212.76 Aligned_cols=173 Identities=28% Similarity=0.483 Sum_probs=146.9
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+|+..+.||+|+||.||+|... ++..|++|.+..... .....+.+.+|+++++.++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999765 789999999865332 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.+||+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999988843 2357888999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCCCccccccccCCccCccccCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.... ......|+..|+|||.+.+..
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~ 177 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQG 177 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCC
Confidence 4332 123356899999999986543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=219.01 Aligned_cols=168 Identities=27% Similarity=0.261 Sum_probs=129.9
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc--CCcEEEEEEeecccc---ChhhHHHHHHHHHHHHhcCCCcccc-eeeEEEcC
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVA-LLGHCLDG 465 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~ 465 (580)
...++|.+.+.||+|+||+||+|.+. +++.||||++..... .......+.+|++++++++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34568999999999999999999764 577789998754311 2234567899999999999999985 4432
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC-CCCCeEecCCCcEEEEe
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVAD 544 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~D 544 (580)
+..|+||||++|++|.... ... ...++.|+++||+|||+ .+|+|||| ||+|||++.++.+||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~~---------~~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR---------PHG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred CCcEEEEEccCCCCHHHhC---------ccc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 4579999999999996211 011 13578899999999998 89999999 99999999999999999
Q ss_pred eccccccCCCCCCc-------cccccccCCccCccccCCCC
Q 008026 545 FGLVRLAPEGKGSI-------ETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 545 fg~a~~~~~~~~~~-------~~~~~Gt~~y~APE~~~~~~ 578 (580)
||+|+......... .+...|++.|+|||++.-.+
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 99998765432111 13456899999999986543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=219.90 Aligned_cols=177 Identities=27% Similarity=0.352 Sum_probs=150.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 471 (580)
.+|....+||+|+||+|.+|+.+ +.+.||||+++++.+. ..+.+--..|-++|+.-. -|.+++++.+|+.-+..|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 47888999999999999999665 5678999999887543 333444456777887774 78999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+.||+|-.++++ ...+.+..+..+|..||-||-|||+ ++||+||||..|||+|.+|.+||+|||+++.-
T Consensus 429 MEyvnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999888744 3467788899999999999999998 89999999999999999999999999999865
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.-+. ....+++|||-|+|||++.-++|+
T Consensus 501 i~~~-~TTkTFCGTPdYiAPEIi~YqPYg 528 (683)
T KOG0696|consen 501 IFDG-VTTKTFCGTPDYIAPEIIAYQPYG 528 (683)
T ss_pred ccCC-cceeeecCCCcccccceEEecccc
Confidence 4333 345668999999999999988874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-26 Score=211.14 Aligned_cols=178 Identities=22% Similarity=0.353 Sum_probs=155.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
.++|.+.++||+|+|++|..+++. +.+.||+|++++...+ ..+.+..+.|-.+.... +||.+|.++.+|+.+...+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999775 6788999999887543 45667788888888877 49999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
|.||+.||+|--++.+ .+.++++.+..+...|+.||.|||+ .|||+||+|..|||+|.+|.+||+|+|+++.
T Consensus 329 vieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999777633 3568999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
...+. ....+++|||.|+|||+++|.+|.
T Consensus 401 ~l~~g-d~tstfcgtpnyiapeilrgeeyg 429 (593)
T KOG0695|consen 401 GLGPG-DTTSTFCGTPNYIAPEILRGEEYG 429 (593)
T ss_pred CCCCC-cccccccCCCcccchhhhcccccC
Confidence 54333 345678999999999999998873
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=215.43 Aligned_cols=170 Identities=28% Similarity=0.420 Sum_probs=134.6
Q ss_pred eeeccCcEEEEEEEEcCCc---EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 402 ILGRGGFGTVYKGELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 402 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
.||+|+||.||+|+..++. .+++|.+.... .....+.+.+|+.+++.++||||+++++++......++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5899999999999755433 45566655422 2334578899999999999999999999999999999999999999
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC-CC
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK-GS 557 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 557 (580)
+|.+++.+... .....++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999865321 12346677788999999999999997 899999999999999999999999999986432211 11
Q ss_pred ccccccccCCccCccccCC
Q 008026 558 IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~ 576 (580)
......|+..|+|||++..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGE 175 (268)
T ss_pred cccCCcCcccccCchhccc
Confidence 1223467899999999753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=211.52 Aligned_cols=176 Identities=24% Similarity=0.414 Sum_probs=148.9
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|+..+.||+|+||.||+|... +++.+|+|.+............+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4888999999999999999664 688999999977555555667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-CcEEEEeeccccccCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPE 553 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~ 553 (580)
+++++|.+++... ....+++..+..++.|++.||+|||+ ++++||||||+||+++++ +.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999988542 23457889999999999999999998 899999999999999854 4689999999987644
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... .....|+..|+|||.+.+..+
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPY 178 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCC
Confidence 321 223468999999999876643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=215.76 Aligned_cols=173 Identities=27% Similarity=0.414 Sum_probs=148.8
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+|++.+.||.|+||.||+|... ++..||+|++.+.... ....+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999775 6899999999765433 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+.+++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999988843 1468889999999999999999997 8999999999999999999999999999876544
Q ss_pred CCCCccccccccCCccCccccCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.. ......|+..|+|||++.+..
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~ 175 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQG 175 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccC
Confidence 32 123346889999999987654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=218.32 Aligned_cols=179 Identities=30% Similarity=0.463 Sum_probs=142.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCc--EEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|... ++. .+++|.++.. ......+.+.+|+++++++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57899999999999999999765 333 4788877642 2334456789999999999 69999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhh-----------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 471 VFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
||||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 99999999999998542210 11357889999999999999999997 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 540 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+||+|||++........ ......+..|+|||++.+..+
T Consensus 158 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 195 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVY 195 (297)
T ss_pred EEECCcCCCccccceec--cCCCCcCccccCchhhccCCC
Confidence 99999999864322111 111123557999999877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=212.74 Aligned_cols=175 Identities=29% Similarity=0.446 Sum_probs=149.2
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|+||.||+|... +++.|++|.+..........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4888899999999999999764 689999999987554445678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999998743 2347888899999999999999998 89999999999999999999999999998776443
Q ss_pred CCCcc---ccccccCCccCccccCCCC
Q 008026 555 KGSIE---TRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 555 ~~~~~---~~~~Gt~~y~APE~~~~~~ 578 (580)
..... ....|++.|+|||++.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~ 179 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGK 179 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCC
Confidence 22211 1246788999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=240.09 Aligned_cols=171 Identities=25% Similarity=0.378 Sum_probs=147.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|.+.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999776 689999999976432 3344567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+.+++|.+++.. ...+++..++.|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++...
T Consensus 84 Ey~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 84 EYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 99999999998843 2357888899999999999999998 799999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCcccc
Q 008026 553 EGKGSIETRIAGTFGYLAPEYA 574 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~ 574 (580)
.... ......||+.|+|||..
T Consensus 156 ~~~~-~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 156 NREL-NMMDILTTPSMAKPKND 176 (669)
T ss_pred CCcc-cccccccCccccCcccc
Confidence 4332 22346789999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=218.02 Aligned_cols=174 Identities=27% Similarity=0.380 Sum_probs=147.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||+||++... +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 56888999999999999999765 68899999886532 23446788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. .+.+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999888743 2468899999999999999999996 35899999999999999999999999999865432
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. .....|+..|+|||++.+..+
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~ 179 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKY 179 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCC
Confidence 22 123568999999999876554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=218.58 Aligned_cols=172 Identities=31% Similarity=0.402 Sum_probs=144.5
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+|++.+.||+|+||.||+|... +++.||+|++...... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999765 6899999999765433 22345677899999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+ +++|.+++.. ....+++..+..++.||++||+|||+ .+|+||||||+||+++.++.++|+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKD----KSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 8899988843 11368899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
..... ......+++.|+|||++.+
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~ 176 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFG 176 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhC
Confidence 54322 2223356888999998854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=217.18 Aligned_cols=173 Identities=26% Similarity=0.383 Sum_probs=144.7
Q ss_pred CCcccceeeccCcEEEEEEEE----cCCcEEEEEEeecccc--ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCee
Q 008026 396 NFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEK 468 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 468 (580)
+|++.+.||+|+||.||+|+. .+|..||+|++..... .....+.+.+|+.++++++ |++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999975 3688999999875332 1223466788999999994 99999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999988843 2357888899999999999999997 89999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+..............|+..|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred eecccccccccccccCCcccCChhhccC
Confidence 7654432222234568999999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=214.62 Aligned_cols=176 Identities=24% Similarity=0.380 Sum_probs=142.7
Q ss_pred cCCcccceeeccCcEEEEEEEEcC----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|.+.+.||+|+||.||+|...+ ...||+|...... .....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 468889999999999999997643 3468999886532 23455688999999999999999999998875 45789
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeee
Confidence 9999999999998843 22358899999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.............++..|+|||.+.+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRF 185 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCC
Confidence 64432222222334568999999876554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=217.44 Aligned_cols=177 Identities=27% Similarity=0.325 Sum_probs=143.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCe-----
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNE----- 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----- 467 (580)
++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999765 6899999988764333334467888999999996 6999999999887665
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-CCcEEEEeec
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFG 546 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 546 (580)
.|+||||+++ +|.+++..........+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 88888755333223568999999999999999999997 89999999999999998 8899999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+++........ .....+++.|+|||++.+
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~ 185 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLG 185 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhC
Confidence 98765432221 122357889999998765
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=212.79 Aligned_cols=177 Identities=28% Similarity=0.425 Sum_probs=145.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccc---cChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--Cee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV---ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 468 (580)
.+|++.+.||+|+||.||+|... ++..||+|++.... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999764 68999999875422 1233456788999999999999999999998764 457
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999988743 2357888899999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCC--CccccccccCCccCccccCCCCC
Q 008026 549 RLAPEGKG--SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 549 ~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+....... .......|+..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCC
Confidence 76532111 11123568999999999887654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=218.07 Aligned_cols=182 Identities=32% Similarity=0.473 Sum_probs=147.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ......++.+|+.++++++||||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 357899999999999999999753 46789999887532 33445678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhh-----------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAE-----------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 530 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~ 530 (580)
.++||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 9999999999999999864311 112347888899999999999999997 89999999999
Q ss_pred CeEecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 531 NILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 531 NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||++++++.++|+|||.++........ ......++..|+|||++.+..+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY 209 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC
Confidence 999999999999999998754332211 1112234677999999877654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=214.94 Aligned_cols=176 Identities=24% Similarity=0.439 Sum_probs=146.1
Q ss_pred CCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccC----hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 396 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS----GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
+|+..+.||+|++|.||+|.. .+++.||+|++...... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999965 47899999998753321 1235678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC-cEEEEeecccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 549 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~ 549 (580)
||||+++++|.+++.+ ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999998843 2367889999999999999999998 8999999999999998765 59999999987
Q ss_pred ccCCCCC---CccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKG---SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~---~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
....... .......|+..|+|||++.+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 185 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCC
Confidence 6643311 11223468899999999876654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=218.00 Aligned_cols=174 Identities=26% Similarity=0.359 Sum_probs=145.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 471 (580)
++|++.+.||+|+||.||+|... +++.+|+|.++...........+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999775 688999999976543333345677899999999999999999998877 889999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++ +|.+++.. ....+++..++.++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 85 ~e~~~~-~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVEH-DLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcCc-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 999974 88887743 22368999999999999999999998 89999999999999999999999999998876
Q ss_pred CCCCCCccccccccCCccCccccCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
..... ......+++.|+|||++.+.
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~ 181 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGA 181 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCC
Confidence 54321 12334578999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=217.56 Aligned_cols=173 Identities=28% Similarity=0.470 Sum_probs=146.5
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
.|+..+.||+|+||.||+|... ++..||+|.+.... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4677788999999999999664 67899999887532 233456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++++|||++......
T Consensus 84 ~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 84 LGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999888732 357889999999999999999997 89999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. .......|+..|+|||++.+..+
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~ 178 (277)
T cd06642 155 Q-IKRNTFVGTPFWMAPEVIKQSAY 178 (277)
T ss_pred c-hhhhcccCcccccCHHHhCcCCC
Confidence 2 12233468899999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=222.11 Aligned_cols=181 Identities=29% Similarity=0.422 Sum_probs=145.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc--------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcC
Q 008026 395 NNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 465 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 465 (580)
.+|++.+.||+|+||.||+|+.. ....||+|.+... ......+++.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46889999999999999999642 1236899987653 2334567889999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
+..+++|||+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 999999999999999999865321 112357888999999999999999997 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 535 GDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+.++.+||+|||+++......... .....++..|+|||++.+..+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY 213 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc
Confidence 999999999999997654322111 111234567999999877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=214.61 Aligned_cols=176 Identities=30% Similarity=0.458 Sum_probs=143.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCc----EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
.+|++.+.||+|+||.||+|... ++. .||+|.+.... ......++.+|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 56888999999999999999764 333 58999876542 23445678899999999999999999999987 7889
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||.++
T Consensus 85 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 99999999999998843 22358899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCccc-cccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSIET-RIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~~~-~~~Gt~~y~APE~~~~~~~ 579 (580)
........... ...++..|+|||.+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIY 188 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCc
Confidence 76543322111 1223568999999876554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=224.37 Aligned_cols=146 Identities=25% Similarity=0.418 Sum_probs=128.4
Q ss_pred CCcccceeeccCcEEEEEEEE-cCCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
-|..++.||-|+||+|.+++. ++...||.|.+.+... ..........|-.+|+..+.+-||++|-.|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 367788999999999999954 4677899999976543 33344557789999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
|++||++-.++.+ ...+++..++.++..+.+|+++.|. .|+|||||||+|||||.+|.+||+|||+|.
T Consensus 710 YIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred ccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccc
Confidence 9999999988854 2578899999999999999999996 999999999999999999999999999985
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=215.69 Aligned_cols=182 Identities=27% Similarity=0.388 Sum_probs=144.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
.++|++.+.||+|+||.||+|.+. .+..||+|.+.... .......+.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 356889999999999999999764 35678999876432 23344678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhh--CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC---cEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 542 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 542 (580)
.++||||+++++|.+++...... ....+++.++++++.||+.||+|||+ .+++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999998653211 12358899999999999999999998 7899999999999998654 5999
Q ss_pred EeeccccccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 543 ADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+|||+++......... .....++..|+|||++.+..+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF 198 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCc
Confidence 9999998663221111 111223567999999877654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=213.69 Aligned_cols=177 Identities=25% Similarity=0.472 Sum_probs=145.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CC---cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|+..+.||+|+||.||+|... ++ ..+|+|.+.... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 46888899999999999999764 33 379999886532 33445678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 9999999999988743 22468899999999999999999998 8999999999999999999999999999876
Q ss_pred cCCCCCCcccc--ccccCCccCccccCCCCC
Q 008026 551 APEGKGSIETR--IAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~~~--~~Gt~~y~APE~~~~~~~ 579 (580)
........... ...+..|+|||++.+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 187 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCc
Confidence 64332211111 123457999999876654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=215.87 Aligned_cols=174 Identities=27% Similarity=0.366 Sum_probs=142.4
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|.+.+.||+|+||.||+|... ++..||+|++..... ......+.+|+.+++.++|+||+++++++..++..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467999999999999999999764 688999999865432 223346778999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+. +++.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9995 677666532 22356788889999999999999997 799999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.... ......+++.|+|||++.+.
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~ 178 (291)
T cd07870 155 IPSQ-TYSSEVVTLWYRPPDVLLGA 178 (291)
T ss_pred CCCC-CCCCccccccccCCceeecC
Confidence 3221 12234578999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=216.50 Aligned_cols=172 Identities=26% Similarity=0.391 Sum_probs=142.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999765 689999999875432 2223456789999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++ +|.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~~-~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLDT-DLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 9975 89887743 22367889999999999999999997 8999999999999999999999999999875432
Q ss_pred CCCCccccccccCCccCccccCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
... ......++..|+|||++.+
T Consensus 156 ~~~-~~~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 156 PSK-TYSNEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCc-cccccccccccCCcHHhhc
Confidence 211 1122346889999998865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=212.12 Aligned_cols=175 Identities=33% Similarity=0.512 Sum_probs=145.2
Q ss_pred ceeeccCcEEEEEEEEcC----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecC
Q 008026 401 NILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
+.||+|+||.||+|.... +..|++|.+....... ..+.+.+|++.++.++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999997653 7889999987643322 46788999999999999999999999999999999999999
Q ss_pred CCChhHHHHHHhhh----CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 477 QGTLSRHIFNWAEE----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 477 ~g~L~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
+++|.+++...... ....+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999988542110 02568999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCC-CccccccccCCccCccccCCCCC
Q 008026 553 EGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .......+++.|+|||.+.+..+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIF 184 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCc
Confidence 4321 11223457889999999876543
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=214.06 Aligned_cols=174 Identities=28% Similarity=0.424 Sum_probs=149.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||.|++|.||+|... +++.||+|.+.... .......+.+|+++++.++|+||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36888899999999999999765 68999999987542 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++|+|||+++....
T Consensus 80 ~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999988743 268899999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......|++.|+|||++.+..+
T Consensus 151 ~~~-~~~~~~~~~~y~~PE~~~~~~~ 175 (274)
T cd06609 151 TMS-KRNTFVGTPFWMAPEVIKQSGY 175 (274)
T ss_pred ccc-ccccccCCccccChhhhccCCC
Confidence 321 2233568999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-26 Score=260.91 Aligned_cols=254 Identities=26% Similarity=0.289 Sum_probs=163.4
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++.|.+|..+ .++..|+.+++++|.+.+..|..+.++++|++|+|++|.+++.+| .+..+++|+.|+|++|++.+.
T Consensus 294 n~l~~~~p~~~--~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~ 371 (968)
T PLN00113 294 NSLSGEIPELV--IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371 (968)
T ss_pred CeeccCCChhH--cCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEee
Confidence 56667777766 446666666666666666666666667777777777777666655 355666666666666666655
Q ss_pred CCccccCCCCCcEEEccCC------------------------cccccCCC-CCcccccccccccCCCCCCCCCCCchhH
Q 008026 81 VPDSLVKLESLKIVNMTNN------------------------LLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRL 135 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N------------------------~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l 135 (580)
+|..+..+++|+.|++++| ++++.+|. +..+.+|+.|++++|.+....+..+..+
T Consensus 372 ~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 451 (968)
T PLN00113 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451 (968)
T ss_pred CChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccC
Confidence 5555555555555555544 44444332 4444555555555555554443322222
Q ss_pred HHHHHHHHhhC----C------ccccccccCCCCCCC-CccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEecc
Q 008026 136 NALLSVVKLMG----Y------PQRFAENWKGNDPCS-DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 204 (580)
Q Consensus 136 ~~l~~~~~~~~----~------~~~~~~~~~~~~~~~-~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls 204 (580)
..|..+..... . ...+....+.++... ..+..+..+++|+.|+|++|++.+.+|..++++++|+.|+|+
T Consensus 452 ~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (968)
T PLN00113 452 PSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531 (968)
T ss_pred CCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECC
Confidence 22221111000 0 012222333334333 355566677889999999999999999999999999999999
Q ss_pred CCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC----ceeecCCCCCCCCCC
Q 008026 205 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN----AIVNTDGNPDIGKEK 257 (580)
Q Consensus 205 ~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~----~~~~~~~n~~~c~~~ 257 (580)
+|+++|.+|..+..+++|+.|||++|+++|.+|..+.. ..+++.+|+..+..+
T Consensus 532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 99999999999999999999999999999999977543 458888888776544
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=211.96 Aligned_cols=170 Identities=33% Similarity=0.513 Sum_probs=141.4
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEE-cCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL-DGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||++... +..||+|.+... ...+.+.+|+.++++++|++++++++++. .....++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46888999999999999999765 788999988642 23457889999999999999999999765 4467899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. .....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999998854 222357889999999999999999997 8999999999999999999999999999876533
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. ....++..|+|||++.+..+
T Consensus 155 ~~----~~~~~~~~y~aPE~~~~~~~ 176 (256)
T cd05082 155 TQ----DTGKLPVKWTAPEALREKKF 176 (256)
T ss_pred cC----CCCccceeecCHHHHccCCC
Confidence 22 12234678999999877654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=211.42 Aligned_cols=173 Identities=30% Similarity=0.463 Sum_probs=149.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|... +++.|++|.+.... ..+++.+|++++++++|+||+++++++......|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57899999999999999999876 47899999986532 25789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 79 ~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 79 YCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999998743 23468899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......|+..|+|||++.+..+
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~ 176 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGY 176 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCC
Confidence 321 2233458899999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=215.74 Aligned_cols=180 Identities=31% Similarity=0.500 Sum_probs=146.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
++|...+.||+|+||.||++... ++..+|+|.+... .......+.+|+++++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 46788899999999999999642 3567899987642 344567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhh----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC
Q 008026 469 LLVFEYMPQGTLSRHIFNWAE----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 538 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 538 (580)
+++|||+++++|.+++..... .....+++.+++.++.|++.|++|||+ .+++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence 999999999999999864321 011357889999999999999999997 8999999999999999999
Q ss_pred cEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 539 RAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.+||+|||+++........ ......+++.|+|||++.+..+
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 201 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc
Confidence 9999999998755332211 1122345788999999887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=218.40 Aligned_cols=170 Identities=30% Similarity=0.409 Sum_probs=134.1
Q ss_pred cceeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--CCeeEEEEEe
Q 008026 400 ENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLVFEY 474 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 474 (580)
...||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 367999999999999765 35789999886532 22457889999999999999999998854 4567999999
Q ss_pred cCCCChhHHHHHHhh----hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe----cCCCcEEEEeec
Q 008026 475 MPQGTLSRHIFNWAE----EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 546 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg 546 (580)
+++ +|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 864 77777643211 122357888999999999999999998 899999999999999 456789999999
Q ss_pred cccccCCCCCC--ccccccccCCccCccccCCC
Q 008026 547 LVRLAPEGKGS--IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 547 ~a~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~ 577 (580)
+++........ ......||+.|+|||++.+.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCC
Confidence 99876443221 12335789999999998764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=214.97 Aligned_cols=182 Identities=21% Similarity=0.369 Sum_probs=147.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEcC-----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-CCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 467 (580)
.++|++.+.||+|+||.||+|.... +..|++|++... ........+.+|+.++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3578899999999999999997764 688999988643 344456778999999999999999999998776 467
Q ss_pred eEEEEEecCCCChhHHHHHHhhh---CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEE---GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
.++++||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999988553211 11468899999999999999999997 8999999999999999999999999
Q ss_pred eccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 545 FGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 545 fg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||+++........ ......++..|+|||++.+..+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 196 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY 196 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC
Confidence 9999865433211 1122345778999999876654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=213.20 Aligned_cols=175 Identities=25% Similarity=0.453 Sum_probs=144.5
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC--------hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS--------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 466 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 466 (580)
+|.+.+.||+|+||.||+|... +++.||+|.++..... ....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999654 6899999988642111 112346788999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999988442 468889999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCC-ccccccccCCccCccccCCCC
Q 008026 547 LVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 547 ~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+++........ ......|+..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhcccc
Confidence 98765432211 122346889999999987543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=218.81 Aligned_cols=178 Identities=28% Similarity=0.393 Sum_probs=144.2
Q ss_pred CCcccceeeccCcEEEEEEEEc---CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeE
Q 008026 396 NFSEENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKL 469 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 469 (580)
+|++.+.||+|+||.||+|... ++..||+|.+..... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999764 478999999876431 122345678899999999999999999999988 7899
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC----CCcEEEEee
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD----DMRAKVADF 545 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 545 (580)
+||||+++ ++.+.+..........+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 77776654333333468899999999999999999998 89999999999999998 899999999
Q ss_pred ccccccCCCCC--CccccccccCCccCccccCCC
Q 008026 546 GLVRLAPEGKG--SIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 546 g~a~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~ 577 (580)
|+++....... .......+++.|+|||++.+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCC
Confidence 99886543322 112235689999999987664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=212.53 Aligned_cols=171 Identities=32% Similarity=0.523 Sum_probs=141.5
Q ss_pred ceeeccCcEEEEEEEEcC--C--cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecC
Q 008026 401 NILGRGGFGTVYKGELHD--G--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|++.+++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999997643 2 36999999775433 456789999999999999999999999988 88999999999
Q ss_pred CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC
Q 008026 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556 (580)
Q Consensus 477 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 556 (580)
+++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999998854221 468899999999999999999997 8999999999999999999999999999987644322
Q ss_pred Cc--cccccccCCccCccccCCCCC
Q 008026 557 SI--ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 557 ~~--~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. .....++..|+|||++.+..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~ 177 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTF 177 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCc
Confidence 11 112356788999999876554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=218.15 Aligned_cols=172 Identities=27% Similarity=0.439 Sum_probs=143.9
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
.|.....||+|+||.||++... ++..||+|++... .....+.+.+|+..++.++|+||+++++.+...+..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3444567999999999999764 6889999988653 233456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ..+++.++..++.||+.||+|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 101 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 101 LEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999887632 357889999999999999999998 79999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. ......|++.|+|||++.+..+
T Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~ 195 (292)
T cd06658 172 VP-KRKSLVGTPYWMAPEVISRLPY 195 (292)
T ss_pred cc-cCceeecCccccCHHHHccCCC
Confidence 22 2233568999999999876554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=212.44 Aligned_cols=161 Identities=24% Similarity=0.418 Sum_probs=133.4
Q ss_pred ceeeccCcEEEEEEEEcCCc-----------EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 401 NILGRGGFGTVYKGELHDGT-----------KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
+.||+|+||.||+|...... .|++|.+.... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999775322 47777765432 125788899999999999999999999988 7789
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC-------cEEE
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-------RAKV 542 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl 542 (580)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++ .+||
T Consensus 77 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence 999999999999988542 2267889999999999999999997 8999999999999999877 7999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccCCC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+|||++...... ....++..|+|||++.+.
T Consensus 150 ~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 150 SDPGIPITVLSR-----EERVERIPWIAPECIRNG 179 (259)
T ss_pred CCCCcccccccc-----cccccCCCccChhhhcCC
Confidence 999999865431 223567889999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=211.37 Aligned_cols=177 Identities=28% Similarity=0.471 Sum_probs=149.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||.|+||.||+|... ++..+|+|++....... ..+.+.+|++.++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47899999999999999999754 68899999987543333 56788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999998854211 2468899999999999999999997 8999999999999999999999999999876654
Q ss_pred CCCC---ccccccccCCccCccccCCC
Q 008026 554 GKGS---IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~---~~~~~~Gt~~y~APE~~~~~ 577 (580)
.... ......|+..|+|||++...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred CccccccccccccCChhhcChHHHccc
Confidence 3322 12335689999999998765
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=203.68 Aligned_cols=171 Identities=26% Similarity=0.393 Sum_probs=142.1
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.+....||.|.+|.|++++.+ +|..+|||.+.+. .+.+..+++...+.++.+.. .|+||+.+|||..+..+++.||
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3445677999999999999876 5899999999874 34556778888898888775 9999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
.|.. .+..++++ -.+++++..+-++...+++||.||.+ +++|+|||+||+|||+|+.|.+|+||||++..+.+
T Consensus 172 lMs~-C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 172 LMST-CAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHH-HHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9843 44444432 23468888888999999999999998 68999999999999999999999999999987766
Q ss_pred CCCCccccccccCCccCccccCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
... .+...|-+.|||||.+.-
T Consensus 245 SkA--htrsAGC~~YMaPERidp 265 (391)
T KOG0983|consen 245 SKA--HTRSAGCAAYMAPERIDP 265 (391)
T ss_pred ccc--cccccCCccccCccccCC
Confidence 543 344579999999999863
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=212.17 Aligned_cols=162 Identities=23% Similarity=0.395 Sum_probs=132.5
Q ss_pred ceeeccCcEEEEEEEEcC-------------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 401 NILGRGGFGTVYKGELHD-------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
+.||+|+||.||+|...+ ...|++|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999997532 235888887653 22344578889999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc-------E
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-------A 540 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~ 540 (580)
.++||||+++++|..++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence 9999999999999877643 22458899999999999999999997 89999999999999986654 8
Q ss_pred EEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+++|||++...... ....|+..|+|||++.+
T Consensus 152 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~ 182 (262)
T cd05077 152 KLSDPGIPITVLSR-----QECVERIPWIAPECVED 182 (262)
T ss_pred EeCCCCCCccccCc-----ccccccccccChhhhcC
Confidence 99999998755322 22357889999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=215.66 Aligned_cols=174 Identities=28% Similarity=0.412 Sum_probs=144.9
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|+..+.||+|++|.||+|... ++..||+|++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999765 689999999875443333446788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+. ++|.+++.. .....+++.++..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 588877743 223468899999999999999999997 89999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.. ......+++.|+|||++.+.
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~ 175 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGC 175 (284)
T ss_pred cc-ccccccccccccCCeEEecC
Confidence 21 12233578899999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=217.84 Aligned_cols=171 Identities=26% Similarity=0.392 Sum_probs=143.7
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
|+....||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 334557999999999999764 68999999986532 233466889999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
++++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 101 QGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999887632 357899999999999999999997 899999999999999999999999999987654332
Q ss_pred CCccccccccCCccCccccCCCCC
Q 008026 556 GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. ......|++.|+|||++.+.++
T Consensus 172 ~-~~~~~~~~~~y~aPE~~~~~~~ 194 (297)
T cd06659 172 P-KRKSLVGTPYWMAPEVISRTPY 194 (297)
T ss_pred c-cccceecCccccCHHHHccCCC
Confidence 1 1233568999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=213.14 Aligned_cols=174 Identities=25% Similarity=0.451 Sum_probs=147.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
..|+..+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45778899999999999999765 68899999987532 23445778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ..+++.++..++.|++.||+|+|+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999988732 357888899999999999999997 8999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......|+..|+|||++.+..+
T Consensus 154 ~~~-~~~~~~~~~~y~apE~~~~~~~ 178 (277)
T cd06640 154 TQI-KRNTFVGTPFWMAPEVIQQSAY 178 (277)
T ss_pred Ccc-ccccccCcccccCHhHhccCCC
Confidence 321 2233468899999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=219.36 Aligned_cols=176 Identities=24% Similarity=0.292 Sum_probs=149.7
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 473 (580)
..|++.++||+||.++||++...+.+.||+|++.....+.....-+.+|+..|.+++ |.+|+++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 468999999999999999998888889999988776677778889999999999997 9999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|- ..||...+... ....+.-.++.+..||+.|+.++|+ .+|||.||||.|+|+-+ |.+||+|||+|..+..
T Consensus 441 ~G-d~DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 441 CG-DIDLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred cc-cccHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 75 56999888542 2223322677889999999999998 89999999999999964 6999999999998876
Q ss_pred CCCCcc-ccccccCCccCccccCCCCC
Q 008026 554 GKGSIE-TRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~-~~~~Gt~~y~APE~~~~~~~ 579 (580)
+..... ...+||+.|||||.+....+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s 538 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSS 538 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccc
Confidence 654433 34789999999999876654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=221.63 Aligned_cols=174 Identities=28% Similarity=0.391 Sum_probs=144.6
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC------
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 465 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 465 (580)
..++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999764 789999999875443444556778899999999999999999988644
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccC
Confidence 34699999996 478776632 27888899999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+++...... ......|++.|+|||++.+.++
T Consensus 163 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 194 (353)
T cd07850 163 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGY 194 (353)
T ss_pred ccceeCCCCC--CCCCCcccccccCHHHHhCCCC
Confidence 9998654332 1233468999999999987665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=211.11 Aligned_cols=174 Identities=26% Similarity=0.432 Sum_probs=142.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++.+.....||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344555678999999999999754 6788999988653 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCc--cHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-CCcEEEEeecccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPL--EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVR 549 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~--~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 549 (580)
||+++++|.+++... ...+ ++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.++|+|||.+.
T Consensus 85 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 85 EQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred ecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999988542 1233 778888999999999999997 89999999999999976 6789999999987
Q ss_pred ccCCCCCCccccccccCCccCccccCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
....... ......|++.|+|||++.+.
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~ 184 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKG 184 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccc
Confidence 6543221 22234589999999998654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=214.61 Aligned_cols=181 Identities=25% Similarity=0.342 Sum_probs=147.5
Q ss_pred HHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcC
Q 008026 388 QVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 465 (580)
Q Consensus 388 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 465 (580)
+.+....++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 444456788999999999999999999764 68899999886532 2345677899999999 799999999998753
Q ss_pred -----CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcE
Q 008026 466 -----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540 (580)
Q Consensus 466 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 540 (580)
+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 357999999999999998854322 23468899999999999999999997 899999999999999999999
Q ss_pred EEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
||+|||.++....... ......|+..|+|||++..
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 202 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIAC 202 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcC
Confidence 9999999876543221 1223468899999999754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=209.28 Aligned_cols=171 Identities=30% Similarity=0.495 Sum_probs=141.4
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCCh
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 480 (580)
+.||+|+||.||+|...+++.||+|.+...... .....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999998776999999988764332 3456789999999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCcc-
Q 008026 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE- 559 (580)
Q Consensus 481 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~- 559 (580)
.+++.. ....+++..++.++.+++.||+|||+ .+++||||||+||+++.++.+||+|||.++..........
T Consensus 80 ~~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRK----KKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 988743 22357888999999999999999997 8999999999999999999999999999876542221111
Q ss_pred ccccccCCccCccccCCCCC
Q 008026 560 TRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 560 ~~~~Gt~~y~APE~~~~~~~ 579 (580)
....++..|+|||++.++.+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~ 172 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRY 172 (251)
T ss_pred ccCcceeccCChHhhccCCC
Confidence 11234567999999877654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=211.82 Aligned_cols=173 Identities=26% Similarity=0.457 Sum_probs=146.0
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
-|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4677889999999999999764 68899999886532 233456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 84 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999888732 357899999999999999999997 89999999999999999999999999998765432
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. .......|+..|+|||++.+..+
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~ 178 (277)
T cd06641 155 Q-IKRNTFVGTPFWMAPEVIKQSAY 178 (277)
T ss_pred h-hhhccccCCccccChhhhccCCC
Confidence 2 12233468899999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=207.49 Aligned_cols=176 Identities=27% Similarity=0.331 Sum_probs=144.4
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.+....||.|+||+|++-.++ .|+..|||++.... ..++.++++.|.+...+- +.||||++||....++..|+.||
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3445678999999999998665 79999999998754 356778899999876665 59999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
.|+ .++..+.+.........+++.-.-.|+...+.||.||-. ...|||||+||+|||++..|.+||||||++..+..
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 994 577666554444444678888888888899999999987 47899999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.. ..+.-+|-..|||||.+...
T Consensus 221 Si--AkT~daGCrpYmAPERi~p~ 242 (361)
T KOG1006|consen 221 SI--AKTVDAGCRPYMAPERIDPS 242 (361)
T ss_pred HH--HhhhccCCccccChhccCCc
Confidence 33 23335788999999998743
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=209.39 Aligned_cols=175 Identities=33% Similarity=0.549 Sum_probs=144.2
Q ss_pred CcccceeeccCcEEEEEEEEcC-----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 397 FSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+++.+.||.|+||.||++.... +..||+|++.... .....+.+..|++++..++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999997653 3889999986532 222567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++..
T Consensus 80 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999998854221 128899999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
............+++.|+|||.+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 180 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGK 180 (258)
T ss_pred ccccccccccCCCcccccChHHhccCC
Confidence 544222211223678999999886544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=212.44 Aligned_cols=169 Identities=33% Similarity=0.461 Sum_probs=141.1
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCCh
Q 008026 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 480 (580)
||+|+||+||+|... +++.||+|.+...... ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999654 6899999998764322 22345667899999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccc
Q 008026 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 560 (580)
Q Consensus 481 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 560 (580)
.+++... ....+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||.+....... ...
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 9888542 22468899999999999999999997 899999999999999999999999999987654322 122
Q ss_pred cccccCCccCccccCCCCC
Q 008026 561 RIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 561 ~~~Gt~~y~APE~~~~~~~ 579 (580)
...|+..|+|||++.+..+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~ 171 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVY 171 (277)
T ss_pred cccCCCCcCCHHHhcCCCC
Confidence 3467889999999877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-24 Score=207.41 Aligned_cols=174 Identities=30% Similarity=0.522 Sum_probs=150.2
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|++|.||++... +++.|++|.+............+.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999765 678999999987654445667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999887432 468899999999999999999997 89999999999999999999999999999876544
Q ss_pred CCCccccccccCCccCccccCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
... .....|+..|+|||...+..
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~ 175 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSG 175 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCC
Confidence 321 23356899999999987654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=210.32 Aligned_cols=177 Identities=24% Similarity=0.427 Sum_probs=148.0
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|+||.||+|... ++..||+|.+..........+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999765 688999999876544444556788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc-EEEEeeccccccCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPE 553 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~ 553 (580)
+++++|.+++.+ .....+++..+..++.|++.||+|||+ .+++|+||||+||++++++. +||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999998854 222357899999999999999999998 89999999999999998754 69999999876644
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......|++.|+|||++.+..+
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~ 179 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPY 179 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCC
Confidence 322 2223468999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=215.56 Aligned_cols=177 Identities=30% Similarity=0.408 Sum_probs=144.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 466 (580)
..++|++.+.||+|+||.||+|... +++.||+|+++...........+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999775 6889999999764433334457788999999999999999999987654
Q ss_pred -----eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEE
Q 008026 467 -----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541 (580)
Q Consensus 467 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 541 (580)
..++|+||+++ ++...+.. ....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 78999999976 66665532 23468899999999999999999998 8999999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCccCccccCCC
Q 008026 542 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 542 l~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
|+|||.+...............++..|+|||++.+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 192 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE 192 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCC
Confidence 999999986654332222233568889999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=211.13 Aligned_cols=173 Identities=35% Similarity=0.510 Sum_probs=137.1
Q ss_pred ceeeccCcEEEEEEEEc-CCc--EEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEEecC
Q 008026 401 NILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
+.||+|+||.||+|... ++. .+++|.+... ......+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999775 343 4688877642 2334456788999999999 79999999999999999999999999
Q ss_pred CCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 477 QGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 477 ~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
+++|.+++..... .....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 9999999865321 112357889999999999999999997 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+++...... .......+..|+|||++.+..+
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~ 188 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVY 188 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCC
Confidence 9986332111 1111223567999999876654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=215.74 Aligned_cols=175 Identities=31% Similarity=0.406 Sum_probs=143.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 470 (580)
.++|++.+.||+|+||.||+|... +++.||+|++............+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999765 689999999875443333334567899999999999999999998765 46899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++ +|.+++.. ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++.
T Consensus 86 v~e~~~~-~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCEQ-DLASLLDN----MPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 9999964 78777743 12468899999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCccCccccCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
...... ......+++.|+|||++.+.
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~ 183 (309)
T cd07845 158 YGLPAK-PMTPKVVTLWYRAPELLLGC 183 (309)
T ss_pred cCCccC-CCCcccccccccChhhhcCC
Confidence 654322 22233468889999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=213.50 Aligned_cols=175 Identities=27% Similarity=0.361 Sum_probs=142.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|++|.||+|... +++.||+|++............+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999765 68899999986543333445678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-CCcEEEEeeccccccC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAP 552 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 552 (580)
|++ ++|.+++.. .....+++..+..++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 577776633 222345788888999999999999997 89999999999999985 5679999999997654
Q ss_pred CCCCCccccccccCCccCccccCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.... ......|++.|+|||++.+.
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~ 178 (294)
T PLN00009 155 IPVR-TFTHEVVTLWYRAPEILLGS 178 (294)
T ss_pred CCcc-ccccCceeecccCHHHHhCC
Confidence 3221 12234678999999988653
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-24 Score=207.44 Aligned_cols=179 Identities=26% Similarity=0.448 Sum_probs=152.9
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||.|+||.||++... ++..||+|++............+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999765 689999999987555555677889999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++..... ....+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999998865322 23578999999999999999999998 79999999999999999999999999999766443
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. .......|++.|+|||...+..+
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~ 180 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPY 180 (258)
T ss_pred c-ceecceeeeecccChhHhccCCC
Confidence 2 12233568999999999876653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=212.21 Aligned_cols=171 Identities=25% Similarity=0.484 Sum_probs=145.7
Q ss_pred CCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC---CCcccceeeEEEcCCeeEEE
Q 008026 396 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 471 (580)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ......++.+|+.++++++ |||++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477889999999999999976 478999999986532 3344567889999999997 99999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999888732 268899999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
..... ......|+..|+|||++.++
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~ 176 (277)
T cd06917 152 NQNSS-KRSTFVGTPYWMAPEVITEG 176 (277)
T ss_pred CCCcc-ccccccCCcceeCHHHhccC
Confidence 54432 22335689999999988653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-24 Score=210.96 Aligned_cols=177 Identities=27% Similarity=0.335 Sum_probs=147.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 471 (580)
++|+..+.||.|++|.||+|... +++.+|+|.+.... ......++.+|++++++++||||+++++++... +..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 36888999999999999999775 68899999987532 234457789999999999999999999988654 468999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++..... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999988754332 33467888999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....++..|+|||.+.+..+
T Consensus 156 ~~~~---~~~~~~~~~y~~pE~~~~~~~ 180 (287)
T cd06621 156 VNSL---AGTFTGTSFYMAPERIQGKPY 180 (287)
T ss_pred cccc---cccccCCccccCHHHhcCCCC
Confidence 4322 123457889999999877654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=212.39 Aligned_cols=161 Identities=23% Similarity=0.378 Sum_probs=130.4
Q ss_pred eeeccCcEEEEEEEEcC-------------------------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCccc
Q 008026 402 ILGRGGFGTVYKGELHD-------------------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456 (580)
Q Consensus 402 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 456 (580)
.||+|+||.||+|.... ...||+|++.... .....++.+|+++++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999986421 1358888876432 22345788899999999999999
Q ss_pred ceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC
Q 008026 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 536 (580)
Q Consensus 457 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 536 (580)
++++++......++||||+++++|..++.. ....+++..++.++.||+.||+|||+ ++|+||||||+||++++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence 999999999999999999999999887743 23467889999999999999999997 89999999999999975
Q ss_pred CC-------cEEEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 537 DM-------RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 537 ~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.+ .+|++|||.+...... ....++..|+|||++.+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPG 194 (274)
T ss_pred cCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcC
Confidence 43 3899999987644322 11357888999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=212.29 Aligned_cols=175 Identities=27% Similarity=0.389 Sum_probs=148.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|+..+.||+|+||.||+|... +++.||+|.+.... ......++.+|++++++++||||+++++++...+..++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36788899999999999999776 68999999987643 23455778899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++... ...+++..+..++.|++.||+|+|+ ..+++||||||+||++++++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 80 YMDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred ecCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999888542 1568889999999999999999996 37899999999999999999999999999876543
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ....|+..|+|||++.+..+
T Consensus 154 ~~~---~~~~~~~~y~~PE~~~~~~~ 176 (265)
T cd06605 154 SLA---KTFVGTSSYMAPERIQGNDY 176 (265)
T ss_pred HHh---hcccCChhccCHHHHcCCCC
Confidence 221 11568899999999876643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=212.04 Aligned_cols=174 Identities=28% Similarity=0.414 Sum_probs=144.3
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|++|.||+|+.. ++..||+|++..... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 5888999999999999999875 689999999876432 23345677899999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++ +|.+++.... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++.....
T Consensus 80 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MDK-DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CCc-cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 975 8888774321 12468999999999999999999998 89999999999999999999999999999765432
Q ss_pred CCCccccccccCCccCccccCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.. ......+++.|+|||++.+.
T Consensus 154 ~~-~~~~~~~~~~y~~PE~~~~~ 175 (284)
T cd07836 154 VN-TFSNEVVTLWYRAPDVLLGS 175 (284)
T ss_pred cc-ccccccccccccChHHhcCC
Confidence 21 12234578999999988653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=211.37 Aligned_cols=176 Identities=29% Similarity=0.423 Sum_probs=146.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCC----
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN---- 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~---- 466 (580)
..++|++.+.||+|++|.||+|... +++.|++|++.... ...+++.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4578999999999999999999775 67899999887532 2346789999999999 6999999999997644
Q ss_pred --eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 467 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 467 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence 48999999999999988755332 23568899999999999999999997 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
||.+........ ......|++.|+|||++..
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 187 (275)
T cd06608 157 FGVSAQLDSTLG-RRNTFIGTPYWMAPEVIAC 187 (275)
T ss_pred Cccceecccchh-hhcCccccccccCHhHhcc
Confidence 999876543221 2233568999999998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=208.43 Aligned_cols=169 Identities=31% Similarity=0.500 Sum_probs=137.3
Q ss_pred ceeeccCcEEEEEEEEc-C---CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecC
Q 008026 401 NILGRGGFGTVYKGELH-D---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
+.||+|+||.||+|.+. . +..||+|.+...... ...+++.+|+.++++++|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46999999999999653 2 268999998764432 45567899999999999999999999876 456899999999
Q ss_pred CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC
Q 008026 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556 (580)
Q Consensus 477 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 556 (580)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 79 ~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999998853 1267899999999999999999997 7899999999999999999999999999986644332
Q ss_pred Ccccc--ccccCCccCccccCCCCC
Q 008026 557 SIETR--IAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 557 ~~~~~--~~Gt~~y~APE~~~~~~~ 579 (580)
..... ..++..|+|||.+.+..+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKF 175 (257)
T ss_pred ccccccCccccccccCHHHhcCCCC
Confidence 21111 223567999999876654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=209.06 Aligned_cols=167 Identities=29% Similarity=0.364 Sum_probs=142.7
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCCh
Q 008026 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 480 (580)
||.|++|.||+|... +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999775 5899999999764332 33456789999999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccc
Q 008026 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 560 (580)
Q Consensus 481 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 560 (580)
.+++.+ ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.++...... ...
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 998843 2357889999999999999999998 899999999999999999999999999998765432 122
Q ss_pred cccccCCccCccccCCCCC
Q 008026 561 RIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 561 ~~~Gt~~y~APE~~~~~~~ 579 (580)
...|++.|+|||++.+.++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~ 169 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGY 169 (262)
T ss_pred cccCCcCccChhHhcCCCC
Confidence 3468999999999877654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=211.53 Aligned_cols=178 Identities=29% Similarity=0.464 Sum_probs=145.2
Q ss_pred HHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEc-
Q 008026 388 QVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD- 464 (580)
Q Consensus 388 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~- 464 (580)
.++....+.|++.+.||+|+||.||+|... +++.||+|++... .....++..|+.+++++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 344445578999999999999999999764 6889999988653 23446788899999998 69999999999853
Q ss_pred -----CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 465 -----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 465 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
....+++|||+++++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCC
Confidence 45789999999999999888542 22357788899999999999999998 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCCccccccccCCccCccccC
Q 008026 540 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
++|+|||++........ ......|++.|+|||++.
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcC
Confidence 99999999876543221 123356899999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=210.85 Aligned_cols=164 Identities=28% Similarity=0.391 Sum_probs=132.2
Q ss_pred eeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhh-HHHHHHHHHHHH---hcCCCcccceeeEEEcCCeeEEEEEecC
Q 008026 402 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKG-LTEFKSEIAVLT---KVRHRHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 402 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
.||+|+||.||++... +++.||+|.+.+....... ...+.+|..+++ ..+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 6899999998765433222 223344444333 3479999999999999999999999999
Q ss_pred CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC
Q 008026 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556 (580)
Q Consensus 477 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 556 (580)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999888743 2468999999999999999999998 899999999999999999999999999987553322
Q ss_pred CccccccccCCccCccccCC
Q 008026 557 SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 557 ~~~~~~~Gt~~y~APE~~~~ 576 (580)
.....||+.|+|||.+.+
T Consensus 152 --~~~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQK 169 (279)
T ss_pred --ccCcCCCcCccCHHHhcC
Confidence 123468999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=208.47 Aligned_cols=177 Identities=32% Similarity=0.469 Sum_probs=151.3
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|++.+.||+|+||.||++... +++.+|+|.+...........++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999654 688999999976554455567788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.+... ....+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999998865332 23568899999999999999999997 89999999999999999999999999999876544
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. .....|++.|+|||++.+..+
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~~~ 178 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGRPY 178 (256)
T ss_pred C---cccccCCccccCHHHHCCCCC
Confidence 2 222458899999999877654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=212.99 Aligned_cols=173 Identities=27% Similarity=0.450 Sum_probs=146.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||++... ++..||+|.+... .....+.+.+|+.++++++||||+++++++...+..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 57889999999999999999654 6889999998643 22334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.+ ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999988743 347788899999999999999997 8999999999999999999999999998876543
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......|++.|+|||++.+..+
T Consensus 168 ~~~-~~~~~~~~~~y~~PE~~~~~~~ 192 (293)
T cd06647 168 EQS-KRSTMVGTPYWMAPEVVTRKAY 192 (293)
T ss_pred ccc-ccccccCChhhcCchhhccCCC
Confidence 322 2223468899999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=217.62 Aligned_cols=173 Identities=27% Similarity=0.426 Sum_probs=144.2
Q ss_pred HHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC--
Q 008026 390 LRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-- 466 (580)
Q Consensus 390 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 466 (580)
...+.++|++.+.||+|+||.||+|... ++..||+|++............+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3446788999999999999999999654 7899999998654333444567889999999999999999999987653
Q ss_pred ----eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 467 ----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 467 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
..++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEE
Confidence 358999999 6788877632 368899999999999999999997 89999999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+|||++...... .....+++.|+|||++.+
T Consensus 160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 160 LDFGLARQTDSE----MTGYVVTRWYRAPEVILN 189 (343)
T ss_pred eecccccccccC----ccccccCCcccCHHHHhC
Confidence 999998765332 123467899999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=208.73 Aligned_cols=171 Identities=30% Similarity=0.465 Sum_probs=135.4
Q ss_pred ceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-CCeeEEEEEec
Q 008026 401 NILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLLVFEYM 475 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 475 (580)
+.||+|+||.||+|... +...||+|.+... ......+.+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999753 2457999987542 233445678899999999999999999997764 55678999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
.+++|.+++.. .....++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999998843 22345677788999999999999997 899999999999999999999999999987553321
Q ss_pred C---CccccccccCCccCccccCCCCC
Q 008026 556 G---SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 556 ~---~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. .......++..|+|||++.+.++
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 179 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKF 179 (262)
T ss_pred ceeecccccCcCCccccChhHhccCcc
Confidence 1 01112346778999999887665
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=208.81 Aligned_cols=169 Identities=37% Similarity=0.565 Sum_probs=140.4
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++|||++++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4688999999999999999975 57889999886532 235788999999999999999999998654 57999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 80 MSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999988542 22357888999999999999999997 89999999999999999999999999998764332
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. .....+..|+|||++.+..+
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~~~ 174 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHKKF 174 (254)
T ss_pred C----CCCCCCceecCHHHhccCCc
Confidence 1 11234567999999876654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=210.37 Aligned_cols=177 Identities=28% Similarity=0.487 Sum_probs=145.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--CCe
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 467 (580)
++|++.+.||+|+||.||+|.+. ++..||+|.+...... .....+.+|+++++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46788899999999999999753 3688999998764322 346789999999999999999999999887 557
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 89999999999999988542 2258899999999999999999997 8999999999999999999999999999
Q ss_pred ccccCCCCCCc--cccccccCCccCccccCCCCC
Q 008026 548 VRLAPEGKGSI--ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 548 a~~~~~~~~~~--~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+.......... .....++..|+|||.+.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 189 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCC
Confidence 98765332211 111234567999999876553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=207.47 Aligned_cols=176 Identities=26% Similarity=0.414 Sum_probs=150.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|++|.||+|... +++.|++|++...... .....+.+|++.+.+++|+|++++++++...+..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888999999999999999776 5899999998764322 456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++... ..+++..+..++.|++.|++|||+ ..+++||||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999988432 468899999999999999999995 27899999999999999999999999999887654
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....|+..|+|||++.+..+
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~ 177 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGESY 177 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCCCC
Confidence 3322 223468899999999877643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=214.22 Aligned_cols=176 Identities=30% Similarity=0.471 Sum_probs=141.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCc----EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|+..+.||+|+||.||+|.+. ++. .||+|.+.... ......++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 46788899999999999999754 444 47888876532 233345788999999999999999999998754 467
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccc
Confidence 99999999999988743 22357888999999999999999997 899999999999999999999999999998
Q ss_pred ccCCCCCCc-cccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSI-ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......... .....++..|+|||++.+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKF 188 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCC
Confidence 654332211 112345778999999887654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=212.05 Aligned_cols=176 Identities=28% Similarity=0.364 Sum_probs=142.1
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 473 (580)
+|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+.++.++. |+||+++++++..++..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 5666788999999999999765 689999999875432 244567889999999996 9999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+. +++.++...........+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 985 466554432222233568999999999999999999996 35899999999999999999999999999976543
Q ss_pred CCCCccccccccCCccCccccCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
... .....|++.|+|||++.+.
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred CCc--cccccCccCccCHHHhccc
Confidence 321 1233689999999998765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=213.56 Aligned_cols=176 Identities=26% Similarity=0.350 Sum_probs=141.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC------
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 466 (580)
.++|++.+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999765 6899999998754333333445678999999999999999999887654
Q ss_pred --eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 467 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 467 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
..++||||+.+ +|.+.+.. ....+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECc
Confidence 34999999964 77776632 22358899999999999999999998 7999999999999999999999999
Q ss_pred eccccccCCCCCC---ccccccccCCccCccccCCC
Q 008026 545 FGLVRLAPEGKGS---IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 545 fg~a~~~~~~~~~---~~~~~~Gt~~y~APE~~~~~ 577 (580)
||++......... ......++..|+|||++.+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 198 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCC
Confidence 9999765432211 11234578899999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=217.93 Aligned_cols=174 Identities=32% Similarity=0.440 Sum_probs=143.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcC--Cee
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG--NEK 468 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~ 468 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999765 688999999865433334456677899999999 999999999988654 367
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999997 588877632 267888899999999999999998 89999999999999999999999999998
Q ss_pred cccCCCCC----CccccccccCCccCccccCC
Q 008026 549 RLAPEGKG----SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 549 ~~~~~~~~----~~~~~~~Gt~~y~APE~~~~ 576 (580)
+....... .....+.||+.|+|||++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 186 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLG 186 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeec
Confidence 76543321 12233568999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=210.18 Aligned_cols=173 Identities=28% Similarity=0.388 Sum_probs=143.8
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
|++.+.||+|++|.||+|... +|..||+|++............+.+|++++++++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667889999999999999764 7999999998765434444567889999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
+ ++|.+++... ....+++..++.++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.++......
T Consensus 81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 6888887432 11368899999999999999999997 799999999999999999999999999997654322
Q ss_pred CCccccccccCCccCccccCCC
Q 008026 556 GSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.. .....+++.|+|||++.+.
T Consensus 154 ~~-~~~~~~~~~~~aPE~~~~~ 174 (283)
T cd07835 154 RT-YTHEVVTLWYRAPEILLGS 174 (283)
T ss_pred cc-cCccccccCCCCCceeecC
Confidence 11 1223568899999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=207.74 Aligned_cols=179 Identities=26% Similarity=0.464 Sum_probs=146.3
Q ss_pred CCcccceeeccCcEEEEEEEEcC--CcEEEEEEeeccc--------cChhhHHHHHHHHHHHHh-cCCCcccceeeEEEc
Q 008026 396 NFSEENILGRGGFGTVYKGELHD--GTKIAVKRMEAGV--------ISGKGLTEFKSEIAVLTK-VRHRHLVALLGHCLD 464 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 464 (580)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998764 6889999885421 122344567788888875 689999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
.+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ ..+++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988754322 23468889999999999999999995 26799999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||.+....... ......|+..|+|||++.+..+
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~ 190 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPY 190 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCC
Confidence 99998654432 2234568999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=208.88 Aligned_cols=165 Identities=27% Similarity=0.373 Sum_probs=132.8
Q ss_pred eeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhh-HHHHHHHH---HHHHhcCCCcccceeeEEEcCCeeEEEEEecC
Q 008026 402 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKG-LTEFKSEI---AVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 402 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
.||+|+||.||+|... +++.||+|.+.+....... ...+..|. +.++...||+|+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 6889999998764332211 12233343 34445579999999999999999999999999
Q ss_pred CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC
Q 008026 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556 (580)
Q Consensus 477 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 556 (580)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 9999887732 2468999999999999999999998 899999999999999999999999999987653322
Q ss_pred CccccccccCCccCccccCCC
Q 008026 557 SIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 557 ~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.....|+..|+|||++.++
T Consensus 152 --~~~~~~~~~y~aPE~~~~~ 170 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKG 170 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCC
Confidence 2234689999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=209.18 Aligned_cols=180 Identities=29% Similarity=0.459 Sum_probs=143.1
Q ss_pred CcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC------
Q 008026 397 FSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 466 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 466 (580)
|++.+.||+|+||.||+|.+. +++.||+|++..+.......+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999653 3688999999776555556778899999999999999999999886532
Q ss_pred eeEEEEEecCCCChhHHHHHHh-hhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWA-EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
..++++||+.+++|.+++.... ......+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988874322 1222357888999999999999999997 89999999999999999999999999
Q ss_pred ccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 546 GLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 546 g~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|.++........ ......+++.|+|||.+.+..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY 192 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCcc
Confidence 998865432211 1112345678999999876543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-26 Score=221.15 Aligned_cols=176 Identities=27% Similarity=0.343 Sum_probs=152.6
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCc-EEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGT-KIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.+++.+..||-|+||.|=++..+... .+|+|++++..+ +.+..+.+..|-.+|..++.|.||++|..|.+...+||.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666788999999999998776433 489999876543 4555667888999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
|-|-||.+...+.+ .+.++...+..++..+++|++|||. ++||+|||||+|.+++.+|-+||.|||+|+.+.
T Consensus 500 EaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999998843 3578889999999999999999997 899999999999999999999999999999987
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.+. ..-+++|||.|.|||++.+.+++
T Consensus 572 ~g~--KTwTFcGTpEYVAPEIILnKGHD 597 (732)
T KOG0614|consen 572 SGR--KTWTFCGTPEYVAPEIILNKGHD 597 (732)
T ss_pred cCC--ceeeecCCcccccchhhhccCcc
Confidence 654 34458999999999999988753
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=215.40 Aligned_cols=176 Identities=27% Similarity=0.415 Sum_probs=144.7
Q ss_pred HHHHHHhhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC
Q 008026 387 IQVLRNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 465 (580)
Q Consensus 387 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 465 (580)
...+..+.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566778999999999999999999965 4789999999876433333456788899999999999999999988643
Q ss_pred ------CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 466 ------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 466 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 3467888877 7788776632 358899999999999999999998 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 540 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+||+|||+++..... .....|++.|+|||++.+
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLN 191 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhC
Confidence 999999998765322 223468999999998765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=217.10 Aligned_cols=171 Identities=27% Similarity=0.492 Sum_probs=141.2
Q ss_pred CCcccceeeccCcEEEEEEEEcC---C--cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 396 NFSEENILGRGGFGTVYKGELHD---G--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
.....++||+|-||.||+|.+.+ | -.||||.-+.+ ......+.|..|..+|+.++||||++++|+|.+ ...|+
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 44567889999999999996532 3 35888987764 344557899999999999999999999999975 46899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
|||.++-|.|+.|+.. +...++......++.||+.||+|||+ .++|||||..+|||+....-+||+|||+++.
T Consensus 468 vmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred EEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhh
Confidence 9999999999999854 34578888899999999999999998 8999999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCccCccccC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
+.+..-...+...=...|||||-+.
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESIN 565 (974)
T ss_pred ccccchhhccccccceeecCccccc
Confidence 8765432222222245799999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=216.64 Aligned_cols=173 Identities=28% Similarity=0.444 Sum_probs=140.5
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-----C
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 466 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++++++|+||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3468999999999999999999754 78999999986421 223456678899999999999999999887654 3
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..++|+||+++ ++.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred eEEEEehhccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccc
Confidence 57999999964 77766532 468899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCC--ccccccccCCccCccccCC
Q 008026 547 LVRLAPEGKGS--IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 547 ~a~~~~~~~~~--~~~~~~Gt~~y~APE~~~~ 576 (580)
+++........ ......||+.|+|||++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhC
Confidence 98765432211 1123568999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=211.15 Aligned_cols=176 Identities=30% Similarity=0.465 Sum_probs=148.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 471 (580)
++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999765 789999999876432 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 999999999988843 2368999999999999999999997 89999999999999999999999999998765
Q ss_pred CCCCC-------------------CccccccccCCccCccccCCCC
Q 008026 552 PEGKG-------------------SIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 552 ~~~~~-------------------~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
..... .......|+..|+|||...+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 198 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP 198 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC
Confidence 43221 1122346789999999887654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=209.85 Aligned_cols=172 Identities=28% Similarity=0.377 Sum_probs=143.4
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeEEEEE
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLVFE 473 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 473 (580)
|++.+.||+|+||.||+|... +++.||+|++............+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999776 588999999987542333456788999999999999999999999888 78999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++ +|.+++.. ....+++.+++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9975 88777643 22468899999999999999999998 7999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
..........++..|+|||.+.+
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLG 175 (287)
T ss_pred CCcccccccccccccCCceeeEc
Confidence 43222233457889999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=210.31 Aligned_cols=174 Identities=26% Similarity=0.364 Sum_probs=144.4
Q ss_pred CCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccC--hhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCee
Q 008026 396 NFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEK 468 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 468 (580)
+|++.+.||+|++|.||+++.. ++..||+|.+...... ....+.+.+|+.++.+++ ||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999998643 5688999998753221 223456889999999994 99999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999888743 2357888999999999999999997 89999999999999999999999999998
Q ss_pred cccCCCCCCccccccccCCccCccccCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+..............|+..|+|||.+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGG 181 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCC
Confidence 76544332222335689999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=209.75 Aligned_cols=163 Identities=22% Similarity=0.388 Sum_probs=133.5
Q ss_pred ceeeccCcEEEEEEEEc-C-------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 401 NILGRGGFGTVYKGELH-D-------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
+.||+|+||.||+|... . ...||+|.+... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 46999999999999653 2 234788877542 2234567888999999999999999999999989999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc--------EEEEe
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVAD 544 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~D 544 (580)
||+++|+|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999988843 22357889999999999999999997 89999999999999987665 69999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
||.+...... ....|++.|+|||++.+.
T Consensus 152 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~ 179 (258)
T cd05078 152 PGISITVLPK-----EILLERIPWVPPECIENP 179 (258)
T ss_pred cccccccCCc-----hhccccCCccCchhccCC
Confidence 9988654321 224678899999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=207.55 Aligned_cols=172 Identities=26% Similarity=0.431 Sum_probs=144.3
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
.|...+.||+|++|.||++... +++.|++|++... .....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 3555678999999999999754 6889999988643 223345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||+|+||+++.++.++|+|||.+......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 98 LEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999988743 357888999999999999999998 89999999999999999999999999988765433
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. ......|++.|+|||.+.+..+
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~ 192 (285)
T cd06648 169 VP-RRKSLVGTPYWMAPEVISRLPY 192 (285)
T ss_pred Cc-ccccccCCccccCHHHhcCCCC
Confidence 21 1223468999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=208.12 Aligned_cols=176 Identities=30% Similarity=0.446 Sum_probs=149.5
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
..+.|+..+.||+|++|.||+|... ++..|++|++..... ....+.+|++.++.++|+|++++++++......++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4466888899999999999999776 688999999875322 456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.++|+|||.+...
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 94 MEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999985421 368999999999999999999997 89999999999999999999999999988755
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..... ......|++.|+|||++.+..+
T Consensus 167 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~ 193 (286)
T cd06614 167 TKEKS-KRNSVVGTPYWMAPEVIKRKDY 193 (286)
T ss_pred ccchh-hhccccCCcccCCHhHhcCCCC
Confidence 43321 1223457889999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=216.48 Aligned_cols=174 Identities=25% Similarity=0.388 Sum_probs=142.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc----CCee
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEK 468 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 468 (580)
.++|++.+.||+|+||.||+|... ++..||+|++............+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999654 68999999987644333445677889999999999999999998763 3467
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999995 588777632 2458999999999999999999998 89999999999999999999999999998
Q ss_pred cccCCCCC---CccccccccCCccCccccCC
Q 008026 549 RLAPEGKG---SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 549 ~~~~~~~~---~~~~~~~Gt~~y~APE~~~~ 576 (580)
+....... .......|+..|+|||++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcC
Confidence 76543221 11123468999999998755
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=227.14 Aligned_cols=173 Identities=31% Similarity=0.471 Sum_probs=150.1
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
+..++|+..+.+|.|.||.||+|++. +++..|+|+++... ..+..-+++|+-+++.++||||+.+++.|...+..|+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 34578999999999999999999764 78999999998643 3355678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
.||||.+|+|.+.- ....++++.++..+.+....||+|||+ ++-+|||||-.||++++.|.+|++|||.+..
T Consensus 90 cMEycgggslQdiy-----~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIY-----HVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQ 161 (829)
T ss_pred EEEecCCCccccee-----eecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhh
Confidence 99999999998765 234678999999999999999999998 7889999999999999999999999999876
Q ss_pred cCCCCCCccccccccCCccCccccC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
+..... ....+.||++|||||+..
T Consensus 162 itati~-KrksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 162 ITATIA-KRKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhhhhh-hhhcccCCccccchhHHH
Confidence 654332 334588999999999864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=205.03 Aligned_cols=172 Identities=20% Similarity=0.258 Sum_probs=138.7
Q ss_pred HHHHHhhcCCccccee--eccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEE
Q 008026 388 QVLRNVTNNFSEENIL--GRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCL 463 (580)
Q Consensus 388 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 463 (580)
.+.....++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|+.....+ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 4444555677777776 99999999999764 68889999987532221 122222222 6999999999999
Q ss_pred cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC-cEEE
Q 008026 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKV 542 (580)
Q Consensus 464 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl 542 (580)
..+..++||||+++++|.+++.. ...+++.++..++.|+++||+|||+ .+++||||||+||+++.++ .++|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEE
Confidence 99999999999999999998843 1378999999999999999999998 8899999999999999888 9999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+|||.++..... ....|+..|+|||++.+.++
T Consensus 152 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 183 (267)
T PHA03390 152 CDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNY 183 (267)
T ss_pred ecCccceecCCC-----ccCCCCCcccChhhhcCCCC
Confidence 999998765432 22458999999999987765
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=215.42 Aligned_cols=173 Identities=28% Similarity=0.422 Sum_probs=143.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-----Ce
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----NE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 467 (580)
.++|.+.+.||+|+||.||+|... ++..||+|.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999764 689999999876433344456778899999999999999999987654 34
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999995 688777632 2468899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
++...... .......|+..|+|||++.+
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 155 ARTTSEKG-DFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred ccccCCCc-ccccccccccCccChHHHhc
Confidence 98664432 22233568999999998764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=209.15 Aligned_cols=168 Identities=26% Similarity=0.428 Sum_probs=141.7
Q ss_pred cceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 400 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
...||+|+||.||++... +++.||+|++... .......+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 467999999999999764 7899999988542 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCc
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 558 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 558 (580)
+|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........ .
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 99887632 357889999999999999999998 8999999999999999999999999999876543221 1
Q ss_pred cccccccCCccCccccCCCCC
Q 008026 559 ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 559 ~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.....|++.|+|||++.+..+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~ 193 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPY 193 (292)
T ss_pred ccccccCccccCHHHhcCCCC
Confidence 233568999999999876554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=209.30 Aligned_cols=168 Identities=30% Similarity=0.438 Sum_probs=141.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccc-cChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..|++.+.||+|+||.||+|... +++.||+|++.... ......+++.+|+++++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46888999999999999999765 68999999986432 22334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||++ |++.+++.. ....+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9996 577666532 22468899999999999999999998 899999999999999999999999999987653
Q ss_pred CCCCCccccccccCCccCccccC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.. ....|++.|+|||++.
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVIL 184 (307)
T ss_pred CC-----CCccCCccccCceeee
Confidence 32 2346889999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=202.01 Aligned_cols=172 Identities=30% Similarity=0.500 Sum_probs=148.4
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++.+++++|++++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4778899999999999999775 688999999876432 3557889999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 79 CSGGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 9999999887431 1468999999999999999999997 89999999999999999999999999998876544
Q ss_pred CCCccccccccCCccCccccCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.. .....|+..|+|||++.+..
T Consensus 152 ~~--~~~~~~~~~~~~PE~~~~~~ 173 (253)
T cd05122 152 KA--RNTMVGTPYWMAPEVINGKP 173 (253)
T ss_pred cc--ccceecCCcccCHHHHcCCC
Confidence 32 23356899999999987654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=208.21 Aligned_cols=175 Identities=33% Similarity=0.489 Sum_probs=140.2
Q ss_pred ceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 401 NILGRGGFGTVYKGELHD-------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.||+|+||.||+|+..+ +..||+|.+.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999997642 2579999886532 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhh--CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC-----cEEEEeec
Q 008026 474 YMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-----RAKVADFG 546 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg 546 (580)
|+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999998653322 22347889999999999999999997 7899999999999999877 89999999
Q ss_pred cccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 547 LVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 547 ~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+++....... .......++..|+|||++.++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 190 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF 190 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCc
Confidence 9876543221 11112345788999999887654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=206.68 Aligned_cols=168 Identities=28% Similarity=0.476 Sum_probs=141.2
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCCh
Q 008026 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 480 (580)
||+|+||.||+++.. +++.|++|.+..... .....+.+.+|++++++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 589999999875432 224456788999999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC----
Q 008026 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG---- 556 (580)
Q Consensus 481 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---- 556 (580)
.+++.. ...+++..+..++.||+.||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLEN-----VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 988843 1368899999999999999999997 8999999999999999999999999999875443311
Q ss_pred ---CccccccccCCccCccccCCCC
Q 008026 557 ---SIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 557 ---~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.......++..|+|||...+..
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~ 177 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQG 177 (265)
T ss_pred cccccccCcccCccccCHHHhcCCC
Confidence 1223346788999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=211.91 Aligned_cols=171 Identities=28% Similarity=0.451 Sum_probs=142.4
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-CCeeE
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKL 469 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 469 (580)
.+.++|++.+.||+|+||.||+|... +++.||+|++.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45788999999999999999999655 78999999886543333445678899999999999999999999876 45788
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.++|+|||.+.
T Consensus 87 lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 87 FVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 999998 5688777632 357788888999999999999998 899999999999999999999999999987
Q ss_pred ccCCCCCCccccccccCCccCccccCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
..... .....+++.|+|||++.+
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred ccCCC----cCCCcccccccCceeeec
Confidence 54322 123467889999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=213.85 Aligned_cols=173 Identities=29% Similarity=0.409 Sum_probs=145.3
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----eeE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 469 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 469 (580)
+|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|+++++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999765 5899999998764433445678899999999999999999999988775 789
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||++ ++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||.+.
T Consensus 81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 478777632 2378899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCC--CccccccccCCccCccccCCC
Q 008026 550 LAPEGKG--SIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 550 ~~~~~~~--~~~~~~~Gt~~y~APE~~~~~ 577 (580)
....... .......|++.|+|||++.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred eecccccccccccccccccCcCCceeeecc
Confidence 7654321 112334689999999998776
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=201.66 Aligned_cols=175 Identities=29% Similarity=0.437 Sum_probs=149.6
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLVF 472 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 472 (580)
+|++.+.||+|++|.||+|... ++..|++|++..........+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999776 789999999876544445677899999999999999999999999988 8899999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999988431 278899999999999999999998 899999999999999999999999999988765
Q ss_pred CCCCC-ccccccccCCccCccccCCCC
Q 008026 553 EGKGS-IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 553 ~~~~~-~~~~~~Gt~~y~APE~~~~~~ 578 (580)
..... ......++..|+|||.+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~ 179 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEE 179 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCC
Confidence 44321 122346889999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=211.18 Aligned_cols=171 Identities=19% Similarity=0.288 Sum_probs=138.1
Q ss_pred ceeecc--CcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRG--GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
..||+| +||+||+|+.. +++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999764 799999999876544445567889999999999999999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
+++.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99998885532 2357888999999999999999997 89999999999999999999999999865432221110
Q ss_pred c------cccccccCCccCccccCCC
Q 008026 558 I------ETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 558 ~------~~~~~Gt~~y~APE~~~~~ 577 (580)
. .....++..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred ccccccccccccCccCccChhhhcCC
Confidence 0 0112356679999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=217.80 Aligned_cols=181 Identities=21% Similarity=0.256 Sum_probs=133.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-----------------cCCcEEEEEEeeccccCh------------hhHHHHHHH
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-----------------HDGTKIAVKRMEAGVISG------------KGLTEFKSE 443 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~E 443 (580)
..++|++.++||+|+||.||+|.. ..++.||||++....... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999953 235679999986432110 011223457
Q ss_pred HHHHHhcCCCcc-----cceeeEEEc--------CCeeEEEEEecCCCChhHHHHHHhh-------------------hC
Q 008026 444 IAVLTKVRHRHL-----VALLGHCLD--------GNEKLLVFEYMPQGTLSRHIFNWAE-------------------EG 491 (580)
Q Consensus 444 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~ 491 (580)
+.++.+++|.++ ++++++|.. .+..|+||||+++++|.+++..... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 567777653 3567999999999999998864210 01
Q ss_pred CCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccccccccCCccCc
Q 008026 492 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571 (580)
Q Consensus 492 ~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~AP 571 (580)
...+++..+..++.|++.||+|+|+ .+|+||||||+||+++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1234677889999999999999997 7999999999999999999999999999976543322111222358999999
Q ss_pred cccCC
Q 008026 572 EYAGN 576 (580)
Q Consensus 572 E~~~~ 576 (580)
|.+..
T Consensus 380 E~l~~ 384 (507)
T PLN03224 380 EELVM 384 (507)
T ss_pred hhhcC
Confidence 99764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=209.02 Aligned_cols=176 Identities=27% Similarity=0.371 Sum_probs=141.9
Q ss_pred cCCcccceeeccCcEEEEEEE-EcCCcEEEEEEeecccc-Chh----hHHHHHHHHHHHHhcCCCcccceeeEEEc-CCe
Q 008026 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGK----GLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 467 (580)
++|-+..+||+|+|+.||+|. +...+.||||+-..... ... ..+...+|.++-+.++||.||++|++|.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 468888999999999999994 45678899997643321 111 12346689999999999999999999875 466
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEEe
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVAD 544 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D 544 (580)
+|-|+|||+|.+|.-|++. .+.+++..+..|+.||+.||.||.+. +.+|||-||||.|||+.+ -|.+||+|
T Consensus 543 FCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 8899999999999988854 35689999999999999999999975 589999999999999953 47899999
Q ss_pred eccccccCCCCC------CccccccccCCccCccccCC
Q 008026 545 FGLVRLAPEGKG------SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 545 fg~a~~~~~~~~------~~~~~~~Gt~~y~APE~~~~ 576 (580)
||+++.+..+.. .......||.+|.+||.+--
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvV 654 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVV 654 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeec
Confidence 999998765421 12234679999999998753
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=203.30 Aligned_cols=166 Identities=30% Similarity=0.436 Sum_probs=135.2
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHH-hcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLT-KVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|... +++.||+|++.+.... ......+..|..++. ..+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999764 6889999998754322 222334455555444 45799999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999998843 2357889999999999999999998 8999999999999999999999999999875433
Q ss_pred ccccccccCCccCccccCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.....|++.|+|||.+.+..+
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~ 170 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGD 170 (260)
T ss_pred -cccCCCCcCccChhhhcCCCC
Confidence 123468899999999887653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=210.77 Aligned_cols=172 Identities=27% Similarity=0.379 Sum_probs=138.2
Q ss_pred CCcccceeeccCcEEEEEEEEc-C--CcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcC----Ce
Q 008026 396 NFSEENILGRGGFGTVYKGELH-D--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDG----NE 467 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~----~~ 467 (580)
+|++.+.||+|+||.||+++.. + +..||+|++..........+.+.+|++++++++ ||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999765 4 778999998754333334567888999999995 99999999875432 45
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++++||++ ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999885 688877732 3468899999999999999999997 8999999999999999999999999999
Q ss_pred ccccCCCCCC---ccccccccCCccCccccCC
Q 008026 548 VRLAPEGKGS---IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 548 a~~~~~~~~~---~~~~~~Gt~~y~APE~~~~ 576 (580)
++........ ......||+.|+|||++.+
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhC
Confidence 9865432211 1123568999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=204.11 Aligned_cols=174 Identities=32% Similarity=0.432 Sum_probs=141.2
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc---CCCcccceeeEEEcCCe-----
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLDGNE----- 467 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 467 (580)
|++.+.||+|+||.||+|+.+ +++.||+|++............+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999876 589999999975433333345566788777666 59999999999988776
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.+++|||+.+ +|.+++... ....+++.++..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhccc-CHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999964 788877432 22358899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+........ .....++..|+|||++.+..+
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~ 183 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSY 183 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCC
Confidence 877643321 223457889999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=204.06 Aligned_cols=168 Identities=29% Similarity=0.347 Sum_probs=137.0
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcC--CeeEEEE
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDG--NEKLLVF 472 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 472 (580)
|++.+.||+|+||.||+|... +++.||+|++....... ......+|+.+++++. |+|++++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 667889999999999999764 68999999987643222 2234457889999886 99999999999987 8899999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||++ +++.+.+.. ....+++.++..++.|++.||+|||+ .+++||||||+||++++ +.+||+|||.++...
T Consensus 80 e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9996 477776643 22468999999999999999999998 89999999999999999 999999999998664
Q ss_pred CCCCCccccccccCCccCccccCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.... .....++..|+|||++.+
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~ 172 (282)
T cd07831 151 SKPP--YTEYISTRWYRAPECLLT 172 (282)
T ss_pred cCCC--cCCCCCCcccCChhHhhc
Confidence 3322 223468999999997654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=208.68 Aligned_cols=172 Identities=19% Similarity=0.212 Sum_probs=139.2
Q ss_pred cccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 398 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
.+.+.+|.|+++.||++.. +++.||+|++............+.+|+++++.++|+||+++++++...+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566666666666644 689999999987544555677899999999999999999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC-
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG- 556 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 556 (580)
++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 84 GSCEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 9999988542 22357888899999999999999998 8999999999999999999999999998865432211
Q ss_pred -----CccccccccCCccCccccCC
Q 008026 557 -----SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 557 -----~~~~~~~Gt~~y~APE~~~~ 576 (580)
.......++..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred ccccccccccccccccccCHHHhcC
Confidence 11122457889999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=209.41 Aligned_cols=176 Identities=28% Similarity=0.360 Sum_probs=140.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC------
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 466 (580)
.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999765 6899999998764433333456788999999999999999999875433
Q ss_pred --eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 467 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 467 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
..++||||+++ ++...+.. ....+++.++..++.|+++||+|||+ .+|+||||||+||++++++.++|+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence 46999999965 66655532 23468999999999999999999998 8999999999999999999999999
Q ss_pred eccccccCCCCCC----------ccccccccCCccCccccCCC
Q 008026 545 FGLVRLAPEGKGS----------IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 545 fg~a~~~~~~~~~----------~~~~~~Gt~~y~APE~~~~~ 577 (580)
||+++........ ..+...|++.|+|||++.+.
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE 201 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC
Confidence 9998765332211 11234678899999987653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=205.30 Aligned_cols=167 Identities=29% Similarity=0.441 Sum_probs=140.1
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.|+..+.||+|+||.||+|... ++..||+|++..... .......+.+|++++++++|||++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677889999999999999764 688999999875322 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+.+ ++.+.+.. ....+++.++..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCLG-SASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCCC-CHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9964 77666532 22458899999999999999999998 8999999999999999999999999999875433
Q ss_pred CCCCccccccccCCccCccccC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
. ....|++.|+|||++.
T Consensus 178 ~-----~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVIL 194 (317)
T ss_pred c-----ccccCCccccChhhhh
Confidence 2 2346889999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=204.73 Aligned_cols=172 Identities=27% Similarity=0.377 Sum_probs=145.1
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
|++.+.||+|++|.||+|... +++.+++|++............+.+|++++++++|++|+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999765 6899999998765444345677889999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
++ ++.+++.. ....+++.++..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 88777643 12468899999999999999999998 899999999999999999999999999987765443
Q ss_pred CCccccccccCCccCccccCCC
Q 008026 556 GSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.......++..|+|||.+.+.
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred -ccccCccCcccccCcHHHhcC
Confidence 122334678899999998765
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=209.37 Aligned_cols=175 Identities=26% Similarity=0.359 Sum_probs=140.4
Q ss_pred hcCCc-ccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChh------------hHHHHHHHHHHHHhcCCCccccee
Q 008026 394 TNNFS-EENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGK------------GLTEFKSEIAVLTKVRHRHLVALL 459 (580)
Q Consensus 394 ~~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~ 459 (580)
.++|. +.+.||+|+||.||+|... +++.||+|++........ ....+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35665 4577999999999999765 689999999865322210 012477899999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 460 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
+++...+..++||||++ ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCC
Confidence 99999999999999996 588887732 2458889999999999999999997 89999999999999999999
Q ss_pred EEEEeeccccccCCCC-------------CCccccccccCCccCccccCCC
Q 008026 540 AKVADFGLVRLAPEGK-------------GSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~-------------~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
++|+|||.++...... ........+++.|+|||++.+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 9999999987654110 0111223468899999998764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=210.42 Aligned_cols=170 Identities=28% Similarity=0.440 Sum_probs=140.0
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC----
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN---- 466 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 466 (580)
.+.++|.+.+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 34578999999999999999999764 6899999998764333334456889999999999999999999987542
Q ss_pred --eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 467 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 467 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
..++|+||+.. +|..+. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CceEEEEeccccc-CHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEee
Confidence 46899999964 665543 1357889999999999999999997 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
||+++..... .....|++.|+|||++.+
T Consensus 161 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 161 FGLARHADAE----MTGYVVTRWYRAPEVILN 188 (342)
T ss_pred CCCCcCCCCC----CCCceeeecccChhhhcC
Confidence 9998765322 223467899999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=200.73 Aligned_cols=176 Identities=26% Similarity=0.326 Sum_probs=146.9
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-C-C----cccceeeEEE
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-H-R----HLVALLGHCL 463 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~ 463 (580)
....++|.+...+|+|.||.|-.+.++ .+..||+|+++. -.+..++.+-|++++.++. + | -++++.++|.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 344789999999999999999999665 578999999864 2344567788999999994 2 2 4778889999
Q ss_pred cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-------
Q 008026 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD------- 536 (580)
Q Consensus 464 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~------- 536 (580)
..++.|+|+|.+ |-++.+++.+ .+..+++..++..|+.|++++++|||+ .+++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEe
Confidence 999999999998 6689898854 456789999999999999999999998 89999999999999932
Q ss_pred -------------CCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 537 -------------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 537 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
...+|++|||.|+...... ...+.|..|.|||++.|.+||
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS 287 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWS 287 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcC
Confidence 2348999999998765543 345679999999999999987
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-25 Score=201.73 Aligned_cols=176 Identities=26% Similarity=0.376 Sum_probs=139.3
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--------C
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--------G 465 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 465 (580)
+.|+...+||+|.||+||+|+.+ +++.||+|++..+.....-.....+|++++..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 35677789999999999999765 67889998764422222234567899999999999999998887653 2
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
...|+|+++|+. +|.-.+.+ ....++..++.+++.++..||.|+|. ..|+|||+||+|+||+.+|.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecc
Confidence 347999999976 77777632 22468889999999999999999996 89999999999999999999999999
Q ss_pred ccccccCCCCCC---ccccccccCCccCccccCCCC
Q 008026 546 GLVRLAPEGKGS---IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 546 g~a~~~~~~~~~---~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|+|+.+...... ..+..+-|..|.+||.+.|..
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r 204 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR 204 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhccc
Confidence 999766543321 223345699999999998764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-23 Score=204.26 Aligned_cols=178 Identities=16% Similarity=0.202 Sum_probs=126.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEcC----CcEEEEEEeeccccChhh---------HHHHHHHHHHHHhcCCCcccceee
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKG---------LTEFKSEIAVLTKVRHRHLVALLG 460 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~ 460 (580)
.++|++.+.||+|+||.||+|...+ +..+|+|+.......... ......+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999997653 345666654321111000 011223334556678999999998
Q ss_pred EEEcCC----eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC
Q 008026 461 HCLDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 536 (580)
Q Consensus 461 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 536 (580)
++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 766543 3467888774 356555422 1235677889999999999999997 89999999999999999
Q ss_pred CCcEEEEeeccccccCCCCC------CccccccccCCccCccccCCCCCC
Q 008026 537 DMRAKVADFGLVRLAPEGKG------SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 537 ~~~~kl~Dfg~a~~~~~~~~------~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++.++|+|||+|+....... .......||+.|+|||+..+..++
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~ 211 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT 211 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC
Confidence 99999999999986543211 111224699999999999877653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-25 Score=201.48 Aligned_cols=173 Identities=27% Similarity=0.390 Sum_probs=141.8
Q ss_pred CcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----eeEE
Q 008026 397 FSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKLL 470 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 470 (580)
.+..+.||-|+||.||.+.+ ++|+.||+|++..-..+-...+++.+|++++.-++|.|++..++...-.. +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999965 58999999998654444455678999999999999999999988765433 4578
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
++|.+. .+|...+ -....++.+.+.-+..||++||+|||+ .+|.||||||.|.|++.+...||||||+|+.
T Consensus 135 ~TELmQ-SDLHKII-----VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQ-SDLHKII-----VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-hhhhhee-----ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccc
Confidence 888884 4777666 334678888899999999999999998 8999999999999999999999999999997
Q ss_pred cCCCCCCccccccccCCccCccccCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
...+.....+..+-|.+|.|||+++|..
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaR 233 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGAR 233 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcch
Confidence 7655444444455699999999999864
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=203.51 Aligned_cols=170 Identities=31% Similarity=0.433 Sum_probs=141.2
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEEe
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
|++.+.||+|++|.||+|... +++.|++|++...... .......+|+..+++++ |+|++++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 667889999999999999875 5788999998764322 22334567999999999 99999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+ +++|.+++... ....+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||.++.....
T Consensus 80 ~-~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 78998877442 12467999999999999999999998 89999999999999999999999999999865433
Q ss_pred CCCccccccccCCccCccccCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.. .....|+..|+|||++.+
T Consensus 153 ~~--~~~~~~~~~~~aPE~~~~ 172 (283)
T cd07830 153 PP--YTDYVSTRWYRAPEILLR 172 (283)
T ss_pred CC--cCCCCCcccccCceeeec
Confidence 21 233568899999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=197.47 Aligned_cols=167 Identities=32% Similarity=0.444 Sum_probs=141.7
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCCh
Q 008026 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 480 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 480 (580)
||+|+||.||++... +++.||+|.+...... ......+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 5899999998765432 23456788999999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccc
Q 008026 481 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 560 (580)
Q Consensus 481 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 560 (580)
.+++.. ...+++..+..++.|++.||.|+|+ .+++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 81 FSHLSK-----EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 988843 2357899999999999999999998 8999999999999999999999999999876544321 223
Q ss_pred cccccCCccCccccCCCC
Q 008026 561 RIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 561 ~~~Gt~~y~APE~~~~~~ 578 (580)
...|+..|+|||...+..
T Consensus 152 ~~~~~~~~~~Pe~~~~~~ 169 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKG 169 (250)
T ss_pred CCcCCccccChHHhCCCC
Confidence 356889999999987654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-23 Score=211.23 Aligned_cols=170 Identities=28% Similarity=0.426 Sum_probs=143.2
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe----
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE---- 467 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 467 (580)
+.++|++.+.||+|++|.||+|+.. +++.||+|++............+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999775 68899999987543333445667889999999999999999998876554
Q ss_pred --eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 468 --KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 468 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 6689887732 468999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
|++...... .....++..|+|||.+.+
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhC
Confidence 999865432 233467899999998754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=200.43 Aligned_cols=178 Identities=26% Similarity=0.370 Sum_probs=142.1
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecc---ccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAG---VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+|.+.+.||+|+||.||++... .+..+++|.++.. ........++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999765 3444555555432 22233345677899999999999999999999998999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++..... ....+++.+++.++.|++.||.|||+ .+++|+||||+||++++ +.++|+|||.++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999988865332 23468999999999999999999997 89999999999999975 57999999998766
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..... ......|++.|+|||.+.+..+
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~ 182 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGY 182 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCC
Confidence 43322 2233568899999999876554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-22 Score=201.22 Aligned_cols=166 Identities=30% Similarity=0.443 Sum_probs=138.8
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
|...+.||+|+||.||+|... ++..|++|++..... .......+.+|+++++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999764 688999999875432 233446788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+. +++.+++.. ....+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 96 577666532 23468899999999999999999998 8999999999999999999999999998864322
Q ss_pred CCCccccccccCCccCccccC
Q 008026 555 KGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.....|+..|+|||++.
T Consensus 174 ----~~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVIL 190 (313)
T ss_pred ----CCCccccccccChhhcc
Confidence 12346899999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=209.81 Aligned_cols=169 Identities=33% Similarity=0.505 Sum_probs=144.5
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+.....+||.|.||.||.|.|+ -...||||.++.+ ....++|++|+.+|+.++|||+|+++|+|..+..+|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 4556788999999999999776 3678999999763 34578999999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
|..|+|.+|+++. +...++....+.+|.||..|++||.. +++|||||.++|+|+.++..+|++|||+++++..+
T Consensus 345 M~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 345 MCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999999663 33456667788999999999999996 89999999999999999999999999999988654
Q ss_pred CCCccccccc---cCCccCccccCC
Q 008026 555 KGSIETRIAG---TFGYLAPEYAGN 576 (580)
Q Consensus 555 ~~~~~~~~~G---t~~y~APE~~~~ 576 (580)
. ++...| ...|.|||-+.-
T Consensus 419 T---YTAHAGAKFPIKWTAPEsLAy 440 (1157)
T KOG4278|consen 419 T---YTAHAGAKFPIKWTAPESLAY 440 (1157)
T ss_pred c---eecccCccCcccccCcccccc
Confidence 3 233344 457999998754
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=201.89 Aligned_cols=172 Identities=31% Similarity=0.408 Sum_probs=144.2
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
|+..+.||+|.+|.||+|... +++.||+|++..........+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999765 5899999999865433444567888999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
+ ++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||.++......
T Consensus 81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 5898888542 1368899999999999999999998 799999999999999999999999999988764432
Q ss_pred CCccccccccCCccCccccCCC
Q 008026 556 GSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
. ......++..|+|||++.+.
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred c-ccCccccCcCcCChHHhcCC
Confidence 2 12234567889999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=202.05 Aligned_cols=174 Identities=26% Similarity=0.397 Sum_probs=140.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|... +++.||||.+..... ......+.+|+.++.+.. ||||+++++++.+....++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 367889999999999999999876 489999999876432 223455667887777775 99999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+. +++.+++.. ....+++..+..++.|++.||+|||+ ..+|+||||+|+||++++++.+||+|||++...
T Consensus 93 ~e~~~-~~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMS-TCLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccC-cCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99985 467666533 12368889999999999999999996 258999999999999999999999999998765
Q ss_pred CCCCCCccccccccCCccCccccCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
..... .....|+..|+|||++.+.
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPP 189 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCC
Confidence 43322 1223578899999998755
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=201.67 Aligned_cols=168 Identities=30% Similarity=0.446 Sum_probs=140.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccc-cChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
+.|+..+.||+|+||.||+|... ++..||+|.+.... .......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999765 67889999886432 22334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+. +++.+.+.. ....+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 577766532 22457889999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.. ....|++.|+|||++.
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVIL 184 (308)
T ss_pred Cc-----ccccCCccccCHHHHh
Confidence 32 2346889999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=185.95 Aligned_cols=143 Identities=18% Similarity=0.216 Sum_probs=110.0
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhh------------------------HHHHHHHHHHHHhcCCCcc
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG------------------------LTEFKSEIAVLTKVRHRHL 455 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 455 (580)
.+.||+|+||.||+|...+|+.||+|+++........ .....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998778999999999764321111 1223459999999988877
Q ss_pred cceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHH-HhCCCCCcEecCCCCCCeEe
Q 008026 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL-HGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 456 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~L-H~~~~~~ivH~Dlkp~NIll 534 (580)
.....+.. ...++||||++++++...... ...+++.++..++.|++.+|+|+ |+ .+|+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 54443322 234899999998777544311 23678889999999999999999 56 799999999999999
Q ss_pred cCCCcEEEEeeccccccCC
Q 008026 535 GDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~~~ 553 (580)
+ ++.++|+|||+|.....
T Consensus 152 ~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred E-CCcEEEEEccccccCCC
Confidence 8 47899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=205.06 Aligned_cols=171 Identities=24% Similarity=0.378 Sum_probs=137.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-------
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------- 465 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 465 (580)
..+|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 368999999999999999999764 68999999986643 23456788999999999999999999876543
Q ss_pred -------CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-CC
Q 008026 466 -------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DD 537 (580)
Q Consensus 466 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~ 537 (580)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++ ++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence 35789999996 588776632 357889999999999999999997 8999999999999997 45
Q ss_pred CcEEEEeeccccccCCCCCC--ccccccccCCccCccccCC
Q 008026 538 MRAKVADFGLVRLAPEGKGS--IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 538 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~Gt~~y~APE~~~~ 576 (580)
+.+|++|||.++........ ......|+..|+|||++.+
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhC
Confidence 67899999998765332111 1122357889999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=216.64 Aligned_cols=174 Identities=23% Similarity=0.252 Sum_probs=121.6
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-C----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeE------
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-D----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH------ 461 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------ 461 (580)
..++|++.+.||+|+||.||+|.+. + +..||+|++..... .+....| .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4578999999999999999999775 4 68999998764211 1111111 1112222222222211
Q ss_pred EEcCCeeEEEEEecCCCChhHHHHHHhh---------h------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 008026 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAE---------E------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 526 (580)
Q Consensus 462 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D 526 (580)
.......++||||+++++|.+++..... . .........+..++.|++.||+|||+ .+|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCc
Confidence 2345678999999999999988853210 0 00011234466899999999999998 8999999
Q ss_pred CCCCCeEecC-CCcEEEEeeccccccCCCCCCccccccccCCccCccccC
Q 008026 527 LKPSNILLGD-DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 527 lkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
|||+|||+++ ++.+||+|||+|+............+.||+.|||||.+.
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 9999999985 579999999999876544444445578999999999754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-23 Score=209.22 Aligned_cols=174 Identities=29% Similarity=0.482 Sum_probs=144.2
Q ss_pred cccceeeccCcEEEEEEEEc--CC--cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 398 SEENILGRGGFGTVYKGELH--DG--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+..++||+|+||.|++|.|. .| -.||||.+..+.... ...+|.+|+.+|.+++|+|++++||+..+ ....||||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 45688999999999999775 33 468999998765443 67899999999999999999999999887 66789999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
+++.|+|.+.++. .....+.......++.|||.|+.||.+ +++|||||..+|+++.....+||+|||+.+.+..
T Consensus 191 LaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999998865 233567788889999999999999998 8999999999999999988999999999998776
Q ss_pred CCCCccc-c-ccccCCccCccccCCCCC
Q 008026 554 GKGSIET-R-IAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~-~-~~Gt~~y~APE~~~~~~~ 579 (580)
..+...- . .--...|+|||.+.....
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kF 292 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKF 292 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccc
Confidence 5543211 0 111456999999987654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=192.13 Aligned_cols=155 Identities=21% Similarity=0.209 Sum_probs=128.0
Q ss_pred cCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCChhHHH
Q 008026 406 GGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI 484 (580)
Q Consensus 406 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 484 (580)
|.+|.||+++.. +++.||+|++.... ...+|...+....||||+++++++...+..++||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999764 78999999986532 2334555555667999999999999999999999999999999888
Q ss_pred HHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccccccc
Q 008026 485 FNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 564 (580)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~G 564 (580)
... ..+++..+..++.|++.||+|+|+ .+|+||||||+||+++.++.++++|||.+....... ....+
T Consensus 77 ~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~ 144 (237)
T cd05576 77 SKF-----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAV 144 (237)
T ss_pred HHh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCc
Confidence 432 358899999999999999999997 899999999999999999999999999876554321 22346
Q ss_pred cCCccCccccCCCCC
Q 008026 565 TFGYLAPEYAGNFGS 579 (580)
Q Consensus 565 t~~y~APE~~~~~~~ 579 (580)
+..|+|||++.+.++
T Consensus 145 ~~~y~aPE~~~~~~~ 159 (237)
T cd05576 145 ENMYCAPEVGGISEE 159 (237)
T ss_pred CccccCCcccCCCCC
Confidence 778999999876553
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-23 Score=213.76 Aligned_cols=173 Identities=28% Similarity=0.433 Sum_probs=141.0
Q ss_pred cccceeeccCcEEEEEEEE-cCC----cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 398 SEENILGRGGFGTVYKGEL-HDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
+..++||+|+||+||+|.+ ..| -+||+|++.... ..+...++..|+-+|++++|||++++++++.... .-||+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4468899999999999954 333 468999887643 3445678999999999999999999999998776 77999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
+|++.|+|.++++.. ...+-....+.|..|||+||.|||+ +++|||||-++|||+.+...+||.|||+|+...
T Consensus 777 q~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HhcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999652 3457778899999999999999997 899999999999999999999999999999887
Q ss_pred CCCCCcccccc-ccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIA-GTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~-Gt~~y~APE~~~~~~~ 579 (580)
.+......... -.+.|||=|.+....|
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~ 877 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKY 877 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCC
Confidence 65443322211 1456888887765544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=210.76 Aligned_cols=171 Identities=30% Similarity=0.429 Sum_probs=135.4
Q ss_pred CcccceeeccCcE-EEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEEe
Q 008026 397 FSEENILGRGGFG-TVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 397 ~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
|.-.+++|.|+.| .||+|.+. ++.||||++... ......+|+..++..+ |||||++++.-.++...||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 4456789999987 58999886 889999987653 3456789999999996 99999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---C--CcEEEEeecccc
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---D--MRAKVADFGLVR 549 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfg~a~ 549 (580)
| ..+|.+++..... ..........+.+..|+++||+|||+ .+||||||||.||||+. + .+++|+|||+++
T Consensus 585 C-~~sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred h-hhhHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9 4599999855211 10111113456778899999999998 78999999999999975 3 468999999999
Q ss_pred ccCCCCCCccc--cccccCCccCccccCCCC
Q 008026 550 LAPEGKGSIET--RIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 550 ~~~~~~~~~~~--~~~Gt~~y~APE~~~~~~ 578 (580)
....+...... ...||-+|+|||++....
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~ 690 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR 690 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccc
Confidence 88766554333 356999999999997653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-23 Score=181.33 Aligned_cols=168 Identities=21% Similarity=0.409 Sum_probs=140.1
Q ss_pred hhcCCcccceeeccCcEEEEEEE-EcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCC--ee
Q 008026 393 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN--EK 468 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~ 468 (580)
..++|++.+.+|+|.|++||.|. ..+.++++||+++. -..+.+.+|+.++..++ ||||+++++...++. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 34689999999999999999995 45688999999865 23467899999999998 999999999988764 45
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-CcEEEEeecc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGL 547 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~ 547 (580)
.+|+||+.+.+...+. +.++...+..++.+++.||.|+|+ +||+|||+||.|++||.. ..++|+|+|+
T Consensus 111 aLiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred hhHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecch
Confidence 7999999998876654 357777889999999999999998 999999999999999954 5699999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|.+.-.+.. ..-.+.+.+|--||++-..+
T Consensus 180 AEFYHp~~e--YnVRVASRyfKGPELLVdy~ 208 (338)
T KOG0668|consen 180 AEFYHPGKE--YNVRVASRYFKGPELLVDYQ 208 (338)
T ss_pred HhhcCCCce--eeeeeehhhcCCchheeech
Confidence 988766543 23345688899999986654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=177.57 Aligned_cols=144 Identities=20% Similarity=0.215 Sum_probs=111.9
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChh------------------------hHHHHHHHHHHHHhcCCCcc
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK------------------------GLTEFKSEIAVLTKVRHRHL 455 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~ni 455 (580)
.+.||+|++|.||+|...+|+.||||++........ ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999877899999999976421100 01234679999999999988
Q ss_pred cceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec
Q 008026 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 535 (580)
Q Consensus 456 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 535 (580)
.....+... ..++||||++++++...... ...++..++..++.|++.++.++|+ ..+|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence 655444433 24899999998765433211 1346778889999999999999996 37999999999999998
Q ss_pred CCCcEEEEeeccccccCC
Q 008026 536 DDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 536 ~~~~~kl~Dfg~a~~~~~ 553 (580)
++.++|+|||+|+....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=209.24 Aligned_cols=181 Identities=29% Similarity=0.400 Sum_probs=146.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc----C----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcC
Q 008026 395 NNFSEENILGRGGFGTVYKGELH----D----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDG 465 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 465 (580)
++..+.+.+|+|.||.|++|... . ...||||.++.... ..+.+.+..|+++|+.+. |+||+.++|++..+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~-~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS-SSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC-cHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 34455679999999999999643 1 45799999887543 367889999999999995 99999999999999
Q ss_pred CeeEEEEEecCCCChhHHHHHHh---------hhCC--CCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWA---------EEGL--KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~--~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
+..++|+||+..|+|.++++..+ .... ..++..+.+.++.|||.|++||++ .++||||+..+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence 99999999999999999997654 0001 238888999999999999999998 889999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCccccccc--cCCccCccccCCCCC
Q 008026 535 GDDMRAKVADFGLVRLAPEGKGSIETRIAG--TFGYLAPEYAGNFGS 579 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~G--t~~y~APE~~~~~~~ 579 (580)
.++..+||+|||+|+............-.| ...|||||.+....|
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f 498 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF 498 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc
Confidence 999999999999999765443222222223 235999999987554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=179.96 Aligned_cols=170 Identities=35% Similarity=0.498 Sum_probs=143.3
Q ss_pred CcccceeeccCcEEEEEEEEcC-CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 397 FSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5667899999999999998764 889999998764322 24678899999999999999999999999989999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
++++|.+++.... ..+++..+..++.+++.++.|||+ .+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999998885421 117888999999999999999998 799999999999999999999999999988765442
Q ss_pred CCccccccccCCccCcccc
Q 008026 556 GSIETRIAGTFGYLAPEYA 574 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~ 574 (580)
........++..|+|||.+
T Consensus 153 ~~~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVL 171 (225)
T ss_pred cccccceeccCCcCCHhHh
Confidence 1122335678899999997
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-22 Score=179.72 Aligned_cols=168 Identities=24% Similarity=0.395 Sum_probs=134.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceee-EEEcCCeeE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG-HCLDGNEKL 469 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~~~~~~ 469 (580)
..+.|.+.+.+|+|.||.+-+++++ +...+|+|.+.+.. ...++|.+|...--.+. |.||+.-|+ .|+..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3467999999999999999999887 56789999887632 34578999988776775 899998776 456677888
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec--CCCcEEEEeecc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGL 547 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~ 547 (580)
.++||++.|+|.+-+. ...+-+....+++.|+++|++|||+ +++||||||.+||||- +..++||||||.
T Consensus 99 F~qE~aP~gdL~snv~------~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE------AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EeeccCccchhhhhcC------cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccc
Confidence 9999999999987662 2456778889999999999999998 8999999999999993 456899999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.+....... ..--+..|.|||....
T Consensus 170 t~k~g~tV~----~~~~~~~y~~pe~~~~ 194 (378)
T KOG1345|consen 170 TRKVGTTVK----YLEYVNNYHAPELCDT 194 (378)
T ss_pred ccccCceeh----hhhhhcccCCcHHHhh
Confidence 876543221 1123667999998653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-22 Score=184.17 Aligned_cols=171 Identities=27% Similarity=0.373 Sum_probs=141.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC------Ce
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------NE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 467 (580)
.+|.-.+.+|.|.- .|..|.+. .+++||+|++..........++..+|..++..+.|+||++++.+|.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666788888888 56666433 689999999877665666677889999999999999999999988643 35
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.|+|||||. ++|...+.. .++-.++..+..|++.|++|+|+ .+|+||||||+||++..++.+||.|||+
T Consensus 96 ~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchh
Confidence 699999994 588888742 35667888999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+..... -..+.++.|.+|.|||++.+.+|
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ 194 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGY 194 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCC
Confidence 9865443 24466788999999999998876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=188.74 Aligned_cols=191 Identities=21% Similarity=0.274 Sum_probs=155.6
Q ss_pred hccCceeeeHHHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-----
Q 008026 378 LEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR----- 451 (580)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~----- 451 (580)
+....-.+.++..+..-.+|.+....|+|-|+.|.+|.+. .|..||||+|.... ...+.=++|+++|++|.
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPE 491 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCch
Confidence 3334445666777777889999999999999999999765 47899999997642 23345578999999994
Q ss_pred -CCcccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 008026 452 -HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 530 (580)
Q Consensus 452 -h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~ 530 (580)
..|+++++..|...+++|||+|-+ .-+|.++++.+... -.+....+..++.|+..||..|-. .+|+|.||||.
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPD 565 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPD 565 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHh---cCeeecccCcc
Confidence 358999999999999999999988 45999999776443 346777889999999999999996 89999999999
Q ss_pred CeEecCC-CcEEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 531 NILLGDD-MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 531 NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+++. ..+||||||.|....... .+.+.-+..|.|||++.|.+|+
T Consensus 566 NiLVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd 613 (752)
T KOG0670|consen 566 NILVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYD 613 (752)
T ss_pred ceEeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCccc
Confidence 9999864 568999999998776543 2334457789999999999885
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=195.88 Aligned_cols=169 Identities=31% Similarity=0.389 Sum_probs=138.8
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
+.+.|.+...+|.|+|+.|-++... +++..++|++.+. ..+..+|+.++... +||||+++.+.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCCceeee
Confidence 5678888899999999999999654 6888999999764 23345677777776 49999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe-cCCCcEEEEeecccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVR 549 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~ 549 (580)
|||++.|+-+.+.+.. .+.....+..|+.+|+.|+.|||+ ++|||||+||+|||+ ++.+.++|+|||.++
T Consensus 394 v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999888776633 122225677899999999999998 899999999999999 589999999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.....- ...+=|..|.|||++...+|+
T Consensus 465 ~~~~~~----~tp~~t~~y~APEvl~~~~yt 491 (612)
T KOG0603|consen 465 ELERSC----DTPALTLQYVAPEVLAIQEYT 491 (612)
T ss_pred hCchhh----cccchhhcccChhhhccCCCC
Confidence 876541 112348889999999988774
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-23 Score=206.91 Aligned_cols=207 Identities=21% Similarity=0.199 Sum_probs=120.4
Q ss_pred CCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCcc-ccCCCCCcEEEccCCcccccCCCCCcc
Q 008026 33 GGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPEFDRS 111 (580)
Q Consensus 33 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~ 111 (580)
++|+.+.+|..|+.||||+|++...+..+..-+++-+|+||+|+|. .||.. |-+|+.|-+||||+|++..+||.+-++
T Consensus 94 GiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL 172 (1255)
T KOG0444|consen 94 GIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRL 172 (1255)
T ss_pred CCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHH
Confidence 3344444455555555555555433333444444455555555554 44444 444555555555555555555555555
Q ss_pred cccccccccCCCCCCCCCCCchhHHHHHHHHHh------------hCCccccccccCCCCCCCCccceeccCCcEEEEEe
Q 008026 112 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL------------MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 179 (580)
Q Consensus 112 ~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l 179 (580)
..|+.|.+++|.+....-...+.+++|..++.. +..+.++....++++.+...|.-+-++.+|+.|+|
T Consensus 173 ~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNL 252 (1255)
T KOG0444|consen 173 SMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNL 252 (1255)
T ss_pred hhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheecc
Confidence 555555555554333322223333333333221 11122222233444444445555566678888888
Q ss_pred cCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc-ccCCCCCCC
Q 008026 180 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY-GKIPSFKSN 242 (580)
Q Consensus 180 s~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~-g~~p~~~~~ 242 (580)
|+|+|+ .+.-..+.+.+|+.|+||.|+|+ .+|+.+..|++|+.|.+.+|+|+ .-||+.++-
T Consensus 253 S~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGK 314 (1255)
T KOG0444|consen 253 SGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGK 314 (1255)
T ss_pred CcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhh
Confidence 888888 67677778888889999999998 88999999999999999999987 567887653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=176.01 Aligned_cols=172 Identities=19% Similarity=0.336 Sum_probs=141.2
Q ss_pred CCcccceeeccCcEEEEEEE-EcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 473 (580)
.|++.++||+|+||.++.|. +-++++||||.-..+ ....++..|.+..+.+. .++|..+|-+...+.+-.+|+|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 68999999999999999994 457999999965432 23467888999999986 7999999988888888899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-----CcEEEEeeccc
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-----MRAKVADFGLV 548 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg~a 548 (580)
.+ |.+|++++ ++ ..+.++..++..+|.|++.-++|+|+ +.+|.|||||+|+||... ..+.++|||+|
T Consensus 105 LL-GPSLEDLF-D~---CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 105 LL-GPSLEDLF-DL---CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hh-CcCHHHHH-HH---hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 98 77998876 33 34579999999999999999999998 899999999999999743 35899999999
Q ss_pred cccCCCCCCcc------ccccccCCccCccccCCCCC
Q 008026 549 RLAPEGKGSIE------TRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 549 ~~~~~~~~~~~------~~~~Gt~~y~APE~~~~~~~ 579 (580)
+.+.+...... ....||.+||+=--..|.+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ 213 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ 213 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchh
Confidence 98876654322 23569999998665555443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-21 Score=182.71 Aligned_cols=191 Identities=20% Similarity=0.271 Sum_probs=150.0
Q ss_pred eHHHHHHhhcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCccccee
Q 008026 386 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459 (580)
Q Consensus 386 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 459 (580)
..+++.....+++...++.+|.||+||+|.++ +.+.|-+|.++.. .++-....+..|...+..+.|||+..+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 34556666677888999999999999999554 3456777877653 3444567788999999999999999999
Q ss_pred eEEEcC-CeeEEEEEecCCCChhHHHHHHhh---hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec
Q 008026 460 GHCLDG-NEKLLVFEYMPQGTLSRHIFNWAE---EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 535 (580)
Q Consensus 460 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 535 (580)
+++... ...++++.++..|+|..++...+. ...+.++..+...++.|++.|++|||. .+|||.||.++|++||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceeh
Confidence 988654 567889999999999999864322 234567778889999999999999997 8999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 536 DDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 536 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+...+||+|=.+++..-+.+-. .....-....|||||.+.+..||
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys 476 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS 476 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhc
Confidence 9999999999999866443211 11112235679999999988765
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-23 Score=175.36 Aligned_cols=178 Identities=24% Similarity=0.347 Sum_probs=154.0
Q ss_pred hcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccc
Q 008026 38 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMA 117 (580)
Q Consensus 38 ~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l 117 (580)
+.++..++.|.||+|+++..+|.+..|.+|+.|++++|++. ++|..+++|++|+.|+++.|++...|-.|+.+..|+.|
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levl 107 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVL 107 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhh
Confidence 45788899999999999999999999999999999999999 99999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCC
Q 008026 118 KGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKS 197 (580)
Q Consensus 118 ~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~ 197 (580)
+++.|.+.+- .+||.+..+..|+.|.|+.|.+. .+|++++++++
T Consensus 108 dltynnl~e~-----------------------------------~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~ 151 (264)
T KOG0617|consen 108 DLTYNNLNEN-----------------------------------SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTN 151 (264)
T ss_pred hccccccccc-----------------------------------cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcc
Confidence 9998876542 23344444456778889999999 89999999999
Q ss_pred CcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC-------ceeecCCCCCCC
Q 008026 198 LQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-------AIVNTDGNPDIG 254 (580)
Q Consensus 198 L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~-------~~~~~~~n~~~c 254 (580)
|+.|.+.+|.+. .+|.+++.|++|++|++.+|+|+- +|..+++ +....+.|||..
T Consensus 152 lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v-lppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 152 LQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV-LPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred eeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee-cChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 999999999998 999999999999999999999994 4444322 346677888863
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.6e-21 Score=183.81 Aligned_cols=148 Identities=22% Similarity=0.377 Sum_probs=129.2
Q ss_pred HHHHHHhhcCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeE
Q 008026 387 IQVLRNVTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGH 461 (580)
Q Consensus 387 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 461 (580)
.+......+.|..+++||+|.|+.||++.+. ..+.||+|.+... ....++..|+++|..+. +.||+++.++
T Consensus 28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhh
Confidence 4556677788999999999999999999543 3678999988653 23467899999999996 9999999999
Q ss_pred EEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-CCCcE
Q 008026 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRA 540 (580)
Q Consensus 462 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 540 (580)
+...+..++|+||++.....++.. .++..++..+++.+..||+|+|. +|||||||||+|+|.+ ..++-
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCc
Confidence 999999999999999988888763 46678899999999999999997 8999999999999998 45778
Q ss_pred EEEeecccc
Q 008026 541 KVADFGLVR 549 (580)
Q Consensus 541 kl~Dfg~a~ 549 (580)
.|+|||+|.
T Consensus 173 ~LvDFgLA~ 181 (418)
T KOG1167|consen 173 VLVDFGLAQ 181 (418)
T ss_pred eEEechhHH
Confidence 999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-19 Score=170.07 Aligned_cols=166 Identities=40% Similarity=0.596 Sum_probs=139.5
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCChh
Q 008026 403 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 481 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 481 (580)
||+|.+|.||++... +++.+++|++....... ....+.+|++.++.++|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999876 48999999987643221 3567899999999999999999999999989999999999999999
Q ss_pred HHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-CCcEEEEeeccccccCCCCCCccc
Q 008026 482 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPEGKGSIET 560 (580)
Q Consensus 482 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 560 (580)
+++.... ..+++..+..++.+++.+++|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 9874421 357889999999999999999998 79999999999999998 89999999999986654321 122
Q ss_pred cccccCCccCccccCCC
Q 008026 561 RIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 561 ~~~Gt~~y~APE~~~~~ 577 (580)
...+...|++||.....
T Consensus 152 ~~~~~~~~~~pe~~~~~ 168 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK 168 (215)
T ss_pred cccCCCCccChhHhccc
Confidence 34578899999998664
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=176.43 Aligned_cols=161 Identities=35% Similarity=0.506 Sum_probs=136.2
Q ss_pred CcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCChhHHHH
Q 008026 407 GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF 485 (580)
Q Consensus 407 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 485 (580)
+||.||+|... +++.+|+|++........ .+.+.+|++.+++++|++++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999876 489999999876432221 5789999999999999999999999999999999999999999998874
Q ss_pred HHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCcccccccc
Q 008026 486 NWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 565 (580)
Q Consensus 486 ~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt 565 (580)
.. ..+++..+..++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......|+
T Consensus 80 ~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 80 KR-----GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred hc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 31 227889999999999999999998 799999999999999999999999999998765432 22335688
Q ss_pred CCccCccccCCCC
Q 008026 566 FGYLAPEYAGNFG 578 (580)
Q Consensus 566 ~~y~APE~~~~~~ 578 (580)
..|+|||.+.+..
T Consensus 150 ~~~~~pE~~~~~~ 162 (244)
T smart00220 150 PEYMAPEVLLGKG 162 (244)
T ss_pred cCCCCHHHHccCC
Confidence 9999999987544
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=165.90 Aligned_cols=172 Identities=22% Similarity=0.330 Sum_probs=137.4
Q ss_pred hhcCCcccceeeccCcEEEEEEE-EcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 470 (580)
+...|.+++.||.|+||.+|.|. ..+|+.||||+-..+. ...++..|.++.+.++ -..|..+..+..++..-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 34689999999999999999994 5689999999754422 2346788999999997 4688888888888888999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEEeecc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGL 547 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~ 547 (580)
|||.+ |.+|++++.- ..+.++..+++..|-|++.-++|+|. +++|||||||+|+|..- ...+.++|||+
T Consensus 89 VMdLL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeecc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccc
Confidence 99998 7799887632 23468889999999999999999997 89999999999999963 34689999999
Q ss_pred ccccCCCCCCc------cccccccCCccCccccCC
Q 008026 548 VRLAPEGKGSI------ETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 548 a~~~~~~~~~~------~~~~~Gt~~y~APE~~~~ 576 (580)
|+.+.+..... .+...||.+|++=-...+
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g 195 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG 195 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhh
Confidence 98776543211 123579999987554443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-20 Score=185.66 Aligned_cols=204 Identities=19% Similarity=0.167 Sum_probs=118.1
Q ss_pred ceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCC-CCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEc
Q 008026 18 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL-PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96 (580)
Q Consensus 18 ~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L 96 (580)
-.|+.+++..|.+.+..-+++..++.|++||||.|.|+.+. |.|..-.+++.|+|++|+|+..--..|.++.+|..|.|
T Consensus 125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkL 204 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKL 204 (873)
T ss_pred cceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeec
Confidence 33555556666555555566666777777777777777544 35665566777777777776333344777777777777
Q ss_pred cCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEE
Q 008026 97 TNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175 (580)
Q Consensus 97 ~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 175 (580)
+.|+++.+++- |.++..|+.|++..|+|..+.+..|..+.++..+....+.+..+.. |.+-.+.+++
T Consensus 205 srNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~D------------G~Fy~l~kme 272 (873)
T KOG4194|consen 205 SRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDD------------GAFYGLEKME 272 (873)
T ss_pred ccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccC------------cceeeecccc
Confidence 77777776664 5557777777777777777766677666666666554444443332 2333333444
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 176 ~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
.|+|+.|+++..-..++.+|++|+.||||+|.|...-++...-.++|++|||++|+++
T Consensus 273 ~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~ 330 (873)
T KOG4194|consen 273 HLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT 330 (873)
T ss_pred eeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc
Confidence 4444444444333334444444444444444444333444444444444444444444
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-21 Score=193.79 Aligned_cols=225 Identities=20% Similarity=0.200 Sum_probs=154.3
Q ss_pred CCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcC--cCCCCCCCCCCCCcEEeccCCcccccCCcc
Q 008026 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF--SGPLPDFSGVKQLESLSLRDNFFTGPVPDS 84 (580)
Q Consensus 7 ~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l--~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~ 84 (580)
.+|+.+ +.|++|+.+.++.|++. .+.+.+..|+.|+.+++.+|++ +|+++++..|..|+.||||+|++. +.|..
T Consensus 46 ~vPeEL--~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~ 121 (1255)
T KOG0444|consen 46 QVPEEL--SRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTN 121 (1255)
T ss_pred hChHHH--HHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchh
Confidence 466666 56777777777777444 3556677777777777777775 355567777778888888888887 77887
Q ss_pred ccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhh--------CCccc---cc
Q 008026 85 LVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLM--------GYPQR---FA 152 (580)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~--------~~~~~---~~ 152 (580)
+..-+++-.|+||+|+|..+|-. |.+++-|-.|++++|++..+||.+- .+..|.++.... ..++. +.
T Consensus 122 LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~R-RL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~ 200 (1255)
T KOG0444|consen 122 LEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIR-RLSMLQTLKLSNNPLNHFQLRQLPSMTSLS 200 (1255)
T ss_pred hhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHH-HHhhhhhhhcCCChhhHHHHhcCccchhhh
Confidence 87788888888888887766655 5677777778888888777776542 222232221111 01111 11
Q ss_pred cccCC--CCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCC
Q 008026 153 ENWKG--NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 230 (580)
Q Consensus 153 ~~~~~--~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N 230 (580)
-+.++ +.....+|..+..+.||..+|||.|.+. .+|+.+-++.+|+.|+||+|+|+ .+-.....+.+|++|++|.|
T Consensus 201 vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrN 278 (1255)
T KOG0444|consen 201 VLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRN 278 (1255)
T ss_pred hhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccc
Confidence 11111 1223356667777778888888888888 78888888888888888888887 77777778888888888888
Q ss_pred cccccCCCC
Q 008026 231 QLYGKIPSF 239 (580)
Q Consensus 231 ~l~g~~p~~ 239 (580)
+|+ .+|+.
T Consensus 279 QLt-~LP~a 286 (1255)
T KOG0444|consen 279 QLT-VLPDA 286 (1255)
T ss_pred hhc-cchHH
Confidence 888 56655
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.7e-19 Score=177.25 Aligned_cols=175 Identities=27% Similarity=0.365 Sum_probs=136.7
Q ss_pred CCcccceeeccCcEEEEEEEEcCC--cEEEEEEeeccccChhhHHHHHHHHHHHHhcCC----CcccceeeEE-EcCCee
Q 008026 396 NFSEENILGRGGFGTVYKGELHDG--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH----RHLVALLGHC-LDGNEK 468 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~ 468 (580)
+|++.+.||+|+||.||.|..... ..+|+|........ .. ..+..|+.++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~-~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS-KP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC-CC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999976543 47888876553211 11 267788888888863 5899999988 477788
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-----CcEEEE
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-----MRAKVA 543 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~ 543 (580)
|+||+.+ |.+|.++..... .+.++..++++|+.|++.+|++||+ .|++||||||+|+++... ..++|.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999988 779998764422 4678999999999999999999998 899999999999999854 358999
Q ss_pred eecccc--ccCCCCCC----c---cccccccCCccCccccCCCCC
Q 008026 544 DFGLVR--LAPEGKGS----I---ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 544 Dfg~a~--~~~~~~~~----~---~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|||+|+ ........ . ...+.||.+|+++....+.+.
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~ 214 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ 214 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc
Confidence 999998 32222111 1 123569999999998877664
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=162.34 Aligned_cols=138 Identities=20% Similarity=0.270 Sum_probs=104.9
Q ss_pred cccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-----CCCcccceeeEEEcCC---e-e
Q 008026 398 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-----RHRHLVALLGHCLDGN---E-K 468 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~ 468 (580)
.-.+.||+|+||.||. ...++.. +||++.... ....+.+.+|+++++.+ .||||++++++++++. . .
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3457899999999996 3334444 689886532 22456789999999999 5799999999998873 3 3
Q ss_pred EEEEEe--cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHH-HHHHhCCCCCcEecCCCCCCeEecC----CCcEE
Q 008026 469 LLVFEY--MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV-EYLHGLAHQSFIHRDLKPSNILLGD----DMRAK 541 (580)
Q Consensus 469 ~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~k 541 (580)
.+|+|| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+ .+||||||||+|||++. +..++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEE
Confidence 378999 557999999843 124444 35677888887 99998 89999999999999974 33799
Q ss_pred EEe-eccccc
Q 008026 542 VAD-FGLVRL 550 (580)
Q Consensus 542 l~D-fg~a~~ 550 (580)
|+| ||....
T Consensus 150 LiDg~G~~~~ 159 (210)
T PRK10345 150 VCDNIGESTF 159 (210)
T ss_pred EEECCCCcce
Confidence 999 554443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=162.53 Aligned_cols=143 Identities=16% Similarity=0.186 Sum_probs=115.6
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChh-hHHH------HHHHHHHHHhcCCCcccceeeEEEc
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK-GLTE------FKSEIAVLTKVRHRHLVALLGHCLD 464 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~niv~~~~~~~~ 464 (580)
...++|+..+++|+|+||.||.+.. ++..+|+|.+........ .... +.+|+..+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3467899999999999999999866 577899999976543322 1122 6799999999999999999988664
Q ss_pred C--------CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC
Q 008026 465 G--------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 536 (580)
Q Consensus 465 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 536 (580)
. +..++||||++|.+|.++. .++. ....+++.++..+|+ .+++|||+||+||++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence 3 3578999999999997763 1222 235589999999997 89999999999999998
Q ss_pred CCcEEEEeeccccccC
Q 008026 537 DMRAKVADFGLVRLAP 552 (580)
Q Consensus 537 ~~~~kl~Dfg~a~~~~ 552 (580)
++ ++|+|||..+...
T Consensus 171 ~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 171 NG-LRIIDLSGKRCTA 185 (232)
T ss_pred CC-EEEEECCCccccc
Confidence 88 9999999887653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-21 Score=187.88 Aligned_cols=215 Identities=19% Similarity=0.187 Sum_probs=119.8
Q ss_pred CchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccc
Q 008026 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS 113 (580)
Q Consensus 34 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 113 (580)
+|.+++.+..++.|+.++|+++..++++..+..|..|+.++|.+. ++|++++.+..|..|+..+|+++..|++++.+.+
T Consensus 83 lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~ 161 (565)
T KOG0472|consen 83 LPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSK 161 (565)
T ss_pred CCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccccCchHHHHHHH
Confidence 344444444444444444444433334444444444444444444 4444444444444444444444444444444444
Q ss_pred cccccccCCCCCCCCCCCchhHHHHH----------HHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCc
Q 008026 114 LDMAKGSNNFCLPSPGACDPRLNALL----------SVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183 (580)
Q Consensus 114 L~~l~l~~n~~~~~~~~~~~~l~~l~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~ 183 (580)
|..+++.+|++..+|++... +..+. .++..++-+..+...++..+.....| .+.....|..|+++.|.
T Consensus 162 l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~ 239 (565)
T KOG0472|consen 162 LSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQ 239 (565)
T ss_pred HHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccH
Confidence 44444444444444433322 22221 22222333333334444444444444 44444566667777777
Q ss_pred ccccCccccc-CCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC--CceeecCCCCCC
Q 008026 184 LTGTISPEFA-SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS--NAIVNTDGNPDI 253 (580)
Q Consensus 184 l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~--~~~~~~~~n~~~ 253 (580)
|. .+|.+.+ ++.+|..|||.+|+++ .+|+++.-|++|..||+|+|.+++..++.-. ...+.++|||..
T Consensus 240 i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 240 IE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred HH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchH
Confidence 76 6777766 7899999999999998 9999999999999999999999966554322 234677888854
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.8e-21 Score=182.34 Aligned_cols=248 Identities=19% Similarity=0.119 Sum_probs=181.3
Q ss_pred CCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccC-CcccccCCcc
Q 008026 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRD-NFFTGPVPDS 84 (580)
Q Consensus 7 ~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~-N~l~~~~P~~ 84 (580)
+||..+. ..-..+++..|++....+++|..+++|+.||||+|.|+.+-| +|.+|++|..|-+.+ |+|+ .+|..
T Consensus 60 eVP~~LP----~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~ 134 (498)
T KOG4237|consen 60 EVPANLP----PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKG 134 (498)
T ss_pred cCcccCC----CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhh
Confidence 4666663 233445566677777777888888888888888888887777 588888877765544 8888 77775
Q ss_pred -ccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCcc-------------
Q 008026 85 -LVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ------------- 149 (580)
Q Consensus 85 -~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~------------- 149 (580)
|++|.+|+.|.+.-|++.-+... |..+.+|..|.+..|.+..+....+..+..+..++...+...
T Consensus 135 ~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a 214 (498)
T KOG4237|consen 135 AFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLA 214 (498)
T ss_pred HhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHh
Confidence 88888888888888888777664 667777778888888888888777776666665554443200
Q ss_pred --ccccccC---------------------------------C-CCCCCCccc-eeccCCcEEEEEecCCcccccCcccc
Q 008026 150 --RFAENWK---------------------------------G-NDPCSDWIG-VTCTKGNITVINFQKMNLTGTISPEF 192 (580)
Q Consensus 150 --~~~~~~~---------------------------------~-~~~~~~~~~-~~~~~~~L~~L~ls~n~l~~~~p~~~ 192 (580)
.....|. + +.+...-|. -+-.+++|+.|+|++|+|++.-+.+|
T Consensus 215 ~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF 294 (498)
T KOG4237|consen 215 MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF 294 (498)
T ss_pred hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence 0000110 0 001111111 12345799999999999999999999
Q ss_pred cCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----CceeecCCCCCCCCCCCC
Q 008026 193 ASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGNPDIGKEKSS 259 (580)
Q Consensus 193 ~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~~~ 259 (580)
..+..+++|+|..|+|...--..|.++.+|+.|+|.+|+++-.-|-.++ ...+++-+|||.|+|...
T Consensus 295 e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 295 EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 9999999999999999855566889999999999999999977776654 345888999999998653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=165.73 Aligned_cols=147 Identities=17% Similarity=0.136 Sum_probs=112.3
Q ss_pred cCCcccceeeccCcEEEEEEE--EcCCcEEEEEEeeccccCh----------------------hhHHHHHHHHHHHHhc
Q 008026 395 NNFSEENILGRGGFGTVYKGE--LHDGTKIAVKRMEAGVISG----------------------KGLTEFKSEIAVLTKV 450 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 450 (580)
..|.+.+.||+|+||.||+|. ..+|+.||+|++....... .....+.+|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999998 4589999999987532110 0113467899999999
Q ss_pred CCCc--ccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC-cEecCC
Q 008026 451 RHRH--LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-FIHRDL 527 (580)
Q Consensus 451 ~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~-ivH~Dl 527 (580)
.+.. +++++++ ...++||||+++.++...... .......++..++.|++.++++||+ .+ |+||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Di 175 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDL 175 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCC
Confidence 7533 3344432 235899999999888654311 1234556678899999999999997 78 999999
Q ss_pred CCCCeEecCCCcEEEEeeccccccCCC
Q 008026 528 KPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 528 kp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
||+||+++ +++++|+|||.|......
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccCCc
Confidence 99999999 789999999999865543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=156.71 Aligned_cols=135 Identities=20% Similarity=0.178 Sum_probs=105.7
Q ss_pred ccceeeccCcEEEEEEEEcCCcEEEEEEeeccccC--hhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEEec
Q 008026 399 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 399 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
+...|++|+||+||.+.. .+.+++.+.+.....- .-....+.+|+++|+++. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998765 5788887776543221 112235789999999996 5889999886 4469999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC-CCCCeEecCCCcEEEEeeccccccCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
.|.+|.+.... ....++.|++.+|+++|+ .+|+|||| ||+|||++.++.++|+|||+|.....
T Consensus 81 ~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99888643310 113467899999999998 89999999 79999999999999999999985543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-20 Score=188.50 Aligned_cols=217 Identities=18% Similarity=0.179 Sum_probs=135.1
Q ss_pred cceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCcc-ccCCCCCcEE
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIV 94 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~-~~~l~~L~~L 94 (580)
+.-|+.+|++.|.+....-..|..-.+|++|+|++|+|+..-. .|.++.+|.+|.|++|+++ .+|.. |.+|++|+.|
T Consensus 148 l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~L 226 (873)
T KOG4194|consen 148 LPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESL 226 (873)
T ss_pred HhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhh
Confidence 4556667777775554444666666777777777777775544 4777777777777777777 66654 6667777777
Q ss_pred EccCCccccc-CCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCC-----------CC--
Q 008026 95 NMTNNLLQGP-VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN-----------DP-- 160 (580)
Q Consensus 95 ~L~~N~l~~~-~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~-----------~~-- 160 (580)
+|..|+|... --.|.++.+|+.|.+..|.|..+..+.|-.+..+.+++...+.+..+.+.|+-+ +.
T Consensus 227 dLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~ 306 (873)
T KOG4194|consen 227 DLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQ 306 (873)
T ss_pred hccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhh
Confidence 7777777654 334677777777777777777777777777766666666555555555444321 10
Q ss_pred ---CCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 161 ---CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 161 ---~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
...|. +| .+|+.|+||+|+|+..-+..|..|.+|++|+|++|++.-.--..|..+++|+.|||++|.+++.|.
T Consensus 307 rih~d~Ws--ft--qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IE 382 (873)
T KOG4194|consen 307 RIHIDSWS--FT--QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIE 382 (873)
T ss_pred eeecchhh--hc--ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEe
Confidence 00111 12 256666666666664445555556666666666666652223345666777777777777776655
Q ss_pred C
Q 008026 238 S 238 (580)
Q Consensus 238 ~ 238 (580)
+
T Consensus 383 D 383 (873)
T KOG4194|consen 383 D 383 (873)
T ss_pred c
Confidence 4
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.1e-18 Score=158.77 Aligned_cols=137 Identities=23% Similarity=0.348 Sum_probs=113.6
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccChh------hHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK------GLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+.||+|++|.||+|.. .+..|++|+......... ....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 578899998654322111 234678899999999999998887777777888999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
++|++|.+.+.. ... ....++.+++.+|.++|+ .+++|||++|.||+++ ++.++++|||.++..
T Consensus 81 ~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999999888732 111 678899999999999998 8999999999999999 788999999998764
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-20 Score=179.49 Aligned_cols=181 Identities=24% Similarity=0.302 Sum_probs=116.3
Q ss_pred CchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccc
Q 008026 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS 113 (580)
Q Consensus 34 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 113 (580)
.|+.++.+..|..|+..+|+++..++++..+..|..|++.+|++. .+|+..-+++.|+.||+..|-++.+||+++.+.+
T Consensus 129 l~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~ 207 (565)
T KOG0472|consen 129 LPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLETLPPELGGLES 207 (565)
T ss_pred cCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhhcCChhhcchhh
Confidence 334444444444444444444444444444444444444444444 4444433355555555555555555555555555
Q ss_pred cccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceec-cCCcEEEEEecCCcccccCcccc
Q 008026 114 LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC-TKGNITVINFQKMNLTGTISPEF 192 (580)
Q Consensus 114 L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~L~ls~n~l~~~~p~~~ 192 (580)
|+.|++..|+|..+| .|+....+.++ ..+.+...-+|...| .+.+|..|||..|++. ..|+++
T Consensus 208 L~~LyL~~Nki~~lP--ef~gcs~L~El-------------h~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~ 271 (565)
T KOG0472|consen 208 LELLYLRRNKIRFLP--EFPGCSLLKEL-------------HVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEI 271 (565)
T ss_pred hHHHHhhhcccccCC--CCCccHHHHHH-------------HhcccHHHhhHHHHhcccccceeeeccccccc-cCchHH
Confidence 555555555555555 23333333333 334444455666666 5689999999999999 899999
Q ss_pred cCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 193 ASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 193 ~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
.-+.+|++||+|+|.|+ .+|.+++++ .|+.|.+.+|++.
T Consensus 272 clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 272 CLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred HHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH
Confidence 99999999999999999 899999999 8999999999997
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.6e-18 Score=157.07 Aligned_cols=140 Identities=22% Similarity=0.195 Sum_probs=109.3
Q ss_pred CCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccCh--------------------hhHHHHHHHHHHHHhcCCCc-
Q 008026 396 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG--------------------KGLTEFKSEIAVLTKVRHRH- 454 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~n- 454 (580)
.|.+.+.||+|+||.||++...+|+.||||++....... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 477889999999999999988889999999876432100 01123677899999998774
Q ss_pred -ccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeE
Q 008026 455 -LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533 (580)
Q Consensus 455 -iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 533 (580)
++..++ ....++||||+++++|..... ......++.+++.++.++|+ .+|+||||||+||+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nil 157 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNIL 157 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEE
Confidence 444443 244589999999999865431 02345788899999999998 89999999999999
Q ss_pred ecCCCcEEEEeeccccccCC
Q 008026 534 LGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 534 l~~~~~~kl~Dfg~a~~~~~ 553 (580)
+++++.++|+|||.+.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=154.50 Aligned_cols=134 Identities=23% Similarity=0.339 Sum_probs=107.8
Q ss_pred eeeccCcEEEEEEEEcCCcEEEEEEeeccccCh------hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 402 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG------KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 402 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
.||+|+||.||+|.+ ++..|++|......... ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 47889999865432211 12356778999999999887766666666677789999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
+|++|.+.+... . . .++.+++.+|.++|+ .+++|||++|+||+++ ++.++++|||.++...
T Consensus 80 ~g~~l~~~~~~~------~-----~-~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG------N-----D-ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc------H-----H-HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999998876321 0 0 678899999999998 8999999999999999 7899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-17 Score=177.64 Aligned_cols=144 Identities=22% Similarity=0.293 Sum_probs=114.5
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccCh------hhHHHHHHHHHHHHhcCCCcccceeeEEEc
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG------KGLTEFKSEIAVLTKVRHRHLVALLGHCLD 464 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 464 (580)
+.....|...+.||+|+||.||+|.+.+. .+++|+...+.... ...+++.+|+++++.++|++++....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33344567789999999999999987543 44445432221111 123568899999999999999988888877
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
....++||||+++++|.+++. ....++.+++.+|.|||+ .+++|||+||+||++ +++.++|+|
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEe
Confidence 778899999999999988773 245788999999999997 899999999999999 577999999
Q ss_pred eccccccC
Q 008026 545 FGLVRLAP 552 (580)
Q Consensus 545 fg~a~~~~ 552 (580)
||+++...
T Consensus 471 FGla~~~~ 478 (535)
T PRK09605 471 FGLGKYSD 478 (535)
T ss_pred CcccccCC
Confidence 99998654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.6e-17 Score=163.47 Aligned_cols=173 Identities=33% Similarity=0.532 Sum_probs=143.0
Q ss_pred CcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChh-hHHHHHHHHHHHHhcCCC-cccceeeEEEcCCeeEEEEEe
Q 008026 397 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKVRHR-HLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 474 (580)
|.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+..++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999776 7889999987544432 567899999999999988 799999999777778999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC-cEEEEeeccccccCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPE 553 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 553 (580)
+.++++.+++...... ..+.......++.|++.+++|+|+ .+++|||+||+||+++..+ .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999998655321110 267888999999999999999997 7899999999999999888 799999999985544
Q ss_pred CCCC-----ccccccccCCccCccccCC
Q 008026 554 GKGS-----IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~-----~~~~~~Gt~~y~APE~~~~ 576 (580)
.... ......||..|+|||.+.+
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred CCccccccccccccccccccCCHHHhcC
Confidence 3321 2345679999999999876
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-19 Score=151.29 Aligned_cols=181 Identities=18% Similarity=0.242 Sum_probs=152.7
Q ss_pred cceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEc
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L 96 (580)
+..+..+-++.|+ ++..|+.++.|.+|+.|++++|+|+..++.++.|+.|+.|+++-|++. .+|..|+.++.|+.|||
T Consensus 32 ~s~ITrLtLSHNK-l~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 32 MSNITRLTLSHNK-LTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhhcccCc-eeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 4555556667774 556778899999999999999999988889999999999999999999 99999999999999999
Q ss_pred cCCcccc-cCC-CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 97 TNNLLQG-PVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 97 ~~N~l~~-~~~-~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
..|++.. ..| .|+.+..|.-|+++.|-+.-+|++ .+++++|
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~d-------------------------------------vg~lt~l 152 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPD-------------------------------------VGKLTNL 152 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCChh-------------------------------------hhhhcce
Confidence 9999975 455 488888888888888876655544 4456699
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCC---CEEEccCCcccccCCC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGAL---KELDVSNNQLYGKIPS 238 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L---~~l~ls~N~l~g~~p~ 238 (580)
+.|.+..|.+. .+|.+++.++.|++|++.+|++. .+|.+++++.-+ +.+.+.+|.+-.+|..
T Consensus 153 qil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIae 217 (264)
T KOG0617|consen 153 QILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIAE 217 (264)
T ss_pred eEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHH
Confidence 99999999999 89999999999999999999999 999998886533 5566777877666554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-17 Score=159.35 Aligned_cols=133 Identities=29% Similarity=0.423 Sum_probs=112.1
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-----C---CcccceeeEEEc-
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----H---RHLVALLGHCLD- 464 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~- 464 (580)
.+|.+.++||-|-|++||+|.+ .+.+.||+|+.+.. ....+....||++|++++ | ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 7899999999999999999965 46789999998752 334466788999999984 2 379999999975
Q ss_pred ---CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC
Q 008026 465 ---GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 536 (580)
Q Consensus 465 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 536 (580)
+.++|||+|++ |.+|..+|.. ...+.++...+..|++||+.||.|||. +.+|||-||||+|||+..
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCS 223 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeec
Confidence 45789999999 6688888855 445678899999999999999999998 579999999999999954
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=7e-17 Score=175.07 Aligned_cols=91 Identities=18% Similarity=0.097 Sum_probs=48.5
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCC-----------------C
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG-----------------V 64 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----------------l 64 (580)
|+|+ ++|..+. .+++ .++++.|++. .+|. .+++|++|+|++|+|+..++.+.+ +
T Consensus 211 ~~Lt-sLP~~l~-~~L~---~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~LtsLP~lp~sL~~L~Ls~N~L~~Lp~lp 281 (788)
T PRK15387 211 SGLT-TLPDCLP-AHIT---TLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALP 281 (788)
T ss_pred CCCC-cCCcchh-cCCC---EEEccCCcCC-CCCC---CCCCCcEEEecCCccCcccCcccccceeeccCCchhhhhhch
Confidence 4454 6787774 2333 4445455433 3443 246777778877777754321110 1
Q ss_pred CCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccC
Q 008026 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 105 (580)
Q Consensus 65 ~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~ 105 (580)
++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++++
T Consensus 282 ~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp 318 (788)
T PRK15387 282 SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLP 318 (788)
T ss_pred hhcCEEECcCCccc-ccccc---ccccceeECCCCccccCC
Confidence 23344445555554 44432 356777777777777654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-16 Score=145.79 Aligned_cols=140 Identities=20% Similarity=0.203 Sum_probs=100.1
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHH----------------------HHHHHHHHHhcCCCc--c
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE----------------------FKSEIAVLTKVRHRH--L 455 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~n--i 455 (580)
.+.||+|+||.||+|...+++.||||++............ ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998878999999998754322111111 135666666665433 4
Q ss_pred cceeeEEEcCCeeEEEEEecCCCChhHH-HHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 456 VALLGHCLDGNEKLLVFEYMPQGTLSRH-IFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 456 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
.+.+++ ...++||||++++.+... +... ... .++..++.+++.++.++|. ..+|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEE
Confidence 444443 245899999998554321 1110 001 5577899999999999996 3789999999999999
Q ss_pred cCCCcEEEEeeccccccCC
Q 008026 535 GDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~~~ 553 (580)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.8e-17 Score=176.23 Aligned_cols=202 Identities=16% Similarity=0.211 Sum_probs=120.8
Q ss_pred CCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCcccc
Q 008026 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLV 86 (580)
Q Consensus 7 ~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~ 86 (580)
.+|..+. ..|..++++.|++. .+|..+. ++|++|+|++|+|+..+..+. .+|+.|+|++|++. .+|..+.
T Consensus 192 sLP~~Ip----~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~ 261 (754)
T PRK15370 192 TIPACIP----EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP 261 (754)
T ss_pred cCCcccc----cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh
Confidence 4676663 34555666667544 5665554 589999999999986544442 47999999999998 8898774
Q ss_pred CCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCc--------cccccccCCC
Q 008026 87 KLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP--------QRFAENWKGN 158 (580)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~--------~~~~~~~~~~ 158 (580)
++|+.|+|++|+|+.++..+. .+|+.|++++|.+..+|...+..+..| ....+.+ ..+......+
T Consensus 262 --s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp~sL~~L---~Ls~N~Lt~LP~~l~~sL~~L~Ls~ 334 (754)
T PRK15370 262 --SALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIRTLPAHLPSGITHL---NVQSNSLTALPETLPPGLKTLEAGE 334 (754)
T ss_pred --CCCCEEECcCCccCccccccC--CCCcEEECCCCccccCcccchhhHHHH---HhcCCccccCCccccccceeccccC
Confidence 589999999999997665554 478999999999998886655433332 1111111 1122222333
Q ss_pred CCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 159 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 159 ~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
+.+..+|+.++ ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+
T Consensus 335 N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~ 401 (754)
T PRK15370 335 NALTSLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV 401 (754)
T ss_pred CccccCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc
Confidence 33333333222 24555555555554 3444332 34555555555555 4444433 23555555555554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=140.28 Aligned_cols=136 Identities=21% Similarity=0.222 Sum_probs=112.6
Q ss_pred ccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCC--CcccceeeEEEcCCeeEEEEEecC
Q 008026 399 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 399 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| ..+++++++....+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 35779999999999998754 7899998765322 4578899999999986 588999988888888999999998
Q ss_pred CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 477 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
++.+..+ +......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8777532 34556678899999999999743357999999999999999899999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.7e-16 Score=171.56 Aligned_cols=173 Identities=23% Similarity=0.224 Sum_probs=135.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcC---CCcccceeeEEEcCCeeE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~ 469 (580)
...|.+.+.||+|+||+||+|...+|+.||+|+=+.... .-....+ ++.+|+ -+.|+.+...+...+..+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHccCCcce
Confidence 457899999999999999999888899999997654321 1122223 333333 356777777777788899
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-------CCcEEE
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------DMRAKV 542 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl 542 (580)
+|+||.+.|+|.+++. ..+.++|..++.+..|++.-+++||. .+|||+||||+|+||.. .--++|
T Consensus 771 lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 9999999999999983 55689999999999999999999997 89999999999999942 234899
Q ss_pred EeeccccccCCCC-CCccccccccCCccCccccCCCCCC
Q 008026 543 ADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 543 ~Dfg~a~~~~~~~-~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+|||.+-.+.--. +..-...++|-.+-.+|+..|.+|+
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt 881 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT 881 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc
Confidence 9999986543221 1233446788899999999999985
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.5e-18 Score=178.42 Aligned_cols=218 Identities=22% Similarity=0.226 Sum_probs=127.4
Q ss_pred ceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEcc
Q 008026 18 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97 (580)
Q Consensus 18 ~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~ 97 (580)
+.|..++++.| .++.+|+.++.+.+|+.|..++|+|+..+-.+..+++|+.|++..|.++ .+|+....+++|+.|+|.
T Consensus 241 ~nl~~~dis~n-~l~~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 241 LNLQYLDISHN-NLSNLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred ccceeeecchh-hhhcchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 34444555555 3344555556666666666666665433334555555555555555555 555555555555555555
Q ss_pred CCcccccCCCC--------------------------CcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCcccc
Q 008026 98 NNLLQGPVPEF--------------------------DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRF 151 (580)
Q Consensus 98 ~N~l~~~~~~~--------------------------~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~ 151 (580)
.|+|...++.+ .....|+.|.+.+|.+++- +++-+.... .+
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~---c~p~l~~~~----------hL 385 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDS---CFPVLVNFK----------HL 385 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccccc---chhhhcccc----------ce
Confidence 55555544411 0112344444555544321 221111111 11
Q ss_pred ccccCCCCCCCCccce-eccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCC
Q 008026 152 AENWKGNDPCSDWIGV-TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 230 (580)
Q Consensus 152 ~~~~~~~~~~~~~~~~-~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N 230 (580)
....+.+|.+..+|.. +-++..|+.|+||+|+|+ .+|..+.+|+.|+.|...+|+|. ..| ++..+++|+++|+|.|
T Consensus 386 KVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N 462 (1081)
T KOG0618|consen 386 KVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCN 462 (1081)
T ss_pred eeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccc
Confidence 1112222222222221 112236888899999999 89999999999999999999998 888 8999999999999999
Q ss_pred cccc-cCCCCC---CCceeecCCCCCC
Q 008026 231 QLYG-KIPSFK---SNAIVNTDGNPDI 253 (580)
Q Consensus 231 ~l~g-~~p~~~---~~~~~~~~~n~~~ 253 (580)
+|+. .+|... ....++++||.|.
T Consensus 463 ~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 463 NLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhhhhhhhhhCCCcccceeeccCCccc
Confidence 9983 444433 3456899999975
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.3e-15 Score=142.92 Aligned_cols=138 Identities=20% Similarity=0.246 Sum_probs=105.0
Q ss_pred ceee-ccCcEEEEEEEEcCCcEEEEEEeecccc-----------ChhhHHHHHHHHHHHHhcCCCcc--cceeeEEEcCC
Q 008026 401 NILG-RGGFGTVYKGELHDGTKIAVKRMEAGVI-----------SGKGLTEFKSEIAVLTKVRHRHL--VALLGHCLDGN 466 (580)
Q Consensus 401 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 466 (580)
..|| .|+.|+||.+... +..+++|.+..... ......++.+|++++.+++|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8899999998775 77899998854211 11233568899999999998875 66676644332
Q ss_pred ----eeEEEEEecCC-CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEE
Q 008026 467 ----EKLLVFEYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541 (580)
Q Consensus 467 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 541 (580)
..++||||+++ .+|.+++.. ..++.. .+.+++.++.+||+ .+|+||||||+|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 23599999997 688877632 234433 35689999999998 8999999999999999888999
Q ss_pred EEeeccccccC
Q 008026 542 VADFGLVRLAP 552 (580)
Q Consensus 542 l~Dfg~a~~~~ 552 (580)
|+|||.++...
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-16 Score=167.52 Aligned_cols=174 Identities=24% Similarity=0.295 Sum_probs=132.7
Q ss_pred cccceeeccCcEEEEEEEEc-CCcEEEEEEee----ccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 398 SEENILGRGGFGTVYKGELH-DGTKIAVKRME----AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
....++|.|++|.|+.+... ..+..+.|... ...........+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988777433 34444555433 11111112223667888888899999998888777776666669
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
|||++ +|...+.. ...+....+..++.|+..|++|+|+ .+|.|||+|++|++++..|.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 99888743 1356777888899999999999998 899999999999999999999999999987554
Q ss_pred CCCC---CccccccccCCccCccccCCCCCC
Q 008026 553 EGKG---SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~---~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.+.. .....++|+..|+|||++.+.+|.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd 502 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYD 502 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccC
Confidence 3322 344567899999999999998874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-16 Score=176.45 Aligned_cols=124 Identities=17% Similarity=0.173 Sum_probs=88.3
Q ss_pred hcCC-CcccceeeEE-------EcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCC
Q 008026 449 KVRH-RHLVALLGHC-------LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520 (580)
Q Consensus 449 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~ 520 (580)
.++| +||..+++++ ......+.++||+ +++|.+++.. ....+++.+++.++.||+.||+|||+ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHS---Q 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHh---C
Confidence 3445 5777788877 2234567888887 6699998842 23468999999999999999999997 8
Q ss_pred CcEecCCCCCCeEecCCC-------------------cEEEEeeccccccCCCC---------------CCccccccccC
Q 008026 521 SFIHRDLKPSNILLGDDM-------------------RAKVADFGLVRLAPEGK---------------GSIETRIAGTF 566 (580)
Q Consensus 521 ~ivH~Dlkp~NIll~~~~-------------------~~kl~Dfg~a~~~~~~~---------------~~~~~~~~Gt~ 566 (580)
+||||||||+|||++..+ .+|++|||+++...... ........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999999999996544 45556666554321100 00011245899
Q ss_pred CccCccccCCCCCC
Q 008026 567 GYLAPEYAGNFGSS 580 (580)
Q Consensus 567 ~y~APE~~~~~~~~ 580 (580)
.|||||++.+..|+
T Consensus 180 ~Y~APE~~~~~~~~ 193 (793)
T PLN00181 180 WYTSPEEDNGSSSN 193 (793)
T ss_pred ceEChhhhccCCCC
Confidence 99999999887663
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.6e-16 Score=168.56 Aligned_cols=211 Identities=18% Similarity=0.190 Sum_probs=147.7
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccC
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV 81 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~ 81 (580)
|+|+ .+|..+. .+|+.+++++|++ +.+|..+. .+|+.|+|++|.+...++.+. ++|+.|+|++|+|+ .+
T Consensus 209 N~Lt-sLP~~l~----~nL~~L~Ls~N~L-tsLP~~l~--~~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls~N~L~-~L 277 (754)
T PRK15370 209 NELK-SLPENLQ----GNIKTLYANSNQL-TSIPATLP--DTIQEMELSINRITELPERLP--SALQSLDLFHNKIS-CL 277 (754)
T ss_pred CCCC-cCChhhc----cCCCEEECCCCcc-ccCChhhh--ccccEEECcCCccCcCChhHh--CCCCEEECcCCccC-cc
Confidence 4454 5777663 3455556666654 45676553 479999999999985443443 57899999999998 78
Q ss_pred CccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhh-C----CccccccccC
Q 008026 82 PDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLM-G----YPQRFAENWK 156 (580)
Q Consensus 82 P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~-~----~~~~~~~~~~ 156 (580)
|..+. ++|+.|+|++|+|+++++.+. .+|+.|++++|.+..+|...+..+..|.-....+ . .+..+....+
T Consensus 278 P~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~L 353 (754)
T PRK15370 278 PENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTALPETLPPGLKTLEAGENALTSLPASLPPELQVLDV 353 (754)
T ss_pred ccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCccccCCccccccceeccccCCccccCChhhcCcccEEEC
Confidence 88764 589999999999988765543 3678888888888877765554443331100000 0 1123444455
Q ss_pred CCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcC----CCCCCEEEccCCcc
Q 008026 157 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV----LGALKELDVSNNQL 232 (580)
Q Consensus 157 ~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~----l~~L~~l~ls~N~l 232 (580)
.++.+..+|+.+. ++|+.|+|++|+|+ .+|+.+. .+|+.|++++|+|. .+|..+.. ++.+..|+|.+|++
T Consensus 354 s~N~L~~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npl 427 (754)
T PRK15370 354 SKNQITVLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPF 427 (754)
T ss_pred CCCCCCcCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCc
Confidence 6666666665443 58999999999999 6888765 47999999999998 78876544 57889999999999
Q ss_pred c
Q 008026 233 Y 233 (580)
Q Consensus 233 ~ 233 (580)
+
T Consensus 428 s 428 (754)
T PRK15370 428 S 428 (754)
T ss_pred c
Confidence 7
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.8e-15 Score=161.99 Aligned_cols=91 Identities=29% Similarity=0.420 Sum_probs=71.0
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC-----ceee
Q 008026 172 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-----AIVN 246 (580)
Q Consensus 172 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~-----~~~~ 246 (580)
.+|+.|+|++|++.|.+|..++.|++|+.|+|++|+++|.+|+.++.+++|+.|+|++|+|+|.+|..+.. ..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 36777777788888788888888888888888888888888888888888888888888888888876543 2477
Q ss_pred cCCCCCCCCCCCCCCC
Q 008026 247 TDGNPDIGKEKSSSFQ 262 (580)
Q Consensus 247 ~~~n~~~c~~~~~~~~ 262 (580)
+.+|++.|+.+....|
T Consensus 522 ~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 522 FTDNAGLCGIPGLRAC 537 (623)
T ss_pred ecCCccccCCCCCCCC
Confidence 8899999976543344
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=167.74 Aligned_cols=239 Identities=19% Similarity=0.155 Sum_probs=150.6
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSL 85 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~ 85 (580)
..+|..|. ...|..+++.+|+ +..++..+..+++|+.|+|++|...+.+|.++.+++|+.|+|++|.....+|..+
T Consensus 602 ~~lP~~f~---~~~L~~L~L~~s~-l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si 677 (1153)
T PLN03210 602 RCMPSNFR---PENLVKLQMQGSK-LEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSI 677 (1153)
T ss_pred CCCCCcCC---ccCCcEEECcCcc-ccccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhh
Confidence 34455442 3556666666664 4556777888999999999988766677888889999999999887666899999
Q ss_pred cCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHH-------HHHHHhhCCccccccccCCC
Q 008026 86 VKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-------LSVVKLMGYPQRFAENWKGN 158 (580)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l-------~~~~~~~~~~~~~~~~~~~~ 158 (580)
+++++|+.|++++|...+.+|...++.+|+.|++++|......+....++..+ ..++... .+..+....+.+
T Consensus 678 ~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~ 756 (1153)
T PLN03210 678 QYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNL-RLENLDELILCE 756 (1153)
T ss_pred hccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCccccccccc-cccccccccccc
Confidence 99999999999987444444443467788888888775443333222221111 0000000 000000000000
Q ss_pred CC-------CCCc-cceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCC
Q 008026 159 DP-------CSDW-IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 230 (580)
Q Consensus 159 ~~-------~~~~-~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N 230 (580)
.. .... +......++|+.|+|++|...+.+|.++++|++|+.|+|++|...+.+|..+ .+++|+.|++++|
T Consensus 757 ~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c 835 (1153)
T PLN03210 757 MKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGC 835 (1153)
T ss_pred cchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCC
Confidence 00 0000 0011123578889999988887889999999999999998875555888766 6888888888887
Q ss_pred cccccCCCCCCC-ceeecCCC
Q 008026 231 QLYGKIPSFKSN-AIVNTDGN 250 (580)
Q Consensus 231 ~l~g~~p~~~~~-~~~~~~~n 250 (580)
.....+|....+ ..+++.+|
T Consensus 836 ~~L~~~p~~~~nL~~L~Ls~n 856 (1153)
T PLN03210 836 SRLRTFPDISTNISDLNLSRT 856 (1153)
T ss_pred CccccccccccccCEeECCCC
Confidence 666666654322 23444444
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-13 Score=150.31 Aligned_cols=176 Identities=18% Similarity=0.188 Sum_probs=103.4
Q ss_pred EecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCc
Q 008026 21 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100 (580)
Q Consensus 21 ~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~ 100 (580)
..++++.+.+ +.+|+.+. ++|+.|+|++|+|+.. |.+ +++|++|+|++|+|+ .+|.. .++|+.|+|++|.
T Consensus 204 ~~LdLs~~~L-tsLP~~l~--~~L~~L~L~~N~Lt~L-P~l--p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 204 AVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLTSL-PAL--PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNP 273 (788)
T ss_pred cEEEcCCCCC-CcCCcchh--cCCCEEEccCCcCCCC-CCC--CCCCcEEEecCCccC-cccCc---ccccceeeccCCc
Confidence 3456666744 46787775 4899999999999964 432 589999999999999 78854 3456666666666
Q ss_pred ccccCCCCC-----------------cccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC
Q 008026 101 LQGPVPEFD-----------------RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 163 (580)
Q Consensus 101 l~~~~~~~~-----------------~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (580)
|+.+++.+. ...+|+.|++++|.+..+|.. +. .+...+..++.+..
T Consensus 274 L~~Lp~lp~~L~~L~Ls~N~Lt~LP~~p~~L~~LdLS~N~L~~Lp~l-p~----------------~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 274 LTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLASLPAL-PS----------------ELCKLWAYNNQLTS 336 (788)
T ss_pred hhhhhhchhhcCEEECcCCccccccccccccceeECCCCccccCCCC-cc----------------cccccccccCcccc
Confidence 655433111 113455555666655555431 11 12223333344433
Q ss_pred ccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 164 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 164 ~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
+|... .+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|... .+|+.|++++|+|++
T Consensus 337 LP~lp---~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt~ 396 (788)
T PRK15387 337 LPTLP---SGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS 396 (788)
T ss_pred ccccc---cccceEecCCCccC-CCCCCC---cccceehhhccccc-cCcccc---cccceEEecCCcccC
Confidence 33211 36777777777777 455432 34555566666665 455432 345566666666653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.7e-16 Score=155.29 Aligned_cols=181 Identities=20% Similarity=0.225 Sum_probs=121.1
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
.|..-...+++.|+ ...+|..++.+..|+.+.|+.|.|..+++.+.+|..|++|||+.|+++ .+|..++.|+ |+.|-
T Consensus 73 ~ltdt~~aDlsrNR-~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 73 DLTDTVFADLSRNR-FSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred cccchhhhhccccc-cccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 45666777787774 456788888888899999999998866667888889999999999998 8898888886 88888
Q ss_pred ccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEE
Q 008026 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175 (580)
Q Consensus 96 L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 175 (580)
+++|+++..++.++.+..|..|+.+.|.+..+|+... .+..+..+....+ ....+|..+|.+ .|.
T Consensus 150 ~sNNkl~~lp~~ig~~~tl~~ld~s~nei~slpsql~-~l~slr~l~vrRn-------------~l~~lp~El~~L-pLi 214 (722)
T KOG0532|consen 150 VSNNKLTSLPEEIGLLPTLAHLDVSKNEIQSLPSQLG-YLTSLRDLNVRRN-------------HLEDLPEELCSL-PLI 214 (722)
T ss_pred EecCccccCCcccccchhHHHhhhhhhhhhhchHHhh-hHHHHHHHHHhhh-------------hhhhCCHHHhCC-cee
Confidence 9999999888888877788888888888877775432 2333333322211 111233333322 344
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccC
Q 008026 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 216 (580)
Q Consensus 176 ~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l 216 (580)
.||+|.|+++ .||-.|.+|+.|++|-|.+|.|. .-|.+|
T Consensus 215 ~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 215 RLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred eeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 5555555555 45555555555555555555554 444444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-15 Score=155.22 Aligned_cols=160 Identities=26% Similarity=0.318 Sum_probs=132.6
Q ss_pred eeccCcEEEEEEEE----cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEEecCC
Q 008026 403 LGRGGFGTVYKGEL----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 403 lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+|+|+||.|+.++. +.+.-+|.|+.++.............|..++..++ ||.+++++..++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999998743 23677899988765443333335566888889987 99999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
|++...+. ....+++.....+...++-|++++|. .+|+|||+|++||+++.+|.+++.|||.++.......
T Consensus 82 g~lft~l~-----~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 82 GDLFTRLS-----KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred chhhhccc-----cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99977663 23456677777788899999999997 8999999999999999999999999999987755432
Q ss_pred ccccccccCCccCccccC
Q 008026 558 IETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~ 575 (580)
.+||..|||||++.
T Consensus 153 ----~cgt~eymApEI~~ 166 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN 166 (612)
T ss_pred ----cccchhhhhhHhhh
Confidence 18999999999988
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=143.98 Aligned_cols=147 Identities=24% Similarity=0.321 Sum_probs=100.6
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChh--h------------------------------------
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK--G------------------------------------ 436 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~------------------------------------ 436 (580)
..|+ .+.||.|++|+||+|+.++|+.||||+.+......- +
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3344 468999999999999999999999999865321100 0
Q ss_pred HHHHHHHHHHHHhcC-----CCcccceeeEE-EcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHH-
Q 008026 437 LTEFKSEIAVLTKVR-----HRHLVALLGHC-LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR- 509 (580)
Q Consensus 437 ~~~~~~E~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~- 509 (580)
.-++.+|++.+.+++ ++++ .+-..+ ......++||||++|++|.+...... . ..+ ...++.+++.
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~---~~~---~~~ia~~~~~~ 268 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-A---GLD---RKALAENLARS 268 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh-c---CCC---HHHHHHHHHHH
Confidence 012445666555552 3332 222222 22345799999999999988753211 1 112 3346666665
Q ss_pred HHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 510 aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
.+..+|. .+++|+|+||.||+++++++++++|||++.....
T Consensus 269 ~l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 269 FLNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 4677886 8999999999999999999999999999976643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-15 Score=160.55 Aligned_cols=225 Identities=20% Similarity=0.205 Sum_probs=174.6
Q ss_pred eEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccC
Q 008026 19 SLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 98 (580)
Q Consensus 19 ~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~ 98 (580)
.|+.++-+.|.+++..+. ..-.+|++++++.|++++.+..++.+.+|+.|+..+|+|. .+|..+...++|+.|.+..
T Consensus 220 ~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~ 296 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAY 296 (1081)
T ss_pred chheeeeccCcceeeccc--cccccceeeecchhhhhcchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhh
Confidence 344444555655543332 2235899999999999977744688999999999999998 9999999999999999999
Q ss_pred CcccccCCCCCcccccccccccCCCCCCCCCCCchhHHH-HHHHHHhhCCcc-----------ccccccCCCCCCCC--c
Q 008026 99 NLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNA-LLSVVKLMGYPQ-----------RFAENWKGNDPCSD--W 164 (580)
Q Consensus 99 N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~-l~~~~~~~~~~~-----------~~~~~~~~~~~~~~--~ 164 (580)
|.++-++|.....++|+.|++..|.+...|...+..+.. +..++.....++ .+..+...+|.+.+ |
T Consensus 297 nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~ 376 (1081)
T KOG0618|consen 297 NELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCF 376 (1081)
T ss_pred hhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccch
Confidence 999999999999999999999999999999866655444 444444333222 22333344555543 5
Q ss_pred cceeccCCcEEEEEecCCcccccCccc-ccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCC---
Q 008026 165 IGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK--- 240 (580)
Q Consensus 165 ~~~~~~~~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~--- 240 (580)
|...+ ..+|+.|+|++|+|. .+|+. +.+|..|++|+||+|+|+ .+|+.+..++.|++|...+|++. .+|+..
T Consensus 377 p~l~~-~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~ 452 (1081)
T KOG0618|consen 377 PVLVN-FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLP 452 (1081)
T ss_pred hhhcc-ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcC
Confidence 55444 458999999999999 67664 688999999999999999 99999999999999999999999 667553
Q ss_pred CCceeecCCC
Q 008026 241 SNAIVNTDGN 250 (580)
Q Consensus 241 ~~~~~~~~~n 250 (580)
+...++++.|
T Consensus 453 qL~~lDlS~N 462 (1081)
T KOG0618|consen 453 QLKVLDLSCN 462 (1081)
T ss_pred cceEEecccc
Confidence 3345666666
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-13 Score=161.07 Aligned_cols=220 Identities=15% Similarity=0.158 Sum_probs=150.6
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCcc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 84 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~ 84 (580)
..+|.++ ..+..|+.++++.+..++.+|+ +..+++|++|+|++|.....+| .+..+++|+.|++++|..-+.+|..
T Consensus 624 ~~L~~~~--~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~ 700 (1153)
T PLN03210 624 EKLWDGV--HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG 700 (1153)
T ss_pred ccccccc--ccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc
Confidence 4566666 5678888888888777777764 8889999999999987655666 6888999999999987554588987
Q ss_pred ccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHh------------------hC
Q 008026 85 LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL------------------MG 146 (580)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~------------------~~ 146 (580)
+ ++++|+.|+|++|...+..|.+ ..+|+.|++++|.+..+|... .+.+|..+... ..
T Consensus 701 i-~l~sL~~L~Lsgc~~L~~~p~~--~~nL~~L~L~~n~i~~lP~~~--~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~ 775 (1153)
T PLN03210 701 I-NLKSLYRLNLSGCSRLKSFPDI--STNISWLDLDETAIEEFPSNL--RLENLDELILCEMKSEKLWERVQPLTPLMTM 775 (1153)
T ss_pred C-CCCCCCEEeCCCCCCccccccc--cCCcCeeecCCCccccccccc--cccccccccccccchhhccccccccchhhhh
Confidence 7 7999999999998665555543 357888899999888887643 12222211110 01
Q ss_pred CccccccccCCCCC-CCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEE
Q 008026 147 YPQRFAENWKGNDP-CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 225 (580)
Q Consensus 147 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l 225 (580)
.+..+....+.+++ ...+|..+..+++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|
T Consensus 776 ~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L 851 (1153)
T PLN03210 776 LSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDL 851 (1153)
T ss_pred ccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEe
Confidence 12233444444443 34577778888899999999986666788765 6777777777776444355542 2456666
Q ss_pred EccCCcccccCCC
Q 008026 226 DVSNNQLYGKIPS 238 (580)
Q Consensus 226 ~ls~N~l~g~~p~ 238 (580)
+|++|.++ .+|.
T Consensus 852 ~Ls~n~i~-~iP~ 863 (1153)
T PLN03210 852 NLSRTGIE-EVPW 863 (1153)
T ss_pred ECCCCCCc-cChH
Confidence 66666665 3443
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7e-15 Score=141.46 Aligned_cols=229 Identities=19% Similarity=0.199 Sum_probs=178.7
Q ss_pred cccccCCCC-CccccccceEEecccCCCCCCCCCchhhcCcccCceEeccc-CcCcCCCC-CCCCCCCCcEEeccCCccc
Q 008026 2 LQLIGGLPA-SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS-NAFSGPLP-DFSGVKQLESLSLRDNFFT 78 (580)
Q Consensus 2 ~~~~~~~P~-~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~L~~N~l~ 78 (580)
|++ ..||+ .| +.+.+|+.+++++|++..+.|++|..|++|.+|-+.+ |+|+..+. .|.+|..|+.|.+.-|++.
T Consensus 77 N~I-~~iP~~aF--~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~ 153 (498)
T KOG4237|consen 77 NQI-SSIPPGAF--KTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHIN 153 (498)
T ss_pred CCc-ccCChhhc--cchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhc
Confidence 444 45565 57 7899999999999999999999999999999887766 99997766 4999999999999999999
Q ss_pred ccCCccccCCCCCcEEEccCCcccccCC-CCCcccccccccccCCCCC------------CCCCCC---ch---------
Q 008026 79 GPVPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCL------------PSPGAC---DP--------- 133 (580)
Q Consensus 79 ~~~P~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~l~l~~n~~~------------~~~~~~---~~--------- 133 (580)
-...+.|..|++|..|.|.+|.+..+.. .|..+.+++.+++..|... ..-+.. +.
T Consensus 154 Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~ 233 (498)
T KOG4237|consen 154 CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYY 233 (498)
T ss_pred chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHH
Confidence 4445569999999999999999998877 5888888888888777611 100000 00
Q ss_pred ----------hHHHHHHHH---------------HhhCCccccccccCCCCCCCC-ccceeccCCcEEEEEecCCccccc
Q 008026 134 ----------RLNALLSVV---------------KLMGYPQRFAENWKGNDPCSD-WIGVTCTKGNITVINFQKMNLTGT 187 (580)
Q Consensus 134 ----------~l~~l~~~~---------------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~L~~L~ls~n~l~~~ 187 (580)
-...+++++ +.+..++.+....++++.... -.+++.....|+.|.|..|+|.-.
T Consensus 234 ~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v 313 (498)
T KOG4237|consen 234 KRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFV 313 (498)
T ss_pred HHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHH
Confidence 011111221 122345566666777777765 455677778999999999999966
Q ss_pred CcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 188 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 188 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
--..|.++.+|+.|+|.+|+|+..-|.+|..+..|..|.|-.|.+.
T Consensus 314 ~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 314 SSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred HHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 6667899999999999999999888999999999999999999886
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.9e-14 Score=131.73 Aligned_cols=169 Identities=21% Similarity=0.425 Sum_probs=132.1
Q ss_pred cccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 398 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
.+..+|.+...|+.|+|+++ |..+++|++..........++|..|.-.++.+.||||+.+++.|.......++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34456888999999999998 66677788877666655667899999999999999999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcE-ecCCCCCCeEecCCCcEEEEeeccccccCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI-HRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iv-H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 556 (580)
|+|...+++ ...-..+..++.+++.+|++|++|||+. .+++ ---+.+..+++|++.+++|+ .+-+++.-...+
T Consensus 272 gslynvlhe---~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltaris-mad~kfsfqe~g 345 (448)
T KOG0195|consen 272 GSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVG 345 (448)
T ss_pred hHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhhee-cccceeeeeccc
Confidence 999999865 2223567789999999999999999996 3444 44688999999999988874 222222111111
Q ss_pred CccccccccCCccCccccCCCC
Q 008026 557 SIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 557 ~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
. .=.|.||+||.++..+
T Consensus 346 r-----~y~pawmspealqrkp 362 (448)
T KOG0195|consen 346 R-----AYSPAWMSPEALQRKP 362 (448)
T ss_pred c-----ccCcccCCHHHHhcCc
Confidence 1 1267899999988655
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.9e-14 Score=133.99 Aligned_cols=117 Identities=29% Similarity=0.387 Sum_probs=86.0
Q ss_pred CCCcccceeeEEEc---------------------------CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHH
Q 008026 451 RHRHLVALLGHCLD---------------------------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 503 (580)
Q Consensus 451 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i 503 (580)
+|||||++.++|.+ ....|+||..++ .+|.+++.. ...+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 69999999988754 234689998884 489888843 23445566678
Q ss_pred HHHHHHHHHHHHhCCCCCcEecCCCCCCeEec--CCC--cEEEEeeccccccCC-----CCCCccccccccCCccCcccc
Q 008026 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDM--RAKVADFGLVRLAPE-----GKGSIETRIAGTFGYLAPEYA 574 (580)
Q Consensus 504 ~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfg~a~~~~~-----~~~~~~~~~~Gt~~y~APE~~ 574 (580)
..|+++|+.|||. ++|.|||+|++|||+. +|+ ...++|||+|--... +..+......|...-||||+.
T Consensus 347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 8899999999996 8999999999999994 443 368999998743222 111222334688889999997
Q ss_pred CCC
Q 008026 575 GNF 577 (580)
Q Consensus 575 ~~~ 577 (580)
...
T Consensus 424 ta~ 426 (598)
T KOG4158|consen 424 TAV 426 (598)
T ss_pred hcC
Confidence 643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.3e-13 Score=143.06 Aligned_cols=150 Identities=22% Similarity=0.266 Sum_probs=95.3
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEcC-CcEEEEEEeeccccCh--------------------------------hhHH
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISG--------------------------------KGLT 438 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~~ 438 (580)
....+|+. +.||+|++|+||+|+.++ |+.||||+.+++.... ...+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34456776 789999999999999887 9999999997542100 0011
Q ss_pred ------HHHHHHHHHHhcC----CCcccceeeEEEc-CCeeEEEEEecCCCChhHHHHHHhhhCC--CCccHHHHHHHHH
Q 008026 439 ------EFKSEIAVLTKVR----HRHLVALLGHCLD-GNEKLLVFEYMPQGTLSRHIFNWAEEGL--KPLEWNRRLTIAL 505 (580)
Q Consensus 439 ------~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~i~~ 505 (580)
++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.+.-.- ...+. ..+....+..++.
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHH
Confidence 2344554444442 3333333333332 4557899999999999764211 11111 1122222333333
Q ss_pred HHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC----cEEEEeeccccccCC
Q 008026 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVADFGLVRLAPE 553 (580)
Q Consensus 506 ~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 553 (580)
|+ +. .|++|+|+||.||+++.++ +++++|||++.....
T Consensus 275 Qi-------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QV-------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 32 6899999999999999887 999999999876643
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.1e-13 Score=141.87 Aligned_cols=199 Identities=23% Similarity=0.260 Sum_probs=156.1
Q ss_pred cccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCC-CCcEEeccCCcccccCCccccCCCCCcEEEccCCcc
Q 008026 23 NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVK-QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101 (580)
Q Consensus 23 ~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~-~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l 101 (580)
+.++.|... ..+..+..++.++.|++.+|.++.+.|....++ +|+.|++++|++. .+|..+..+++|+.|++++|++
T Consensus 98 l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l 175 (394)
T COG4886 98 LDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL 175 (394)
T ss_pred eeccccccc-cCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchh
Confidence 444444332 334456677889999999999997777666674 9999999999999 8988899999999999999999
Q ss_pred cccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecC
Q 008026 102 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 181 (580)
Q Consensus 102 ~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~ 181 (580)
+..++..+.+..|+.|++++|.+..+|... +.+..+...+.++++....+.....+.++..|.+++
T Consensus 176 ~~l~~~~~~~~~L~~L~ls~N~i~~l~~~~--------------~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~ 241 (394)
T COG4886 176 SDLPKLLSNLSNLNNLDLSGNKISDLPPEI--------------ELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSN 241 (394)
T ss_pred hhhhhhhhhhhhhhheeccCCccccCchhh--------------hhhhhhhhhhhcCCcceecchhhhhcccccccccCC
Confidence 999887778889999999999999998753 011112223444443334444555566888888999
Q ss_pred CcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCC
Q 008026 182 MNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK 240 (580)
Q Consensus 182 n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~ 240 (580)
|++. .++..++.+++|+.|++++|+++ .++. ++.+.+++.||+++|.++..+|...
T Consensus 242 n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 242 NKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred ceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhh
Confidence 9998 56888999999999999999998 7776 8999999999999999998877543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.7e-14 Score=144.92 Aligned_cols=181 Identities=17% Similarity=0.084 Sum_probs=145.3
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSL 85 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~ 85 (580)
.++|..+ ..+-.|+.+.+..| -...+|.++++|..|++|||+.|+++..++.+..|+ |+.|-+++|++. .+|+++
T Consensus 88 ~elp~~~--~~f~~Le~liLy~n-~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~i 162 (722)
T KOG0532|consen 88 SELPEEA--CAFVSLESLILYHN-CIRTIPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLT-SLPEEI 162 (722)
T ss_pred ccCchHH--HHHHHHHHHHHHhc-cceecchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccc-cCCccc
Confidence 3567666 33555666666666 445678899999999999999999997766777765 899999999999 899999
Q ss_pred cCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCcc
Q 008026 86 VKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 165 (580)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (580)
+.+..|..||.+.|++..+++.++.+.+|+.|++..|++..+|+... + -.+.++.+++|....+|
T Consensus 163 g~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~lp~El~-------~--------LpLi~lDfScNkis~iP 227 (722)
T KOG0532|consen 163 GLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLEDLPEELC-------S--------LPLIRLDFSCNKISYLP 227 (722)
T ss_pred ccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhhCCHHHh-------C--------CceeeeecccCceeecc
Confidence 99999999999999999999999999999999999998887775422 1 13556677888888899
Q ss_pred ceeccCCcEEEEEecCCcccccCcccccC---CCCCcEEeccCCc
Q 008026 166 GVTCTKGNITVINFQKMNLTGTISPEFAS---FKSLQRLILADNN 207 (580)
Q Consensus 166 ~~~~~~~~L~~L~ls~n~l~~~~p~~~~~---l~~L~~L~ls~N~ 207 (580)
..++.|..|++|-|.+|-|. ..|..++. ..--++|+..-++
T Consensus 228 v~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred hhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 99999999999999999999 77777753 3335677777775
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.5e-13 Score=147.77 Aligned_cols=170 Identities=21% Similarity=0.203 Sum_probs=124.1
Q ss_pred CCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccc--cChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+|...+.+|.+.|=+|.+|+++.|. |+||++-+.. .+-....+..+|++ .+.++|||.+.+.-+-......|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667789999999999999988777 8999986643 22223334444555 556689999999877777777788888
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc--
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-- 551 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~-- 551 (580)
|... +|.|.+.. ..-+...+.+.|+.|++.||..+|. .+|+|||||.+||||+.-.-+.|+||..-+..
T Consensus 102 yvkh-nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVKH-NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHhh-hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence 8744 78777632 2335566778899999999999997 89999999999999999888999999865532
Q ss_pred CCCCCCcccccccc----CCccCccccCC
Q 008026 552 PEGKGSIETRIAGT----FGYLAPEYAGN 576 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt----~~y~APE~~~~ 576 (580)
..+.....+-+..| ..|+|||.+-.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhc
Confidence 22222111212222 35999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.6e-12 Score=115.91 Aligned_cols=132 Identities=20% Similarity=0.162 Sum_probs=95.9
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcc-cceeeEEEcCCeeEEEEEecCCC
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL-VALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 478 (580)
.+.++.|.++.||+++.. +..|++|....... ....+.+|+++++.+.+.++ ++++.+. ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 356889999999999865 78899998754321 12346789999998865544 4455443 23458999999998
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
++.+.. . ....++.+++.+|+.||+.. ...++|+|++|.||+++ ++.++++|||.+...
T Consensus 77 ~l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 77 ELLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 875320 0 11235678999999999732 12359999999999998 668999999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-11 Score=113.04 Aligned_cols=139 Identities=14% Similarity=0.124 Sum_probs=98.6
Q ss_pred ceeeccCcEEEEEEEEcC-------CcEEEEEEeecccc-----------C---------hhhHH----HHHHHHHHHHh
Q 008026 401 NILGRGGFGTVYKGELHD-------GTKIAVKRMEAGVI-----------S---------GKGLT----EFKSEIAVLTK 449 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~----~~~~E~~~l~~ 449 (580)
..||.|.=+.||.|...+ +..+|||+.+.... + ....+ ..++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999996543 47899998743110 0 00112 23489999999
Q ss_pred cCC--CcccceeeEEEcCCeeEEEEEecCCCChhH-HHHHHhhhCCCCccHHHHHHHHHHHHHHHHHH-HhCCCCCcEec
Q 008026 450 VRH--RHLVALLGHCLDGNEKLLVFEYMPQGTLSR-HIFNWAEEGLKPLEWNRRLTIALDVARGVEYL-HGLAHQSFIHR 525 (580)
Q Consensus 450 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~L-H~~~~~~ivH~ 525 (580)
+.. -.+++.+++ ...++||||+++..+.. .+.+ ..++..+...+..+++.+|..+ |. .+||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 963 456666654 45789999997654422 1211 1234455667789999999999 75 799999
Q ss_pred CCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 526 DLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 526 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++.||+++ ++.++++|||.|.....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999997 46899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.9e-11 Score=107.44 Aligned_cols=135 Identities=24% Similarity=0.331 Sum_probs=105.0
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhh------HHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG------LTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
..+++|+=+.+|.+.+. |.++++|.-.++...... ..+..+|++++++++--.|...+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 555777765444443322 34567899999999877777777777788888999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
++|..|.+++... ...++..+..-+.-||. .+|||+|+.++||++..+ .+.++|||++....
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCC-cEEEEECCcccccc
Confidence 9998888887331 24566778888889996 899999999999999765 49999999997543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.4e-11 Score=104.50 Aligned_cols=146 Identities=23% Similarity=0.267 Sum_probs=110.6
Q ss_pred ccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChh------hHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 399 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK------GLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 399 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
....+-+|+-+.|+++.+. |+.++||.-..+.+... ...+..+|++.+.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578899999999999876 88888886654444322 2356788999999998667776666777777788999
Q ss_pred EecCC-CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC---cEEEEeeccc
Q 008026 473 EYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLV 548 (580)
Q Consensus 473 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a 548 (580)
||++| .++.+++...... .........++.+|.+.+.-||. .+|||+||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 99977 4777777553322 22222336788899999999997 8999999999999997554 4689999998
Q ss_pred ccc
Q 008026 549 RLA 551 (580)
Q Consensus 549 ~~~ 551 (580)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.7e-11 Score=116.70 Aligned_cols=170 Identities=24% Similarity=0.351 Sum_probs=105.9
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccc-cChhhHHHHHHHHHHHHhcCC----------CcccceeeEEE-
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRH----------RHLVALLGHCL- 463 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~- 463 (580)
+...+.||.|+++.||.+.+. +++++|+|+..... ......+++.+|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 455789999999999999875 68999999886433 223345667776655544322 12332233222
Q ss_pred --------cC---C-----eeEEEEEecCCCChhHHHHHHhhhCCC--CccHHHHHHHHHHHHHHHHHHHhCCCCCcEec
Q 008026 464 --------DG---N-----EKLLVFEYMPQGTLSRHIFNWAEEGLK--PLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 525 (580)
Q Consensus 464 --------~~---~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~ 525 (580)
.. . ..+++|+-+ .+||.+++......... ......++.+..|+++.+++||+ .|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11 1 125677766 56888876543222211 23344556777999999999998 899999
Q ss_pred CCCCCCeEecCCCcEEEEeeccccccCCCCCCccccccccCCccCcccc
Q 008026 526 DLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574 (580)
Q Consensus 526 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~ 574 (580)
||||+|++++.+|.++|+||+......... .....+..|.+||..
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~ 214 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELE 214 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhh
Confidence 999999999999999999998776543211 112346789999975
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.3e-14 Score=142.04 Aligned_cols=110 Identities=19% Similarity=0.085 Sum_probs=72.4
Q ss_pred cceEEecccCCCCCC------CCCchhhcCcccCceEecccCcCcCCCC-CCCCCC---CCcEEeccCCcccc----cCC
Q 008026 17 IQSLWVNGQNGNAKL------GGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVK---QLESLSLRDNFFTG----PVP 82 (580)
Q Consensus 17 l~~L~~~~~~~n~~~------~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~---~L~~L~L~~N~l~~----~~P 82 (580)
.+.|+.++++.+... ...+..+.++++|+.|+|++|.+.+..+ .+..+. +|+.|++++|++++ .+.
T Consensus 50 ~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~ 129 (319)
T cd00116 50 QPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129 (319)
T ss_pred CCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence 344555555555433 1223467778889999998888876444 343343 48889998888872 334
Q ss_pred ccccCC-CCCcEEEccCCcccccCC-----CCCcccccccccccCCCCCC
Q 008026 83 DSLVKL-ESLKIVNMTNNLLQGPVP-----EFDRSVSLDMAKGSNNFCLP 126 (580)
Q Consensus 83 ~~~~~l-~~L~~L~L~~N~l~~~~~-----~~~~~~~L~~l~l~~n~~~~ 126 (580)
..+..+ ++|+.|+|++|.+++... .+..+..|+.|++++|.+..
T Consensus 130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 456666 888999999888884322 24556678888888887653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-13 Score=137.26 Aligned_cols=112 Identities=21% Similarity=0.077 Sum_probs=82.3
Q ss_pred cccceEEecccCCCCCCCC----CchhhcCcccCceEecccCcCcCCC------C-CCCCCCCCcEEeccCCcccccCCc
Q 008026 15 SQIQSLWVNGQNGNAKLGG----GIDVIQNMTSLKEIWLHSNAFSGPL------P-DFSGVKQLESLSLRDNFFTGPVPD 83 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~----~~~~~~~l~~L~~L~L~~N~l~~~~------p-~~~~l~~L~~L~L~~N~l~~~~P~ 83 (580)
..+..|+.++++++.+... ++..+...++|++|+++++.+.+.. + .+..+++|+.|+|++|.+.+..+.
T Consensus 20 ~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~ 99 (319)
T cd00116 20 PKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG 99 (319)
T ss_pred HHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHH
Confidence 3456677777777765332 3455677888999999999887411 1 256688999999999999876777
Q ss_pred cccCCCC---CcEEEccCCcccccCC-----CCCcc-cccccccccCCCCCC
Q 008026 84 SLVKLES---LKIVNMTNNLLQGPVP-----EFDRS-VSLDMAKGSNNFCLP 126 (580)
Q Consensus 84 ~~~~l~~---L~~L~L~~N~l~~~~~-----~~~~~-~~L~~l~l~~n~~~~ 126 (580)
.+..+.+ |+.|++++|+++.... .+..+ .+|+.|++++|.+..
T Consensus 100 ~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 151 (319)
T cd00116 100 VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEG 151 (319)
T ss_pred HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCc
Confidence 7777776 9999999999884211 24455 788999999998764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.5e-12 Score=137.30 Aligned_cols=139 Identities=28% Similarity=0.483 Sum_probs=94.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..+|..++.|..|+||.||.++++ +.+.+|+| +.++.. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee----------------
Confidence 357899999999999999999876 46778884 433211 1110 22222333333
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||-...+ +..+.++. +++.|++|+|+ .+|+|||+||+|.+|+.-|.+|++|||+.+...
T Consensus 136 -----gDc~tll-----k~~g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -----GDCATLL-----KNIGPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -----chhhhhc-----ccCCCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 3333333 12233332 33789999997 899999999999999999999999999986432
Q ss_pred CCCC--------------CccccccccCCccCccccCCCCC
Q 008026 553 EGKG--------------SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~--------------~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... -....++|||.|+|||++..++|
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy 235 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY 235 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc
Confidence 2110 01123689999999999988876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-10 Score=111.01 Aligned_cols=144 Identities=20% Similarity=0.301 Sum_probs=107.3
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCC--cccceeeEEEcCC---eeEEEEEec
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR--HLVALLGHCLDGN---EKLLVFEYM 475 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~---~~~lv~e~~ 475 (580)
+.++.|..+.||+++..+|..+++|........ ....++.+|+++++.+++. .+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998876789999987653221 2345788999999999753 4567777766532 568999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA------------------------------------- 518 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~------------------------------------- 518 (580)
+|.++.+.+.. ..++..+...++.+++.+|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888664410 23556666677777777777777421
Q ss_pred ----------------CCCcEecCCCCCCeEecC--CCcEEEEeecccccc
Q 008026 519 ----------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVRLA 551 (580)
Q Consensus 519 ----------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~ 551 (580)
...++|+|++|.||+++. ++.+.|+||+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 566899999988653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-11 Score=133.82 Aligned_cols=112 Identities=24% Similarity=0.438 Sum_probs=98.8
Q ss_pred CCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHh
Q 008026 66 QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL 144 (580)
Q Consensus 66 ~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~ 144 (580)
.++.|+|++|.+.|.+|..++.|++|+.|+|++|+++|.+|. +..
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~---------------------------------- 464 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS---------------------------------- 464 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhC----------------------------------
Confidence 378999999999999999999999999999999999988774 222
Q ss_pred hCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCC-CCCC
Q 008026 145 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL-GALK 223 (580)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l-~~L~ 223 (580)
+.+|+.|+|++|+++|.+|+.+++|++|+.|+|++|+++|.+|..+..+ .++.
T Consensus 465 --------------------------l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~ 518 (623)
T PLN03150 465 --------------------------ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA 518 (623)
T ss_pred --------------------------CCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCc
Confidence 2378899999999999999999999999999999999999999998874 4678
Q ss_pred EEEccCCcccccCC
Q 008026 224 ELDVSNNQLYGKIP 237 (580)
Q Consensus 224 ~l~ls~N~l~g~~p 237 (580)
.+++++|......|
T Consensus 519 ~l~~~~N~~lc~~p 532 (623)
T PLN03150 519 SFNFTDNAGLCGIP 532 (623)
T ss_pred eEEecCCccccCCC
Confidence 99999998765555
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2e-12 Score=138.75 Aligned_cols=175 Identities=23% Similarity=0.311 Sum_probs=137.3
Q ss_pred CCcccceeeccCcEEEEEEEEc--CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 472 (580)
.|.+.+.||+|+|+.|-.+... ....+|+|.+...............|..+-+.+. |+|++++++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 5677788999999999887543 3456777766554323334455666888888887 999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHH-hCCCCCcEecCCCCCCeEecCCC-cEEEEeeccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH-GLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRL 550 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 550 (580)
+|.+++++.+.+. .......+...+..++.|+..++.|+| . .++.|||+||+|.+++..+ ..+++|||+|..
T Consensus 101 ~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred Ccccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999987662 122224555667788999999999999 5 8999999999999999988 999999999987
Q ss_pred cCC--CCCCccccccc-cCCccCccccCC
Q 008026 551 APE--GKGSIETRIAG-TFGYLAPEYAGN 576 (580)
Q Consensus 551 ~~~--~~~~~~~~~~G-t~~y~APE~~~~ 576 (580)
+.. +........+| ++.|+|||...+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccc
Confidence 655 22223334578 999999999877
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.5e-11 Score=110.07 Aligned_cols=82 Identities=24% Similarity=0.207 Sum_probs=67.7
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
|+|.+++.. ....+++.+++.|+.||+.||+|||+ .+ ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc--
Confidence 678888743 22468999999999999999999997 44 999999999999999 99988764322
Q ss_pred ccccccccCCccCccccCCCCCC
Q 008026 558 IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 558 ~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..||+.|||||++.+..|+
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~ 82 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYT 82 (176)
T ss_pred ----CCCcccccChHHhcCCCCc
Confidence 2589999999999887763
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.8e-11 Score=124.13 Aligned_cols=183 Identities=21% Similarity=0.247 Sum_probs=138.3
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcc-cCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMT-SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
.+..+..+++..|. ...+++....++ +|+.|++++|.+...+..+..+++|+.|++++|+++ .+|...+.+++|+.|
T Consensus 114 ~~~~l~~L~l~~n~-i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 114 ELTNLTSLDLDNNN-ITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred cccceeEEecCCcc-cccCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 34567777777774 445666677775 999999999999966556888999999999999999 999988899999999
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
++++|+++.+++.......|+.+.+++|.+...+.... .+..+ ...-..++.....+.....+.+|
T Consensus 192 ~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~-~~~~l-------------~~l~l~~n~~~~~~~~~~~l~~l 257 (394)
T COG4886 192 DLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLS-NLKNL-------------SGLELSNNKLEDLPESIGNLSNL 257 (394)
T ss_pred eccCCccccCchhhhhhhhhhhhhhcCCcceecchhhh-hcccc-------------cccccCCceeeeccchhcccccc
Confidence 99999999998877777789999999996444432211 11111 11112233333334455566689
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 216 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l 216 (580)
+.|++++|.++ .++. ++.+.+|+.|++++|.++..+|...
T Consensus 258 ~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 258 ETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred ceecccccccc-cccc-ccccCccCEEeccCccccccchhhh
Confidence 99999999999 6666 9999999999999999996555543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-09 Score=98.11 Aligned_cols=129 Identities=22% Similarity=0.253 Sum_probs=84.0
Q ss_pred EEEEEEEcCCcEEEEEEeeccccC------------------------hhhHHHHHHHHHHHHhcCCC--cccceeeEEE
Q 008026 410 TVYKGELHDGTKIAVKRMEAGVIS------------------------GKGLTEFKSEIAVLTKVRHR--HLVALLGHCL 463 (580)
Q Consensus 410 ~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 463 (580)
.||.|...+|..+|+|+.+..... ........+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489998888999999987432100 00124567899999999865 466666553
Q ss_pred cCCeeEEEEEecC--CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHH-HhCCCCCcEecCCCCCCeEecCCCcE
Q 008026 464 DGNEKLLVFEYMP--QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL-HGLAHQSFIHRDLKPSNILLGDDMRA 540 (580)
Q Consensus 464 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~L-H~~~~~~ivH~Dlkp~NIll~~~~~~ 540 (580)
..++||||++ |..+..+. .. .++......++.+++..+..+ |. .+|||+|+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~------~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DV------DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HC------GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHH-hc------cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 3579999998 65554432 21 111334556777888866665 55 899999999999999887 99
Q ss_pred EEEeeccccccCC
Q 008026 541 KVADFGLVRLAPE 553 (580)
Q Consensus 541 kl~Dfg~a~~~~~ 553 (580)
.++|||.+.....
T Consensus 146 ~iIDf~qav~~~~ 158 (188)
T PF01163_consen 146 YIIDFGQAVDSSH 158 (188)
T ss_dssp EE--GTTEEETTS
T ss_pred EEEecCcceecCC
Confidence 9999998876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.6e-11 Score=105.99 Aligned_cols=61 Identities=28% Similarity=0.416 Sum_probs=10.5
Q ss_pred cccCceEecccCcCcCCCCCCC-CCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCccccc
Q 008026 41 MTSLKEIWLHSNAFSGPLPDFS-GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 104 (580)
Q Consensus 41 l~~L~~L~L~~N~l~~~~p~~~-~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~ 104 (580)
...+++|+|.+|.|+. +..++ .+.+|+.|+|++|+|+ .++ .+..+++|+.|+|++|+++.+
T Consensus 18 ~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i 79 (175)
T PF14580_consen 18 PVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSI 79 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-
T ss_pred cccccccccccccccc-ccchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCcc
Confidence 3345555555555552 23333 3455555555555555 343 344555555555555555543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.4e-09 Score=101.79 Aligned_cols=143 Identities=15% Similarity=0.149 Sum_probs=101.1
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccCh---------hhHHHHHHHHHHHHhcCCCccc--ceeeEEEc-----
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG---------KGLTEFKSEIAVLTKVRHRHLV--ALLGHCLD----- 464 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv--~~~~~~~~----- 464 (580)
+.+-+-....|++.+. +|+.|.||......... .....+.+|.+.+.++...+|. ..+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455444555777766 47889999764322110 0112478999999888644444 44556543
Q ss_pred CCeeEEEEEecCCC-ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-------
Q 008026 465 GNEKLLVFEYMPQG-TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD------- 536 (580)
Q Consensus 465 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~------- 536 (580)
....++|||++++. +|.+++..+.. ...+......++.+++..+.-||. .||+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence 23468999999886 88888754322 234556677899999999999998 89999999999999975
Q ss_pred CCcEEEEeeccccc
Q 008026 537 DMRAKVADFGLVRL 550 (580)
Q Consensus 537 ~~~~kl~Dfg~a~~ 550 (580)
+..+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46799999998854
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.9e-10 Score=116.80 Aligned_cols=125 Identities=29% Similarity=0.438 Sum_probs=100.9
Q ss_pred HHhcCCCcccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 008026 447 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 526 (580)
Q Consensus 447 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D 526 (580)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.-...+.++|+.||+|+|+ ..-..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeee
Confidence 3567899999999999999999999999999999999854 34568888899999999999999997 23339999
Q ss_pred CCCCCeEecCCCcEEEEeeccccccCCC-CCCccccccccCCccCccccCCC
Q 008026 527 LKPSNILLGDDMRAKVADFGLVRLAPEG-KGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 527 lkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+++.|+++|....+||+|||+....... .........-..-|.|||.+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA 126 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence 9999999999999999999998766421 00111111234569999999875
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-10 Score=102.98 Aligned_cols=118 Identities=22% Similarity=0.403 Sum_probs=35.6
Q ss_pred ccCcCcCCCCCCCCCCCCcEEeccCCcccccCCcccc-CCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCC
Q 008026 50 HSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLV-KLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSP 128 (580)
Q Consensus 50 ~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~ 128 (580)
..+.|. ..|.+.+...++.|+|++|+|+ .| +.++ .+.+|+.|+|++|.++.+. .+..+
T Consensus 5 t~~~i~-~~~~~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l~-~l~~L----------------- 63 (175)
T PF14580_consen 5 TANMIE-QIAQYNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKLE-GLPGL----------------- 63 (175)
T ss_dssp ----------------------------------S--TT-TT--EEE-TTS--S--T-T---------------------
T ss_pred cccccc-cccccccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcccc-CccCh-----------------
Confidence 344444 4455666667889999999988 55 3566 5788889999999888543 23222
Q ss_pred CCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccc-cCCCCCcEEeccCCc
Q 008026 129 GACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF-ASFKSLQRLILADNN 207 (580)
Q Consensus 129 ~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~-~~l~~L~~L~ls~N~ 207 (580)
.+|+.|++++|+|+ .+++.+ ..+++|++|+|++|+
T Consensus 64 -------------------------------------------~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~ 99 (175)
T PF14580_consen 64 -------------------------------------------PRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNK 99 (175)
T ss_dssp -------------------------------------------TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS-
T ss_pred -------------------------------------------hhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCc
Confidence 26777777777777 454444 357778888888887
Q ss_pred ccccCC--ccCcCCCCCCEEEccCCccc
Q 008026 208 LSGMIP--EGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 208 l~g~~p--~~l~~l~~L~~l~ls~N~l~ 233 (580)
|. .+- ..+..+++|+.|+|.+|+++
T Consensus 100 I~-~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 100 IS-DLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp ---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CC-ChHHhHHHHcCCCcceeeccCCccc
Confidence 76 332 34566778888888888776
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.2e-11 Score=112.41 Aligned_cols=133 Identities=20% Similarity=0.282 Sum_probs=101.9
Q ss_pred CCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHH
Q 008026 61 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLS 140 (580)
Q Consensus 61 ~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~ 140 (580)
+...+.|+.||||+|.|+ .|-+++.-+++++.|++|+|.+..+-. +..+.+|..|++++|.+.++-
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~~~------------ 345 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAECV------------ 345 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHhhh------------
Confidence 334567788888888888 777788888888888888888875543 667777888888888654332
Q ss_pred HHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCC--ccCcC
Q 008026 141 VVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP--EGLSV 218 (580)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~l~~ 218 (580)
|+-..++|++.|.|+.|.|. .+ ..++.|=+|..||+++|+|. .+- ..|++
T Consensus 346 -------------------------Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~ 397 (490)
T KOG1259|consen 346 -------------------------GWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGN 397 (490)
T ss_pred -------------------------hhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheeccccccchh-hHHHhccccc
Confidence 22334568999999999998 44 35778889999999999997 443 47899
Q ss_pred CCCCCEEEccCCccccc
Q 008026 219 LGALKELDVSNNQLYGK 235 (580)
Q Consensus 219 l~~L~~l~ls~N~l~g~ 235 (580)
|+.|+.+.|.+|++.+.
T Consensus 398 LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 398 LPCLETLRLTGNPLAGS 414 (490)
T ss_pred ccHHHHHhhcCCCcccc
Confidence 99999999999999843
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.5e-11 Score=119.76 Aligned_cols=106 Identities=31% Similarity=0.420 Sum_probs=86.3
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..|+.|++|...+|.+++.+... ....++...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 56899999999999999954322 2345677889999999999999 479999999999999999899999999
Q ss_pred cccccCCCC-----CCccccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGK-----GSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~-----~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+........ ....+..+||..||+||.+.|..|+
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~ 440 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS 440 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh
Confidence 987654433 1223446799999999999988774
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.5e-09 Score=107.17 Aligned_cols=123 Identities=15% Similarity=0.176 Sum_probs=101.0
Q ss_pred EEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCC
Q 008026 415 ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP 494 (580)
Q Consensus 415 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 494 (580)
+..++.+|.|...+.... .......+.++.++.++||+|+++++.++..+..|+|+|-+. .|..++.+.
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------- 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------- 101 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------
Confidence 445788899988876432 345567788899999999999999999999999999999984 466666442
Q ss_pred ccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 495 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 495 ~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
.......-+.||+.||.|||+ +.+++|++|.-..|+++..|+.||++|..+...
T Consensus 102 -~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 102 -GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 234556678899999999997 578999999999999999999999999887543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.4e-09 Score=78.83 Aligned_cols=60 Identities=33% Similarity=0.535 Sum_probs=54.9
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcc
Q 008026 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232 (580)
Q Consensus 173 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l 232 (580)
+|+.|++++|+++...+..|.++++|+.|++++|++....|..|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 799999999999965557889999999999999999977678999999999999999986
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.5e-09 Score=79.91 Aligned_cols=60 Identities=32% Similarity=0.516 Sum_probs=49.9
Q ss_pred ccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcc
Q 008026 42 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101 (580)
Q Consensus 42 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l 101 (580)
++|++|+|++|+|+..++ .|.++++|++|++++|+++..-|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 478899999999997776 478899999999999999844455689999999999999875
|
... |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.4e-10 Score=110.30 Aligned_cols=180 Identities=16% Similarity=0.199 Sum_probs=119.3
Q ss_pred cccceEEecccCCCCCCCCCc--hhhcCcccCceEecccCcCcCCCC--CC-CCCCCCcEEeccCCcccccCCcc-ccCC
Q 008026 15 SQIQSLWVNGQNGNAKLGGGI--DVIQNMTSLKEIWLHSNAFSGPLP--DF-SGVKQLESLSLRDNFFTGPVPDS-LVKL 88 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p--~~-~~l~~L~~L~L~~N~l~~~~P~~-~~~l 88 (580)
++++.|+...+.+. -.+..+ +....|++++.||||.|-|..--| .+ ..|++|+.|+|+.|++.--..+. -..+
T Consensus 118 sn~kkL~~IsLdn~-~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNY-RVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCc-cccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45666666665444 233333 356778888888888888876444 33 55888888888888887322222 4457
Q ss_pred CCCcEEEccCCcccccCC--CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccc
Q 008026 89 ESLKIVNMTNNLLQGPVP--EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIG 166 (580)
Q Consensus 89 ~~L~~L~L~~N~l~~~~~--~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (580)
+.|+.|.|+.+.|+.--- -...+.+|+.|.+..|.+.-+......
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~--------------------------------- 243 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTK--------------------------------- 243 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhh---------------------------------
Confidence 788888888888873211 134556777888777742211111111
Q ss_pred eeccCCcEEEEEecCCcccccCc--ccccCCCCCcEEeccCCcccccC--Ccc-----CcCCCCCCEEEccCCccc
Q 008026 167 VTCTKGNITVINFQKMNLTGTIS--PEFASFKSLQRLILADNNLSGMI--PEG-----LSVLGALKELDVSNNQLY 233 (580)
Q Consensus 167 ~~~~~~~L~~L~ls~n~l~~~~p--~~~~~l~~L~~L~ls~N~l~g~~--p~~-----l~~l~~L~~l~ls~N~l~ 233 (580)
.+..|+.|||++|.+. ..+ ...+.++.|+.|+++.+.+. .+ |+. ....++|++|+++.|++.
T Consensus 244 ---i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~-si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 244 ---ILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIA-SIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ---hhhHHhhccccCCccc-ccccccccccccchhhhhccccCcc-hhcCCCccchhhhcccccceeeecccCccc
Confidence 1126888999999988 555 45788999999999999887 33 443 355788999999999886
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.2e-09 Score=110.41 Aligned_cols=175 Identities=24% Similarity=0.245 Sum_probs=132.3
Q ss_pred cCCcccceeec--cCcEEEEEEEE---cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGR--GGFGTVYKGEL---HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 468 (580)
..|.+.+.+|. |.+|.||.+.. +++..+|+|+-+...........=.+|+..-++++ |++.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566788999 99999999865 46888999975433222233334456777777776 99999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHH----HHHHHHhCCCCCcEecCCCCCCeEecCC-CcEEEE
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR----GVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVA 543 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~----aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~ 543 (580)
++-+|++. .+|..+... ....++....+.+..+... ||.++|+ .+++|-|+||.||+..++ ...+++
T Consensus 194 fiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecC
Confidence 99999995 577666533 2233566677777778888 9999998 899999999999999988 789999
Q ss_pred eeccccccCCCCCCc----cccccccCCccCccccCCC
Q 008026 544 DFGLVRLAPEGKGSI----ETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~----~~~~~Gt~~y~APE~~~~~ 577 (580)
|||+...+..+.... ..+..|...|++||...+.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l 303 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL 303 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccc
Confidence 999988776543111 1222577889999998764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.1e-08 Score=91.91 Aligned_cols=138 Identities=22% Similarity=0.197 Sum_probs=97.9
Q ss_pred CcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccC--------------------hhhHHHHHHHHHHHHhcCCC--c
Q 008026 397 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--------------------GKGLTEFKSEIAVLTKVRHR--H 454 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~--n 454 (580)
+.+...||.|.=+.||.|....|.++|||.=+....+ .-.....++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999888999999954221100 01234567899999999744 6
Q ss_pred ccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 455 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
+++.+++ +..++||||++|-.|...- ++....-.++..|++-+.-+-. .||||+|+.+-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 7777765 5668999999987664321 1122233344444444443333 789999999999999
Q ss_pred cCCCcEEEEeecccccc
Q 008026 535 GDDMRAKVADFGLVRLA 551 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~ 551 (580)
+++|.+.++||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 99999999999766543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.5e-09 Score=108.15 Aligned_cols=151 Identities=21% Similarity=0.282 Sum_probs=120.9
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc--CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCee
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEK 468 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 468 (580)
....+|..+..||.|.|+.|+.+..+ ++..|++|..............-..|+-+...+. |.+++.++..+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999998544 6789999988765544444444456777777775 88999888777777777
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-CcEEEEeecc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGL 547 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~ 547 (580)
|+-.||++++++..... -...+++...+++..|++.|+.++|+ +.++|+|+||+||++..+ +..++.|||+
T Consensus 342 ~ip~e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cCchhhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccc
Confidence 89999999998876552 12346777888999999999999997 899999999999999875 7789999998
Q ss_pred ccc
Q 008026 548 VRL 550 (580)
Q Consensus 548 a~~ 550 (580)
+..
T Consensus 414 ~t~ 416 (524)
T KOG0601|consen 414 WTR 416 (524)
T ss_pred ccc
Confidence 864
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.3e-09 Score=113.72 Aligned_cols=196 Identities=22% Similarity=0.202 Sum_probs=115.7
Q ss_pred ceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEcc
Q 008026 18 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97 (580)
Q Consensus 18 ~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~ 97 (580)
..+..+++..|.+.+ .-..+..+++|+.|++.+|+|.++...+..+++|++|+|++|+|+ .+. .+..++.|+.|+++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~-~i~-~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKIT-KLE-GLSTLTLLKELNLS 148 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheeccccccc-ccc-chhhccchhhheec
Confidence 444444455554333 223356677777777777777754433566777777777777777 332 35566667777777
Q ss_pred CCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEE
Q 008026 98 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVI 177 (580)
Q Consensus 98 ~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L 177 (580)
+|.++... .+..+..|+.++++.|.+..+.......+.. +...|.+++....+.+ ...+..+..+
T Consensus 149 ~N~i~~~~-~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~-------------l~~l~l~~n~i~~i~~-~~~~~~l~~~ 213 (414)
T KOG0531|consen 149 GNLISDIS-GLESLKSLKLLDLSYNRIVDIENDELSELIS-------------LEELDLGGNSIREIEG-LDLLKKLVLL 213 (414)
T ss_pred cCcchhcc-CCccchhhhcccCCcchhhhhhhhhhhhccc-------------hHHHhccCCchhcccc-hHHHHHHHHh
Confidence 77776443 3444667777777777776665520011111 1122333332222111 1112245555
Q ss_pred EecCCcccccCcccccCCCC--CcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 178 NFQKMNLTGTISPEFASFKS--LQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 178 ~ls~n~l~~~~p~~~~~l~~--L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
++..|+++..-+ +..+.. |+.+++++|.+. .++..+..+..+..||+++|+++.
T Consensus 214 ~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 214 SLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred hcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccc
Confidence 778888873222 223333 788889999887 666778888888888888888873
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.6e-09 Score=106.35 Aligned_cols=183 Identities=18% Similarity=0.127 Sum_probs=131.0
Q ss_pred cccceEEecccCCCCCCCCCc--hhhcCcccCceEecccCcCcCCCCC--CCCCCCCcEEeccCCccccc-CCccccCCC
Q 008026 15 SQIQSLWVNGQNGNAKLGGGI--DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGP-VPDSLVKLE 89 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~--~~~l~~L~~L~L~~N~l~~~-~P~~~~~l~ 89 (580)
..+..++-+|++.|.+..-.+ .....|++|+.|+|+.|++.-...+ -..+..|+.|.|++|.|+.. +-..+..++
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fP 222 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFP 222 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCC
Confidence 457788888888885554333 4467899999999999999855543 24588999999999999832 333467789
Q ss_pred CCcEEEccCCc-ccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCcccee
Q 008026 90 SLKIVNMTNNL-LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 168 (580)
Q Consensus 90 ~L~~L~L~~N~-l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (580)
+|..|+|..|. +...--...-+..|+.|++++|.+...+... ..
T Consensus 223 sl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~-----------------------------------~~ 267 (505)
T KOG3207|consen 223 SLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGY-----------------------------------KV 267 (505)
T ss_pred cHHHhhhhcccccceecchhhhhhHHhhccccCCccccccccc-----------------------------------cc
Confidence 99999999995 2222223445567899999999877665221 12
Q ss_pred ccCCcEEEEEecCCcccc-cCccc-----ccCCCCCcEEeccCCcccccCC--ccCcCCCCCCEEEccCCccc
Q 008026 169 CTKGNITVINFQKMNLTG-TISPE-----FASFKSLQRLILADNNLSGMIP--EGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 169 ~~~~~L~~L~ls~n~l~~-~~p~~-----~~~l~~L~~L~ls~N~l~g~~p--~~l~~l~~L~~l~ls~N~l~ 233 (580)
..++.|..|+++.+.+.. .+|+. ...+++|++|+++.|++. ..+ ..+..+++|+.|....|.|+
T Consensus 268 ~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 268 GTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhccccccc
Confidence 334578888999998884 23443 456889999999999996 444 24556677777777677766
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-07 Score=88.67 Aligned_cols=108 Identities=26% Similarity=0.358 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHHhcCCCc--ccceeeEEEcCC----eeEEEEEecCCC-ChhHHHHHHhhhCCCCccHHHHHHHHHHHHH
Q 008026 437 LTEFKSEIAVLTKVRHRH--LVALLGHCLDGN----EKLLVFEYMPQG-TLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509 (580)
Q Consensus 437 ~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~ 509 (580)
.....+|...+..+.... .++.+++.+... ..++|+|++++. +|.+++.... ..+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 346788888888886443 445666665532 358999999874 7888874321 1445567788999999
Q ss_pred HHHHHHhCCCCCcEecCCCCCCeEecCCC---cEEEEeeccccccC
Q 008026 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAP 552 (580)
Q Consensus 510 aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~ 552 (580)
.+.-||+ .+|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 130 ~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 130 LIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 8999999999999999876 79999999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.8e-09 Score=100.86 Aligned_cols=138 Identities=17% Similarity=0.155 Sum_probs=106.4
Q ss_pred hhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccc
Q 008026 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLD 115 (580)
Q Consensus 36 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~ 115 (580)
.++...+.|++||||+|.|+..-.++.-++.++.|++|+|.|. .+-. +..|++|+.||||+|.++...---..+-+.+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIK 355 (490)
T ss_pred EecchHhhhhhccccccchhhhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEe
Confidence 3455678899999999999965556666899999999999998 5544 8899999999999999886543223445677
Q ss_pred cccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCccccc-CcccccC
Q 008026 116 MAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT-ISPEFAS 194 (580)
Q Consensus 116 ~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~-~p~~~~~ 194 (580)
.|.+++|.|..+.+ + ..+.+|..||+++|+|... --..+|+
T Consensus 356 tL~La~N~iE~LSG-----------L---------------------------~KLYSLvnLDl~~N~Ie~ldeV~~IG~ 397 (490)
T KOG1259|consen 356 TLKLAQNKIETLSG-----------L---------------------------RKLYSLVNLDLSSNQIEELDEVNHIGN 397 (490)
T ss_pred eeehhhhhHhhhhh-----------h---------------------------HhhhhheeccccccchhhHHHhccccc
Confidence 88888887643321 1 1234899999999999831 1246899
Q ss_pred CCCCcEEeccCCcccccCCc
Q 008026 195 FKSLQRLILADNNLSGMIPE 214 (580)
Q Consensus 195 l~~L~~L~ls~N~l~g~~p~ 214 (580)
|+-|+.|.|.+|.|+ .+|+
T Consensus 398 LPCLE~l~L~~NPl~-~~vd 416 (490)
T KOG1259|consen 398 LPCLETLRLTGNPLA-GSVD 416 (490)
T ss_pred ccHHHHHhhcCCCcc-ccch
Confidence 999999999999998 5554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.6e-07 Score=96.98 Aligned_cols=143 Identities=20% Similarity=0.263 Sum_probs=91.2
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccCh--h--------------------------h----------HHHHHH
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG--K--------------------------G----------LTEFKS 442 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~--------------------------~----------~~~~~~ 442 (580)
+.|+.++-|+||+|++++|+.||||+.+.+.... . . .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999875421100 0 0 011345
Q ss_pred HHHHHHhcC-----CCcccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHH-HHHHHh
Q 008026 443 EIAVLTKVR-----HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG-VEYLHG 516 (580)
Q Consensus 443 E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~a-L~~LH~ 516 (580)
|..-+.+++ .+.+.-..=|........++|||++|..+.+...-.. ...+.. .++..++.+ +..+=
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k---~ia~~~~~~f~~q~~- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRK---ELAELLVRAFLRQLL- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHH---HHHHHHHHHHHHHHH-
Confidence 555555552 2333222222223466789999999998887742211 223322 223223222 11111
Q ss_pred CCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 517 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
..++.|.|.+|.||+++.++++.+.|||+.....+
T Consensus 283 --~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 --RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 25899999999999999999999999999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-06 Score=80.75 Aligned_cols=141 Identities=21% Similarity=0.173 Sum_probs=100.6
Q ss_pred eeccCcEEEEEEEEcCCcEEEEEEeecccc---C-hhhHHHHHHHHHHHHhcCCCc--ccceeeEEEcC----CeeEEEE
Q 008026 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVI---S-GKGLTEFKSEIAVLTKVRHRH--LVALLGHCLDG----NEKLLVF 472 (580)
Q Consensus 403 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~----~~~~lv~ 472 (580)
-|+|+.+.|++.... |..+-+|.-..... . +-....|.+|+..+.++..-+ +++...+.... -..++|+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999998765 45788887642111 1 224578999999999986333 44444221111 2357999
Q ss_pred EecCC-CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc--EEEEeecccc
Q 008026 473 EYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGLVR 549 (580)
Q Consensus 473 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 549 (580)
|-+++ .+|.+++.+ ....+.+......+..+++..+.-||+ .++.|+|+-+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 478777633 222345667778899999999999998 89999999999999986666 9999998765
Q ss_pred c
Q 008026 550 L 550 (580)
Q Consensus 550 ~ 550 (580)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.1e-06 Score=83.45 Aligned_cols=142 Identities=18% Similarity=0.206 Sum_probs=86.1
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCc--ccceeeEEEcCCeeEEEEEecCCC
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 25567888775422 2345788999999986433 467788877777788999999986
Q ss_pred C-hhHH--------------HHH----HhhhCCCCccHHHH-HHHHH----------HHHH-HHHHHHhC-CCCCcEecC
Q 008026 479 T-LSRH--------------IFN----WAEEGLKPLEWNRR-LTIAL----------DVAR-GVEYLHGL-AHQSFIHRD 526 (580)
Q Consensus 479 ~-L~~~--------------l~~----~~~~~~~~~~~~~~-~~i~~----------~i~~-aL~~LH~~-~~~~ivH~D 526 (580)
+ +... +.+ .............. ..+.. .+.. ..++|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 1111 111 00000001111000 00000 0111 12222211 124578999
Q ss_pred CCCCCeEecCCCcEEEEeeccccc
Q 008026 527 LKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 527 lkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
+.|.||++++++ +.++||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999887 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.1e-09 Score=89.12 Aligned_cols=128 Identities=20% Similarity=0.203 Sum_probs=91.6
Q ss_pred CCcEEeccCCcccccCCccccC---CCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHH
Q 008026 66 QLESLSLRDNFFTGPVPDSLVK---LESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVV 142 (580)
Q Consensus 66 ~L~~L~L~~N~l~~~~P~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~ 142 (580)
.+..++|++++|- .+++.... ...|+..+|++|.|...++.|....
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf------------------------------ 76 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKF------------------------------ 76 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhcc------------------------------
Confidence 4667888888887 67765444 4445556888888887776432111
Q ss_pred HhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCC
Q 008026 143 KLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGAL 222 (580)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L 222 (580)
+.++.|+|++|.|+ .+|.++..|+.|+.|+++.|.|. ..|..+..|.++
T Consensus 77 -----------------------------~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l 125 (177)
T KOG4579|consen 77 -----------------------------PTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKL 125 (177)
T ss_pred -----------------------------chhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhH
Confidence 14667788899998 78999999999999999999998 888888889999
Q ss_pred CEEEccCCcccccCCCC-C---CCceeecCCCCCCCCC
Q 008026 223 KELDVSNNQLYGKIPSF-K---SNAIVNTDGNPDIGKE 256 (580)
Q Consensus 223 ~~l~ls~N~l~g~~p~~-~---~~~~~~~~~n~~~c~~ 256 (580)
..||..+|.+. +||-- + ......+..+||..++
T Consensus 126 ~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~ 162 (177)
T KOG4579|consen 126 DMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDET 162 (177)
T ss_pred HHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccC
Confidence 99999998887 44422 1 1123445555665444
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-06 Score=80.84 Aligned_cols=140 Identities=19% Similarity=0.251 Sum_probs=91.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChh-hH------HHHHHHHHHHHhcCCC---cccceeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK-GL------TEFKSEIAVLTKVRHR---HLVALLGHC 462 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~------~~~~~E~~~l~~l~h~---niv~~~~~~ 462 (580)
...+|...+++.......|.+-+.+ |..+++|.......... .. ....+++..+.+++.. ....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3467888888888877777776664 78899998765322111 01 1123444444444322 233333332
Q ss_pred Ec-----CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC
Q 008026 463 LD-----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537 (580)
Q Consensus 463 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 537 (580)
+. ....+++|||++|..|.+.. .+++ .++..+.+++.-+|. .|+.|+|..|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~---------~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE---------DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch---------hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence 22 23456899999998886543 1222 244567788999997 899999999999999865
Q ss_pred CcEEEEeeccccc
Q 008026 538 MRAKVADFGLVRL 550 (580)
Q Consensus 538 ~~~kl~Dfg~a~~ 550 (580)
.++++||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.9e-06 Score=80.18 Aligned_cols=156 Identities=21% Similarity=0.247 Sum_probs=102.4
Q ss_pred eHHHHHHhhcCCcccce---eeccCcEEEEEEEEcCCcEEEEEEeeccccChhh----------------------HHHH
Q 008026 386 SIQVLRNVTNNFSEENI---LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG----------------------LTEF 440 (580)
Q Consensus 386 ~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~ 440 (580)
+...+....++..+.+. |+.|.-+.||+|...++..+|+|++.......+. ....
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34555556666655555 4567778999998878999999998643221111 1234
Q ss_pred HHHHHHHHhcC--CCcccceeeEEEcCCeeEEEEEecCCCCh-hHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhC
Q 008026 441 KSEIAVLTKVR--HRHLVALLGHCLDGNEKLLVFEYMPQGTL-SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517 (580)
Q Consensus 441 ~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~ 517 (580)
.+|..-|.++. +=.+++.+++. .-.+||||+..... .-.+.+ -.++..++..+..++++.+.-|-.
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~- 184 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK- 184 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH-
Confidence 56777777774 33445555543 34699999965311 111110 122223566677788888887764
Q ss_pred CCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 518 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
..++||+||+.=|||+. ++.+.++|||-|.....+
T Consensus 185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred -hcCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 37899999999999998 789999999988765543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.4e-07 Score=89.81 Aligned_cols=129 Identities=19% Similarity=0.246 Sum_probs=93.1
Q ss_pred HHHHhcCCCcccceeeEEEcCC-----eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCC
Q 008026 445 AVLTKVRHRHLVALLGHCLDGN-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519 (580)
Q Consensus 445 ~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~ 519 (580)
.-+-.+.|.||++++.|+.+.. ...+++||+.-|++..++++..... ..+......+|+.||..||.|||++ .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3444557999999999886543 4689999999999999998765543 4667778889999999999999985 5
Q ss_pred CCcEecCCCCCCeEecCCCcEEEEeecccc--c-cCCCCCCccccccccCCccCccccC
Q 008026 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVR--L-APEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 520 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~--~-~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
..|+|+++.-.-|++..+|-+|+.--.-.. . .............|-++|.|||+-.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc
Confidence 899999999999999988888874221110 0 0000000111234678899998743
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.5e-08 Score=105.73 Aligned_cols=153 Identities=24% Similarity=0.315 Sum_probs=114.9
Q ss_pred cCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCccccccccc
Q 008026 39 QNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAK 118 (580)
Q Consensus 39 ~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~ 118 (580)
..+..++.+++..|.+......+..+++|+.|++.+|+|. .+...+..+++|+.|+|++|+|+.+.+ +..+..|+.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~-l~~l~~L~~L~ 146 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG-LSTLTLLKELN 146 (414)
T ss_pred HHhHhHHhhccchhhhhhhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc-hhhccchhhhe
Confidence 4577888888999999975556888999999999999999 676668899999999999999987654 66666799999
Q ss_pred ccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCccc-ccCCCC
Q 008026 119 GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKS 197 (580)
Q Consensus 119 l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~-~~~l~~ 197 (580)
+.+|.|..+..... +.+|+.+++++|++. .+... ...+.+
T Consensus 147 l~~N~i~~~~~~~~--------------------------------------l~~L~~l~l~~n~i~-~ie~~~~~~~~~ 187 (414)
T KOG0531|consen 147 LSGNLISDISGLES--------------------------------------LKSLKLLDLSYNRIV-DIENDELSELIS 187 (414)
T ss_pred eccCcchhccCCcc--------------------------------------chhhhcccCCcchhh-hhhhhhhhhccc
Confidence 99999887654321 237778888888888 34332 467777
Q ss_pred CcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 198 LQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 198 L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
|+.+++.+|.+. . ...+..+..+..+++..|.++-
T Consensus 188 l~~l~l~~n~i~-~-i~~~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 188 LEELDLGGNSIR-E-IEGLDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred hHHHhccCCchh-c-ccchHHHHHHHHhhccccccee
Confidence 888888888775 2 2345555555556666776663
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.9e-09 Score=85.15 Aligned_cols=112 Identities=20% Similarity=0.190 Sum_probs=93.2
Q ss_pred cceEEecccCCCCCCCCCchh---hcCcccCceEecccCcCcCCCCCCCC-CCCCcEEeccCCcccccCCccccCCCCCc
Q 008026 17 IQSLWVNGQNGNAKLGGGIDV---IQNMTSLKEIWLHSNAFSGPLPDFSG-VKQLESLSLRDNFFTGPVPDSLVKLESLK 92 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~---~~~l~~L~~L~L~~N~l~~~~p~~~~-l~~L~~L~L~~N~l~~~~P~~~~~l~~L~ 92 (580)
-..+..++++.+++. ..+++ +.....|+..+|++|.|...++.|.. .+.++.|+|++|+|+ .+|.++..++.|+
T Consensus 26 akE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr 103 (177)
T KOG4579|consen 26 AKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR 103 (177)
T ss_pred HHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh
Confidence 345667777777443 33444 45556788889999999977776644 678999999999999 9999999999999
Q ss_pred EEEccCCcccccCCCCCcccccccccccCCCCCCCCCC
Q 008026 93 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGA 130 (580)
Q Consensus 93 ~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~ 130 (580)
.|++++|.|...+..+..+.+|.+|+..+|.+.+++-+
T Consensus 104 ~lNl~~N~l~~~p~vi~~L~~l~~Lds~~na~~eid~d 141 (177)
T KOG4579|consen 104 SLNLRFNPLNAEPRVIAPLIKLDMLDSPENARAEIDVD 141 (177)
T ss_pred hcccccCccccchHHHHHHHhHHHhcCCCCccccCcHH
Confidence 99999999999888888899999999999999988855
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.4e-07 Score=105.51 Aligned_cols=116 Identities=18% Similarity=0.215 Sum_probs=72.5
Q ss_pred ccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCc
Q 008026 5 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPD 83 (580)
Q Consensus 5 ~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~ 83 (580)
+-.++....+++|+.|-+.++.. .+.....+.|..|+.|++|||++|.=-+.+| .++.|-+|++|+|+...++ .+|.
T Consensus 535 ~~~~~~~~~~~~L~tLll~~n~~-~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~ 612 (889)
T KOG4658|consen 535 IEHIAGSSENPKLRTLLLQRNSD-WLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPS 612 (889)
T ss_pred hhhccCCCCCCccceEEEeecch-hhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccch
Confidence 33444444333444444444321 1344444557778888888888776555666 4677788888888888887 7888
Q ss_pred cccCCCCCcEEEccCCcccccCCCCC-cccccccccccCC
Q 008026 84 SLVKLESLKIVNMTNNLLQGPVPEFD-RSVSLDMAKGSNN 122 (580)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~l~l~~n 122 (580)
.+++|++|.+|++..+.....+|.+. .+.+|++|.+...
T Consensus 613 ~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 613 GLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred HHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence 88888888888887775554555543 3667777665444
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.6e-06 Score=85.29 Aligned_cols=143 Identities=19% Similarity=0.226 Sum_probs=105.9
Q ss_pred CcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc----CCeeEEEEEecCC-CCh
Q 008026 407 GFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLVFEYMPQ-GTL 480 (580)
Q Consensus 407 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~L 480 (580)
--.+.|++.. .||..|++|+++..... .......-++.++++.|+|+|++.+++.. +...++|++|+++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3467899955 48999999999543211 11223445788999999999999998873 3457899999986 466
Q ss_pred hHHHHHHh----------hhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 481 SRHIFNWA----------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 481 ~~~l~~~~----------~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
.++-.... .......++...+.++.|+..||.++|+ .|+.-+-+.|.+|+++.+.+++|+..|+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceee
Confidence 55442211 1122346788899999999999999998 7899999999999999888999988887665
Q ss_pred cCCC
Q 008026 551 APEG 554 (580)
Q Consensus 551 ~~~~ 554 (580)
...+
T Consensus 443 l~~d 446 (655)
T KOG3741|consen 443 LQED 446 (655)
T ss_pred ecCC
Confidence 4433
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.7e-07 Score=61.57 Aligned_cols=39 Identities=36% Similarity=0.544 Sum_probs=27.7
Q ss_pred CCCcEEeccCCcccccCCccccCCCCCcEEEccCCccccc
Q 008026 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 104 (580)
Q Consensus 65 ~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~ 104 (580)
++|++|+|++|+|+ .+|..|++|++|+.|+|++|+++..
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i 39 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDI 39 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBE
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCC
Confidence 46777777777777 6777777777777777777777744
|
... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.3e-06 Score=87.56 Aligned_cols=143 Identities=19% Similarity=0.279 Sum_probs=89.0
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccCh--hh---------------------------------HHHHHHHH
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG--KG---------------------------------LTEFKSEI 444 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~---------------------------------~~~~~~E~ 444 (580)
.+.|+.-+.|+||+|+.++|+.||||+-+...... .+ .-+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999865421110 00 00133454
Q ss_pred HHHHhc----CCCc------ccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHH
Q 008026 445 AVLTKV----RHRH------LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514 (580)
Q Consensus 445 ~~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~L 514 (580)
+-..++ +|-+ |++++-.+ .....++||||+|..+.+.-. ..+. .++... ++..+.++ |+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~-i~~~---gi~~~~---i~~~l~~~--~~ 314 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDA-IDKR---GISPHD---ILNKLVEA--YL 314 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHH-HHHc---CCCHHH---HHHHHHHH--HH
Confidence 443333 3444 33333222 345789999999987766531 1122 233333 33333333 22
Q ss_pred HhCCCCCcEecCCCCCCeEecC----CCcEEEEeeccccccCC
Q 008026 515 HGLAHQSFIHRDLKPSNILLGD----DMRAKVADFGLVRLAPE 553 (580)
Q Consensus 515 H~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfg~a~~~~~ 553 (580)
+.....|++|+|-+|.||++.. ++++.+-|||+......
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2222368999999999999984 67899999999876543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.6e-07 Score=90.20 Aligned_cols=174 Identities=21% Similarity=0.268 Sum_probs=105.5
Q ss_pred hhhcCcccCceEecccCcCcCCCC-----CCCCCCCCcEEeccCC---cccccCCcc-------ccCCCCCcEEEccCCc
Q 008026 36 DVIQNMTSLKEIWLHSNAFSGPLP-----DFSGVKQLESLSLRDN---FFTGPVPDS-------LVKLESLKIVNMTNNL 100 (580)
Q Consensus 36 ~~~~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~L~~N---~l~~~~P~~-------~~~l~~L~~L~L~~N~ 100 (580)
+.+..+.++++|+|++|.|...-. .+...++|+.-++|+= ++...+|+. +-.+++|+.||||+|-
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 456778899999999999875332 2566778888888652 222245543 4456789999999998
Q ss_pred ccccCC-C----CCcccccccccccCCCCCCCCCCCch-hHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 101 LQGPVP-E----FDRSVSLDMAKGSNNFCLPSPGACDP-RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 101 l~~~~~-~----~~~~~~L~~l~l~~n~~~~~~~~~~~-~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
|.-.-+ . +..+..|++|.+.||-+.+..+.... .+..+. ..+..... +.|
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~-~~kk~~~~-----------------------~~L 159 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELA-VNKKAASK-----------------------PKL 159 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHH-HHhccCCC-----------------------cce
Confidence 864333 1 56688999999999988766554322 122221 11111111 256
Q ss_pred EEEEecCCccccc----CcccccCCCCCcEEeccCCccc--c--cCCccCcCCCCCCEEEccCCccc
Q 008026 175 TVINFQKMNLTGT----ISPEFASFKSLQRLILADNNLS--G--MIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 175 ~~L~ls~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~--g--~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
+++..++|++... +...|...+.|+.+.++.|.|. | .+-..+..++.|+.|||..|-|+
T Consensus 160 rv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft 226 (382)
T KOG1909|consen 160 RVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFT 226 (382)
T ss_pred EEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhh
Confidence 6666666666521 2223455566666666666553 0 01123455666666666666665
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.28 E-value=1e-05 Score=78.16 Aligned_cols=143 Identities=17% Similarity=0.138 Sum_probs=85.0
Q ss_pred eeeccCc-EEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEEecCCCC
Q 008026 402 ILGRGGF-GTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQGT 479 (580)
Q Consensus 402 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~ 479 (580)
.|..|.. ..||+.... +..+++|...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3445555 789999764 4678888765421 235678888888885 4445677877776667899999999987
Q ss_pred hhHHHH----------------HHhhhCC--CCccH--HHHHHHHH--------------------HHHHHHHHHHh---
Q 008026 480 LSRHIF----------------NWAEEGL--KPLEW--NRRLTIAL--------------------DVARGVEYLHG--- 516 (580)
Q Consensus 480 L~~~l~----------------~~~~~~~--~~~~~--~~~~~i~~--------------------~i~~aL~~LH~--- 516 (580)
+..... +...... ..+.. ........ .+...++.|-.
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 764320 0000000 01110 00000000 01111222211
Q ss_pred -CCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 517 -LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 517 -~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
.....++|+|+.|.|||++.+..+.|+||+.|..
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1124589999999999999877788999998854
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.2e-06 Score=78.12 Aligned_cols=147 Identities=20% Similarity=0.244 Sum_probs=85.8
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCC--cccceeeEEEc---CCeeEEEEEe
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR--HLVALLGHCLD---GNEKLLVFEY 474 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~ 474 (580)
++.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 3678999999999998876 68999986542 3456788899998888533 35566664433 2346899999
Q ss_pred cCCCChhH----------------HHHHHhhh--CCCCccHHH---------HHHH------------HHHHHH-HHHHH
Q 008026 475 MPQGTLSR----------------HIFNWAEE--GLKPLEWNR---------RLTI------------ALDVAR-GVEYL 514 (580)
Q Consensus 475 ~~~g~L~~----------------~l~~~~~~--~~~~~~~~~---------~~~i------------~~~i~~-aL~~L 514 (580)
++|..+.. .+...... ......... .... ...+.. .++.+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99987776 11111111 001111100 0000 111222 23333
Q ss_pred Hh----CCCCCcEecCCCCCCeEec-CCCcEEEEeecccccc
Q 008026 515 HG----LAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLA 551 (580)
Q Consensus 515 H~----~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~ 551 (580)
+. .....++|+|+.|.||+++ +++.+.|+||+.+...
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 32 1246799999999999999 6666789999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 580 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-10 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-10 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-10 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-10 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-06 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 5e-92
Identities = 81/212 (38%), Positives = 118/212 (55%), Gaps = 15/212 (7%)
Query: 371 EPGDIQMLEAGNMVISIQVLRNVTNNFSEE------NILGRGGFGTVYKGELHDGTKIAV 424
E +++ + S L+NVTNNF E N +G GGFG VYKG + + T +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 425 KRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSR 482
K++ A V + + +F EI V+ K +H +LV LLG DG++ LV+ YMP G+L
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 483 HIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542
+ +G PL W+ R IA A G+ +LH IHRD+K +NILL + AK+
Sbjct: 120 RLSCL--DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKI 174
Query: 543 ADFGLVRLAPEGKGS-IETRIAGTFGYLAPEY 573
+DFGL R + + + + +RI GT Y+APE
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 1e-90
Identities = 77/214 (35%), Positives = 121/214 (56%), Gaps = 7/214 (3%)
Query: 362 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 421
S+ + ++ + + + L TNNF + ++G G FG VYKG L DG K
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 422 IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 481
+A+KR S +G+ EF++EI L+ RH HLV+L+G C + NE +L+++YM G L
Sbjct: 66 VALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 482 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541
RH++ ++ + W +RL I + ARG+ YLH ++ IHRD+K NILL ++ K
Sbjct: 124 RHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179
Query: 542 VADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYA 574
+ DFG+ + E + + T + GT GY+ PEY
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 5e-88
Identities = 80/185 (43%), Positives = 115/185 (62%), Gaps = 2/185 (1%)
Query: 390 LRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
L+ ++NFS +NILGRGGFG VYKG L DGT +AVKR++ G G +F++E+ +++
Sbjct: 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISM 83
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
HR+L+ L G C+ E+LLV+ YM G+++ + E PL+W +R IAL AR
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSAR 142
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
G+ YLH IHRD+K +NILL ++ A V DFGL +L + T + GT G++
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 202
Query: 570 APEYA 574
APEY
Sbjct: 203 APEYL 207
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-57
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 22/202 (10%)
Query: 385 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEI 444
+ + L + + RG FG V+K + +AVK + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW---QNEYEV 69
Query: 445 AVLTKVRHRHLVALLGHCLDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 500
L ++H +++ +G G + L+ + +G+LS + + WN
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNEL 123
Query: 501 LTIALDVARGVEYLH-------GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553
IA +ARG+ YLH + HRD+K N+LL +++ A +ADFGL
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 554 GKGSIET-RIAGTFGYLAPEYA 574
GK + +T GT Y+APE
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVL 205
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-56
Identities = 59/180 (32%), Positives = 96/180 (53%), Gaps = 8/180 (4%)
Query: 396 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
+ + + +G G FGTV++ E H G+ +AVK + + + EF E+A++ ++RH
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
++V +G +V EY+ +G+L R + + L+ RRL++A DVA+G+
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMN 151
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
YLH + +HR+LK N+L+ KV DFGL RL S AGT ++APE
Sbjct: 152 YLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPE 209
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-51
Identities = 56/179 (31%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
E ++GRG FG V K + +A+K++E S F E+ L++V H +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE----SESERKAFIVELRQLSRVNHPN 62
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V L G CL N LV EY G+L + E L ++ L ++GV YL
Sbjct: 63 IVKLYGACL--NPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
H + ++ IHRDLKP N+LL K+ DFG + T G+ ++APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPE 173
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-50
Identities = 38/182 (20%), Positives = 73/182 (40%), Gaps = 16/182 (8%)
Query: 396 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
+F + L G ++KG G I VK ++ S + +F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 453 RHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
+++ +LG C + +MP G+L + E ++ ++ + ALD+ARG
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALDMARG 123
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 570
+ +LH L L ++++ +DM A+++ + ++A
Sbjct: 124 MAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVA 176
Query: 571 PE 572
PE
Sbjct: 177 PE 178
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-50
Identities = 58/190 (30%), Positives = 90/190 (47%), Gaps = 23/190 (12%)
Query: 396 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKV 450
+F+E E I+G GGFG VY+ G ++AVK + + + E + +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
+H +++AL G CL LV E+ G L+R + K + + + A+ +ARG
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARG 117
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVADFGLVRLAPEGKGSIETRI 562
+ YLH A IHRDLK SNIL+ + K+ DFGL R + +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSA 174
Query: 563 AGTFGYLAPE 572
AG + ++APE
Sbjct: 175 AGAYAWMAPE 184
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 44/184 (23%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 396 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
F + ++G+G FG VY G H ++A++ ++ + L FK E+ + RH
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
++V +G C+ ++ TL + + L+ N+ IA ++ +G+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMG 144
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE----TRIAGTFGY 568
YLH + +H+DLK N+ D+ + + DFGL ++ + G +
Sbjct: 145 YLHA---KGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 569 LAPE 572
LAPE
Sbjct: 201 LAPE 204
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 22/189 (11%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLT 448
N E +G+GGFG V+KG + D + +A+K + G G+ EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
+ H ++V L G + +V E++P G L + + A P++W+ +L + LD+A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIA 132
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILL-----GDDMRAKVADFGLVRLAPEGKGSIETRIA 563
G+EY+ + +HRDL+ NI L + AKVADFGL + + + +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGLL 187
Query: 564 GTFGYLAPE 572
G F ++APE
Sbjct: 188 GNFQWMAPE 196
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 57/171 (33%), Positives = 90/171 (52%), Gaps = 11/171 (6%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462
+G G FGTVYKG+ H +AVK + + + L FK+E+ VL K RH +++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 522
+V ++ +L H+ E + + IA ARG++YLH +S
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 523 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGYLAPE 572
IHRDLK +NI L +D K+ DFGL GS + +++G+ ++APE
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-49
Identities = 51/200 (25%), Positives = 78/200 (39%), Gaps = 32/200 (16%)
Query: 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAV--LTKVR 451
+N ++GRG +G VYKG L +AVK S F +E + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF-----SFANRQNFINEKNIYRVPLME 65
Query: 452 HRHLVALLGHCLDGN-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 506
H ++ + E LLV EY P G+L +++ +W +A
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHS 119
Query: 507 VARGVEYLH------GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE- 559
V RG+ YLH + HRDL N+L+ +D ++DFGL +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 560 ------TRIAGTFGYLAPEY 573
GT Y+APE
Sbjct: 180 EEDNAAISEVGTIRYMAPEV 199
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 389 VLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE--IAV 446
+ R V + + +G+G +G V++G G +AVK + S + + E +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVK-----IFSSRDEKSWFRETELYN 55
Query: 447 LTKVRHRHLVALLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 502
+RH +++ + + L+ Y G+L ++ L+ L
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLR 109
Query: 503 IALDVARGVEYLHGLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557
I L +A G+ +LH + HRDLK NIL+ + + +AD GL + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 558 IE---TRIAGTFGYLAPE 572
++ GT Y+APE
Sbjct: 170 LDVGNNPRVGTKRYMAPE 187
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-44
Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 23/187 (12%)
Query: 400 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
+LG+G FG K + G + +K + + F E+ V+ + H +++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+G + EY+ GTL I + W++R++ A D+A G+ YLH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH--- 125
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR-------------IAGT 565
+ IHRDL N L+ ++ VADFGL RL + K E + G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 566 FGYLAPE 572
++APE
Sbjct: 186 PYWMAPE 192
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-44
Identities = 43/187 (22%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE--IAVLTKVRHRHLVA 457
+G+G +G V+ G+ G K+AVK V + E I +RH +++
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVK-----VFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 458 LLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
+ + G L+ +Y G+L ++ + L+ L +A G+ +
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCH 149
Query: 514 LHGLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE---TRIAGT 565
LH + HRDLK NIL+ + +AD GL ++ GT
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 566 FGYLAPE 572
Y+ PE
Sbjct: 210 KRYMPPE 216
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 26/187 (13%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE--IAVLTKVRHRHLVA 457
+ +G+G FG V++G+ G ++AVK + S + + E I +RH +++
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 458 LLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
+ N LV +Y G+L ++ + + +AL A G+ +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAH 154
Query: 514 LHGLAHQS-----FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE---TRIAGT 565
LH + HRDLK NIL+ + +AD GL +I+ GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 566 FGYLAPE 572
Y+APE
Sbjct: 215 KRYMAPE 221
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 19/190 (10%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
++ LG GGF V E LHDG A+KR+ + E + E + H +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPN 87
Query: 455 LVALLGHCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
++ L+ +CL +E L+ + +GTL I ++ L ++ L + L + RG
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRG 146
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA------- 563
+E +H + + HRDLKP+NILLGD+ + + D G + A +
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 564 -GTFGYLAPE 572
T Y APE
Sbjct: 204 RCTISYRAPE 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 54/160 (33%), Positives = 87/160 (54%), Gaps = 13/160 (8%)
Query: 400 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
ILG G FG+V +G L K+AVK M+ S + + EF SE A + H ++
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 456 VALLGHCLDGN-----EKLLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVAR 509
+ LLG C++ + + +++ +M G L ++ ++ E G K + L +D+A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
G+EYL ++++F+HRDL N +L DDM VADFGL +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 57/165 (34%), Positives = 80/165 (48%), Gaps = 19/165 (11%)
Query: 400 ENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHL 455
++++G G FG V K + A+KRM+ S +F E+ VL K+ H ++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNI 88
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNRRLTIA 504
+ LLG C L EY P G L + F A L + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 400 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
+LG+G FG+V + +L K+AVK ++A +I+ + EF E A + + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 456 VALLGHCLDGNEK------LLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVA 508
L+G L K +++ +M G L + + E L + +D+A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
G+EYL + ++FIHRDL N +L +DM VADFGL R
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 50/175 (28%), Positives = 75/175 (42%), Gaps = 29/175 (16%)
Query: 400 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
LG G FG V K T +AVK ++ S L + SE VL +V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHP 86
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTL-------------------SRHIFNWAEEGLKP 494
H++ L G C LL+ EY G+L SR+ + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 495 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L ++ A +++G++Y LA +HRDL NIL+ + + K++DFGL R
Sbjct: 147 LTMGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 401 NILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
LG+G FG VY+G T++A+K + S + EF +E +V+ + H
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHH 89
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+V LLG G L++ E M +G L S L P ++ + +A ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
G+ YL F+HRDL N ++ +D K+ DFG+ R
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+G G FG V+ G + K+A+K + G +S + +F E V+ K+ H LV L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLY 69
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
G CL+ LV E+M G L ++ L + LDV G+ YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCL----SDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553
IHRDL N L+G++ KV+DFG+ R +
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 24/170 (14%)
Query: 400 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 450
LG G FG V E +AVK ++ + K L++ SE+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG 98
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNR 499
+H++++ LLG C ++ EY +G L + ++ + + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R
Sbjct: 159 LVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 24/170 (14%)
Query: 400 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 450
LG G FG V E +AVK ++ + K L++ SE+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG 144
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNR 499
+H++++ LLG C ++ EY +G L + ++ + + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R
Sbjct: 205 LVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 24/170 (14%)
Query: 400 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 450
LG G FG V E TK+AVK +++ + K L++ SE+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIG 132
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNR 499
+H++++ LLG C ++ EY +G L + +N + + L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
++ A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 51/175 (29%), Positives = 74/175 (42%), Gaps = 24/175 (13%)
Query: 395 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
N S LG G FG V + + +AVK ++ SE+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLS 81
Query: 449 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-------------SRHIFNWAEEGLKP 494
+ H ++V LLG C G L++ EY G L S+ E+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 495 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L+ L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R
Sbjct: 142 LDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 16/163 (9%)
Query: 400 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
LG+G FG+V G +AVK+++ + + L +F+ EI +L ++H +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 103
Query: 455 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+V G C + L+ EY+P G+L ++ E ++ + L + +G+E
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGME 159
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P+ K
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 20/166 (12%)
Query: 400 ENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RH 452
LG G FG V + K+AVK +++ SE+ +++ + +H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQH 109
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTL---------SRHIFNWAEEGLKPLEWNRRLTI 503
++V LLG C G L++ EY G L L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ VA+G+ +L A ++ IHRD+ N+LL + AK+ DFGL R
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 18/182 (9%)
Query: 400 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
LG+G FG+V G +AVK+++ + + L +F+ EI +L ++H +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 72
Query: 455 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+V G C + L+ EY+P G+L ++ ++ + ++ + L + +G+E
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGME 128
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 570
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P+ K + + G + A
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 571 PE 572
PE
Sbjct: 186 PE 187
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 49/154 (31%), Positives = 69/154 (44%), Gaps = 10/154 (6%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
LG G FG V G+ +A+K ++ G +S EF E V+ + H LV L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLY 85
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
G C ++ EYM G L N+ E + + L + DV +EYL
Sbjct: 86 GVCTKQRPIFIITEYMANGCL----LNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ES 138
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553
+ F+HRDL N L+ D KV+DFGL R +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 9/156 (5%)
Query: 400 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
+GRG FG V+ G L D T +AVK + +F E +L + H ++V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+G C +V E + G + EG L L + D A G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RTEG-ARLRVKTLLQMVGDAAAGMEYLES-- 231
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554
+ IHRDL N L+ + K++DFG+ R +G
Sbjct: 232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 400 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
LG G FG V G ++AVK ++ G + + K EI +L + H +
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHEN 84
Query: 455 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+V G C + L+ E++P G+L ++ + + ++L A+ + +G++
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMD 140
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 570
YL + ++HRDL N+L+ + + K+ DFGL + K + + A
Sbjct: 141 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 571 PE 572
PE
Sbjct: 198 PE 199
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 22/167 (13%)
Query: 400 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+ LG G FG V+ E ++ +AVK ++ + +F+ E +LT ++H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHE 77
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNRRLT 502
H+V G C DG+ ++VFEYM G L + + L ++ L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
IA +A G+ YL A Q F+HRDL N L+G ++ K+ DFG+ R
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 29/175 (16%)
Query: 400 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+G G FG V++ T +AVK ++ S +F+ E A++ + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNP 110
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTL-------------------SRHIFNWAEEGLKP 494
++V LLG C G L+FEYM G L + G P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 495 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L +L IA VA G+ Y L+ + F+HRDL N L+G++M K+ADFGL R
Sbjct: 171 LSCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-33
Identities = 50/154 (32%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
LG G FG V G+ +AVK ++ G +S EF E + K+ H LV
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFY 69
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
G C +V EY+ G L N+ K LE ++ L + DV G+ +L
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLL----NYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ES 122
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553
FIHRDL N L+ D+ KV+DFG+ R +
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 401 NILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 453
LGRG FG V + + +AVK ++ G + SE+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHL 91
Query: 454 HLVALLGHCLDGNEKLLV-FEYMPQGTL------SRHIFNWAEEGL-----KPLEWNRRL 501
++V LLG C L+V E+ G L R+ F + L +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 502 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ VA+G+E+L A + IHRDL NILL + K+ DFGL R
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 400 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+ LG G FG V+ E H+ +AVK ++ S +F+ E +LT ++H+
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQ 103
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTL----------SRHIFNWAEEGLKPLEWNRRLTI 503
H+V G C +G L+VFEYM G L ++ + + PL + L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
A VA G+ YL A F+HRDL N L+G + K+ DFG+ R
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 29/175 (16%)
Query: 400 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RH 452
+LG G FG V + ++AVK ++ SE+ ++T++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSH 108
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTL------SRHIFNWA------------EEGLKP 494
++V LLG C L+FEY G L R F+ EE L
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 495 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L + L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-33
Identities = 42/167 (25%), Positives = 68/167 (40%), Gaps = 21/167 (12%)
Query: 400 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
LG FG VYKG L +A+K ++ G EF+ E + +++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHP 72
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNRRLT 502
++V LLG ++F Y G L + LE +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ +A G+EYL + +H+DL N+L+ D + K++D GL R
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 53/151 (35%), Positives = 83/151 (54%), Gaps = 12/151 (7%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+G+G FG V G+ G K+AVK ++ + F +E +V+T++RH +LV LL
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 80
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
G ++ L +V EYM +G+L ++ G L + L +LDV +EYL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---E 134
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+F+HRDL N+L+ +D AKV+DFGL +
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-33
Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 27/191 (14%)
Query: 399 EENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
E+ LG G FGTV KG +AVK ++ E +E V+ ++ + ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVAR 509
V ++G C +LV E G L K L+ NR + + V+
Sbjct: 81 VRMIGICE-AESWMLVMEMAELGPL-----------NKYLQQNRHVKDKNIIELVHQVSM 128
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--G 567
G++YL +F+HRDL N+LL AK++DFGL + + + + G +
Sbjct: 129 GMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 568 YLAPEYAGNFG 578
+ APE N+
Sbjct: 186 WYAPE-CINYY 195
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 10/152 (6%)
Query: 400 ENILGRGGFGTVYKGELHDG-TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 74
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
LG C ++ E+M G L ++ E + + L +A ++ +EYL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL---E 128
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
++FIHRDL N L+G++ KVADFGL RL
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 55/202 (27%), Positives = 80/202 (39%), Gaps = 30/202 (14%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+F LGRGGFG V++ + D A+KR+ + E+ L K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 63
Query: 454 HLVALLGHCLDGNEKL------------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 501
+V L+ N + + + L + ++ E + L
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCL 121
Query: 502 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----------L 550
I L +A VE+LH + +HRDLKPSNI D KV DFGLV L
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 551 APEGKGSIETRIAGTFGYLAPE 572
P + T GT Y++PE
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPE 200
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 53/167 (31%), Positives = 74/167 (44%), Gaps = 25/167 (14%)
Query: 400 ENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
LG G FG V G +AVK ++A + + +K EI +L + H H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEH 94
Query: 455 LVALLGHCLDGNEK--LLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVA 508
++ G C D LV EY+P G+L RH + + L A +
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----------SIGLAQLLLFAQQIC 144
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
G+ YLH Q +IHRDL N+LL +D K+ DFGL + PEG
Sbjct: 145 EGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 53/151 (35%), Positives = 83/151 (54%), Gaps = 12/151 (7%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+G+G FG V G+ G K+AVK ++ + F +E +V+T++RH +LV LL
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 252
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
G ++ L +V EYM +G+L ++ G L + L +LDV +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---E 306
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+F+HRDL N+L+ +D AKV+DFGL +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-32
Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 10/152 (6%)
Query: 400 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQL 281
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
LG C ++ E+M G L ++ E + + L +A ++ +EYL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL---E 335
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
++FIHR+L N L+G++ KVADFGL RL
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 29/213 (13%)
Query: 368 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM 427
PS E D + +V I F +++LG G GT+ + D +AVKR
Sbjct: 5 PSLEQDDGDEETSVVIVGKIS--------FCPKDVLGHGAEGTIVYRGMFDNRDVAVKR- 55
Query: 428 EAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN 486
I + + E+ +L + H +++ D + + E TL ++
Sbjct: 56 ----ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV-- 108
Query: 487 WAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAK 541
E+ +T+ G+ +LH + +HRDLKP NIL+ ++A
Sbjct: 109 --EQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAM 163
Query: 542 VADFGLVRLAPEGKGSIETR--IAGTFGYLAPE 572
++DFGL + G+ S R + GT G++APE
Sbjct: 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 400 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
++GRG FG VY G L D AVK + +++F +E ++ H ++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNV 88
Query: 456 VALLGHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
++LLG CL L V YM G L I + L VA+G++YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
A + F+HRDL N +L + KVADFGL R
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 400 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
LG G FG VY+G++ ++AVK + S + +F E +++K H+
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQ 93
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARG 510
++V +G L + ++ E M G L R + L L +A D+A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP-SSLAMLDLLHVARDIACG 152
Query: 511 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 549
+Y L FIHRD+ N LL G AK+ DFG+ R
Sbjct: 153 CQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 15/185 (8%)
Query: 400 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
E I+G G G V G L +A+K ++AG + +F SE +++ + H ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNI 112
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
+ L G G ++V EYM G+L + + + + V G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSL----DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL- 167
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL--APEY 573
+ ++HRDL N+L+ ++ KV+DFGL R+ + + T G APE
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE- 224
Query: 574 AGNFG 578
A F
Sbjct: 225 AIAFR 229
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 51/186 (27%), Positives = 78/186 (41%), Gaps = 16/186 (8%)
Query: 400 ENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 454
LG G FG V +GE +AVK ++ V+S + + +F E+ + + HR+
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
L+ L G L +V E P G+L + + A+ VA G+ YL
Sbjct: 83 LIRLYGVVL-TPPMKMVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPE 572
+ FIHRDL N+LL K+ DFGL+R P+ + + APE
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 573 YAGNFG 578
+
Sbjct: 195 -SLKTR 199
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 16/186 (8%)
Query: 400 ENILGRGGFGTVYKGELHDGT-----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ ++G G FG VYKG L + +A+K ++AG + K +F E ++ + H +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHN 107
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
++ L G +++ EYM G L + E + + + +A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGAL----DKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPE 572
A+ +++HRDL NIL+ ++ KV+DFGL R+ + + T G APE
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 573 YAGNFG 578
A ++
Sbjct: 221 -AISYR 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 7/183 (3%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
++ +G G +G K DG + K ++ G ++ SE+ +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 454 HLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
++V +D L V EY G L+ I +E + L+ L + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 512 EYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
+ H + +HRDLKP+N+ L K+ DFGL R+ +T + GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 570 APE 572
+PE
Sbjct: 184 SPE 186
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 399 EENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ ++G+G FG VY GE D + A+K + + + F E ++ + H +
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPN 83
Query: 455 LVALLGHCLDGNE-KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
++AL+G L ++ YM G L + I + ++ L VARG+EY
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEY 139
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
L A Q F+HRDL N +L + KVADFGL R
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 400 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ LG+G FG+V G +AVK+++ +F+ EI +L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDF 85
Query: 455 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+V G + LV EY+P G L + + L+ +R L + + +G+E
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGME 141
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
YL + +HRDL NIL+ + K+ADFGL +L P K
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 37/206 (17%)
Query: 394 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
++F E +LG+G FG V K D A+K++ + + L+ SE+ +L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 453 RHLVALLGHCLDGNEKL-------------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 499
+++V L+ + + EY GTL ++ + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDE 117
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--------- 550
+ + + Y+H Q IHRDLKP NI + + K+ DFGL +
Sbjct: 118 YWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 551 ----APEGKGSIETRIAGTFGYLAPE 572
G T GT Y+A E
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 20/240 (8%)
Query: 320 QKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLE 379
R ++ A I I +++ A SE + I +
Sbjct: 11 HHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSA 70
Query: 380 AGNMVISIQVLRNVTNNFSEENI-----LGRGGFGTVYKGELHDG----TKIAVKRMEAG 430
++ Q +++V S + +GRG FG VY G L D AVK +
Sbjct: 71 LNPELV--QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 128
Query: 431 VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL-VFEYMPQGTLSRHIFNWAE 489
+++F +E ++ H ++++LLG CL L V YM G L I
Sbjct: 129 T-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----R 183
Query: 490 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ L VA+G+++L A + F+HRDL N +L + KVADFGL R
Sbjct: 184 NETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
LG G FG V+ G + TK+AVK ++ G +S F +E ++ +++H+ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLY 74
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
++ EYM G+L F G L N+ L +A +A G+ ++
Sbjct: 75 AVVT-QEPIYIITEYMENGSLVD--FLKTPSG-IKLTINKLLDMAAQIAEGMAFI---EE 127
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553
+++IHRDL+ +NIL+ D + K+ADFGL RL +
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 42/179 (23%), Positives = 77/179 (43%), Gaps = 8/179 (4%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+ +G G FG + DG + +K + +S K E + E+AVL ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
++V + +V +Y G L + I + + ++ L + + +++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+H + +HRD+K NI L D ++ DFG+ R+ I GT YL+PE
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPE 195
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 45/241 (18%), Positives = 89/241 (36%), Gaps = 18/241 (7%)
Query: 335 HPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT 394
H H S + + + + D + + N IS++
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG----- 55
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-- 452
+S +G GG V++ A+K + + L +++EIA L K++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
++ L + + +V E L+ + + K ++ R + ++ V
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVH 169
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAP 571
+H +H DLKP+N L+ D K+ DFG+ + P+ ++ G Y+ P
Sbjct: 170 TIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 572 E 572
E
Sbjct: 226 E 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 37/181 (20%), Positives = 72/181 (39%), Gaps = 13/181 (7%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-- 452
+S +G GG V++ A+K + + L +++EIA L K++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
++ L + + +V E L+ + ++ + ++ V
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKS--YWKNMLEAVH 141
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAP 571
+H +H DLKP+N L+ D K+ DFG+ + P+ ++ GT Y+ P
Sbjct: 142 TIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 572 E 572
E
Sbjct: 198 E 198
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 53/243 (21%), Positives = 90/243 (37%), Gaps = 29/243 (11%)
Query: 319 KQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQML 378
+ + + S K++ ++ + + + +
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66
Query: 379 EAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVI 432
E V R N + LG G FG VY+G++ ++AVK +
Sbjct: 67 E---------VPRK---NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC- 113
Query: 433 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAE 489
S + +F E +++K H+++V +G L + ++ E M G L R
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 173
Query: 490 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFG 546
+ L L +A D+A G +Y L FIHRD+ N LL G AK+ DFG
Sbjct: 174 QP-SSLAMLDLLHVARDIACGCQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 547 LVR 549
+ R
Sbjct: 230 MAR 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 399 EENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
+ LG G FG+V +G +A+K ++ G E E ++ ++ + ++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYI 72
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
V L+G C +LV E G L + + EE + + + V+ G++YL
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL- 126
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLAPEY 573
++F+HRDL N+LL + AK++DFGL + R AG + + APE
Sbjct: 127 --EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE- 183
Query: 574 AGNFG 578
NF
Sbjct: 184 CINFR 188
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 16/157 (10%)
Query: 400 ENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+LG G FGTVYKG +A+K + S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEY 513
+ LLG CL + L+ + MP G L ++ + G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
L + +HRDL N+L+ K+ DFGL +L
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 28/201 (13%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+++ N E ILG G GTV G +AVKRM EI +LT+
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTES 65
Query: 451 -RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGLKPLEWNRRLTIALDV 507
H +++ + E L + N ++E LK + +++ +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILL-------------GDDMRAKVADFGLVRLAPEG 554
A GV +LH IHRDLKP NIL+ +++R ++DFGL + G
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 555 KGSIETR---IAGTFGYLAPE 572
+ S T +GT G+ APE
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPE 202
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 33/196 (16%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+F E ++G GGFG V+K + DG +KR++ + + E+ L K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHV 64
Query: 454 HLVALLGHCLDGNEKL----------------LVFEYMPQGTLSRHIFNWAEEGLKPLEW 497
++V G + + E+ +GTL + I + + L+
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDK 121
Query: 498 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKG 556
L + + +GV+Y+H + I+RDLKPSNI L D + K+ DFGLV L +GK
Sbjct: 122 VLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 557 SIETRIAGTFGYLAPE 572
TR GT Y++PE
Sbjct: 179 ---TRSKGTLRYMSPE 191
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 10/156 (6%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
E LG G FG V+ + TK+AVK M+ G +S + F +E V+ ++H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLH 249
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
++ E+M +G+L + + +EG + + + +A G+ ++
Sbjct: 250 AVVT-KEPIYIITEFMAKGSLLDFLKS--DEG-SKQPLPKLIDFSAQIAEGMAFI---EQ 302
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+++IHRDL+ +NIL+ + K+ADFGL R+ + +
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 46/185 (24%), Positives = 86/185 (46%), Gaps = 15/185 (8%)
Query: 400 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
+ ++G G FG V G L +K +A+K ++ G K +F E +++ + H ++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-KQRRDFLGEASIMGQFDHPNI 108
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
+ L G ++V EYM G+L ++ + + + + +A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLD----SFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL--APEY 573
+ ++HRDL NIL+ ++ KV+DFGL R+ + + T G +PE
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE- 220
Query: 574 AGNFG 578
A +
Sbjct: 221 AIAYR 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 52/156 (33%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
E LG+G FG V+ G + T++A+K ++ G +S F E V+ K+RH LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLY 245
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
+ +V EYM +G+L + E K L + + +A +A G+ Y+
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYV---ER 298
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+++HRDL+ +NIL+G+++ KVADFGL RL + +
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 59/259 (22%), Positives = 101/259 (38%), Gaps = 28/259 (10%)
Query: 3 QLIGGLPASFS-GSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP- 59
L G +P +++L ++ N L G I + N T+L I L +N +G +P
Sbjct: 453 MLEGEIPQELMYVKTLETLILDF---N-DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 60 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 119
++ L L L +N F+G +P L SL +++ NL G +P S +A
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN 568
Query: 120 SNNFCLPSPGACDPRLNAL---LSVVKLMG-YPQRFAE------------NWKGNDPCSD 163
D ++++ G ++ + G+
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS--P 626
Query: 164 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK 223
++ ++ L+G I E S L L L N++SG IP+ + L L
Sbjct: 627 TFD-NNG--SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN 683
Query: 224 ELDVSNNQLYGKIPSFKSN 242
LD+S+N+L G+IP S
Sbjct: 684 ILDLSSNKLDGRIPQAMSA 702
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-29
Identities = 71/255 (27%), Positives = 108/255 (42%), Gaps = 39/255 (15%)
Query: 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI--DVIQNMTSLKEIWLHSNAFSGPLPD 60
Q +G +P +Q L + K G I + +L + L N F G +P
Sbjct: 258 QFVGPIP-PLPLKSLQYLSL----AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312
Query: 61 -FSGVKQLESLSLRDNFFTGPVP-DSLVKLESLKIVNMTNNLLQGPVPEFDRSVS----- 113
F LESL+L N F+G +P D+L+K+ LK+++++ N G +PE ++S
Sbjct: 313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT 372
Query: 114 LDMAKGSNNFC--LPSPGACDPRLNAL----LSVVKLMGYPQRFAENWKGNDPCSDWIGV 167
LD++ SNNF + P C N L L G +
Sbjct: 373 LDLS--SNNFSGPIL-PNLCQNPKNTLQELYLQNNGFTG-------------KIPPTLS- 415
Query: 168 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 227
C+ + ++ L+GTI S L+ L L N L G IP+ L + L+ L +
Sbjct: 416 NCS--ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 228 SNNQLYGKIPSFKSN 242
N L G+IPS SN
Sbjct: 474 DFNDLTGEIPSGLSN 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-28
Identities = 52/244 (21%), Positives = 92/244 (37%), Gaps = 44/244 (18%)
Query: 3 QLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF 61
+ G + L +GN K+ G +D + +L+ + + SN FS +P
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGN-KISGDVD-VSRCVNLEFLDVSSNNFSTGIPFL 219
Query: 62 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS--VSLDMAKG 119
L+ L + N +G ++ LK++N+++N GP+P L +
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSL--A 277
Query: 120 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 179
N F D++ C +T ++
Sbjct: 278 ENKF----------------------------------TGEIPDFLSGACD--TLTGLDL 301
Query: 180 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIP-EGLSVLGALKELDVSNNQLYGKIPS 238
+ G + P F S L+ L L+ NN SG +P + L + LK LD+S N+ G++P
Sbjct: 302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
Query: 239 FKSN 242
+N
Sbjct: 362 SLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 67/254 (26%), Positives = 105/254 (41%), Gaps = 41/254 (16%)
Query: 3 QLIGGLPASFSG--SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP 59
+ G +P SG + L + G + + + L+ + L SN FSG LP
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDL----SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335
Query: 60 D--FSGVKQLESLSLRDNFFTGPVPDSLVKL-ESLKIVNMTNNLLQGPVP-EFDRS---- 111
++ L+ L L N F+G +P+SL L SL +++++N GP+ ++
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 112 -VSLDMAKGSNNFC---LPSPGACDPRLNAL-LSVVKLMGY-PQRFAENWKGNDPCSDWI 165
L + +N F P+ C L +L LS L G P
Sbjct: 396 LQELYL--QNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSL----------- 441
Query: 166 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 225
+ + L G I E K+L+ LIL N+L+G IP GLS L +
Sbjct: 442 ------SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 226 DVSNNQLYGKIPSF 239
+SNN+L G+IP +
Sbjct: 496 SLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-26
Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 40/255 (15%)
Query: 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-F 61
++ G + S ++ L V+ N GI + + ++L+ + + N SG
Sbjct: 189 KISGDVDVS-RCVNLEFLDVSSNN----FSTGIPFLGDCSALQHLDISGNKLSGDFSRAI 243
Query: 62 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS-----VSLDM 116
S +L+ L++ N F GP+P L+SL+ +++ N G +P+F LD+
Sbjct: 244 STCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 301
Query: 117 AKGSNNF--CLPSP-GACDPRLNAL-LSVVKLMGY-PQRFAENWKGNDPCSDWIGVTCTK 171
N+F +P G+C L +L LS G P +
Sbjct: 302 --SGNHFYGAVPPFFGSC-SLLESLALSSNNFSGELPMDTLLKMR--------------- 343
Query: 172 GNITVINFQKMNLTGTISPEFASFK-SLQRLILADNNLSGMIPEGL--SVLGALKELDVS 228
+ V++ +G + + SL L L+ NN SG I L + L+EL +
Sbjct: 344 -GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 229 NNQLYGKIPSFKSNA 243
NN GKIP SN
Sbjct: 403 NNGFTGKIPPTLSNC 417
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 53/251 (21%), Positives = 93/251 (37%), Gaps = 54/251 (21%)
Query: 3 QLIGGLPASFSG--SQIQSLWVNGQNGNAKLGGGI-DVIQNMT-SLKEIWLHSNAFSGPL 58
G LP ++ L + + G + + + N++ SL + L SN FSGP+
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDL----SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384
Query: 59 PDFSGV---KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP----EFDRS 111
L+ L L++N FTG +P +L L ++++ N L G +P +
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL 444
Query: 112 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 171
L + N +G P +
Sbjct: 445 RDLKL--WLNML--------------------------------EGEIP--QELMYVK-- 466
Query: 172 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 231
+ + +LTG I ++ +L + L++N L+G IP+ + L L L +SNN
Sbjct: 467 -TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 232 LYGKIPSFKSN 242
G IP+ +
Sbjct: 526 FSGNIPAELGD 536
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 44/246 (17%), Positives = 79/246 (32%), Gaps = 50/246 (20%)
Query: 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP-D 60
G + + + +L N G I + N + L + L N SG +P
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNN-GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 61 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS----VSLDM 116
+ +L L L N G +P L+ +++L+ + + N L G +P + + +
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497
Query: 117 AKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 176
+N WIG N+ +
Sbjct: 498 --SNNRL----------------------------------TGEIPKWIG---RLENLAI 518
Query: 177 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 236
+ + +G I E +SL L L N +G IP + ++ N + GK
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKR 574
Query: 237 PSFKSN 242
+ N
Sbjct: 575 YVYIKN 580
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 47/237 (19%), Positives = 87/237 (36%), Gaps = 46/237 (19%)
Query: 13 SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSL 72
++ S+ ++ + N + ++T L+ ++L ++ +G + F L SL L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDL 107
Query: 73 RDNFFTGPVPD--SLVKLESLKIVNMTNNLLQG--PVPEFDRSVSL---DMAKGSNNFCL 125
N +GPV SL LK +N+++N L V + SL D+ +N+
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL--SANSI-- 163
Query: 126 PSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT 185
G + + C + + ++
Sbjct: 164 ------------------------------SGANVVGWVLSDGCG--ELKHLAISGNKIS 191
Query: 186 GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 242
G + + +L+ L ++ NN S IP L AL+ LD+S N+L G S
Sbjct: 192 GDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAIST 245
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-19
Identities = 51/254 (20%), Positives = 91/254 (35%), Gaps = 42/254 (16%)
Query: 3 QLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLPD 60
G +P + S S++ SL + L G I + +++ L+++ L N G +P
Sbjct: 405 GFTGKIPPTLSNCSELVSLHL----SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 61 -FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS----LD 115
VK LE+L L N TG +P L +L ++++NN L G +P++ + L
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 116 MAKGSNNF--CLPSP-GACDPRLNAL-LSVVKLMGY-PQRFAENWKGNDPCSDWIGVTCT 170
+ +N+F +P+ G C L L L+ G P +
Sbjct: 521 L--SNNSFSGNIPAELGDC-RSLIWLDLNTNLFNGTIPAAMFKQSG-------------- 563
Query: 171 KGNITVINFQKMNLTGTISPEFASFKSLQRLILADN--NLSGMIPEGLSVLGALKELDVS 228
+ G + + A N G+ E L+ L +++
Sbjct: 564 -------KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 229 NNQLYGKIPSFKSN 242
+ G N
Sbjct: 617 SRVYGGHTSPTFDN 630
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-19
Identities = 55/265 (20%), Positives = 93/265 (35%), Gaps = 72/265 (27%)
Query: 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP-- 59
+L G +P ++++L + + N G I + + SL + L++N F+G +P
Sbjct: 501 RLTGEIPKWIG--RLENLAILKLSNN-SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
Query: 60 -------------------DFSGVKQLESLSLRDNF--FTGPVPDSLVKLESLKIVNMTN 98
+ N F G + L +L + N+T+
Sbjct: 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617
Query: 99 NLLQGPVPEFDRS----VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY-PQRFAE 153
+ G + + LDM S N L GY P+
Sbjct: 618 RVYGGHTSPTFDNNGSMMFLDM---SYN--------------------MLSGYIPKEIGS 654
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
+ ++N +++G+I E + L L L+ N L G IP
Sbjct: 655 -------MP----------YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP 697
Query: 214 EGLSVLGALKELDVSNNQLYGKIPS 238
+ +S L L E+D+SNN L G IP
Sbjct: 698 QAMSALTMLTEIDLSNNNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-18
Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 4/91 (4%)
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLT---GTISPEFASFKSLQRLILADNNLSG 210
+W N + GVTC +T I+ L +S S L+ L L++++++G
Sbjct: 32 DWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHING 91
Query: 211 MIPEGLSVLGALKELDVSNNQLYGKIPSFKS 241
+ +L LD+S N L G + + S
Sbjct: 92 SVSG-FKCSASLTSLDLSRNSLSGPVTTLTS 121
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 46/180 (25%), Positives = 88/180 (48%), Gaps = 7/180 (3%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
NF E +GRG F VY+ L DG +A+K+++ ++ K + EI +L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+++ ++ NE +V E G LSR I ++ ++ + + + + +E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALE 150
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++H + +HRD+KP+N+ + K+ D GL R + + + GT Y++PE
Sbjct: 151 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 206
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 38/175 (21%), Positives = 73/175 (41%), Gaps = 13/175 (7%)
Query: 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVAL 458
+G GG V++ A+K + + L +++EIA L K++ ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+ + +V E L+ + + K ++ R + ++ V +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIH--- 125
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 572
+H DLKP+N L+ D K+ DFG+ + P+ ++ GT Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 41/188 (21%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVK---------------RMEAGVISGKGLTEFKSEIAVL 447
L +G F + E D A+K + +FK+E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 448 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI---FNWAEEGLKPLEWNRRLTIA 504
T +++ + + G + +E +++EYM ++ + F + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 564
V Y+H ++ HRD+KPSNIL+ + R K++DFG + K I+ G
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--IKG-SRG 212
Query: 565 TFGYLAPE 572
T+ ++ PE
Sbjct: 213 TYEFMPPE 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 8e-30
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 15/184 (8%)
Query: 400 ENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 456
+ LG G FG+V +G +A+K ++ G E E ++ ++ + ++V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIV 399
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
L+G C +LV E G L + + EE + + + V+ G++YL
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL-- 452
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPEYA 574
++F+HR+L N+LL + AK++DFGL + R AG + APE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-C 510
Query: 575 GNFG 578
NF
Sbjct: 511 INFR 514
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 400 ENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+LG G FGTV+KG + +K +E + + + + H H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAH 76
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEY 513
+V LLG C G+ LV +Y+P G+L H+ G + L L + +A+G+ Y
Sbjct: 77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
L +HR+L N+LL + +VADFG+ L
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 53/180 (29%), Positives = 75/180 (41%), Gaps = 14/180 (7%)
Query: 396 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 453
+F + LG G +G V+K DG AVKR + K +E+ KV +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
V L +G L E +L +H E L + D + +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 572
LH Q +H D+KP+NI LG R K+ DFGL+ L G G ++ G Y+APE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE 226
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 13/155 (8%)
Query: 400 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
ILG G FG VY+G + +AVK + + +F SE ++ + H H+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHI 75
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
V L+G ++ E P G L ++ E L+ + +L + + + YL
Sbjct: 76 VKLIGIIE-EEPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYL- 129
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
+ +HRD+ NIL+ K+ DFGL R
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 52/156 (33%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
E LG+G FG V+ G + T++A+K ++ G +S F E V+ K+RH LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLY 328
Query: 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 519
+ +V EYM +G+L + E K L + + +A +A G+ Y+
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYV---ER 381
Query: 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+++HRDL+ +NIL+G+++ KVADFGL RL + +
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 460
LG+G FG VY E +A+K + + G+ + E+ + + +RH +++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
+ D L+ EY P GT+ R + L + R T ++A + Y H +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCH---SK 128
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
IHRD+KP N+LLG K+ADFG AP + T + GT YL PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPE 177
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 37/167 (22%), Positives = 76/167 (45%), Gaps = 25/167 (14%)
Query: 400 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 451
LG+G F ++KG + T++ +K ++ + F ++++K+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMMSKLS 70
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
H+HLV G C+ G+E +LV E++ G+L ++ ++ + +L +A +A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAM 126
Query: 512 EYLHGLAHQSFIHRDLKPSNILL--------GDDMRAKVADFGLVRL 550
+ L + IH ++ NILL G+ K++D G+
Sbjct: 127 HF---LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 400 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
+G G FG V++G +A+K + S +F E + + H H+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHI 78
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
V L+G N ++ E G L ++ + L+ + A ++ + YL
Sbjct: 79 VKLIGVIT-ENPVWIIMELCTLGEL----RSFLQVRKYSLDLASLILYAYQLSTALAYL- 132
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
+ F+HRD+ N+L+ + K+ DFGL R
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 16/157 (10%)
Query: 400 ENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+LG G FGTVYKG +A+K + S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEY 513
+ LLG CL + L+ + MP G L ++ + G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
L + +HRDL N+L+ K+ DFGL +L
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 45/193 (23%), Positives = 73/193 (37%), Gaps = 25/193 (12%)
Query: 400 ENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVA 457
+L GGF VY+ + + G + A+KR+ + E+ + K+ H ++V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 458 LLGHCL-------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
G + L+ + +G L + G PL + L I R
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRA 148
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---------PEGKGSIETR 561
V+++H IHRDLK N+LL + K+ DFG + + +E
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 562 IA--GTFGYLAPE 572
I T Y PE
Sbjct: 208 ITRNTTPMYRTPE 220
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 63/249 (25%), Positives = 103/249 (41%), Gaps = 36/249 (14%)
Query: 2 LQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP 59
L +P+S + + L++ G N L G I I +T L +++ SG +P
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGIN---NLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 60 DF-SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-----FDRSVS 113
DF S +K L +L N +G +P S+ L +L + N + G +P+ S
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 114 LDMAKGSNNF--CLP-SPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTC 169
+ + N +P + + L + LS L G S G +
Sbjct: 179 MTI--SRNRLTGKIPPTFANLN--LAFVDLSRNMLEG-------------DASVLFG-SD 220
Query: 170 TKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN 229
N I+ K +L + + K+L L L +N + G +P+GL+ L L L+VS
Sbjct: 221 K--NTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 230 NQLYGKIPS 238
N L G+IP
Sbjct: 278 NNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-23
Identities = 40/206 (19%), Positives = 77/206 (37%), Gaps = 41/206 (19%)
Query: 38 IQNMTSLKEIWLHS-NAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+ N+ L +++ N GP+P + + QL L + +G +PD L ++++L ++
Sbjct: 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGY-PQRFAE 153
+ N L G +P PS + P L + ++ G P +
Sbjct: 132 FSYNALSGTLP-------------------PSISSL-PNLVGITFDGNRISGAIPDSY-- 169
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
G+ T + + LTG I P FA+ +L + L+ N L G
Sbjct: 170 ---GS-----------FSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS 214
Query: 214 EGLSVLGALKELDVSNNQLYGKIPSF 239
+++ ++ N L +
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKV 240
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 8e-19
Identities = 50/238 (21%), Positives = 89/238 (37%), Gaps = 34/238 (14%)
Query: 3 QLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP- 59
L+G +P + + +Q+ L++ + G I D + + +L + NA SG LP
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITH---T-NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143
Query: 60 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV-NMTNNLLQGPVPEFDRSVSLDMAK 118
S + L ++ N +G +PDS L ++ N L G +P +++L
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD 203
Query: 119 GSNNF---CLPSP-GACDPRLNAL-LSVVKLMGY-PQRFAENWKGNDPCSDWIGVTCTKG 172
S N G+ + L+ L + +G
Sbjct: 204 LSRNMLEGDASVLFGSD-KNTQKIHLAKNSLAFDLGK---------------VG-LSK-- 244
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 230
N+ ++ + + GT+ K L L ++ NNL G IP+G L +NN
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 34/122 (27%), Positives = 54/122 (44%), Gaps = 11/122 (9%)
Query: 131 CDPR-LNALLSVVKLMGYPQRFAENWKGNDPCSD--WIGVTCTK----GNITVINFQKMN 183
C+P+ ALL + K +G P + +W C + W+GV C + ++ +N
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 184 LTGT--ISPEFASFKSLQRLILAD-NNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK 240
L I A+ L L + NNL G IP ++ L L L +++ + G IP F
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 241 SN 242
S
Sbjct: 122 SQ 123
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 32/124 (25%), Positives = 59/124 (47%), Gaps = 5/124 (4%)
Query: 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLPDF 61
+L G +P +F+ + + + +N L G + + + ++I L N+ + L
Sbjct: 185 RLTGKIPPTFANLNLAFVDL-SRN---MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240
Query: 62 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSN 121
K L L LR+N G +P L +L+ L +N++ N L G +P+ D++ +N
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN 300
Query: 122 NFCL 125
N CL
Sbjct: 301 NKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 42/194 (21%), Positives = 72/194 (37%), Gaps = 44/194 (22%)
Query: 52 NAFSGPLPD-FSGVKQLESLSLRDNFFTG--PVPDSLVKLESLKIVNMTN-NLLQGPVPE 107
+ G L D + ++ +L L P+P SL L L + + N L GP+P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP- 94
Query: 108 FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGY-PQRFAENWKGNDPCSDWI 165
P+ +L+ L ++ + G P D++
Sbjct: 95 ------------------PAIAKL-TQLHYLYITHTNVSGAIP--------------DFL 121
Query: 166 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKE- 224
+ ++F L+GT+ P +S +L + N +SG IP+ L
Sbjct: 122 S-QIK--TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 225 LDVSNNQLYGKIPS 238
+ +S N+L GKIP
Sbjct: 179 MTISRNRLTGKIPP 192
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 48/180 (26%), Positives = 73/180 (40%), Gaps = 27/180 (15%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 460
LG+GGF ++ + A K + ++ E EI++ + H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVE 512
D + +V E + +L + LT AR G +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKR-----------RKALT--EPEARYYLRQIVLGCQ 129
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
YLH IHRDLK N+ L +D+ K+ DFGL E G + + GT Y+APE
Sbjct: 130 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPE 185
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 10/172 (5%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 460
LG+G F VY+ +H G ++A+K ++ + G+ + ++E+ + +++H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
+ D N LV E G ++R++ + +KP N + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+HRDL SN+LL +M K+ADFGL T + GT Y++PE
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 51/221 (23%), Positives = 81/221 (36%), Gaps = 27/221 (12%)
Query: 362 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGT 420
+ + PG + + V + LG+GGF ++ +
Sbjct: 8 GKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKE 67
Query: 421 KIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 479
A K + ++ E EI++ + H+H+V G D + +V E + +
Sbjct: 68 VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 480 LSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEYLHGLAHQSFIHRDLKPSN 531
L + LT AR G +YLH IHRDLK N
Sbjct: 128 LLELHKR-----------RKALT--EPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGN 171
Query: 532 ILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ L +D+ K+ DFGL E G + + GT Y+APE
Sbjct: 172 LFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPE 211
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 15/178 (8%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
+GRG F TVYKG + ++A ++ ++ FK E +L ++H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 461 HCLDG--NEKLLVF--EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
+K +V E M GTL ++ + K ++ + + +G+++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 517 LAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
IHRDLK NI + G K+ D G LA + S + GT ++APE
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLG---LATLKRASFAKAVIGTPEFMAPEM 201
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 45/226 (19%), Positives = 73/226 (32%), Gaps = 29/226 (12%)
Query: 368 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGE------LHDGTK 421
SS P + + + + ++LG G F VY+ + K
Sbjct: 38 VSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK 97
Query: 422 IAVKRMEAGVISGKGLTEF---KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478
+K V EF + L + L N +LV E G
Sbjct: 98 FVLK-----VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152
Query: 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 538
TL I + K + ++ A+ + +E +H IH D+KP N +LG+
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGF 209
Query: 539 RA-----------KVADFGL-VRLAPEGKGSIETRIAGTFGYLAPE 572
+ D G + + KG+I T T G+ E
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 460
LG+G FG VY E + +A+K + + +G+ + EI + + +RH +++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 520
+ D L+ E+ P+G L + + + G E + ++A + Y H +
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSATFME-ELADALHYCHE---R 133
Query: 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
IHRD+KP N+L+G K+ADFG AP + T + GT YL PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--RRT-MCGTLDYLPPE 182
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 15/188 (7%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+ + +ILG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 451 RHRHLVALLG--HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
H+++V L K+L+ E+ P G+L + L + L + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVV 122
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPEGKGSIETRIAG 564
G+ +L +HR++KP NI+ K+ DFG R + + + G
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-G 177
Query: 565 TFGYLAPE 572
T YL P+
Sbjct: 178 TEEYLHPD 185
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 22/204 (10%), Positives = 42/204 (20%), Gaps = 38/204 (18%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALL 459
L G V+ ++ A+K G S L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 460 GHC--------------------------LDGNEKLLVFEYMPQGTLSRHI--FNWAEEG 491
LL+ L ++
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 492 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551
+ + R L + +H P N+ + D R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 552 PEGKGSIETRIAGTFGYLAPEYAG 575
G+ + Y E+
Sbjct: 245 ----GTRGPASSVPVTYAPREFLN 264
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 400 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
+G G FG V++G +A+K + S +F E + + H H+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHI 453
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
V L+G + N ++ E G L + + L+ + A ++ + YL
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYL- 507
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
+ F+HRD+ N+L+ + K+ DFGL R
Sbjct: 508 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 43/282 (15%), Positives = 84/282 (29%), Gaps = 54/282 (19%)
Query: 335 HPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLR--- 391
H H S E++ G V + + + M A + ++S +
Sbjct: 3 HHHHH-SSGRENLYFQGPGDVV-IEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQ 60
Query: 392 --NVTNNFSEE-------NILGRGGFGTVYKG-ELHDGTKIAVK--------------RM 427
V + E +LG+ + + G V +M
Sbjct: 61 PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120
Query: 428 EAGVISGKGLTEFKSEIAVLTKVR------------HRHLVALLGHCLDGNEKLLVFEYM 475
+ V+ + L K++ +R + ++ + D F Y
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180
Query: 476 ----PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 531
T + + + K L + RL + L V R + LH H +H L+P +
Sbjct: 181 RMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVD 236
Query: 532 ILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
I+L + F + + + + G+ PE
Sbjct: 237 IVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPEL 273
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 403 LGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 458
LG GG TVY D K+A+K + + + F+ E+ +++ H+++V++
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+ + + LV EY+ TLS +I G PL + + + G+++ A
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG--PLSVDTAINFTNQILDGIKH----A 127
Query: 519 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
H +HRD+KP NIL+ + K+ DFG+ + E + + GT Y +PE A
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 114 bits (285), Expect = 1e-26
Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 18/190 (9%)
Query: 393 VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 451
+ + LG GGFG V + G ++A+K+ + K + EI ++ K+
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-KNRERWCLEIQIMKKLN 70
Query: 452 HRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
H ++V+ + LL EY G L +++ E L+ T+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN--QFENCCGLKEGPIRTLLS 128
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRI 562
D++ + YLH IHRDLKP NI+L + K+ D G + +G+ +
Sbjct: 129 DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFV 184
Query: 563 AGTFGYLAPE 572
GT YLAPE
Sbjct: 185 -GTLQYLAPE 193
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 45/192 (23%), Positives = 76/192 (39%), Gaps = 28/192 (14%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
++N+ + LG+G F V + G + A K + +S + + + E + K+
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT------I 503
+H ++V L + + LVF+ + G L F +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVARE--------FYSEADASHC 110
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIET 560
+ + Y H +HR+LKP N+LL K+ADFGL + +
Sbjct: 111 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWH 165
Query: 561 RIAGTFGYLAPE 572
AGT GYL+PE
Sbjct: 166 GFAGTPGYLSPE 177
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 9/181 (4%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
+ F + +LGRGGFG V+ ++ K+ A K++ + KG E +L KV
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
R +V+L + + L LV M G + HI+N E+ E A + G+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGL 302
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
E+LH ++ I+RDLKP N+LL DD +++D GL G+ + AGT G++AP
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMAP 358
Query: 572 E 572
E
Sbjct: 359 E 359
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 15/188 (7%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+ + +ILG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 451 RHRHLVALLG--HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
H+++V L K+L+ E+ P G+L + L + L + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVV 122
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPEGKGSIETRIAG 564
G+ +L +HR++KP NI+ K+ DFG R + + + G
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-G 177
Query: 565 TFGYLAPE 572
T YL P+
Sbjct: 178 TEEYLHPD 185
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 18/177 (10%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 460
+LG+G +G VY G +L + +IA+K + + EIA+ ++H+++V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 461 HCLDGNEKLLVF-EYMPQGTLSRHIFNWAEEGLKPLEWNRRLT--IALDVARGVEYLHGL 517
+ + +F E +P G+LS + PL+ N + + G++YLH
Sbjct: 87 SFSENG-FIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD- 140
Query: 518 AHQSFIHRDLKPSNILLGDDM-RAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPE 572
+HRD+K N+L+ K++DFG RLA G GT Y+APE
Sbjct: 141 --NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPE 193
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 53/197 (26%), Positives = 76/197 (38%), Gaps = 33/197 (16%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK-------RMEAGVISGKGLTEFKSE 443
N+ + ILGRG V + + AVK + + E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 444 IAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRL 501
+ +L KV H +++ L LVF+ M +G L F++ E+ L
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKV--------TL 121
Query: 502 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+ I + + LH + +HRDLKP NILL DDM K+ DFG
Sbjct: 122 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-- 176
Query: 556 GSIETRIAGTFGYLAPE 572
G + GT YLAPE
Sbjct: 177 GEKLREVCGTPSYLAPE 193
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 52/199 (26%), Positives = 80/199 (40%), Gaps = 35/199 (17%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE------FKSE 443
+ + + + LG G G V E K+A+K + + E ++E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 444 IAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT 502
I +L K+ H ++ + D + +V E M G L F+ RL
Sbjct: 66 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNK--------RLK 112
Query: 503 ------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPE 553
+ V+YLH IHRDLKP N+LL +D K+ DFG ++
Sbjct: 113 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--L 167
Query: 554 GKGSIETRIAGTFGYLAPE 572
G+ S+ + GT YLAPE
Sbjct: 168 GETSLMRTLCGTPTYLAPE 186
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 50/190 (26%), Positives = 75/190 (39%), Gaps = 24/190 (12%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
++ +LG+G FG V K + + AVK + K + E+ +L K+
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIAL 505
H +++ L D + +V E G L R F+ + I
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIK 128
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRI 562
V G+ Y+H + +HRDLKP NILL D K+ DFGL +
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDR 183
Query: 563 AGTFGYLAPE 572
GT Y+APE
Sbjct: 184 IGTAYYIAPE 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 368 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKR 426
+S G QM +++ ++N+ + LG+G F V + G + A K
Sbjct: 4 MASMTGGQQMGRGSEFMMNAS--TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 427 MEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----S 481
+ +S + + + E + K++H ++V L + + LVF+ + G L +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 482 RHIFNWAEEGLKPLEWNRRLTIALDVAR----GVEYLHGLAHQSFIHRDLKPSNILL--- 534
R ++ A+ A + + Y H +HR+LKP N+LL
Sbjct: 122 REFYSEAD--------------ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASK 164
Query: 535 GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
K+ADFGL + + AGT GYL+PE
Sbjct: 165 AKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPE 200
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 56/275 (20%), Positives = 104/275 (37%), Gaps = 33/275 (12%)
Query: 313 FCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEP 372
K++++ ++ + R + + A +++ +
Sbjct: 13 NKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENL 72
Query: 373 GDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK-----R 426
M + + + ++++GRG V + G + AVK
Sbjct: 73 YFQSMGPEDELPDWAAA-KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131
Query: 427 MEAGVISGKGLTE-FKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI 484
+ + E + E +L +V H H++ L+ + LVF+ M +G L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL---- 187
Query: 485 FNW-AEEGLKPLEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537
F++ E+ L+ I + V +LH + +HRDLKP NILL D+
Sbjct: 188 FDYLTEKV--------ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDN 236
Query: 538 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
M+ +++DFG G+ + GT GYLAPE
Sbjct: 237 MQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPE 269
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 23/241 (9%)
Query: 339 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 398
SGS +S + + ++ + + +L + R + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 399 EENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLV 456
+ +GRG FG V++ + G + AVK++ L F+ E+ + +V
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPRIV 113
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
L G +G + E + G+L + I L +R L G+EYLH
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT 168
Query: 517 LAHQSFIHRDLKPSNILLGDD-MRAKVADFGL-VRLAPEGKGSIETR---IAGTFGYLAP 571
+ +H D+K N+LL D RA + DFG + L P+G G I GT ++AP
Sbjct: 169 ---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 572 E 572
E
Sbjct: 226 E 226
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 40/194 (20%), Positives = 71/194 (36%), Gaps = 33/194 (17%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE--FKSEIAVL 447
+ + + LGRG FG V++ E K + KG + K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-----FVKVKGTDQVLVKKEISIL 55
Query: 448 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 507
RHR+++ L E +++FE++ + I + E ++
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNE--------REI 104
Query: 508 AR-------GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSI 558
+++LH + H D++P NI+ K+ +FG R G
Sbjct: 105 VSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159
Query: 559 ETRIAGTFGYLAPE 572
+ Y APE
Sbjct: 160 FRLLFTAPEYYAPE 173
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 33/202 (16%), Positives = 57/202 (28%), Gaps = 35/202 (17%)
Query: 402 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAG-VISGKGLTEFKSEIAVLTKVR-------- 451
+LG+ + G V + + K E+ L +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 452 --HRHLVALLGHCLDGNEKLLV--------------FEYMPQ-----GTLSRHIFNWAEE 490
H + D +K ++ F P+ T + + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 491 GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550
K L + RL + L V R + LH H +H L+P +I+L + F +
Sbjct: 205 H-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 551 APEGKGSIETRIAGTFGYLAPE 572
S R A
Sbjct: 261 DGASAVSPIGRGFAPPETTAER 282
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 52/186 (27%), Positives = 78/186 (41%), Gaps = 33/186 (17%)
Query: 403 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE------FKSEIAVLTKVRHRHL 455
LG G G V E K+A++ + + E ++EI +L K+ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVAR 509
+ + D + +V E M G L F+ N+RL +
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGEL----FDKVVG-------NKRLKEATCKLYFYQMLL 250
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 566
V+YLH IHRDLKP N+LL +D K+ DFG ++ G+ S+ + GT
Sbjct: 251 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTP 305
Query: 567 GYLAPE 572
YLAPE
Sbjct: 306 TYLAPE 311
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 47/235 (20%), Positives = 77/235 (32%), Gaps = 47/235 (20%)
Query: 382 NMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK---RMEAGVISGKGL 437
N+ L + + + +G+G +G V E A+K + + I+ K +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 438 TEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI------------- 484
K+E+ ++ K+ H ++ L D LV E G L +
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 485 ----------------FNWAEEGLKPLEWNRRLT------IALDVARGVEYLHGLAHQSF 522
+ I + + YLH +Q
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGI 189
Query: 523 IHRDLKPSNILLGDDMRA--KVADFGL---VRLAPEGKGSIETRIAGTFGYLAPE 572
HRD+KP N L + K+ DFGL G+ T AGT ++APE
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 354 SNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYK 413
+ V +E S Q A MV+ + +G G G V
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQG---DPRLLLDSYVKIGEGSTGIVCL 63
Query: 414 G-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472
E H G ++AVK M+ + + +E+ ++ +H ++V + L G E ++
Sbjct: 64 AREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 532
E++ G L+ + L + T+ V + + YLH Q IHRD+K +I
Sbjct: 122 EFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172
Query: 533 LLGDDMRAKVADFG 546
LL D R K++DFG
Sbjct: 173 LLTLDGRVKLSDFG 186
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 43/177 (24%), Positives = 72/177 (40%), Gaps = 16/177 (9%)
Query: 403 LGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 458
+GRGG G VY+ D +A+K M + S + E +++ H+V +
Sbjct: 42 VGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
+ + + L+ + +G PL R + I + ++ A
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML---RRQG--PLAPPRAVAIVRQIGSALDA----A 150
Query: 519 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
H + HRD+KP NIL+ D A + DFG+ + K + GT Y+APE
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 33/197 (16%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIAV 446
V +++ LG G F V K + G + A K R + G E + E+ +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 447 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT--- 502
L ++RH +++ L + + +L+ E + G L F++ AE+ LT
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKE--------SLTEDE 109
Query: 503 ---IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGK 555
+ GV YLH + H DLKP NI+L + R K+ DFG+ G
Sbjct: 110 ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 556 GSIETRIAGTFGYLAPE 572
I GT ++APE
Sbjct: 167 --EFKNIFGTPEFVAPE 181
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 62/181 (34%), Positives = 94/181 (51%), Gaps = 12/181 (6%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
N F + +LG+GGFG V ++ K+ A K++E + KG +E +L KV
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
R +V+L + + + L LV M G L HI++ + G E A ++ G+
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--EARAVFYAA-EICCGL 299
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
E LH + ++RDLKP NILL D +++D GL PEG+ +I+ R GT GY+AP
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR-VGTVGYMAP 354
Query: 572 E 572
E
Sbjct: 355 E 355
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 24/184 (13%)
Query: 403 LGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 458
LG GG V+ D +AVK + A + F+ E + H +VA+
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 459 L--GHCLDGNEKL--LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
G L +V EY+ TL + EG P+ R + + D + + +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEG--PMTPKRAIEVIADACQALNF- 131
Query: 515 HGLAHQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR---IAGTFGYLA 570
+HQ+ IHRD+KP+NI++ KV DFG+ R + S+ T+ + GT YL+
Sbjct: 132 ---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQYLS 187
Query: 571 PEYA 574
PE A
Sbjct: 188 PEQA 191
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 47/202 (23%), Positives = 74/202 (36%), Gaps = 30/202 (14%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
T F E +G G FG+V+K + DG A+KR + + E+ +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 451 -RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+H H+V + + L+ EY G+L+ I + + L V R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGR 126
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDD-------------------MRAKVADFGLVRL 550
G+ Y+H S +H D+KPSNI + + K+ D G V
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 551 APEGKGSIETRIAGTFGYLAPE 572
S + G +LA E
Sbjct: 184 I----SSPQVEE-GDSRFLANE 200
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-25
Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 31/194 (15%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
T + LG+G F V + ++ G + A + +S + + + E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIAL 505
+H ++V L + L+F+ + G L +R ++ A+ A
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD--------------AS 113
Query: 506 DVAR----GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSI 558
+ V + H +HR+LKP N+LL K+ADFGL + +
Sbjct: 114 HCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 559 ETRIAGTFGYLAPE 572
AGT GYL+PE
Sbjct: 171 FG-FAGTPGYLSPE 183
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 53/195 (27%), Positives = 79/195 (40%), Gaps = 37/195 (18%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVL 447
N+ F +LG G F V+ + G A+K I ++EIAVL
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK-----CIKKSPAFRDSSLENEIAVL 60
Query: 448 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT---- 502
K++H ++V L LV + + G L F+ E G T
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERG--------VYTEKDA 108
Query: 503 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGS 557
+ V V+YLH +HRDLKP N+L ++ + + DFGL ++ G
Sbjct: 109 SLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163
Query: 558 IETRIAGTFGYLAPE 572
+ GT GY+APE
Sbjct: 164 -MSTACGTPGYVAPE 177
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 51/191 (26%), Positives = 75/191 (39%), Gaps = 24/191 (12%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
++ +LG+G FG V K + + AVK + K + E+ +L K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIA 504
+ H +++ L D + +V E G L R F+ E I
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAA--------RII 127
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETR 561
V G+ Y+H + +HRDLKP NILL D K+ DFGL +
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKD 182
Query: 562 IAGTFGYLAPE 572
GT Y+APE
Sbjct: 183 RIGTAYYIAPE 193
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 48/184 (26%), Positives = 67/184 (36%), Gaps = 31/184 (16%)
Query: 400 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVA 457
+ LG G F K AVK +IS + + EI L H ++V
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGV 511
L D LV E + G L I + + I + V
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKK-----------KKHFSETEASYIMRKLVSAV 119
Query: 512 EYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 568
++H +HRDLKP N+L D++ K+ DFG RL P ++T T Y
Sbjct: 120 SHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHY 175
Query: 569 LAPE 572
APE
Sbjct: 176 AAPE 179
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 10/161 (6%)
Query: 387 IQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIA 445
++ + + LG G FG VYK G A K +E S + L ++ EI
Sbjct: 11 VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIE 68
Query: 446 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
+L H ++V LLG + ++ E+ P G + E + L + +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCR 124
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546
+ + +LH + IHRDLK N+L+ + ++ADFG
Sbjct: 125 QMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFG 162
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 56/222 (25%), Positives = 84/222 (37%), Gaps = 29/222 (13%)
Query: 365 HTVPSSEPGDIQMLEAGNMVISIQVL-----RNVTNNFSEENILGRGGFGTVYKG-ELHD 418
H G + G++ + + +++ + LG G +G V +
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 419 GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 478
+ A+K + +S ++ E+AVL + H +++ L D LV E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 479 TL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533
L R FN E I V GV YLH + +HRDLKP N+L
Sbjct: 122 ELFDEIIHRMKFN--EVDAA--------VIIKQVLSGVTYLH---KHNIVHRDLKPENLL 168
Query: 534 L---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
L D K+ DFGL + K GT Y+APE
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPE 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 19/191 (9%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIA 445
+ V + + LG G F V K E G + A K R G E + E++
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 446 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
+L +V H +++ L + + +L+ E + G L F++ + E I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFI-K 122
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGKGSIETR 561
+ GV YLH + H DLKP NI+L K+ DFGL +G
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKN 177
Query: 562 IAGTFGYLAPE 572
I GT ++APE
Sbjct: 178 IFGTPEFVAPE 188
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 396 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLT---EFKSEIAVLTKVR 451
S+ ILG G FG V+K E G K+A K +I +G+ E K+EI+V+ ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAK-----IIKTRGMKDKEEVKNEISVMNQLD 144
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
H +L+ L N+ +LV EY+ G L I +E E + L + + G+
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFM-KQICEGI 200
Query: 512 EYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
++H +H DLKP NIL D + K+ DFGL R GT +L
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNFGTPEFL 255
Query: 570 APE 572
APE
Sbjct: 256 APE 258
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/197 (25%), Positives = 78/197 (39%), Gaps = 33/197 (16%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIAV 446
V + + LG G F V K E G + A K R G E + E+++
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 447 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT--- 502
L +V H +++ L + + +L+ E + G L F++ A++ L+
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKE--------SLSEEE 116
Query: 503 ---IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGK 555
+ GV YLH + H DLKP NI+L K+ DFGL
Sbjct: 117 ATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IED 171
Query: 556 GSIETRIAGTFGYLAPE 572
G I GT ++APE
Sbjct: 172 GVEFKNIFGTPEFVAPE 188
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 42/181 (23%), Positives = 71/181 (39%), Gaps = 28/181 (15%)
Query: 403 LGRGGFGTVYKGELH--DGTKIAVKRMEAGVISG--KGLTEFKSEIAVLTKVRHRHLVAL 458
+ GG G +Y +G + +K + SG + +E L +V H +V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 459 L--GHCLDGNEKL---LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
D + +V EY+ +L R + L + L++ + Y
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSY 197
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
LH ++ DLKP NI+L ++ + K+ D G V G + GT G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY----LYGTPGFQAPEI 248
Query: 574 A 574
Sbjct: 249 V 249
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 28/191 (14%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVL 447
+V + + LG G FG V++ E G K I+ + K+EI+++
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK-----FINTPYPLDKYTVKNEISIM 102
Query: 448 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 507
++ H L+ L D E +L+ E++ G L I A E K E ++
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSE-----AEVINY 154
Query: 508 AR----GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSIETR 561
R G++++H S +H D+KP NI+ K+ DFGL + I
Sbjct: 155 MRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKV 209
Query: 562 IAGTFGYLAPE 572
T + APE
Sbjct: 210 TTATAEFAAPE 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 16/180 (8%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVLTKVRHRHLVA 457
++G+G F V + G + AVK ++ + K E ++ ++H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 458 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL--DVARGVEYLH 515
LL +VFE+M L I + ++ + + + Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 516 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ IHRD+KP +LL + K+ FG+ E G + GT ++APE
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGTPHFMAPE 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 49/193 (25%), Positives = 76/193 (39%), Gaps = 32/193 (16%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVL 447
++ ++ EN +GRG +G V + + A K I + + FK EI ++
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK-----KIPKYFVEDVDRFKQEIEIM 60
Query: 448 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLT 502
+ H +++ L D + LV E G L + +F ++
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA----------R 110
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIE 559
I DV V Y H + HRDLKP N L D K+ DFGL GK +
Sbjct: 111 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MM 165
Query: 560 TRIAGTFGYLAPE 572
GT Y++P+
Sbjct: 166 RTKVGTPYYVSPQ 178
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 52/190 (27%), Positives = 76/190 (40%), Gaps = 29/190 (15%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
+F ILG G F TV ++ A+K +E +I + E V++++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 509
V L D +EKL Y G L ++I + + R
Sbjct: 90 PFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYI-------------RKIGSFDETCTRFY 135
Query: 510 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR-I 562
+EYLHG IHRDLKP NILL +DM ++ DFG ++
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 563 AGTFGYLAPE 572
GT Y++PE
Sbjct: 193 VGTAQYVSPE 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 53/196 (27%), Positives = 79/196 (40%), Gaps = 31/196 (15%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIAV 446
NV + + LG G F V K E G + A K R G + + E+++
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 447 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---- 502
L +++H +++ L + + +L+ E + G L + AE+ LT
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKE--------SLTEEEA 116
Query: 503 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGKG 556
+ GV YLH L H DLKP NI+L R K+ DFGL G
Sbjct: 117 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 172
Query: 557 SIETRIAGTFGYLAPE 572
I GT ++APE
Sbjct: 173 -EFKNIFGTPEFVAPE 187
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 49/202 (24%), Positives = 79/202 (39%), Gaps = 37/202 (18%)
Query: 387 IQVLRNVTNNFSEE----NILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFK 441
+Q L + F++ +G G + + + AVK +I K +
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK-----IID-KSKRDPT 63
Query: 442 SEIAVLTK-VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 500
EI +L + +H +++ L DG +V E M G L I +
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-----------QKF 112
Query: 501 LT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL 550
+ + + + VEYLH Q +HRDLKPSNIL G+ ++ DFG +
Sbjct: 113 FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 551 APEGKGSIETRIAGTFGYLAPE 572
G + T T ++APE
Sbjct: 170 LRAENGLLMT-PCYTANFVAPE 190
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 15/174 (8%)
Query: 374 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 432
D ++LE ++S+ + ++ +G+G GTVY ++ G ++A+++M +
Sbjct: 2 DEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQ 56
Query: 433 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 492
+EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------ 110
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546
++ + + + + +E+LH IHRD+K NILLG D K+ DFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFG 161
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-24
Identities = 51/192 (26%), Positives = 75/192 (39%), Gaps = 25/192 (13%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLT 448
++ + + +LG+G FG V + G + AVK + V E+ +L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTI 503
++ H +++ L D LV E G L SR F+ E I
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS--EVDAA--------RI 131
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIET 560
V G+ Y+H +HRDLKP N+LL D ++ DFGL K
Sbjct: 132 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMK 186
Query: 561 RIAGTFGYLAPE 572
GT Y+APE
Sbjct: 187 DKIGTAYYIAPE 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 60/205 (29%), Positives = 85/205 (41%), Gaps = 53/205 (25%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVK-----------------------RMEAGVISGKGLT 438
+G+G +G V +D T A+K G I +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 439 EF-KSEIAVLTKVRHRHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPL 495
E EIA+L K+ H ++V L+ D NE L VFE + QG +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132
Query: 496 EWNRRLTIALDVAR--------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547
L+ D AR G+EYLH +Q IHRD+KPSN+L+G+D K+ADFG+
Sbjct: 133 ----PLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 548 VRLAPEGKGSIETRIAGTFGYLAPE 572
+ GT ++APE
Sbjct: 184 SNEFKGSDALLSNT-VGTPAFMAPE 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 51/254 (20%), Positives = 90/254 (35%), Gaps = 19/254 (7%)
Query: 324 SRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNM 383
QS P + + + + T + +
Sbjct: 87 KHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQ 146
Query: 384 VISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS 442
+ I+ +V +++ LG G FG V++ E G A K + +
Sbjct: 147 PVEIKH-DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESDKETVRK 203
Query: 443 EIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 502
EI ++ +RH LV L D NE ++++E+M G L + E + +
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHN----KMSEDEA 257
Query: 503 IAL--DVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSI 558
+ V +G+ ++H +++H DLKP NI+ K+ DFGL +
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312
Query: 559 ETRIAGTFGYLAPE 572
GT + APE
Sbjct: 313 VKVTTGTAEFAAPE 326
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 61/250 (24%), Positives = 91/250 (36%), Gaps = 44/250 (17%)
Query: 335 HPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT 394
H H S + S SV A + T I ++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDA----------LS 52
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 452
+ F E+ LGRG VY+ + A+K V+ + ++EI VL ++ H
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKTVDKKIVRTEIGVLLRLSH 107
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT------IAL 505
+++ L E LV E + G L F+ E+G +
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKG--------YYSERDAADAVK 155
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRI 562
+ V YLH +HRDLKP N+L D K+ADFGL ++ + +
Sbjct: 156 QILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTV 210
Query: 563 AGTFGYLAPE 572
GT GY APE
Sbjct: 211 CGTPGYCAPE 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 19/189 (10%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE----FKSEIAV 446
+ + F + LG G FG V+ E G + +K I+ ++EI V
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK-----TINKDRSQVPMEQIEAEIEV 73
Query: 447 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 506
L + H +++ + D + +V E G L I + G E +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQ 132
Query: 507 VARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIA 563
+ + Y H Q +H+DLKP NIL K+ DFGL L + T A
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAA 187
Query: 564 GTFGYLAPE 572
GT Y+APE
Sbjct: 188 GTALYMAPE 196
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 54/189 (28%), Positives = 75/189 (39%), Gaps = 18/189 (9%)
Query: 392 NVTNNFS-EENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
N N + LGRG F V + G + A K ++ E EIAVL
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 450 VRHR-HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL--D 506
+ ++ L + +E +L+ EY G + E + + + I L
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC---LPELAEMV--SENDVIRLIKQ 139
Query: 507 VARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIA 563
+ GV YLH + +H DLKP NILL K+ DFG+ R G I
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM 194
Query: 564 GTFGYLAPE 572
GT YLAPE
Sbjct: 195 GTPEYLAPE 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 12/189 (6%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+++ + ++G G V K+A+KR+ + E EI +++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQC 70
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDV 507
H ++V+ + +E LV + + G++ +HI E L+ + TI +V
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIA 563
G+EYLH IHRD+K NILLG+D ++ADFG L + +
Sbjct: 131 LEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 564 GTFGYLAPE 572
GT ++APE
Sbjct: 188 GTPCWMAPE 196
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 35/189 (18%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
+G+G F V + G ++A+K ++ ++ L + E+ ++ + H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF-E 81
Query: 462 CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVE 512
++ + L L+ EY G + ++ + R+ AR V+
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVA-----------HGRMKE--KEARSKFRQIVSAVQ 128
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
Y H + +HRDLK N+LL DM K+ADFG G G ++ G Y APE
Sbjct: 129 YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAF-CGAPPYAAPE 183
Query: 573 ------YAG 575
Y G
Sbjct: 184 LFQGKKYDG 192
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 10/158 (6%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLT 448
+ FS+ +G G FG VY ++ + +A+K+M +G S + + E+ L
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
K+RH + + G L + LV EY G+ S + E KPL+ +
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAVTHGAL 164
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546
+G+ YLH + IHRD+K NILL + K+ DFG
Sbjct: 165 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFG 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 52/231 (22%), Positives = 102/231 (44%), Gaps = 47/231 (20%)
Query: 366 TVPSSEPGDIQM--LEAGNMVISIQV-----LRNVTNNFSEENILGRGGFGTVYKGELHD 418
T+ ++ +++ L+ N VI + ++ ++G G FG V++ +L +
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 419 GTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL------GHCLDGNEKLLV 471
++A+K++ FK+ E+ ++ V+H ++V L G D LV
Sbjct: 64 SDEVAIKKVLQD-------KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL------DVARGVEYLHGLAHQSFIHR 525
EY+P+ T+ R ++A+ + + + L + R + Y+H + HR
Sbjct: 117 LEYVPE-TVYRASRHYAKL-------KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHR 165
Query: 526 DLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIE---TRIAGTFGYLAPE 572
D+KP N+LL K+ DFG ++ G+ ++ +R Y APE
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPE 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 12/162 (7%)
Query: 386 SIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEI 444
+ + F LG G +G+VYK G +A+K++ L E EI
Sbjct: 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEI 75
Query: 445 AVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 504
+++ + H+V G + +V EY G++S I K L + TI
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII----RLRNKTLTEDEIATIL 131
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546
+G+EYLH IHRD+K NILL + AK+ADFG
Sbjct: 132 QSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFG 170
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 53/230 (23%), Positives = 85/230 (36%), Gaps = 35/230 (15%)
Query: 363 ETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTK 421
H E Q + + + + ++ + LG G +G V E + ++
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 422 IAVK-----------RMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470
A+K + K E +EI++L + H +++ L D L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 471 VFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 525
V E+ G L +RH F+ E I + G+ YLH + +HR
Sbjct: 124 VTEFYEGGELFEQIINRHKFD--ECDAA--------NIMKQILSGICYLH---KHNIVHR 170
Query: 526 DLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
D+KP NILL + K+ DFGL + GT Y+APE
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPE 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 50/192 (26%), Positives = 76/192 (39%), Gaps = 37/192 (19%)
Query: 400 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR-HRH 454
E++LG G V L + AVK +I G + E+ +L + + HR+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVK-----IIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----FNWAEEGLKPLEWNRRLTIALDVAR 509
++ L+ + + LVFE M G++ HI FN E + DVA
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----------VVVQDVAS 122
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETR----- 561
+++LH ++ HRDLKP NIL K+ DF L
Sbjct: 123 ALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 562 -IAGTFGYLAPE 572
G+ Y+APE
Sbjct: 180 TPCGSAEYMAPE 191
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 3e-22
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 18/161 (11%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLT 448
NF + +G G +G VYK G +A+K R++ GV S T + EI++L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS----TAIR-EISLLK 57
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
++ H ++V LL N+ LVFE++ Q L + + A G+ + L
Sbjct: 58 ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL-IKSYLFQL--L 113
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+G+ + H +HRDLKP N+L+ + K+ADFGL R
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 18/160 (11%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLTK 449
+ + +G G +G VYK + G +A+K R++A G+ S T + EI++L +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS----TAIR-EISLLKE 75
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+ H ++V+L+ LVFE+M + L + + +E L+ ++ + R
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQLLR 130
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
GV + H +HRDLKP N+L+ D K+ADFGL R
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 19/163 (11%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEA--GVISGKGLTEFKSEIAVLTK 449
+ F + LG G + TVYKG G +A+K ++++ G S T + EI+++ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS----TAIR-EISLMKE 59
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRRLTIALD 506
++H ++V L N+ LVFE+M + GL+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL---VKYFQWQ 116
Query: 507 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ +G+ + H +HRDLKP N+L+ + K+ DFGL R
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 4e-22
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 18/184 (9%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKV-- 450
N+FS I+GRGGFG VY D K+ A+K ++ + +G T +E +L+ V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 451 -RHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
+V + + +KL + + M G L H+ G+ E + R A ++
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFS-EADMRFYAA-EII 302
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 568
G+E++H ++RDLKP+NILL + +++D GL + K GT GY
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS-VGTHGY 356
Query: 569 LAPE 572
+APE
Sbjct: 357 MAPE 360
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 29/176 (16%)
Query: 385 ISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSE 443
I + LR+ F ++G G +G VYKG + G A+K M+ ++G E K E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQE 70
Query: 444 IAVLTKV-RHRHLVALLG-----HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLE 496
I +L K HR++ G + +++L LV E+ G+++ + +K +
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT--------DLIKNTK 122
Query: 497 WNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546
L I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG
Sbjct: 123 -GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 40/196 (20%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFK--SEIAVLTKVRHRHLVALL 459
LG G +G V + + AVK ++ + E EI +L ++RH++++ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 460 GHCLDGNEKL---LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR------- 509
L EK +V EY G + + E R + A
Sbjct: 73 -DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK--------RFPV--CQAHGYFCQLI 119
Query: 510 -GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK--GSIETRIAGTF 566
G+EYLH Q +H+D+KP N+LL K++ G+ + T G+
Sbjct: 120 DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSP 175
Query: 567 GYLAPE-------YAG 575
+ PE ++G
Sbjct: 176 AFQPPEIANGLDTFSG 191
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-22
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 41/241 (17%)
Query: 350 TVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFG 409
+ A S V S ++ S D + R ++++ ++G G FG
Sbjct: 9 SFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 410 TVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALLGHCLDGNE 467
VY+ +L D G +A+K++ FK+ E+ ++ K+ H ++V L E
Sbjct: 69 VVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 468 KL------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL------DVARGVEYLH 515
K LV +Y+P+ T+ R +++ + L + + R + Y+H
Sbjct: 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRA-------KQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVRLAPEGKGSIE---TRIAGTFGYLAP 571
HRD+KP N+LL D K+ DFG + G+ ++ +R Y AP
Sbjct: 174 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 225
Query: 572 E 572
E
Sbjct: 226 E 226
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 21/173 (12%)
Query: 385 ISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFK 441
+++ V + + + LG G F TVYK + + +A+K ++ + G
Sbjct: 1 MALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG---IN 56
Query: 442 S----EIAVLTKVRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLE 496
EI +L ++ H +++ LL + LVF++M L I ++ L
Sbjct: 57 RTALREIKLLQELSHPNIIGLLD-AFGHKSNISLVFDFMETD-LEVII----KDNSLVLT 110
Query: 497 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ L +G+EYLH +HRDLKP+N+LL ++ K+ADFGL +
Sbjct: 111 PSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 8e-22
Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 19/161 (11%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLT 448
+ + +G G +GTV+K +A+K R++ GV S + + EI +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS----SALR-EICLLK 56
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
+++H+++V L + LVFE+ Q L ++ + L+ + +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF----DSCNGDLDPEIVKSFLFQLL 111
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+G+ + H ++ +HRDLKP N+L+ + K+A+FGL R
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 9e-22
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS--------EIA 445
+ + +G G +G V+K G +A+K+ +E EI
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL--------ESEDDPVIKKIALREIR 54
Query: 446 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
+L +++H +LV LL LVFEY T+ + + + + + +I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL----DRYQRGVPEHLVKSITW 109
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ V + H + IHRD+KP NIL+ K+ DFG R
Sbjct: 110 QTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 40/157 (25%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
+ F++ +G+G FG V+KG + +A+K ++ + + + + EI VL++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQ 76
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
++ G L + ++ EY+ G+ + PL+ + TI ++ +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILK 130
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546
G++YLH + IHRD+K +N+LL + K+ADFG
Sbjct: 131 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 164
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 403 LGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+GRG +G VYK + D A+K++E IS EIA+L +++H ++++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 84
Query: 460 GHCLDGNEKL--LVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
L ++ L+F+Y + H + A + L ++ + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRA----KVADFGLVRL--APEGKGSIETRIAGTFGY 568
H +HRDLKP+NIL+ + K+AD G RL +P + + TF Y
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 569 LAPE 572
APE
Sbjct: 202 RAPE 205
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 20/186 (10%)
Query: 395 NNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK-VR 451
+ + +GRG +G+V K +H G +AVKR+ + V + + ++ V+ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKM-VHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSD 79
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
++V G + + E M + + + I L + +
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSI-ETRIAGTF 566
+L + IHRD+KPSNILL K+ DFG LV SI +TR AG
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-------SIAKTRDAGCR 189
Query: 567 GYLAPE 572
Y+APE
Sbjct: 190 PYMAPE 195
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 34/188 (18%), Positives = 71/188 (37%), Gaps = 15/188 (7%)
Query: 394 TNNFSEENILGRG--GFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+ ++G+G TV G + V+R+ S + +T + E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
H ++V + NE +V +M G+ + + + I V +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMD--GMNELAIAYILQGVLKA 140
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGK-----GSIETRIAG 564
++Y+H H ++HR +K S+IL+ D + ++ + + G+
Sbjct: 141 LDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 565 TFGYLAPE 572
+L+PE
Sbjct: 198 VLPWLSPE 205
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 25/170 (14%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFKS----EIAVL 447
+ + +G G +GTVYK + H G +A+K R+ G G E+A+L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALL 65
Query: 448 ---TKVRHRHLVALL----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 499
H ++V L+ D K+ LVFE++ Q L ++ GL
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA---ET 121
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ RG+++LH +HRDLKP NIL+ K+ADFGL R
Sbjct: 122 IKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 48/190 (25%), Positives = 70/190 (36%), Gaps = 35/190 (18%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
LG G +G V +AVK ++ K EI + + H ++V GH
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGH 73
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEY 513
+GN + L EY G L I + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK--GSIETRIAGTFGYLAP 571
LH HRD+KP N+LL + K++DFGL + + GT Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAP 176
Query: 572 E------YAG 575
E +
Sbjct: 177 ELLKRREFHA 186
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 395 NNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK-VR 451
++ LGRG +G V K H G +AVKR+ A ++ + ++ + + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKM-RHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVD 64
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
V G + + E M +L + + + + + + IA+ + + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSI-ETRIAGTF 566
E+LH IHRD+KPSN+L+ + K+ DFG LV + + AG
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD-------DVAKDIDAGCK 173
Query: 567 GYLAPE 572
Y+APE
Sbjct: 174 PYMAPE 179
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-21
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLTK 449
+ +G G +G VYK + + G A+K R+E G+ S T + EI++L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS----TTIR-EISILKE 56
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
++H ++V L +LVFE++ Q L + + + LE + L +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL----DVCEGGLESVTAKSFLLQLLN 111
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
G+ Y H + +HRDLKP N+L+ + K+ADFGL R
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS--------EIA 445
+ ++G G +G V K G +A+K+ ++ EI
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL--------ESDDDKMVKKIAMREIK 76
Query: 446 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
+L ++RH +LV LL C LVFE++ T+ + E L++
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL----ELFPNGLDYQVVQKYLF 131
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ G+ + H + IHRD+KP NIL+ K+ DFG R
Sbjct: 132 QIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 28/187 (14%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
++F + + LG G G V+K H + +A K + + + E+ VL +
Sbjct: 33 DDFEKISELGAGNGGVVFKV-SHKPSGLVMARKLIHLEIKPAI-RNQIIRELQVLHECNS 90
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVAR 509
++V G E + E+M G+L + E+ L +++ V +
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--------KVSIAVIK 142
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIAGT 565
G+ YL +HRD+KPSNIL+ K+ DFG L+ S+ GT
Sbjct: 143 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGT 193
Query: 566 FGYLAPE 572
Y++PE
Sbjct: 194 RSYMSPE 200
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 61/190 (32%), Positives = 80/190 (42%), Gaps = 36/190 (18%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 460
LG G FG V GE G K+AVK + I + K EI L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY- 77
Query: 461 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 511
+ +V EY+ G L +I + R+ AR V
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICK-----------HGRVEE--MEARRLFQQILSAV 124
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
+Y H +HRDLKP N+LL M AK+ADFGL + +G + T G+ Y AP
Sbjct: 125 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS-CGSPNYAAP 179
Query: 572 E------YAG 575
E YAG
Sbjct: 180 EVISGRLYAG 189
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 51/205 (24%), Positives = 78/205 (38%), Gaps = 45/205 (21%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFK----SEIA 445
R + F E + G+G FGTV G E G +A+K+ VI F+ +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VIQDP---RFRNRELQIMQ 71
Query: 446 VLTKVRHRHLVALLGHCL------DGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEW 497
L + H ++V L D + +V EY+P TL R N+
Sbjct: 72 DLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR------- 122
Query: 498 NRRLTIAL------DVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRL 550
L + R + LH + HRD+KP N+L+ D K+ DFG +
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 551 APEGKGSIE---TRIAGTFGYLAPE 572
+ ++ +R Y APE
Sbjct: 182 LSPSEPNVAYICSRY-----YRAPE 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 45/211 (21%), Positives = 79/211 (37%), Gaps = 42/211 (19%)
Query: 382 NMVISIQVLRNVTNNFSE-----ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGK 435
+ + Q ++ + +LG G G V + G K A+K ++
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-----LLYDS 65
Query: 436 GLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEE 490
+ E+ + H+V +L + + L++ E M G L I E
Sbjct: 66 PK--ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI---QER 120
Query: 491 GLKPLEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAK 541
G ++ T I D+ +++LH + HRD+KP N+L D K
Sbjct: 121 G------DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLK 171
Query: 542 VADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ DFG + + ++T T Y+APE
Sbjct: 172 LTDFGFAKETTQNA--LQT-PCYTPYYVAPE 199
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 48/190 (25%), Positives = 70/190 (36%), Gaps = 35/190 (18%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
LG G +G V +AVK ++ K EI + + H ++V GH
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGH 73
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEY 513
+GN + L EY G L I + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK--GSIETRIAGTFGYLAP 571
LH HRD+KP N+LL + K++DFGL + + GT Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAP 176
Query: 572 E------YAG 575
E +
Sbjct: 177 ELLKRREFHA 186
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 53/237 (22%), Positives = 85/237 (35%), Gaps = 42/237 (17%)
Query: 362 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGT 420
+ VP + + + + + +LG GGFG+VY G + D
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 421 KIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR--HLVALLGHCLDGNEKLLVFEY 474
+A+K +E IS G E+ +L KV ++ LL + +L+ E
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 475 -MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEYLHGLAHQSFIHR 525
P L F++ + L ++AR V + H + +HR
Sbjct: 130 PEPVQDL----FDF-------ITERGALQ--EELARSFFWQVLEAVRHCH---NCGVLHR 173
Query: 526 DLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE------YAG 575
D+K NIL+ + K+ DFG L + GT Y PE Y G
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF-DGTRVYSPPEWIRYHRYHG 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 23/160 (14%), Positives = 51/160 (31%), Gaps = 20/160 (12%)
Query: 403 LGRGGFGTVYKGELHD---GTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
G ++ D ++A+ ++ GV+ L E S L+++ + +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
L L+V E++ G+L + P+ + +A + A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPV---GAIRAMQSLAAAADA----A 145
Query: 519 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557
H++ PS + + D +A +
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPAT--MPDANPQD 183
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 30/189 (15%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
++F +G+G FG V + +D K+ A+K M + + E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 509
LV L D E + +V + + G L H L+ N + +
Sbjct: 75 PFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYH-----------LQQNVHFKE--ETVKLF 120
Query: 510 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 563
++YL Q IHRD+KP NILL + + DF + + P T +A
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMA 175
Query: 564 GTFGYLAPE 572
GT Y+APE
Sbjct: 176 GTKPYMAPE 184
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 25/197 (12%)
Query: 364 THTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKI 422
H + Q G+M +S + + LG G +G VYK + +
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 423 AVK--RMEA---GVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477
A+K R+E GV T + E+++L +++HR+++ L + L+FEY
Sbjct: 63 AIKRIRLEHEEEGVPG----TAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL--- 534
L +++ + + + + GV + H + +HRDLKP N+LL
Sbjct: 118 -DLKKYM-----DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVS 168
Query: 535 --GDDMRAKVADFGLVR 549
+ K+ DFGL R
Sbjct: 169 DASETPVLKIGDFGLAR 185
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 395 NNFSEENILGRGGFGTVYKGELHD-GTKIAVK--RMEA--GVISGKGLTEFKSEIAVLTK 449
+ + + LG G + TVYKG+ +A+K R+E G T + E+++L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC----TAIR-EVSLLKD 56
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
++H ++V L LVFEY+ + L +++ ++ + + + R
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL----DDCGNIINMHNVKLFLFQLLR 111
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
G+ Y H Q +HRDLKP N+L+ + K+ADFGL R
Sbjct: 112 GLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 48/202 (23%), Positives = 76/202 (37%), Gaps = 24/202 (11%)
Query: 379 EAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKG 436
+ G + I Q + N+ +G G G V+K T IAVK+M +
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKM-RFRKTGHVIAVKQMRRSGNKEE- 66
Query: 437 LTEFKSEIAVLTK-VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 495
++ V+ K ++V G + + + E M P+
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-----RMQGPI 121
Query: 496 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLA 551
+ + + + + YL IHRD+KPSNILL + + K+ DFG LV
Sbjct: 122 PERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177
Query: 552 PEGKGSI-ETRIAGTFGYLAPE 572
+ R AG Y+APE
Sbjct: 178 -----DKAKDRSAGCAAYMAPE 194
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 6e-20
Identities = 61/190 (32%), Positives = 82/190 (43%), Gaps = 36/190 (18%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 460
LG G FG V G+ G K+AVK + I + + EI L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY- 82
Query: 461 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 511
+ + +V EY+ G L +I N RL +R GV
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICK-----------NGRLDE--KESRRLFQQILSGV 129
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
+Y H +HRDLKP N+LL M AK+ADFGL + +G + T G+ Y AP
Sbjct: 130 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS-CGSPNYAAP 184
Query: 572 E------YAG 575
E YAG
Sbjct: 185 EVISGRLYAG 194
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 50/186 (26%), Positives = 78/186 (41%), Gaps = 21/186 (11%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 452
++F ++GRG F V ++ ++ A+K M + +G F+ E VL
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDV 507
R + L L LV EY G L + P E R + +A+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAI-- 175
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTF 566
+ +H L ++HRD+KP NILL ++ADFG ++L +G GT
Sbjct: 176 ----DSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTP 227
Query: 567 GYLAPE 572
YL+PE
Sbjct: 228 DYLSPE 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 50/202 (24%), Positives = 72/202 (35%), Gaps = 54/202 (26%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRM------EAGVISGKGLTEFKSEIAVLTKVRHRHL 455
LG G FG V+ ++ VK + E I L + EIA+L++V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 456 VALLGHCLDGNEKL-LVFEYMPQG---------------TLSRHIFNWAEEGLKPLEWNR 499
+ +L + LV E G L+ +IF
Sbjct: 92 IKVL-DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR------------- 137
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 559
+ V YL + IHRD+K NI++ +D K+ DFG G
Sbjct: 138 ------QLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFY 187
Query: 560 TRIAGTFGYLAPE------YAG 575
T GT Y APE Y G
Sbjct: 188 T-FCGTIEYCAPEVLMGNPYRG 208
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 395 NNFSEENILGRGGFGTVYKG--ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVL 447
+ +G G +G V+K + G +A+K R++ G+ + + E+AVL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL----STIR-EVAVL 65
Query: 448 ---TKVRHRHLVALL----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 499
H ++V L D KL LVFE++ Q L+ ++ E G+
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT---ET 121
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ + RG+++LH +HRDLKP NIL+ + K+ADFGL R
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 48/197 (24%), Positives = 74/197 (37%), Gaps = 42/197 (21%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRME----AGVISGKGLTEFKSEIAVLTKVR----HR 453
LG+GGFGTV+ G L D ++A+K + G E+A+L KV H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR---- 509
++ LL +LV E + +F++ + L +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA---QDLFDY-------ITEKGPLG--EGPSRCFFG 146
Query: 510 ----GVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAG 564
+++ H + +HRD+K NIL+ AK+ DFG L + G
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTD-FDG 200
Query: 565 TFGYLAPE------YAG 575
T Y PE Y
Sbjct: 201 TRVYSPPEWISRHQYHA 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 48/190 (25%), Positives = 77/190 (40%), Gaps = 31/190 (16%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
++ ++GRG FG V K+ A+K + +I F E ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 509
+V L + + L +V EYMP G L + + AR
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARFY 173
Query: 510 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRI 562
++ +H + FIHRD+KP N+LL K+ADFG +++ EG +T
Sbjct: 174 TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-A 229
Query: 563 AGTFGYLAPE 572
GT Y++PE
Sbjct: 230 VGTPDYISPE 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 452
+F ++GRG FG V +L + K+ A+K + + + T F+ E VL
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDV 507
+ + L D + L LV +Y G L + + E P E R + IA+
Sbjct: 134 KWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAI-- 188
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA-GTF 566
+ +H L ++HRD+KP NIL+ + ++ADFG E G++++ +A GT
Sbjct: 189 ----DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTP 240
Query: 567 GYLAPE 572
Y++PE
Sbjct: 241 DYISPE 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 39/159 (24%), Positives = 60/159 (37%), Gaps = 16/159 (10%)
Query: 425 KRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI 484
+ + + S + +I + ++ V L + + + L +
Sbjct: 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152
Query: 485 FNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544
L+ E L I + +A VE+LH + +HRDLKPSNI D KV D
Sbjct: 153 NR--RCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 207
Query: 545 FGLVR-----------LAPEGKGSIETRIAGTFGYLAPE 572
FGLV L P + T GT Y++PE
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 12/237 (5%)
Query: 339 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 398
+ E E ++ + S P D E + ++ R N F
Sbjct: 92 TPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE 151
Query: 399 EENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKVRHRHLV 456
+LG+G FG V + + A+K ++ VI K +E VL RH L
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 457 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
AL + +++L V EY G L H+ + E + E R A ++ ++YLH
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHL---SRERVFS-EDRARFYGA-EIVSALDYLH 265
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++ ++RDLK N++L D K+ DFGL + + +++T GT YLAPE
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 319
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 47/236 (19%), Positives = 77/236 (32%), Gaps = 48/236 (20%)
Query: 26 NGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDS- 84
NG + G TSLK + L N +F G++QLE L + + S
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 85 LVKLESLKIVNMTNNLLQGPVPE-FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLS 140
+ L +L +++++ + F+ SL M + N
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM---AGN------------------ 455
Query: 141 VVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQR 200
F EN+ + N+T ++ + L F S SLQ
Sbjct: 456 ---------SFQENFLPDIFTE------LR--NLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 201 LILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS-----FKSNAIVNTDGNP 251
L ++ NN + L +L+ LD S N + S A +N N
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 43/214 (20%), Positives = 73/214 (34%), Gaps = 21/214 (9%)
Query: 28 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVK 87
+ L ID+ +T++ L S + DFS + L L + F L
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 88 LESLKIVNMTNNLLQGPVPEFDRS--VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLM 145
L+ L T+N E D LD+ S N L G C S+ L
Sbjct: 327 LKRL---TFTSNKGGNAFSEVDLPSLEFLDL---SRNG-LSFKGCCSQSDFGTTSLKYL- 378
Query: 146 GYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILA 204
+ N S+++G+ + ++FQ NL F S ++L L ++
Sbjct: 379 ----DLSFNGVITMS-SNFLGLE----QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 205 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
+ + L +L+ L ++ N
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 37/246 (15%), Positives = 69/246 (28%), Gaps = 52/246 (21%)
Query: 2 LQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD 60
L G S G + ++ L ++ N + + L+ + +
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSF---N-GVITMSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 61 --FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP--EFDRSVS--- 113
F ++ L L + L SL+++ M N Q F +
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 114 LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN 173
LD+ S +L L P F S +
Sbjct: 475 LDL---SQC-----------QLEQLS--------PTAFN-------SLS----------S 495
Query: 174 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNNQL 232
+ V+N N + + SLQ L + N++ + L +L L+++ N
Sbjct: 496 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
Query: 233 YGKIPS 238
Sbjct: 556 ACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 37/247 (14%), Positives = 74/247 (29%), Gaps = 55/247 (22%)
Query: 5 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA--FSGPLPD-F 61
G P S ++ L G ++ SL+ + L N F G
Sbjct: 316 FGQFPTLKLKS-LKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 62 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSVSL---DM 116
G L+ L L N + + + LE L+ ++ ++ L+ F +L D+
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 117 AKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 176
+ + + G ++ V
Sbjct: 429 S--HTHTRVAFNGIF-------------------------NGLS------------SLEV 449
Query: 177 INFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 235
+ + P+ F ++L L L+ L + P + L +L+ L++S+N +
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 236 IPSFKSN 242
Sbjct: 510 DTFPYKC 516
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 43/241 (17%), Positives = 79/241 (32%), Gaps = 20/241 (8%)
Query: 36 DVIQNMTSLKEIWLHSNAF-SGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I ++ +LKE+ + N S LP+ FS + LE L L N L L + +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177
Query: 94 VNMTNNLLQGPVPEFDRSV-------SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 146
+N++ +L P+ L + +N L C L L V +L+
Sbjct: 178 LNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR--NNFDSLNVMKTCIQGLAG-LEVHRLVL 234
Query: 147 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILAD 205
R N + D + I ++ + F ++ L
Sbjct: 235 GEFRNEGNLEKFDKSA---LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 206 NNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQGSP 265
+ + S + L++ N + G+ P+ K ++ + S P
Sbjct: 292 VTIERVKD--FSYNFGWQHLELVNCKF-GQFPTLKLKSLKRLTFT-SNKGGNAFSEVDLP 347
Query: 266 S 266
S
Sbjct: 348 S 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 30/220 (13%), Positives = 56/220 (25%), Gaps = 32/220 (14%)
Query: 41 MTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
S K + L N F +L+ L L + L L + +T N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 100 LLQGPVPE-FDRSVSL---DMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQRFA 152
+Q F SL N L L ++
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAV--ETNLASLENFPIGHLKTLKELNVA------------ 132
Query: 153 ENWKGNDPCSDWIGVTCTK-GNITVINFQKMNLTGTISPEFASFKSLQ----RLILADNN 207
N S + + N+ ++ + + + L L+ N
Sbjct: 133 ----HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 208 LSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNT 247
++ + P + L +L + NN + +
Sbjct: 189 MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGL 227
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 38/244 (15%), Positives = 77/244 (31%), Gaps = 32/244 (13%)
Query: 3 QLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLPD 60
L SF ++Q L ++ + Q+++ L + L N
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCE----IQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94
Query: 61 -FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVS----L 114
FSG+ L+ L + + L++LK +N+ +NL+Q +PE+ +++ L
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 115 DMAKGSNNFCLPSPGACDP--RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG 172
D++ SN ++ L + L P F + +
Sbjct: 155 DLS--SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI------------ 200
Query: 173 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEG---LSVLGALKELDVS 228
+ + + + + L+ L S L L L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 229 NNQL 232
+L
Sbjct: 261 EFRL 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 41/257 (15%), Positives = 76/257 (29%), Gaps = 56/257 (21%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQ---------------------------L 67
+ N+T+L+ + L SN D + Q L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 68 ESLSLRDNFFTGPVP-DSLVKLESLKIVNMTNNLLQG-------PVPEFDRSVSLDMAKG 119
L+LR+NF + V + L L++ + + + +L + +
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 120 SNNFCLPSPGACDPRLNALLSVVKL------MGYPQRFAENWK-------GNDPCSDWIG 166
+ N L +V + + F+ N+ G
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK-----FG 317
Query: 167 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS--GMIPEGLSVLGALKE 224
T ++ + G + SL+ L L+ N LS G + +LK
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 225 LDVSNNQLYGKIPSFKS 241
LD+S N + +F
Sbjct: 378 LDLSFNGVITMSSNFLG 394
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 16/80 (20%), Positives = 26/80 (32%), Gaps = 10/80 (12%)
Query: 159 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 218
+PC NIT ++N I S + L L+ N L +
Sbjct: 1 EPC------VEVVPNITY-QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFS 50
Query: 219 LGALKELDVSNNQLYGKIPS 238
L+ LD+S ++
Sbjct: 51 FPELQVLDLSRCEIQTIEDG 70
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 37/190 (19%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 460
LG G FG V K+A+K + ++ + + EI+ L +RH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY- 75
Query: 461 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 511
+ + +V EY G L +I +R+T D R +
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVE-----------KKRMTE--DEGRRFFQQIICAI 121
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
EY H +HRDLKP N+LL D++ K+ADFGL + +G ++T G+ Y AP
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS-CGSPNYAAP 176
Query: 572 E------YAG 575
E YAG
Sbjct: 177 EVINGKLYAG 186
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 41/176 (23%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTE---FKS----EI 444
+ + + +G+G FG V+K G K+A+K ME E F EI
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME---------NEKEGFPITALREI 67
Query: 445 AVLTKVRHRHLVALLGHCLDGNEKL--------LVFEYMPQ---GTLSRHIFNWAEEGLK 493
+L ++H ++V L+ C LVF++ G LS + + +K
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 494 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
+ + G+ Y+H +HRD+K +N+L+ D K+ADFGL R
Sbjct: 128 --------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 50/190 (26%), Positives = 69/190 (36%), Gaps = 38/190 (20%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 461
+G G FG +AVK +E G + + + EI +RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIVRFKEV 84
Query: 462 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEY 513
L ++ EY G L I N R + D AR GV Y
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICN-----------AGRFSE--DEARFFFQQLLSGVSY 131
Query: 514 LHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
H HRDLK N LL R K+ DFG + + ++ + GT Y+AP
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAP 186
Query: 572 E------YAG 575
E Y G
Sbjct: 187 EVLLRQEYDG 196
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 41/264 (15%), Positives = 87/264 (32%), Gaps = 50/264 (18%)
Query: 3 QLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI--DVIQNMTSLKEIWLHSNAFSGPLP 59
++ +FS ++ L + N ++G + + + ++ EI+L N +
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGL---N-EIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 60 D-FSGVKQLESLSLRDNFFTG--PVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS--- 113
+ F+ V L+ L LR P L +L I++++NN + + +
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 114 -LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG 172
LD+ +N L L G
Sbjct: 508 ILDL---QHN-----------NLARLWKHANPGGPIYFLKGL-----------------S 536
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
++ ++N + F L+ + L NNL+ + + +LK L++ N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 233 YGKIPS-----FKSNAIVNTDGNP 251
F++ ++ NP
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNP 620
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 46/215 (21%), Positives = 81/215 (37%), Gaps = 27/215 (12%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
T+L E+ L SN+ + F K L +L L N + + V+LE+L+ +
Sbjct: 91 KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQEL 150
Query: 95 NMTNNLLQGPVPEFDRS------VSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLM 145
++NN +Q E L+++ SN SPG RL L L+ V+L
Sbjct: 151 LLSNNKIQALKSEELDIFANSSLKKLELS--SNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208
Query: 146 GYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK--SLQRLIL 203
+ + +I ++ L+ T + F K +L L L
Sbjct: 209 PSLTE-------------KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 204 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
+ NNL+ + + + L L+ + N +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 43/225 (19%), Positives = 69/225 (30%), Gaps = 36/225 (16%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD----------FSGVKQLESLSLRDNFFTGPVPDSL 85
+ + +++ + L + + F +K LE L++ DN G +
Sbjct: 290 HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349
Query: 86 VKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAK------GSNNFCLPSPGACD--PRLNA 137
L +LK ++++N+ + VSL + N A L
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409
Query: 138 LLSVVKLMGYPQRFAENW-KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK 196
L N +W G+ NI I FA
Sbjct: 410 L-----------DLGLNEIGQELTGQEWRGLE----NIFEIYLSYNKYLQLTRNSFALVP 454
Query: 197 SLQRLILADNNLSGM--IPEGLSVLGALKELDVSNNQLYGKIPSF 239
SLQRL+L L + P L L LD+SNN +
Sbjct: 455 SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 33/206 (16%), Positives = 61/206 (29%), Gaps = 35/206 (16%)
Query: 36 DVIQNMTSLKEIWLHSNAFSG-PLPDFSGVK--QLESLSLRDNFFTGPVPDSLVKLESLK 92
+ +L+E+ L +N + L+ L L N P + L
Sbjct: 139 GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLF 198
Query: 93 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRF 151
+ + N L + E CL + L LS +L
Sbjct: 199 GLFLNNVQLGPSLTE--------------KLCLELAN---TSIRNLSLSNSQL----STT 237
Query: 152 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 211
+ + N+T+++ NL + FA L+ L NN+ +
Sbjct: 238 SNTTFLGLKWT----------NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287
Query: 212 IPEGLSVLGALKELDVSNNQLYGKIP 237
L L ++ L++ + I
Sbjct: 288 FSHSLHGLFNVRYLNLKRSFTKQSIS 313
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 45/246 (18%), Positives = 83/246 (33%), Gaps = 26/246 (10%)
Query: 9 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVK- 65
P F ++ L++N L + + TS++ + L ++ S F G+K
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKW 247
Query: 66 -QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNF 123
L L L N DS L L+ + N +Q ++ +F
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307
Query: 124 CLPS------PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVI 177
S P D L + L +N + + G+ N+ +
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLN-----MEDNDIPGIKSNMFTGLI----NLKYL 358
Query: 178 NFQKMNLTGTISPEFASF-----KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ + T + +F L L L N +S + + S LG L+ LD+ N++
Sbjct: 359 SLSN-SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 233 YGKIPS 238
++
Sbjct: 418 GQELTG 423
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 36/215 (16%), Positives = 73/215 (33%), Gaps = 25/215 (11%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
++ Q + LK + L N S F+ L L L N + VK ++L +
Sbjct: 67 ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITL 126
Query: 95 NMTNNLLQG-PVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP-Q 149
++++N L + + +L ++ +N D N+ L ++L +
Sbjct: 127 DLSHNGLSSTKLGTQVQLENLQELLLS--NNKIQALKSEELDIFANSSLKKLELSSNQIK 184
Query: 150 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF---KSLQRLILADN 206
F+ + + + L +++ + S++ L L+++
Sbjct: 185 EFSPGCFHAIG------------RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232
Query: 207 NLSGMIPEGLSVLG--ALKELDVSNNQLYGKIPSF 239
LS L L LD+S N L
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 35/217 (16%), Positives = 66/217 (30%), Gaps = 46/217 (21%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
+ L + + N S P+ + L+ L+L+ N + + +L +++
Sbjct: 45 FTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104
Query: 97 TNNLLQGPVPE-FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
+N +Q F + +L D+ N G L
Sbjct: 105 MSNSIQKIKNNPFVKQKNLITLDL--SHNGLSSTKLGTQVQ-----LE------------ 145
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK--SLQRLILADNNLSG 210
N+ + + S E F SL++L L+ N +
Sbjct: 146 --------------------NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 211 MIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNT 247
P +G L L ++N QL + + NT
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 38/204 (18%), Positives = 72/204 (35%), Gaps = 46/204 (22%)
Query: 42 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
T++ + L N +F+ QL SL + N + P+ KL LK++N+ +N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 101 LQGPVPE-FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 156
L + F +L + SN+
Sbjct: 85 LSQLSDKTFAFCTNLTELHLM--SNSIQKIKNNP----FVKQ------------------ 120
Query: 157 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 216
N+ ++ L+ T ++LQ L+L++N + + E L
Sbjct: 121 ---------------KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 217 SVLG--ALKELDVSNNQLYGKIPS 238
+ +LK+L++S+NQ+ P
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPG 189
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 28/131 (21%), Positives = 47/131 (35%), Gaps = 17/131 (12%)
Query: 3 QLIGGLPA----SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL 58
++ GL + + LW +A GG I ++ ++ L + L SN F
Sbjct: 498 DMLEGLEKLEILDLQHNNLARLW-----KHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552
Query: 59 PD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV----- 112
+ F + +L+ + L N SLK +N+ NL+ +
Sbjct: 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT 612
Query: 113 SLDMAKGSNNF 123
LDM N F
Sbjct: 613 ELDM--RFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 40/235 (17%), Positives = 71/235 (30%), Gaps = 38/235 (16%)
Query: 36 DVIQNMTSLKEIWLHSNAFSG---PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 92
+ + SL+ + L A F ++ L L L +N D L LE L+
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 93 IVNMTNNLLQGPVPEFDRSVSLDMAKG----------SNNFCLPSPGACD--PRLNAL-L 139
I+++ +N L + + KG SN F L + L
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567
Query: 140 SVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA-SFKSL 198
+ L P N + ++ +N QK +T F +F++L
Sbjct: 568 GLNNLNTLPASVFNN----------------QVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 199 QRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI-----PSFKSNAIVNTD 248
L + N + + E + +L P + + D
Sbjct: 612 TELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFD 666
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 30/195 (15%), Positives = 57/195 (29%), Gaps = 45/195 (23%)
Query: 42 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101
S + + +PD + L+L N + + L +++ N +
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDLP-TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 102 QGPVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157
PE + + L++ N S ++ +L N
Sbjct: 62 SKLEPELCQKLPMLKVLNLQ--HNELSQLSDKT----FAFCTNLTEL-----HLMSN--- 107
Query: 158 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 217
++ + F K+L L L+ N LS
Sbjct: 108 -------------------------SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 218 VLGALKELDVSNNQL 232
L L+EL +SNN++
Sbjct: 143 QLENLQELLLSNNKI 157
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 13/66 (19%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ V + + LT + + ++ L L N L + + L LDV N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 233 YGKIPS 238
P
Sbjct: 62 SKLEPE 67
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 55/189 (29%), Positives = 74/189 (39%), Gaps = 32/189 (16%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
+ F LG G FG V + + A+K ++ V+ K + +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 509
LV L D N L +V EY+ G + H L R + AR
Sbjct: 101 PFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSH-----------LRRIGRFSE--PHARFY 146
Query: 510 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 563
EYLH I+RDLKP N+L+ +V DFG A KG T +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG---FAKRVKGRTWT-LC 199
Query: 564 GTFGYLAPE 572
GT LAPE
Sbjct: 200 GTPEALAPE 208
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 39/256 (15%), Positives = 81/256 (31%), Gaps = 44/256 (17%)
Query: 1 MLQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGP- 57
Q + + + V + ++ + ++ I + N
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCP----NLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 58 --------LPDFSGVKQLESLSLRDN-FFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 108
L D ++++ + + N T PV SL K++ L ++ N L+G +P F
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF 349
Query: 109 DRSVSL---DMAKGSNNF-CLPSPGACDPRLNALL-SVVKLMGYPQRFAENWKGNDPCSD 163
+ L ++ N +P V L FA N P
Sbjct: 350 GSEIKLASLNL--AYNQITEIP------ANFCGFTEQVENL-----SFAHNKLKYIPNIF 396
Query: 164 WIGVTCTKGNITVINFQKMNLTG-------TISPEFASFKSLQRLILADNNLSGMIPEGL 216
+ + ++ I+F + + P ++ + L++N +S E
Sbjct: 397 DAK-SVS--VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453
Query: 217 SVLGALKELDVSNNQL 232
S L +++ N L
Sbjct: 454 STGSPLSSINLMGNML 469
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-18
Identities = 32/261 (12%), Positives = 70/261 (26%), Gaps = 35/261 (13%)
Query: 2 LQLIGGLPASFSG-SQIQSLWVN-----GQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF- 54
+ LP ++Q + V + ++ I++ N
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 55 SGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS-- 111
+ P+ +K+L L N G + L +N+ N + F
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 112 --VSLDMAKGSNNFCLPSPGACDPRLNALLSVV----KLMGYPQRFAENWKGNDPCSDWI 165
+L N ++ + ++ ++ +
Sbjct: 378 QVENLSF--AHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVD----GKNFDPLDPT--- 428
Query: 166 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM-------IPEGLSV 218
N++ IN ++ F++ L + L N L+ + E
Sbjct: 429 --PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 219 LGALKELDVSNNQLYGKIPSF 239
L +D+ N+L F
Sbjct: 487 TYLLTSIDLRFNKLTKLSDDF 507
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 25/217 (11%), Positives = 56/217 (25%), Gaps = 34/217 (15%)
Query: 40 NMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGP----VPDSLVKLESLKIV 94
+ + + L SG +PD + +LE L+L + P + S +
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE- 153
Q ++D P + L ++
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFV 198
Query: 154 ------------------NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF 195
+ + C N + T ++ +
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICE----------AWENENSEYAQQYKTEDLKWDNL 248
Query: 196 KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
K L + + + +P L L ++ ++V+ N+
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 38/257 (14%), Positives = 75/257 (29%), Gaps = 61/257 (23%)
Query: 5 IGGLPASFSGSQIQSLWV--------NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 56
+ +P F + + +G ++ I L +N S
Sbjct: 389 LKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN-FDPLDPTPFKGINVSSINLSNNQISK 447
Query: 57 PLPD-FSGVKQLESLSLRDNFFTG-------PVPDSLVKLESLKIVNMTNNLLQGPVPEF 108
+ FS L S++L N T ++ L +++ N L +F
Sbjct: 448 FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDF 507
Query: 109 DRS-----VSLDMAKGSNNF-CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 162
+ V +D++ N+F P+ L+ L G+ R + +GN
Sbjct: 508 RATTLPYLVGIDLS--YNSFSKFPT---------QPLNSSTLKGFGIRNQRDAQGN---- 552
Query: 163 DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGAL 222
SL +L + N++ + E + +
Sbjct: 553 --------------------RTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNI 589
Query: 223 KELDVSNNQLYGKIPSF 239
LD+ +N S+
Sbjct: 590 SVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 34/247 (13%), Positives = 70/247 (28%), Gaps = 20/247 (8%)
Query: 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF 61
+ L + N + + + +I SN +
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAV 202
Query: 62 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL-DMAKGS 120
+ +L + ++ F + E+ + + ++D L D+ +
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWENENSE----YAQQYKTEDLKWDNLKDLTDVEVYN 258
Query: 121 NNF--CLPSP-GACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 176
LP+ A P + + ++ + + Q +G I +
Sbjct: 259 CPNLTKLPTFLKAL-PEMQLINVACNRGISGEQ---LKDDWQALADAPVG-----EKIQI 309
Query: 177 INFQKMNL-TGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 235
I NL T + K L L N L G +P L L+++ NQ+
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEI 368
Query: 236 IPSFKSN 242
+F
Sbjct: 369 PANFCGF 375
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 32/247 (12%), Positives = 76/247 (30%), Gaps = 47/247 (19%)
Query: 38 IQNMTSLKEIWLHSNAFSG-------PLPDFSG-VKQLESLSLRDNFFTGPVPDSLVKLE 89
++++ + I N PL + S++L +N + +
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 90 SLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYP 148
L +N+ N+L + + + L ++ L KL
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYL-------------LTSIDLRFNKLTKLS 504
Query: 149 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL------I 202
F T + I+ + + + + +L+
Sbjct: 505 DDFRA---------------TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD 548
Query: 203 LADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIGKEKSSS 260
N PEG+++ +L +L + +N + K+ + ++++ NP+I + S
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISIDLSYV 607
Query: 261 FQGSPSG 267
+G
Sbjct: 608 CPYIEAG 614
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 28/222 (12%), Positives = 69/222 (31%), Gaps = 50/222 (22%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLP--------------------DFSGVKQLESLSLRDNFF 77
+ +T L++ ++ ++ F + +K L + + +
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261
Query: 78 TGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNA 137
+P L L ++++N+ N +++ + ++
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQL------------KDDWQALADAPVGEKIQI 309
Query: 138 L-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK 196
+ + L +P E + ++ L G + P F S
Sbjct: 310 IYIGYNNLKTFP---VETSLQK----------MK--KLGMLECLYNQLEGKL-PAFGSEI 353
Query: 197 SLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
L L LA N ++ + ++ L ++N+L IP+
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPN 394
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 29/225 (12%), Positives = 61/225 (27%), Gaps = 57/225 (25%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGV---KQLESLSLRDNFFTG-------PVPDSL 85
+ ++ + N +P+ + ++ N P+ +
Sbjct: 371 NFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
Query: 86 VKLESLKIVNMTNNLLQGPVPE-FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSV 141
K ++ +N++NN + E F L ++ N + +
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINL--MGNMLTEIPKNSLKDENENFKNT 487
Query: 142 VKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA--SFKSLQ 199
L T I+ + LT +S +F + L
Sbjct: 488 YLL------------------------------TSIDLRFNKLTK-LSDDFRATTLPYLV 516
Query: 200 RLILADNNLSGMIPEGLSVLGALKELDVSN------NQLYGKIPS 238
+ L+ N+ S P LK + N N+ + P
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 28/199 (14%), Positives = 62/199 (31%), Gaps = 39/199 (19%)
Query: 66 QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV-----PEFDRSVSLDMAKGS 120
++ LSL +G VPD++ +L L+++ + ++ + ++S + +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 121 NNFCLPSPGACDPRLNAL-LSVVKLMGYPQR-FAENWKGNDPCSDWIGVTCTKGNITVIN 178
+ DPR + L + PQ+ + T I
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL------------KDTQIG 189
Query: 179 FQKMNLTGTISPEFASFKSLQRLILADNNLSGM-------------------IPEGLSVL 219
N+T +S L++ + ++ L
Sbjct: 190 QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL 248
Query: 220 GALKELDVSNNQLYGKIPS 238
L +++V N K+P+
Sbjct: 249 KDLTDVEVYNCPNLTKLPT 267
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 13/114 (11%)
Query: 4 LIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQ--NMTSLKEIWLHSNAFSGPLPD 60
+ +F + S+ + N KL D + + L I L N+FS
Sbjct: 476 SLKDENENFKNTYLLTSIDLRF---N-KLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQ 531
Query: 61 FSGVKQLESLSLRD------NFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 108
L+ +R+ N P+ + SL + + +N ++ +
Sbjct: 532 PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 16/96 (16%), Positives = 26/96 (27%), Gaps = 26/96 (27%)
Query: 154 NWKGNDPCSDW---IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
NW N W GV+ + + L L SG
Sbjct: 59 NWNFNKELDMWGAQPGVSL--NSNG---------------------RVTGLSLEGFGASG 95
Query: 211 MIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVN 246
+P+ + L L+ L + ++ F I
Sbjct: 96 RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA 131
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 28/212 (13%), Positives = 52/212 (24%), Gaps = 65/212 (30%)
Query: 12 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD---FSGVKQLE 68
G+ + + N L + +N L I L N + L D + + L
Sbjct: 464 LMGNMLTEIPKN------SLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLV 516
Query: 69 SLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL------LQGPVP-EFDRSVSL---DMAK 118
+ L N F+ P + +LK + N P SL +
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQI-- 573
Query: 119 GSNNF-CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVI 177
GSN+ + + NI+V+
Sbjct: 574 GSNDIRKVNE---------KITP--------------------------------NISVL 592
Query: 178 NFQKMNLTGTISPEFASFKSLQRLILADNNLS 209
+ + + +L +
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 43/251 (17%), Positives = 84/251 (33%), Gaps = 40/251 (15%)
Query: 341 SENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSE- 399
+ +S + + P ++P + + + +
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63
Query: 400 ---ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRH 454
+LG G G V + K A+K ++ + + E+ + + + H
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDC--PKARREVELHWRASQCPH 116
Query: 455 LVALLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 504
+V ++ + L+V E + G L I + G ++ T I
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRG------DQAFTEREASEIM 167
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETR 561
+ ++YLH + HRD+KP N+L + K+ DFG + + T
Sbjct: 168 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTT- 222
Query: 562 IAGTFGYLAPE 572
T Y+APE
Sbjct: 223 PCYTPYYVAPE 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 32/189 (16%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
+F LG G FG V+ + A+K ++ V+ K + E +L+ V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 453 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 509
++ + G D +++ ++ +Y+ G L L ++R VA+
Sbjct: 66 PFIIRMWGTFQD-AQQIFMIMDYIEGGELFSL-----------LRKSQRFPN--PVAKFY 111
Query: 510 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 563
+EYLH + I+RDLKP NILL + K+ DFG A T +
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFG---FAKYVPDVTYT-LC 164
Query: 564 GTFGYLAPE 572
GT Y+APE
Sbjct: 165 GTPDYIAPE 173
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 44/198 (22%), Positives = 73/198 (36%), Gaps = 30/198 (15%)
Query: 392 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKS--------- 442
+ + ++ + + G +G V G +G +A+KR+ V G+ +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 443 EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEW 497
EI +L H +++ L ++ LV E M + L++ I + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVI----HDQRIVISP 133
Query: 498 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557
+ G+ LH A +HRDL P NILL D+ + DF L R
Sbjct: 134 QHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 558 IE---TRIAGTFGYLAPE 572
R Y APE
Sbjct: 191 THYVTHRW-----YRAPE 203
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 25/180 (13%)
Query: 403 LGRGGFGTVY---KGELHDGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
LG+G FG V+ K D ++ A+K ++ + + K E +L +V H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 459 LGH-CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVARGVE 512
H KL L+ +++ G L + ++E + E + L +AL +
Sbjct: 92 --HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALAL------D 140
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+LH L I+RDLKP NILL ++ K+ DFGL + + + + + GT Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 196
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 79/234 (33%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS----EIAV 446
+ +S LG G FG V + ++ G + A+K+ + + E+ +
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK----------VLQDPRYKNRELDI 53
Query: 447 LTKVRHRHLVALLGHCLDGNEKL------------------------------------- 469
+ + H +++ L+ + ++
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 470 -LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL------DVARGVEYLHGLAHQSF 522
++ EY+P TL + + ++ R + + L + R V ++H L
Sbjct: 114 NVIMEYVPD-TLHKVLKSFIRS-------GRSIPMNLISIYIYQLFRAVGFIHSL---GI 162
Query: 523 IHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIE---TRIAGTFGYLAPE 572
HRD+KP N+L+ D K+ DFG + + S+ +R Y APE
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE 211
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 33/209 (15%), Positives = 71/209 (33%), Gaps = 19/209 (9%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+ + L+E+ L + S G+ L+ L L N F S SL ++
Sbjct: 272 NTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331
Query: 96 MTNNLLQGPVPE--FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 150
+ N + + + +L D+ S++ + + C+ +L L + L
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDL---SHD-DIETSDCCNLQLRNLSHLQSL-----N 382
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLS 209
+ N + + + +++ L + F + L+ L L+ + L
Sbjct: 383 LSYNEPLSLKTEAFKECP----QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 210 GMIPEGLSVLGALKELDVSNNQLYGKIPS 238
+ L AL+ L++ N
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 46/263 (17%), Positives = 83/263 (31%), Gaps = 42/263 (15%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
+ +LK ++ S K LESL L N + E LK++
Sbjct: 99 TALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVL 158
Query: 95 NMTNNLLQG-PVPEFD-----RSVSLDMAKGSNNF--CLPSPGACDPRLNAL-LSVVKLM 145
+ NN + + ++SL++ + N + +L + +
Sbjct: 159 DFQNNAIHYLSKEDMSSLQQATNLSLNL---NGNDIAGIEPGAFDSAVFQSLNFGGTQNL 215
Query: 146 GYP--------------QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 191
F + + + + G + ++ IN QK S
Sbjct: 216 LVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG--LCEMSVESINLQKHYFFNISSNT 273
Query: 192 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNT---- 247
F F LQ L L +LS +P GL L LK+L +S N+ + + N
Sbjct: 274 FHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANK----FENLCQISASNFPSLT 328
Query: 248 ----DGNPDIGKEKSSSFQGSPS 266
GN + + + +
Sbjct: 329 HLSIKGNTKRLELGTGCLENLEN 351
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 42/251 (16%), Positives = 78/251 (31%), Gaps = 37/251 (14%)
Query: 5 IGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--F 61
+ LP+ G S ++ L ++ N L N SL + + N L
Sbjct: 290 LSELPSGLVGLSTLKKLVLSA-NKFENLCQI--SASNFPSLTHLSIKGNTKRLELGTGCL 346
Query: 62 SGVKQLESLSLRDNFFT--GPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSL---D 115
++ L L L + L L L+ +N++ N E F L D
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 116 MAKGSNNF-CLPSPGACD--PRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 171
+A + L L LS L ++ +
Sbjct: 407 LA--FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP--------------- 449
Query: 172 GNITVINFQKMNLTGTI---SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 228
+ +N Q + + + L+ L+L+ +LS + + L + +D+S
Sbjct: 450 -ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 229 NNQLYGKIPSF 239
+N+L
Sbjct: 509 HNRLTSSSIEA 519
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 32/212 (15%), Positives = 65/212 (30%), Gaps = 23/212 (10%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
D Q+ L + L +N SG K L+ L + L ++L+ +
Sbjct: 75 DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134
Query: 95 NMTNNLLQG-PVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 150
+ +N + +P+ + L D +N S + + L
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQ--NNAIHYLSKEDMSSLQQ--ATNLSL------ 184
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE--FASFKSLQRLILADNNL 208
N GND G + +NF I ++ +SL D +
Sbjct: 185 ---NLNGNDIAGIEPGAFDSA-VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 209 SGMIPEGLSVLGA--LKELDVSNNQLYGKIPS 238
+ P L ++ +++ + + +
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 39/239 (16%), Positives = 77/239 (32%), Gaps = 27/239 (11%)
Query: 9 PASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVK-- 65
P +F + QSL G N + + SL P F G+
Sbjct: 196 PGAFDSAVFQSLNFGG-TQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
Query: 66 QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS---LDMAKGSNN 122
+ES++L+ ++F ++ L+ +++T L + L + +N
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVL--SANK 312
Query: 123 FCLPSPGACD--PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 180
F + P L L N K + + + N+ ++
Sbjct: 313 FENLCQISASNFPSLTHL-----------SIKGNTKRLELGTGCLENL---ENLRELDLS 358
Query: 181 KMNLT--GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237
++ + + + LQ L L+ N + E L+ LD++ +L K
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 24/198 (12%), Positives = 48/198 (24%), Gaps = 46/198 (23%)
Query: 42 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
S + + N FS + L L L D+ L + +T N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 101 LQG-PVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 156
L +L L+ ++ L
Sbjct: 93 LIFMAETALSGPKALKHLFFI--QTGISSIDFIP----LHNQKTLESL------------ 134
Query: 157 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 216
+++ P+ + L+ L +N + + E +
Sbjct: 135 ---------------------YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
Query: 217 SVLGALK--ELDVSNNQL 232
S L L+++ N +
Sbjct: 174 SSLQQATNLSLNLNGNDI 191
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 45/237 (18%), Positives = 83/237 (35%), Gaps = 33/237 (13%)
Query: 9 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQ 66
++ L ++ + ++N++ L+ + L N F Q
Sbjct: 343 TGCLENLENLRELDLSH-DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401
Query: 67 LESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPE-FDRSVSL---DMAKGSN 121
LE L L S L LK++N++++LL + FD +L ++ N
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ--GN 459
Query: 122 NFCLPSPGACD-----PRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175
+F + + RL L LS L Q + +
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS----------------LKMMN 503
Query: 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
++ LT + S E S L LA N++S ++P L +L + +++ N L
Sbjct: 504 HVDLSHNRLT-SSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 10/66 (15%), Positives = 21/66 (31%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ + F L + F+ +L L L + + + L L ++ N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 233 YGKIPS 238
+
Sbjct: 94 IFMAET 99
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 29/223 (13%), Positives = 61/223 (27%), Gaps = 35/223 (15%)
Query: 1 MLQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP 59
++ S +QSL ++ N L + + L+ + L
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSY---NEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
Query: 60 D--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS---- 113
F + L+ L+L + L +L+ +N+ N + S+
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 114 ---LDMAKGSNNFCLPSPGA--CDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGV 167
L + + A +N + LS +L + KG
Sbjct: 478 LEILVL--SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG---------- 525
Query: 168 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
+N +++ + + + L N L
Sbjct: 526 -------IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 4/72 (5%)
Query: 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 220
S + N T N + + L I S + L + N L + S L
Sbjct: 2 TSSDQKCIEKEVNKTY-NCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLI 57
Query: 221 ALKELDVSNNQL 232
L LD++ Q+
Sbjct: 58 NLTFLDLTRCQI 69
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 54/181 (29%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 403 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKVRHRHLVALLG 460
LG+G FG V + A+K + VI K +E VL RH L AL
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 461 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 511
+ +++L V EY G L H L R T + AR +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFH-----------LSRERVFT--EERARFYGAEIVSAL 118
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
EYLH ++RD+K N++L D K+ DFGL + +++T GT YLAP
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 174
Query: 572 E 572
E
Sbjct: 175 E 175
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 1e-16
Identities = 58/258 (22%), Positives = 91/258 (35%), Gaps = 19/258 (7%)
Query: 324 SRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNM 383
S +Q S E + + + G E
Sbjct: 265 SELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTAN 324
Query: 384 VISIQVLRNVTNNFSEEN-----ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGL 437
IS + + +LG+G FG V E ++ AVK ++ V+
Sbjct: 325 TISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD 384
Query: 438 TEF-KSEIAVLTKV-RHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKP 494
E E VL + L L C ++L V EY+ G L HI + G
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFK 440
Query: 495 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554
A ++A G+ +L + I+RDLK N++L + K+ADFG+ +
Sbjct: 441 EPHAV--FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495
Query: 555 KGSIETRIAGTFGYLAPE 572
+ +T GT Y+APE
Sbjct: 496 GVTTKT-FCGTPDYIAPE 512
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 27/182 (14%)
Query: 403 LGRGGFGTVY---KGELHDGTKI-AVKRMEAGVISGKG--LTEFKSEIAVLTKVRHRHLV 456
LG+GG+G V+ K + KI A+K ++ +I K+E +L +V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 457 ALLGH-CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVARG 510
L KL L+ EY+ G L + EG+ + +++AL
Sbjct: 85 DL--IYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMAL----- 134
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 570
+LH I+RDLKP NI+L K+ DFGL + + T GT Y+A
Sbjct: 135 -GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMA 189
Query: 571 PE 572
PE
Sbjct: 190 PE 191
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 46/210 (21%)
Query: 388 QVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS---- 442
+++ N++++F +++LG G +G V G +A+K++E F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----------FDKPLFA 53
Query: 443 -----EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGT-LSRHIFNWAEEG 491
EI +L +H +++ + + NE ++ E M T L R I
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST----- 106
Query: 492 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551
+ L + R V+ LHG ++ IHRDLKPSN+L+ + KV DFGL R+
Sbjct: 107 -QMLSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 552 PEGKGSIETRIAGTFG---------YLAPE 572
E G Y APE
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPE 192
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 66/272 (24%), Positives = 103/272 (37%), Gaps = 58/272 (21%)
Query: 332 MVIHPRHSGSENSESVKITVA---GSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQ 388
M +H + SE + VKI V V I++ H S D Q S++
Sbjct: 1 MSLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAK-HYNMSKSKVDNQF-------YSVE 52
Query: 389 VLRN---VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-- 442
V + V + +G G G V + +A+K++ F++
Sbjct: 53 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---------PFQNQT 103
Query: 443 -------EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAE 489
E+ ++ V H+++++LL + + LV E M L + I
Sbjct: 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----- 157
Query: 490 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R
Sbjct: 158 --QMELDHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 550 LAPEGKGSIE---TRIAGTFGYLAPEYAGNFG 578
A TR Y APE G
Sbjct: 213 TAGTSFMMTPYVVTRY-----YRAPEVILGMG 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 27/226 (11%)
Query: 362 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT----NNFSEENILGRGGFGTVY---KG 414
T G Q+L + + + + + NF +LG G +G V+ K
Sbjct: 17 GAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKI 76
Query: 415 ELHDGTKI-AVKRME-AGVISGKGLTEF-KSEIAVLTKVRHRHLVALLGHCLDGNEKL-L 470
HD K+ A+K ++ A ++ TE ++E VL +R + L + KL L
Sbjct: 77 SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136
Query: 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVARGVEYLHGLAHQSFIHRD 526
+ +Y+ G L H+ ++ + + +AL E+LH L I+RD
Sbjct: 137 ILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLAL------EHLHKL---GIIYRD 184
Query: 527 LKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+K NILL + + DFGL + + GT Y+AP+
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 35/161 (21%), Positives = 62/161 (38%), Gaps = 25/161 (15%)
Query: 402 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALL 459
+LG G G V + K A+K ++ + + E+ + + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDC--PKARREVELHWRASQCPHIVRIV 77
Query: 460 GHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
+ L+V E + G L I + G + I + ++YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 516 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPE 553
+ HRD+KP N+L + K+ DFG A E
Sbjct: 135 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKE 169
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 49/206 (23%), Positives = 78/206 (37%), Gaps = 44/206 (21%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 442
V + +G G G V + +A+K++ F++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---------PFQNQTHAKRAY 72
Query: 443 -EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 495
E+ ++ V H++++ LL + + +V E M L + I L
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-------QMEL 124
Query: 496 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R A
Sbjct: 125 DHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 556 GSIE---TRIAGTFGYLAPEYAGNFG 578
TR Y APE G
Sbjct: 182 MMTPYVVTRY-----YRAPEVILGMG 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 33/173 (19%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 442
+ + + +++G G +G V + + + +A+K++ F+
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL---------RVFEDLIDCKRIL 100
Query: 443 -EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 496
EIA+L ++ H H+V +L +E +V E + L
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF-----RTPVYLT 154
Query: 497 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
T+ ++ GV+Y+H +HRDLKP+N L+ D KV DFGL R
Sbjct: 155 ELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 37/198 (18%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 442
+V ++ + +G G +G V + + ++A+K++ F+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----------FEHQTYCQRTL 73
Query: 443 -EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 496
EI +L + RH +++ + + +V + M + L + + + L
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT------QHLS 126
Query: 497 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 556
+ + RG++Y+H + +HRDLKPSN+LL K+ DFGL R+A
Sbjct: 127 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 557 SIE--TRIAGTFGYLAPE 572
T T Y APE
Sbjct: 184 HTGFLTEYVATRWYRAPE 201
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 5e-15
Identities = 36/273 (13%), Positives = 81/273 (29%), Gaps = 47/273 (17%)
Query: 2 LQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPL- 58
+ S+S + + + + D + ++ L+ + + N
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCP----NMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 59 ---------PDFSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPVPEF 108
D +++ + N P SL K+ L +++ +N ++ + F
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAF 591
Query: 109 DRSVSL---DMAKGSNNF-CLPSP-GACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCS 162
+V L + N +P A ++ L S KL P F
Sbjct: 592 GTNVKLTDLKL--DYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFN---------- 639
Query: 163 DWIGVTCTKGNITVINFQKMNLTG-----TISPEFASFKSLQRLILADNNLSGMIPEGLS 217
+ + ++F + + S + + + L+ N + E +
Sbjct: 640 -----AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694
Query: 218 VLGALKELDVSNNQLYGKIPSFKSNAIVNTDGN 250
+ + +SNN + IP N
Sbjct: 695 TGSPISTIILSNNLM-TSIPENSLKPKDGNYKN 726
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 30/253 (11%), Positives = 74/253 (29%), Gaps = 37/253 (14%)
Query: 3 QLIGGLPASFSG-SQIQSLWVNG------QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 55
+ LP ++QSL + A D ++ ++ N
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561
Query: 56 G--PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRS 111
+ +L L N ++ L + + N ++ +PE +
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFT 618
Query: 112 VSLDMAKGSNNF--CLPSPGACD--PRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIG 166
++ S+N +P+ + ++ S K+ + + +
Sbjct: 619 DQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD---------- 668
Query: 167 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS-------GMIPEGLSVL 219
N + + + + FA+ + +IL++N ++
Sbjct: 669 -DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727
Query: 220 GALKELDVSNNQL 232
L +D+ N+L
Sbjct: 728 YLLTTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 27/228 (11%), Positives = 63/228 (27%), Gaps = 34/228 (14%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
+ N + + L G +PD + +L+ LS + T + + +
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 97 TNNLLQGPVPE--FDRSVSLDMAKGSNN--FCLPSPGACDPRLNALLSVVKLMGYPQRF- 151
+ ++ + D L+++ + P L ++ R
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 152 -----------------AENW-KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA 193
A + ++ DW N ++
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAVDW----------EDANSDYAKQYENEELSWS 488
Query: 194 SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 241
+ K L + L + +P+ L L L+ L+++ N+
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 30/221 (13%), Positives = 59/221 (26%), Gaps = 55/221 (24%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTG-PVPDSLVKLESL 91
++ L ++ L N +P+ + Q+E L N P + + +
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVM 646
Query: 92 KIVNMTNNLLQGPVPEFDRS---------VSLDMAKGSNNFCLPSPGACD--PRLNAL-L 139
V+ + N + S ++ + N ++ + L
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL--SYNEIQKFPTELFATGSPISTIIL 704
Query: 140 SVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQ 199
S N +T I N + + L
Sbjct: 705 S----------------NN--------------LMTSIPE---NSLKPKDGNYKNTYLLT 731
Query: 200 RLILADNNLSGMIPEGLSV--LGALKELDVSNNQLYGKIPS 238
+ L N L+ + + L L +DVS N P+
Sbjct: 732 TIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCF-SSFPT 770
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 29/241 (12%), Positives = 70/241 (29%), Gaps = 40/241 (16%)
Query: 4 LIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-F 61
I + + +++Q ++ ++ +
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSP--------FTYDNIAVDWEDANSDYAKQYENEELSW 487
Query: 62 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSN 121
S +K L + L + +PD L L L+ +N+ N ++
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK-----------AD 536
Query: 122 NFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 180
L P++ + L +P S + + +++
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPA------------SASLQ-KMV--KLGLLDCV 581
Query: 181 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK 240
+ + F + L L L N + + + + ++ L S+N+L IP+
Sbjct: 582 HNKVR-HL-EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIF 638
Query: 241 S 241
+
Sbjct: 639 N 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 6e-13
Identities = 37/274 (13%), Positives = 78/274 (28%), Gaps = 63/274 (22%)
Query: 5 IGGLPASFSGSQIQSLWV-----NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP 59
+ +P F+ + + N + + + L N
Sbjct: 631 LKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690
Query: 60 D-FSGVKQLESLSLRDNFFT-------GPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 111
+ F+ + ++ L +N T P + L +++ N L +F +
Sbjct: 691 ELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRAT 750
Query: 112 -----VSLDMAKGSNNF-CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 165
++D++ N F P+ L+ +L + R + +GN
Sbjct: 751 TLPYLSNMDVS--YNCFSSFPT---------QPLNSSQLKAFGIRHQRDAEGN------- 792
Query: 166 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 225
+ + SL +L + N++ + E L L L
Sbjct: 793 -----------------RILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYIL 832
Query: 226 DVSNNQL-YGKIPSFKSNAIVNT-----DGNPDI 253
D+++N + S D DI
Sbjct: 833 DIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 30/223 (13%), Positives = 62/223 (27%), Gaps = 55/223 (24%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD---FSGVKQLESLSLRDNFFTG-----PVPDSLVK 87
D ++ + N +P+ V + S+ N K
Sbjct: 613 DFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671
Query: 88 LESLKIVNMTNNLLQGPVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSVVK 143
+ V ++ N +Q E + S + ++ +N + P+ +
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILS--NNLMTSIPENSLKPKDGNYKNTYL 729
Query: 144 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA--SFKSLQRL 201
L T I+ + LT ++S +F + L +
Sbjct: 730 L------------------------------TTIDLRFNKLT-SLSDDFRATTLPYLSNM 758
Query: 202 ILADNNLSGMIPEGLSVLGALKEL------DVSNNQLYGKIPS 238
++ N S P LK D N++ + P+
Sbjct: 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 34/250 (13%), Positives = 74/250 (29%), Gaps = 36/250 (14%)
Query: 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ 66
F ++ + ++ + L L +A + P+ +K+
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKK 419
Query: 67 LESLSLRDNFFTG------PVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 120
+SL+D + ++ +L L+I+ N+ D D
Sbjct: 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD---WEDANSDY 476
Query: 121 NNFCLPSPGACDPRLNAL--LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK------- 171
+ + L L+ V+L P D++ +
Sbjct: 477 AKQYENEELS----WSNLKDLTDVELYNC------PNMTQLP--DFLY-DLPELQSLNIA 523
Query: 172 GN-ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE-GLSVLGALKELDVSN 229
N K + T ++ + + +Q + NNL L + L LD +
Sbjct: 524 CNRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH 582
Query: 230 NQLYGKIPSF 239
N++ + +F
Sbjct: 583 NKV-RHLEAF 591
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 9/95 (9%), Positives = 22/95 (23%), Gaps = 4/95 (4%)
Query: 148 PQRFAENWKGNDPCSDWIGVTCTK----GNITVINFQKMNLTGTISPEFASFKSLQRLIL 203
+ NW N W G +T ++ G + L+ L
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354
Query: 204 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
++ + + +++
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 34/245 (13%), Positives = 66/245 (26%), Gaps = 53/245 (21%)
Query: 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDN 75
+ L + N N ++ + +I +N + + +L+ + ++
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANS 458
Query: 76 FFTGP-------------------VPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDM 116
FT S L+ L V + N +P+
Sbjct: 459 PFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD--------- 509
Query: 117 AKGSNNFC-LPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174
LP L +L ++ + + Q A+ + D I
Sbjct: 510 -----FLYDLPE-------LQSLNIACNRGISAAQLKADWTRLADDEDTG-------PKI 550
Query: 175 TVINFQKMNLTG-TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233
+ NL S L L N + + L +L + NQ+
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEA-FGTNVKLTDLKLDYNQI- 607
Query: 234 GKIPS 238
+IP
Sbjct: 608 EEIPE 612
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 62/214 (28%), Positives = 84/214 (39%), Gaps = 31/214 (14%)
Query: 368 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKI-AVKR 426
P + I + + N +F ++G+G FG V AVK
Sbjct: 18 PPAPSQQINLGPSSNPHAKPS-------DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV 70
Query: 427 MEAGVISGKGLTEF-KSEIAVLTK-VRHRHLVALLGH-CLDGNEKL-LVFEYMPQGTLSR 482
++ I K + SE VL K V+H LV L H +KL V +Y+ G L
Sbjct: 71 LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL--HFSFQTADKLYFVLDYINGGELFY 128
Query: 483 HIFNWAEEGLKPLEWNR----RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 538
H+ E R + AL YLH L + ++RDLKP NILL
Sbjct: 129 HL---QRERCFLEPRARFYAAEIASAL------GYLHSL---NIVYRDLKPENILLDSQG 176
Query: 539 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ DFGL + E + T GT YLAPE
Sbjct: 177 HIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPE 209
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVAL 458
++GRG + V L +I A+K ++ +++ ++ ++E V + H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 459 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
C +L V EY+ G L H+ + P E R A +++ + YLH
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 128
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLK N+LL + K+ D+G+ + + T GT Y+APE
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE 180
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 14/174 (8%)
Query: 403 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVALL 459
LG+G FG V E ++ AVK ++ V+ E E VL + L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
C ++L V EY+ G L HI + G A ++A G+ +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAV--FYAAEIAIGLFFLQS-- 139
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLK N++L + K+ADFG+ + + +T GT Y+APE
Sbjct: 140 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPE 191
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 7e-15
Identities = 35/222 (15%), Positives = 73/222 (32%), Gaps = 15/222 (6%)
Query: 25 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVP 82
G + +N+ +L + L N P F + L+S+ N
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165
Query: 83 DSLVKLE--SLKIVNMTNNLLQGPVP-------EFDRSVSLDMAKGSNNFCLPSPGACDP 133
L L+ +L ++ N L V R++ L++ S N
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225
Query: 134 RLNALLSVVKLMGYPQRFAENWKGND--PCSDWIGVTCTKGNITVINFQKMNLTGTISPE 191
+ L+ + ++ + ++ ++ + +++
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSR 284
Query: 192 -FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
F + K L+ L LA N ++ + E L L+ L++S N L
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 39/218 (17%), Positives = 82/218 (37%), Gaps = 30/218 (13%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
V + + LK + L N + + D F G+ L+ L+L N + L +
Sbjct: 284 RVFETLKDLKVLNLAYNKINK-IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342
Query: 94 VNMTNNLLQGPVPEFDRSVS----LDMAKGSNN-----FCLPSPGACDPRLNALLSVVKL 144
+++ N + + + + LD+ +N +PS N L+++ K+
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDL---RDNALTTIHFIPSIPDIFLSGNKLVTLPKI 399
Query: 145 --MGYPQRFAENW-KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE--FASFKSLQ 199
+EN + D + V ++ ++ + + + S + + SL+
Sbjct: 400 NLTANLIHLSENRLENLDILYFLLRVP----HLQILILNQNRFS-SCSGDQTPSENPSLE 454
Query: 200 RLILADNNLSGMIPEGLSV-----LGALKELDVSNNQL 232
+L L +N L L L L+ L +++N L
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 40/215 (18%), Positives = 75/215 (34%), Gaps = 24/215 (11%)
Query: 36 DVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
+ + +L+ + L N +F G+ ++ + L+ N + LE L+ +
Sbjct: 308 EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNF-CLPSPGACDPRLNAL-LSVVKLMGYPQR-F 151
++ +N L + + + N LP + N + LS +L F
Sbjct: 368 DLRDNALTT-IHFIPSIPDIFL--SGNKLVTLPK---INLTANLIHLSENRLENLDILYF 421
Query: 152 AENWK--------GNDPCSDWIGVTCTK-GNITVIN-----FQKMNLTGTISPEFASFKS 197
N S T ++ ++ + Q T F
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 198 LQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
LQ L L N L+ + P S L AL+ L +++N+L
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 41/243 (16%), Positives = 82/243 (33%), Gaps = 24/243 (9%)
Query: 9 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQ 66
+SF Q+Q L + Q + + +N+ +L+ + L S+ PD F G+
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDK--EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFH 98
Query: 67 LESLSLRDNFFTGPV--PDSLVKLESLKIVNMTNNLLQ--GPVPEFDRSVSL---DMAKG 119
L L L + V L++L ++++ N ++ P F + SL D
Sbjct: 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF--S 156
Query: 120 SNNFCLPSPGACD----PRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174
SN L + L+ L+ L + +
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW 216
Query: 175 TVI---NFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG--ALKELDVSN 229
TV NF ++ + + + +N+ + L +++ LD+S+
Sbjct: 217 TVDITGNFSN-AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH 275
Query: 230 NQL 232
+
Sbjct: 276 GFV 278
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 37/204 (18%), Positives = 69/204 (33%), Gaps = 19/204 (9%)
Query: 42 TSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
+S++ + L F +K L+ L+L N ++ L++L+++N++ NL
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 101 LQGPVPEFDRSVS----LDMAKGSNNFCLPSPGACD--PRLNAL-LSV---VKLMGYPQR 150
L + +D+ N+ + +L L L + P
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQ--KNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSI 383
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG-TISPEFASFKSLQRLILADNNLS 209
GN + +I+ + L I LQ LIL N S
Sbjct: 384 PDIFLSGNKLVTLPKINLTA----NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439
Query: 210 GMIPEGL-SVLGALKELDVSNNQL 232
+ S +L++L + N L
Sbjct: 440 SCSGDQTPSENPSLEQLFLGENML 463
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 42/233 (18%), Positives = 81/233 (34%), Gaps = 29/233 (12%)
Query: 39 QNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97
+ + I L N + F +++L++L LRDN T ++ + S+ + ++
Sbjct: 335 YGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLS 389
Query: 98 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL----LSVVKLMGYPQRFAE 153
N L + + ++ N R+ L L+ +
Sbjct: 390 GNKLVTLPKINLTANLIHLS--ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447
Query: 154 NW---------KGNDPCSDWIGVTCTKGNITVINFQKMNLTG----TISPE-FASFKSLQ 199
+ N W C + + Q + L ++ P F+ +L+
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 200 RLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS-FKSNAIVNTDGNP 251
L L N L+ + L L+ LD+S NQL P F S ++++ N
Sbjct: 508 GLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 31/204 (15%), Positives = 68/204 (33%), Gaps = 38/204 (18%)
Query: 39 QNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPV-PDSLVKLESLKIVNM 96
Q + + + + L N F ++QL+ L L + + ++ L +L+I+++
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 97 TNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 155
++ + P+ F L + L D L ++ +L ++N
Sbjct: 81 GSSKIYFLHPDAFQGLFHLFELRLYFCG-LSDAVLKDGYFRNLKALTRL-----DLSKN- 133
Query: 156 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 215
I + + P F SL+ + + N + +
Sbjct: 134 -----------------QIRSLY---------LHPSFGKLNSLKSIDFSSNQIFLVCEHE 167
Query: 216 LSVLGA--LKELDVSNNQLYGKIP 237
L L L ++ N LY ++
Sbjct: 168 LEPLQGKTLSFFSLAANSLYSRVS 191
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 15/72 (20%), Positives = 28/72 (38%), Gaps = 6/72 (8%)
Query: 37 VIQNMTSLKEIWLHSNAFSG------PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 90
SL++++L N F G+ L+ L L N+ P L +
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505
Query: 91 LKIVNMTNNLLQ 102
L+ +++ +N L
Sbjct: 506 LRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 42/258 (16%), Positives = 72/258 (27%), Gaps = 49/258 (18%)
Query: 36 DVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQ--LESLSLRDNFFTGPVPDSLVK----- 87
+ SLK I SN + ++ L SL N V K
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 88 ----LESLKI----------VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 133
LE L + N +N + + + + A + + P
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH-NIKDPDQNTF 260
Query: 134 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC------TKGNITVIN---FQKM-- 182
A SV L + + + + + I I F +
Sbjct: 261 AGLARSSVRHL-----DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN 315
Query: 183 --------NLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233
NL G + F + + L N+++ + + L L+ LD+ +N L
Sbjct: 316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL- 374
Query: 234 GKIPSFKSNAIVNTDGNP 251
I S + GN
Sbjct: 375 TTIHFIPSIPDIFLSGNK 392
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 28/177 (15%), Positives = 58/177 (32%), Gaps = 41/177 (23%)
Query: 61 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAK 118
+ E L L N+ S LE L+++ + + + + F +L +
Sbjct: 20 PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79
Query: 119 GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVIN 178
++ ++ L P F ++ +
Sbjct: 80 LGSS-----------KIYFLH--------PDAFQGL-----------------FHLFELR 103
Query: 179 FQKMNLTGTISPE--FASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSNNQL 232
L+ + + F + K+L RL L+ N + + L +LK +D S+NQ+
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 402 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVAL 458
++GRG + V L +I A++ ++ +++ ++ ++E V + H LV L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 459 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 517
C +L V EY+ G L H+ + P E R A +++ + YLH
Sbjct: 119 HS-CFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 171
Query: 518 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLK N+LL + K+ D+G+ + + T GT Y+APE
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 41/256 (16%), Positives = 79/256 (30%), Gaps = 48/256 (18%)
Query: 5 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGV 64
+ + L ++ N + G SL+ + L N +F G+
Sbjct: 340 GSISFKKVALPSLSYLDLSR-NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGL 398
Query: 65 KQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVS---LDMAKG 119
++L+ L + + + + LE L ++++ + F S L M
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM--- 455
Query: 120 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 179
+ N ++K N + + T N+T ++
Sbjct: 456 AGN-------------------------------SFKDNTLSNVFANTT----NLTFLDL 480
Query: 180 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 239
K L F + LQ L ++ NNL + + L +L LD S N++
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
Query: 240 KSNA----IVNTDGNP 251
+ N N
Sbjct: 541 QHFPKSLAFFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 34/206 (16%), Positives = 64/206 (31%), Gaps = 17/206 (8%)
Query: 36 DVIQNMTSLKEIWLHSNAFSG-PLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I + +LK++ + N LP FS + L + L N+ + L L
Sbjct: 122 FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181
Query: 94 VNMTNNLLQGPVPEFDRSV-------SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 146
VN++ ++ P+ L + NF + + A L V +L
Sbjct: 182 VNLSLDMSLNPIDFIQDQAFQGIKLHELTL---RGNFNSSNIMKTCLQNLAGLHVHRL-- 236
Query: 147 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADN 206
F + + C I N +F ++ + LA
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLC-DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 207 NLSGMIPEGLSVLGALKELDVSNNQL 232
++ + E + + L + QL
Sbjct: 296 SIKYL--EDVPKHFKWQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 35/200 (17%), Positives = 56/200 (28%), Gaps = 47/200 (23%)
Query: 42 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
+S K I L N FS +L+ L L + L L + +T N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 101 LQGPVPE-FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 156
+Q P F SL + L+++ KL A N
Sbjct: 92 IQSFSPGSFSGLTSLENLVAV--ETKLASLESFP----IGQLITLKKL-----NVAHN-- 138
Query: 157 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 216
I + F++ +L + L+ N + + L
Sbjct: 139 ----------------FIHSCK---------LPAYFSNLTNLVHVDLSYNYIQTITVNDL 173
Query: 217 SVLGALK----ELDVSNNQL 232
L LD+S N +
Sbjct: 174 QFLRENPQVNLSLDMSLNPI 193
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 30/206 (14%), Positives = 58/206 (28%), Gaps = 43/206 (20%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
+ L + L N P FSG+ LE+L + + +L +LK +
Sbjct: 74 KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL 133
Query: 95 NMTNNLLQG-PVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ 149
N+ +N + +P + +++ +D++ N + + L
Sbjct: 134 NVAHNFIHSCKLPAYFSNLTNLVHVDLS--YNYIQTITVNDLQFLRENPQVNLSL----- 186
Query: 150 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 209
+ +N I + L L L N S
Sbjct: 187 ----------------------------DMS-LNPIDFIQDQAFQGIKLHELTLRGNFNS 217
Query: 210 GMIPEG-LSVLGALKELDVSNNQLYG 234
I + L L L + +
Sbjct: 218 SNIMKTCLQNLAGLHVHRLILGEFKD 243
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 26/214 (12%), Positives = 58/214 (27%), Gaps = 31/214 (14%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKI 93
+TSL+ + + + L+ L++ NF +P L +L
Sbjct: 98 GSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVH 157
Query: 94 VNMTNNLLQGPVPEF--------DRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVK 143
V+++ N +Q ++SLDM S N + + + + +
Sbjct: 158 VDLSYNYIQTITVNDLQFLRENPQVNLSLDM---SLNPIDFIQ------DQAFQGIKLHE 208
Query: 144 LMGYPQRFAEN-WKGNDPCSDWIGVTCTKG-NITVINFQKMNLTGTISPE-FASFKSLQR 200
L N N + + + + F+ P +
Sbjct: 209 L-----TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 201 LILAD--NNLSGMIPEGLSVLGALKELDVSNNQL 232
N L + + ++ +
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 36/245 (14%), Positives = 68/245 (27%), Gaps = 57/245 (23%)
Query: 9 PASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-------PLPDF 61
+F G ++ L + G ++ + +QN+ L L F
Sbjct: 198 DQAFQGIKLHELTLRGNFNSSNIMKTC--LQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 62 SGVKQL--ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 119
G+ + + L L ++ +++ ++ + + +
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSI 314
Query: 120 SNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVIN 178
P P L +L L+
Sbjct: 315 IRCQLKQFPTLDLPFLKSLTLT-------------------------------------- 336
Query: 179 FQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG--ALKELDVSNNQLYGKI 236
G+IS + + SL L L+ N LS S LG +L+ LD+S N
Sbjct: 337 ----MNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS 392
Query: 237 PSFKS 241
+F
Sbjct: 393 ANFMG 397
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 24/182 (13%), Positives = 52/182 (28%), Gaps = 28/182 (15%)
Query: 38 IQNMTSLKEIWLHSNAFSG--PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+ L+ + + F +++L L + + L SL +
Sbjct: 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK 454
Query: 96 MT-NNLLQGPVPEFDRSVS----LDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGY 147
M N+ + + + LD+ S G D RL L +S L+
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDL--SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 148 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 207
+++ ++ + + KSL L +N+
Sbjct: 513 DSSHYNQLY----------------SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 208 LS 209
++
Sbjct: 557 VA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 12/67 (17%), Positives = 23/67 (34%), Gaps = 1/67 (1%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
V + L+ + + N ++ + L +L N +SL
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550
Query: 95 NMTNNLL 101
N+TNN +
Sbjct: 551 NLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 14/66 (21%), Positives = 25/66 (37%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ I+ L S F++F LQ L L+ + + + L L L ++ N +
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 233 YGKIPS 238
P
Sbjct: 93 QSFSPG 98
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 15/71 (21%), Positives = 36/71 (50%), Gaps = 1/71 (1%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+++ + + F+ SL+ L+ + L+ + + L LK+L+V++N +
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 233 YG-KIPSFKSN 242
+ K+P++ SN
Sbjct: 141 HSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 11/66 (16%), Positives = 21/66 (31%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ ++ + + + L LIL N + P S L +L+ L +L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 233 YGKIPS 238
Sbjct: 117 ASLESF 122
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 14/174 (8%)
Query: 403 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVALL 459
LG+G FG V + + + AVK ++ VI E +E +L+ H L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
C ++L V E++ G L HI + R A ++ + +LH
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARAR--FYAAEIISALMFLHD-- 142
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
+ I+RDLK N+LL + K+ADFG+ + + T GT Y+APE
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPE 194
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 35/235 (14%), Positives = 90/235 (38%), Gaps = 11/235 (4%)
Query: 7 GLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGV 64
G+ + F + +Q+L + +++ +TSL E+ + + + +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRI--DFAGLTSLNELEIKALSLRNYQSQSLKSI 171
Query: 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG--PVPEFDRSVSLDMAKGSNN 122
+ + L+L + + L S++ + + + L P VS M K +
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 123 FCLPSPGACDPRLNALLSVVKLMGYP-QRFAENWKGNDPCSDWIGVTCTKG----NITVI 177
+ + + + L L +++L N G+ S+ V+ I +
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291
Query: 178 NFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ + L +S ++ + ++R+ + ++ + + L +L+ LD+S N +
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 29/196 (14%), Positives = 53/196 (27%), Gaps = 42/196 (21%)
Query: 42 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
++K + L N + D L+ L L+ + D+ L SL+ +++++N
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85
Query: 101 LQG-PVPEFDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157
L F SL N L L L
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP-NLTNL------------------- 125
Query: 158 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL 216
+ + I FA SL L + +L + L
Sbjct: 126 -----------------QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168
Query: 217 SVLGALKELDVSNNQL 232
+ + L + ++
Sbjct: 169 KSIRDIHHLTLHLSES 184
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 31/209 (14%), Positives = 66/209 (31%), Gaps = 37/209 (17%)
Query: 36 DVIQNMTSLKEIWLHSNAFS----GPLPDFSGVKQLESLSLRDNFFT--GPVPDSLVKLE 89
Q++ SL+ + L N L++L L N + L+ L+
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
Query: 90 SLKIVNMTNNLLQGPVPEFDRSVS---LDMAKGSNNFCLPSPGACDP-RLNAL-LSVVKL 144
+L ++++ N L++ S+ + C P L L +S L
Sbjct: 388 NLTSLDISRNTFHPMPDSCQWPEKMRFLNL---SSTG-IRVVKTCIPQTLEVLDVSNNNL 443
Query: 145 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 204
+ + + + L T+ P+ + F L + ++
Sbjct: 444 DSFSLFL--------------------PRLQELYISRNKLK-TL-PDASLFPVLLVMKIS 481
Query: 205 DNNLSGMIPEGLSVLGALKELDVSNNQLY 233
N L + L +L+++ + N
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 30/205 (14%), Positives = 63/205 (30%), Gaps = 48/205 (23%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
++ +L+ + L S+ + + F + LE L L DN + L SLK
Sbjct: 44 GDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102
Query: 94 VNMTNNLLQ--GPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP 148
+N+ N Q G F +L + F L +L
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIG-NVETFSEIRRIDFAG-LTSL---------- 150
Query: 149 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNN 207
+ + ++L + S + + L L +
Sbjct: 151 --------------------------NELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSE 183
Query: 208 LSGMIPEGLSVLGALKELDVSNNQL 232
+ ++ +L +++ L++ + L
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNL 208
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 26/208 (12%), Positives = 67/208 (32%), Gaps = 44/208 (21%)
Query: 40 NMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 98
+++ + + L +S +++++ +++ ++ L+SL+ ++++
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 99 NLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LS---VVKLMGYPQRFAEN 154
NL+ + P L L LS + + +
Sbjct: 344 NLMV-----------------EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
N+T ++ + N + + ++ L L+ + ++
Sbjct: 387 -----------------KNLTSLDISR-NTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKT 427
Query: 215 GLSVLGALKELDVSNNQLYGKIPSFKSN 242
+ L+ LDVSNN L F
Sbjct: 428 CI--PQTLEVLDVSNNNL-DSFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 20/202 (9%), Positives = 52/202 (25%), Gaps = 44/202 (21%)
Query: 38 IQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
+ T + + + L + + + LE +K + +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 97 TNNLLQG-PVPEFDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
N+ + P S LD+ S N + +
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLDL---SEN-LMVEEYLKNSACKGAWP------------ 361
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT--GTISPEFASFKSLQRLILADNNLSG 210
++ + + +L + K+L L ++ N
Sbjct: 362 --------------------SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH- 400
Query: 211 MIPEGLSVLGALKELDVSNNQL 232
+P+ ++ L++S+ +
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 19/139 (13%), Positives = 51/139 (36%), Gaps = 8/139 (5%)
Query: 2 LQLIGGLPASFSG--SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP 59
+ ++ G +Q+L ++ N + +++ + +L + + N F
Sbjct: 346 MVEEYLKNSACKGAWPSLQTLVLSQ-NHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPD 404
Query: 60 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 119
+++ L+L V + ++L++++++NN L R L ++
Sbjct: 405 SCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFSLFLPRLQELYIS-- 459
Query: 120 SNNFCLPSPGACDPRLNAL 138
N + P L +
Sbjct: 460 RNKLKTLPDASLFPVLLVM 478
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 35/247 (14%), Positives = 75/247 (30%), Gaps = 45/247 (18%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDN--------FFTGPVPDSLV 86
++++ + + LH + + L + + L LRD S +
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM 225
Query: 87 KLESLKIVNMTNNLLQGPVPEFDRSVSLDMAK---------GSNNFCLPSPGACDPRLNA 137
K + + +T+ + + L + G N + ++
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET 285
Query: 138 L------LSVVKLMGYPQRFAENWK--------GND----PCSDWIGVTCTKGNITVINF 179
+ + L + + PCS + ++ ++
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLK----SLEFLDL 341
Query: 180 QK---MNLTGTISPEFASFKSLQRLILADNNLSGM--IPEGLSVLGALKELDVSNNQLYG 234
+ + S ++ SLQ L+L+ N+L M E L L L LD+S N +
Sbjct: 342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP 401
Query: 235 KIPSFKS 241
S +
Sbjct: 402 MPDSCQW 408
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 53/174 (30%), Positives = 74/174 (42%), Gaps = 14/174 (8%)
Query: 403 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKV-RHRHLVALL 459
LG+G FG V+ E + A+K ++ V+ E E VL+ H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 460 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 518
E L V EY+ G L HI L R A ++ G+++LH
Sbjct: 85 C-TFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLS--RATFYAAEIILGLQFLHSK- 137
Query: 519 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
++RDLK NILL D K+ADFG+ + G T GT Y+APE
Sbjct: 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 188
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 42/198 (21%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 442
+ + +G G +G+V + G K+A+K++ F+S
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---------PFQSEIFAKRAY 71
Query: 443 -EIAVLTKVRHRHLVALL-----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPL 495
E+ +L ++H +++ LL L LV +M Q L + +
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-------GLKF 123
Query: 496 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEG 554
+ + + +G++Y+H +HRDLKP N+ + +D K+ DFGL R A E
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 555 KGSIETRIAGTFGYLAPE 572
G + TR Y APE
Sbjct: 181 TGYVVTRW-----YRAPE 193
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 39/176 (22%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 442
+V +N+ ++++GRG +G VY + + +A+K++ F+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---------MFEDLIDCKRIL 73
Query: 443 -EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGT-LSRHIFNWAEEGLKPL 495
EI +L +++ +++ L L +E +V E + L + + L
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLF-----KTPIFL 126
Query: 496 EWNRRLTIALDVARGVEYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
TI ++ G ++H G+ IHRDLKP+N LL D KV DFGL R
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGI-----IHRDLKPANCLLNQDCSVKVCDFGLAR 177
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 41/198 (20%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 442
V + + +G G +G V + G K+A+K++ F+S
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---------PFQSELFAKRAY 72
Query: 443 -EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 495
E+ +L +RH +++ LL D + LV +M L + + + + L
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH------EKL 125
Query: 496 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEG 554
+R + + +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A E
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 555 KGSIETRIAGTFGYLAPE 572
G + TR Y APE
Sbjct: 183 TGYVVTRW-----YRAPE 195
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 41/198 (20%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 442
V + + +G G +G+V + G ++AVK K F+S
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---------KLSRPFQSIIHAKRTY 76
Query: 443 -EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 495
E+ +L ++H +++ LL + N+ LV M L+ + + L
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKL 129
Query: 496 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEG 554
+ + + RG++Y+H IHRDLKPSN+ + +D K+ DFGL R A E
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 555 KGSIETRIAGTFGYLAPE 572
G + TR Y APE
Sbjct: 187 TGYVATRW-----YRAPE 199
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 45/203 (22%), Positives = 82/203 (40%), Gaps = 38/203 (18%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS---EIAVL 447
++ + + + LG GG G V+ + ++A+K+ I K EI ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK-----IVLTDPQSVKHALREIKII 62
Query: 448 TKVRHRHLVALL--------------GHCLDGNEKLLVFEYMPQGT-LSRHIFNWAEEGL 492
++ H ++V + G + N +V EYM T L+ +
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQ------ 114
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLA 551
PL + RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL R+
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 552 --PEGKGSIETRIAGTFGYLAPE 572
+ T Y +P
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPR 194
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 25/198 (12%), Positives = 63/198 (31%), Gaps = 46/198 (23%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
++ QN K + ++ L ++ L L N + L L+++
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
N+++N+L + + +L +NN + LL +
Sbjct: 64 NLSSNVLYE-TLDLESLSTLRTLDLNNN-----------YVQELLVGPSI---------- 101
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
++ N++ +S + + + LA+N ++ +
Sbjct: 102 --------------------ETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDL 138
Query: 215 GLSVLGALKELDVSNNQL 232
++ LD+ N++
Sbjct: 139 DEGCRSRVQYLDLKLNEI 156
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 30/220 (13%), Positives = 61/220 (27%), Gaps = 18/220 (8%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
+ LK + L SN + P+F + +SLR+N + +L ++L+
Sbjct: 184 VKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHF 242
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL----LSVVKLMGYPQR 150
++ N S + + + G + P
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
FA+ + K + + + T + E + + +
Sbjct: 303 FADR------------LIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 211 MIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGN 250
+I + A L+ L + S A DG
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELDGT 389
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 31/202 (15%), Positives = 66/202 (32%), Gaps = 32/202 (15%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+ T L+ + L SN D + L +L L +N+ L+ S++ ++
Sbjct: 52 ADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLH 105
Query: 96 MTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQR- 150
NN + ++ +A +N + R+ L L + ++
Sbjct: 106 AANNNISRVSCSRGQGKKNIYLA--NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
A + + +N Q + + F L+ L L+ N L+
Sbjct: 164 LAASSD----------------TLEHLNLQYNFIY-DV-KGQVVFAKLKTLDLSSNKLA- 204
Query: 211 MIPEGLSVLGALKELDVSNNQL 232
+ + + + NN+L
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKL 226
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 30/207 (14%), Positives = 59/207 (28%), Gaps = 58/207 (28%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+ + S++ + +N S G +++ L +N T ++
Sbjct: 92 VQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 94 VNMTNNLLQG-PVPEFDRS----VSLDMAKGSNNF--CLPSPGACDPRLNAL-LSVVKLM 145
+++ N + E S L++ NF + +L L LS
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNL---QYNFIYDVK-GQVVFAKLKTLDLS----- 199
Query: 146 GYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILAD 205
N + + PEF S + + L +
Sbjct: 200 -----------SN--------------KLA-----------FMGPEFQSAAGVTWISLRN 223
Query: 206 NNLSGMIPEGLSVLGALKELDVSNNQL 232
N L +I + L L+ D+ N
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 14/67 (20%), Positives = 28/67 (41%), Gaps = 1/67 (1%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ +L ++ S +++ L L+ N LS + L+ L+ L++S+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 233 YGKIPSF 239
Y
Sbjct: 71 YE-TLDL 76
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 25/198 (12%), Positives = 63/198 (31%), Gaps = 46/198 (23%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
++ QN K + ++ L ++ L L N + L L+++
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
N+++N+L + + +L +NN + LL +
Sbjct: 64 NLSSNVLYE-TLDLESLSTLRTLDLNNN-----------YVQELLVGPSI---------- 101
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
++ N++ +S + + + LA+N ++ +
Sbjct: 102 --------------------ETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDL 138
Query: 215 GLSVLGALKELDVSNNQL 232
++ LD+ N++
Sbjct: 139 DEGCRSRVQYLDLKLNEI 156
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 31/202 (15%), Positives = 67/202 (33%), Gaps = 32/202 (15%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+ T L+ + L SN D + L +L L +N+ L+ S++ ++
Sbjct: 52 ADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLH 105
Query: 96 MTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQR- 150
NN + ++ +A +N + R+ L L + ++
Sbjct: 106 AANNNISRVSCSRGQGKKNIYLA--NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
A + + +N Q + + + F L+ L L+ N L+
Sbjct: 164 LAASSD----------------TLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA- 204
Query: 211 MIPEGLSVLGALKELDVSNNQL 232
+ + + + NN+L
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 31/234 (13%), Positives = 67/234 (28%), Gaps = 60/234 (25%)
Query: 5 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSG 63
+ S S +++L +N N + + S++ + +N S G
Sbjct: 70 LYETLDLESLSTLRTLDLNN---NY-----VQELLVGPSIETLHAANNNISRVSCSRGQG 121
Query: 64 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRS----VSLDMAK 118
+++ L +N T ++ +++ N + E S L++
Sbjct: 122 ---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL-- 176
Query: 119 GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVIN 178
N + + V + ++
Sbjct: 177 -QYN-----------FIYDVKGQVVF---------------------------AKLKTLD 197
Query: 179 FQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
L + PEF S + + L +N L +I + L L+ D+ N
Sbjct: 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 1/67 (1%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ +L ++ S +++ L L+ N LS + L+ L+ L++S+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 233 YGKIPSF 239
Y +
Sbjct: 71 Y-ETLDL 76
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 14/63 (22%), Positives = 27/63 (42%), Gaps = 1/63 (1%)
Query: 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
LK + L SN + P+F + +SLR+N + +L ++L+ ++ N
Sbjct: 189 VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247
Query: 100 LLQ 102
Sbjct: 248 GFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 10/45 (22%), Positives = 18/45 (40%)
Query: 188 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
I + + + D++L + +KELD+S N L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 39/193 (20%), Positives = 78/193 (40%), Gaps = 37/193 (19%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+++ LGRG + V++ + + K+ VK ++ + K EI +L +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENL 87
Query: 451 R-HRHLVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 507
R +++ L D + LVFE++ + + LT D+
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------------QTLTDY-DI 132
Query: 508 A-------RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVRLAPEGKGSIE 559
+ ++Y H +HRD+KP N+++ + R ++ D+GL G+
Sbjct: 133 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 560 TRIAGTFGYLAPE 572
R+A + + PE
Sbjct: 190 -RVA-SRYFKGPE 200
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 2e-12
Identities = 33/228 (14%), Positives = 58/228 (25%), Gaps = 55/228 (24%)
Query: 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM------EAGVISGKGLTEFKSEIAVL 447
T +G G FG V++ D T +A+K + K E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 448 TKV---------RHRHLVALLGHCL------------------------------DGNEK 468
++ R + L ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 528
+V E+ G + K +I + + F HRDL
Sbjct: 138 FIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 529 PSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576
N+LL K+ + + ++ I + E G
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI-IDYTLSRLERDGI 236
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 34/199 (17%)
Query: 388 QVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS---- 442
+V R+V + LG+G +G V+K + G +AVK++ F++
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---------FQNSTDA 52
Query: 443 -----EIAVLTKVR-HRHLVALLGHCL---DGNEKLLVFEYMPQGTLSRHIFNWAEEGLK 493
EI +LT++ H ++V LL + L + + LVF+YM + L I
Sbjct: 53 QRTFREIMILTELSGHENIVNLL-NVLRADNDRDVYLVFDYM-ETDLHAVIRA------N 104
Query: 494 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553
LE + + + + ++YLH +HRD+KPSNILL + KVADFGL R
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 554 GKGSIETRIAGTFGYLAPE 572
+
Sbjct: 162 IRRVTNNIPLSINENTENF 180
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 44/208 (21%), Positives = 77/208 (37%), Gaps = 32/208 (15%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I V+ +T+L+ + +N S + + L+ LSL N +L L +L
Sbjct: 191 DISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 94 VNMTNNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQ 149
+++ NN + + L + G+N SP A L L L+ +L
Sbjct: 248 LDLANNQISN-LAPLSGLTKLTELKL--GANQISNISPLAGLTALTNLELNENQL----- 299
Query: 150 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 209
D ++ K N+T + N++ +S LQRL +N +S
Sbjct: 300 ------------EDISPISNLK-NLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVS 344
Query: 210 GMIPEGLSVLGALKELDVSNNQLYGKIP 237
L+ L + L +NQ+ P
Sbjct: 345 D--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 37/220 (16%), Positives = 75/220 (34%), Gaps = 47/220 (21%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I + ++T+L ++ L +N S L SG+ +L L L N + L L +L
Sbjct: 235 DIGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNI--SPLAGLTALTN 291
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153
+ + N L+ + +L N ++ + V L
Sbjct: 292 LELNENQLED-ISPISNLKNLTYLTLYFN-----------NISDISPVSSL--------- 330
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
+ + F ++ A+ ++ L N +S + P
Sbjct: 331 ------------------TKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370
Query: 214 EGLSVLGALKELDVSNNQLYGKIPSFKSN-AIVNTDGNPD 252
L+ L + +L +++ ++K+N +I NT N
Sbjct: 371 --LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 34/218 (15%), Positives = 79/218 (36%), Gaps = 52/218 (23%)
Query: 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD 74
Q+ +L + ID ++ + +L +I +N + + + +L + + +
Sbjct: 46 DQVTTLQADRLGIK-----SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNN 99
Query: 75 NFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPR 134
N P L L +L + + NN + + +L+ + S+N
Sbjct: 100 NQIADITP--LANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSN-----------T 145
Query: 135 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFAS 194
++ + ++ L ++ ++F +T A+
Sbjct: 146 ISDISALSGL---------------------------TSLQQLSFG-NQVTDLKP--LAN 175
Query: 195 FKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+L+RL ++ N +S L+ L L+ L +NNQ+
Sbjct: 176 LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI 211
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 43/212 (20%), Positives = 85/212 (40%), Gaps = 31/212 (14%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+ + N+T+L+ + + SN S + + + LESL +N + P L L +L
Sbjct: 169 DLKPLANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 225
Query: 94 VNMTNNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 150
+++ N L+ + +L D+ +N +P L+ L + +L +
Sbjct: 226 LSLNGNQLKD-IGTLASLTNLTDLDL--ANNQISNLAP------LSGLTKLTEL-----K 271
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
N S+ + +T + + L ++ K+L L L NN+S
Sbjct: 272 LGAN-----QISNISPLAGLT-ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD 323
Query: 211 MIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 242
+ P +S L L+ L NN++ + S +
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKVSD-VSSLANL 352
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 47/210 (22%), Positives = 77/210 (36%), Gaps = 30/210 (14%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I + N+T+L + L +N + + + L L L N + +L L SL+
Sbjct: 104 DITPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQ 160
Query: 94 VNMTNNLLQ-GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRF 151
++ N + P+ LD+ SN S A L +L + ++
Sbjct: 161 LSFGNQVTDLKPLANLTTLERLDI--SSNKVSDISVLAKLTNLESLIATNNQI------- 211
Query: 152 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 211
SD + N+ ++ L I AS +L L LA+N +S +
Sbjct: 212 ----------SDITPLGILT-NLDELSLNGNQLKD-IGT-LASLTNLTDLDLANNQISNL 258
Query: 212 IPEGLSVLGALKELDVSNNQLYGKIPSFKS 241
P LS L L EL + NQ+ I
Sbjct: 259 AP--LSGLTKLTELKLGANQI-SNISPLAG 285
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 39/204 (19%), Positives = 72/204 (35%), Gaps = 47/204 (23%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I + +TSL+++ N + P + + LE L + N + L KL +L+
Sbjct: 148 DISALSGLTSLQQLSF-GNQVTDLKP-LANLTTLERLDISSNKVSDI--SVLAKLTNLES 203
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153
+ TNN + + +LD + N +L + ++ L
Sbjct: 204 LIATNNQISD-ITPLGILTNLDELSLNGN-----------QLKDIGTLASLT-------- 243
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
N+T ++ ++ + L L L N +S + P
Sbjct: 244 -------------------NLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP 282
Query: 214 EGLSVLGALKELDVSNNQLYGKIP 237
L+ L AL L+++ NQL P
Sbjct: 283 --LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 30/198 (15%), Positives = 58/198 (29%), Gaps = 46/198 (23%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
I + + L + + + + Q+ +L D + L +L +
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 73
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
N +NN L + L +NN ++ + + L
Sbjct: 74 NFSNNQLTD-ITPLKNLTKLVDILMNNN-----------QIADITPLANL---------- 111
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
N+T + +T + +L RL L+ N +S
Sbjct: 112 -----------------TNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--IS 150
Query: 215 GLSVLGALKELDVSNNQL 232
LS L +L++L N
Sbjct: 151 ALSGLTSLQQLSFGNQVT 168
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 34/199 (17%), Positives = 65/199 (32%), Gaps = 22/199 (11%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+ + +T L E+ L +N S + +G+ L +L L +N P + L++L
Sbjct: 257 NLAPLSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTY 313
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153
+ + N + + L NN + L L ++ L
Sbjct: 314 LTLYFNNISD-ISPVSSLTKLQRLFFYNNK-VSDV----SSLANLTNINWL-----SAGH 362
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
N SD + IT + T + + S+ + + P
Sbjct: 363 N-----QISDLTPLA-NLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAP 414
Query: 214 EGLSVLGALKELDVSNNQL 232
+S G+ E D++ N
Sbjct: 415 ATISDGGSYTEPDITWNLP 433
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 28/199 (14%), Positives = 60/199 (30%), Gaps = 47/199 (23%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
++ + + + + L ++ +N T P L L L
Sbjct: 38 DTVSQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 94
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153
+ M NN + + +L NN ++ + + L
Sbjct: 95 ILMNNNQIAD-ITPLANLTNLTGLTLFNN-----------QITDIDPLKNL--------- 133
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
N+ + ++ + SLQ+L N ++ + P
Sbjct: 134 ------------------TNLNRLELSSNTISDI--SALSGLTSLQQLSF-GNQVTDLKP 172
Query: 214 EGLSVLGALKELDVSNNQL 232
L+ L L+ LD+S+N++
Sbjct: 173 --LANLTTLERLDISSNKV 189
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 15/65 (23%), Positives = 24/65 (36%), Gaps = 4/65 (6%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
K N+T T+S + L + +G+ L L +++ SNNQL
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQL 80
Query: 233 YGKIP 237
P
Sbjct: 81 TDITP 85
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 34/151 (22%), Positives = 57/151 (37%), Gaps = 26/151 (17%)
Query: 397 FSEENI-----LGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIA 445
F + + LGRG FG V + + +AVK ++ G + SE+
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELK 77
Query: 446 VLTKV-RHRHLVALLGHCLDGNEKLLV-FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 503
+L + H ++V LLG C L+V E+ G LS ++ ++R
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------------RSKRNEF 125
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534
+G + G + I DLK +
Sbjct: 126 VPYKTKGARFRQGKDYVGAIPVDLKRRLDSI 156
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 22/57 (38%), Positives = 30/57 (52%), Gaps = 3/57 (5%)
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
L + + VA+G+E+L A + IHRDL NILL + K+ DFGL R
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 7e-12
Identities = 32/208 (15%), Positives = 62/208 (29%), Gaps = 45/208 (21%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+ I N+T L + L+ N + + + L + N T + + L
Sbjct: 169 DVTPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDI--TPVANMTRLNS 225
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153
+ + NN + + L + N +++ + +V L
Sbjct: 226 LKIGNNKITD-LSPLANLSQLTWLEIGTN-----------QISDINAVKDL--------- 264
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
+ ++N ++ IS + L L L +N L
Sbjct: 265 ------------------TKLKMLNVGSNQISD-ISV-LNNLSQLNSLFLNNNQLGNEDM 304
Query: 214 EGLSVLGALKELDVSNNQLYGKIPSFKS 241
E + L L L +S N + I S
Sbjct: 305 EVIGGLTNLTTLFLSQNHITD-IRPLAS 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 28/199 (14%), Positives = 61/199 (30%), Gaps = 44/199 (22%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I + ++TSL + N + + + + +L SL + +N T L L L
Sbjct: 191 DISPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITD--LSPLANLSQLTW 247
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153
+ + N + + L M +N +++ + + L
Sbjct: 248 LEIGTNQISD-INAVKDLTKLKMLNVGSN-----------QISDISVLNNL--------- 286
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
+ + L +L L L+ N+++ + P
Sbjct: 287 ------------------SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 214 EGLSVLGALKELDVSNNQL 232
L+ L + D +N +
Sbjct: 329 --LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 29/207 (14%), Positives = 63/207 (30%), Gaps = 46/207 (22%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
I I+ +T+L+ + L+ N + + S + +L +L + N T +L L +L+ +
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLREL 115
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
+ + + + + LN L + +
Sbjct: 116 YLNEDNISD-ISPLANLTKMY------------------SLN--LGANHNLSDLSPLSNM 154
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
+ + + + A+ L L L N + + P
Sbjct: 155 -----------------TGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP- 194
Query: 215 GLSVLGALKELDVSNNQLYGKIPSFKS 241
L+ L +L NQ+ I +
Sbjct: 195 -LASLTSLHYFTAYVNQITD-ITPVAN 219
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 7e-11
Identities = 33/208 (15%), Positives = 72/208 (34%), Gaps = 46/208 (22%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
I +QN+T+L+E++L+ + S + + + ++ SL+L N L + L +
Sbjct: 103 ISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYL 160
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
+T + ++ V L + N ++ + + L
Sbjct: 161 TVTESKVKD-VTPIANLTDLYSLSLNYN-----------QIEDISPLASL---------- 198
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
++ +T A+ L L + +N ++ + P
Sbjct: 199 -----------------TSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP- 238
Query: 215 GLSVLGALKELDVSNNQLYGKIPSFKSN 242
L+ L L L++ NQ+ I + K
Sbjct: 239 -LANLSQLTWLEIGTNQI-SDINAVKDL 264
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 8e-11
Identities = 31/208 (14%), Positives = 63/208 (30%), Gaps = 46/208 (22%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I + N+T + + L +N L S + L L++ ++ P + L L
Sbjct: 124 DISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYS 181
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153
+++ N ++ + SL N ++ + V +
Sbjct: 182 LSLNYNQIED-ISPLASLTSLHYFTAYVN-----------QITDITPVANM--------- 220
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
+ + +T A+ L L + N +S
Sbjct: 221 ------------------TRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--I 258
Query: 214 EGLSVLGALKELDVSNNQLYGKIPSFKS 241
+ L LK L+V +NQ+ I +
Sbjct: 259 NAVKDLTKLKMLNVGSNQI-SDISVLNN 285
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 6e-10
Identities = 38/224 (16%), Positives = 68/224 (30%), Gaps = 50/224 (22%)
Query: 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD 74
+++ SL + N + + NMT L + + + + + + L SLSL
Sbjct: 132 TKMYSLNLGA---N-HNLSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLSLNY 186
Query: 75 NFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPR 134
N L L SL N + + L+ K NN +
Sbjct: 187 NQIED--ISPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNN-----------K 232
Query: 135 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFAS 194
+ L + L +T + ++ I+
Sbjct: 233 ITDLSPLANL---------------------------SQLTWLEIGTNQIS-DINA-VKD 263
Query: 195 FKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
L+ L + N +S L+ L L L ++NNQL +
Sbjct: 264 LTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 22/206 (10%), Positives = 57/206 (27%), Gaps = 46/206 (22%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
I ++ L + + + ++ + L + + L +L+ +
Sbjct: 15 IFPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVASI--QGIEYLTNLEYL 71
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
N+ N + + V L N ++ + ++ L
Sbjct: 72 NLNGNQITD-ISPLSNLVKLTNLYIGTN-----------KITDISALQNL---------- 109
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
N+ + + N++ A+ + L L N+
Sbjct: 110 -----------------TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLS 149
Query: 215 GLSVLGALKELDVSNNQLYGKIPSFK 240
LS + L L V+ +++ +
Sbjct: 150 PLSNMTGLNYLTVTESKV-KDVTPIA 174
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 16/70 (22%), Positives = 31/70 (44%), Gaps = 3/70 (4%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 92
I V+ N++ L ++L++N + G+ L +L L N T P L L +
Sbjct: 279 DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD 336
Query: 93 IVNMTNNLLQ 102
+ N +++
Sbjct: 337 SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 4e-05
Identities = 23/198 (11%), Positives = 59/198 (29%), Gaps = 46/198 (23%)
Query: 44 LKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 103
+ + PD + + + L+ T V +LES+ + + +
Sbjct: 2 AATLATLPAPINQIFPD-ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58
Query: 104 PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 163
+ + +L+ + N ++ + + L
Sbjct: 59 -IQGIEYLTNLEYLNLNGN-----------QITDISPLSNL------------------- 87
Query: 164 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK 223
+T + +T + +L+ L L ++N+S + P L+ L +
Sbjct: 88 --------VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMY 135
Query: 224 ELDVSNNQLYGKIPSFKS 241
L++ N + +
Sbjct: 136 SLNLGANHNLSDLSPLSN 153
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 41/226 (18%), Positives = 70/226 (30%), Gaps = 33/226 (14%)
Query: 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFT--GPVPDSLVKLESLKIVNMT 97
+ SLK + SN + LE L L N + G S SLK ++++
Sbjct: 323 KLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 98 NNLLQGPVPEFDRSVS---LDMAKGSNNF-CLPSPGACD--PRLNAL-LSVVKLMGYPQR 150
N + F LD +N + L L +S
Sbjct: 382 FNGVITMSSNFLGLEQLEHLDFQ--HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLS 209
++ V+ + P+ F ++L L L+ L
Sbjct: 440 IFNGLS----------------SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 210 GMIPEGLSVLGALKELDVSNNQLY----GKIPSFKSNAIVNTDGNP 251
+ P + L +L+ L++++NQL G S + NP
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 44/235 (18%), Positives = 81/235 (34%), Gaps = 46/235 (19%)
Query: 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSG 63
G + ++ L ++ NG + G TSLK + L N +F G
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSR-NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG 394
Query: 64 VKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVS---LDMAK 118
++QLE L + + + L +L +++++ + F+ S L M
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM-- 452
Query: 119 GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVIN 178
+ N F EN+ + + N+T ++
Sbjct: 453 -AGN---------------------------SFQENFLPDIFT----ELR----NLTFLD 476
Query: 179 FQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ L +SP F S SLQ L +A N L + L +L+++ + N
Sbjct: 477 LSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 41/235 (17%), Positives = 73/235 (31%), Gaps = 40/235 (17%)
Query: 36 DVIQNMTSLKEIWLHSNAF-SGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I ++ +LKE+ + N S LP+ FS + LE L L N L L + +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177
Query: 94 VNMT---------------------------NNLLQGPVPE--FDRSVSLDMAKGSNNFC 124
+N++ NN V + L++ +
Sbjct: 178 LNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 125 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 184
+AL + L R A + D I + N++ + + +
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYL---DYYLDDIIDLFNCLTNVSSFSLVSVTI 294
Query: 185 TGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 239
+F+ Q L L + L +LK L ++N+ G S
Sbjct: 295 ERV--KDFSYNFGWQHLELVNCKFGQFPTLKLK---SLKRLTFTSNKG-GNAFSE 343
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 42/209 (20%), Positives = 72/209 (34%), Gaps = 25/209 (11%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
ID+ +T++ L S + DFS + L L + F L L+ L
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL--- 330
Query: 95 NMTNNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRF 151
T+N SL D+ S N L G C S+ L
Sbjct: 331 TFTSNKGGN-AFSEVDLPSLEFLDL---SRN-GLSFKGCCSQSDFGTTSLKYL-----DL 380
Query: 152 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE--FASFKSLQRLILADNNLS 209
+ N S+++G+ + ++FQ NL +S F S ++L L ++ +
Sbjct: 381 SFN-GVITMSSNFLGLE----QLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 210 GMIPEGLSVLGALKELDVSNNQLYGKIPS 238
+ L +L+ L ++ N
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 31/198 (15%), Positives = 55/198 (27%), Gaps = 43/198 (21%)
Query: 42 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
S K + L N F +L+ L L + L L + +T N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 101 LQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159
+Q + F SL L +L +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVET-----------NLASLEN------------------- 117
Query: 160 PCSDWIGVTCTKGNITVINFQKMNLT-GTISPEFASFKSLQRLILADNNLSGMIPEGLSV 218
+ +N + + F++ +L+ L L+ N + + L V
Sbjct: 118 ------FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 219 LGALK----ELDVSNNQL 232
L + LD+S N +
Sbjct: 172 LHQMPLLNLSLDLSLNPM 189
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 38/217 (17%), Positives = 76/217 (35%), Gaps = 39/217 (17%)
Query: 36 DVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
Q+++ L + L N L FSG+ L+ L + + L++LK +
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 95 NMTNNLLQ-GPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
N+ +NL+Q +PE F +L+ S+N ++ ++
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSN-----------KIQSI-------------- 164
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
C+D + ++ +N I P L +L L +N S +
Sbjct: 165 -------YCTDLRVLHQMPLLNLSLDLS-LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNV 216
Query: 213 PEG-LSVLGALKELDVSNNQL--YGKIPSFKSNAIVN 246
+ + L L+ + + G + F +A+
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 35/219 (15%), Positives = 77/219 (35%), Gaps = 28/219 (12%)
Query: 36 DVIQNMTSLKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES--L 91
+ + +TSL+ + L N P F +++ L L N + L+ +
Sbjct: 123 NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF 182
Query: 92 KIVNMTNNLLQ---------GPVPEFDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLS 140
++ +++ LQ ++ S+ S N + D ++
Sbjct: 183 TLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD-----AIA 237
Query: 141 VVKLMGYPQRFAENWKGNDPCSDWIGVT-CTKGNITVINFQKMNLTG----TISPE-FAS 194
K+ + N + +++ T + + +L+ + F+
Sbjct: 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSH 297
Query: 195 FKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSNNQL 232
F L++L LA N ++ I + L L +L++S N L
Sbjct: 298 FTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 44/261 (16%), Positives = 81/261 (31%), Gaps = 41/261 (15%)
Query: 9 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVK 65
SFS +Q L V Q + + ++SL + L N F L F+G+
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNN--TFRGLSSLIILKLDYNQFLQ-LETGAFNGLA 103
Query: 66 QLESLSLRDNFFTGPV--PDSLVKLESLKIVNMTNNLLQ--GPVPEFDRSVSLDMAKGSN 121
LE L+L G V + L SL+++ + +N ++ P F + +
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 122 N--FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 179
N + ++++L +IT+ +
Sbjct: 164 NKVKSIC-EEDLLNFQGKHFTLLRL---------------------------SSITLQDM 195
Query: 180 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL-DVSNNQLYGKIPS 238
+ L S+ L L+ N + + A ++ + + Y S
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 239 FKSNAIVNTDGNPDIGKEKSS 259
F + D G E S
Sbjct: 256 FGHTNFKDPDNFTFKGLEASG 276
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 24/91 (26%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+ +T L ++ L N + F + +LE L L N S + L +LK
Sbjct: 317 NAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375
Query: 94 VNMTNNLLQGPVPE--FDRSVSLDMAKGSNN 122
+ + N L+ VP+ FDR SL N
Sbjct: 376 LALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 10/62 (16%), Positives = 24/62 (38%), Gaps = 3/62 (4%)
Query: 173 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNN 230
++ ++ ++ ++ F+ + LQ L + +I L +L L + N
Sbjct: 31 HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 231 QL 232
Q
Sbjct: 90 QF 91
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 15/66 (22%), Positives = 32/66 (48%), Gaps = 3/66 (4%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
+ T L+++ L N + + D F G+ L L+L NF L+ L+++++
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354
Query: 97 TNNLLQ 102
+ N ++
Sbjct: 355 SYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 35/241 (14%), Positives = 73/241 (30%), Gaps = 37/241 (15%)
Query: 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSL 72
+ + + ++ N A+L + L+ + + + + F G+ L L L
Sbjct: 30 AHVNYVDLSL-NSIAELNET--SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 73 RDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPE--FDRSVSLDMAKGSNN--FCLPS 127
N F + L +L+++ +T L G + F SL+M +N +
Sbjct: 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ- 145
Query: 128 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 187
P + + + N + D + +F + L
Sbjct: 146 PASFFLNMRRFHVL--------DLTFNKVKSICEEDLLNFQGK-------HFTLLRL--- 187
Query: 188 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNT 247
S+ + + L ++ LD+S N + +AI T
Sbjct: 188 --------SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 248 D 248
Sbjct: 240 K 240
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 39/168 (23%), Positives = 73/168 (43%), Gaps = 29/168 (17%)
Query: 393 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 451
V N + +G G FG +Y G + G ++A+K +E L E + ++
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQL---HIESKIYKMMQ 62
Query: 452 H-RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 504
+ + +G+ ++V E + G +FN+ +R+ + +A
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFC---------SRKFSLKTVLLLA 111
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFGLVR 549
+ +EY+H ++FIHRD+KP N L+G + + DFGL +
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 36/200 (18%), Positives = 69/200 (34%), Gaps = 22/200 (11%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
N+ +L+ + L SN +P F+G+ L L + +N + L +LK + +
Sbjct: 77 NNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135
Query: 97 TNNLLQG-PVPEFD---RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
+N L F L + N A L+ L ++ L R
Sbjct: 136 GDNDLVYISHRAFSGLNSLEQLTLE--KCNLTSIPTEA----LSHLHGLIVL-----RLR 184
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
+ + + V+ T++P +L L + NL+ +
Sbjct: 185 HLNINAIRDYSFKRLY----RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVP 240
Query: 213 PEGLSVLGALKELDVSNNQL 232
+ L L+ L++S N +
Sbjct: 241 YLAVRHLVYLRFLNLSYNPI 260
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 41/238 (17%), Positives = 74/238 (31%), Gaps = 40/238 (16%)
Query: 9 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQ 66
F ++SL V N + + SL+++ L + P S +
Sbjct: 121 DYMFQDLYNLKSLEVGD-NDLVYISHR--AFSGLNSLEQLTLEKCNLTSIPTEALSHLHG 177
Query: 67 LESLSLRDNFFTGPVPDSLVKLESLKIVNMT-NNLLQGPVPEFDRSVSL-DMAKGSNNFC 124
L L LR S +L LK++ ++ L P ++L ++ N
Sbjct: 178 LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
Query: 125 LPSPGACD--PRLNAL------LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 176
A L L +S ++ E +
Sbjct: 238 AVPYLAVRHLVYLRFLNLSYNPISTIE----GSMLHEL-----------------LRLQE 276
Query: 177 INFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNNQL 232
I L + P F L+ L ++ N L+ + E + +G L+ L + +N L
Sbjct: 277 IQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 38/203 (18%), Positives = 74/203 (36%), Gaps = 22/203 (10%)
Query: 42 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
T + + L N +F+ LE L L +N + P + L +L+ + + +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 101 LQG-PVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 156
L+ P+ F +L D++ N + L ++ L +N
Sbjct: 92 LKLIPLGVFTGLSNLTKLDIS--ENKIVILLDYM----FQDLYNLKSL-----EVGDNDL 140
Query: 157 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEG 215
+ G+ ++ + +K NLT +I E + L L L N++ +
Sbjct: 141 VYISHRAFSGLN----SLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 216 LSVLGALKELDVSNNQLYGKIPS 238
L LK L++S+ +
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTP 218
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 31/213 (14%), Positives = 62/213 (29%), Gaps = 48/213 (22%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
+ L+E+ L+ N S + F+ + L +L LR N L +L +++
Sbjct: 53 ASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111
Query: 97 TNNLLQG-PVPEFDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVKLMGYPQRFAE 153
+ N + F +L + +N + A + L S+ +L +
Sbjct: 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYIS-HRA----FSGLNSLEQL-----TLEK 161
Query: 154 NWKGNDPCSDWIGVTCTKGNITVIN---FQKM----------NLTGTISPE-FASFKSLQ 199
N+T I + I F L+
Sbjct: 162 C------------------NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 200 RLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
L ++ + L L +++ L
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 13/66 (19%), Positives = 26/66 (39%), Gaps = 3/66 (4%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
+ L+EI L + + F G+ L L++ N T + +L+ + +
Sbjct: 269 HELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL 327
Query: 97 TNNLLQ 102
+N L
Sbjct: 328 DSNPLA 333
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 26/174 (14%), Positives = 58/174 (33%), Gaps = 41/174 (23%)
Query: 403 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL--- 459
+G+GGFG +Y +++ + + +E+ + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 460 --------------GHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT- 502
G + ++ + G+ + I+ +R +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN---------AKRFSR 151
Query: 503 -----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVR 549
++L + +EY+H ++H D+K SN+LL +V D+GL
Sbjct: 152 KTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 38/229 (16%), Positives = 73/229 (31%), Gaps = 32/229 (13%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
N L + + +N + D F L++L L N T V SL + SL N+
Sbjct: 144 HNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANV 199
Query: 97 TNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRL-------NALLSVVKLMGYP 148
+ NLL +P + N+ + L N L L+ YP
Sbjct: 200 SYNLLSTLAIPIAVEELDAS----HNSINVVRGPVN-VELTILKLQHNNLTDTAWLLNYP 254
Query: 149 Q----RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 204
+ N ++ + + + L ++ +L+ L L+
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQ----RLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 309
Query: 205 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--SFKSNAIVNTDGNP 251
N+L + L+ L + +N + + + + + N
Sbjct: 310 HNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKLSTHHTLKNLTLSHND 356
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 38/209 (18%), Positives = 72/209 (34%), Gaps = 47/209 (22%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
V QN+ L + L N S LP F +L +LS+ +N D+ SL+
Sbjct: 117 HVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 94 VNMTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
+ +++N L + +++ N L ++V +L +
Sbjct: 176 LQLSSNRLTHVDLSLIPSLFHANVS--YNLL---------STLAIPIAVEEL-----DAS 219
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVI------NFQKMNLTG---TISPEFASFKSLQRLIL 203
N +I V+ + L T + ++ L + L
Sbjct: 220 HN------------------SINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDL 261
Query: 204 ADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ N L ++ + L+ L +SNN+L
Sbjct: 262 SYNELEKIMYHPFVKMQRLERLYISNNRL 290
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 37/202 (18%), Positives = 67/202 (33%), Gaps = 33/202 (16%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+++++++ NA LP F V L L L N + L
Sbjct: 93 YAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTT 151
Query: 94 VNMTNNLLQG-PVPEFDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVKLMGYPQR 150
++M+NN L+ F + SL + S+N + L+ + S+
Sbjct: 152 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------LSLIPSLFHA------ 197
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
N N + + ++ ++ + L L L NNL+
Sbjct: 198 ---NVSYNL-----LSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD 246
Query: 211 MIPEGLSVLGALKELDVSNNQL 232
L L E+D+S N+L
Sbjct: 247 --TAWLLNYPGLVEVDLSYNEL 266
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 35/198 (17%), Positives = 65/198 (32%), Gaps = 47/198 (23%)
Query: 40 NMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97
+ + K + ++ LP +Q+E L+L D + +++ + M
Sbjct: 49 TLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 98 NNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 155
N ++ +P F L + N L++L F
Sbjct: 108 FNAIRY-LPPHVFQNVPLLTVLVLERN-----------DLSSL--------PRGIFHNT- 146
Query: 156 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPE 214
+T ++ NL I + F + SLQ L L+ N L+ +
Sbjct: 147 ----------------PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDL 188
Query: 215 GLSVLGALKELDVSNNQL 232
L + +L +VS N L
Sbjct: 189 SL--IPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 23/235 (9%), Positives = 75/235 (31%), Gaps = 23/235 (9%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
M L+ +++ +N + L+ L L N V + + + L+ +
Sbjct: 272 HPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLY 330
Query: 96 MTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL--LSVVKLMGYPQRFA 152
+ +N + + +L ++ N++ C+ ++ + Q
Sbjct: 331 LDHNSIVTLKLSTHHTLKNLTLS--HNDW------DCNSLRALFRNVARPAVDDADQHCK 382
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINF-----QKMNLTGTISPEFASFKSLQRLILADNN 207
+++ G+ C + + ++ ++ + + + +
Sbjct: 383 IDYQLEH------GLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSL 436
Query: 208 LSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQ 262
+ +G L ++L+ N+L ++ + I + E ++ +
Sbjct: 437 SHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLR 491
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 8/69 (11%), Positives = 24/69 (34%), Gaps = 3/69 (4%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
++ + ++ + L+ + F+ ++ L + N P + L +
Sbjct: 69 ALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 127
Query: 94 VNMTNNLLQ 102
+ + N L
Sbjct: 128 LVLERNDLS 136
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 33/170 (19%), Positives = 66/170 (38%), Gaps = 31/170 (18%)
Query: 393 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 451
V ++ +G G FG +++G L + ++A+K E L + E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQL---RDEYRTYKLLA 63
Query: 452 H-RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 504
+ + +G +LV + + +L + + R+ + A
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLC---------GRKFSVKTVAMAA 112
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR 549
+ V+ +H +S ++RD+KP N L+G V DFG+V+
Sbjct: 113 KQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 31/202 (15%), Positives = 67/202 (33%), Gaps = 66/202 (32%)
Query: 388 QVLRNVT-NNFSEENILGRGGFGTVYKGE---------LHDGTKIAVKRMEAGVISGKGL 437
VL + + + ++ R G +Y+ K ++K ++A G+
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDA--KDGRLF 90
Query: 438 TEFKS--------EIAVLTKV-------------------RHRHLV-ALLGHCLDGNEKL 469
E ++ K+ ++R LV LG L +
Sbjct: 91 NEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSL---QSA 147
Query: 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 529
+ P+ LS + + L +A + +E+LH ++H ++
Sbjct: 148 --LDVSPKHVLS----------ERSV-----LQVACRLLDALEFLH---ENEYVHGNVTA 187
Query: 530 SNILLGDDMRAKV--ADFGLVR 549
NI + + +++V A +G
Sbjct: 188 ENIFVDPEDQSQVTLAGYGFAF 209
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 42/207 (20%), Positives = 77/207 (37%), Gaps = 33/207 (15%)
Query: 39 QNMTSLKEIWLHSN---AFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+T L ++ L SN G L+ L L N + + + LE L+ ++
Sbjct: 49 DKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 107
Query: 96 MTNNLLQ--GPVPEFDRSVSL---DMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGY 147
++ L+ F +L D+ + + G + L L ++
Sbjct: 108 FQHSNLKQMSEFSVFLSLRNLIYLDI--SHTHTRVAFNGIFNGLSSLEVLKMA------- 158
Query: 148 PQRFAENWKGNDPCSDWIGVTCTK-GNITVINFQKMNLTGTISPE-FASFKSLQRLILAD 205
GN +++ T+ N+T ++ + L +SP F S SLQ L ++
Sbjct: 159 ---------GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSH 208
Query: 206 NNLSGMIPEGLSVLGALKELDVSNNQL 232
NN + L +L+ LD S N +
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHI 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 38/203 (18%), Positives = 68/203 (33%), Gaps = 31/203 (15%)
Query: 42 TSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFT--GPVPDSLVKLESLKIVNMT 97
+S + L SN LP F + QL LSL N + G S SLK ++++
Sbjct: 28 SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 98 NNLLQGPVPEFDRSVSLDMAKGSNN--FCLPSPGACD--PRLNAL-LSVVKLMGYPQR-F 151
N + F L+ ++ + L L +S F
Sbjct: 87 FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 152 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSG 210
G++ ++ V+ + P+ F ++L L L+ L
Sbjct: 147 N-------------GLS----SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE- 188
Query: 211 MIPEGLSV-LGALKELDVSNNQL 232
+ L +L+ L++S+N
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNF 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 30/204 (14%), Positives = 55/204 (26%), Gaps = 51/204 (25%)
Query: 39 QNMTSLKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
+ L+ + + F ++ L L + L SL+++ M
Sbjct: 98 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 157
Query: 97 TNNLLQGPVPE--FDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRF 151
N Q F + LD+ SP A N+L S+ L
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDL--SQCQLEQLSPTA----FNSLSSLQVL------- 204
Query: 152 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSG 210
N N ++ + SLQ L + N++
Sbjct: 205 --------------------------NMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM- 236
Query: 211 MIPEGL--SVLGALKELDVSNNQL 232
+ +L L+++ N
Sbjct: 237 TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 15/69 (21%), Positives = 31/69 (44%), Gaps = 2/69 (2%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+ ++SL+ + + N+F F+ ++ L L L P + L SL++
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203
Query: 94 VNMTNNLLQ 102
+NM++N
Sbjct: 204 LNMSHNNFF 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 14/67 (20%), Positives = 25/67 (37%), Gaps = 4/67 (5%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKL-ESLK 92
+++SL+ + + N F L + + L+ L N L SL
Sbjct: 193 TAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 251
Query: 93 IVNMTNN 99
+N+T N
Sbjct: 252 FLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 13/69 (18%), Positives = 28/69 (40%), Gaps = 3/69 (4%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
D+ + +L + L L F+ + L+ L++ N F L SL++
Sbjct: 169 DIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 94 VNMTNNLLQ 102
++ + N +
Sbjct: 228 LDYSLNHIM 236
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 39/177 (22%), Positives = 68/177 (38%), Gaps = 32/177 (18%)
Query: 386 SIQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEI 444
S+ VL V NF +G G FG + G+ L+ +A+K +E L E
Sbjct: 1 SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQL---HLEY 55
Query: 445 AVLTKVRH-RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT- 502
++ + + G +V E + G +F+ +R +
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLC---------DRTFSL 104
Query: 503 -----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR 549
IA+ + +EY+H ++ I+RD+KP N L+G + DF L +
Sbjct: 105 KTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 38/232 (16%), Positives = 74/232 (31%), Gaps = 32/232 (13%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+ N L + + +N + D F L++L L N T V SL + SL
Sbjct: 135 GIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFH 190
Query: 94 VNMTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRL-------NALLSVVKLM 145
N++ NLL +P + N+ + L N L L+
Sbjct: 191 ANVSYNLLSTLAIPIAVEELDAS----HNSINVVRGPVN-VELTILKLQHNNLTDTAWLL 245
Query: 146 GYPQ----RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL 201
YP + N ++ + + + L ++ +L+ L
Sbjct: 246 NYPGLVEVDLSYNELEKIMYHPFVKMQ----RLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 202 ILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--SFKSNAIVNTDGNP 251
L+ N+L + L+ L + +N + + + + + N
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKLSTHHTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 38/209 (18%), Positives = 72/209 (34%), Gaps = 47/209 (22%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
V QN+ L + L N S LP F +L +LS+ +N D+ SL+
Sbjct: 111 HVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 169
Query: 94 VNMTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
+ +++N L + +++ N L ++V +L +
Sbjct: 170 LQLSSNRLTHVDLSLIPSLFHANVS--YNLL---------STLAIPIAVEEL-----DAS 213
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVI------NFQKMNLTG---TISPEFASFKSLQRLIL 203
N +I V+ + L T + ++ L + L
Sbjct: 214 HN------------------SINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDL 255
Query: 204 ADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ N L ++ + L+ L +SNN+L
Sbjct: 256 SYNELEKIMYHPFVKMQRLERLYISNNRL 284
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 37/202 (18%), Positives = 67/202 (33%), Gaps = 33/202 (16%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+++++++ NA LP F V L L L N + L
Sbjct: 87 YAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTT 145
Query: 94 VNMTNNLLQG-PVPEFDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVKLMGYPQR 150
++M+NN L+ F + SL + S+N + L+ + S+
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------LSLIPSLFHA------ 191
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
N N + + ++ ++ + L L L NNL+
Sbjct: 192 ---NVSYNL-----LSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD 240
Query: 211 MIPEGLSVLGALKELDVSNNQL 232
L L E+D+S N+L
Sbjct: 241 --TAWLLNYPGLVEVDLSYNEL 260
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 36/198 (18%), Positives = 67/198 (33%), Gaps = 47/198 (23%)
Query: 40 NMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97
+ + K + ++ LP +Q+E L+L D + +++ + M
Sbjct: 43 TLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 101
Query: 98 NNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 155
N ++ +P F L + N L++L F
Sbjct: 102 FNAIRY-LPPHVFQNVPLLTVLVLERN-----------DLSSL--------PRGIFHNT- 140
Query: 156 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPE 214
+T ++ NL I + F + SLQ L L+ N L+ +
Sbjct: 141 ----------------PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD- 181
Query: 215 GLSVLGALKELDVSNNQL 232
LS++ +L +VS N L
Sbjct: 182 -LSLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 14/110 (12%), Positives = 38/110 (34%), Gaps = 10/110 (9%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
M L+ +++ +N + L+ L L N V + + + L+ +
Sbjct: 266 HPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLY 324
Query: 96 MTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL 144
+ +N + + +L ++ N++ C+ +V +
Sbjct: 325 LDHNSIVTLKLSTHHTLKNLTLS--HNDW------DCNSLRALFRNVARP 366
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 27/218 (12%), Positives = 69/218 (31%), Gaps = 46/218 (21%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
++ + ++ + L+ + F+ ++ L + N P + L +
Sbjct: 63 ALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121
Query: 94 VNMT-NNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ 149
+ + N+L P F + L M+ +NN A S+ L
Sbjct: 122 LVLERNDLSSLPRGIFHNTPKLTTLSMS--NNNLERIEDDT----FQATTSLQNL----- 170
Query: 150 RFAENWKGNDPCSDWIGVTCTKGNITVINF------QKMNLTGTISPEFASFKSLQRLIL 203
+ + N +T ++ N++ + A +++ L
Sbjct: 171 QLSSN------------------RLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDA 212
Query: 204 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 241
+ N+++ ++ + L L + +N L +
Sbjct: 213 SHNSIN-VVRGPV--NVELTILKLQHNNL-TDTAWLLN 246
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 6/56 (10%), Positives = 24/56 (42%), Gaps = 2/56 (3%)
Query: 177 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
I+ Q ++ E + + + + ++ + + L ++ L++++ Q+
Sbjct: 28 IDMQTQDVYF--GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 55/203 (27%)
Query: 402 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGKGLTE-FKSEIAVLTKVR------- 451
LG G F TV+ + + + T +A+K ++ K TE + EI +L +V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 452 ----HRHLVALLGH-----------CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 496
H++ LL H + VFE + + L I + G+ PL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVM-------VFEVLGE-NLLALIKKYEHRGI-PLI 131
Query: 497 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA------KVADFGLVRL 550
+ ++ I+ + G++Y+H IH D+KP N+L+ K+AD G
Sbjct: 132 YVKQ--ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 551 APEGKGS-IETRIAGTFGYLAPE 572
E + I+TR Y +PE
Sbjct: 188 YDEHYTNSIQTRE-----YRSPE 205
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 35/172 (20%), Positives = 62/172 (36%), Gaps = 40/172 (23%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGL-TEFK-----SEIAVLTKVRHRHL 455
+G GGFG +Y + K A ++ L +E K ++ + K R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 456 VALLG----------HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT--- 502
+ LG + + +V E + G + I N
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQ----------NGTFKKST 152
Query: 503 ---IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVR 549
+ + + +EY+H ++H D+K +N+LLG +V AD+GL
Sbjct: 153 VLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 393 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 451
V N F +G G FG +Y G + ++A+K +E L E + ++
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL---LYESKIYRILQ 60
Query: 452 -HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 504
+ + ++G+ +LV + + +L +FN+ +R+L+ +A
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFC---------SRKLSLKTVLMLA 109
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFGLVR 549
+ VE++H +SF+HRD+KP N L+G RA + DFGL +
Sbjct: 110 DQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 44/205 (21%), Positives = 71/205 (34%), Gaps = 51/205 (24%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRD-NFFTGPVPDSLVKLESLK 92
+ ++ L+E+WL +N +P F+ V L L L + + L +LK
Sbjct: 141 GAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK 199
Query: 93 IVNMTNNLLQGPVPEFDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ 149
+N+ ++ +P V L+M N+F PG+ + L S+ KL
Sbjct: 200 YLNLGMCNIKD-MPNLTPLVGLEELEM--SGNHFPEIRPGS----FHGLSSLKKL----- 247
Query: 150 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNL 208
++ I F SL L LA NNL
Sbjct: 248 ----------------------------WVMNSQVS-LIERNAFDGLASLVELNLAHNNL 278
Query: 209 SGMIPEG-LSVLGALKELDVSNNQL 232
S +P + L L EL + +N
Sbjct: 279 S-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 4/95 (4%)
Query: 9 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 67
+F+ + L + + G + + +LK + L +P+ + + L
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGA--FEGLFNLKYLNLGMCNIKD-MPNLTPLVGL 220
Query: 68 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 102
E L + N F P S L SLK + + N+ +
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 32/221 (14%), Positives = 69/221 (31%), Gaps = 47/221 (21%)
Query: 39 QNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM- 96
+ SL + L N + P F + +L L LR+N + ++ SL +++
Sbjct: 120 NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG 179
Query: 97 -TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 155
L F+ +L + + ++ L
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMC-----------NIKDMPNLTPL----------- 217
Query: 156 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPE 214
+ + + I P F SL++L + ++ +S +
Sbjct: 218 ----------------VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERN 260
Query: 215 GLSVLGALKELDVSNNQL----YGKIPSFKSNAIVNTDGNP 251
L +L EL++++N L + + ++ NP
Sbjct: 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 39/200 (19%), Positives = 69/200 (34%), Gaps = 47/200 (23%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
+++ L+ + L N+ + F+G+ L +L L DN+ T + L L+ + +
Sbjct: 96 RHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154
Query: 97 T-NNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
N + P F+R SL D+ S GA L ++ L
Sbjct: 155 RNNPIESIPSYAFNRVPSLMRLDLG-ELKKLEYISEGA----FEGLFNLKYL-----NLG 204
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
NI + P L+ L ++ N+ +
Sbjct: 205 MC------------------NIKDM------------PNLTPLVGLEELEMSGNHFPEIR 234
Query: 213 PEGLSVLGALKELDVSNNQL 232
P L +LK+L V N+Q+
Sbjct: 235 PGSFHGLSSLKKLWVMNSQV 254
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 15/68 (22%), Positives = 29/68 (42%), Gaps = 1/68 (1%)
Query: 36 DVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
++SLK++W+ ++ S F G+ L L+L N + D L L +
Sbjct: 236 GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL 295
Query: 95 NMTNNLLQ 102
++ +N
Sbjct: 296 HLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 19/78 (24%), Positives = 34/78 (43%), Gaps = 13/78 (16%)
Query: 167 VTCTKGNITVI------NFQKMNLTG----TISPE-FASFKSLQRLILADNNLSGMIPEG 215
V CT+ ++ + N + +NL I + F L+ L L N++ I G
Sbjct: 59 VVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVG 117
Query: 216 -LSVLGALKELDVSNNQL 232
+ L +L L++ +N L
Sbjct: 118 AFNGLASLNTLELFDNWL 135
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 39/233 (16%), Positives = 75/233 (32%), Gaps = 31/233 (13%)
Query: 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG--PLPDFSGV-KQLESLSL 72
++ L V +++ G + ++ L+E+ L + +G P P L L+L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 73 RDNFFTGPVPD----SLVKLESLKIVNMTNNLLQG-PVPEFDRSVSL---DMAKGSNNFC 124
R+ + LK++++ + +L D+ S+N
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL---SDNPE 185
Query: 125 LPSPG----ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 180
L G C + L + N P + + + ++
Sbjct: 186 LGERGLISALCPLKFPTLQVLALR---------NAGMETPSGVCSALAAARVQLQGLDLS 236
Query: 181 KMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+L L L L+ L +P+GL L LD+S N+L
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRL 286
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 33/213 (15%), Positives = 62/213 (29%), Gaps = 46/213 (21%)
Query: 40 NMTSLKEIWLHSNAFSGPLPD----FSGVKQLESLSLRDNFFTGPVPDSLVKL--ESLKI 93
SLK + + + + G+ L+ L+L + TG P L++ L I
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFA 152
+N+ N P L L ++ + +
Sbjct: 126 LNLRNVSWATRDAWLAELQQW----------------LKPGLKVLSIAQAHSLNFSCEQV 169
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA----SFKSLQRLILADNN- 207
+ ++ ++ G A F +LQ L L +
Sbjct: 170 RVFP----------------ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 208 --LSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
SG+ + L+ LD+S+N L +
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 19/102 (18%), Positives = 32/102 (31%), Gaps = 6/102 (5%)
Query: 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSL 72
+Q L + G + L+ + L N+ QL SL+L
Sbjct: 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
Query: 73 RDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL 114
VP L L +++++ N L P D +
Sbjct: 261 SFTGLKQ-VPKGL--PAKLSVLDLSYNRLDR-NPSPDELPQV 298
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 37/205 (18%), Positives = 72/205 (35%), Gaps = 51/205 (24%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRD-NFFTGPVPDSLVKLESLK 92
++ LKE+WL +N +P F+ + L L L + + + L +L+
Sbjct: 130 GAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188
Query: 93 IVNMTNNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ 149
+N+ L+ +P + L D+ N+ PG+ L+ + KL
Sbjct: 189 YLNLAMCNLRE-IPNLTPLIKLDELDL--SGNHLSAIRPGS----FQGLMHLQKL----- 236
Query: 150 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNL 208
+ + I F + +SL + LA NNL
Sbjct: 237 ----------------------------WMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL 267
Query: 209 SGMIPEG-LSVLGALKELDVSNNQL 232
+ ++P + L L+ + + +N
Sbjct: 268 T-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 16/95 (16%), Positives = 40/95 (42%), Gaps = 4/95 (4%)
Query: 9 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 67
+F+ ++ L + + + G + +++L+ + L +P+ + + +L
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEG--AFEGLSNLRYLNLAMCNLRE-IPNLTPLIKL 209
Query: 68 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 102
+ L L N + P S L L+ + M + +Q
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 40/198 (20%), Positives = 68/198 (34%), Gaps = 49/198 (24%)
Query: 42 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
T+ + + LH N + F ++ LE L L N + L +L + + +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 101 LQGPVPE--FDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 155
L +P F L + NN + ++
Sbjct: 124 LTT-IPNGAFVYLSKLKELWL---RNN-----------PIESI----------------- 151
Query: 156 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPE 214
P + + ++ ++ ++ IS F +L+ L LA NL IP
Sbjct: 152 ----PSYAFNRIP----SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN 202
Query: 215 GLSVLGALKELDVSNNQL 232
L+ L L ELD+S N L
Sbjct: 203 -LTPLIKLDELDLSGNHL 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 12/68 (17%), Positives = 27/68 (39%), Gaps = 1/68 (1%)
Query: 36 DVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
Q + L+++W+ + F ++ L ++L N T D L L+ +
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284
Query: 95 NMTNNLLQ 102
++ +N
Sbjct: 285 HLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 30/127 (23%), Positives = 51/127 (40%), Gaps = 25/127 (19%)
Query: 125 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC-------SDWIGVTCTKGNITVI 177
LPSPG L +LLSV+ + + C + + V C + N+ +
Sbjct: 4 LPSPGMPALLLVSLLSVLLMGCVAE-----TGSAQTCPSVCSCSNQFSKVICVRKNLREV 58
Query: 178 ------NFQKMNLTG----TISPE-FASFKSLQRLILADNNLSGMIPEG-LSVLGALKEL 225
N + +NL I F + L+ L L+ N++ I G + L L L
Sbjct: 59 PDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTL 117
Query: 226 DVSNNQL 232
++ +N+L
Sbjct: 118 ELFDNRL 124
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 13/70 (18%), Positives = 27/70 (38%), Gaps = 5/70 (7%)
Query: 187 TISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL----YGKIPSFKS 241
I P F LQ+L + + + + L +L E+++++N L +
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280
Query: 242 NAIVNTDGNP 251
++ NP
Sbjct: 281 LERIHLHHNP 290
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 17/61 (27%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 183 NLTGTISPE-FASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSNNQLYGKIPSFK 240
N +I F SL+RL L + I EG L L+ L+++ L +IP+
Sbjct: 146 NPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLT 204
Query: 241 S 241
Sbjct: 205 P 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 39/166 (23%)
Query: 401 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR-- 453
+++G+G FG V K + +A+K +I K F + E+ +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-----II--KNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 454 ----HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLK-------PLEWNRRLT 502
++V L H + N LVFE LS +++ + L+ L R+
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLY----DLLRNTNFRGVSLNLTRK-- 161
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFG 546
A + + +L S IH DLKP NILL + R+ K+ DFG
Sbjct: 162 FAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 43/236 (18%), Positives = 72/236 (30%), Gaps = 30/236 (12%)
Query: 8 LPASFSGSQIQSLWV--NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGV 64
L F ++ L + + SL + + F +S
Sbjct: 269 LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328
Query: 65 KQLESLSLRDN---FFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGS 120
++ L + F P S L N T N+ L
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFL---NFTQNVFTDSVFQGCSTLKRLQTLILQ 385
Query: 121 NNFC--LPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVI 177
N +++L V L D W +I V+
Sbjct: 386 RNGLKNFFKVALMTKNMSSLETLDVSLNSLN------SHAYDRTCAW------AESILVL 433
Query: 178 NFQKMNLTGTISPEFASF-KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
N LTG++ F ++ L L +N + IP+ ++ L AL+EL+V++NQL
Sbjct: 434 NLSSNMLTGSV---FRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 28/244 (11%), Positives = 69/244 (28%), Gaps = 16/244 (6%)
Query: 39 QNMTSLKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
M SL+ + L N F +F + +L L L F L+ + L + +
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCI 174
Query: 97 TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 156
+L+ + + + ++N ++ + + N +
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL-SNIKLNDE 233
Query: 157 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF---KSLQRLILADNNLSGMIP 213
++ + + Q + T S + F + ++ L + + ++ I
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293
Query: 214 EGL-----SVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQGSPSGS 268
+ L +L V N + + + + S
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMN-IKMLSISDTPFIHMVCPPS 351
Query: 269 PTGT 272
P+
Sbjct: 352 PSSF 355
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 29/203 (14%), Positives = 59/203 (29%), Gaps = 9/203 (4%)
Query: 37 VIQNMTSLKEIWLHSNAF-SGPLPDFSGVK-QLESLSLRDNFFTGPVPDSLVKLESLKIV 94
N+T L + L + F L + + L L G +SL + +
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
+ + V +L + SN C + L + + ++
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN--CQRLMTFLSELTRGPTLLNVTLQH 258
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG---- 210
+ CS + + +N + +T I E ++ L ++
Sbjct: 259 IETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL 318
Query: 211 MIPEGL-SVLGALKELDVSNNQL 232
E L SV + +S +
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDT 341
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 22/112 (19%), Positives = 41/112 (36%), Gaps = 16/112 (14%)
Query: 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGV 64
LP ++L ++ QN ++L I ++ L+ + L N L F
Sbjct: 49 DLPPR-----TKALSLS-QNSISELRMP--DISFLSELRVLRLSHNRIRS-LDFHVFLFN 99
Query: 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ--GPVPEFDRSVSL 114
+ LE L + N + + SL+ ++++ N EF L
Sbjct: 100 QDLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKL 148
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 25/114 (21%), Positives = 47/114 (41%), Gaps = 4/114 (3%)
Query: 11 SFSGSQIQSLWVNGQNGNAKLGGGIDVI-QNMTSLKEIWLHSNAFSGPLPDFSGVKQLES 69
+ + SL + N+ D S+ + L SN +G + +++
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKV 454
Query: 70 LSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNN 122
L L +N +P + L++L+ +N+ +N L+ P FDR SL +N
Sbjct: 455 LDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 37/232 (15%), Positives = 74/232 (31%), Gaps = 52/232 (22%)
Query: 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGV 64
GL + ++SL ++ N + +Q +L+ + L SN + + + FS +
Sbjct: 49 GLTEA-----VKSLDLSN-NRITYISNS--DLQRCVNLQALVLTSNGINT-IEEDSFSSL 99
Query: 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ--GPVPEFDRSVSLDMAKGSNN 122
LE L L N+ + L SL +N+ N + G F L + + N
Sbjct: 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159
Query: 123 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM 182
+ L +
Sbjct: 160 DTFTKIQR-----KDFAGLTFL------------------------------EELEIDAS 184
Query: 183 NLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNNQL 232
+L + P+ S +++ LIL ++ E V +++ L++ + L
Sbjct: 185 DLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDL 234
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 27/201 (13%), Positives = 64/201 (31%), Gaps = 44/201 (21%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
++T L+ + + + + F+G+ LE L + + P SL ++++ + +
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 97 TNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
+ E D + S++ + + + L +
Sbjct: 206 HMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFH------FSELSTGE------------ 246
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTG----TISPEFASFKSLQRLILADNNLSG 210
T I F+ + +T + L L + N L
Sbjct: 247 ---------------TNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK- 290
Query: 211 MIPEG-LSVLGALKELDVSNN 230
+P+G L +L+++ + N
Sbjct: 291 SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 27/202 (13%), Positives = 62/202 (30%), Gaps = 35/202 (17%)
Query: 36 DVIQNMTSLKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPD-SLVKLESLK 92
+ ++SL + L N + G FS + +L+ L + + + L L+
Sbjct: 118 SWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE 177
Query: 93 IVNMTNNLLQG-PVPEFDRSVSLDMAK-GSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 150
+ + + LQ ++ L D +++ +
Sbjct: 178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD-VTSSVECL--------E 228
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
+ + F L+ + + + + + D +L
Sbjct: 229 LRDTD--------------------LDTFHFSELSTGETNSLIKKFTFRNVKITDESLF- 267
Query: 211 MIPEGLSVLGALKELDVSNNQL 232
+ + L+ + L EL+ S NQL
Sbjct: 268 QVMKLLNQISGLLELEFSRNQL 289
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 11/88 (12%), Positives = 32/88 (36%), Gaps = 2/88 (2%)
Query: 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDN 75
+++ ++ + + G + + + + + + + + + + L L N
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287
Query: 76 FFTGPVPDSLVK-LESLKIVNMTNNLLQ 102
VPD + L SL+ + + N
Sbjct: 288 QLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 43/166 (25%)
Query: 402 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR--- 453
++G+G FG V K +A+K ++ + F EI +L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK-----MV--RNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 454 ---HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-LKPLEWNRRLT 502
+++ +L H C+ FE LS +++ ++ +
Sbjct: 157 NTMNVIHMLENFTFRNHICM-------TFEL-----LSMNLYELIKKNKFQGFSLPLVRK 204
Query: 503 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFG 546
A + + ++ LH IH DLKP NILL R+ KV DFG
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 42/200 (21%), Positives = 71/200 (35%), Gaps = 38/200 (19%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
+ +QN + LK I + +N+ LPD LE ++ +N L L L +
Sbjct: 146 LPELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLE--ELPELQNLPFLTAI 200
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNF-CLPSPGACDPRLNAL-LSVVKLMGYPQRFA 152
NN L+ S+ G+N LP P L + L P
Sbjct: 201 YADNNSLKKLPDLPLSLESIVA--GNNILEELPELQNL-PFLTTIYADNNLLKTLP---- 253
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
D ++ +N + LT + +SL L +++N SG +
Sbjct: 254 ----------DLP------PSLEALNVRDNYLT-DLPEL---PQSLTFLDVSENIFSG-L 292
Query: 213 PEGLSVLGALKELDVSNNQL 232
E + L L+ S+N++
Sbjct: 293 SE---LPPNLYYLNASSNEI 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 39/198 (19%), Positives = 67/198 (33%), Gaps = 38/198 (19%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+ SL+ I +N LP+ + L ++ +N +PD LE+L N
Sbjct: 209 KLPDLPLSLESIVAGNNILEE-LPELQNLPFLTTIYADNNLLKT-LPDLPPSLEAL---N 263
Query: 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAEN 154
+ +N L LD+++ + L P L L S ++
Sbjct: 264 VRDNYLTDLPELPQSLTFLDVSENIFS-GLSE---LPPNLYYLNASSNEIRSLCDLP--- 316
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
++ +N L + L+RLI + N+L+ +PE
Sbjct: 317 -----------------PSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE 354
Query: 215 GLSVLGALKELDVSNNQL 232
LK+L V N L
Sbjct: 355 LP---QNLKQLHVEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 42/200 (21%), Positives = 73/200 (36%), Gaps = 40/200 (20%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+ SL+ I +N LP+ + L ++ +N +PD + LES+
Sbjct: 167 KLPDLPPSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLKK-LPDLPLSLESI---V 221
Query: 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNF--CLPSPGACDPRLNAL-LSVVKLMGYPQRFA 152
NN+L+ PE L NN LP P L AL + L P+
Sbjct: 222 AGNNILEEL-PELQNLPFLTTIYADNNLLKTLPDLP---PSLEALNVRDNYLTDLPELP- 276
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
++T ++ + + +S +L L + N + +
Sbjct: 277 -------------------QSLTFLDVSENIFS-GLS---ELPPNLYYLNASSNEIRS-L 312
Query: 213 PEGLSVLGALKELDVSNNQL 232
+ +L+EL+VSNN+L
Sbjct: 313 CDLPP---SLEELNVSNNKL 329
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 39/208 (18%), Positives = 67/208 (32%), Gaps = 51/208 (24%)
Query: 42 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101
E+ L++ S LP+ LESL N T +P+ L+SL + N L
Sbjct: 71 RQAHELELNNLGLS-SLPEL--PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 102 QGPVPEFDRSVSLDMAKGSNNF--CLPSPGAC------DPRLNALLSVVKLMGYPQRFAE 153
+P + + SNN LP D N+L + L
Sbjct: 127 SD-LPPLLEYLGV-----SNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPP------- 173
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
++ I L + PE + L + +N+L +
Sbjct: 174 -------------------SLEFIAAGNNQLE-EL-PELQNLPFLTAIYADNNSLKKLPD 212
Query: 214 EGLSVLGALKELDVSNNQLYGKIPSFKS 241
+L+ + NN L ++P ++
Sbjct: 213 L----PLSLESIVAGNNIL-EELPELQN 235
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 40/200 (20%), Positives = 68/200 (34%), Gaps = 41/200 (20%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
++ Q++ SL + A S P LE L + +N +P+ L LKI++
Sbjct: 108 ELPQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNNQLEK-LPE-LQNSSFLKIID 159
Query: 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNF--CLPSPGACDPRLNAL-LSVVKLMGYPQRFA 152
+ NN L+ + NN LP P L A+ L P
Sbjct: 160 VDNNSLKKLPDLPPSLEFIAA---GNNQLEELPELQNL-PFLTAIYADNNSLKKLPDLP- 214
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
++ I N+ + PE + L + +N L +
Sbjct: 215 -------------------LSLESIVAGN-NILEEL-PELQNLPFLTTIYADNNLLK-TL 252
Query: 213 PEGLSVLGALKELDVSNNQL 232
P+ +L+ L+V +N L
Sbjct: 253 PDL---PPSLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 33/216 (15%), Positives = 65/216 (30%), Gaps = 68/216 (31%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLPDFSG--------------VKQLESLSLRDNFFTGPVPD 83
+N+ S E + + + P +G +Q L L + + +P+
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE 88
Query: 84 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK 143
LESL N+L + P SL + + L+ L
Sbjct: 89 LPPHLESLVASC--NSLTELP-ELPQSLKSLLVDNNNLK-----------ALSDLPP--- 131
Query: 144 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 203
+ + L + PE + L+ + +
Sbjct: 132 -----------------------------LLEYLGVSNNQLE-KL-PELQNSSFLKIIDV 160
Query: 204 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 239
+N+L +P+ +L+ + NNQL ++P
Sbjct: 161 DNNSLK-KLPDL---PPSLEFIAAGNNQL-EELPEL 191
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 32/226 (14%), Positives = 59/226 (26%), Gaps = 54/226 (23%)
Query: 13 SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLS 71
+ D ++ L+ + + + LPD LE+L+
Sbjct: 89 RSVPLPQFP--------------DQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLT 133
Query: 72 LRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 131
L N +P S+ L L+ +++ +PE
Sbjct: 134 LARNPLRA-LPASIASLNRLRELSIRACPELTELPE--------------PLASTDASGE 178
Query: 132 DPRLNAL----LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 187
L L L + P N + N+ + + L+
Sbjct: 179 HQGLVNLQSLRLEWTGIRSLPASI-ANLQ----------------NLKSLKIRNSPLS-A 220
Query: 188 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN-NQL 232
+ P L+ L L P LK L + + + L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 9e-07
Identities = 35/213 (16%), Positives = 66/213 (30%), Gaps = 48/213 (22%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDN---------FFTGPVPDSL 85
D +Q L+ + L N LP + + +L LS+R +
Sbjct: 121 DTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 86 VKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLM 145
L +L+ + + ++ +L K N+ L+AL
Sbjct: 180 QGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNS-----------PLSAL------- 221
Query: 146 GYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILAD 205
+ I + ++ + P F L+RLIL D
Sbjct: 222 --------------GPA--IH-HLP--KLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262
Query: 206 NNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
+ +P + L L++LD+ ++PS
Sbjct: 263 CSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 5/96 (5%)
Query: 8 LPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVK 65
L + +++ L + G + LK + L + LP +
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNY---PPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 66 QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101
QLE L LR +P + +L + I+ + +L
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 19/109 (17%), Positives = 46/109 (42%), Gaps = 12/109 (11%)
Query: 8 LPASFSG-SQIQSLWVNGQNGNAKL------GGGIDVIQNMTSLKEIWLHSNAFSGPLPD 60
LPAS + ++++ L + +L Q + +L+ + L LP
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPA 200
Query: 61 -FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT-NNLLQGPVPE 107
+ ++ L+SL +R++ + + ++ L L+ +++ L+ P
Sbjct: 201 SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN-YPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 17/168 (10%), Positives = 40/168 (23%), Gaps = 40/168 (23%)
Query: 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFC 124
E+L + + P D L + + + + ++ G
Sbjct: 12 SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-SNNPQIETRTGRALKA 70
Query: 125 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 184
D + T+ + + + L
Sbjct: 71 TA------------------------------------DLLED-ATQPGRVALELRSVPL 93
Query: 185 TGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ LQ + + L +P+ + L+ L ++ N L
Sbjct: 94 P-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPL 139
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 31/236 (13%), Positives = 68/236 (28%), Gaps = 41/236 (17%)
Query: 8 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQ 66
+ S + ++ + L S PD +
Sbjct: 48 SAWRQANSNNPQIETRTGRALKATADLLE-DATQPGRVALELRSVPLPQ-FPDQAFRLSH 105
Query: 67 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSL---DMAKGSNN 122
L+ +++ +PD++ + L+ + + N L+ P L +
Sbjct: 106 LQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRALP-ASIASLNRLRELSIRACPEL 163
Query: 123 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM 182
LP P A +A L N+ + +
Sbjct: 164 TELPEPLA---STDASGEHQGL---------------------------VNLQSLRLEWT 193
Query: 183 NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
+ ++ A+ ++L+ L + ++ LS + + L L+ELD+ P
Sbjct: 194 GIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 27/217 (12%), Positives = 59/217 (27%), Gaps = 58/217 (26%)
Query: 31 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 90
+G + + + ++ + P D + Q + D +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHD--VLSQWQRHYNADRNRWHS-AWRQANSNN 57
Query: 91 LKIVNMTNNLLQGPVPEFDRS-----VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLM 145
+I T L+ + + V+L++ + L
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALEL---RSV-----------PLPQF------- 96
Query: 146 GYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG----TISPEFASFKSLQRL 201
P + ++ + Q M + + F L+ L
Sbjct: 97 --PDQA--------------------FRLS--HLQHMTIDAAGLMELPDTMQQFAGLETL 132
Query: 202 ILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
LA N L +P ++ L L+EL + ++P
Sbjct: 133 TLARNPLRA-LPASIASLNRLRELSIRACPELTELPE 168
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 35/201 (17%), Positives = 67/201 (33%), Gaps = 20/201 (9%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97
+ + +L + H+++ + + + L L N T L L +
Sbjct: 38 EEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDS-- 94
Query: 98 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL------LSVVKLMGYPQRF 151
N L V + L+ N + +P L L L+ + + Q
Sbjct: 95 NKLTNLDVTPLTKLTYLNC---DTNKLTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLT 151
Query: 152 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 211
+ N + T +T ++ +T + + K L RL NN++
Sbjct: 152 ELDCHLNKKITKLDVTPQT--QLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNNIT-K 205
Query: 212 IPEGLSVLGALKELDVSNNQL 232
+ L+ L LD S+N+L
Sbjct: 206 LD--LNQNIQLTFLDCSSNKL 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 30/195 (15%), Positives = 54/195 (27%), Gaps = 51/195 (26%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97
+ L + SN + D + + QL N T + S L L ++
Sbjct: 208 LNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCI 262
Query: 98 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157
L +D+ ++N L A R L V
Sbjct: 263 QTDLL----------EIDL---THNTQLIYFQAEGCRKIKELDVTHNT------------ 297
Query: 158 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 217
+ +++ Q +T + + L L L + L+ + +S
Sbjct: 298 ---------------QLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VS 336
Query: 218 VLGALKELDVSNNQL 232
LK L N +
Sbjct: 337 HNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 32/206 (15%), Positives = 50/206 (24%), Gaps = 52/206 (25%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97
+ +T L + +N + D S L L+ N T +L L
Sbjct: 102 VTPLTKLTYLNCDTNKLTKL--DVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHL-- 157
Query: 98 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157
N + + L S N + + LN L
Sbjct: 158 NKKIT--KLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRL------------------- 196
Query: 158 NDPCSDWIGVTCTKGNITVINFQKM-----------NLTGTISPEFASFKSLQRLILADN 206
C NIT ++ + LT + L + N
Sbjct: 197 ----------NCDTNNITKLDLNQNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVN 243
Query: 207 NLSGMIPEGLSVLGALKELDVSNNQL 232
L+ + LS L L L
Sbjct: 244 PLTELDVSTLS---KLTTLHCIQTDL 266
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 34/207 (16%), Positives = 57/207 (27%), Gaps = 62/207 (29%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+ + L LP L L + N T +P L+ L +
Sbjct: 98 VLPPGLLELSIFSNPLTHLP-ALPS-----GLCKLWIFGNQLTS-LPVLPPGLQEL---S 147
Query: 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 155
+++N L L NN +L +L P
Sbjct: 148 VSDNQLASLPALPSELCKLWA---YNN-----------QLTSL---------PMLP---- 180
Query: 156 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 215
+ ++ L ++ + L +L +N L+ +P
Sbjct: 181 ----------------SGLQELSVSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPAL 219
Query: 216 LSVLGALKELDVSNNQLYGKIPSFKSN 242
LKEL VS N+L +P S
Sbjct: 220 ---PSGLKELIVSGNRL-TSLPVLPSE 242
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 33/192 (17%), Positives = 61/192 (31%), Gaps = 39/192 (20%)
Query: 42 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101
+ + + + LPD + +L + DN T +P +L +L++ N L
Sbjct: 40 NGNAVLNVGESGLTT-LPDCLP-AHITTLVIPDNNLTS-LPALPPELRTLEVSG--NQLT 94
Query: 102 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDP 160
P + L + P L L + +L P
Sbjct: 95 SLP-VLPPGLLELSIFSNPLTHLPALPSG----LCKLWIFGNQLTSLPVLP--------- 140
Query: 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 220
+ ++ L ++ + L +L +N L+ +P
Sbjct: 141 -----------PGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLP---S 181
Query: 221 ALKELDVSNNQL 232
L+EL VS+NQL
Sbjct: 182 GLQELSVSDNQL 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 35/198 (17%), Positives = 64/198 (32%), Gaps = 47/198 (23%)
Query: 41 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
L+E+ + N + LP +L L +N T +P L+ L ++++N
Sbjct: 140 PPGLQELSVSDNQLAS-LPA--LPSELCKLWAYNNQLTS-LPMLPSGLQEL---SVSDNQ 192
Query: 101 LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL------LSVVKLMGYPQRFAEN 154
L L NN RL +L L + + + N
Sbjct: 193 LASLPTLPSELYKLWA---YNN-----------RLTSLPALPSGLKELIV-------SGN 231
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
+ P + + LT ++ + L L + N L+ +PE
Sbjct: 232 RLTSLPVL--------PSELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPE 278
Query: 215 GLSVLGALKELDVSNNQL 232
L L + +++ N L
Sbjct: 279 SLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 19/64 (29%), Positives = 29/64 (45%), Gaps = 7/64 (10%)
Query: 169 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 228
C V+N + LT T+ + L++ DNNL+ +P L+ L+VS
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALP---PELRTLEVS 89
Query: 229 NNQL 232
NQL
Sbjct: 90 GNQL 93
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 29/115 (25%), Positives = 41/115 (35%), Gaps = 5/115 (4%)
Query: 41 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
+ LKE+ + N + LP L SLS+ N T +P+SL+ L S VN+ N
Sbjct: 240 PSELKELMVSGNRLTS-LPMLPS--GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNP 295
Query: 101 LQGPVPEFDRS-VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
L + R S G + + AL P R E
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 43/229 (18%), Positives = 68/229 (29%), Gaps = 55/229 (24%)
Query: 8 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 67
LP + L + + + L ++W+ N + LP L
Sbjct: 96 LPVLPP--GLLELSIFSNPLT-------HLPALPSGLCKLWIFGNQLTS-LPVLPP--GL 143
Query: 68 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF--CL 125
+ LS+ DN +P +L L N N L P L + S+N L
Sbjct: 144 QELSVSDNQLAS-LPALPSELCKLWAYN--NQLTSLP-MLPSGLQELSV---SDNQLASL 196
Query: 126 P-SPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
P P L L +L P + +
Sbjct: 197 PTLPS----ELYKLWAYNNRLTSLPALP--------------------SGLKELIVSGNR 232
Query: 184 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
LT ++ L+ L+++ N L+ +P L L V NQL
Sbjct: 233 LT-SLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQL 273
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 44/233 (18%), Positives = 72/233 (30%), Gaps = 53/233 (22%)
Query: 5 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGV 64
+ LP +Q L V+ N A L + L ++W ++N + LP
Sbjct: 133 LTSLPVLPP--GLQELSVSD-NQLASLPALP------SELCKLWAYNNQLTS-LPM--LP 180
Query: 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV-SLDMAKGSNNF 123
L+ LS+ DN +P +L L N N L +P + L + S N
Sbjct: 181 SGLQELSVSDNQLAS-LPTLPSELYKLWAYN--NRLTS--LPALPSGLKELIV---SGNR 232
Query: 124 --CLP-SPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 179
LP P L L +S +L P + ++
Sbjct: 233 LTSLPVLPS----ELKELMVSGNRLTSLPMLP--------------------SGLLSLSV 268
Query: 180 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ LT + S + L N LS + L + + +
Sbjct: 269 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ---ALREITSAPGYSGPI 317
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 25/203 (12%), Positives = 57/203 (28%), Gaps = 8/203 (3%)
Query: 39 QNMTSLKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV-N 95
+LK + L NAF +F + QL+ L L + L K++
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 155
+ + PE + + + D + + ++
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 156 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 215
+ N+T+ N + + + ++ +++ L G +
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 216 L-----SVLGALKELDVSNNQLY 233
+ L AL V ++
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFG 289
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 29/233 (12%), Positives = 65/233 (27%), Gaps = 47/233 (20%)
Query: 8 LPASFSGSQIQSLWV--NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGV 64
+ + + + G ++ +L + S+ F P +
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 65 KQLESLSLRDN---FFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGS 120
+ + + P + L + +NNLL L+
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHL---DFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 121 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 180
N +L L S +T ++ ++
Sbjct: 357 MN-----------QLKEL-----------------------SKIAEMTTQMKSLQQLDIS 382
Query: 181 KMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+ +++ + KSL L ++ N L+ I L +K LD+ +N++
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 50/287 (17%), Positives = 88/287 (30%), Gaps = 64/287 (22%)
Query: 9 PASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH-SNAFSGPLPDFSGVKQL 67
+SG+ +++L ++ + + + +++ S + S +
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 68 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ---GPVPEFDRSVSLDMAKGSNNF- 123
L +N T V ++ L L+ + + N L+ + SL S N
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSV 386
Query: 124 -CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM 182
G C +L +N
Sbjct: 387 SYDEKKGDCS-WTKSL------------------------------------LSLNMSSN 409
Query: 183 NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP----- 237
LT TI ++ L L N + IP+ + L AL+EL+V++NQL +P
Sbjct: 410 ILTDTIFRCLPP--RIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQL-KSVPDGIFD 465
Query: 238 SFKSNAIVNTDGNP------DIG------KEKSSSFQGSPSGSPTGT 272
S + NP I + S QGS S +G
Sbjct: 466 RLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGSGK 512
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 32/146 (21%), Positives = 58/146 (39%), Gaps = 28/146 (19%)
Query: 3 QLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD- 60
L + + +++++L + N +L ++ M SL+++ + N+ S
Sbjct: 335 LLTDTVFENCGHLTELETLILQM-NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 61 -FSGVKQLESLSLRDNFFTGPVPDSLV---------------------KLESLKIVNMTN 98
S K L SL++ N T + L KLE+L+ +N+ +
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVAS 453
Query: 99 NLLQGPVPE--FDRSVSLDMAKGSNN 122
N L+ VP+ FDR SL N
Sbjct: 454 NQLKS-VPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 36/231 (15%), Positives = 64/231 (27%), Gaps = 39/231 (16%)
Query: 37 VIQNMTSLKEIWLHSNAF-SGPLPDFSGVKQLE-SLSLRDNFFTGPVPDSLVKL--ESLK 92
NM+ LK + L + + + + + L L + + P+ L ESL
Sbjct: 110 EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLH 169
Query: 93 IVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRF 151
IV TN + +L++ SN C+ C L+ L +
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLEL---SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
Query: 152 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-------------------- 191
N + I + + + L G +
Sbjct: 227 LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD 286
Query: 192 ---------FASFKSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNNQL 232
+ F ++ + M+ S + LD SNN L
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLL 336
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 35/202 (17%), Positives = 74/202 (36%), Gaps = 28/202 (13%)
Query: 43 SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGP-----VPDSLVKLESLKIVNMT 97
+L I N+F L + S+ + G S L++L I +
Sbjct: 226 TLNNIETTWNSFIRILQ-LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
Query: 98 NNLLQGPVPE-FDRSVSLDMAK--GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
+++ P ++ ++++ S + C +++ L + F+ N
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHL--------DFSNN 334
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE---FASFKSLQRLILADNNLSGM 211
+ + +T + + Q L +S KSLQ+L ++ N++S
Sbjct: 335 LLTDTVFENCGHLT----ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYD 389
Query: 212 IPEGL-SVLGALKELDVSNNQL 232
+G S +L L++S+N L
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNIL 411
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 16/112 (14%)
Query: 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGV 64
L L ++ QN ++L I +++ L+ + + N L F
Sbjct: 18 DLSQK-----TTILNIS-QNYISELWTS--DILSLSKLRILIISHNRIQY-LDISVFKFN 68
Query: 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ--GPVPEFDRSVSL 114
++LE L L N V L+ L +++ N EF L
Sbjct: 69 QELEYLDLSHNKLVKISCHPTVNLKHL---DLSFNAFDALPICKEFGNMSQL 117
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 45/156 (28%), Positives = 63/156 (40%), Gaps = 38/156 (24%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF-KSEIAVLTKVR--------H 452
LG G F TV+ + +A+K V S + TE EI +L VR
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 453 RHLVALLGH-----------CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 501
+V LL C+ VFE + L + I +GL PL ++
Sbjct: 101 EMVVQLLDDFKISGVNGTHICM-------VFEVL-GHHLLKWIIKSNYQGL-PLPCVKK- 150
Query: 502 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537
I V +G++YLH IH D+KP NILL +
Sbjct: 151 -IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN 183
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 48/219 (21%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
D + + L + L +N S + + FS +++L+ L + N +P +L SL
Sbjct: 72 DDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVE 127
Query: 94 VNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRF 151
+ + +N ++ VP+ F +++ + N L + G +P L + L R
Sbjct: 128 LRIHDNRIRK-VPKGVFSGLRNMNCIEMGGN-PLENSGF-EPGAFDGLKLNYL-----RI 179
Query: 152 AENWKGNDPCSDWIGVTCTKGNITVI------NFQKMNLTG----TISPE-FASFKSLQR 200
+E +T I +++L I E + L R
Sbjct: 180 SEA------------------KLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYR 221
Query: 201 LILADNNLSGMIPEG-LSVLGALKELDVSNNQLYGKIPS 238
L L N + MI G LS L L+EL + NN+L ++P+
Sbjct: 222 LGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPA 258
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 38/196 (19%), Positives = 66/196 (33%), Gaps = 25/196 (12%)
Query: 42 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
+ L +N S DF G++ L +L L +N + + L L+ + ++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 101 LQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL-MGYPQRFAENWKGN 158
L P V L + N G + L ++ + MG GN
Sbjct: 114 LVEIPPNLPSSLVELRIH--DNRIRKVPKGV----FSGLRNMNCIEMG----------GN 157
Query: 159 DPCSDWIGVTCTKG-NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG-L 216
+ G + + + LT I + ++L L L N + I L
Sbjct: 158 PLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKD--LPETLNELHLDHNKIQ-AIELEDL 213
Query: 217 SVLGALKELDVSNNQL 232
L L + +NQ+
Sbjct: 214 LRYSKLYRLGLGHNQI 229
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 15/69 (21%), Positives = 29/69 (42%), Gaps = 4/69 (5%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+ + + L + L N + + S + L L L +N + VP L L+ L++
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQV 268
Query: 94 VNMTNNLLQ 102
V + N +
Sbjct: 269 VYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 28/202 (13%), Positives = 57/202 (28%), Gaps = 29/202 (14%)
Query: 42 TSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFT-GPVPDSLVKLESLKIVNMTN 98
+SL E+ +H N +P FSG++ + + + N L + ++
Sbjct: 123 SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 99 NLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157
L G P + L + N L + +L N
Sbjct: 182 AKLTGIPKDLPETLNELHLD--HNKIQAIELED----LLRYSKLYRL-----GLGHNQIR 230
Query: 158 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG-- 215
+ + ++ L+ + K LQ + L NN++ +
Sbjct: 231 MIENGSLSFLP----TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDF 284
Query: 216 -----LSVLGALKELDVSNNQL 232
+ + NN +
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPV 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 39/196 (19%), Positives = 66/196 (33%), Gaps = 24/196 (12%)
Query: 42 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
+ L +N + DF +K L +L L +N + P + L L+ + ++ N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 101 LQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159
L+ P L + N N L ++ + N
Sbjct: 112 LKELPEKMPKTLQELRVH--ENEITKVRKSV----FNGLNQMIVV---------ELGTNP 156
Query: 160 PCSDWIGVTCTKG--NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG-L 216
S I +G ++ I N+T TI SL L L N ++ + L
Sbjct: 157 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKIT-KVDAASL 212
Query: 217 SVLGALKELDVSNNQL 232
L L +L +S N +
Sbjct: 213 KGLNNLAKLGLSFNSI 228
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 30/210 (14%), Positives = 68/210 (32%), Gaps = 31/210 (14%)
Query: 42 TSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPV--PDSLVKLESLKIVNMT 97
+L+E+ +H N + + F+G+ Q+ + L N + ++ L + +
Sbjct: 121 KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 98 NNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 156
+ + P L + N + L L ++ KL + N
Sbjct: 180 DTNITTIPQGLPPSLTELHLD--GNKITKVDAAS----LKGLNNLAKL-----GLSFNSI 228
Query: 157 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG- 215
++ ++ L + A K +Q + L +NN+S I
Sbjct: 229 SAVDNGSLANTP----HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSND 282
Query: 216 ------LSVLGALKELDVSNNQL-YGKIPS 238
+ + + + +N + Y +I
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 34/208 (16%), Positives = 64/208 (30%), Gaps = 55/208 (26%)
Query: 39 QNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM- 96
+ L+ ++L N P L+ L + +N T L + +V +
Sbjct: 97 APLVKLERLYLSKNQLKELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQMIVVELG 153
Query: 97 TNNLLQGPVPE--FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRF 151
TN L + F L +A N G
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIA--DTNITTIPQGL--------------------P 191
Query: 152 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSG 210
++T ++ +T + +L +L L+ N++S
Sbjct: 192 P--------------------SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA 230
Query: 211 MIPEGLSVLGALKELDVSNNQLYGKIPS 238
+ L+ L+EL ++NN+L K+P
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPG 257
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 10/101 (9%)
Query: 9 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 67
AS G + + L ++ N + + G + N L+E+ L++N + K +
Sbjct: 209 AASLKGLNNLAKLGLSF-NSISAVDNG--SLANTPHLRELHLNNNKLVKVPGGLADHKYI 265
Query: 68 ESLSLRDNFFTG------PVPDSLVKLESLKIVNMTNNLLQ 102
+ + L +N + P K S V++ +N +Q
Sbjct: 266 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 34/172 (19%), Positives = 59/172 (34%), Gaps = 40/172 (23%)
Query: 402 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR--- 453
+G G FG V + + + AVK V+ + + ++ K E +L K+++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK-----VV--RNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 454 --HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTI 503
++V H CL +FE L ++
Sbjct: 95 NNNIVKYHGKFMYYDHMCL-------IFE-----PLGPSLYEIITRNNYNGFHIEDIKLY 142
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+++ + + YL + S H DLKP NILL D K +
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 32/198 (16%), Positives = 70/198 (35%), Gaps = 46/198 (23%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
I+ +Q + +L + L N + L + ++ L L N ++ L+S+K +
Sbjct: 56 IEGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTL 112
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
++T+ + V +L + N ++ + + L
Sbjct: 113 DLTSTQITD-VTPLAGLSNLQVLYLDLN-----------QITNISPLAGLT--------- 151
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
N+ ++ ++ ++P A+ L L DN +S +
Sbjct: 152 ------------------NLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDI--S 189
Query: 215 GLSVLGALKELDVSNNQL 232
L+ L L E+ + NNQ+
Sbjct: 190 PLASLPNLIEVHLKNNQI 207
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 34/220 (15%), Positives = 77/220 (35%), Gaps = 47/220 (21%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
+ ++N+T + E+ L N + +G++ +++L L T P L L +L+++
Sbjct: 78 LAPLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL 134
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
+ N + + +L N +++ L + L
Sbjct: 135 YLDLNQITN-ISPLAGLTNLQYLSIGNA-----------QVSDLTPLANL---------- 172
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
+T + ++ ISP AS +L + L +N +S +
Sbjct: 173 -----------------SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--S 211
Query: 215 GLSVLGALKELDVSNNQLYGKIPSFKSN-AIVNTDGNPDI 253
L+ L + ++N + + + +N + N P
Sbjct: 212 PLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 34/209 (16%), Positives = 63/209 (30%), Gaps = 47/209 (22%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
++ + + + + + L L L+DN T P L L +
Sbjct: 33 DTVTQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITE 89
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153
+ ++ N L+ V S+ ++ + V L G
Sbjct: 90 LELSGNPLKN-VSAIAGLQSIKTLDLTST--------------QITDVTPLAGLS----- 129
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
N+ V+ +T ISP A +LQ L + + +S +
Sbjct: 130 -------------------NLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL-- 166
Query: 214 EGLSVLGALKELDVSNNQLYGKIPSFKSN 242
L+ L L L +N++ I S
Sbjct: 167 TPLANLSKLTTLKADDNKI-SDISPLASL 194
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 26/193 (13%), Positives = 63/193 (32%), Gaps = 46/193 (23%)
Query: 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
+ + +I + + + + + + +LS T + + L +L + + +N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 100 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159
+ + + + S N L + ++ L
Sbjct: 74 QITD-LAPLKNLTKITELELSGN-----------PLKNVSAIAGL--------------- 106
Query: 160 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 219
+I ++ +T ++P A +LQ L L N ++ + L+ L
Sbjct: 107 ------------QSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNI--SPLAGL 150
Query: 220 GALKELDVSNNQL 232
L+ L + N Q+
Sbjct: 151 TNLQYLSIGNAQV 163
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 4e-06
Identities = 30/198 (15%), Positives = 60/198 (30%), Gaps = 22/198 (11%)
Query: 37 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDN--FFTGPVPDSLVKLESLKIV 94
+ S KE L + D + +QL L +S +L+ L+
Sbjct: 321 IWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPE 380
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
N L + + + S +K + + +
Sbjct: 381 NKWCLLTIILLMRALDPLLYE-----------------KETLQYFSTLKAVDPMRAAYLD 423
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
+ + + ++ V++ +LT + + L L+ N L +P
Sbjct: 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLRA-LPP 480
Query: 215 GLSVLGALKELDVSNNQL 232
L+ L L+ L S+N L
Sbjct: 481 ALAALRCLEVLQASDNAL 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 21/84 (25%), Positives = 39/84 (46%), Gaps = 8/84 (9%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
+T ++ L + P A+ + L+ L +DN L + +G++ L L+EL + NN+L
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRL 520
Query: 233 -----YGKIPSFKSNAIVNTDGNP 251
+ S ++N GN
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNS 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 15/68 (22%), Positives = 28/68 (41%), Gaps = 2/68 (2%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
+ ++ + + + L N P + ++ LE L DN D + L L+ +
Sbjct: 456 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE--NVDGVANLPRLQEL 513
Query: 95 NMTNNLLQ 102
+ NN LQ
Sbjct: 514 LLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 5e-04
Identities = 13/66 (19%), Positives = 26/66 (39%), Gaps = 2/66 (3%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNM 96
+ + L+ + NA + + + +L+ L L +N LV L ++N+
Sbjct: 482 LAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 540
Query: 97 TNNLLQ 102
N L
Sbjct: 541 QGNSLC 546
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 42/176 (23%)
Query: 402 ILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR-- 453
LG G FG V + H K +A+K +I + + ++ + EI VL K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALK-----II--RNVGKYREAARLEINVLKKIKEKDK 78
Query: 454 ----HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRL 501
V + GH C+ FE L ++ F + +E +P
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKENNFQPYPLPHVR 126
Query: 502 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557
+A + + +LH H DLKP NIL + + + K +
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 47/292 (16%), Positives = 76/292 (26%), Gaps = 74/292 (25%)
Query: 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGV 64
LP S ++L ++ N LG + L+ + L + D + +
Sbjct: 25 NLPFS-----TKNLDLSF-NPLRHLGSY--SFFSFPELQVLDLSRCEIQT-IEDGAYQSL 75
Query: 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNNF 123
L +L L N + L SL+ + L +L ++N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 124 --CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 181
P L L ++
Sbjct: 136 IQSFKLPEYFS-NLTNL------------------------------------EHLDLSS 158
Query: 182 MNLTGTISPE-FASFKSLQ----RLILADNNLSGMIPEGLSVLGALKELDVSNNQL---- 232
+ +I + L L+ N ++ I G LKEL + NQL
Sbjct: 159 NKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVP 216
Query: 233 YGKIPSFKSNAIVNTDGNP------DIG------KEKSSSFQGSPSGSPTGT 272
G S + NP I + S QGS S +G
Sbjct: 217 DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGSGK 268
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 16/89 (17%)
Query: 159 DPCS---DWIGVTCTKGNITVI------NFQKMNLTG----TISPE-FASFKSLQRLILA 204
+PC I C + N I + + ++L+ + F SF LQ L L+
Sbjct: 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 205 DNNLSGMIPEGL-SVLGALKELDVSNNQL 232
+ I +G L L L ++ N +
Sbjct: 61 RCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 41/197 (20%), Positives = 60/197 (30%), Gaps = 50/197 (25%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 98
+ SLK + + +N + LP+ LE ++ +N T +P+ LE L ++ N
Sbjct: 117 ELPASLKHLDVDNNQLTM-LPELPA--LLEYINADNNQLTM-LPELPTSLEVL---SVRN 169
Query: 99 NLLQGPVPEFDRSVSLDMAKGSNNF--CLP-SPGACDPRLNALLSVVKLMGYPQRFAENW 155
N L + +LD+ S N LP P + EN
Sbjct: 170 NQLTFLPELPESLEALDV---STNLLESLPAVPVRN-HHSEETEIFFRC-------REN- 217
Query: 156 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 215
IT I S +IL DN LS I E
Sbjct: 218 -----------------RIT-----------HIPENILSLDPTCTIILEDNPLSSRIRES 249
Query: 216 LSVLGALKELDVSNNQL 232
LS A +
Sbjct: 250 LSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 42/192 (21%), Positives = 62/192 (32%), Gaps = 57/192 (29%)
Query: 41 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
+ E+ L+ S LPD Q+ L + N +P+ LE L + N L
Sbjct: 58 INQFSELQLNRLNLSS-LPDNLP-PQITVLEITQNALI-SLPELPASLEYLDACD--NRL 112
Query: 101 LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 160
P LD+ NN +L L
Sbjct: 113 STLP-ELPASLKHLDV---DNN-----------QLTML---------------------- 135
Query: 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 220
+ + IN LT PE SL+ L + +N L+ +PE +
Sbjct: 136 -PELPA------LLEYINADNNQLTML--PE--LPTSLEVLSVRNNQLTF-LPE---LPE 180
Query: 221 ALKELDVSNNQL 232
+L+ LDVS N L
Sbjct: 181 SLEALDVSTNLL 192
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 13/64 (20%), Positives = 27/64 (42%), Gaps = 7/64 (10%)
Query: 169 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 228
C + + ++NL+ ++ + L + N L +PE +L+ LD
Sbjct: 56 CLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPEL---PASLEYLDAC 108
Query: 229 NNQL 232
+N+L
Sbjct: 109 DNRL 112
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 15/98 (15%), Positives = 34/98 (34%), Gaps = 8/98 (8%)
Query: 41 MTSLKEIWLHSNAFSGPLPDFSG-----VKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
SL+ + + +N LP + R+N T +P++++ L+ +
Sbjct: 179 PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTII 236
Query: 96 MTNN-LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACD 132
+ +N L + + G + S G +
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 11/107 (10%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
D +++ +L ++LH N S +P+ F G+ L+ L L N P + L L
Sbjct: 147 DTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 94 VNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 138
+ + N L +P +L + ++N P CD R L
Sbjct: 206 LYLFANNLSA-LPTEALAPLRALQYLRLNDN-----PWVCDCRARPL 246
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 36/202 (17%), Positives = 62/202 (30%), Gaps = 49/202 (24%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96
+ L+++ L NA + F G+ +L +L L P L +L+ + +
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 97 T-NNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
N L P F +L + N A L
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFL--HGNRISSVPERA----FRGL-------------- 176
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGM 211
++ + + + + P F L L L NNLS
Sbjct: 177 -------------------HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-A 215
Query: 212 IPEG-LSVLGALKELDVSNNQL 232
+P L+ L AL+ L +++N
Sbjct: 216 LPTEALAPLRALQYLRLNDNPW 237
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 1e-05
Identities = 16/93 (17%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 9 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQ 66
G + L++ Q L ++ + L+ + + + PD F +
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELR--DLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 67 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
L L+L N + V+ SL+ + ++ N
Sbjct: 82 LSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 21/129 (16%), Positives = 44/129 (34%), Gaps = 12/129 (9%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95
+ +L E+++ + L G+ +L +L++ + PD+ L +N
Sbjct: 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86
Query: 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 155
++ N L+ + + +SL S N P C L L + +
Sbjct: 87 LSFNALESLSWKTVQGLSLQELVLSGN-----PLHCSCALRWLQRWEE-----EGLGGVP 136
Query: 156 KGNDPCSDW 164
+ C
Sbjct: 137 EQKLQCHGQ 145
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 14/86 (16%), Positives = 27/86 (31%), Gaps = 14/86 (16%)
Query: 161 CSDWIGVTCTK-------------GNITVINFQKMNLTGTISPE-FASFKSLQRLILADN 206
G+ CT+ N+T + + + L+ L + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 207 NLSGMIPEGLSVLGALKELDVSNNQL 232
L + P+ L L++S N L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNAL 92
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 5/63 (7%)
Query: 173 NITVINFQKMNLTGTISPE--FASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSN 229
+++ NL+ + E +L L+L+ N+L+ I + L+ LD+S+
Sbjct: 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 230 NQL 232
N L
Sbjct: 98 NHL 100
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 24/114 (21%), Positives = 48/114 (42%), Gaps = 16/114 (14%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVP----DSLVKLE 89
+ ++ +L+ + L++N + F + QL+ L L N + P KL
Sbjct: 106 FLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLP 163
Query: 90 SLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGS--NNFCLPSPGACDPRLNALLS 140
L ++++++N L+ P+ + + + NN P CD +L L S
Sbjct: 164 KLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN-----PLECDCKLYQLFS 212
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 38/228 (16%), Positives = 64/228 (28%), Gaps = 54/228 (23%)
Query: 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ 66
LP L ++ N + T L ++ L + L +
Sbjct: 28 DLPKD-----TTILHLSE-NLLYTFSLA--TLMPYTRLTQLNLDRAELTK-LQVDGTLPV 78
Query: 67 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNN--F 123
L +L L N +P L +L +++++ N L P+ L N
Sbjct: 79 LGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137
Query: 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 183
LP PG L ++ N
Sbjct: 138 TLP-PGLLT-PTPKL------------------------------------EKLSLANNN 159
Query: 184 LTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 230
LT + ++L L+L +N+L IP+G L + N
Sbjct: 160 LT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 36/197 (18%), Positives = 61/197 (30%), Gaps = 46/197 (23%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPDFSGV-KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97
+ S E+ + LP + K L L +N +L+ L +N+
Sbjct: 7 SKVASHLEVNCDKRNLTA-LP--PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 98 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157
L + L S+N +L +L P
Sbjct: 64 RAELTK-LQVDGTLPVLGTLDLSHN-----------QLQSL---------PLLGQ----- 97
Query: 158 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL 216
+ +TV++ LT ++ LQ L L N L +P GL
Sbjct: 98 --------TLP----ALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGL 143
Query: 217 -SVLGALKELDVSNNQL 232
+ L++L ++NN L
Sbjct: 144 LTPTPKLEKLSLANNNL 160
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 24/122 (19%), Positives = 47/122 (38%), Gaps = 10/122 (8%)
Query: 5 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FS 62
+ L + + +L ++ N L + Q + +L + + N + LP
Sbjct: 67 LTKLQVDGTLPVLGTLDLSH-NQLQSLPL---LGQTLPALTVLDVSFNRLTS-LPLGALR 121
Query: 63 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGS 120
G+ +L+ L L+ N P L L+ +++ NN L +P + +LD
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQ 180
Query: 121 NN 122
N
Sbjct: 181 EN 182
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 42/233 (18%), Positives = 90/233 (38%), Gaps = 59/233 (25%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD--SLVKLESLK 92
+ IQ + ++ +++L+ N + + + +K L L L +N + D SL L+ LK
Sbjct: 58 VQGIQYLPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDEN----KIKDLSSLKDLKKLK 112
Query: 93 IVNMTNNLLQ--GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 150
+++ +N + + + SL + NN ++ + + +L
Sbjct: 113 SLSLEHNGISDINGLVHLPQLESLYL---GNN-----------KITDITVLSRLT----- 153
Query: 151 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 210
+ ++ + ++ I P A LQ L L+ N++S
Sbjct: 154 ----------------------KLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD 189
Query: 211 MIPEGLSVLGALKELDVSNNQLYGKIPSFKS-----NAIVNTDGNPDIGKEKS 258
+ L+ L L L++ + + K + +S N + NTDG+ + S
Sbjct: 190 L--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 29/193 (15%), Positives = 57/193 (29%), Gaps = 54/193 (27%)
Query: 44 LKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101
+ E S P F + +L+ T V +L S+ + N+ +
Sbjct: 1 MGETITVSTPIKQIFPDDAF---AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55
Query: 102 Q--GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159
+ + L + + N +L + + L
Sbjct: 56 KSVQGIQYLPNVTKLFL---NGN-----------KLTDIKPLTNL--------------- 86
Query: 160 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 219
N+ + + + +S K L+ L L N +S + GL L
Sbjct: 87 ------------KNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDI--NGLVHL 130
Query: 220 GALKELDVSNNQL 232
L+ L + NN++
Sbjct: 131 PQLESLYLGNNKI 143
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 21/200 (10%), Positives = 56/200 (28%), Gaps = 50/200 (25%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
I + L + + + + ++ + ++ + L ++ +
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK--SVQGIQYLPNVTKL 70
Query: 95 NMTNNLLQ--GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
+ N L P+ L + + N + + L
Sbjct: 71 FLNGNKLTDIKPLTNLKNLGWLFLDE-----------------NKIKDLSSLKDLK---- 109
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
+ ++ + ++ I+ L+ L L +N ++ +
Sbjct: 110 --------------------KLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI- 146
Query: 213 PEGLSVLGALKELDVSNNQL 232
LS L L L + +NQ+
Sbjct: 147 -TVLSRLTKLDTLSLEDNQI 165
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 67/512 (13%), Positives = 138/512 (26%), Gaps = 151/512 (29%)
Query: 105 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP----QRFAE------- 153
V + +S+ ++K + + S D L L+ Q+F E
Sbjct: 38 VQDMPKSI---LSKEEIDHIIMSK---DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY 91
Query: 154 NW-------KGNDPCSDWIGVTCTKGNI--TVINFQKMNLTGTISPEFASFKS-LQRLIL 203
+ + P + + F K N++ + + L L
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS--RLQPYLKLRQALLELRP 149
Query: 204 ADN-NLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAI----VNTDGNPD--IGKE 256
A N + G++ G + + DV + K+ I + +P+ +
Sbjct: 150 AKNVLIDGVLGSGKTWVAL----DVCLSY---KVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 257 KSSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLC 316
+ +Q P+ + S N + ++ L +L
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE-------------------LRRLL----- 238
Query: 317 KKKQKRFSR-------VQSP---NAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHT 366
K K + VQ+ NA + + + +T V+ + T T
Sbjct: 239 --KSKPYENCLLVLLNVQNAKAWNAFNLSCK---------ILLTTRFKQVTDFLSAATTT 287
Query: 367 VPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEE----NILGRGGFGTVYKGELHDGT-- 420
S + + + + ++ L + E N + DG
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE----SIRDGLAT 343
Query: 421 -----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE-- 473
+ ++ T +S + VL +R + ++L VF
Sbjct: 344 WDNWKHVNCDKLT---------TIIESSLNVLEPAEYRKMF----------DRLSVFPPS 384
Query: 474 -YMPQGTLSRHIFNWA-------EEGLKPLEWNRRLTIALDVARGVEYLHGLA------- 518
++P LS + W + L L + + +
Sbjct: 385 AHIPTILLS--LI-WFDVIKSDVMVVVNKLH-KYSL-VEKQPKESTISIPSIYLELKVKL 439
Query: 519 ------HQSFIHRDLKPSNILLGDDMRAKVAD 544
H+S + P DD+ D
Sbjct: 440 ENEYALHRSIVDHYNIPKT-FDSDDLIPPYLD 470
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 44/255 (17%), Positives = 84/255 (32%), Gaps = 49/255 (19%)
Query: 305 ISLTGVLVFCLCKKKQ---KRF-SRVQSPN----AMVIHPRHSGSENSESVKITVAGSNV 356
+S T L + L K++ ++F V N I + I
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 357 SVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFG-TVYKGE 415
+ + + V +P L+ ++ ++ +NV I G G G T +
Sbjct: 121 NDNQVFAKYNVSRLQP----YLKLRQALLELRPAKNVL-------IDGVLGSGKTWVALD 169
Query: 416 LHDGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473
+ K+ +M+ + ++ L S VL L LL + +D N +
Sbjct: 170 VCLSYKV-QCKMDFKIFWLN---LKNCNSPETVL-----EMLQKLL-YQIDPN-----WT 214
Query: 474 YMPQGTLS-RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 532
+ + + + + L+ L ++ L V V+ +F +L I
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF---NLS-CKI 268
Query: 533 LL--GDDMRAKVADF 545
LL +V DF
Sbjct: 269 LLTTRF---KQVTDF 280
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 12/73 (16%), Positives = 33/73 (45%), Gaps = 1/73 (1%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
+ I+ ++K++ +++ + SG+ LE L + T +L L SL ++
Sbjct: 59 LTGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 95 NMTNNLLQGPVPE 107
+++++ +
Sbjct: 118 DISHSAHDDSILT 130
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 15/70 (21%), Positives = 32/70 (45%), Gaps = 2/70 (2%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
NI + ++ T +P + +L+RL + +++ LS L +L LD+S++
Sbjct: 67 NIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 233 YGKIPSFKSN 242
I + +
Sbjct: 125 DDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 13/70 (18%), Positives = 27/70 (38%)
Query: 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232
N+ + ++T P + SL L ++ + I ++ L + +D+S N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 233 YGKIPSFKSN 242
I K+
Sbjct: 149 ITDIMPLKTL 158
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 29/194 (14%), Positives = 58/194 (29%), Gaps = 43/194 (22%)
Query: 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVP-DSLVKLESLKIVNMTN 98
M SL I L + + L ++ L++ + T P L LE L+I+
Sbjct: 42 QMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMG--K 98
Query: 99 NLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 158
++ +P SL + S++ D L + ++ K+
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHS------AHDDSILTKINTLPKV-------------- 138
Query: 159 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 218
I+ I P + L+ L + + + G+
Sbjct: 139 ----------------NSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY--RGIED 179
Query: 219 LGALKELDVSNNQL 232
L +L + +
Sbjct: 180 FPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 17/86 (19%), Positives = 33/86 (38%), Gaps = 5/86 (5%)
Query: 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLR 73
S ++ L + G I + +TSL + + +A L + + ++ S+ L
Sbjct: 88 SNLERLRIMG---KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144
Query: 74 DNFFTGPVPDSLVKLESLKIVNMTNN 99
N L L LK +N+ +
Sbjct: 145 YNGAIT-DIMPLKTLPELKSLNIQFD 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 13/89 (14%), Positives = 30/89 (33%), Gaps = 11/89 (12%)
Query: 161 CSDWIGVTCTKGNITVI-----NFQKMNLTG----TISPE-FASFKSLQRLILADNNLSG 210
C T +I I + Q + L TI F++ ++ R+ ++ +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 211 MIPEGL-SVLGALKELDVSNNQLYGKIPS 238
+ L + +++ N + I
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDP 98
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 36/208 (17%), Positives = 63/208 (30%), Gaps = 50/208 (24%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDN-FFTGPVPDSLVKLESLK 92
N+ ++ I++ + L F + ++ + +R+ T PD+L +L LK
Sbjct: 49 HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK 108
Query: 93 IVNMTNNLLQGPVPEF------DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 146
+ + N L+ P+ D L++ +P A L +KL
Sbjct: 109 FLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIP-VNAFQ-GLCNETLTLKLYN 165
Query: 147 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADN 206
N T + Q GT L + L N
Sbjct: 166 -------N------------------GFTSV--QGYAFNGT---------KLDAVYLNKN 189
Query: 207 NLSGMIPEGL--SVLGALKELDVSNNQL 232
+I + V LDVS +
Sbjct: 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 20/98 (20%), Positives = 33/98 (33%), Gaps = 7/98 (7%)
Query: 173 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSNN 230
NI+ I + F + + + + + I L L LK L + N
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 231 QL-----YGKIPSFKSNAIVNTDGNPDIGKEKSSSFQG 263
L K+ S I+ NP + ++FQG
Sbjct: 116 GLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 42/182 (23%), Positives = 64/182 (35%), Gaps = 54/182 (29%)
Query: 402 ILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR-- 453
LG G FG V + H G +AVK ++ K + + +SEI VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVK-----IV--KNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 454 ----HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLK-------PL 495
V +L GH C+ VFE L + + +K L
Sbjct: 74 NSTFRCVQMLEWFEHHGHICI-------VFE-----LLGLSTY----DFIKENGFLPFRL 117
Query: 496 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+ R+ +A + + V +LH H DLKP NIL + + + R
Sbjct: 118 DHIRK--MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 556 GS 557
Sbjct: 173 NP 174
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 36/200 (18%), Positives = 64/200 (32%), Gaps = 24/200 (12%)
Query: 42 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVP----DSLVKLESLKIVNM 96
+ E+ FSG LE + + N + +L KL ++I
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK- 88
Query: 97 TNNLLQGPVPEFDRSVSLDMAKGSNN--FCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
NNLL F +L SN LP L ++ + +N
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLP-DVHKIHSLQ--KVLLDI-------QDN 138
Query: 155 WKGND-PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
+ + ++G++ ++ K + I + L L L+DNN +P
Sbjct: 139 INIHTIERNSFVGLS---FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 214 EG-LSVLGALKELDVSNNQL 232
LD+S ++
Sbjct: 195 NDVFHGASGPVILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 28/210 (13%), Positives = 67/210 (31%), Gaps = 23/210 (10%)
Query: 39 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSL-RDNFFTGPVPDSLVKLESLKIVN 95
L++I + N + FS + +L + + + N P++ L +L+ +
Sbjct: 51 SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110
Query: 96 MTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPS--PGACDPRLNALLSVVKLMGYPQRFA 152
++N ++ P S+ + +N + + + L+ ++ L
Sbjct: 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG-LSFESVILWL-------- 161
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGM 211
N + NL + + F L ++ + +
Sbjct: 162 ---NKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL 217
Query: 212 IPEGLSVLGALKELDVSNNQLYGKIPSFKS 241
GL L L+ N + K+P+ +
Sbjct: 218 PSYGLENLKKLRARSTYNLK---KLPTLEK 244
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 21/200 (10%), Positives = 56/200 (28%), Gaps = 50/200 (25%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
I + L + + + + ++ + ++ + L ++ +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK--SVQGIQYLPNVTKL 73
Query: 95 NMTNNLLQ--GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
+ N L P+ L + + N + + L
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDE-----------------NKVKDLSSLKDLK---- 112
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
+ ++ + ++ I+ L+ L L +N ++ +
Sbjct: 113 --------------------KLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI- 149
Query: 213 PEGLSVLGALKELDVSNNQL 232
LS L L L + +NQ+
Sbjct: 150 -TVLSRLTKLDTLSLEDNQI 168
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 27/113 (23%), Positives = 45/113 (39%), Gaps = 15/113 (13%)
Query: 8 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVK 65
+ ++ L + N + ++ +T+L + L N LP+ F +
Sbjct: 56 VQGIQYLPNVRYLALG-GNKLHDIS----ALKELTNLTYLILTGNQLQS-LPNGVFDKLT 109
Query: 66 QLESLSLRDNFFTG-P--VPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSL 114
L+ L L +N P V D L L L N+ +N LQ P FD+ +L
Sbjct: 110 NLKELVLVENQLQSLPDGVFDKLTNLTYL---NLAHNQLQSLPKGVFDKLTNL 159
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 15/88 (17%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD 74
S ++ L ++ N G + L+ + + + + + + +L+ L L D
Sbjct: 17 SDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 75 NFFTGPVPDSLVKLESLKIVNMTNNLLQ 102
N +G + K +L +N++ N ++
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 19/67 (28%), Positives = 30/67 (44%), Gaps = 2/67 (2%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFS-GVKQLESLSLRDNFFTGP-VPDSLVKLESLK 92
I + + LK++ L N SG L + L L+L N + L KLE+LK
Sbjct: 57 IANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLK 116
Query: 93 IVNMTNN 99
+++ N
Sbjct: 117 SLDLFNC 123
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 18/104 (17%), Positives = 36/104 (34%), Gaps = 8/104 (7%)
Query: 42 TSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
E+ L++N F+ F + QL ++ +N T + + + +T+N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 100 LLQG-PVPEFDRSVSLDMAKGSNN--FCLPSPGACD--PRLNAL 138
L+ F SL +N C+ + + L
Sbjct: 92 RLENVQHKMFKGLESLKTLMLRSNRITCVG-NDSFIGLSSVRLL 134
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 3/66 (4%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
+ + + SLK + L SN + + + F G+ + LSL DN T P + L SL
Sbjct: 99 KMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST 157
Query: 94 VNMTNN 99
+N+ N
Sbjct: 158 LNLLAN 163
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 17/72 (23%), Positives = 28/72 (38%), Gaps = 5/72 (6%)
Query: 35 IDVIQNM----TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 90
I VI+N+ I N L F +++L++L + +N L
Sbjct: 31 IPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89
Query: 91 LKIVNMTNNLLQ 102
L + +TNN L
Sbjct: 90 LTELILTNNSLV 101
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 28/104 (26%), Positives = 42/104 (40%), Gaps = 9/104 (8%)
Query: 42 TSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
++ EI L N +P FS K+L + L +N + PD+ L SL + + N
Sbjct: 32 ETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90
Query: 100 LLQG-PVPEFDRSVSLDMAKGSNN--FCLPSPGACD--PRLNAL 138
+ P F+ SL + + N CL A LN L
Sbjct: 91 KITELPKSLFEGLFSLQLLLLNANKINCLR-VDAFQDLHNLNLL 133
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 580 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.98 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.96 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.96 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.96 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.95 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.95 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.95 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.95 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.95 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.95 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.95 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.95 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.94 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.94 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.94 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.94 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.94 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.94 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.93 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.93 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.93 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.93 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.93 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.92 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.91 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.91 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.91 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.91 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.91 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.91 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.91 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.9 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.9 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.89 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.89 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.89 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.89 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.89 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.89 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.88 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.88 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.88 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.88 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.88 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.88 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.88 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.88 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.88 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.87 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.87 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.87 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.87 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.87 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.86 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.85 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.85 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.85 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.85 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.85 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.85 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.84 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.83 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.83 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.83 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.82 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.81 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.81 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.8 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.77 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.77 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.77 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.77 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.72 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.72 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.71 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.71 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.68 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.67 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.67 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.67 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.66 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.56 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.16 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.91 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.89 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.87 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.7 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.67 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.41 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.2 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.17 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.14 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.58 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.54 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.46 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.45 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.35 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.17 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.05 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.04 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.91 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.75 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.72 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.7 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.58 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.39 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.19 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.04 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.62 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.84 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.57 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=335.73 Aligned_cols=179 Identities=23% Similarity=0.388 Sum_probs=153.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||+||+|+.. +|+.||||++.+........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999765 79999999998776666677889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||+||+|.+++.. .+...+++.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999854 233467899999999999999999998 8999999999999999999999999999987643
Q ss_pred CCCCccccccccCCccCccccCCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.. ......+||+.|||||++.+.+|+
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~ 203 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYN 203 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCC
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCC
Confidence 21 123456899999999999998875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=326.52 Aligned_cols=178 Identities=27% Similarity=0.438 Sum_probs=156.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||+||+|+.. +++.||||++.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999765 799999999986533 2344678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||++||+|.+++.+ ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999854 2468999999999999999999998 899999999999999999999999999999775
Q ss_pred CCC-CCccccccccCCccCccccCCCCCC
Q 008026 553 EGK-GSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~-~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... ......++||+.|||||++.+.+|+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~ 212 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSAC 212 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBC
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCC
Confidence 432 2234557899999999999887764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.89 Aligned_cols=174 Identities=25% Similarity=0.416 Sum_probs=154.3
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56999999999999999999775 799999999976432 234568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||++|+|.+++.. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 152 y~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 152 FLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999998843 358999999999999999999998 8999999999999999999999999999987754
Q ss_pred CCCCccccccccCCccCccccCCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.. ......+||+.|||||++.+.+|+
T Consensus 223 ~~-~~~~~~~GTp~YmAPEvl~~~~y~ 248 (346)
T 4fih_A 223 EV-PRRKSLVGTPYWMAPELISRLPYG 248 (346)
T ss_dssp SS-CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred CC-CcccccccCcCcCCHHHHCCCCCC
Confidence 43 234557899999999999988774
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=328.08 Aligned_cols=175 Identities=25% Similarity=0.414 Sum_probs=154.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.+.|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||+++++|.+.+..|+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 357999999999999999999775 799999999976432 33456889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
|||+||+|.+++.. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+...
T Consensus 228 Ey~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp ECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999998843 358999999999999999999998 899999999999999999999999999998775
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... ......+||+.|||||++.+.+|+
T Consensus 299 ~~~-~~~~~~~GTp~YmAPEvl~~~~y~ 325 (423)
T 4fie_A 299 KEV-PRRKSLVGTPYWMAPELISRLPYG 325 (423)
T ss_dssp SSC-CCBCCCEECTTTCCHHHHTTCCBC
T ss_pred CCC-ccccccccCcCcCCHHHHCCCCCC
Confidence 443 234557899999999999988774
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=310.63 Aligned_cols=174 Identities=29% Similarity=0.456 Sum_probs=139.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||+||+|+.. +++.||+|++.+.... ......+.+|++++++++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999765 7999999999875433 334567999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+ +|+|.+++.+ ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 6799888843 2479999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... .....+||+.|||||++.+.+|
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y 188 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLY 188 (275)
T ss_dssp -------------CTTSCHHHHSSSSC
T ss_pred CCC--ccCCeeECcccCChhhhcCCCC
Confidence 432 2345689999999999998775
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=322.49 Aligned_cols=177 Identities=25% Similarity=0.369 Sum_probs=147.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||+||+|+.. +++.||+|++++.........++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999763 47899999998755444445578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
|||||+||+|.+++.+ ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999854 2468999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ......+||+.|||||++.+.+|+
T Consensus 176 ~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~ 204 (304)
T 3ubd_A 176 SIDHE-KKAYSFCGTVEYMAPEVVNRRGHT 204 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCC
T ss_pred ccCCC-ccccccccCcccCCHHHhccCCCC
Confidence 54433 223457899999999999988774
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=310.79 Aligned_cols=172 Identities=26% Similarity=0.403 Sum_probs=147.7
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc----CCeeEEE
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLV 471 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 471 (580)
|++.+.||+|+||+||+|.+. ++..||+|++..........+.+.+|++++++++|||||++++++.+ +...|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366788999999999999775 68999999998766666677889999999999999999999999875 3457999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeEec-CCCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a 548 (580)
||||++|+|.+++.+ ...+++..+..|+.||+.||+|||+ ++ ||||||||+|||++ .++.+||+|||+|
T Consensus 108 mEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999854 2468999999999999999999997 55 99999999999998 4789999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+..... .....+||+.|||||++.+ +|+
T Consensus 180 ~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~ 207 (290)
T 3fpq_A 180 TLKRAS---FAKAVIGTPEFMAPEMYEE-KYD 207 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGGT-CCC
T ss_pred EeCCCC---ccCCcccCccccCHHHcCC-CCC
Confidence 865332 3345789999999999865 453
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=318.13 Aligned_cols=181 Identities=30% Similarity=0.512 Sum_probs=152.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
++|.+.+.||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++|||||++++++.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 46888999999999999999764 4788999999753 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHh--------hhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcE
Q 008026 469 LLVFEYMPQGTLSRHIFNWA--------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 540 (580)
++|||||++|+|.+++.... ......++|.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 99999999999999996532 1223579999999999999999999998 899999999999999999999
Q ss_pred EEEeeccccccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 541 KVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
||+|||+|+........ ......||++|||||++.+.+|+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 208 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 208 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC
Confidence 99999999866443221 22235699999999999888764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.36 Aligned_cols=181 Identities=32% Similarity=0.529 Sum_probs=147.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
++|.+.+.||+|+||+||+|+++ ++..||||+++.. .....++|.+|++++++++|||||+++++|.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46778899999999999999864 4788999999753 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhh----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC
Q 008026 469 LLVFEYMPQGTLSRHIFNWAE----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 538 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 538 (580)
|+|||||++|+|.+++..... ....+++|.+++.|+.||+.||+|||+ ++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 999999999999999865321 123468999999999999999999998 8999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCCC
Q 008026 539 RAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.+||+|||+|+....... ......+||+.|||||++.+..|+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 238 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCC
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC
Confidence 999999999987644322 223346799999999999988875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=313.73 Aligned_cols=180 Identities=30% Similarity=0.441 Sum_probs=141.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-------
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------- 466 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 466 (580)
++|++.+.||+|+||+||+|+.. +++.||||+++... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46999999999999999999775 78999999997643 3445678999999999999999999999987544
Q ss_pred -----eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEE
Q 008026 467 -----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541 (580)
Q Consensus 467 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 541 (580)
..|+|||||++|+|.+++.... .....++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEE
Confidence 3689999999999999985421 11234566788999999999999998 8999999999999999999999
Q ss_pred EEeeccccccCCCCCC-----------ccccccccCCccCccccCCCCCC
Q 008026 542 VADFGLVRLAPEGKGS-----------IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 542 l~Dfg~a~~~~~~~~~-----------~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|+|||+|+........ ..+..+||+.|||||++.+.+|+
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 208 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCC
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC
Confidence 9999999876543211 12335799999999999998875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=311.48 Aligned_cols=172 Identities=29% Similarity=0.516 Sum_probs=144.3
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+++++.+.||+|+||+||+|+++ ..||||+++.........++|.+|++++++++|||||++++++.. +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 56788999999999999999875 369999997655556667889999999999999999999998754 568999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
|++|+|.+++.. ....+++.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+.....
T Consensus 113 ~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 113 CEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred CCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999998843 23469999999999999999999998 89999999999999999999999999999876433
Q ss_pred CC-CccccccccCCccCccccCC
Q 008026 555 KG-SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 555 ~~-~~~~~~~Gt~~y~APE~~~~ 576 (580)
.. ......+||+.|||||++.+
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~ 208 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRM 208 (307)
T ss_dssp --------CCCCTTSCCHHHHHC
T ss_pred CcceeecccccCCCccCHHHhhc
Confidence 22 22344689999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=316.97 Aligned_cols=171 Identities=27% Similarity=0.349 Sum_probs=146.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.|++.+.||+|+||+||+|++. +|+.||||+++.+.. ..+|+.++++++|||||++++++.+++..|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46888899999999999999875 799999999976432 2469999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC-cEEEEeeccccccC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAP 552 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~ 552 (580)
||+||+|.+++.+. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999998542 468999999999999999999997 8999999999999999887 69999999998765
Q ss_pred CCCCC----ccccccccCCccCccccCCCCCC
Q 008026 553 EGKGS----IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~----~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ....++||+.|||||++.+.+|+
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 234 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCC
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCC
Confidence 43211 12235799999999999998875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.00 Aligned_cols=182 Identities=25% Similarity=0.387 Sum_probs=152.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
+++++.+.||+|+||+||+|++. +++.||||+++.. ......++|.+|+.++++++|||||+++|++.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 35677889999999999999863 4678999999754 2344567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhh-----------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 537 (580)
++|||||++|+|.+++...... ....++|.+++.|+.||+.||+|||+ ++||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCC
Confidence 9999999999999999643211 12468999999999999999999998 899999999999999999
Q ss_pred CcEEEEeeccccccCCCC-CCccccccccCCccCccccCCCCCC
Q 008026 538 MRAKVADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 538 ~~~kl~Dfg~a~~~~~~~-~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+.+||+|||+|+...... .......+||++|||||++.++.|+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s 225 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS 225 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC
Confidence 999999999998664322 1223446799999999999888775
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=302.75 Aligned_cols=173 Identities=25% Similarity=0.378 Sum_probs=139.7
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC----eeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----EKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l 470 (580)
++|.+.+.||+|+||+||+|++ +|+.||||++.... ......+.|+..+.+++|||||++++++.+++ ..|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4688899999999999999987 48999999986532 11223345666667889999999999998654 5799
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhC-----CCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
||||+++|+|.+++.. ..++|.++.+++.|++.||+|||+. +..+||||||||+|||++.++++||+||
T Consensus 79 V~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 9999999999999854 3689999999999999999999973 1248999999999999999999999999
Q ss_pred ccccccCCCCCC---ccccccccCCccCccccCCC
Q 008026 546 GLVRLAPEGKGS---IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 546 g~a~~~~~~~~~---~~~~~~Gt~~y~APE~~~~~ 577 (580)
|+|+........ .....+||+.|||||++.+.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 187 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhccc
Confidence 999876544322 12335799999999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.73 Aligned_cols=191 Identities=26% Similarity=0.377 Sum_probs=157.6
Q ss_pred eHHHHHHhhcCCcccceeeccCcEEEEEEEEcC------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCC-Ccccce
Q 008026 386 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVAL 458 (580)
Q Consensus 386 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~ 458 (580)
.....+...++|++.+.||+|+||+||+|++.. ++.||||++.... .....+++.+|++++++++| ||||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 334444556789999999999999999997642 3679999997643 34456789999999999975 899999
Q ss_pred eeEEEcC-CeeEEEEEecCCCChhHHHHHHhhh-----------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 008026 459 LGHCLDG-NEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 526 (580)
Q Consensus 459 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D 526 (580)
+|+|... +..++|||||++|+|.++++..... ....+++.+++.|+.|||.||+|||+ ++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCc
Confidence 9998765 5689999999999999999764321 12458999999999999999999998 8999999
Q ss_pred CCCCCeEecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 527 LKPSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 527 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+|||+++++.+||+|||+|+........ .....+||+.|||||++.+..|+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~ 265 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 265 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence 9999999999999999999999876544332 23346799999999999888775
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=305.95 Aligned_cols=176 Identities=24% Similarity=0.398 Sum_probs=149.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc------CC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------GN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 466 (580)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.........+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 467999999999999999999775 79999999998765555566788999999999999999999998764 35
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..|+|||||+ |+|.+++. ....+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~-----~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH-----SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT-----SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence 7899999996 68988873 23579999999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCC---CCccccccccCCccCccccCCCC
Q 008026 547 LVRLAPEGK---GSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 547 ~a~~~~~~~---~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+|+...... .......+||+.|||||++.+..
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~ 238 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 238 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCS
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCC
Confidence 998764321 12334578999999999988754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=296.69 Aligned_cols=175 Identities=22% Similarity=0.361 Sum_probs=147.2
Q ss_pred HHHHhhcCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEE
Q 008026 389 VLRNVTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCL 463 (580)
Q Consensus 389 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 463 (580)
.+..+.++|++.+.||+|+||+||+|+.+ +++.||+|++... ....++.+|+++++.+ +||||+++++++.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 34456788999999999999999999753 4688999998653 2345688999999998 5999999999999
Q ss_pred cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-CcEEE
Q 008026 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKV 542 (580)
Q Consensus 464 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl 542 (580)
+.+..|+||||+++|+|.+++ +.+++.++..++.||+.||+|||+ ++||||||||+|||++.+ +.+||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEE
T ss_pred ECCEEEEEEeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEE
Confidence 999999999999999999887 248899999999999999999998 899999999999999876 79999
Q ss_pred EeeccccccCCCCC---------------------------CccccccccCCccCccccCCCC
Q 008026 543 ADFGLVRLAPEGKG---------------------------SIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~---------------------------~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+|||+|+....... ......+||+.|||||++.+.+
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 222 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP 222 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 99999986543211 1123357999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=311.97 Aligned_cols=176 Identities=27% Similarity=0.387 Sum_probs=148.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh-hhHHHHH---HHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFK---SEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.+..... .....+. .++.+++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999775 79999999997653321 1222333 345667778999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
|+||||++||+|.+++.+ ...+++..+..++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEeccccee
Confidence 999999999999999854 2468999999999999999999997 89999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCC-CCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGN-FGSS 580 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~ 580 (580)
+...... ....+||+.|||||++.+ .+|+
T Consensus 340 ~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~ 369 (689)
T 3v5w_A 340 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYD 369 (689)
T ss_dssp EECSSCC---CCSCCSCGGGCCHHHHSTTCCCC
T ss_pred eecCCCC---CCCccCCcCccCHHHHhCCCCCC
Confidence 8765433 344689999999999964 4553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=305.39 Aligned_cols=176 Identities=25% Similarity=0.394 Sum_probs=154.4
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999775 79999999997632 344577899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC--CcEEEEeeccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFGLVRL 550 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~ 550 (580)
|||+||+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 234 E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 234 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp ECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred eecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999999988843 23468999999999999999999998 899999999999999854 8999999999998
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... .....+||+.|||||++.+.+|+
T Consensus 307 ~~~~~--~~~~~~GT~~y~APEv~~~~~y~ 334 (573)
T 3uto_A 307 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVG 334 (573)
T ss_dssp CCTTS--EEEEECSSGGGCCHHHHTTCCBC
T ss_pred ccCCC--ceeeeEECccccCHHHhCCCCCC
Confidence 75433 33456899999999999988764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=273.97 Aligned_cols=177 Identities=23% Similarity=0.366 Sum_probs=157.2
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
..++|++.+.||+|+||.||+|++ .+|+.||+|++..........+++.+|+++++.++||||+++++++...+..|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999987 4799999999987666666678899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp ECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999988542 458899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....+||+.|+|||++.+..+
T Consensus 165 ~~~~--~~~~~~gt~~y~aPE~~~~~~~ 190 (328)
T 3fe3_A 165 TVGG--KLDAFCGAPPYAAPELFQGKKY 190 (328)
T ss_dssp SSSC--GGGTTSSSGGGCCHHHHHTCCC
T ss_pred CCCC--ccccccCCcceeCcccccCCCc
Confidence 5432 2345689999999999987764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=270.12 Aligned_cols=178 Identities=28% Similarity=0.391 Sum_probs=153.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999775 689999999976432 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 999999999988853 1468899999999999999999998 89999999999999999999999999999864
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... ......+||+.|+|||++.+.+|+
T Consensus 156 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 183 (337)
T 1o6l_A 156 ISDG-ATMKTFCGTPEYLAPEVLEDNDYG 183 (337)
T ss_dssp CCTT-CCBCCCEECGGGCCGGGGSSSCBC
T ss_pred ccCC-CcccccccChhhCChhhhcCCCCC
Confidence 3322 223456899999999999887653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=279.99 Aligned_cols=183 Identities=26% Similarity=0.334 Sum_probs=155.2
Q ss_pred HHHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEc
Q 008026 387 IQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 464 (580)
Q Consensus 387 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 464 (580)
.+..+...++|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3444555689999999999999999999876 689999999976322 12233457899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
.+..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence 9999999999999999998843 358899999999999999999998 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
||+|+.............+||+.|+|||++.+.+
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 245 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTT
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccC
Confidence 9999876544322334568999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=280.51 Aligned_cols=182 Identities=24% Similarity=0.322 Sum_probs=155.0
Q ss_pred HHHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEc
Q 008026 387 IQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 464 (580)
Q Consensus 387 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 464 (580)
.+..+...++|++.+.||+|+||+||+|+.. +++.||+|++.+... .......+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3455556789999999999999999999876 578999999976322 12223448899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
.+..|+||||+++|+|.+++.. ....+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999843 23468999999999999999999998 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
||+|+.............+||+.|+|||++.
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHh
Confidence 9999876554433334468999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=273.33 Aligned_cols=178 Identities=22% Similarity=0.370 Sum_probs=152.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
.++|++.+.||+|+||+||+|+.. +++.||+|++++.... ......+.+|..++.++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 367999999999999999999876 6889999999875433 23345688899999887 79999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999888541 468999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ......+||+.|+|||++.+.+|+
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~ 231 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYG 231 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTCCBC
T ss_pred cccCC-CccccccCCcccCCchhhcCCCCC
Confidence 43322 234457899999999999987764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=261.22 Aligned_cols=175 Identities=26% Similarity=0.434 Sum_probs=152.6
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46899999999999999999976 4789999999976432 23567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp ECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999998843 358899999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... ......||+.|+|||++.+..|+
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 194 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYG 194 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBC
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCC
Confidence 4332 23446799999999999877653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=262.02 Aligned_cols=177 Identities=27% Similarity=0.466 Sum_probs=151.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 57899999999999999999875 689999998854 345566789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 88 YIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp CCTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 9999999999854 23468999999999999999999998 8999999999999999999999999999987643
Q ss_pred CCCCc-------------cccccccCCccCccccCCCCCC
Q 008026 554 GKGSI-------------ETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~-------------~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... .....||+.|+|||++.+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCC
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCC
Confidence 32211 1145799999999999887653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=262.41 Aligned_cols=178 Identities=26% Similarity=0.429 Sum_probs=148.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|+.. ++..||+|++..... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999765 689999999865432 334567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999988542 368999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
............||+.|+|||++.+..+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 189 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEAT 189 (294)
T ss_dssp -------------CCSSCCHHHHHTCCC
T ss_pred ccccccccCccccCccccCHhHhcCCCC
Confidence 5443333344679999999999887665
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=266.97 Aligned_cols=178 Identities=26% Similarity=0.367 Sum_probs=154.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh----hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
+.++|++.+.||+|+||.||+|+.. +|+.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4568999999999999999999775 68999999998654322 135789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC----cEEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 543 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 543 (580)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||++++++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 9999999999999998832 3468999999999999999999998 8999999999999998776 79999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+++...... .....+||+.|+|||++.+.+|+
T Consensus 162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 196 (361)
T 2yab_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLG 196 (361)
T ss_dssp CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCC
T ss_pred ecCCceEcCCCC--ccccCCCCccEECchHHcCCCCC
Confidence 999998765432 23346799999999999887653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=271.59 Aligned_cols=177 Identities=27% Similarity=0.405 Sum_probs=147.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999875 689999999986432 233456788999999998 69999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 102 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999888542 468999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..... ......+||+.|+|||++.+..|
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 201 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLY 201 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHC
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCc
Confidence 43322 23345689999999999876544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-31 Score=267.50 Aligned_cols=179 Identities=26% Similarity=0.411 Sum_probs=155.5
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
.+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999775 68999999998766666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC---CcEEEEeecc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGL 547 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~ 547 (580)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999888742 3468999999999999999999998 899999999999999864 4599999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++...... ......||+.|+|||++.+.+|+
T Consensus 178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 208 (362)
T 2bdw_A 178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYS 208 (362)
T ss_dssp CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCC
T ss_pred ceEecCCc--ccccCCCCccccCHHHHccCCCC
Confidence 98765432 23346799999999999887653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=276.57 Aligned_cols=183 Identities=25% Similarity=0.325 Sum_probs=155.7
Q ss_pred eHHHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEE
Q 008026 386 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCL 463 (580)
Q Consensus 386 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 463 (580)
..++.+...++|++.+.||+|+||+||+|+.. +++.||+|++.+... .......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556789999999999999999999875 799999999976322 2223456889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEE
Q 008026 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 543 (580)
Q Consensus 464 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 543 (580)
+.+..|+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 999999999999999999998542 2368899999999999999999998 899999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
|||+|+.............+||+.|+|||++.
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred echhheeccCCCccccceeccccCcCCHHHHh
Confidence 99999876544332233468999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=265.80 Aligned_cols=177 Identities=23% Similarity=0.375 Sum_probs=153.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 471 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999875 689999999987543 334456788999999988 799999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999888531 368999999999999999999998 89999999999999999999999999999864
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... ......+||+.|+|||++.+.+|+
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 188 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYG 188 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred cCCC-CcccccCCCccccCccccCCCCCC
Confidence 3322 223456899999999999887653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=274.74 Aligned_cols=180 Identities=23% Similarity=0.322 Sum_probs=154.9
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
.+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 35678999999999999999999764 78999999998766556667789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec---CCCcEEEEeecc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGL 547 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~ 547 (580)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999999988843 2468999999999999999999998 8999999999999998 467899999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++...... .......||+.|+|||++.+.+|+
T Consensus 160 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~ 191 (444)
T 3soa_A 160 AIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYG 191 (444)
T ss_dssp CBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBC
T ss_pred eEEecCCC-ceeecccCCcccCCHHHhcCCCCC
Confidence 98765433 223446799999999999887653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=266.77 Aligned_cols=179 Identities=27% Similarity=0.441 Sum_probs=153.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 469 (580)
..++|++.+.||+|+||.||+|+.. +++.||+|++++... .......+..|.+++..+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3578999999999999999999875 689999999976432 223456778899999887 8999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+
T Consensus 95 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999988541 368899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
...... ......+||+.|+|||++.+.+|+
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 196 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYN 196 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCC
Confidence 653322 223456899999999999887653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=262.66 Aligned_cols=180 Identities=32% Similarity=0.547 Sum_probs=145.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|+. +++.||+|++..........+++.+|++++++++||||+++++++...+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46799999999999999999977 58899999998766566667789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|+++++|.+++...... ..+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+++..
T Consensus 115 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp CCTTCBHHHHHHSTTHH--HHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred cCCCCcHHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999998542111 238899999999999999999997 67 999999999999999999999999999865
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... .......||+.|+|||++.+..++
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 217 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSN 217 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCC
T ss_pred cccc-cccccCCCCccccChhhhcCCCCC
Confidence 4332 122345799999999999887653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=263.48 Aligned_cols=175 Identities=27% Similarity=0.433 Sum_probs=152.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999775 789999999976432 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 999999999998843 2468899999999999999999997 89999999999999999999999999999875
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... ....+||+.|+|||++.+.+|+
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~~~ 181 (318)
T 1fot_A 157 PDV----TYTLCGTPDYIAPEVVSTKPYN 181 (318)
T ss_dssp SSC----BCCCCSCTTTCCHHHHTTCCBC
T ss_pred CCc----cccccCCccccCHhHhcCCCCC
Confidence 432 2345799999999999887653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=269.00 Aligned_cols=179 Identities=23% Similarity=0.293 Sum_probs=151.9
Q ss_pred hcCCcccceeeccCcEEEEEEE------EcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC---CCcccceeeEEEc
Q 008026 394 TNNFSEENILGRGGFGTVYKGE------LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLD 464 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 464 (580)
.++|.+.+.||+|+||.||+|. ..+++.||+|++... ...++.+|++++++++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4679999999999999999993 346889999998653 3456788888888887 9999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC--------
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 536 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------- 536 (580)
.+..++||||+++|+|.+++..........+++.+++.|+.||+.||+|||+ .+||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999976554445679999999999999999999997 89999999999999988
Q ss_pred ---CCcEEEEeeccccccCC-CCCCccccccccCCccCccccCCCCCC
Q 008026 537 ---DMRAKVADFGLVRLAPE-GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 537 ---~~~~kl~Dfg~a~~~~~-~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++.+||+|||+|+.... .........+||+.|||||++.+..|+
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 263 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC
Confidence 89999999999976432 122233456799999999999987764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=268.72 Aligned_cols=195 Identities=42% Similarity=0.733 Sum_probs=163.8
Q ss_pred eeeeHHHHHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEE
Q 008026 383 MVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462 (580)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 462 (580)
..++.+++....++|++.+.||+|+||.||+|+..+++.||+|++..... ......+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45677889999999999999999999999999888899999999876432 22234689999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 463 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
...+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999855322 2345899999999999999999999832239999999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+|||+++..............||+.|+|||++.+..+
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 212 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 212 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEE
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCC
Confidence 9999998775544444455679999999999865543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=265.96 Aligned_cols=183 Identities=23% Similarity=0.346 Sum_probs=153.5
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999765 6899999999753221 22457899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc---EEEEee
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADF 545 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 545 (580)
|+||||+++++|.+++...... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999999888654332 2458899999999999999999998 89999999999999986554 999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|+++...... ......+||+.|+|||++.+..|+
T Consensus 178 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 211 (351)
T 3c0i_A 178 GVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYG 211 (351)
T ss_dssp TTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBC
T ss_pred cceeEecCCC-eeecCCcCCcCccCHHHHcCCCCC
Confidence 9998765432 223345799999999999887653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=268.03 Aligned_cols=172 Identities=25% Similarity=0.409 Sum_probs=150.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999765 688999999976432 2334577889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999988843 3468999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
... .....+||+.|+|||++.+
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCC
T ss_pred CCC--ceeccCCCccccCCeeecc
Confidence 432 2345689999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=260.51 Aligned_cols=176 Identities=27% Similarity=0.372 Sum_probs=147.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
+.++|++.+.||+|+||.||+|+..+++.||+|++............+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999888999999999765444445678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFMEK-DLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCSE-EHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCCC-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99975 78777643 33458999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.... ......||+.|+|||++.+.
T Consensus 171 ~~~~-~~~~~~~t~~y~aPE~~~~~ 194 (311)
T 3niz_A 171 IPVR-SYTHEVVTLWYRAPDVLMGS 194 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTC
T ss_pred CCcc-cccCCcccCCcCCHHHhcCC
Confidence 3322 22335789999999998763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=266.27 Aligned_cols=178 Identities=26% Similarity=0.336 Sum_probs=152.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|.++++.+ +||+|+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999876 578999999976432 233456788999999988 79999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 99 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999988542 358899999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ......+||+.|+|||++.+.+|+
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 199 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYG 199 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBS
T ss_pred cccCC-cccccccCCccccChhhhcCCCcC
Confidence 43322 223456899999999999887653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=263.41 Aligned_cols=182 Identities=29% Similarity=0.428 Sum_probs=148.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 466 (580)
+.++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 3467999999999999999999876 79999999997643 3445678999999999999999999999986543
Q ss_pred ----------------------------------------------------eeEEEEEecCCCChhHHHHHHhhhCCCC
Q 008026 467 ----------------------------------------------------EKLLVFEYMPQGTLSRHIFNWAEEGLKP 494 (580)
Q Consensus 467 ----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 494 (580)
..++||||+++++|.+++.... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccc
Confidence 2799999999999999985422 1234
Q ss_pred ccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC-----------Ccccccc
Q 008026 495 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-----------SIETRIA 563 (580)
Q Consensus 495 ~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~ 563 (580)
.++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 5666789999999999999998 8999999999999999999999999999987654321 1123356
Q ss_pred ccCCccCccccCCCCCC
Q 008026 564 GTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 564 Gt~~y~APE~~~~~~~~ 580 (580)
||+.|+|||++.+.+++
T Consensus 238 gt~~y~aPE~~~~~~~~ 254 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYS 254 (332)
T ss_dssp -CGGGSCHHHHHCCCCC
T ss_pred CCcCccChHHhcCCCCc
Confidence 99999999999876653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=256.64 Aligned_cols=175 Identities=23% Similarity=0.338 Sum_probs=150.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++............+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 68999999998765555566788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++ ++.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 66555532 23568999999999999999999998 8999999999999999999999999999987653
Q ss_pred CCCCccccccccCCccCccccCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
... ......||+.|+|||++.+.+
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~ 177 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCS
T ss_pred ccc-cccCCccccCCcChHHHcCCC
Confidence 322 233457899999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=260.45 Aligned_cols=175 Identities=22% Similarity=0.313 Sum_probs=151.9
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4578999999999999999999775 6889999998653 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC--CCcEEEEeecccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 549 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~ 549 (580)
|||+++++|.+++.. ....+++.++..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 80 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 80 FEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 999999999988832 22468999999999999999999998 89999999999999986 7899999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
...... ......||+.|+|||++.+..+
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 180 (321)
T 1tki_A 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEE
T ss_pred ECCCCC--ccccccCChhhcCcHHhcCCCC
Confidence 775433 2344679999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=262.45 Aligned_cols=178 Identities=27% Similarity=0.452 Sum_probs=141.9
Q ss_pred hcCCcccceeeccCcEEEEEEEE----cCCcEEEEEEeecccc--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
.++|++.+.||+|+||.||+|+. .+++.||+|++.+... .......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35799999999999999999986 4789999999976532 22344567899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.|+||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 9999999999999988853 1357889999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++...... ......+||+.|+|||++.+.+++
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 199 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHN 199 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCC
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCC
Confidence 97643322 223346799999999999877653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.83 Aligned_cols=174 Identities=27% Similarity=0.362 Sum_probs=152.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999875 689999999976432 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999988542 358899999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.. ....+||+.|+|||++.+.+|+
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~ 216 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYN 216 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBC
T ss_pred CC----cccccCCccccCHHHhcCCCCC
Confidence 32 2345799999999999887653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=265.66 Aligned_cols=183 Identities=26% Similarity=0.424 Sum_probs=152.4
Q ss_pred hcCCcccceeeccCcEEEEEEEEc--------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEc
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 464 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 464 (580)
.++|++.+.||+|+||.||+|+.. ++..||+|+++.. ......+++.+|+++++++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 367999999999999999999752 3567999999764 3445567899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeE
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 533 (580)
.+..|+||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 9999999999999999999865321 112357899999999999999999998 89999999999999
Q ss_pred ecCCCcEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCCC
Q 008026 534 LGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 534 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++.++.+||+|||+++....... .......||+.|+|||++.+..|+
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 283 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 283 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC
Confidence 99999999999999986644322 122334578899999998877653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=258.19 Aligned_cols=178 Identities=26% Similarity=0.376 Sum_probs=153.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh----hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457999999999999999999775 68999999997643321 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC----cEEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 543 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 543 (580)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 9999999999999998832 3468999999999999999999998 8999999999999998877 79999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+++...... ......||+.|+|||++.+..++
T Consensus 161 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 195 (326)
T 2y0a_A 161 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLG 195 (326)
T ss_dssp CCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCC
T ss_pred ECCCCeECCCCC--ccccccCCcCcCCceeecCCCCC
Confidence 999998764332 22345799999999999877653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=266.33 Aligned_cols=178 Identities=30% Similarity=0.401 Sum_probs=143.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHH-HHhcCCCcccceeeEEEcCCeeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAV-LTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999876 6889999999875432 2334556677776 567899999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 9999999999998854 1357889999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ......+||+.|+|||++.+.+|+
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 217 (373)
T 2r5t_A 189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYD 217 (373)
T ss_dssp GBCCC-CCCCSBSCCCCCCCHHHHTTCCCC
T ss_pred cccCC-CccccccCCccccCHHHhCCCCCC
Confidence 43332 223456899999999999887764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=255.05 Aligned_cols=175 Identities=30% Similarity=0.464 Sum_probs=150.8
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 57899999999999999999988889999999976432 346789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999998843 23468999999999999999999998 89999999999999999999999999999866443
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.........||+.|+|||++.+.++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRY 184 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred ccccccCcccccccCCHHHhcCCCC
Confidence 2222233457888999999876655
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=260.72 Aligned_cols=178 Identities=27% Similarity=0.403 Sum_probs=149.5
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3578999999999999999999776 789999999975432 22346688999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++. ....+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 84 LEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EECCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 99999999998873 23468999999999999999999998 89999999999999999999999999999865
Q ss_pred CCCC-CCccccccccCCccCccccCCCCC
Q 008026 552 PEGK-GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~-~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... ........||+.|+|||++.+.++
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 184 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREF 184 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCC
Confidence 4322 122234679999999999876653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=256.01 Aligned_cols=174 Identities=27% Similarity=0.369 Sum_probs=146.5
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||+|+..+++.||+|++............+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999888899999999976544444457788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 975 88887743 23468899999999999999999998 89999999999999999999999999999876433
Q ss_pred CCCccccccccCCccCccccCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.. ......||+.|+|||++.+.
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~ 175 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGS 175 (288)
T ss_dssp ---------CCCTTCCHHHHTTC
T ss_pred cc-ccccccccccccCchheeCC
Confidence 21 22335789999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-30 Score=256.64 Aligned_cols=171 Identities=26% Similarity=0.378 Sum_probs=149.5
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEec
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 677789999999999999876 79999999997543 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCC
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 555 (580)
++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 125 ~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 125 QGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp CSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 99999988732 368999999999999999999998 899999999999999999999999999998765432
Q ss_pred CCccccccccCCccCccccCCCCC
Q 008026 556 GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 556 ~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. ......||+.|+|||++.+..+
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2c30_A 196 P-KRKSLVGTPYWMAPEVISRSLY 218 (321)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCB
T ss_pred c-ccccccCCccccCHhhhcCCCC
Confidence 2 2344679999999999987765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-31 Score=263.15 Aligned_cols=185 Identities=41% Similarity=0.755 Sum_probs=156.0
Q ss_pred HHHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 389 VLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 389 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
++....++|++.+.||+|+||.||+|++++++.||+|++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 344567899999999999999999999888999999988753 234567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||+++++|.+++.... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999999884321 112358999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCC-CCccccccccCCccCccccCCCCC
Q 008026 549 RLAPEGK-GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 549 ~~~~~~~-~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+...... ........||+.|+|||++.+..+
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL 218 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCC
Confidence 8654322 122334569999999999876554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=275.25 Aligned_cols=178 Identities=34% Similarity=0.507 Sum_probs=153.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.+... .......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 799999999976432 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++|+|.+++.. .+...+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+..
T Consensus 263 mEy~~gg~L~~~l~~---~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHS---SSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999988853 223458999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....+||+.|+|||++.+.+|
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~ 362 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERY 362 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEE
T ss_pred ccCc--cccccCCCccccCHHHHcCCCC
Confidence 5433 2334589999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=260.46 Aligned_cols=175 Identities=27% Similarity=0.439 Sum_probs=150.7
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999986 47899999999764322 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+ +|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 67998887541 468999999999999999999998 79999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....+||+.|+|||++.+..+
T Consensus 159 ~~~~--~~~~~~gt~~y~aPE~~~~~~~ 184 (336)
T 3h4j_B 159 TDGN--FLKTSCGSPNYAAPEVINGKLY 184 (336)
T ss_dssp TTSB--TTCCCTTSTTTSCGGGSCCSGG
T ss_pred cCCc--ccccccCCcCcCCHHHHcCCCC
Confidence 5432 2344579999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=273.71 Aligned_cols=182 Identities=31% Similarity=0.461 Sum_probs=155.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+.... ......+.+|++++++++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999875 6999999999764332 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++|+|.+++..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999998854221 13468999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... .....+||+.|+|||++.+.+|+
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~ 367 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYD 367 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBC
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCC
Confidence 54432 23345899999999999987664
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-30 Score=254.37 Aligned_cols=175 Identities=31% Similarity=0.480 Sum_probs=144.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh------------------------hhHHHHHHHHHHHH
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG------------------------KGLTEFKSEIAVLT 448 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 448 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999765 68999999997643211 12356889999999
Q ss_pred hcCCCcccceeeEEEc--CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 008026 449 KVRHRHLVALLGHCLD--GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 526 (580)
Q Consensus 449 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D 526 (580)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++.++..++.||+.||+|||+ .+|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccC
Confidence 9999999999999987 567899999999999987642 2468999999999999999999998 8999999
Q ss_pred CCCCCeEecCCCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 527 LKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 527 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 213 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETR 213 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTC
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCC
Confidence 99999999999999999999998765432 2233457999999999998654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=266.82 Aligned_cols=169 Identities=21% Similarity=0.278 Sum_probs=138.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeecccc------ChhhHHHHHHHHHHHHhcC---------CCcccce
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVI------SGKGLTEFKSEIAVLTKVR---------HRHLVAL 458 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~~ 458 (580)
.++|++.+.||+|+||+||+|+. +++.||||++..... .....+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35789999999999999999987 689999999986532 2234478899999999886 5555554
Q ss_pred -----------------eeEEEc-------------CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHH
Q 008026 459 -----------------LGHCLD-------------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508 (580)
Q Consensus 459 -----------------~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~ 508 (580)
++++.+ .+..|+||||+++|++.+.+.+ ..+++.+++.++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 444443 6789999999999977666522 4578999999999999
Q ss_pred HHHHHHH-hCCCCCcEecCCCCCCeEecCCC--------------------cEEEEeeccccccCCCCCCccccccccCC
Q 008026 509 RGVEYLH-GLAHQSFIHRDLKPSNILLGDDM--------------------RAKVADFGLVRLAPEGKGSIETRIAGTFG 567 (580)
Q Consensus 509 ~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~ 567 (580)
.||+||| + .+|+||||||+|||++.++ .+||+|||+|+..... ..+||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 7 7999999999999999876 8999999999876532 3479999
Q ss_pred ccCccccCCCC
Q 008026 568 YLAPEYAGNFG 578 (580)
Q Consensus 568 y~APE~~~~~~ 578 (580)
|||||++.+..
T Consensus 243 y~aPE~~~g~~ 253 (336)
T 2vuw_A 243 SMDEDLFTGDG 253 (336)
T ss_dssp TTCSGGGCCCS
T ss_pred ccChhhhcCCC
Confidence 99999998653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=271.54 Aligned_cols=177 Identities=25% Similarity=0.349 Sum_probs=136.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-----Ce
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----NE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 467 (580)
.++|++.+.||+|+||.||+|+.. +++.||||++..........+++.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999765 789999999976555556678899999999999999999999998543 56
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.|+||||+ +++|.+++. ....+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR-----TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeeccccc
Confidence 89999998 568888873 23568999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCC--------------------------CccccccccCCccCccccC-CCCC
Q 008026 548 VRLAPEGKG--------------------------SIETRIAGTFGYLAPEYAG-NFGS 579 (580)
Q Consensus 548 a~~~~~~~~--------------------------~~~~~~~Gt~~y~APE~~~-~~~~ 579 (580)
|+....... ......+||+.|+|||++. +..|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 261 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY 261 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCC
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCC
Confidence 987643211 1223467899999999864 4334
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=250.91 Aligned_cols=175 Identities=30% Similarity=0.443 Sum_probs=150.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|+..++..||+|++..... ..+++.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 467999999999999999999988888999999976432 34678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999998542 1358899999999999999999998 8999999999999999999999999999987655
Q ss_pred CCCCccccccccCCccCccccCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
..........||+.|+|||++.+.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~ 181 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFK 181 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSE
T ss_pred hhhhcccCCCcCcccCCHHHHhccC
Confidence 4332233345677899999986544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=258.76 Aligned_cols=178 Identities=26% Similarity=0.425 Sum_probs=147.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
.++|++.+.||+|+||.||+|++. .+..||||++... ......+.+.+|++++++++||||+++++++.+.+..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 357999999999999999999874 3456999999763 24455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999998843 23468999999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCc--cccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSI--ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~--~~~~~Gt~~y~APE~~~~~~~ 579 (580)
......... .....||+.|+|||++.+..+
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 231 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEE
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCC
Confidence 765432211 122346788999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=261.76 Aligned_cols=176 Identities=19% Similarity=0.272 Sum_probs=152.1
Q ss_pred cCCcccceeecc--CcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 395 NNFSEENILGRG--GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
++|++.+.||+| +||.||+|+.. +++.||||++..........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 579999999999 99999999876 799999999987665566677889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+...
T Consensus 105 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 105 TSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999998542 22468999999999999999999998 89999999999999999999999999988654
Q ss_pred CCCCC------CccccccccCCccCccccCC
Q 008026 552 PEGKG------SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 552 ~~~~~------~~~~~~~Gt~~y~APE~~~~ 576 (580)
..... .......||+.|+|||++.+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred ccccccccccccccccccccccccCHHHHhc
Confidence 22110 11122478999999999987
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=291.64 Aligned_cols=258 Identities=23% Similarity=0.281 Sum_probs=190.9
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|+++|.+|..| .++..|+.++++.|.+.+..|..+..+++|++|+|++|++++.+| .+.++++|++|+|++|++++.
T Consensus 428 N~l~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 505 (768)
T 3rgz_A 428 NYLSGTIPSSL--GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505 (768)
T ss_dssp SEEESCCCGGG--GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred CcccCcccHHH--hcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCc
Confidence 56667777777 456667777777777777777777777888888888888877777 477778888888888888877
Q ss_pred CCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCC-CCCCCCchhHHHHH-------------------
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCL-PSPGACDPRLNALL------------------- 139 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~-~~~~~~~~~l~~l~------------------- 139 (580)
+|.+|+.+++|+.|+|++|++++.+|. +..+.+|+.|++++|.+. .+|...+. ...+.
T Consensus 506 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 584 (768)
T 3rgz_A 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK-QSGKIAANFIAGKRYVYIKNDGMK 584 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGT-TTTCBCCSTTCSCEEEEEECCSCC
T ss_pred CChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhc-ccchhhhhcccccccccccccccc
Confidence 888888888888888888888776664 777778888888888766 33332211 00000
Q ss_pred ---------------------HHH-----------------HhhCCccccccccCCCCCCC-CccceeccCCcEEEEEec
Q 008026 140 ---------------------SVV-----------------KLMGYPQRFAENWKGNDPCS-DWIGVTCTKGNITVINFQ 180 (580)
Q Consensus 140 ---------------------~~~-----------------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~L~~L~ls 180 (580)
.+. .....+..+....++++... ..|..+..+++|+.|+|+
T Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls 664 (768)
T 3rgz_A 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664 (768)
T ss_dssp TTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCc
Confidence 000 00111222333445555554 467788888999999999
Q ss_pred CCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC---ceeecCCCCCCCCCC
Q 008026 181 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN---AIVNTDGNPDIGKEK 257 (580)
Q Consensus 181 ~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~n~~~c~~~ 257 (580)
+|+++|.+|.+++++++|+.|||++|+++|.+|.++..++.|++||+++|+|+|.||+..+. ....+.|||++|+.+
T Consensus 665 ~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred CCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 99999999999999999999999999999999999999999999999999999999987543 346788999999977
Q ss_pred CCCCCC
Q 008026 258 SSSFQG 263 (580)
Q Consensus 258 ~~~~~~ 263 (580)
.. .|.
T Consensus 745 l~-~C~ 749 (768)
T 3rgz_A 745 LP-RCD 749 (768)
T ss_dssp SC-CCC
T ss_pred Cc-CCC
Confidence 54 454
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-30 Score=263.10 Aligned_cols=176 Identities=33% Similarity=0.464 Sum_probs=139.8
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCC--
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN-- 466 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-- 466 (580)
+.+.++|++.+.||+|+||.||+|... +++.||+|++...........++.+|+.+++++. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 345689999999999999999999764 7899999999765555666778899999999997 999999999997654
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999997 588888743 368889999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCC--------------------CCccccccccCCccCccccCC
Q 008026 547 LVRLAPEGK--------------------GSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 547 ~a~~~~~~~--------------------~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+|+...... .......+||+.|+|||++.+
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 998653211 112234679999999999876
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=254.20 Aligned_cols=173 Identities=29% Similarity=0.360 Sum_probs=144.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||+||+|+.. +++.||||++...........+...|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999876 799999999876544445555666677666666 899999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 67998887542 2468999999999999999999998 79999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.... ......||+.|+|||++.+
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT
T ss_pred ccCC--CCcccCCCccccCHhHhcC
Confidence 4432 2234569999999999876
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=249.30 Aligned_cols=178 Identities=26% Similarity=0.419 Sum_probs=154.8
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999775 689999999987666666678899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc---EEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a 548 (580)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||.+
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999998887542 458899999999999999999998 89999999999999986554 999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
....... ......||+.|+|||++.+.+++
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 185 (284)
T 3kk8_A 156 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYS 185 (284)
T ss_dssp EECCSSC--BCCCSCSCGGGCCHHHHTTCCBC
T ss_pred EEcccCc--cccCCCCCcCCcCchhhcCCCCC
Confidence 8765433 22345799999999999887653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=265.68 Aligned_cols=174 Identities=28% Similarity=0.385 Sum_probs=145.9
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-----C
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 466 (580)
+.++|++.+.||+|+||.||+|... +++.||||++..........+++.+|++++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3468999999999999999999765 688999999987555556678899999999999999999999999766 5
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 6899999996 599888732 3468999999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCC---------------------ccccccccCCccCccccC
Q 008026 547 LVRLAPEGKGS---------------------IETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 547 ~a~~~~~~~~~---------------------~~~~~~Gt~~y~APE~~~ 575 (580)
+|+........ .....+||+.|+|||++.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 224 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHT
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence 99876443211 124568999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=259.14 Aligned_cols=176 Identities=23% Similarity=0.335 Sum_probs=151.2
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999775 68999999987632 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC--CCcEEEEeecccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 549 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~ 549 (580)
|||+++++|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++. .+.+||+|||+++
T Consensus 127 ~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 127 LEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccce
Confidence 999999999988742 22468999999999999999999998 89999999999999974 5779999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
...... ......||+.|+|||++.+.++
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 227 (387)
T 1kob_A 200 KLNPDE--IVKVTTATAEFAAPEIVDREPV 227 (387)
T ss_dssp ECCTTS--CEEEECSSGGGCCHHHHTTCCB
T ss_pred ecCCCc--ceeeeccCCCccCchhccCCCC
Confidence 765432 2334579999999999987765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=253.73 Aligned_cols=176 Identities=27% Similarity=0.418 Sum_probs=148.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|.+.++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 357999999999999999999998888999999976432 34678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999988542 2358899999999999999999998 8999999999999999999999999999986644
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........||+.|+|||++.+.++
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKF 198 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCC
T ss_pred cccccccCCccCcccCCHHHhccCCC
Confidence 32222223456888999999876654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=253.46 Aligned_cols=178 Identities=26% Similarity=0.385 Sum_probs=137.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 467999999999999999999765 68999999997643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhh-CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 473 EYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
||++ ++|.+++...... ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 5999988654322 22458899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
..... ......||+.|+|||++.+.
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~ 183 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGS 183 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTC
T ss_pred CCCcc-cCCCCcccccccCchHhhCC
Confidence 43322 22345789999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=267.76 Aligned_cols=176 Identities=31% Similarity=0.468 Sum_probs=153.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|.+.+.||+|+||.||+|+.. +|+.||||++...... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999876 7999999999764322 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 95 MEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 999999999998832 3468999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....+||+.|+|||++.+..+
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~ 192 (476)
T 2y94_A 167 SDGE--FLRTSCGSPNYAAPEVISGRLY 192 (476)
T ss_dssp CTTC--CBCCCCSCSTTCCHHHHTTCCB
T ss_pred cccc--cccccCCCcCeEChhhccCCCC
Confidence 5432 2344679999999999987654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-30 Score=268.32 Aligned_cols=175 Identities=27% Similarity=0.372 Sum_probs=144.1
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC------
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 465 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 465 (580)
..++|++.+.||+|+||.||+|... +++.||||++..........+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999765 689999999987655566677899999999999999999999999654
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
...|+||||+++ ++.+.+. ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEE
Confidence 356999999976 5655552 248899999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|+|+...... .....+||+.|+|||++.+.+|+
T Consensus 209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 241 (464)
T 3ttj_A 209 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 241 (464)
T ss_dssp CCC-----CC--CC----CCCTTCCHHHHTTCCCC
T ss_pred EeeeecCCCc--ccCCCcccccccCHHHHcCCCCC
Confidence 9998765432 23456899999999999988764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=258.57 Aligned_cols=180 Identities=26% Similarity=0.408 Sum_probs=144.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe---
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE--- 467 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 467 (580)
+.++|++.+.||+|+||.||+|+. .+++.||+|++..... .......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 346899999999999999999986 4789999999976533 23445678999999999999999999999876543
Q ss_pred -eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 468 -KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 468 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
.|+||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 39999999999999988531 368899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCC--ccccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGKGS--IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+++........ ......||+.|+|||++.+..++
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 197 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 197 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCC
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCC
Confidence 99866443221 12335699999999999877653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-30 Score=255.97 Aligned_cols=170 Identities=30% Similarity=0.471 Sum_probs=144.8
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC----eeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----EKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l 470 (580)
++|++.+.||+|+||.||+|+.. ++.||||++... ........+|+.++++++||||+++++++.... ..++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 57999999999999999999876 899999998653 233455677999999999999999999998754 3699
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCC----------CcEecCCCCCCeEecCCCcE
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ----------SFIHRDLKPSNILLGDDMRA 540 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~----------~ivH~Dlkp~NIll~~~~~~ 540 (580)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+
T Consensus 100 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 9999999999999843 358999999999999999999997 6 99999999999999999999
Q ss_pred EEEeeccccccCCCCCC-ccccccccCCccCccccCCC
Q 008026 541 KVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~ 577 (580)
||+|||+++........ ......||+.|+|||++.+.
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 208 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccc
Confidence 99999999876543321 22335799999999998863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=260.17 Aligned_cols=173 Identities=25% Similarity=0.309 Sum_probs=141.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 367999999999999999999876 789999999976432 2356889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc--EEEEeeccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGLVRL 550 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 550 (580)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+++.
T Consensus 96 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 96 EYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999999988843 1358999999999999999999998 89999999999999987665 99999999975
Q ss_pred cCCCCCCccccccccCCccCccccCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..... ......||+.|+|||++.+..+
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 194 (361)
T 3uc3_A 168 SVLHS--QPKSTVGTPAYIAPEVLLRQEY 194 (361)
T ss_dssp ---------------CTTSCHHHHHCSSC
T ss_pred ccccC--CCCCCcCCCCcCChhhhcCCCC
Confidence 43322 2234579999999999887665
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=273.13 Aligned_cols=180 Identities=28% Similarity=0.390 Sum_probs=143.2
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+++++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999765 789999999976432 23345677889999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 226 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999988843 1368899999999999999999995 26899999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ......+||+.|+|||++.+..|+
T Consensus 299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 327 (446)
T 4ejn_A 299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYG 327 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCC
T ss_pred ccCCC-cccccccCCccccCHhhcCCCCCC
Confidence 44332 223446899999999999877664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=258.21 Aligned_cols=181 Identities=27% Similarity=0.331 Sum_probs=153.4
Q ss_pred eHHHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-----CCccccee
Q 008026 386 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----HRHLVALL 459 (580)
Q Consensus 386 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~ 459 (580)
..++...+.++|++.+.||+|+||.||+|+.. +++.||||++.. .......+..|+++++.++ ||||++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 33444556789999999999999999999874 689999999864 2334567788999999996 99999999
Q ss_pred eEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---
Q 008026 460 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--- 536 (580)
Q Consensus 460 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--- 536 (580)
+++...+..++||||+ +++|.+++.. .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITR---NNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 9999999999999999 8999998854 223458899999999999999999998 89999999999999975
Q ss_pred ----------------------CCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 537 ----------------------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 537 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++.+||+|||+|+...... ....||+.|+|||++.+.+|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCC
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCC
Confidence 7889999999998654322 345789999999999887764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=252.23 Aligned_cols=174 Identities=25% Similarity=0.327 Sum_probs=144.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999875 5899999998765545555677889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.++...
T Consensus 82 e~~~~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDR-----YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHh-----hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 9999999887763 23468999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.... ......||+.|+|||++.+
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 154 GPSD-YYDDEVATRWYRSPELLVG 176 (311)
T ss_dssp -------------GGGCCHHHHHT
T ss_pred Cccc-ccCCCcCCccccChHHHhc
Confidence 3322 2334578999999999865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=261.71 Aligned_cols=177 Identities=25% Similarity=0.432 Sum_probs=139.8
Q ss_pred cCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|+.. ++..||||+++... .....+++.+|++++++++||||+++++++...+..++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 57999999999999999999765 46789999997642 44556789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 124 v~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999843 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCCcc--ccccccCCccCccccCCCCC
Q 008026 551 APEGKGSIE--TRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~--~~~~Gt~~y~APE~~~~~~~ 579 (580)
......... ....+|+.|+|||++.+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227 (373)
T ss_dssp -----------------CTTSCHHHHHHCCC
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCc
Confidence 654322111 12345788999999877665
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=260.22 Aligned_cols=185 Identities=31% Similarity=0.474 Sum_probs=152.5
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 464 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 464 (580)
....++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 445678999999999999999999874 34889999997642 34456789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhh-------------------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEec
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEE-------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 525 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~ 525 (580)
.+..++||||+++++|.+++...... ....+++.+++.++.||+.||+|||+ .+|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 99999999999999999998653211 12568999999999999999999998 899999
Q ss_pred CCCCCCeEecCCCcEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 526 DLKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 526 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..+
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 253 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 253 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc
Confidence 9999999999999999999999976533211 12233568999999999876654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=253.40 Aligned_cols=167 Identities=28% Similarity=0.367 Sum_probs=127.3
Q ss_pred cceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEEecCC
Q 008026 400 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
.+.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 378999999999999775 6899999998652 3467789999999997 99999999999999999999999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC---cEEEEeeccccccCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAPEG 554 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~ 554 (580)
++|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 91 GELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999998843 2468999999999999999999998 8999999999999998665 7999999999876543
Q ss_pred CCCccccccccCCccCccccCCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.. .....+||+.|+|||++.+.+|+
T Consensus 163 ~~-~~~~~~~t~~y~aPE~~~~~~~~ 187 (325)
T 3kn6_A 163 NQ-PLKTPCFTLHYAAPELLNQNGYD 187 (325)
T ss_dssp ----------------------CCCC
T ss_pred CC-cccccCCCcCccCHHHhcCCCCC
Confidence 32 23345789999999999887764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=259.07 Aligned_cols=183 Identities=29% Similarity=0.420 Sum_probs=152.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc--------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEc
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 464 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 464 (580)
.++|++.+.||+|+||.||+|+.. ++..||+|++... .......++.+|+++++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 367899999999999999999753 2357999999764 3445567899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhh-----------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeE
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 533 (580)
.+..++||||+++++|.+++...... ....+++.+++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 99999999999999999998653211 12358999999999999999999998 89999999999999
Q ss_pred ecCCCcEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCCC
Q 008026 534 LGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 534 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++.++.+||+|||+++....... .......||+.|+|||++.+..++
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 271 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence 99999999999999986654321 122334578999999998876653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=256.44 Aligned_cols=174 Identities=29% Similarity=0.429 Sum_probs=135.6
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 4578999999999999999999876 58899999997532 345688999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a 548 (580)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 127 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 127 LELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp ECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 999999999988842 3468999999999999999999998 89999999999999975 889999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+...... ......||+.|+|||++.+..++
T Consensus 199 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 228 (349)
T 2w4o_A 199 KIVEHQV--LMKTVCGTPGYCAPEILRGCAYG 228 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCC
T ss_pred cccCccc--ccccccCCCCccCHHHhcCCCCC
Confidence 8664332 22345799999999999887653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=257.97 Aligned_cols=178 Identities=27% Similarity=0.358 Sum_probs=152.1
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh------hhHHHHHHHHHHHHhcCCCcccceeeEEEc
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG------KGLTEFKSEIAVLTKVRHRHLVALLGHCLD 464 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 464 (580)
...++|++.+.||+|+||.||+|+.. +++.||||++....... .....+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 35578999999999999999999764 78999999998654221 134467789999999999999999999999
Q ss_pred CCeeEEEEEecCCC-ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEE
Q 008026 465 GNEKLLVFEYMPQG-TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 543 (580)
Q Consensus 465 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 543 (580)
.+..++||||+.+| +|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999776 99888732 3468999999999999999999998 899999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|||+++...... ......||+.|+|||++.+..+
T Consensus 173 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 206 (335)
T 3dls_A 173 DFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPY 206 (335)
T ss_dssp CCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCB
T ss_pred ecccceECCCCC--ceeccCCCccccChhhhcCCCC
Confidence 999998765443 2334679999999999987664
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=251.22 Aligned_cols=178 Identities=26% Similarity=0.373 Sum_probs=153.1
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh----hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
+.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999875 68999999997653322 135789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC----cEEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 543 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 543 (580)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 9999999999999998843 3468999999999999999999998 8999999999999999887 79999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+++...... ......||+.|+|||++.+..++
T Consensus 162 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 196 (321)
T 2a2a_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLG 196 (321)
T ss_dssp CCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCC
T ss_pred cCccceecCccc--cccccCCCCCccCcccccCCCCC
Confidence 999998765432 22345699999999999877653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-29 Score=245.01 Aligned_cols=176 Identities=26% Similarity=0.385 Sum_probs=151.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
..++|++.+.||+|+||.||+|... +++.||+|++...........++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999876 799999999987655555677889999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-------------
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------------- 537 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~------------- 537 (580)
||||+++++|.+++...... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999998654332 2468999999999999999999998 899999999999999844
Q ss_pred ------CcEEEEeeccccccCCCCCCccccccccCCccCccccCCC
Q 008026 538 ------MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 538 ------~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
..+||+|||.+....... ...||+.|+|||++.+.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQEN 205 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTC
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCC
Confidence 479999999998765432 23589999999999765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=254.36 Aligned_cols=175 Identities=20% Similarity=0.267 Sum_probs=149.2
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46799999999999999999976 4789999999875422 24578999999999 899999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc-----EEEEeec
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADFG 546 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg 546 (580)
|||+ +++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 84 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999 99999988542 3478999999999999999999998 89999999999999998877 9999999
Q ss_pred cccccCCCCCCc------cccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGKGSI------ETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~~~~------~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+++......... .....||+.|+|||++.+.+++
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 195 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS 195 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCC
Confidence 998764433211 2346799999999999987764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-30 Score=260.13 Aligned_cols=190 Identities=26% Similarity=0.378 Sum_probs=153.8
Q ss_pred HHHHHHhhcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCccccee
Q 008026 387 IQVLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALL 459 (580)
Q Consensus 387 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 459 (580)
........++|++.+.||+|+||.||+|++. +++.||||++... ......+.+.+|+++++++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3445556688999999999999999999742 4688999999763 2344567899999999999 699999999
Q ss_pred eEEEcCCe-eEEEEEecCCCChhHHHHHHhhhC-----------------------------------------------
Q 008026 460 GHCLDGNE-KLLVFEYMPQGTLSRHIFNWAEEG----------------------------------------------- 491 (580)
Q Consensus 460 ~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~----------------------------------------------- 491 (580)
+++.+.+. .++||||+++|+|.+++.......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 899999999999999986532210
Q ss_pred --------------CCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCC-
Q 008026 492 --------------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG- 556 (580)
Q Consensus 492 --------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 556 (580)
...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1228899999999999999999998 8999999999999999999999999999986644322
Q ss_pred CccccccccCCccCccccCCCCCC
Q 008026 557 SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 557 ~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.......||+.|+|||++.+..++
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~ 273 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYT 273 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCC
T ss_pred hhccccCCCceeEChhhhcCCCCC
Confidence 223345689999999998776653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=251.06 Aligned_cols=174 Identities=25% Similarity=0.386 Sum_probs=147.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC--eeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--EKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 470 (580)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 357999999999999999999876 589999999976432 234567889999999999999999999998765 6799
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe----cCCCcEEEEeec
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 546 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg 546 (580)
||||+++++|.+++..... ...+++.+++.++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999865322 2348999999999999999999998 899999999999999 777889999999
Q ss_pred cccccCCCCCCccccccccCCccCccccC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
+++....... .....||+.|+|||++.
T Consensus 162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 162 AARELEDDEQ--FVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHH
T ss_pred CceecCCCCc--eeecccCCCccCHHHhh
Confidence 9987654432 23457999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=246.09 Aligned_cols=188 Identities=43% Similarity=0.717 Sum_probs=159.2
Q ss_pred eeeeHHHHHHhhcCCccc------ceeeccCcEEEEEEEEcCCcEEEEEEeeccc--cChhhHHHHHHHHHHHHhcCCCc
Q 008026 383 MVISIQVLRNVTNNFSEE------NILGRGGFGTVYKGELHDGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHRH 454 (580)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~n 454 (580)
..+...++..++++|... +.||+|+||.||+|.. +++.||+|++.... ......+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 456778888888888776 8999999999999986 58899999987542 12344678999999999999999
Q ss_pred ccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 455 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
|+++++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999885432 23468999999999999999999998 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCC
Q 008026 535 GDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~ 576 (580)
+.++.+||+|||+++........ ......||+.|+|||++.+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG 209 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence 99999999999999876543222 2233579999999998865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=253.80 Aligned_cols=185 Identities=30% Similarity=0.467 Sum_probs=137.2
Q ss_pred hhcCCcccceeeccCcEEEEEEEEcC-C---cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELHD-G---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
..++|++.+.||+|+||.||+|+... + ..||+|++..........+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34689999999999999999997653 3 2799999987655556678899999999999999999999999887655
Q ss_pred ------EEEEEecCCCChhHHHHHHhhh-CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEE
Q 008026 469 ------LLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 541 (580)
Q Consensus 469 ------~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 541 (580)
++||||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 9999999999999998654322 22358999999999999999999998 8999999999999999999999
Q ss_pred EEeeccccccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 542 VADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 542 l~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|+|||+++........ ......||+.|+|||++.+..++
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 217 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT 217 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCC
Confidence 9999999866443221 12234568899999998776553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=277.59 Aligned_cols=179 Identities=26% Similarity=0.331 Sum_probs=153.6
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 469 (580)
..++|++.+.||+|+||.||+|+.. +++.||||++.+... .....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3568999999999999999999775 688999999986432 233456788899999988 6999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++|+|.+++... ..+++.+++.++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999988542 368999999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
...... ......+||+.|+|||++.+.+|+
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~ 520 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYG 520 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBS
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCC
Confidence 643332 234457899999999999887764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=260.22 Aligned_cols=175 Identities=25% Similarity=0.355 Sum_probs=149.5
Q ss_pred cCCcccceeeccCcEEEEEEEE----cCCcEEEEEEeecccc--ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCe
Q 008026 395 NNFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 467 (580)
++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 3689999999875432 122345677899999999 69999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999988542 358899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
++.............+||+.|+|||++.+.
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 235 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGG 235 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCC
Confidence 987644333333456799999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=260.25 Aligned_cols=183 Identities=26% Similarity=0.355 Sum_probs=150.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
.++|++.+.||+|+||.||+|++. ++..||||++... .......++.+|+.++++++||||+++++++.....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 357899999999999999999843 4678999998653 344456678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhh--CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC---cEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 542 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 542 (580)
.++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999998654321 22458899999999999999999998 8999999999999999554 5999
Q ss_pred EeeccccccCCCC-CCccccccccCCccCccccCCCCCC
Q 008026 543 ADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 543 ~Dfg~a~~~~~~~-~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+|||+|+...... ........||+.|+|||++.+..++
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 264 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT 264 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCC
Confidence 9999997543211 1122335689999999998776653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=252.04 Aligned_cols=178 Identities=28% Similarity=0.524 Sum_probs=144.9
Q ss_pred hcCCcccceeeccCcEEEEEEEE-----cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--C
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--N 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 466 (580)
.++|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|++++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 36799999999999999999974 26889999998753 344567899999999999999999999998654 5
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 589999999999999998542 2358899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCC--CccccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGKG--SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+++....... .......||..|+|||++.+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS 195 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCC
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCC
Confidence 9987644322 112234578889999998776653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=250.73 Aligned_cols=177 Identities=22% Similarity=0.341 Sum_probs=136.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEcC----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
.++|++.+.||+|+||.||+|.... +..||+|++... ......+.+.+|+.++++++||||+++++++. .+..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 4679999999999999999997642 457999988653 23445678999999999999999999999974 56789
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence 99999999999998853 22468899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..............||+.|+|||++.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRF 194 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCC
Confidence 765433222333457889999999876654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=255.63 Aligned_cols=177 Identities=24% Similarity=0.336 Sum_probs=139.5
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
...++|++.+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999765 78999999997654444455678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-----CCCcEEEEee
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-----DDMRAKVADF 545 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~Df 545 (580)
||||+++ +|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++ ..+.+||+||
T Consensus 111 v~e~~~~-~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEECCSE-EHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEecCCC-CHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 9999974 99888743 2358899999999999999999998 8999999999999994 4556999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|+++....... ......||+.|+|||++.+..
T Consensus 182 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~ 213 (329)
T 3gbz_A 182 GLARAFGIPIR-QFTHEIITLWYRPPEILLGSR 213 (329)
T ss_dssp THHHHHC------------CCTTCCHHHHTTCC
T ss_pred CCccccCCccc-ccCCCcCCccccCHHHhcCCC
Confidence 99987643322 223457899999999987743
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=255.70 Aligned_cols=173 Identities=23% Similarity=0.334 Sum_probs=145.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCC--CcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|...+++.||+|++..........+.+.+|++++++++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35699999999999999999988889999999998765566667889999999999986 9999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
||+ .+++|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp ECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 994 57899998843 2468899999999999999999998 8999999999999997 578999999999876
Q ss_pred CCCCCC-ccccccccCCccCccccCC
Q 008026 552 PEGKGS-IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 552 ~~~~~~-~~~~~~Gt~~y~APE~~~~ 576 (580)
...... ......||+.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp ------------CCCCSSCCHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhh
Confidence 543322 2234679999999999854
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=249.08 Aligned_cols=170 Identities=25% Similarity=0.450 Sum_probs=142.3
Q ss_pred hhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHh--cCCCcccceeeEEEcC----C
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK--VRHRHLVALLGHCLDG----N 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~ 466 (580)
+.++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999987 5899999998652 33556667777776 7899999999986542 4
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHH--------hCCCCCcEecCCCCCCeEecCCC
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH--------GLAHQSFIHRDLKPSNILLGDDM 538 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~ 538 (580)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| + .+|+||||||+|||++.++
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTS
T ss_pred eeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCC
Confidence 57999999999999999832 46899999999999999999999 6 8999999999999999999
Q ss_pred cEEEEeeccccccCCCCCCc---cccccccCCccCccccCCC
Q 008026 539 RAKVADFGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 577 (580)
.+||+|||+|+......... .....||+.|+|||++.+.
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCc
Confidence 99999999997665433221 1234799999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=266.44 Aligned_cols=177 Identities=25% Similarity=0.422 Sum_probs=149.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 346789999999999999999999888999999997643 34678999999999999999999999986 56789999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 262 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp CCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred eecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999864322 247788999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
...........+|+.|+|||++.+..+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 362 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSF 362 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCC
T ss_pred CCceeccCCCcccccccCHHHhccCCC
Confidence 322111222346788999999876655
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=248.01 Aligned_cols=179 Identities=29% Similarity=0.403 Sum_probs=144.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccC---hhhHHHHHHHHHHHHhcC---CCcccceeeEEEcC
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDG 465 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 465 (580)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999986 47899999998753321 122346677777777664 99999999999876
Q ss_pred C-----eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcE
Q 008026 466 N-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540 (580)
Q Consensus 466 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 540 (580)
. ..++||||++ ++|.+++.. .....+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK---APPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT---CCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence 5 4789999996 599988843 222348999999999999999999998 899999999999999999999
Q ss_pred EEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
||+|||+++...... ......||+.|+|||++.+..++
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 197 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYA 197 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCC
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCC
Confidence 999999998764432 23446799999999999877653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=245.21 Aligned_cols=176 Identities=28% Similarity=0.392 Sum_probs=146.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|.+.+.||+|+||.||+|+.. ++..||+|++.... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 357999999999999999999775 68999999997643 3334678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec---CCCcEEEEeecccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLVR 549 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~ 549 (580)
||+++++|.+++...... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++ .++.+||+|||+++
T Consensus 100 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999988664433 2568999999999999999999998 8999999999999994 56789999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
...... ......||+.|+|||++.+
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFKR 200 (285)
T ss_dssp C------------CTTGGGCCHHHHTT
T ss_pred ecCCcc--cCcCcccccCcCChHHhcc
Confidence 664432 2234578999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=252.85 Aligned_cols=186 Identities=28% Similarity=0.350 Sum_probs=154.3
Q ss_pred HHHHHHhhcCCccc-ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEE
Q 008026 387 IQVLRNVTNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCL 463 (580)
Q Consensus 387 ~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 463 (580)
++..+.+.++|.+. +.||+|+||.||+|... +++.||+|++............+.+|+.+++.++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34455667788887 89999999999999776 6899999999876555555678999999999996 799999999999
Q ss_pred cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcE
Q 008026 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRA 540 (580)
Q Consensus 464 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~ 540 (580)
..+..++||||+++++|.+++.. .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred eCCeEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999988733 223568999999999999999999998 89999999999999987 7899
Q ss_pred EEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
||+|||+++...... ......||+.|+|||++.+.+++
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 211 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPIT 211 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCC
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCC
Confidence 999999998765432 22345799999999999887653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=249.33 Aligned_cols=177 Identities=29% Similarity=0.445 Sum_probs=153.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|.+. ++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 467999999999999999999876 5889999998753 334578899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 89 e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 89 EFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp ECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999854 233568999999999999999999998 799999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
...........||+.|+|||++.+..+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 189 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKF 189 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCC
T ss_pred CCccccccCCccccCcCChhhhccCCC
Confidence 544333344567889999999876654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=246.17 Aligned_cols=175 Identities=30% Similarity=0.447 Sum_probs=150.1
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 57899999999999999999988889999999976432 346789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999998853 22468899999999999999999998 89999999999999999999999999999866432
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.........||+.|+|||++.+..+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRY 182 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred cccccccccccccccChhhhcCCCc
Confidence 2112223457889999999876554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=244.81 Aligned_cols=177 Identities=25% Similarity=0.383 Sum_probs=152.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357999999999999999999876 588999999976543 334567789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.++..
T Consensus 94 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 999999999988743 1368899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..... ......||+.|+|||++.+..+
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 192 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGH 192 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCB
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCC
Confidence 43322 2334579999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=249.19 Aligned_cols=178 Identities=24% Similarity=0.321 Sum_probs=143.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999875 6899999999764332 33457789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999988542 368899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
............||+.|+|||++.+..+
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 212 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHA 212 (309)
T ss_dssp ------------CCGGGCCGGGTCC---
T ss_pred cccccccccccCCCcCccCHHHHcCCCC
Confidence 5443223334579999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=262.10 Aligned_cols=177 Identities=27% Similarity=0.401 Sum_probs=148.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|++. +++.||||++... ......+++.+|++++++++||||+++++++...+..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 357899999999999999999886 7899999998753 23344567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++... ...+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp ECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999998542 1357889999999999999999998 899999999999999999999999999998654
Q ss_pred CCCCCc-cccccccCCccCccccCCCC
Q 008026 553 EGKGSI-ETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 553 ~~~~~~-~~~~~Gt~~y~APE~~~~~~ 578 (580)
...... .....+++.|+|||++.+..
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~ 291 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGR 291 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCE
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCC
Confidence 321111 11123577899999986544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=256.12 Aligned_cols=169 Identities=28% Similarity=0.419 Sum_probs=141.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC------
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 466 (580)
.++|++.+.||+|+||.||+|... +|+.||||++..........+++.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999774 7999999999765545555678899999999999999999999997653
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 7899988743 368899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+++..... ....+||+.|+|||++.+
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHT
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhC
Confidence 99875432 234578999999999876
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=254.95 Aligned_cols=171 Identities=32% Similarity=0.406 Sum_probs=141.1
Q ss_pred cccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecC
Q 008026 398 SEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 476 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 476 (580)
...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 33678999999999999764 68999999997632 2455789999999999999999999999999999999999999
Q ss_pred CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe--cCCCcEEEEeeccccccCCC
Q 008026 477 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 477 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 170 ~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 170 GGELFDRIIDE----SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp TCEEHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99999887541 2358899999999999999999998 899999999999999 56788999999999876543
Q ss_pred CCCccccccccCCccCccccCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.. .....||+.|+|||++.+..+
T Consensus 243 ~~--~~~~~gt~~y~aPE~~~~~~~ 265 (373)
T 2x4f_A 243 EK--LKVNFGTPEFLAPEVVNYDFV 265 (373)
T ss_dssp CB--CCCCCSSCTTCCHHHHTTCBC
T ss_pred cc--cccccCCCcEeChhhccCCCC
Confidence 32 233569999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=269.10 Aligned_cols=177 Identities=29% Similarity=0.442 Sum_probs=150.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|.+. ++..||||+++... ...+++.+|++++++++||||+++++++......++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 457889999999999999999876 48899999997632 24578999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.. .....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999854 223468899999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
...........+++.|+|||++.+..+
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 396 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKF 396 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEE
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCC
Confidence 432222223456788999999875543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=245.19 Aligned_cols=178 Identities=29% Similarity=0.500 Sum_probs=134.7
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999977 47899999999754322 22356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+...
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999988843 23568999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..... ......||+.|+|||++.+..+
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 189 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAH 189 (278)
T ss_dssp C---------------------------
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCC
Confidence 43322 2233578999999999887654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=265.80 Aligned_cols=174 Identities=29% Similarity=0.421 Sum_probs=149.8
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|+.. +++.||+|++............+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4467999999999999999999875 789999999976544445567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec---CCCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a 548 (580)
|||+.+++|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999887542 468999999999999999999998 8999999999999995 4567999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+...... .....+||+.|+|||++.+
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCC
Confidence 8765432 2334579999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=255.60 Aligned_cols=183 Identities=24% Similarity=0.314 Sum_probs=147.0
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 466 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 466 (580)
..+.++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 455678999999999999999999774 688999999976432 3345678999999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhhh-----------------------------------CCCCccHHHHHHHHHHHHHHH
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEE-----------------------------------GLKPLEWNRRLTIALDVARGV 511 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------~~~~~~~~~~~~i~~~i~~aL 511 (580)
..++||||+++++|.+++...... ....+++..+..++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999988421110 011246778889999999999
Q ss_pred HHHHhCCCCCcEecCCCCCCeEecCCC--cEEEEeeccccccCCCCC---CccccccccCCccCccccCC
Q 008026 512 EYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPEGKG---SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 512 ~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~---~~~~~~~Gt~~y~APE~~~~ 576 (580)
+|||+ .+|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.+
T Consensus 182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 99998 7999999999999998766 899999999986533211 12234579999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=245.53 Aligned_cols=175 Identities=30% Similarity=0.513 Sum_probs=147.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|... ++..||+|++...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999765 5789999998764322 22356788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999888542 358899999999999999999997 89999999999999999999999999998654
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....||+.|+|||++.+..+
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~ 184 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMH 184 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCC
T ss_pred Cccc---ccccCCCCCccCHhHhccCCC
Confidence 3322 234578999999999987664
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=257.28 Aligned_cols=172 Identities=22% Similarity=0.331 Sum_probs=145.6
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC--CCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999998888999999999876555666788999999999997 599999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
| +.+++|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 568899998853 2367888999999999999999997 8999999999999995 5799999999998765
Q ss_pred CCCCC-ccccccccCCccCccccCC
Q 008026 553 EGKGS-IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~~~-~~~~~~Gt~~y~APE~~~~ 576 (580)
..... .....+||+.|+|||++.+
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHC
T ss_pred CCCccccCCCCCcCCCccChHHhhh
Confidence 43221 2234679999999999865
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=243.13 Aligned_cols=173 Identities=27% Similarity=0.440 Sum_probs=149.9
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4567999999999999999999775 578999999976432 3457889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe---cCCCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 548 (580)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 85 MELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 999999999988744 1458899999999999999999998 899999999999999 78889999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
....... ......||+.|+|||++.+.
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~ 183 (277)
T 3f3z_A 157 ARFKPGK--MMRTKVGTPYYVSPQVLEGL 183 (277)
T ss_dssp EECCTTS--CBCCCCSCTTTCCHHHHTTC
T ss_pred eeccCcc--chhccCCCCCccChHHhccc
Confidence 8765433 23345799999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-29 Score=250.05 Aligned_cols=177 Identities=25% Similarity=0.384 Sum_probs=152.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999775 578999999976543 334567789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++... ..+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999887431 468899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..... ......||+.|+|||++.+..+
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 218 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGH 218 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCB
T ss_pred ccCcc-cccccCCCccccCHHHhccCCC
Confidence 43322 2334579999999999877654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-29 Score=255.86 Aligned_cols=172 Identities=23% Similarity=0.328 Sum_probs=136.7
Q ss_pred hcCCccc-ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHh-cCCCcccceeeEEEc----CC
Q 008026 394 TNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK-VRHRHLVALLGHCLD----GN 466 (580)
Q Consensus 394 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~ 466 (580)
.++|.+. +.||+|+||.||+|... +++.||||++... ..+.+|++++.+ .+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4567766 78999999999999775 6899999998642 356788888755 479999999999875 56
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEE
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 543 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 543 (580)
..|+||||+++|+|.+++.. .....+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHC---C---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEE
Confidence 78999999999999999854 222468999999999999999999998 89999999999999987 7889999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+++...... .....+||+.|+|||++.+..|+
T Consensus 207 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 241 (400)
T 1nxk_A 207 DFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYD 241 (400)
T ss_dssp CCTTCEECC-------------CTTCCGGGSCCCCSS
T ss_pred ecccccccCCCC--ccccCCCCCCccCHhhcCCCCCC
Confidence 999998764332 22346799999999999887664
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=251.14 Aligned_cols=181 Identities=28% Similarity=0.423 Sum_probs=150.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
.++|.+.+.||+|+||.||+|... ++..||+|++... ......+.+.+|++++++++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 467999999999999999999752 3578999999753 244556789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhh-------------------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEE-------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 528 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlk 528 (580)
.++||||+++++|.+++...... ....+++.+++.++.||+.||+|||+ .+|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 99999999999999998653221 12348899999999999999999998 899999999
Q ss_pred CCCeEecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCC
Q 008026 529 PSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 529 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|+||+++.++.+||+|||+++........ ......||+.|+|||++.+..
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC
Confidence 99999999999999999999876443221 122345788999999886554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=250.72 Aligned_cols=175 Identities=26% Similarity=0.387 Sum_probs=146.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999875 5899999999765555555677889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLEL-----FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHH-----STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 9999988877652 23468999999999999999999998 899999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccCccccCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.... ......||+.|+|||++.+.
T Consensus 176 ~~~~-~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 176 APGE-VYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTC
T ss_pred CCcc-ccCCCcCCccccCcccccCC
Confidence 4322 22345789999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=245.47 Aligned_cols=181 Identities=24% Similarity=0.417 Sum_probs=151.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--CCeeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 470 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999775 78999999998765556667789999999999999999999998754 567899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC-----cEecCCCCCCeEecCCCcEEEEee
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-----FIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999865432 23468999999999999999999998 56 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|.++...... .......||+.|+|||++.+..+
T Consensus 161 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 193 (279)
T 2w5a_A 161 GLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSY 193 (279)
T ss_dssp CHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-C
T ss_pred chheeecccc-ccccccCCCccccChHHhccCCC
Confidence 9998764432 12234578999999999887655
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=257.96 Aligned_cols=242 Identities=24% Similarity=0.261 Sum_probs=200.0
Q ss_pred Cccccc--CCCCCccccccceEEecccCC-CCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCc
Q 008026 1 MLQLIG--GLPASFSGSQIQSLWVNGQNG-NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNF 76 (580)
Q Consensus 1 ~~~~~~--~~P~~~~~~~l~~L~~~~~~~-n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~ 76 (580)
.|++.| .+|..| .+++.|+.+++++ |.+.+..|..|.++++|++|+|++|.|++.+| .|.++++|++|+|++|+
T Consensus 59 ~~~l~~~~~~~~~l--~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 136 (313)
T 1ogq_A 59 GLNLPKPYPIPSSL--ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136 (313)
T ss_dssp CCCCSSCEECCGGG--GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred CCCccCCcccChhH--hCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence 367788 899988 5678888888884 77888889999999999999999999998777 58889999999999999
Q ss_pred ccccCCccccCCCCCcEEEccCCcccccCC-CCCccc-ccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccc
Q 008026 77 FTGPVPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSV-SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154 (580)
Q Consensus 77 l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~-~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~ 154 (580)
+++.+|..|.++++|++|+|++|++++.+| .+..+. +|+.|++++|.+....+..+..+. +...
T Consensus 137 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~--------------L~~L 202 (313)
T 1ogq_A 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--------------LAFV 202 (313)
T ss_dssp EESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC--------------CSEE
T ss_pred cCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc--------------ccEE
Confidence 999999999999999999999999997666 577887 899999999988755444333221 2333
Q ss_pred cCCCCCCC-CccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 155 WKGNDPCS-DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 155 ~~~~~~~~-~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
.+.++... ..+..+..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|.++..+++|++|+|++|+++
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 281 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccc
Confidence 34444333 3455667778999999999999977665 899999999999999999999999999999999999999999
Q ss_pred ccCCCCCC---CceeecCCCCCCCCCCCC
Q 008026 234 GKIPSFKS---NAIVNTDGNPDIGKEKSS 259 (580)
Q Consensus 234 g~~p~~~~---~~~~~~~~n~~~c~~~~~ 259 (580)
|.+|.... ...+.+.+|++.|+.+..
T Consensus 282 ~~ip~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 282 GEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp EECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred ccCCCCccccccChHHhcCCCCccCCCCC
Confidence 99998732 235888999999987554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=253.24 Aligned_cols=171 Identities=26% Similarity=0.409 Sum_probs=144.2
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeE
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 469 (580)
.+.++|++.+.||+|+||.||+|... +++.||+|++.+... ...+|++++.++ +||||+++++++.+.+..|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 34578999999999999999999775 689999999976432 235688888888 6999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC----CcEEEEee
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADF 545 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Df 545 (580)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+||
T Consensus 93 lv~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 93 VVTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 99999999999988843 2468999999999999999999998 899999999999998533 35999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
|+++....... .....+||+.|+|||++.+.
T Consensus 165 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 195 (342)
T 2qr7_A 165 GFAKQLRAENG-LLMTPCYTANFVAPEVLERQ 195 (342)
T ss_dssp TTCEECBCTTC-CBCCSSCCSSCCCHHHHHHH
T ss_pred CCcccCcCCCC-ceeccCCCccccCHHHhcCC
Confidence 99987654432 23346799999999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=248.84 Aligned_cols=176 Identities=26% Similarity=0.501 Sum_probs=146.0
Q ss_pred cCCcccceeeccCcEEEEEEEE-----cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--Ce
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 467 (580)
++|++.+.||+|+||.||+|++ .+++.||+|++.... .....+.+.+|++++++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4588999999999999999984 368999999997643 334557899999999999999999999999876 66
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence 89999999999999998542 2458899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCC--CccccccccCCccCccccCCCC
Q 008026 548 VRLAPEGKG--SIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 548 a~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
++....... .......||..|+|||++.+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 205 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCC
Confidence 987654432 1123356888999999886554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=244.47 Aligned_cols=175 Identities=29% Similarity=0.469 Sum_probs=147.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 35799999999999999999998888899999987643 23567899999999999999999999886 456899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.++....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999854221 258889999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
..........|++.|+|||++.+..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~ 186 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGT 186 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCE
T ss_pred cccccccCCCCccCccChhhhccCC
Confidence 3322223345788999999986544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=249.02 Aligned_cols=180 Identities=24% Similarity=0.396 Sum_probs=144.3
Q ss_pred HHHHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc--CCCcccceeeEEEcC
Q 008026 388 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV--RHRHLVALLGHCLDG 465 (580)
Q Consensus 388 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~ 465 (580)
.....+.++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 344556678999999999999999999876 899999998642 223445566665554 899999999999887
Q ss_pred ----CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC-----CCCcEecCCCCCCeEecC
Q 008026 466 ----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLGD 536 (580)
Q Consensus 466 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~ 536 (580)
...++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ +.+|+||||||+||+++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 678999999999999999843 36899999999999999999999720 129999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCCc---cccccccCCccCccccCCCCC
Q 008026 537 DMRAKVADFGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 537 ~~~~kl~Dfg~a~~~~~~~~~~---~~~~~Gt~~y~APE~~~~~~~ 579 (580)
++.+||+|||+++......... .....||+.|+|||++.+..+
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 223 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccC
Confidence 9999999999997664433211 123579999999999987643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=242.77 Aligned_cols=176 Identities=27% Similarity=0.410 Sum_probs=148.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh----hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999876 68999999997654322 2367899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC----cEEEEe
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVAD 544 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 544 (580)
++||||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 999999999999998853 1368899999999999999999998 8999999999999998776 899999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||.++...... ......||+.|+|||++.+..+
T Consensus 156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 188 (283)
T 3bhy_A 156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPL 188 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCC
T ss_pred cccceeccCCC--cccccCCCcCccCcceecCCCC
Confidence 99998764432 2233568999999999987665
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=263.35 Aligned_cols=176 Identities=31% Similarity=0.493 Sum_probs=143.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|.+.++..||||+++.... ..+++.+|++++++++||||+++++++.. +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 457899999999999999999998788899999976432 34678999999999999999999999876 67899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++..... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999854222 358889999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........+++.|+|||++.+..+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~ 358 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRF 358 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCC
T ss_pred CceecccCCcccccccCHhHHhcCCC
Confidence 32222233457889999999876654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=252.98 Aligned_cols=182 Identities=28% Similarity=0.412 Sum_probs=148.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 466 (580)
.++|++.+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 468999999999999999999862 45689999997532 334457899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhhh------------------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEE------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 528 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlk 528 (580)
..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999998653210 11347899999999999999999998 899999999
Q ss_pred CCCeEecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 529 PSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 529 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+||+++.++.+||+|||+++........ ......||+.|+|||++.+..+
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence 99999999999999999999866443322 2233567899999999876654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=256.59 Aligned_cols=174 Identities=26% Similarity=0.409 Sum_probs=138.0
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC------hhhHHHHHHHHHHHHhcCCCcccceeeEEEc
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 464 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 464 (580)
...++|.+.+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999765 6899999999764322 1122357899999999999999999999754
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC---CcEE
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAK 541 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~k 541 (580)
+..++||||+++++|.+++. ....+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ ..+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS-----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -CceEEEEEcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence 56799999999999988773 23568999999999999999999998 899999999999999754 4599
Q ss_pred EEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 542 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 542 l~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
|+|||+|+...... .....+||+.|+|||++.+
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC-
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeec
Confidence 99999998764432 2344679999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=248.58 Aligned_cols=182 Identities=29% Similarity=0.420 Sum_probs=151.6
Q ss_pred hcCCcccceeeccCcEEEEEEEE------cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCC
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 466 (580)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 45799999999999999999975 246889999997542 334567899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhh-------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeE
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAE-------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 533 (580)
..++||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 99999999999999999865321 112258999999999999999999998 89999999999999
Q ss_pred ecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 534 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 534 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
++.++.+||+|||+++........ ......||+.|+|||++.+..+
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence 999999999999999876544322 1223457889999999876654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=252.49 Aligned_cols=174 Identities=26% Similarity=0.363 Sum_probs=140.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC------
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 466 (580)
.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999765 6899999999875555556678899999999999999999999997665
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCCC-CHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEee
Confidence 67999999975 7777762 247889999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+++...... ......||+.|+|||++.+.+|+
T Consensus 173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 204 (371)
T 2xrw_A 173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 204 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCC
T ss_pred ccccccccc--ccCCceecCCccCHHHhcCCCCC
Confidence 998654322 23346799999999999887653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=258.55 Aligned_cols=172 Identities=34% Similarity=0.521 Sum_probs=146.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-eeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-EKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++.... ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 467899999999999999999876 7899999997532 4568999999999999999999999987765 789999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++... +...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999998642 23357889999999999999999998 899999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... ....+++.|+|||++.+..++
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~~~ 364 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKKFS 364 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCC
T ss_pred ccc----cCCCCCcceeCHHHhcCCCCC
Confidence 321 223578899999999877653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=244.20 Aligned_cols=182 Identities=25% Similarity=0.426 Sum_probs=143.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccc-cChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|... +++.||+|++.... .......++.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999764 78999999997533 2344567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999865433 23568899999999999999999998 89999999999999999999999999999866
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ......||+.|+|||++.+..++
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 214 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYN 214 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCC
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCC
Confidence 44322 22335689999999999877653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=264.14 Aligned_cols=174 Identities=29% Similarity=0.407 Sum_probs=144.9
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|+.. ++..||+|++............+.+|+.+++.++||||+++++++.+....|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999875 789999999987554445567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a 548 (580)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999998887542 458899999999999999999998 89999999999999975 455999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+...... .....+||+.|+|||++.+
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~~ 212 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLRK 212 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHTT
T ss_pred eECCCCc--cccccCCCcCeeCHHHHcc
Confidence 8765432 2334579999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=241.15 Aligned_cols=178 Identities=27% Similarity=0.405 Sum_probs=152.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 3467999999999999999999875 789999999976432 33457889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999999999988732 3468899999999999999999998 89999999999999999999999999999765
Q ss_pred CCCC-CCccccccccCCccCccccCCCCC
Q 008026 552 PEGK-GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~-~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... ........||+.|+|||++.+.++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREF 184 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSB
T ss_pred CCCcchhcccCCccccCccChHHHhcCCC
Confidence 4322 112234578999999999987653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=261.78 Aligned_cols=174 Identities=27% Similarity=0.406 Sum_probs=146.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh-----------hhHHHHHHHHHHHHhcCCCcccceee
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-----------KGLTEFKSEIAVLTKVRHRHLVALLG 460 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~~~~ 460 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999875 68899999997643321 33567899999999999999999999
Q ss_pred EEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC--
Q 008026 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 538 (580)
Q Consensus 461 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 538 (580)
++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999888541 468999999999999999999998 8999999999999998765
Q ss_pred -cEEEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 539 -RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 539 -~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.+||+|||+++...... ......||+.|+|||++.+
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc
Confidence 69999999998765432 2334579999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=243.36 Aligned_cols=171 Identities=21% Similarity=0.328 Sum_probs=148.6
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|++. ++.||+|++..........+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57999999999999999999885 89999999987655666677899999999999999999999999887 7789999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||+++++|.+++.. .....+++.+++.++.|++.||+|||+ .+ |+||||||+||+++.++.++|+|||++..
T Consensus 89 e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 89 HWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp ECCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred cccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999853 222358999999999999999999997 67 99999999999999999999999998764
Q ss_pred cCCCCCCccccccccCCccCccccCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
... ....||+.|+|||++.+..
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~ 184 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKP 184 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCG
T ss_pred ecc------cCccCCccccChhhhccCC
Confidence 322 2246899999999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-29 Score=263.42 Aligned_cols=174 Identities=28% Similarity=0.415 Sum_probs=151.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
+.++|++.+.||+|+||.||+|+.. +++.||||++...... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999876 7899999999765432 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe---cCCCcEEEEeecc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 547 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~ 547 (580)
||||+.+++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999988743 3468999999999999999999998 899999999999999 4678999999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
++...... ......||+.|+|||++.+
T Consensus 176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 176 STHFEASK--KMKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp HHHBCCCC--SHHHHTTGGGTCCHHHHHT
T ss_pred eEEccccc--ccccCCCCccccCceeecC
Confidence 98765443 2344579999999999865
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=249.51 Aligned_cols=168 Identities=30% Similarity=0.451 Sum_probs=145.0
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
+.|++.+.||+|+||.||+|+. .+++.||||++..... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999976 4789999999976432 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+. |+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9997 588777643 22468999999999999999999998 799999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccCccccC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.. ....||+.|+|||++.
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHH
T ss_pred CC-----CcccCCcceeCHhhhc
Confidence 32 2357999999999984
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=244.32 Aligned_cols=169 Identities=24% Similarity=0.403 Sum_probs=145.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CC-------cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DG-------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 465 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 465 (580)
.++|++.+.||+|+||.||+|... ++ ..||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 357999999999999999999765 33 47999998653 234557899999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc------
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR------ 539 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~------ 539 (580)
+..++||||+++++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999998542 2348889999999999999999998 89999999999999998876
Q ss_pred --EEEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 540 --AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 540 --~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+||+|||+++.... .....||+.|+|||++.+
T Consensus 158 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP-----KDILQERIPWVPPECIEN 191 (289)
T ss_dssp CEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHC
T ss_pred ceeeeccCcccccccC-----ccccCCcCcccCHHHhCC
Confidence 99999999875532 223468999999999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-29 Score=250.42 Aligned_cols=177 Identities=29% Similarity=0.450 Sum_probs=140.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcE----EEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|++. +++. ||+|.+... ......+++.+|+.++++++||||+++++++.... .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 57999999999999999999764 4443 577777543 23345678999999999999999999999998754 78
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+
T Consensus 93 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCccee
Confidence 99999999999998854 23468999999999999999999998 799999999999999999999999999998
Q ss_pred ccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
........ ......||+.|+|||++.+..++
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 197 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCC
T ss_pred EccCCcccccccCCCccccccChHHhccCCCC
Confidence 76543322 22234578899999998876653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=250.62 Aligned_cols=184 Identities=27% Similarity=0.441 Sum_probs=152.4
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 465 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 465 (580)
...++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 34568999999999999999999654 36789999987532 334556789999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhh-----CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcE
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 540 (580)
+..++||||+++++|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeE
Confidence 9999999999999999998764321 12456889999999999999999998 899999999999999999999
Q ss_pred EEEeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 541 KVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||+|||+++....... .......||+.|+|||++.+..+
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 217 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 217 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCC
Confidence 9999999976543221 11223457899999999876654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=249.77 Aligned_cols=177 Identities=29% Similarity=0.377 Sum_probs=141.6
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh---hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG---KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
...++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 68999999987533221 123467899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999976 88777632 33468889999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
++...... .......||+.|+|||++.+.
T Consensus 159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 187 (346)
T 1ua2_A 159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGA 187 (346)
T ss_dssp GSTTTSCC-CCCCCSCCCCTTCCHHHHTTC
T ss_pred ceeccCCc-ccCCcccccccccCchHhhCC
Confidence 98764432 223345789999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-28 Score=242.44 Aligned_cols=174 Identities=26% Similarity=0.447 Sum_probs=151.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 56899999999999999999764 689999999976432 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 101 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 101 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999988732 468999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......||+.|+|||++.+..+
T Consensus 172 ~~~-~~~~~~~~~~y~aPE~~~~~~~ 196 (303)
T 3a7i_A 172 TQI-KRNTFVGTPFWMAPEVIKQSAY 196 (303)
T ss_dssp TBC-CBCCCCSCGGGCCHHHHTTCCB
T ss_pred ccc-ccCccCCCcCccCHHHHhcCCC
Confidence 321 2234578999999999987664
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=243.82 Aligned_cols=172 Identities=32% Similarity=0.553 Sum_probs=136.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|+.. ..||+|++..........+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999764 4699999987655666678899999999999999999999965 4566899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999888743 23468899999999999999999998 8999999999999999999999999999976543
Q ss_pred CC-CCccccccccCCccCccccC
Q 008026 554 GK-GSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 554 ~~-~~~~~~~~Gt~~y~APE~~~ 575 (580)
.. ........||+.|+|||++.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp -----------CCCTTCCHHHHC
T ss_pred ccccccccccCCCccccCchhhc
Confidence 22 12223457999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=242.47 Aligned_cols=175 Identities=27% Similarity=0.473 Sum_probs=150.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|... ++..||+|++...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999775 6789999998754322 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999988542 358899999999999999999997 89999999999999999999999999998765
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... .....||+.|+|||++.+..+
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~~~~ 189 (284)
T 2vgo_A 165 PSLR---RRTMCGTLDYLPPEMIEGKTH 189 (284)
T ss_dssp SSSC---BCCCCSCGGGCCHHHHTTCCB
T ss_pred cccc---cccccCCCCcCCHHHhccCCC
Confidence 4322 234578999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=249.20 Aligned_cols=181 Identities=27% Similarity=0.435 Sum_probs=148.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc--------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEc
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 464 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 464 (580)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... .....+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 367999999999999999999763 46789999997642 445567899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhh-----------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeE
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 533 (580)
.+..++||||+++++|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 99999999999999999998653211 11348899999999999999999998 89999999999999
Q ss_pred ecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCC
Q 008026 534 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 534 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~ 578 (580)
++.++.+||+|||+++........ ......||+.|+|||++.+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 235 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC
Confidence 999999999999999876543211 122245788999999886544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-28 Score=240.96 Aligned_cols=170 Identities=26% Similarity=0.410 Sum_probs=146.7
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc----CCeeEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLL 470 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 470 (580)
.|++.+.||+|+||.||+|... ++..||+|++..........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4788899999999999999765 68899999998766666677889999999999999999999998875 355799
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeEec-CCCcEEEEeecc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGL 547 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~ 547 (580)
||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+||+++ +++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999998542 468899999999999999999997 66 99999999999998 789999999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+...... ......||+.|+|||++.+
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~~ 204 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGGT
T ss_pred ccccccc---ccccccCCcCcCCHHHHhc
Confidence 9765433 2234579999999998864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=250.09 Aligned_cols=175 Identities=26% Similarity=0.384 Sum_probs=146.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--------C
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--------G 465 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 465 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++............+.+|+++++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57999999999999999999874 78999999997655444455678899999999999999999999887 3
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
+..++||||+++ +|.+.+.. ....+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCC-CHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 468999999975 77766632 23468999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCC---CccccccccCCccCccccCCC
Q 008026 546 GLVRLAPEGKG---SIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 546 g~a~~~~~~~~---~~~~~~~Gt~~y~APE~~~~~ 577 (580)
|+|+....... .......||+.|+|||++.+.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 203 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCC
Confidence 99987643221 122345789999999998763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-28 Score=241.82 Aligned_cols=176 Identities=19% Similarity=0.289 Sum_probs=149.1
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+++++++ +|++++++++++......++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 346799999999999999999976 478999999986532 234578899999999 69999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc-----EEEEee
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADF 545 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Df 545 (580)
||||+ +++|.+++.. ....+++.++..++.||+.||+|||+ .+|+||||||+||+++.++. +||+||
T Consensus 84 v~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp EEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEEec-CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 99999 9999999854 22458999999999999999999997 89999999999999987765 999999
Q ss_pred ccccccCCCCCC------ccccccccCCccCccccCCCCCC
Q 008026 546 GLVRLAPEGKGS------IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 546 g~a~~~~~~~~~------~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|+++........ ......||+.|+|||++.+..++
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS 196 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCC
Confidence 999876543221 12345799999999999887653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=241.69 Aligned_cols=173 Identities=32% Similarity=0.515 Sum_probs=136.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|.+. ++.||+|++...... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357999999999999999999875 899999998754322 23357789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC---cEecCCCCCCeEecC--------CCcE
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS---FIHRDLKPSNILLGD--------DMRA 540 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~ 540 (580)
|||+++++|.+++. ...+++..+..++.|++.||+|||+ .+ |+||||||+||+++. ++.+
T Consensus 85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence 99999999988873 2468999999999999999999998 56 999999999999985 6789
Q ss_pred EEEeeccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 541 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 541 kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||+|||+++...... .....||+.|+|||++.+..+
T Consensus 156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 191 (271)
T 3dtc_A 156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMF 191 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHCCC
T ss_pred EEccCCccccccccc---ccCCCCccceeCHHHhccCCC
Confidence 999999998654432 223568999999999877654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=253.61 Aligned_cols=176 Identities=25% Similarity=0.363 Sum_probs=150.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|... ++..||+|++... ......+.+.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 367999999999999999999876 7899999999764 24445678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++... ..+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||+++...
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999998542 358899999999999999999997 1389999999999999999999999999987553
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... .....||+.|+|||++.+..++
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~~~~ 208 (360)
T 3eqc_A 184 DSM---ANSFVGTRSYMSPERLQGTHYS 208 (360)
T ss_dssp HHC-------CCCCTTCCHHHHTTCCCS
T ss_pred ccc---ccCCCCCCCeECHHHHcCCCCC
Confidence 221 2335799999999999887653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=246.05 Aligned_cols=172 Identities=31% Similarity=0.533 Sum_probs=145.4
Q ss_pred CcccceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC--CeeE
Q 008026 397 FSEENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKL 469 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 469 (580)
|++.+.||+|+||.||++.+. +++.||+|++... ......+.+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488999999999999988653 6889999999764 3345567899999999999999999999999874 5789
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++++|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 112 lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccc
Confidence 99999999999998843 348899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCC--ccccccccCCccCccccCCCC
Q 008026 550 LAPEGKGS--IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 550 ~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~ 578 (580)
........ ......||+.|+|||++.+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 213 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCE
T ss_pred cccccccccccccCCCCCceeeChHHhcCCC
Confidence 77544321 123346788999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=239.54 Aligned_cols=176 Identities=32% Similarity=0.461 Sum_probs=144.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999876 789999999976432 223456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999988542 358899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
.... ......||+.|+|||++.+..+
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~ 187 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLY 187 (276)
T ss_dssp CC---------------CCTGGGTTSCC
T ss_pred CCCc--ceecccCCccccCHHHHcCCCC
Confidence 4432 2234568999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=252.50 Aligned_cols=169 Identities=28% Similarity=0.424 Sum_probs=130.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC------C
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------N 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 466 (580)
.++|++.+.||+|+||.||+|... +++.||||++..........+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999764 789999999976544555667889999999999999999999998754 5
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..++|+||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 6899888732 468999999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+++..... .....||+.|+|||++.+
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp -----------------CCCTTCCHHHHTT
T ss_pred cccccccc----CCCcCcCcCccChHHHcC
Confidence 99865432 234579999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-29 Score=249.63 Aligned_cols=177 Identities=27% Similarity=0.464 Sum_probs=142.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcE----EEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|.+. +++. ||+|.+.... .......+.+|+.++++++||||+++++++. ....+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 57999999999999999999764 4443 7777775432 2233456788999999999999999999886 45689
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+.+|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccc
Confidence 999999999999988532 2367889999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
........ ......||+.|+|||++.+..++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCC
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCC
Confidence 76544322 23345688899999998776653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=242.35 Aligned_cols=173 Identities=31% Similarity=0.516 Sum_probs=147.6
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-------
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------- 464 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------- 464 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4467999999999999999999876 78999999987532 356789999999999999999998864
Q ss_pred ---------CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec
Q 008026 465 ---------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 535 (580)
Q Consensus 465 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 535 (580)
....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLV 156 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEc
Confidence 345799999999999999986532 2468899999999999999999998 8999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 536 DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 536 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+++.+||+|||+++....... .....||+.|+|||++.+..+
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 198 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDY 198 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCC
T ss_pred CCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCC
Confidence 999999999999987654332 233568999999999877654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=243.20 Aligned_cols=175 Identities=29% Similarity=0.459 Sum_probs=148.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4567999999999999999999875 78999999997532 22345788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe---cCCCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 548 (580)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999888441 358899999999999999999998 899999999999999 77889999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+..... ......||+.|+|||++.+..++
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 185 (304)
T 2jam_A 157 KMEQNG---IMSTACGTPGYVAPEVLAQKPYS 185 (304)
T ss_dssp CCCCCB---TTHHHHSCCCBCCTTTBSSCSCC
T ss_pred eecCCC---ccccccCCCCccChHHhccCCCC
Confidence 765332 22345699999999999887653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-29 Score=250.04 Aligned_cols=173 Identities=25% Similarity=0.377 Sum_probs=138.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57999999999999999999876 789999999865321 1122245579999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 997 588887743 23468899999999999999999998 8999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccCccccCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
... ......||+.|+|||++.+.
T Consensus 153 ~~~-~~~~~~~t~~y~aPE~~~~~ 175 (324)
T 3mtl_A 153 PTK-TYDNEVVTLWYRPPDILLGS 175 (324)
T ss_dssp -----------CGGGCCHHHHTTC
T ss_pred Ccc-ccccccCcccccChhhhcCC
Confidence 322 22345789999999998763
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=241.76 Aligned_cols=174 Identities=26% Similarity=0.345 Sum_probs=135.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467999999999999999999874 7899999999765433333444555556678889999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCC-CcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
||++ ++|.+++..... ....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 488888765433 33578999999999999999999998 6 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCcccc
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYA 574 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~ 574 (580)
..... .....||+.|+|||++
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERI 181 (290)
T ss_dssp -----------CCCCCCSCHHHH
T ss_pred ccccc--ccccCCCccccChhhc
Confidence 54322 2334699999999996
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=249.69 Aligned_cols=181 Identities=24% Similarity=0.336 Sum_probs=144.3
Q ss_pred eHHHHHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccC---------hhhHHHHHHHHHHHHhcCCCccc
Q 008026 386 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS---------GKGLTEFKSEIAVLTKVRHRHLV 456 (580)
Q Consensus 386 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv 456 (580)
..+++....++|++.+.||+|+||.||+|...++..||||++...... ....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456778889999999999999999999998888999999998653221 12247889999999999999999
Q ss_pred ceeeEEEc-----CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 008026 457 ALLGHCLD-----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 531 (580)
Q Consensus 457 ~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N 531 (580)
++++++.. ....++||||++ ++|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHH
Confidence 99999854 335799999997 588777742 23468999999999999999999998 899999999999
Q ss_pred eEecCCCcEEEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 532 ILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 532 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
|+++.++.+||+|||+++...... ......||+.|+|||++.+
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTT
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcC
Confidence 999999999999999997554332 2234578999999999876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=248.28 Aligned_cols=179 Identities=28% Similarity=0.455 Sum_probs=153.1
Q ss_pred HHHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC------hhhHHHHHHHHHHHHhc-CCCcccce
Q 008026 387 IQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKV-RHRHLVAL 458 (580)
Q Consensus 387 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~h~niv~~ 458 (580)
......+.++|++.+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 4455666788999999999999999999875 7999999998764311 11245678999999999 79999999
Q ss_pred eeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC
Q 008026 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 538 (580)
Q Consensus 459 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 538 (580)
++++......++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence 9999999999999999999999998853 1368899999999999999999998 8999999999999999999
Q ss_pred cEEEEeeccccccCCCCCCccccccccCCccCccccC
Q 008026 539 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.+||+|||++....... ......||+.|+|||++.
T Consensus 238 ~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILK 272 (365)
T ss_dssp CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHH
T ss_pred CEEEEecCcccccCCCc--ccccCCCCCCccChhhcc
Confidence 99999999998765432 233467999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=244.98 Aligned_cols=184 Identities=31% Similarity=0.468 Sum_probs=141.9
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe-
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE- 467 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 467 (580)
..++|.+.+.||+|+||.||+|... ++..||+|++..........+.+.+|+.++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3467999999999999999999764 34589999998765555667789999999999999999999999987653
Q ss_pred ----eEEEEEecCCCChhHHHHHHhh-hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 468 ----KLLVFEYMPQGTLSRHIFNWAE-EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 468 ----~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
.++||||+++++|.+++..... .....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 4999999999999998854321 234578999999999999999999997 89999999999999999999999
Q ss_pred EeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 543 ADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+|||+++....... .......|++.|+|||.+.+..+
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 226 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 226 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCc
Confidence 99999986644321 11223457889999999877665
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=241.95 Aligned_cols=175 Identities=27% Similarity=0.440 Sum_probs=142.1
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-------
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------- 464 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------- 464 (580)
+.++|++.+.||+|+||.||+|+.. +++.||+|++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 3567999999999999999999875 789999999865 23455788999999999999999999998865
Q ss_pred ------CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC
Q 008026 465 ------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 538 (580)
Q Consensus 465 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 538 (580)
....++||||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCC
Confidence 3467899999999999999853 22357788899999999999999998 8999999999999999999
Q ss_pred cEEEEeeccccccCCCC-------------CCccccccccCCccCccccCCC
Q 008026 539 RAKVADFGLVRLAPEGK-------------GSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~-------------~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.+||+|||+++...... ........||+.|+|||++.+.
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 99999999997654321 1112345689999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=246.16 Aligned_cols=178 Identities=25% Similarity=0.452 Sum_probs=143.0
Q ss_pred cCCcccceeeccCcEEEEEEEEcC-----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|.... +..||+|++.... .......+.+|++++++++||||+++++++...+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 578889999999999999997652 2469999987542 4445667899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++++|.+++.. ....+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999998853 23468999999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCc--cccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGSI--ETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~~--~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
......... .....||+.|+|||++.+..++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 228 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCC
Confidence 764432111 1223467889999998776653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-29 Score=266.23 Aligned_cols=176 Identities=31% Similarity=0.493 Sum_probs=148.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|.+.++..||||+++.... ..+++.+|++++++++||||+++++++.. +..++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 467899999999999999999998888899999976432 34679999999999999999999999876 67899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++..... ..+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999864322 357889999999999999999998 8999999999999999999999999999986643
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........++..|+|||++.+..+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~ 441 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRF 441 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCC
T ss_pred CceecccCCcCcccccCHHHhccCCC
Confidence 21111122346788999999876654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=253.14 Aligned_cols=175 Identities=25% Similarity=0.383 Sum_probs=147.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC--eeEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--EKLL 470 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 470 (580)
.++|++.+.||+|+||.||+|++. +++.||||++..... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 357999999999999999999876 589999999975432 234567889999999999999999999998765 6799
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe----cCCCcEEEEeec
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 546 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg 546 (580)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999999854322 2348999999999999999999998 899999999999999 777789999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+++...... ......||+.|+|||++.+
T Consensus 162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 162 AARELEDDE--QFVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp GCEECCCGG--GSSCSSSCCTTCCHHHHHH
T ss_pred CceEccCCC--ccccccCCccccCHHHhhc
Confidence 998765432 2234579999999998753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=247.57 Aligned_cols=182 Identities=27% Similarity=0.420 Sum_probs=150.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEcC-C-----cEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHD-G-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 466 (580)
.++|++.+.||+|+||.||+|.... + ..||+|.+.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4689999999999999999997642 2 479999987632 334567899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHHHHhhh---------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEE---------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 537 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 537 (580)
..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCC
Confidence 999999999999999998654321 12457899999999999999999998 899999999999999999
Q ss_pred CcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 538 MRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 538 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+.+||+|||+++........ ......||+.|+|||++.+..+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 243 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC
Confidence 99999999999865433221 2233457889999999876554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=240.94 Aligned_cols=177 Identities=24% Similarity=0.378 Sum_probs=144.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEcC----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|++++++++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 3579999999999999999997642 3469999987642 34456789999999999999999999999865 4578
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 999999999999998542 2458899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..............||+.|+|||++.+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 191 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRF 191 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCC
Confidence 765433222333457889999999876654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-29 Score=252.94 Aligned_cols=179 Identities=18% Similarity=0.263 Sum_probs=141.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEcC------CcEEEEEEeeccccChh---------hHHHHHHHHHHHHhcCCCcccce
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGK---------GLTEFKSEIAVLTKVRHRHLVAL 458 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~ 458 (580)
.++|++.+.||+|+||.||+|.+.. ++.||+|++........ ....+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999998754 47899999875421100 01223456667778889999999
Q ss_pred eeEEEcC----CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 459 LGHCLDG----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 459 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
++++... ...++||||+ +++|.+++.. ....+++.+++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 9998764 4579999999 9999998854 23568999999999999999999998 899999999999999
Q ss_pred c--CCCcEEEEeeccccccCCCCC------CccccccccCCccCccccCCCCCC
Q 008026 535 G--DDMRAKVADFGLVRLAPEGKG------SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 535 ~--~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+ .++.+||+|||+++....... .......||+.|+|||++.+..++
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 239 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS 239 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC
Confidence 9 889999999999976543211 111335699999999999887653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=239.05 Aligned_cols=169 Identities=35% Similarity=0.667 Sum_probs=142.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhh-----HHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
++|++.+.||+|+||.||+|+.. +++.||+|++......... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57999999999999999999874 7899999998654332211 267899999999999999999999986654
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeEecCCCc-----EE
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMR-----AK 541 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~k 541 (580)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++. +|
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 799999999999888743 23468999999999999999999997 67 999999999999987776 99
Q ss_pred EEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 542 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 542 l~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
|+|||+++.... ......||+.|+|||++.+
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~ 200 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGA 200 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSC
T ss_pred eCCCCccccccc----cccccCCCccccCchhhcc
Confidence 999999975433 2334579999999999843
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=245.32 Aligned_cols=188 Identities=26% Similarity=0.380 Sum_probs=152.6
Q ss_pred HHHHHhhcCCcccceeeccCcEEEEEEEE------cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceee
Q 008026 388 QVLRNVTNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLG 460 (580)
Q Consensus 388 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 460 (580)
.......++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+++++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 34444567899999999999999999974 246889999997642 344556889999999999 6999999999
Q ss_pred EEEcCC-eeEEEEEecCCCChhHHHHHHhhhC-----------CCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 008026 461 HCLDGN-EKLLVFEYMPQGTLSRHIFNWAEEG-----------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 528 (580)
Q Consensus 461 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlk 528 (580)
++...+ ..++||||+++++|.+++....... ...+++..++.++.|++.||+|||+ .+|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCc
Confidence 988755 4899999999999999985422110 1238899999999999999999998 899999999
Q ss_pred CCCeEecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCC
Q 008026 529 PSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 529 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
|+||+++.++.+||+|||+++........ ......||+.|+|||++.+..+
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 99999999999999999999866443322 2233568999999999876654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=249.43 Aligned_cols=174 Identities=22% Similarity=0.335 Sum_probs=142.4
Q ss_pred HhhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-----
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----- 465 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 465 (580)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3457899999999999999999976 4789999999875321 224799999999999999999998543
Q ss_pred ---------------------------------CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHH
Q 008026 466 ---------------------------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512 (580)
Q Consensus 466 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~ 512 (580)
...++||||++ ++|.+.+...... ...+++..+..++.||+.||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHH
Confidence 34789999997 5888888654433 357899999999999999999
Q ss_pred HHHhCCCCCcEecCCCCCCeEec-CCCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 513 YLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 513 ~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|||+ .+|+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++.+..
T Consensus 156 ~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~ 217 (383)
T 3eb0_A 156 FIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGAT 217 (383)
T ss_dssp HHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCS
T ss_pred HHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCC
Confidence 9997 8999999999999998 688999999999987654332 23457899999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=244.18 Aligned_cols=173 Identities=32% Similarity=0.517 Sum_probs=138.5
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||.||+|+.. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 57899999999999999999875 788999998642 345788999999999999999999998863 47999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc-EEEEeeccccccCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPE 553 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~ 553 (580)
+++++|.+++... .....+++..++.++.|++.||+|||+...++|+||||||+||+++.++. +||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999998532 11224678899999999999999999743368999999999999998876 79999999976543
Q ss_pred CCCCccccccccCCccCccccCCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
. .....||+.|+|||++.+..++
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~ 181 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYS 181 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCC
T ss_pred c----cccCCCCCceEChhhhCCCCCC
Confidence 2 2234689999999999887653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=245.95 Aligned_cols=175 Identities=28% Similarity=0.462 Sum_probs=147.6
Q ss_pred cCCcccceeeccCcEEEEEEEE-----cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEE--cCCe
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL--DGNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~ 467 (580)
++|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|++++++++||||+++++++. ....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 5799999999999999999984 36889999998753 3445577999999999999999999999887 4566
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccc
Confidence 899999999999999985422 258899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCC--ccccccccCCccCccccCCCC
Q 008026 548 VRLAPEGKGS--IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 548 a~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~ 578 (580)
++........ ......||+.|+|||++.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCC
Confidence 9876543321 122345888999999986554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-29 Score=256.59 Aligned_cols=175 Identities=17% Similarity=0.216 Sum_probs=140.5
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeecccc-ChhhHHHHHHHH---HHHHhcCCCccccee-------eE
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEI---AVLTKVRHRHLVALL-------GH 461 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~ 461 (580)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999986 4699999999975432 344567889999 555566899999998 66
Q ss_pred EEcCC-----------------eeEEEEEecCCCChhHHHHHHhhhC--CCCccHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 008026 462 CLDGN-----------------EKLLVFEYMPQGTLSRHIFNWAEEG--LKPLEWNRRLTIALDVARGVEYLHGLAHQSF 522 (580)
Q Consensus 462 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~i 522 (580)
+...+ ..|+||||+ +|+|.+++....... ...+++..++.|+.||+.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 65553 278999999 679999986542211 1235568888999999999999998 899
Q ss_pred EecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccccccccCCccCccccCCC
Q 008026 523 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 523 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+||||||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+.
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhccc
Confidence 9999999999999999999999999986432 2344578 999999998765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=241.85 Aligned_cols=177 Identities=30% Similarity=0.451 Sum_probs=144.3
Q ss_pred cCCcccceeeccCcEEEEEEEEcC----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEE-cCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL-DGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~ 469 (580)
.+|++.+.||+|+||.||+|...+ ...||+|.+... ......+.+.+|++++++++||||+++++++. .++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 468889999999999999997642 236899988752 34445678999999999999999999999865 456789
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccc
Confidence 99999999999998843 23467889999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCC---CccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKG---SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~---~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
....... .......||+.|+|||.+.+..+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCC
Confidence 6543221 11233467889999999876655
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=244.08 Aligned_cols=179 Identities=25% Similarity=0.412 Sum_probs=149.3
Q ss_pred HHHHHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHh--cCCCcccceeeEEEc
Q 008026 387 IQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK--VRHRHLVALLGHCLD 464 (580)
Q Consensus 387 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~ 464 (580)
......+.++|++.+.||+|+||.||+|+. +++.||+|++... ....+.+|++++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 334455677899999999999999999987 4899999998642 34567889999888 689999999999988
Q ss_pred CC----eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhC-----CCCCcEecCCCCCCeEec
Q 008026 465 GN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLG 535 (580)
Q Consensus 465 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivH~Dlkp~NIll~ 535 (580)
.. ..++||||+++++|.+++.. ..+++.+++.++.|++.||+|||.. +..+|+||||||+||+++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 76 78999999999999999843 3588999999999999999999921 017999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC---ccccccccCCccCccccCCC
Q 008026 536 DDMRAKVADFGLVRLAPEGKGS---IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 536 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~Gt~~y~APE~~~~~ 577 (580)
.++.+||+|||+++........ ......||+.|+|||++.+.
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence 9999999999999876543321 12335799999999998765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=241.77 Aligned_cols=176 Identities=31% Similarity=0.459 Sum_probs=146.2
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
...++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34568999999999999999999775 68999999997532 34678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||.+..
T Consensus 102 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999998843 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCccCccccCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
...... ......||+.|+|||++.+..+
T Consensus 175 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 202 (314)
T 3com_A 175 LTDTMA-KRNTVIGTPFWMAPEVIQEIGY 202 (314)
T ss_dssp CBTTBS-CBCCCCSCGGGCCHHHHSSSCB
T ss_pred hhhhcc-ccCccCCCCCccChhhcCCCCC
Confidence 654322 2234578999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=242.10 Aligned_cols=173 Identities=26% Similarity=0.371 Sum_probs=141.0
Q ss_pred hcCCccc-ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 394 TNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 394 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
.+.|++. +.||+|+||.||+|... +++.||||++.... ......+.+|++++.++ +||||+++++++.+.+..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4578874 78999999999999764 78999999997642 33457889999999995 69999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc---EEEEeecc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFGL 547 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~ 547 (580)
||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 89 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 99999999999998542 368899999999999999999998 79999999999999987765 99999999
Q ss_pred ccccCCCCC------CccccccccCCccCccccCC
Q 008026 548 VRLAPEGKG------SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 548 a~~~~~~~~------~~~~~~~Gt~~y~APE~~~~ 576 (580)
++....... .......||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHH
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhc
Confidence 876532211 11123469999999999754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=239.46 Aligned_cols=177 Identities=27% Similarity=0.419 Sum_probs=146.2
Q ss_pred CCcccceeeccCcEEEEEEEEc-CC---cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee-EE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK-LL 470 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~l 470 (580)
.|+..+.||+|+||.||+|.+. ++ ..||+|++... ......+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4666799999999999999754 22 37999998752 3344567889999999999999999999999876655 99
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+.+++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999998843 23568899999999999999999998 8999999999999999999999999999976
Q ss_pred cCCCC---CCccccccccCCccCccccCCCCCC
Q 008026 551 APEGK---GSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~---~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ........||+.|+|||.+.+..++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 206 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFT 206 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCC
Confidence 54321 1112335678999999999887653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=239.00 Aligned_cols=175 Identities=25% Similarity=0.420 Sum_probs=145.2
Q ss_pred cCCcccc-eeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEEN-ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|.+.+ .||+|+||.||+|.+. ++..||+|++... ......+++.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4566666 9999999999999753 5788999999764 2345567899999999999999999999999 4566899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 9999999999998842 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCCc--cccccccCCccCccccCCCC
Q 008026 551 APEGKGSI--ETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 551 ~~~~~~~~--~~~~~Gt~~y~APE~~~~~~ 578 (580)
........ .....||+.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRK 189 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred eccCcceeeccccccccccccCHHHhccCC
Confidence 65432211 12235688999999986544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=241.80 Aligned_cols=178 Identities=29% Similarity=0.388 Sum_probs=146.6
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc----CCee
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEK 468 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 468 (580)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 35799999999999999999987 47899999998653 34456788999999999999999999999873 3478
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 999999999999999866433 23578999999999999999999998 79999999999999999999999999998
Q ss_pred cccCCCCCC--------ccccccccCCccCccccCCC
Q 008026 549 RLAPEGKGS--------IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 549 ~~~~~~~~~--------~~~~~~Gt~~y~APE~~~~~ 577 (580)
+........ ......||+.|+|||++.+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 218 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ 218 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccC
Confidence 765321110 01224579999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=245.72 Aligned_cols=168 Identities=30% Similarity=0.522 Sum_probs=134.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHH--HHhcCCCcccceeeEEEc-----CC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAV--LTKVRHRHLVALLGHCLD-----GN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~ 466 (580)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 36899999999999999999976 58999999986531 2334444444 455899999999986542 23
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCC---------CcEecCCCCCCeEecCC
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ---------SFIHRDLKPSNILLGDD 537 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~---------~ivH~Dlkp~NIll~~~ 537 (580)
..++||||+++|+|.+++.. ...++..+..++.||+.||+|||+ . +|+||||||+|||++.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred eEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCC
Confidence 56899999999999999843 245888999999999999999997 5 99999999999999999
Q ss_pred CcEEEEeeccccccCCCC-------CCccccccccCCccCccccCC
Q 008026 538 MRAKVADFGLVRLAPEGK-------GSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 538 ~~~kl~Dfg~a~~~~~~~-------~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+.+||+|||+++...... ........||+.|+|||++.+
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 999999999998764321 111223569999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=243.29 Aligned_cols=172 Identities=27% Similarity=0.404 Sum_probs=141.0
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC------hhhHHHHHHHHHHHHhcCCCcccceeeEEEcC
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 465 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 465 (580)
..++|++.+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999775 6899999998754321 12234588999999999999999999998765
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc---EEE
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKV 542 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl 542 (580)
. .++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 5 8999999999999888732 3568999999999999999999998 89999999999999986654 999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
+|||+++..... .......||+.|+|||++.
T Consensus 159 ~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 159 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp CCCTTCEECCCC--HHHHHHHSCCTTCCHHHHH
T ss_pred ccCccceecccc--cccccccCCcCccCchhhc
Confidence 999999876432 2233457999999999973
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=246.54 Aligned_cols=173 Identities=25% Similarity=0.389 Sum_probs=145.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-----Ce
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----NE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 467 (580)
.++|++.+.||+|+||.||+|... +++.||+|++... ......+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999999765 6889999999753 2344557889999999999999999999998765 36
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||++ ++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 899999997 589888743 358899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCC--ccccccccCCccCccccCCC
Q 008026 548 VRLAPEGKGS--IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 548 a~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~ 577 (580)
++........ ......||+.|+|||++.+.
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 206 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTB
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCC
Confidence 9866432211 12345799999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-28 Score=250.85 Aligned_cols=174 Identities=24% Similarity=0.290 Sum_probs=146.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc------CCCcccceeeEEEcC
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV------RHRHLVALLGHCLDG 465 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~ 465 (580)
+..+|++.+.||+|+||.||+|... +++.||||++... ......+.+|+++++.+ .|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3467999999999999999999765 6899999999752 33446777888888877 577999999999999
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc--EEEE
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVA 543 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~ 543 (580)
+..++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+ .+||||||||+|||++.++. +||+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKK---NKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred CeEEEEEeccC-CCHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEe
Confidence 99999999996 689888854 233458999999999999999999998 79999999999999998887 9999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+|+..... ....+||+.|+|||++.+..|+
T Consensus 245 DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 277 (429)
T 3kvw_A 245 DFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYG 277 (429)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCC
T ss_pred ecccceecCCc----ccccCCCCCccChHHHhCCCCC
Confidence 99999765432 2335789999999999887653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=247.68 Aligned_cols=169 Identities=25% Similarity=0.402 Sum_probs=142.9
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee---
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK--- 468 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 468 (580)
+.++|.+.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999765 689999999987555555667889999999999999999999999877654
Q ss_pred ---EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 469 ---LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 469 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999997 58876652 348999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
|+++..... .....||+.|+|||++.+
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSC
T ss_pred CcccccccC----cCCcccCccccCHHHhcC
Confidence 999865432 234578999999999876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=241.39 Aligned_cols=164 Identities=21% Similarity=0.373 Sum_probs=142.8
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEc--CCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLD--GNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~l 470 (580)
++|++.+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|++++++++ ||||+++++++.. ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6799999999999999999976 47899999998642 2467899999999997 9999999999987 567899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC-cEEEEeecccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 549 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~ 549 (580)
||||+++++|.+++. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 111 v~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999988872 37888999999999999999998 8999999999999999766 89999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
....... .....||+.|+|||++.+
T Consensus 180 ~~~~~~~--~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 180 FYHPGQE--YNVRVASRYFKGPELLVD 204 (330)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTT
T ss_pred EcCCCCc--cccccccccccChhhhcC
Confidence 7654332 233578999999999876
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-28 Score=242.29 Aligned_cols=179 Identities=27% Similarity=0.381 Sum_probs=146.3
Q ss_pred hhcCCcccceeeccCcEEEEEEEE--cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc---CCCcccceeeEEE----
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL--HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCL---- 463 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---- 463 (580)
..++|++.+.||+|+||.||+|+. .+++.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 447899999999999999999987 3688999999976443333334566777777766 8999999999987
Q ss_pred -cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 464 -DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 464 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
.....++||||++ ++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 5999888542 22358899999999999999999998 89999999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+|||+++...... ......||+.|+|||++.+..++
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 197 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYA 197 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCC
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCC
Confidence 9999997654321 23345789999999999877653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=246.73 Aligned_cols=178 Identities=24% Similarity=0.395 Sum_probs=150.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChh---------------hHHHHHHHHHHHHhcCCCcccce
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK---------------GLTEFKSEIAVLTKVRHRHLVAL 458 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~~ 458 (580)
.++|++.+.||+|+||.||+|.. +++.||+|++........ ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 899999999976432211 12789999999999999999999
Q ss_pred eeEEEcCCeeEEEEEecCCCChhHHHHHH---hhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec
Q 008026 459 LGHCLDGNEKLLVFEYMPQGTLSRHIFNW---AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 535 (580)
Q Consensus 459 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~ 535 (580)
++++.+.+..++||||+++++|.+++... .......+++..+..++.|++.||+|||+ ..+|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 99999999999999999999999883210 11124578999999999999999999996 37899999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCCccccccccCCccCccccCCC
Q 008026 536 DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 536 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.++.+||+|||.++..... ......||+.|+|||++.+.
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSC
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCC
Confidence 9999999999999876443 23345789999999999876
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=250.11 Aligned_cols=176 Identities=30% Similarity=0.451 Sum_probs=135.9
Q ss_pred CCcccceeeccCcEEEEEEEEc--C--CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-CCeeEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH--D--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLL 470 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 470 (580)
.|++.+.||+|+||.||+|... + +..||+|.+... ......+++.+|+.++++++||||+++++++.. .+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4777899999999999999764 2 246899988652 334556789999999999999999999998754 457899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ....+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccc
Confidence 9999999999999843 23457889999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCC---ccccccccCCccCccccCCCCC
Q 008026 551 APEGKGS---IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~---~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
....... ......||+.|+|||++.+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 273 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCC
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCC
Confidence 5432211 1223457889999999877655
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=244.35 Aligned_cols=175 Identities=30% Similarity=0.461 Sum_probs=143.1
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEc----
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD---- 464 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---- 464 (580)
....++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 345678999999999999999999874 78999999987532 2346788999999999 79999999999987
Q ss_pred --CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 465 --GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 465 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
.+..++||||+++++|.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEE
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEE
Confidence 467899999999999999986532 2368889999999999999999998 89999999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
+|||++........ ......||+.|+|||++.
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhc
Confidence 99999886543321 223457899999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=240.48 Aligned_cols=175 Identities=26% Similarity=0.410 Sum_probs=143.1
Q ss_pred cCCcccc-eeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEEN-ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+ .||+|+||.||+|.+. +++.||+|++..........+++.+|+++++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5688887 9999999999999543 468899999976544445567899999999999999999999999 5667899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 95 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999998843 2458899999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCCcc--ccccccCCccCccccCCCC
Q 008026 551 APEGKGSIE--TRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 551 ~~~~~~~~~--~~~~Gt~~y~APE~~~~~~ 578 (580)
......... ....||+.|+|||++.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 196 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYK 196 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCE
T ss_pred eccCCCcccccccCCCCceeeChHHhccCC
Confidence 654432211 2234678899999986543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=244.63 Aligned_cols=177 Identities=29% Similarity=0.450 Sum_probs=139.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcE----EEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|++. +++. ||+|.+... ......+.+.+|+.++++++||||+++++++.... .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 57999999999999999999764 4544 577766542 23445678999999999999999999999998764 78
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+|+||+.+++|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 99999999999998854 23468899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
........ ......||+.|+|||++.+..++
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 197 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCC
Confidence 76443221 12234568899999998776653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=244.86 Aligned_cols=178 Identities=34% Similarity=0.513 Sum_probs=143.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcE--EEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|+.. ++.. ||+|.+... ......+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 57899999999999999999765 5664 499988753 2334456789999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 471 VFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
||||+++++|.+++..... .....+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 9999999999999854320 123468999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 540 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+||+|||+++...... ......+++.|+|||++.+..
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 217 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSV 217 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCE
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhcccc
Confidence 9999999987543221 122245788999999986544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=236.86 Aligned_cols=177 Identities=28% Similarity=0.403 Sum_probs=151.8
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
..+.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345578999999999999999999875 7899999999876555556788999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC---CcEEEEeec
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFG 546 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg 546 (580)
+||||+++++|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.+ +.+||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999998887431 358899999999999999999998 899999999999999754 469999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+++....... .....||+.|+|||++.+.
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 198 (287)
T 2wei_A 170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRGT 198 (287)
T ss_dssp GGGTBCCCSS--CSCHHHHHTTCCHHHHTTC
T ss_pred cceeecCCCc--cccccCcccccChHHhcCC
Confidence 9987644322 2334689999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=264.08 Aligned_cols=171 Identities=27% Similarity=0.400 Sum_probs=140.7
Q ss_pred ceeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||.||+|.+. +++.||||+++.........+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999653 46789999998765555567889999999999999999999999864 458899999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
|+|.+++.. ...+++.+++.|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+........
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999843 2468899999999999999999998 89999999999999999999999999999876543321
Q ss_pred --ccccccccCCccCccccCCCCCC
Q 008026 558 --IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 558 --~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
......||+.|+|||++.+..++
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~ 550 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFS 550 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCC
T ss_pred cccccCCCCceeeeChhhhcCCCCC
Confidence 12234568899999999776653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=238.03 Aligned_cols=178 Identities=22% Similarity=0.365 Sum_probs=144.8
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC--hhhHHHHHHHHHHHHhcCCCcccceeeEEE--cCCe
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKVRHRHLVALLGHCL--DGNE 467 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~ 467 (580)
..++|++.+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++. ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999875 6899999999764321 234578999999999999999999999985 4457
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||++++ |.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 76666432 23568999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCC-CCccccccccCCccCccccCCC
Q 008026 548 VRLAPEGK-GSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 548 a~~~~~~~-~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+....... ........||+.|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGL 186 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCc
Confidence 98764322 1222345689999999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=236.42 Aligned_cols=174 Identities=30% Similarity=0.370 Sum_probs=148.9
Q ss_pred HhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc---C----hhhHHHHHHHHHHHHhcC-CCcccceeeEE
Q 008026 392 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI---S----GKGLTEFKSEIAVLTKVR-HRHLVALLGHC 462 (580)
Q Consensus 392 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 462 (580)
...++|++.+.||+|+||.||+|... +++.||+|++..... . ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45678999999999999999999875 689999999975421 1 123456889999999996 99999999999
Q ss_pred EcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 463 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 463 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
...+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEE
Confidence 9999999999999999999998541 368899999999999999999998 89999999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCccCccccC
Q 008026 543 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
+|||++....... ......||+.|+|||++.
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHH
T ss_pred ecccchhhcCCCc--ccccccCCccccCHHHhc
Confidence 9999998765432 223457899999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=247.84 Aligned_cols=178 Identities=18% Similarity=0.224 Sum_probs=139.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccCh---------hhHHHHHHHHHHHHhcCCCcccceee
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISG---------KGLTEFKSEIAVLTKVRHRHLVALLG 460 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~ 460 (580)
.++|++.+.||+|+||.||+|... ++..||+|++....... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999875 57889999987642111 01234667889999999999999999
Q ss_pred EEEc----CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC
Q 008026 461 HCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 536 (580)
Q Consensus 461 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 536 (580)
++.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 9988 67889999999 99999988431 268999999999999999999998 89999999999999987
Q ss_pred CC--cEEEEeeccccccCCCCC------CccccccccCCccCccccCCCCCC
Q 008026 537 DM--RAKVADFGLVRLAPEGKG------SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 537 ~~--~~kl~Dfg~a~~~~~~~~------~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++ .+||+|||+++....... .......||+.|+|||++.+..++
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 238 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS 238 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC
Confidence 77 999999999986543211 112345799999999999877653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=247.45 Aligned_cols=172 Identities=15% Similarity=0.243 Sum_probs=143.0
Q ss_pred cCCcccceeeccCcEEEEEEEEcC---------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccc--------
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD---------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA-------- 457 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 457 (580)
++|++.+.||+|+||.||+|+... ++.||+|++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 579999999999999999997753 789999998753 35789999999999999998
Q ss_pred -------eeeEEEc-CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 008026 458 -------LLGHCLD-GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 529 (580)
Q Consensus 458 -------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp 529 (580)
+++++.. ....++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+ .+|+||||||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp 187 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTA 187 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCH
Confidence 5677765 67889999999 999999986421 2468999999999999999999998 8999999999
Q ss_pred CCeEecCCC--cEEEEeeccccccCCCCC------CccccccccCCccCccccCCCCCC
Q 008026 530 SNILLGDDM--RAKVADFGLVRLAPEGKG------SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 530 ~NIll~~~~--~~kl~Dfg~a~~~~~~~~------~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+||+++.++ .+||+|||+++....... .......||+.|+|||++.+..++
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 246 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS 246 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC
Confidence 999999988 899999999976543221 112335799999999999887653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=249.89 Aligned_cols=177 Identities=29% Similarity=0.405 Sum_probs=131.0
Q ss_pred hcCCcc-cceeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--CCe
Q 008026 394 TNNFSE-ENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNE 467 (580)
Q Consensus 394 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 467 (580)
.+.|++ .++||+|+||.||+|+.. +++.||+|++..... ...+.+|++++++++||||+++++++.. ...
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 345666 458999999999999865 578899999975332 2467899999999999999999999954 678
Q ss_pred eEEEEEecCCCChhHHHHHHhhh----CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe----cCCCc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEE----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMR 539 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 539 (580)
.++||||++ ++|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCc
Confidence 899999996 5888877543322 12248999999999999999999998 899999999999999 67789
Q ss_pred EEEEeeccccccCCCCC--CccccccccCCccCccccCCCC
Q 008026 540 AKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+||+|||+|+....... ......+||+.|+|||++.+.+
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 211 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 211 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC
Confidence 99999999987654321 1223467999999999998743
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=242.63 Aligned_cols=176 Identities=28% Similarity=0.519 Sum_probs=146.6
Q ss_pred hcCCcccceeeccCcEEEEEEEE-----cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC--
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-- 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 466 (580)
.++|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 35689999999999999999984 36899999998763 3445678999999999999999999999987654
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH----STTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceEEEEECCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 67999999999999999854 22458899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCCc--cccccccCCccCccccCCCC
Q 008026 547 LVRLAPEGKGSI--ETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 547 ~a~~~~~~~~~~--~~~~~Gt~~y~APE~~~~~~ 578 (580)
+++......... .....|+..|+|||++.+..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 224 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCC
Confidence 998765433211 12245778899999986543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=262.18 Aligned_cols=176 Identities=24% Similarity=0.401 Sum_probs=141.3
Q ss_pred CCcccc-eeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 396 NFSEEN-ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 396 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
++.+.+ .||+|+||.||+|.+. ++..||||+++.. ......+++.+|++++++++||||+++++++.. +..++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 344444 7999999999999764 4567999999764 234456789999999999999999999999976 568999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++|+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 414 ~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999998843 23468999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCcc--ccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIE--TRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~--~~~~Gt~~y~APE~~~~~~~~ 580 (580)
........ ....+|+.|+|||++.+..++
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~ 517 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFS 517 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCC
Confidence 44322111 123457899999998766653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=262.88 Aligned_cols=164 Identities=22% Similarity=0.240 Sum_probs=125.7
Q ss_pred eeeccCcEEEEEE-EEcCCcEEEEEEeecccc--------ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEE
Q 008026 402 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI--------SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 402 ~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 471 (580)
..+.|++|.+..+ +...|+.||+|++.+... .....+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777777666 344689999999976421 123346799999999999 599999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||++|++|.+++.+ ..+++.. +|+.||+.||+|+|+ ++||||||||+|||+++++.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 999999999999843 2355554 578999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.... ......+||+.|||||++.+.
T Consensus 390 ~~~~-~~~~t~vGTp~YmAPE~l~g~ 414 (569)
T 4azs_A 390 PQDC-SWPTNLVQSFFVFVNELFAEN 414 (569)
T ss_dssp C----CCSHHHHHHHHHHHHHHC---
T ss_pred CCCC-ccccCceechhhccHHHhCCC
Confidence 5443 233457899999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=248.28 Aligned_cols=170 Identities=25% Similarity=0.416 Sum_probs=138.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC----C--e
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----N--E 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~--~ 467 (580)
.+|++.+.||+|+||.||+|++. +++.||||++.... ....+|++++++++||||+++++++... + .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 36899999999999999999875 68999999986532 1234799999999999999999988542 2 3
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-CcEEEEeec
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 546 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg 546 (580)
.++||||+++ ++.+.+..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence 5799999975 67666654332 33578999999999999999999997 899999999999999955 678999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+++....... .....||+.|+|||++.+.
T Consensus 203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~ 231 (420)
T 1j1b_A 203 SAKQLVRGEP--NVSYICSRYYRAPELIFGA 231 (420)
T ss_dssp TCEECCTTCC--CCSCCSCTTSCCHHHHTTC
T ss_pred hhhhcccCCC--ceeeeeCCCcCCHHHHcCC
Confidence 9987654332 2345789999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=243.15 Aligned_cols=179 Identities=26% Similarity=0.432 Sum_probs=132.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|... +++.||+|++..... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 468999999999999999999764 689999998865322 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhh---CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 473 EYMPQGTLSRHIFNWAEE---GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
||+++++|.+++...... ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998654332 23458999999999999999999998 899999999999999999999999999987
Q ss_pred ccCCCCC----CccccccccCCccCccccCC
Q 008026 550 LAPEGKG----SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 550 ~~~~~~~----~~~~~~~Gt~~y~APE~~~~ 576 (580)
....... .......||+.|+|||++.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHH
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhcc
Confidence 6543221 11233579999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=243.41 Aligned_cols=182 Identities=26% Similarity=0.359 Sum_probs=145.4
Q ss_pred hcCCcccceeeccCcEEEEEEEE------cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
.++|++.+.||+|+||.||+|++ .++..||+|++... .......++.+|+.++++++||||+++++++.....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 35799999999999999999974 25778999999653 244456788999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhh--CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 542 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 542 (580)
.++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999998653221 12358899999999999999999998 89999999999999984 446999
Q ss_pred EeeccccccCCCCC-CccccccccCCccCccccCCCCC
Q 008026 543 ADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+|||+++....... .......||+.|+|||++.+..+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 222 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 222 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCC
Confidence 99999875533221 12233568999999999876654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=246.49 Aligned_cols=171 Identities=24% Similarity=0.394 Sum_probs=138.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe------
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE------ 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 467 (580)
..+|++.+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 346999999999999999999987777799998865321 12379999999999999999999865433
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-CCCcEEEEeec
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFG 546 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg 546 (580)
.++||||+++ ++.+.+..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 7899999976 44444433222 23578999999999999999999998 8999999999999999 78999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+|+....... .....||+.|+|||++.+.
T Consensus 188 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~ 216 (394)
T 4e7w_A 188 SAKILIAGEP--NVSYICSRYYRAPELIFGA 216 (394)
T ss_dssp TCEECCTTCC--CCSSCSCGGGCCHHHHTTC
T ss_pred CcccccCCCC--CcccccCcCccCHHHHcCC
Confidence 9987644332 2345789999999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=240.59 Aligned_cols=172 Identities=26% Similarity=0.428 Sum_probs=142.1
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3468999999999999999999876 6899999998753 233467889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999887542 2458899999999999999999998 89999999999999999999999999987543
Q ss_pred CCCCCCccccccccCCccCcccc
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYA 574 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~ 574 (580)
.... .......||+.|+|||++
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~ 189 (302)
T 2j7t_A 168 LKTL-QKRDSFIGTPYWMAPEVV 189 (302)
T ss_dssp HHHH-HC-----CCGGGCCHHHH
T ss_pred cccc-cccccccCChhhcCCeee
Confidence 2111 111234689999999997
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=242.07 Aligned_cols=173 Identities=29% Similarity=0.424 Sum_probs=143.3
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-----C
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 466 (580)
+.++|++.+.||+|+||.||+|... +++.||||++... ........+.+|++++++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3578999999999999999999875 6899999999642 2334456788999999999999999999987654 6
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 7899999997 589888743 368899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCC---------ccccccccCCccCccccCC
Q 008026 547 LVRLAPEGKGS---------IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 547 ~a~~~~~~~~~---------~~~~~~Gt~~y~APE~~~~ 576 (580)
+++........ ......||+.|+|||++.+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHS
T ss_pred cccccccccccccCccccccchhhccccccccCCeeecc
Confidence 99876432211 1123578999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=239.22 Aligned_cols=174 Identities=28% Similarity=0.406 Sum_probs=147.3
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-c-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCc------ccceeeEEEc
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-H-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH------LVALLGHCLD 464 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~ 464 (580)
+.++|++.+.||+|+||.||+|.. . +++.||+|++... ....+.+.+|+++++.++|++ ++++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 356899999999999999999976 3 6889999998652 344567889999999987654 9999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC--------
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 536 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------- 536 (580)
.+..++||||+ +++|.+++.. .....+++.++..++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKE---NGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred CCcEEEEEcCC-CCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999 8899998854 233468899999999999999999998 89999999999999987
Q ss_pred -----------CCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 537 -----------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 537 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++.+||+|||+++..... .....||+.|+|||++.+.+++
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 212 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWS 212 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCC
T ss_pred CccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCC
Confidence 668999999999865432 2335789999999999887653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=243.16 Aligned_cols=168 Identities=25% Similarity=0.397 Sum_probs=142.0
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe-----
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE----- 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 467 (580)
.++|.+.+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999775 68999999997755455556788999999999999999999999987654
Q ss_pred -eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 468 -KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 468 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
.++||||++ ++|.+++. ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 58877652 248899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+++..... .....||+.|+|||++.+
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSC
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhC
Confidence 99865432 234578999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=234.91 Aligned_cols=174 Identities=25% Similarity=0.403 Sum_probs=143.5
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
+|.....||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 4555679999999999999764 6889999998764 233457789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-CCcEEEEeeccccccCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPE 553 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 553 (580)
+++++|.+++... .....+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 101 VPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999988542 122356788899999999999999998 89999999999999987 89999999999987643
Q ss_pred CCCCccccccccCCccCccccCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.. .......||+.|+|||++.+.
T Consensus 176 ~~-~~~~~~~~~~~y~aPE~~~~~ 198 (295)
T 2clq_A 176 IN-PCTETFTGTLQYMAPEIIDKG 198 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHG
T ss_pred CC-CcccccCCCccccChhhhcCC
Confidence 32 122345789999999998653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=239.21 Aligned_cols=175 Identities=25% Similarity=0.355 Sum_probs=129.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHH-HHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|... +++.||||++.... ......++.+|+. +++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 367899999999999999999875 78999999997643 3334455666666 67778999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCC-CcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
|||+++ +|.+++..........+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 88887765444345678999999999999999999998 6 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCccCccccC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
..... ......||+.|+|||++.
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERID 198 (327)
T ss_dssp -------------------------
T ss_pred ccccc--ccccCCCCccccCceeec
Confidence 64432 123346999999999983
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=239.51 Aligned_cols=172 Identities=27% Similarity=0.367 Sum_probs=130.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEE--------c
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCL--------D 464 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~ 464 (580)
.+|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.+++++. ||||+++++++. .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 47899999999999999999865 7899999998653 3445577899999999996 999999999984 2
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeEecCCCcEEE
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl 542 (580)
....++||||++ |+|.+++..... ...+++.+++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEE
Confidence 345789999995 699988865332 3468999999999999999999997 67 999999999999999999999
Q ss_pred EeeccccccCCCCCCc-----------cccccccCCccCcccc
Q 008026 543 ADFGLVRLAPEGKGSI-----------ETRIAGTFGYLAPEYA 574 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~~~-----------~~~~~Gt~~y~APE~~ 574 (580)
+|||+++......... .....||+.|+|||++
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp CCCTTCBCCSSCC------------------------------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 9999998765432111 1134689999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-28 Score=235.91 Aligned_cols=171 Identities=33% Similarity=0.511 Sum_probs=138.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-CeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-NEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.. ++.||+|++... ...+.+.+|++++++++||||+++++++... +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 357999999999999999999875 889999998753 2456789999999999999999999987654 4789999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 95 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999865322 237888999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ....+++.|+|||++.+.++
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~~~ 191 (278)
T 1byg_A 169 STQ----DTGKLPVKWTAPEALREKKF 191 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCC
T ss_pred ccc----cCCCccccccCHHHhCCCCC
Confidence 322 22357899999999876654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-27 Score=233.06 Aligned_cols=176 Identities=22% Similarity=0.375 Sum_probs=145.5
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEE-EcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC-LDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~l 470 (580)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... ..++.+|+++++.++|++++..+.++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 357899999999999999999986 5789999999875432 24688999999999988876665554 56678899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe---cCCCcEEEEeecc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 547 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~ 547 (580)
||||+ +++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||++ ++++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 99999 8999998843 22468999999999999999999998 899999999999999 4788999999999
Q ss_pred ccccCCCCCC------ccccccccCCccCccccCCCCCC
Q 008026 548 VRLAPEGKGS------IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 548 a~~~~~~~~~------~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++........ ......||+.|+|||++.+..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 193 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCC
Confidence 9876544321 12345799999999999887653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-27 Score=233.33 Aligned_cols=176 Identities=22% Similarity=0.375 Sum_probs=141.9
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEE-EcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC-LDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~l 470 (580)
+.++|++.+.||+|+||.||+|+. .+++.||+|++..... ..++.+|+++++.++|++++..+..+ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 457899999999999999999986 4789999998765322 23578899999999988877666655 66778899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe---cCCCcEEEEeecc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 547 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~ 547 (580)
||||+ +++|.+++.. ....+++.++..++.||+.||+|||+ .+|+||||||+||++ ++++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEcc-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 99999 9999998843 22468999999999999999999998 899999999999999 7889999999999
Q ss_pred ccccCCCCCC------ccccccccCCccCccccCCCCCC
Q 008026 548 VRLAPEGKGS------IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 548 a~~~~~~~~~------~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++........ ......||+.|+|||++.+..++
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 193 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCC
Confidence 9876543321 12345799999999999887653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=246.71 Aligned_cols=174 Identities=27% Similarity=0.326 Sum_probs=144.6
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC--------CCcccceeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--------HRHLVALLGHCL 463 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~ 463 (580)
+.++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 3478999999999999999999764 6899999999752 344567889999999985 788999999987
Q ss_pred ----cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCC-CcEecCCCCCCeEecCCC
Q 008026 464 ----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDM 538 (580)
Q Consensus 464 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~ 538 (580)
.....++||||+ ++++.+.+.. .....+++..++.++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccc
Confidence 556789999999 5677666643 223468999999999999999999998 6 999999999999998775
Q ss_pred -------------------------------------------------cEEEEeeccccccCCCCCCccccccccCCcc
Q 008026 539 -------------------------------------------------RAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569 (580)
Q Consensus 539 -------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~ 569 (580)
.+||+|||.++..... .....||+.|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~ 260 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGC
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCccc
Confidence 7999999999876432 23347899999
Q ss_pred CccccCCCCCC
Q 008026 570 APEYAGNFGSS 580 (580)
Q Consensus 570 APE~~~~~~~~ 580 (580)
|||++.+.+|+
T Consensus 261 aPE~~~~~~~~ 271 (397)
T 1wak_A 261 SLEVLIGSGYN 271 (397)
T ss_dssp CHHHHHTSCCC
T ss_pred CChhhcCCCCC
Confidence 99999887653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-28 Score=246.48 Aligned_cols=170 Identities=12% Similarity=0.089 Sum_probs=126.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhc--CCCccccee-------eEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV--RHRHLVALL-------GHCL 463 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~ 463 (580)
.+|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999865 789999999987543 234456777885544444 699988755 4443
Q ss_pred cC-----------------CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHH------HHHHHHHHHHHHHHHhCCCC
Q 008026 464 DG-----------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR------LTIALDVARGVEYLHGLAHQ 520 (580)
Q Consensus 464 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~------~~i~~~i~~aL~~LH~~~~~ 520 (580)
.. ...|+||||++ ++|.+++..... .+++..+ ..++.||+.||+|||+ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 32 23799999998 899999965422 2344445 6788999999999998 8
Q ss_pred CcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccccccccCCccCccccCC
Q 008026 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 521 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+|+||||||+|||++.++.+||+|||+|+..... .....||+.|+|||++.+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTC
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccC
Confidence 9999999999999999999999999999866432 213457799999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=241.84 Aligned_cols=180 Identities=25% Similarity=0.311 Sum_probs=135.2
Q ss_pred HHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 389 VLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 389 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
......++|++.+.||+|+||.||+|+.. +++.||||++.... .......+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 44556689999999999999999999875 68999999986532 223456778888999999999999999876433
Q ss_pred -------eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHH--hCCCCCcEecCCCCCCeEecC-C
Q 008026 468 -------KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH--GLAHQSFIHRDLKPSNILLGD-D 537 (580)
Q Consensus 468 -------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH--~~~~~~ivH~Dlkp~NIll~~-~ 537 (580)
.++||||+++ +|.+.+..... ....+++..+..++.|++.||.||| + .+|+||||||+|||++. +
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCC
Confidence 7899999976 66555543322 3356888999999999999999999 6 89999999999999996 8
Q ss_pred CcEEEEeeccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 538 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 538 ~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
+.+||+|||+++....... .....||+.|+|||++.+..
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~ 207 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQ 207 (360)
T ss_dssp TEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCS
T ss_pred CcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCC
Confidence 9999999999987654332 23457899999999986543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=240.45 Aligned_cols=174 Identities=22% Similarity=0.325 Sum_probs=144.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC--CCcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~l 470 (580)
..++|++.+.||+|+||.||+|...+++.||+|++..........+.+.+|++++++++ ||||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34679999999999999999998888999999999876555666788999999999997 5999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||| +.+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++ +.+||+|||+++.
T Consensus 106 v~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999 557899998853 2468889999999999999999998 89999999999999965 8999999999987
Q ss_pred cCCCCCC-ccccccccCCccCccccCC
Q 008026 551 APEGKGS-IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 551 ~~~~~~~-~~~~~~Gt~~y~APE~~~~ 576 (580)
....... ......||+.|+|||++.+
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp --------------CCGGGCCHHHHTT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhh
Confidence 6443221 1234568999999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=260.90 Aligned_cols=178 Identities=22% Similarity=0.333 Sum_probs=144.8
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCee
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 468 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 468 (580)
..++|++.+.||+|+||.||+|.+. .+..||+|++... ......+.+.+|+.++++++||||+++++++. .+..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3467999999999999999999764 2467999988653 23445578999999999999999999999985 4668
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCC
Confidence 999999999999998853 22358899999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
+..............||+.|+|||++.+..+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 569 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRF 569 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCC
Confidence 8765443322333457889999999876655
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-28 Score=240.95 Aligned_cols=180 Identities=27% Similarity=0.348 Sum_probs=149.0
Q ss_pred HHHHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh----hhHHHHHHHHHHHHhcC--CCcccceee
Q 008026 388 QVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVR--HRHLVALLG 460 (580)
Q Consensus 388 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~ 460 (580)
.+.....++|++.+.||+|+||.||+|... +++.||||++....... .....+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344456678999999999999999999764 78999999997654322 12345678999999996 599999999
Q ss_pred EEEcCCeeEEEEEecCC-CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-CCC
Q 008026 461 HCLDGNEKLLVFEYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDM 538 (580)
Q Consensus 461 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 538 (580)
++...+..++||||+.+ ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++ +++
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCC
Confidence 99999999999999976 899988854 1468899999999999999999998 8999999999999999 788
Q ss_pred cEEEEeeccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 539 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.+||+|||+++...... .....||+.|+|||++.+.+
T Consensus 188 ~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 224 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHR 224 (320)
T ss_dssp EEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSC
T ss_pred CEEEeeCcccccccccc---ccCCCCCccCCChHHhccCC
Confidence 99999999998765432 23457999999999987554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=244.84 Aligned_cols=176 Identities=22% Similarity=0.353 Sum_probs=146.1
Q ss_pred hhcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCC-CcccceeeEEEcCCeeEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~l 470 (580)
+.++|++.+.||+|+||.||+|+. .+++.||||++..... ..++.+|+++++.++| +++..+..++...+..++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 347899999999999999999986 4789999998875432 2357889999999986 566666677778888999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe---cCCCcEEEEeecc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 547 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~ 547 (580)
||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+ .+||||||||+|||+ +.++.+||+|||+
T Consensus 81 vme~~-g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEECC-CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 99999 8999998853 23468999999999999999999998 899999999999999 5788999999999
Q ss_pred ccccCCCCCC------ccccccccCCccCccccCCCCCC
Q 008026 548 VRLAPEGKGS------IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 548 a~~~~~~~~~------~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++........ ......||+.|+|||++.+.+++
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s 191 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS 191 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCC
Confidence 9876544321 11246799999999999987764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=263.07 Aligned_cols=167 Identities=23% Similarity=0.369 Sum_probs=142.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEc--CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe----
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE---- 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 467 (580)
.++|++.+.||+|+||.||+|.+. +++.||||++... ........+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 468999999999999999999875 5899999998653 234455678999999999999999999999987665
Q ss_pred -eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 468 -KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 468 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
.|+||||+++++|.+++. ..+++.+++.++.||+.||+|||+ .+||||||||+|||++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999987662 268999999999999999999998 899999999999999875 89999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+++..... ....||+.|+|||++.+.
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~ 252 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTG 252 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHC
T ss_pred cchhcccC-----CccCCCccccCHHHHcCC
Confidence 99876443 335699999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=241.46 Aligned_cols=178 Identities=24% Similarity=0.303 Sum_probs=147.2
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CC-----cccceeeEEE
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HR-----HLVALLGHCL 463 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~ 463 (580)
..+.++|++.+.||+|+||.||+|... +++.||||++... .....++.+|+++++.++ |+ +|+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 345678999999999999999999765 6889999999752 334567788999988885 55 4999999999
Q ss_pred cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec--CCCcEE
Q 008026 464 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAK 541 (580)
Q Consensus 464 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~k 541 (580)
..+..++||||++ ++|.+++.. .....+++..+..++.|++.||.|||+. ..+||||||||+|||++ .++.+|
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRN---TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred cCCceEEEEecCC-CCHHHHHhh---cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 9999999999996 599988854 2224588999999999999999999952 26899999999999995 477899
Q ss_pred EEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 542 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 542 l~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|+|||+|+..... .....||+.|+|||++.+.+++
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~ 236 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYD 236 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCC
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCCCC
Confidence 9999999876432 2335789999999999987764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=234.92 Aligned_cols=172 Identities=24% Similarity=0.392 Sum_probs=136.7
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEE--------
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL-------- 463 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-------- 463 (580)
+.++|++.+.||+|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 3468999999999999999999876 5899999998753 3445678899999999999999999999874
Q ss_pred ------cCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-C
Q 008026 464 ------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-D 536 (580)
Q Consensus 464 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~ 536 (580)
.....++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ +
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTE 156 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCC
Confidence 3467899999997 599888732 468899999999999999999998 8999999999999997 5
Q ss_pred CCcEEEEeeccccccCCCCC--CccccccccCCccCccccCC
Q 008026 537 DMRAKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 537 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~~Gt~~y~APE~~~~ 576 (580)
++.+||+|||+++....... .......||+.|+|||++.+
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred CCeEEEccCccccccCCCcccccccccccccccccCcHHhcC
Confidence 67999999999986543211 11233467999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-28 Score=240.19 Aligned_cols=178 Identities=28% Similarity=0.383 Sum_probs=139.7
Q ss_pred HHHhhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh----hhHHHHHHHHHHHHhc----CCCcccceee
Q 008026 390 LRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKV----RHRHLVALLG 460 (580)
Q Consensus 390 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~~~~ 460 (580)
.....++|++.+.||+|+||.||+|+.. +++.||+|++....... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3455678999999999999999999764 68999999997643221 1233456799999998 8999999999
Q ss_pred EEEcCCeeEEEEEe-cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec-CCC
Q 008026 461 HCLDGNEKLLVFEY-MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDM 538 (580)
Q Consensus 461 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 538 (580)
++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCC
Confidence 99999999999999 7899999988541 358899999999999999999998 7999999999999999 889
Q ss_pred cEEEEeeccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 539 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.+||+|||+++...... .....||+.|+|||++.+..
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 214 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQ 214 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSC
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCC
Confidence 99999999998765432 23456899999999886544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=269.02 Aligned_cols=250 Identities=25% Similarity=0.291 Sum_probs=183.5
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|+++|.+|..| .++..|+.+++++|.+.+..|..|.++++|++|+|++|.+++.+| .+..+++|++|+|++|++++.
T Consensus 404 n~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 481 (768)
T 3rgz_A 404 NGFTGKIPPTL--SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481 (768)
T ss_dssp SEEEEECCGGG--GGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred CccccccCHHH--hcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCc
Confidence 56677777777 456777777777777777777888888888888888888887777 477788888888888888888
Q ss_pred CCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhC----Cc-cccccc
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG----YP-QRFAEN 154 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~----~~-~~~~~~ 154 (580)
+|..+.++++|+.|+|++|++++.+|. +..+.+|+.|++++|.+....+..+..+..|..+..... .+ ..+...
T Consensus 482 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~ 561 (768)
T 3rgz_A 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTT
T ss_pred CCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcc
Confidence 888888888888888888888877664 677788888888888877554444444433322211100 00 000000
Q ss_pred -------cCC--------C-------------------------------------CCCC-CccceeccCCcEEEEEecC
Q 008026 155 -------WKG--------N-------------------------------------DPCS-DWIGVTCTKGNITVINFQK 181 (580)
Q Consensus 155 -------~~~--------~-------------------------------------~~~~-~~~~~~~~~~~L~~L~ls~ 181 (580)
+.. + +... ..+..+..+.+|+.|||++
T Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~ 641 (768)
T 3rgz_A 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641 (768)
T ss_dssp TTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCS
T ss_pred cchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcC
Confidence 000 0 0000 0122344567899999999
Q ss_pred CcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC----ceeecCCCCCC
Q 008026 182 MNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN----AIVNTDGNPDI 253 (580)
Q Consensus 182 n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~----~~~~~~~n~~~ 253 (580)
|+++|.+|.++++|++|+.|+|++|+++|.+|.+++.+++|+.|||++|+++|.+|..+.. ..+++++|...
T Consensus 642 N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp SCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred CcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 9999999999999999999999999999999999999999999999999999999987653 45888888654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=234.74 Aligned_cols=176 Identities=30% Similarity=0.495 Sum_probs=136.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc--CCc--EEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH--DGT--KIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|++. ++. .||+|++..... .....+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57999999999999999999753 233 689999876433 2345678999999999999999999999998765 88
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 97 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999885421 357899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCC--ccccccccCCccCccccCCCC
Q 008026 550 LAPEGKGS--IETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 550 ~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~ 578 (580)
........ ......||+.|+|||++.+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCC
Confidence 76543321 112345788999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=235.99 Aligned_cols=174 Identities=26% Similarity=0.385 Sum_probs=145.2
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CC-cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCc------ccceeeEEEc
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DG-TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH------LVALLGHCLD 464 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~ 464 (580)
+.++|++.+.||+|+||.||+|... ++ ..||+|++... ....+.+.+|++++++++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3478999999999999999999775 44 78999998642 344567889999999997766 8999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe----------
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---------- 534 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---------- 534 (580)
.+..++||||+ ++++.+++.. .....+++.++..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred CCeEEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccc
Confidence 99999999999 6677776643 233468999999999999999999997 899999999999999
Q ss_pred ---------cCCCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 535 ---------GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 535 ---------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+.++.+||+|||+++...... ....||+.|+|||++.+.+++
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~ 217 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWA 217 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCC
T ss_pred ccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCC
Confidence 567899999999998654322 335799999999999887653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-27 Score=236.13 Aligned_cols=171 Identities=25% Similarity=0.339 Sum_probs=121.4
Q ss_pred hhcCCccc-ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc----CC
Q 008026 393 VTNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GN 466 (580)
Q Consensus 393 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 466 (580)
+.++|.+. +.||+|+||.||+|... +++.||+|++... . ....+....++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 34678885 46999999999999876 7899999998652 1 122223344667789999999999876 44
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEE
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 543 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 543 (580)
..++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHT---C-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEe
Confidence 57999999999999999854 223468999999999999999999998 89999999999999975 4559999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|||+++...... .....||+.|+|||++.+..
T Consensus 174 Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~ 205 (336)
T 3fhr_A 174 DFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEK 205 (336)
T ss_dssp CCTTCEEC-------------------------CH
T ss_pred ccccceeccccc---cccCCCCcCccChhhhCCCC
Confidence 999998664322 23357899999999986654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=244.32 Aligned_cols=173 Identities=29% Similarity=0.344 Sum_probs=131.7
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 456667899999999998776678999999998653 235678899999987 79999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCC--CCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC-------------C
Q 008026 474 YMPQGTLSRHIFNWAEEGL--KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-------------M 538 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~ 538 (580)
|++ |+|.+++........ ...++..++.++.||+.||+|||+ .+|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCce
Confidence 996 699999854221110 112334567899999999999998 899999999999999754 4
Q ss_pred cEEEEeeccccccCCCCCC---ccccccccCCccCccccCC
Q 008026 539 RAKVADFGLVRLAPEGKGS---IETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 539 ~~kl~Dfg~a~~~~~~~~~---~~~~~~Gt~~y~APE~~~~ 576 (580)
.+||+|||+++........ ......||+.|+|||++.+
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 8999999999876544322 1223579999999999976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=238.64 Aligned_cols=174 Identities=24% Similarity=0.448 Sum_probs=142.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
..++|++.+.||+|+||.||+|.... .||+|++..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35689999999999999999998753 4999998765444444566788999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++++|.+++.. ....+++.++..++.||+.||+|||+ .+|+||||||+||+++ ++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp BCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999998843 23468899999999999999999998 8999999999999998 6799999999987543
Q ss_pred CCC----CCccccccccCCccCccccCC
Q 008026 553 EGK----GSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 553 ~~~----~~~~~~~~Gt~~y~APE~~~~ 576 (580)
... ........||+.|+|||++.+
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccccccCCCcccccChHHhhh
Confidence 211 112223468999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=238.28 Aligned_cols=172 Identities=25% Similarity=0.335 Sum_probs=143.4
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-----------CCcccceeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----------HRHLVALLGHC 462 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~ 462 (580)
++|++.+.||+|+||.||+|+. .+++.||||++... ......+.+|++++++++ ||||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 5799999999999999999976 47899999998752 334567889999999886 88999999998
Q ss_pred EcCC----eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCC-CcEecCCCCCCeEec--
Q 008026 463 LDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLG-- 535 (580)
Q Consensus 463 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~-- 535 (580)
...+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+ + +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEecc
Confidence 8654 689999999 88999988542 22458899999999999999999998 6 999999999999994
Q ss_pred ----CCCcEEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 536 ----DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 536 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..+.+||+|||+++..... .....||+.|+|||++.+..++
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~ 213 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWG 213 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCC
T ss_pred CCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCC
Confidence 3447999999999876432 2234789999999999877653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=252.65 Aligned_cols=178 Identities=29% Similarity=0.443 Sum_probs=148.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc------CCe
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------GNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 467 (580)
++|++.+.||+|+||.||+|... +++.||||++... ......+.+.+|++++++++||||+++++++.. .+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 68999999999999999999764 6899999998763 345556789999999999999999999998765 667
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc---EEEEe
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVAD 544 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D 544 (580)
.++||||+++++|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 899999999999999885421 22358888999999999999999998 89999999999999997664 99999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
||.++...... ......||+.|+|||++.+..++
T Consensus 168 FG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s 201 (676)
T 3qa8_A 168 LGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYT 201 (676)
T ss_dssp CCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCS
T ss_pred ccccccccccc--ccccccCCcccCChHHhccCCCC
Confidence 99998765433 22346799999999999887653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=231.20 Aligned_cols=172 Identities=26% Similarity=0.365 Sum_probs=127.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999875 7899999999865433333344555566788889999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCC-CcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
||+ ++.+..+... ....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 104 e~~-~~~~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999 4455444322 12468899999999999999999997 4 8999999999999999999999999999765
Q ss_pred CCCCCCccccccccCCccCccccC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
.... ......||+.|+|||++.
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERID 197 (318)
T ss_dssp -------------CCTTCCHHHHC
T ss_pred cCCc--cccccCCCccccChhhcc
Confidence 4432 223356899999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=240.85 Aligned_cols=169 Identities=26% Similarity=0.414 Sum_probs=132.9
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +||||+++++++.+....|+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 35888999999999997766566799999999865332 2356899999999 79999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-----CCcEEEEeeccc
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFGLV 548 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a 548 (580)
|++ |+|.+++.. ......+..+..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+|
T Consensus 99 ~~~-g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 99 LCA-ATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CCS-EEHHHHHHS----SSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CCC-CCHHHHHHh----cCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 996 599888843 22234445677899999999999998 89999999999999953 235889999999
Q ss_pred cccCCCCC--CccccccccCCccCccccCC
Q 008026 549 RLAPEGKG--SIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 549 ~~~~~~~~--~~~~~~~Gt~~y~APE~~~~ 576 (580)
+....... .......||+.|+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhc
Confidence 87654321 12234679999999999974
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=237.29 Aligned_cols=130 Identities=19% Similarity=0.123 Sum_probs=100.9
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCC-chhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG-IDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTG 79 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~ 79 (580)
|++.+..|..| .+++.|+.+++++|.+.... +..|.++++|++|+|++|++++..| .|.++++|++|+|++|++++
T Consensus 40 n~i~~~~~~~~--~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 117 (455)
T 3v47_A 40 NSIAELNETSF--SRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDG 117 (455)
T ss_dssp SCCCEECTTTT--SSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBT
T ss_pred CccCcCChhHh--ccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCc
Confidence 66777777778 56777888888888766444 4678888888888888888888766 57888888888888888886
Q ss_pred cCCcc--ccCCCCCcEEEccCCcccccCCC--CCcccccccccccCCCCCCCCCCCch
Q 008026 80 PVPDS--LVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDP 133 (580)
Q Consensus 80 ~~P~~--~~~l~~L~~L~L~~N~l~~~~~~--~~~~~~L~~l~l~~n~~~~~~~~~~~ 133 (580)
.+|.. |..+++|++|+|++|++++..|. +..+.+|+.|++++|.+..+++..+.
T Consensus 118 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 175 (455)
T 3v47_A 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL 175 (455)
T ss_dssp HHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSG
T ss_pred cccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhh
Confidence 56655 88888888888888888888665 67788888888888888777655443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=231.00 Aligned_cols=209 Identities=17% Similarity=0.147 Sum_probs=142.4
Q ss_pred ceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEcc
Q 008026 18 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97 (580)
Q Consensus 18 ~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~ 97 (580)
..++.+++++|.+. .+|..+.++++|++|+|++|.|+..+..+..+++|++|+|++|+++ .+|..|+++++|+.|+|+
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 33444455555433 5566666677777777777777733224666777777777777777 667777777777777777
Q ss_pred CCcccccCCC-CC---------cccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccce
Q 008026 98 NNLLQGPVPE-FD---------RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV 167 (580)
Q Consensus 98 ~N~l~~~~~~-~~---------~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (580)
+|++.+.+|. +. .+.+|+.|++++|.+..+|.. +. .+..+....+.++....++..
T Consensus 159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~-l~-------------~l~~L~~L~L~~N~l~~l~~~ 224 (328)
T 4fcg_A 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPAS-IA-------------NLQNLKSLKIRNSPLSALGPA 224 (328)
T ss_dssp EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGG-GG-------------GCTTCCEEEEESSCCCCCCGG
T ss_pred CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHh-hc-------------CCCCCCEEEccCCCCCcCchh
Confidence 7666655553 32 266677777777766655432 11 112223333344444455555
Q ss_pred eccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC
Q 008026 168 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 242 (580)
Q Consensus 168 ~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~ 242 (580)
+..+++|+.|+|++|++.+.+|..++.+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..+..
T Consensus 225 l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp GGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred hccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 666778899999998888888888889999999999998888888988888999999999999998888877543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-27 Score=234.66 Aligned_cols=217 Identities=22% Similarity=0.312 Sum_probs=187.1
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++++.+|..| .++..|+.+++++|.+.+..|..|.++++|++|+|++|.|++.+| .|..+++|++|+|++|++++.
T Consensus 87 n~l~~~~p~~l--~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 164 (313)
T 1ogq_A 87 NNLVGPIPPAI--AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164 (313)
T ss_dssp TTEESCCCGGG--GGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEE
T ss_pred CcccccCChhH--hcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCc
Confidence 78899999999 668888888998998888899999999999999999999998888 588999999999999999999
Q ss_pred CCccccCCC-CCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCC
Q 008026 81 VPDSLVKLE-SLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 158 (580)
Q Consensus 81 ~P~~~~~l~-~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~ 158 (580)
+|..+++++ +|+.|+|++|++++.+|. +..+. |+.|++++|.+...++..+. .+..+....+.+
T Consensus 165 ~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~-------------~l~~L~~L~L~~ 230 (313)
T 1ogq_A 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFG-------------SDKNTQKIHLAK 230 (313)
T ss_dssp CCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCC-------------TTSCCSEEECCS
T ss_pred CCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHh-------------cCCCCCEEECCC
Confidence 999999998 999999999999987775 55555 99999999998876554433 233444455555
Q ss_pred CCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCc-cccc
Q 008026 159 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ-LYGK 235 (580)
Q Consensus 159 ~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~-l~g~ 235 (580)
+.....+..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|+++|.+|.. ..+++|+.+++++|+ +.|.
T Consensus 231 N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred CceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCC
Confidence 555544444666789999999999999999999999999999999999999999986 899999999999998 6664
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.56 Aligned_cols=235 Identities=16% Similarity=0.102 Sum_probs=192.0
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCcc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 84 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~ 84 (580)
..+|..+. ..|+.+++++|++....++.|.++++|++|+|++|.|++..| .|.++++|++|+|++|+|++..+..
T Consensus 67 ~~iP~~~~----~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 142 (452)
T 3zyi_A 67 SEVPQGIP----SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGA 142 (452)
T ss_dssp SSCCSCCC----TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTT
T ss_pred CccCCCCC----CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhh
Confidence 45787773 455666777788877778899999999999999999998877 5889999999999999999444445
Q ss_pred ccCCCCCcEEEccCCcccccCCC-CCcccccccccccC-CCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCC
Q 008026 85 LVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSN-NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 162 (580)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~-n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 162 (580)
|.++++|++|+|++|+++.+++. |..+.+|+.|++++ |.+..++...+..+. .+....+.++...
T Consensus 143 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~-------------~L~~L~L~~n~l~ 209 (452)
T 3zyi_A 143 FEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF-------------NLKYLNLGMCNIK 209 (452)
T ss_dssp SSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCT-------------TCCEEECTTSCCS
T ss_pred hcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCC-------------CCCEEECCCCccc
Confidence 99999999999999999988874 78899999999998 566666665554333 3334444555555
Q ss_pred CccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC-
Q 008026 163 DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS- 241 (580)
Q Consensus 163 ~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~- 241 (580)
.++ .+..+.+|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..+.
T Consensus 210 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 210 DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 544 355677999999999999998899999999999999999999988899999999999999999999977766543
Q ss_pred ---CceeecCCCCCCCCCCC
Q 008026 242 ---NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 242 ---~~~~~~~~n~~~c~~~~ 258 (580)
...+++++|||.|+|..
T Consensus 289 l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CTTCCEEECCSSCEECSTTT
T ss_pred ccCCCEEEccCCCcCCCCCc
Confidence 34689999999999864
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=234.21 Aligned_cols=234 Identities=16% Similarity=0.132 Sum_probs=186.0
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCc-
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPD- 83 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~- 83 (580)
..+|..+. ..|+.+++++|++....+..|.++++|++|+|++|.|++..+ .|.++++|++|+|++|+|+ .+|.
T Consensus 56 ~~iP~~~~----~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~ 130 (440)
T 3zyj_A 56 REVPDGIS----TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNG 130 (440)
T ss_dssp SSCCSCCC----TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCS-SCCTT
T ss_pred CcCCCCCC----CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCC-eeCHh
Confidence 46777773 345556677777777667888889999999999999887776 5888899999999999988 4554
Q ss_pred cccCCCCCcEEEccCCcccccCCC-CCcccccccccccC-CCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCC
Q 008026 84 SLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSN-NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 161 (580)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~-n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 161 (580)
.|..+++|+.|+|++|+++.+++. |..+.+|+.|++++ |.+..++...+..+ ..+....+.++..
T Consensus 131 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l-------------~~L~~L~L~~n~l 197 (440)
T 3zyj_A 131 AFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL-------------SNLRYLNLAMCNL 197 (440)
T ss_dssp TSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTC-------------SSCCEEECTTSCC
T ss_pred HhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcc-------------cccCeecCCCCcC
Confidence 588899999999999998887774 77888888888887 45555665544333 3344444555555
Q ss_pred CCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC
Q 008026 162 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 241 (580)
Q Consensus 162 ~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~ 241 (580)
..++. +..+.+|+.|+|++|++++..|..|.++++|+.|+|++|++.+..|..+..+++|+.|+|++|++++..+..+.
T Consensus 198 ~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 276 (440)
T 3zyj_A 198 REIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276 (440)
T ss_dssp SSCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTS
T ss_pred ccccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhc
Confidence 55543 55667999999999999988899999999999999999999988899999999999999999999977776543
Q ss_pred ----CceeecCCCCCCCCCCC
Q 008026 242 ----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 242 ----~~~~~~~~n~~~c~~~~ 258 (580)
...+++++|||.|+|..
T Consensus 277 ~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 277 PLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp SCTTCCEEECCSSCEECSSTT
T ss_pred cccCCCEEEcCCCCccCCCCc
Confidence 34689999999999864
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=244.98 Aligned_cols=255 Identities=17% Similarity=0.062 Sum_probs=183.5
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++++..|..| .++..|+.+++++|.+.+..|..|.++++|++|+|++|++++.++. |.++++|++|+|++|++.+.
T Consensus 42 n~l~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~ 119 (477)
T 2id5_A 42 NRIKTLNQDEF--ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVIL 119 (477)
T ss_dssp SCCCEECTTTT--TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEE
T ss_pred CccceECHhHc--cCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccC
Confidence 56666666777 5577777777777877777677888888888888888888876664 67788888888888888866
Q ss_pred CCccccCCCCCcEEEccCCcccccCC-CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhC-----------Cc
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG-----------YP 148 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~-----------~~ 148 (580)
.|..|.++++|+.|+|++|.+++..+ .|..+.+|+.|++++|.+..+++..+..+..|..+..... .+
T Consensus 120 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l 199 (477)
T 2id5_A 120 LDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199 (477)
T ss_dssp CTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSC
T ss_pred ChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccC
Confidence 67778888888888888888887766 4777778888888888777666433322222211110000 00
Q ss_pred c------------------------ccccccCCCCCCCCcc-ceeccCCcEEEEEecCCcccccCcccccCCCCCcEEec
Q 008026 149 Q------------------------RFAENWKGNDPCSDWI-GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 203 (580)
Q Consensus 149 ~------------------------~~~~~~~~~~~~~~~~-~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l 203 (580)
. .+....+.++....++ ..+..+++|+.|+|++|++.+..+..|..+++|++|+|
T Consensus 200 ~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 279 (477)
T 2id5_A 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL 279 (477)
T ss_dssp TTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEEC
T ss_pred cccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEEC
Confidence 0 1111112223333333 24556678999999999999777778899999999999
Q ss_pred cCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----CceeecCCCCCCCCCCC
Q 008026 204 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 204 s~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~~ 258 (580)
++|++.+..|..+..+++|+.|+|++|++++..+..+. ...+++++|+|.|.|..
T Consensus 280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 280 VGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp CSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred CCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 99999988899999999999999999999976665543 34689999999999864
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-26 Score=244.73 Aligned_cols=160 Identities=19% Similarity=0.214 Sum_probs=124.0
Q ss_pred cccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChh------hHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 398 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK------GLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
...+.||+|+||.||+|.. .+..+++|+...+..... ..+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999954 478899998755433221 235589999999999999999766666677788999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++++|.+++.. +..++.|++.||+|||+ ++|+||||||+|||+++ .+||+|||+|+..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999998832 45789999999999998 89999999999999998 9999999999987
Q ss_pred CCCCCCc------cccccccCCccCccccCC
Q 008026 552 PEGKGSI------ETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 552 ~~~~~~~------~~~~~Gt~~y~APE~~~~ 576 (580)
....... .....||+.|||||++.+
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 5432111 235689999999999865
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=219.40 Aligned_cols=213 Identities=22% Similarity=0.254 Sum_probs=177.5
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCc-ccccCCc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNF-FTGPVPD 83 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~-l~~~~P~ 83 (580)
..+|..+. ..|+.+++++|.+....+..|.++++|++|+|++|.+++..| .|.++++|++|+|++|+ +....|.
T Consensus 24 ~~ip~~~~----~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~ 99 (285)
T 1ozn_A 24 QAVPVGIP----AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPA 99 (285)
T ss_dssp SSCCTTCC----TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTT
T ss_pred ccCCcCCC----CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHH
Confidence 45676662 455666677777777666789999999999999999998877 58889999999999997 7744477
Q ss_pred cccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCC
Q 008026 84 SLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 162 (580)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 162 (580)
.|..+++|+.|+|++|++++.+|. +..+.+|+.|++++|.+..+++..+.
T Consensus 100 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----------------------------- 150 (285)
T 1ozn_A 100 TFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR----------------------------- 150 (285)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT-----------------------------
T ss_pred HhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhc-----------------------------
Confidence 899999999999999999998775 77889999999999998877755332
Q ss_pred CccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCC--
Q 008026 163 DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK-- 240 (580)
Q Consensus 163 ~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~-- 240 (580)
.+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+
T Consensus 151 -------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 223 (285)
T 1ozn_A 151 -------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223 (285)
T ss_dssp -------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTT
T ss_pred -------cCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHccc
Confidence 23489999999999996666679999999999999999998889999999999999999999998665432
Q ss_pred --CCceeecCCCCCCCCCCC
Q 008026 241 --SNAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 241 --~~~~~~~~~n~~~c~~~~ 258 (580)
....+++++|++.|.|..
T Consensus 224 l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 224 LRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp CTTCCEEECCSSCEECSGGG
T ss_pred CcccCEEeccCCCccCCCCc
Confidence 345689999999998754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=214.31 Aligned_cols=145 Identities=12% Similarity=0.040 Sum_probs=127.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+..+++++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999875 5899999999865433 34557899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
|||+++++|.+++.. . ....++.+++.|++.||+|||+ .+|+||||||+|||++.++.+||+++|..
T Consensus 110 ~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999998832 1 2445688899999999999998 89999999999999999999999987754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-25 Score=220.22 Aligned_cols=235 Identities=18% Similarity=0.111 Sum_probs=188.4
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCC--C-CCCCCCCCcEEeccCCcccccCC
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL--P-DFSGVKQLESLSLRDNFFTGPVP 82 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~l~~L~~L~L~~N~l~~~~P 82 (580)
..+|..+. ..|+.+++++|++....+..|.++++|++|+|++|.++... | .+..+++|++|+|++|++. .+|
T Consensus 20 ~~ip~~~~----~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~ 94 (306)
T 2z66_A 20 TSVPTGIP----SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 94 (306)
T ss_dssp SSCCSCCC----TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEE
T ss_pred ccCCCCCC----CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cCh
Confidence 45777663 34556667777666544456899999999999999998542 3 5667899999999999999 789
Q ss_pred ccccCCCCCcEEEccCCcccccCC--CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCC
Q 008026 83 DSLVKLESLKIVNMTNNLLQGPVP--EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 160 (580)
Q Consensus 83 ~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 160 (580)
..+..+++|+.|+|++|++++.++ .+..+.+|+.|++++|.+...++..+..+. .+....+.++.
T Consensus 95 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-------------~L~~L~l~~n~ 161 (306)
T 2z66_A 95 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-------------SLEVLKMAGNS 161 (306)
T ss_dssp EEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCT-------------TCCEEECTTCE
T ss_pred hhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCc-------------CCCEEECCCCc
Confidence 899999999999999999999876 588899999999999998877766554333 33333444444
Q ss_pred CCC--ccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCC
Q 008026 161 CSD--WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238 (580)
Q Consensus 161 ~~~--~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~ 238 (580)
... .+..+..+++|+.|++++|++++..|..+..+++|+.|+|++|++++..+..+..+++|++||+++|++++.+|.
T Consensus 162 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 241 (306)
T 2z66_A 162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241 (306)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSS
T ss_pred cccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHH
Confidence 432 455666778999999999999988899999999999999999999966666899999999999999999998887
Q ss_pred CCC-----CceeecCCCCCCCCCCC
Q 008026 239 FKS-----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 239 ~~~-----~~~~~~~~n~~~c~~~~ 258 (580)
.+. ...+++++|++.|.|..
T Consensus 242 ~~~~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 242 ELQHFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp SCCCCCTTCCEEECTTCCEECSGGG
T ss_pred HHHhhhccCCEEEccCCCeecccCh
Confidence 643 34588999999998753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=250.22 Aligned_cols=91 Identities=23% Similarity=0.262 Sum_probs=76.9
Q ss_pred eeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC-cee
Q 008026 167 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-AIV 245 (580)
Q Consensus 167 ~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~-~~~ 245 (580)
.+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|..+.. ..+
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l 552 (844)
T 3j0a_A 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVL 552 (844)
T ss_dssp CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEE
T ss_pred hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEE
Confidence 345567899999999999988888899999999999999999965555554 89999999999999999987653 468
Q ss_pred ecCCCCCCCCCCCC
Q 008026 246 NTDGNPDIGKEKSS 259 (580)
Q Consensus 246 ~~~~n~~~c~~~~~ 259 (580)
++++|||.|+|...
T Consensus 553 ~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 553 DITHNKFICECELS 566 (844)
T ss_dssp EEEEECCCCSSSCC
T ss_pred EecCCCcccccccH
Confidence 99999999998753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=238.70 Aligned_cols=241 Identities=15% Similarity=0.099 Sum_probs=131.8
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCccc-CceEecccCcCcCCCCCCCCC--CCCcEEeccCCccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTS-LKEIWLHSNAFSGPLPDFSGV--KQLESLSLRDNFFT 78 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~l--~~L~~L~L~~N~l~ 78 (580)
|+++|.+| .| .++..|+.+++++|.+. .+|..+.++++ |++|+|++|.++..+..+..+ ++|+.|+|++|++.
T Consensus 340 N~l~g~ip-~~--~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~ 415 (636)
T 4eco_A 340 NQLEGKLP-AF--GSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIG 415 (636)
T ss_dssp CCCEEECC-CC--EEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTT
T ss_pred CcCccchh-hh--CCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCC
Confidence 44444555 44 33444555555555333 44444555555 555555555555222233332 25555555555555
Q ss_pred ccCCcccc-------CCCCCcEEEccCCcccccCCCC-CcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccc
Q 008026 79 GPVPDSLV-------KLESLKIVNMTNNLLQGPVPEF-DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 150 (580)
Q Consensus 79 ~~~P~~~~-------~l~~L~~L~L~~N~l~~~~~~~-~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~ 150 (580)
+.+|..|. .+++|+.|+|++|+++.+++.+ ..+.+|+.|++++|.+..+|...+.... .....+..
T Consensus 416 ~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~------~~~~~l~~ 489 (636)
T 4eco_A 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN------ENFKNTYL 489 (636)
T ss_dssp TTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETT------EECTTGGG
T ss_pred CcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccc------ccccccCC
Confidence 55555554 4555555555555555444432 2345555555555555555544332110 00001113
Q ss_pred cccccCCCCCCCCccceec--cCCcEEEEEecCCcccccCcccccCCCCCcEEec------cCCcccccCCccCcCCCCC
Q 008026 151 FAENWKGNDPCSDWIGVTC--TKGNITVINFQKMNLTGTISPEFASFKSLQRLIL------ADNNLSGMIPEGLSVLGAL 222 (580)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~--~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l------s~N~l~g~~p~~l~~l~~L 222 (580)
+....+.++....+|..+. .+++|+.|+|++|++++ +|..++++++|+.|+| ++|++.+.+|.++..+++|
T Consensus 490 L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L 568 (636)
T 4eco_A 490 LTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568 (636)
T ss_dssp CCEEECCSSCCCBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred ccEEECcCCcCCccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCC
Confidence 3444455555555666555 66777777777777775 7777777777777777 4566677777777777777
Q ss_pred CEEEccCCcccccCCCCCC--CceeecCCCCCCC
Q 008026 223 KELDVSNNQLYGKIPSFKS--NAIVNTDGNPDIG 254 (580)
Q Consensus 223 ~~l~ls~N~l~g~~p~~~~--~~~~~~~~n~~~c 254 (580)
++|+|++|++ +.+|..+. ...+++++|++.|
T Consensus 569 ~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 569 TQLQIGSNDI-RKVNEKITPNISVLDIKDNPNIS 601 (636)
T ss_dssp CEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCE
T ss_pred CEEECCCCcC-CccCHhHhCcCCEEECcCCCCcc
Confidence 7777777777 56665443 2346677777665
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-25 Score=227.42 Aligned_cols=171 Identities=19% Similarity=0.225 Sum_probs=127.4
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccc-cChhhHHHHHHHHHHHHhcCC-Ccccce---------e---
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRH-RHLVAL---------L--- 459 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv~~---------~--- 459 (580)
..|...+.||+|+||.||+|++. +|+.||||++.... ......+.+.+|+.+++.++| ++.... .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778899999999999999854 79999999987432 223346789999999999987 221111 1
Q ss_pred ---------eEEEc-----CCeeEEEEEecCCCChhHHHHHHhh--hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 008026 460 ---------GHCLD-----GNEKLLVFEYMPQGTLSRHIFNWAE--EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 523 (580)
Q Consensus 460 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iv 523 (580)
.++.. ....+++|+++ +++|.+++..... .....+++..++.++.||+.||+|||+ ++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 11111 12356777765 6799988854321 123457888999999999999999998 8999
Q ss_pred ecCCCCCCeEecCCCcEEEEeeccccccCCCCCCccccccccCCccCcccc
Q 008026 524 HRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574 (580)
Q Consensus 524 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~ 574 (580)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETT 279 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhh
Confidence 9999999999999999999999998865432 334568 999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=209.18 Aligned_cols=147 Identities=22% Similarity=0.369 Sum_probs=126.4
Q ss_pred hcCCccc-ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHH-HhcCCCcccceeeEEEc----CC
Q 008026 394 TNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVL-TKVRHRHLVALLGHCLD----GN 466 (580)
Q Consensus 394 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~ 466 (580)
.++|.+. +.||+|+||.||+|... +++.||+|++... ..+.+|++++ +..+||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3567776 78999999999999774 7899999998642 4567888887 55589999999999876 66
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEE
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 543 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 543 (580)
..++||||+++++|.+++.. .....+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 78999999999999999854 223468999999999999999999998 89999999999999997 7889999
Q ss_pred eeccccccCC
Q 008026 544 DFGLVRLAPE 553 (580)
Q Consensus 544 Dfg~a~~~~~ 553 (580)
|||++.....
T Consensus 163 Dfg~a~~~~~ 172 (299)
T 3m2w_A 163 DFGFAKETTG 172 (299)
T ss_dssp CCTTCEECTT
T ss_pred cccccccccc
Confidence 9999986654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=209.43 Aligned_cols=212 Identities=15% Similarity=0.058 Sum_probs=172.8
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCcc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 84 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~ 84 (580)
..+|..+. ..|+.+++++|++....+..|.++++|++|+|++|.+++..+ .|.++++|++|+|++|++++..|..
T Consensus 20 ~~ip~~l~----~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 95 (276)
T 2z62_A 20 YKIPDNLP----FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA 95 (276)
T ss_dssp SSCCSSSC----TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT
T ss_pred cccCCCCC----CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhh
Confidence 35777773 345666777777776666789999999999999999998777 5888999999999999999666678
Q ss_pred ccCCCCCcEEEccCCcccccCC-CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC
Q 008026 85 LVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 163 (580)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (580)
|.++++|+.|++++|++++.++ .+..+.+|+.|++++|.+..+.
T Consensus 96 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~----------------------------------- 140 (276)
T 2z62_A 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK----------------------------------- 140 (276)
T ss_dssp TTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC-----------------------------------
T ss_pred hcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceec-----------------------------------
Confidence 9999999999999999999887 5889999999999999887642
Q ss_pred ccceeccCCcEEEEEecCCcccccCcccccCCCCCc----EEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCC
Q 008026 164 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQ----RLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 239 (580)
Q Consensus 164 ~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~----~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~ 239 (580)
++..+..+++|+.|++++|++++..+..+..+++|+ .|++++|++. .+|.......+|+.|++++|++++..+..
T Consensus 141 l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 219 (276)
T 2z62_A 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGI 219 (276)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCC-EECTTSSCSCCEEEEECCSSCCSCCCTTT
T ss_pred CchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCccc-ccCccccCCCcccEEECCCCceeecCHhH
Confidence 112233456999999999999987778888777777 9999999999 55555556668999999999999776655
Q ss_pred CC----CceeecCCCCCCCCCC
Q 008026 240 KS----NAIVNTDGNPDIGKEK 257 (580)
Q Consensus 240 ~~----~~~~~~~~n~~~c~~~ 257 (580)
+. ...+++++|++.|.|+
T Consensus 220 ~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 220 FDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp TTTCCSCCEEECCSSCBCCCTT
T ss_pred hcccccccEEEccCCcccccCC
Confidence 43 3468999999999875
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-23 Score=210.94 Aligned_cols=214 Identities=15% Similarity=0.144 Sum_probs=102.4
Q ss_pred EEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccC
Q 008026 20 LWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 98 (580)
Q Consensus 20 L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~ 98 (580)
|+.+++++|++.+..+..|.++++|++|+|++|.+++..| .|..+++|++|+|++|+++ .+|..+. ++|+.|++++
T Consensus 54 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~ 130 (330)
T 1xku_A 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHE 130 (330)
T ss_dssp CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCS
T ss_pred CeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCC
Confidence 3444555555544444456666666666666666666544 3566666666666666666 5555443 4555555555
Q ss_pred CcccccCCC-CCcccccccccccCCCCCC--CCCCCchhHHHHHHHHHhhC--------CccccccccCCCCCCCCc-cc
Q 008026 99 NLLQGPVPE-FDRSVSLDMAKGSNNFCLP--SPGACDPRLNALLSVVKLMG--------YPQRFAENWKGNDPCSDW-IG 166 (580)
Q Consensus 99 N~l~~~~~~-~~~~~~L~~l~l~~n~~~~--~~~~~~~~l~~l~~~~~~~~--------~~~~~~~~~~~~~~~~~~-~~ 166 (580)
|++++.++. +..+.+|+.|++++|.+.. ..+..+..+..|..+..... ....+....+.++..... +.
T Consensus 131 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~ 210 (330)
T 1xku_A 131 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAA 210 (330)
T ss_dssp SCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTG
T ss_pred CcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCCcCCccCHH
Confidence 555554443 4444555555555554432 12221111111110000000 001112222223333222 23
Q ss_pred eeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 167 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 167 ~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
.+..+++|+.|+|++|++++..|..+..+++|++|+|++|++. .+|..+..+++|++|++++|++++..+
T Consensus 211 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~ 280 (330)
T 1xku_A 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280 (330)
T ss_dssp GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred HhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccCh
Confidence 3444455555555555555444445555555555555555555 555555555555555555555554433
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-23 Score=210.57 Aligned_cols=230 Identities=16% Similarity=0.133 Sum_probs=136.8
Q ss_pred ccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCC
Q 008026 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVP 82 (580)
Q Consensus 3 ~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P 82 (580)
++.+..|..| .++..|+.+++++|++....|..|.++++|++|+|++|.++..++.+. ++|++|+|++|++.+..+
T Consensus 65 ~i~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~ 140 (332)
T 2ft3_A 65 DISELRKDDF--KGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPK 140 (332)
T ss_dssp CCCEECTTTT--TTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCS
T ss_pred cCCccCHhHh--hCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcccc--ccCCEEECCCCccCccCH
Confidence 3333334444 334445555555554444444555555555555555555553333322 455555555555552222
Q ss_pred ccccCCCCCcEEEccCCcccc--cCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCC
Q 008026 83 DSLVKLESLKIVNMTNNLLQG--PVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159 (580)
Q Consensus 83 ~~~~~l~~L~~L~L~~N~l~~--~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 159 (580)
..|.++++|+.|+|++|.++. ..+. +..+ +|+.|++++|.+..+|...+ ..+....+.++
T Consensus 141 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~----------------~~L~~L~l~~n 203 (332)
T 2ft3_A 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP----------------ETLNELHLDHN 203 (332)
T ss_dssp GGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSC----------------SSCSCCBCCSS
T ss_pred hHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcccc----------------CCCCEEECCCC
Confidence 235555556666666555542 3332 3333 55566666666555554332 12333444455
Q ss_pred CCCCcc-ceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCC
Q 008026 160 PCSDWI-GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238 (580)
Q Consensus 160 ~~~~~~-~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~ 238 (580)
.....+ ..+..+++|+.|+|++|++.+..|..+..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+.
T Consensus 204 ~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~ 282 (332)
T 2ft3_A 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVN 282 (332)
T ss_dssp CCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTT
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChh
Confidence 544433 45666778888888888888777778888888888888888888 8888888888888899988888866554
Q ss_pred CCCC----------ceeecCCCCCCC
Q 008026 239 FKSN----------AIVNTDGNPDIG 254 (580)
Q Consensus 239 ~~~~----------~~~~~~~n~~~c 254 (580)
.+.. ..+.+.+||+.+
T Consensus 283 ~~~~~~~~~~~~~l~~L~l~~N~~~~ 308 (332)
T 2ft3_A 283 DFCPVGFGVKRAYYNGISLFNNPVPY 308 (332)
T ss_dssp SSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred HccccccccccccccceEeecCcccc
Confidence 4321 246777888764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-24 Score=210.61 Aligned_cols=198 Identities=20% Similarity=0.181 Sum_probs=172.6
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCc-CcCCCC-CCCCCCCCcEEeccCCcccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA-FSGPLP-DFSGVKQLESLSLRDNFFTG 79 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~L~~N~l~~ 79 (580)
|++++..|..| .++..|+.+++++|.+.+..|..|.++++|++|+|++|. ++...| .|..+++|++|+|++|++.+
T Consensus 42 n~i~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 119 (285)
T 1ozn_A 42 NRISHVPAASF--RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE 119 (285)
T ss_dssp SCCCEECTTTT--TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC
T ss_pred CcCCccCHHHc--ccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCE
Confidence 56666556678 568888888999998887778899999999999999998 887766 58899999999999999997
Q ss_pred cCCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCC
Q 008026 80 PVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 158 (580)
Q Consensus 80 ~~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~ 158 (580)
..|..|.++++|++|+|++|++++.++. +..+.+|+.|++++|.+..+++..+.
T Consensus 120 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~------------------------- 174 (285)
T 1ozn_A 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR------------------------- 174 (285)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT-------------------------
T ss_pred ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhc-------------------------
Confidence 6678899999999999999999998886 78899999999999998877654332
Q ss_pred CCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 159 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 159 ~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
.+++|+.|++++|++.+..|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++....+
T Consensus 175 -----------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 175 -----------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp -----------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred -----------CccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 23489999999999999889999999999999999999996555679999999999999999986544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=216.60 Aligned_cols=214 Identities=14% Similarity=0.077 Sum_probs=180.7
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccC
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV 81 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~ 81 (580)
|++. .+|..+ .++..|+.+++++|.+. .+|..|.++++|++|+|++|.|+..++.+.++++|++|+|++|++.+.+
T Consensus 91 n~l~-~lp~~l--~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~ 166 (328)
T 4fcg_A 91 VPLP-QFPDQA--FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTEL 166 (328)
T ss_dssp SCCS-SCCSCG--GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCC
T ss_pred CCch-hcChhh--hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCcccc
Confidence 4554 889888 45888888888888766 7888999999999999999999954446899999999999999988899
Q ss_pred CccccC---------CCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccc
Q 008026 82 PDSLVK---------LESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152 (580)
Q Consensus 82 P~~~~~---------l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~ 152 (580)
|..++. +++|+.|+|++|+++.+++.+..+.+|+.|++++|.+..+|+. +.. +..+.
T Consensus 167 p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~~~-l~~-------------l~~L~ 232 (328)
T 4fcg_A 167 PEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPA-IHH-------------LPKLE 232 (328)
T ss_dssp CSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCCGG-GGG-------------CTTCC
T ss_pred ChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCchh-hcc-------------CCCCC
Confidence 988765 9999999999999997777789999999999999999987753 222 22333
Q ss_pred cccCCCC-CCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCc
Q 008026 153 ENWKGND-PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 231 (580)
Q Consensus 153 ~~~~~~~-~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~ 231 (580)
...+.++ ....++..+..+++|+.|+|++|++.+.+|..++++++|+.|+|++|++.+.+|++++.+++|+.+++..|.
T Consensus 233 ~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp EEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred EEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 4444443 334466777888899999999999999999999999999999999999999999999999999999999876
Q ss_pred cc
Q 008026 232 LY 233 (580)
Q Consensus 232 l~ 233 (580)
+.
T Consensus 313 ~~ 314 (328)
T 4fcg_A 313 QA 314 (328)
T ss_dssp SC
T ss_pred HH
Confidence 65
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-24 Score=233.27 Aligned_cols=253 Identities=17% Similarity=0.125 Sum_probs=170.6
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-C-CCCCCCCcEEeccCCcccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-D-FSGVKQLESLSLRDNFFTG 79 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~-~~~l~~L~~L~L~~N~l~~ 79 (580)
|+++ .+|+.+ ..+..|+.+++++|.+....|..+.++++|++|+|++|.+.+.+| . +..+++|+.|+|++|++.+
T Consensus 288 n~l~-~lp~~l--~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 364 (606)
T 3t6q_A 288 THLS-ELPSGL--VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364 (606)
T ss_dssp SCCS-CCCSSC--CSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCE
T ss_pred CccC-CCChhh--cccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCcccc
Confidence 4444 677777 456777777777776666666677777777777777777765554 2 6667777777777777664
Q ss_pred cC--CccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCC-CCchhHHHHHHHHH-----------h
Q 008026 80 PV--PDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPG-ACDPRLNALLSVVK-----------L 144 (580)
Q Consensus 80 ~~--P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~-~~~~~l~~l~~~~~-----------~ 144 (580)
.. |..+..+++|+.|+|++|++++.+|. +..+.+|+.|++++|.+....+ ..+..+..+..+.. .
T Consensus 365 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 444 (606)
T 3t6q_A 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444 (606)
T ss_dssp EEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTT
T ss_pred ccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHH
Confidence 33 55566666666777766666666553 5556666666666666554432 22333332221111 1
Q ss_pred hCCccccccccCCCCCCCC----ccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCC
Q 008026 145 MGYPQRFAENWKGNDPCSD----WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 220 (580)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~ 220 (580)
...+..+....+.++.... .+..+..+++|+.|++++|++++..|..|+.+++|+.|+|++|++++..|..+..++
T Consensus 445 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 524 (606)
T 3t6q_A 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524 (606)
T ss_dssp TTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCC
T ss_pred HhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccc
Confidence 1122334444444444432 113456678899999999999988888999999999999999999988899999999
Q ss_pred CCCEEEccCCcccccCCCCCC----CceeecCCCCCCCCCCC
Q 008026 221 ALKELDVSNNQLYGKIPSFKS----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 221 ~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~~ 258 (580)
.| +|++++|++++.+|..+. ...+++.+|||.|.|+.
T Consensus 525 ~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 525 GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp SC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred cc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 99 999999999988776543 35689999999998763
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.3e-24 Score=234.75 Aligned_cols=91 Identities=22% Similarity=0.194 Sum_probs=80.0
Q ss_pred eccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC-----
Q 008026 168 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN----- 242 (580)
Q Consensus 168 ~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~----- 242 (580)
+..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|++|||++|+|++.+|+.+..
T Consensus 490 ~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L 569 (635)
T 4g8a_A 490 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 569 (635)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTC
T ss_pred hhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcC
Confidence 344568999999999999888999999999999999999999777888999999999999999999999987642
Q ss_pred ceeecCCCCCCCCCCC
Q 008026 243 AIVNTDGNPDIGKEKS 258 (580)
Q Consensus 243 ~~~~~~~n~~~c~~~~ 258 (580)
..+++++|||.|+|..
T Consensus 570 ~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 570 AFLNLTQNDFACTCEH 585 (635)
T ss_dssp CEEECTTCCBCCSGGG
T ss_pred CEEEeeCCCCcccCCc
Confidence 4589999999999864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=241.47 Aligned_cols=190 Identities=17% Similarity=0.214 Sum_probs=125.0
Q ss_pred CchhhcCcccCceEecccCcCcC------------------CCCCCC--CCCCCcEEeccCCcccccCCccccCCCCCcE
Q 008026 34 GIDVIQNMTSLKEIWLHSNAFSG------------------PLPDFS--GVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93 (580)
Q Consensus 34 ~~~~~~~l~~L~~L~L~~N~l~~------------------~~p~~~--~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~ 93 (580)
+|..|.+|++|++|+|++|.|++ .+++++ ++++|+.|+|++|++.+.+|..|++|++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 67778888888888888888888 444566 8888888888888888888888888888888
Q ss_pred EEccCCc-ccc-cCC-CCCccc-------ccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC
Q 008026 94 VNMTNNL-LQG-PVP-EFDRSV-------SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 163 (580)
Q Consensus 94 L~L~~N~-l~~-~~~-~~~~~~-------~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (580)
|+|++|+ +++ .+| .+..+. +|+.|++++|.+..+|.. ..+..+..+....+.++....
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~------------~~l~~L~~L~~L~Ls~N~l~~ 587 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPAS------------ASLQKMVKLGLLDCVHNKVRH 587 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCH------------HHHTTCTTCCEEECTTSCCCB
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCCh------------hhhhcCCCCCEEECCCCCccc
Confidence 8888887 887 444 355554 888888888888766540 011122233333344444444
Q ss_pred ccceeccCCcEEEEEecCCcccccCcccccCCCC-CcEEeccCCcccccCCccCcCCCC--CCEEEccCCcccccCCC
Q 008026 164 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKS-LQRLILADNNLSGMIPEGLSVLGA--LKELDVSNNQLYGKIPS 238 (580)
Q Consensus 164 ~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~-L~~L~ls~N~l~g~~p~~l~~l~~--L~~l~ls~N~l~g~~p~ 238 (580)
+| .+..+++|+.|+|++|++. .+|..+.++++ |+.|+|++|+|. .+|..+..++. |+.|+|++|+++|.+|.
T Consensus 588 lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~ 662 (876)
T 4ecn_A 588 LE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662 (876)
T ss_dssp CC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSS
T ss_pred ch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCcccc
Confidence 44 4455556666666666666 56666666665 666666666665 55655555443 66666666666655553
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=207.73 Aligned_cols=201 Identities=19% Similarity=0.105 Sum_probs=163.1
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~ 93 (580)
.++..|+.++++++.+. .+|..+. ++|++|+|++|.|++..| .|.++++|+.|+|++|+|+ .+|.. +.+++|+.
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~-~~l~~L~~ 81 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGT 81 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC-SCCTTCCE
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCC-CCCCcCCE
Confidence 45666777777777554 5665553 689999999999998777 5888999999999999998 55554 78999999
Q ss_pred EEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCc
Q 008026 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN 173 (580)
Q Consensus 94 L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (580)
|+|++|+++.++..+..+.+|+.|++++|.+..+++..+. .+++
T Consensus 82 L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~------------------------------------~l~~ 125 (290)
T 1p9a_G 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR------------------------------------GLGE 125 (290)
T ss_dssp EECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTT------------------------------------TCTT
T ss_pred EECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHc------------------------------------CCCC
Confidence 9999999998877788899999999999999888765442 2348
Q ss_pred EEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----CceeecCC
Q 008026 174 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDG 249 (580)
Q Consensus 174 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~ 249 (580)
|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+++ .+|..+. ...+.+.+
T Consensus 126 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~ 204 (290)
T 1p9a_G 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204 (290)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCS
T ss_pred CCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCC
Confidence 999999999999766667889999999999999999444445678999999999999999 5555432 34588899
Q ss_pred CCCCCCCC
Q 008026 250 NPDIGKEK 257 (580)
Q Consensus 250 n~~~c~~~ 257 (580)
|||.|.|.
T Consensus 205 Np~~C~c~ 212 (290)
T 1p9a_G 205 NPWLCNCE 212 (290)
T ss_dssp CCBCCSGG
T ss_pred CCccCcCc
Confidence 99999875
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.3e-25 Score=240.92 Aligned_cols=230 Identities=15% Similarity=0.135 Sum_probs=152.5
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCC-----------------Cchhhc--CcccCceEecccCcCcCCCC-CC
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGG-----------------GIDVIQ--NMTSLKEIWLHSNAFSGPLP-DF 61 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p-~~ 61 (580)
|+++| ||..| .+++.|+.+++++|.+.+. +|+.++ ++++|++|+|++|.+.+.+| .|
T Consensus 193 n~l~~-ip~~l--~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l 269 (636)
T 4eco_A 193 NNITF-VSKAV--MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269 (636)
T ss_dssp CEEEE-ECGGG--GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTT
T ss_pred CCCcc-CCHHH--hcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHH
Confidence 67888 99998 6688888888888876654 888888 99999999999999998888 58
Q ss_pred CCCCCCcEEeccCCc-ccc-cCCccccCC------CCCcEEEccCCcccccCC--CCCcccccccccccCCCCC-CCCCC
Q 008026 62 SGVKQLESLSLRDNF-FTG-PVPDSLVKL------ESLKIVNMTNNLLQGPVP--EFDRSVSLDMAKGSNNFCL-PSPGA 130 (580)
Q Consensus 62 ~~l~~L~~L~L~~N~-l~~-~~P~~~~~l------~~L~~L~L~~N~l~~~~~--~~~~~~~L~~l~l~~n~~~-~~~~~ 130 (580)
.++++|++|+|++|+ ++| .+|..++++ ++|+.|+|++|+++.+++ .+..+.+|+.|++++|.+. .+|
T Consensus 270 ~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-- 347 (636)
T 4eco_A 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-- 347 (636)
T ss_dssp TTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECC--
T ss_pred hcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchh--
Confidence 889999999999998 888 788888876 888888888888886555 5888888888888888887 666
Q ss_pred CchhHHHHHHHH----------HhhCCccc-cccccCCCCCCCCccceeccCC--cEEEEEecCCcccccCccccc----
Q 008026 131 CDPRLNALLSVV----------KLMGYPQR-FAENWKGNDPCSDWIGVTCTKG--NITVINFQKMNLTGTISPEFA---- 193 (580)
Q Consensus 131 ~~~~l~~l~~~~----------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~L~~L~ls~n~l~~~~p~~~~---- 193 (580)
.+..+..|..+. ..+..+.. +....+.++....+|..+..+. +|+.|++++|++.+.+|..+.
T Consensus 348 ~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~ 427 (636)
T 4eco_A 348 AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427 (636)
T ss_dssp CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCS
T ss_pred hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCCCcchhhhccccc
Confidence 332222221111 01111122 3333334444444444443332 555566666655555555555
Q ss_pred ---CCCCCcEEeccCCcccccCCccC-cCCCCCCEEEccCCcccccCCC
Q 008026 194 ---SFKSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNNQLYGKIPS 238 (580)
Q Consensus 194 ---~l~~L~~L~ls~N~l~g~~p~~l-~~l~~L~~l~ls~N~l~g~~p~ 238 (580)
.+++|+.|+|++|+++ .+|..+ ..+++|++|+|++|+++ .+|.
T Consensus 428 ~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~ 474 (636)
T 4eco_A 428 TPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPK 474 (636)
T ss_dssp SCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCS
T ss_pred ccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCH
Confidence 5555556666666555 444433 23555666666666655 4443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-24 Score=239.90 Aligned_cols=244 Identities=14% Similarity=0.107 Sum_probs=160.2
Q ss_pred cc-ccc-CCCCCccccccc-------eEEecccCCCCCCCCCch--hhcCcccCceEecccCcCcCCCCCCCCCCCCcEE
Q 008026 2 LQ-LIG-GLPASFSGSQIQ-------SLWVNGQNGNAKLGGGID--VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESL 70 (580)
Q Consensus 2 ~~-~~~-~~P~~~~~~~l~-------~L~~~~~~~n~~~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L 70 (580)
|+ ++| .+|..| .++. .|+.+++++|++. .+|. .|.++++|++|+|++|+|+ .+|.|..+++|+.|
T Consensus 525 N~~lsg~~iP~~i--~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L 600 (876)
T 4ecn_A 525 NRGISAAQLKADW--TRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDL 600 (876)
T ss_dssp CTTSCHHHHHHHH--HHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEE
T ss_pred CCCcccccchHHH--HhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEE
Confidence 55 666 777766 3343 6777777777665 6666 7788888888888888877 55577777888888
Q ss_pred eccCCcccccCCccccCCCC-CcEEEccCCcccccCCCCCcccc--cccccccCCCCCCCCCCCchhHH-----HHH---
Q 008026 71 SLRDNFFTGPVPDSLVKLES-LKIVNMTNNLLQGPVPEFDRSVS--LDMAKGSNNFCLPSPGACDPRLN-----ALL--- 139 (580)
Q Consensus 71 ~L~~N~l~~~~P~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~--L~~l~l~~n~~~~~~~~~~~~l~-----~l~--- 139 (580)
+|++|++. .+|..+.++++ |+.|+|++|+++.++..+..+.. |+.|++++|.+...++.....+. +|.
T Consensus 601 ~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~ 679 (876)
T 4ecn_A 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679 (876)
T ss_dssp ECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEE
T ss_pred ECcCCccc-cchHHHhhccccCCEEECcCCCCCcCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEE
Confidence 88888887 77777777777 88888888777755444444432 66666666666544332210000 000
Q ss_pred -------HHHHh-hCCccccccccCCCCCCCCccceeccC--------CcEEEEEecCCcccccCccccc--CCCCCcEE
Q 008026 140 -------SVVKL-MGYPQRFAENWKGNDPCSDWIGVTCTK--------GNITVINFQKMNLTGTISPEFA--SFKSLQRL 201 (580)
Q Consensus 140 -------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~L~~L~ls~n~l~~~~p~~~~--~l~~L~~L 201 (580)
.++.. ...+..+....+.++.+..+|...+.. ++|+.|+|++|+++ .+|..+. .+++|+.|
T Consensus 680 Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L 758 (876)
T 4ecn_A 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758 (876)
T ss_dssp CCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEE
T ss_pred ccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEE
Confidence 00000 012233444445555555555544432 27888888888888 7888887 88888888
Q ss_pred eccCCcccccCCccCcCCCCCCEEEccC------CcccccCCCCCCC----ceeecCCCCC
Q 008026 202 ILADNNLSGMIPEGLSVLGALKELDVSN------NQLYGKIPSFKSN----AIVNTDGNPD 252 (580)
Q Consensus 202 ~ls~N~l~g~~p~~l~~l~~L~~l~ls~------N~l~g~~p~~~~~----~~~~~~~n~~ 252 (580)
+|++|+|++ +|.++..+++|+.|+|++ |++.+.+|..+.. ..+++++|..
T Consensus 759 ~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818 (876)
T ss_dssp ECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred EeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence 888888885 788888888888888866 7778888876543 3477777765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-23 Score=199.70 Aligned_cols=197 Identities=22% Similarity=0.187 Sum_probs=161.3
Q ss_pred EecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCcc-ccCCCCCcEEEccC
Q 008026 21 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTN 98 (580)
Q Consensus 21 ~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~-~~~l~~L~~L~L~~ 98 (580)
..++++++.+. .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+++ .+|.. |.++++|++|+|++
T Consensus 19 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 19 NSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCS
T ss_pred CEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCC
Confidence 34556666444 5665443 589999999999998877 5889999999999999999 56655 68899999999999
Q ss_pred CcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEE
Q 008026 99 NLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVI 177 (580)
Q Consensus 99 N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L 177 (580)
|++++.++. +..+.+|+.|++++|.+..+++..+. .+++|+.|
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~------------------------------------~l~~L~~L 138 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFD------------------------------------SLTKLTYL 138 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTT------------------------------------TCTTCCEE
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhC------------------------------------cCcCCCEE
Confidence 999998876 67889999999999998887765432 23489999
Q ss_pred EecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----CceeecCCCCCC
Q 008026 178 NFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGNPDI 253 (580)
Q Consensus 178 ~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~ 253 (580)
+|++|++.+..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+. ...+.+.+|||.
T Consensus 139 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 139 SLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 9999999966556689999999999999999965566789999999999999999976665443 346899999999
Q ss_pred CCCC
Q 008026 254 GKEK 257 (580)
Q Consensus 254 c~~~ 257 (580)
|.|.
T Consensus 219 c~c~ 222 (270)
T 2o6q_A 219 CTCN 222 (270)
T ss_dssp CSSS
T ss_pred CCCc
Confidence 9875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=206.53 Aligned_cols=153 Identities=16% Similarity=0.092 Sum_probs=119.8
Q ss_pred HHHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccCh----------------hhHHHHHHHHHHHHhcCC
Q 008026 389 VLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG----------------KGLTEFKSEIAVLTKVRH 452 (580)
Q Consensus 389 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h 452 (580)
.+......|.+.+.||+|+||.||+|...+|+.||+|++....... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 3444455677889999999999999988779999999986432111 13567899999999999
Q ss_pred CcccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCe
Q 008026 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 532 (580)
Q Consensus 453 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI 532 (580)
| +++.+++.. +..|+||||+++++|.+ +. . .....++.|++.||+|||+ .+|+||||||+||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---------~--~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NI 224 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR---------V--ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNV 224 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cc---------h--hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHE
Confidence 4 666665533 55699999999999987 41 1 2245799999999999998 8999999999999
Q ss_pred EecCCCcEEEEeeccccccCCCCCCccccccccCCccCccccC
Q 008026 533 LLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAG 575 (580)
Q Consensus 533 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~ 575 (580)
|++ ++.+||+|||+|+. +..|+|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999 99999999999864 33467777764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=227.38 Aligned_cols=226 Identities=18% Similarity=0.158 Sum_probs=150.7
Q ss_pred cccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCcccccCC
Q 008026 4 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVP 82 (580)
Q Consensus 4 ~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~P 82 (580)
-.+.+|..+. .++..|+.+++++|.+.+..|..|.++++|++|+|++|.|++.+|. |.++++|++|+|++|+|+ .+|
T Consensus 62 ~l~~lp~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~ 139 (597)
T 3oja_B 62 TMRKLPAALL-DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLP 139 (597)
T ss_dssp EESEECTHHH-HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred CCCCcCHHHH-ccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCC
Confidence 3455666532 4567778888888877776667888899999999999999888774 788899999999999988 566
Q ss_pred cc-ccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHH----------------HHHHHh
Q 008026 83 DS-LVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL----------------LSVVKL 144 (580)
Q Consensus 83 ~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l----------------~~~~~~ 144 (580)
.. |+++++|+.|+|++|.+++.+|. |..+.+|+.|++++|.+..++...++.+..+ ..+...
T Consensus 140 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls 219 (597)
T 3oja_B 140 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDAS 219 (597)
T ss_dssp TTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECC
T ss_pred HHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeecc
Confidence 55 68899999999999999888875 7888888889988888877653332222110 000000
Q ss_pred --------hCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccC
Q 008026 145 --------MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 216 (580)
Q Consensus 145 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l 216 (580)
...+..+....+.++..... ..+..+++|+.|+|++|.+.+.+|..|+.+++|+.|+|++|+++ .+|..+
T Consensus 220 ~n~l~~~~~~~~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~ 297 (597)
T 3oja_B 220 HNSINVVRGPVNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297 (597)
T ss_dssp SSCCCEEECSCCSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC-EEECSS
T ss_pred CCcccccccccCCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC-CCCccc
Confidence 00011233333444444332 34555566777777777777666666666666666666666666 355555
Q ss_pred cCCCCCCEEEccCCccc
Q 008026 217 SVLGALKELDVSNNQLY 233 (580)
Q Consensus 217 ~~l~~L~~l~ls~N~l~ 233 (580)
..+++|+.|+|++|+++
T Consensus 298 ~~l~~L~~L~Ls~N~l~ 314 (597)
T 3oja_B 298 QPIPTLKVLDLSHNHLL 314 (597)
T ss_dssp SCCTTCCEEECCSSCCC
T ss_pred ccCCCCcEEECCCCCCC
Confidence 66666666666666665
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-23 Score=203.30 Aligned_cols=186 Identities=17% Similarity=0.142 Sum_probs=163.0
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSL 85 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~ 85 (580)
..+|..+. ..|+.+++++|.+....+..|.++++|++|+|++|.|++..+. ..+++|++|+|++|+|+ .+|..+
T Consensus 23 ~~ip~~~~----~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~ 96 (290)
T 1p9a_G 23 TALPPDLP----KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLG 96 (290)
T ss_dssp SSCCSCCC----TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSCCS-SCCCCT
T ss_pred CcCCCCCC----CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCCEEECCCCcCC-cCchhh
Confidence 36787773 4566677888888777778999999999999999999976554 78999999999999999 899999
Q ss_pred cCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCc
Q 008026 86 VKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 164 (580)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (580)
..+++|+.|+|++|+++++++. |..+.+|+.|++++|.+..+++..+.
T Consensus 97 ~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~------------------------------- 145 (290)
T 1p9a_G 97 QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT------------------------------- 145 (290)
T ss_dssp TTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTT-------------------------------
T ss_pred ccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcc-------------------------------
Confidence 9999999999999999999875 88999999999999999988866542
Q ss_pred cceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 165 IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 165 ~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
.+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+..+..|+.|+|++|++..
T Consensus 146 -----~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 146 -----PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp -----TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred -----cccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 2348999999999999555555788999999999999999 999999999999999999999974
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=199.00 Aligned_cols=194 Identities=19% Similarity=0.204 Sum_probs=162.8
Q ss_pred ccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCcccccC
Q 008026 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPV 81 (580)
Q Consensus 3 ~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~ 81 (580)
+++ .+|..+. ..|+.+++++|++....+..|.++++|++|+|++|.|+..++. |.++++|++|+|++|++.+..
T Consensus 27 ~l~-~ip~~~~----~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~ 101 (270)
T 2o6q_A 27 KLT-AIPSNIP----ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALP 101 (270)
T ss_dssp CCS-SCCSCCC----TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCC
T ss_pred CCC-ccCCCCC----CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCC
Confidence 344 5888773 3455566777777766667899999999999999999987775 688999999999999999544
Q ss_pred CccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCC
Q 008026 82 PDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 160 (580)
Q Consensus 82 P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 160 (580)
+..|.++++|+.|+|++|++++.++. |..+.+|+.|++++|.+..+++..+.
T Consensus 102 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~--------------------------- 154 (270)
T 2o6q_A 102 IGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFD--------------------------- 154 (270)
T ss_dssp TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT---------------------------
T ss_pred HhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHcc---------------------------
Confidence 45689999999999999999999886 78999999999999999888765432
Q ss_pred CCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 161 ~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
.+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++...-+
T Consensus 155 ---------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 155 ---------KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp ---------TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred ---------CCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 23489999999999997666679999999999999999995555568899999999999999986543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=229.99 Aligned_cols=230 Identities=17% Similarity=0.103 Sum_probs=166.7
Q ss_pred ceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC--CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 18 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 18 ~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
..|+.++++.|++.+..|..|.++++|++|+|++|.+++.+| .|.++++|++|+|++|++.+..|..|..+++|+.|+
T Consensus 381 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ 460 (680)
T 1ziw_A 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEE
T ss_pred CcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccch
Confidence 456666777777777667777778888888888888776554 367777888888888887766666677777777777
Q ss_pred ccCCccc--ccCC-CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCc-----c--
Q 008026 96 MTNNLLQ--GPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW-----I-- 165 (580)
Q Consensus 96 L~~N~l~--~~~~-~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-- 165 (580)
+++|.++ +..| .+..+.+|+.|++++|.+..+++..+..+..|.. ..+.++....+ |
T Consensus 461 l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~-------------L~Ls~N~l~~~~~~~~~~~ 527 (680)
T 1ziw_A 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI-------------LDLQHNNLARLWKHANPGG 527 (680)
T ss_dssp CTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-------------EECCSSCCGGGGSTTSTTS
T ss_pred hccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCE-------------EeCCCCCccccchhhccCC
Confidence 7777775 2333 4677777777777777777777665544433322 22222222211 1
Q ss_pred --ceeccCCcEEEEEecCCcccccCcc-cccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCC--
Q 008026 166 --GVTCTKGNITVINFQKMNLTGTISP-EFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK-- 240 (580)
Q Consensus 166 --~~~~~~~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~-- 240 (580)
..+..+++|+.|+|++|+++ .+|. .|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++++..|..+
T Consensus 528 ~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 606 (680)
T 1ziw_A 528 PIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606 (680)
T ss_dssp CCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHH
T ss_pred cchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcc
Confidence 12455679999999999999 5664 68999999999999999995555567899999999999999998877533
Q ss_pred ---CCceeecCCCCCCCCCCC-CCC
Q 008026 241 ---SNAIVNTDGNPDIGKEKS-SSF 261 (580)
Q Consensus 241 ---~~~~~~~~~n~~~c~~~~-~~~ 261 (580)
....+++++|||.|+|.. ..+
T Consensus 607 ~~~~L~~l~l~~N~~~c~c~~~~~~ 631 (680)
T 1ziw_A 607 AFRNLTELDMRFNPFDCTCESIAWF 631 (680)
T ss_dssp HHTTCSEEECTTCCCCBCCCCCSSE
T ss_pred cccccCEEEccCCCcccCCccHHHH
Confidence 345699999999999874 444
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-24 Score=216.42 Aligned_cols=232 Identities=18% Similarity=0.125 Sum_probs=175.0
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCcc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 84 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~ 84 (580)
..+|..+. ..|+.+++++|++....+..|.++++|++|+|++|++++..| .|.++++|++|+|++|+++ .+|..
T Consensus 44 ~~iP~~~~----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~ 118 (353)
T 2z80_A 44 NSIPSGLT----EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSS 118 (353)
T ss_dssp SSCCTTCC----TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHH
T ss_pred cccccccc----ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHh
Confidence 46787773 356666777777666555689999999999999999998877 4889999999999999999 56665
Q ss_pred -ccCCCCCcEEEccCCcccccCC--CCCcccccccccccCC-CCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCC
Q 008026 85 -LVKLESLKIVNMTNNLLQGPVP--EFDRSVSLDMAKGSNN-FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 160 (580)
Q Consensus 85 -~~~l~~L~~L~L~~N~l~~~~~--~~~~~~~L~~l~l~~n-~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 160 (580)
|.++++|++|+|++|+++++++ .+..+.+|+.|++++| .+..+++..+..+. .+....+.++.
T Consensus 119 ~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~-------------~L~~L~l~~n~ 185 (353)
T 2z80_A 119 WFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT-------------FLEELEIDASD 185 (353)
T ss_dssp HHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC-------------EEEEEEEEETT
T ss_pred HhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCC-------------CCCEEECCCCC
Confidence 8999999999999999998877 4788999999999998 57766655543332 33333333333
Q ss_pred CCC-ccceeccCCcEEEEEecCCcccccCccc-ccCCCCCcEEeccCCccccc---------------------------
Q 008026 161 CSD-WIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGM--------------------------- 211 (580)
Q Consensus 161 ~~~-~~~~~~~~~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~--------------------------- 211 (580)
... .+..+..+++|+.|++++|++. .+|.. +..+++|+.|++++|++++.
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred cCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 333 2445566678888888888886 45544 44578888888888888753
Q ss_pred ----CCccCcCCCCCCEEEccCCcccccCCCC-CC----CceeecCCCCCCCCCC
Q 008026 212 ----IPEGLSVLGALKELDVSNNQLYGKIPSF-KS----NAIVNTDGNPDIGKEK 257 (580)
Q Consensus 212 ----~p~~l~~l~~L~~l~ls~N~l~g~~p~~-~~----~~~~~~~~n~~~c~~~ 257 (580)
+|..+..+++|+.||+++|+++ .+|.. +. ...+++++|++.|.|+
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred chhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 3445678899999999999999 55554 22 3468999999999874
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=218.13 Aligned_cols=242 Identities=17% Similarity=0.123 Sum_probs=188.3
Q ss_pred cccccCCC-CCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-C--CCCCCCCcEEeccCCcc
Q 008026 2 LQLIGGLP-ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-D--FSGVKQLESLSLRDNFF 77 (580)
Q Consensus 2 ~~~~~~~P-~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~--~~~l~~L~~L~L~~N~l 77 (580)
|++.+.+| ..| .+++.|+.+++++|.+.+..|..|.++++|++|+|++|.+++.+| . |..+++|++|+|++|++
T Consensus 64 n~~~~~i~~~~~--~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l 141 (455)
T 3v47_A 64 QTPGLVIRNNTF--RGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141 (455)
T ss_dssp CSTTCEECTTTT--TTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBC
T ss_pred CcccceECcccc--cccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCcc
Confidence 55666775 457 568888888888898887778889999999999999999987544 3 78899999999999999
Q ss_pred cccCCcc-ccCCCCCcEEEccCCcccccCCC-CCc----------------------------------ccccccccccC
Q 008026 78 TGPVPDS-LVKLESLKIVNMTNNLLQGPVPE-FDR----------------------------------SVSLDMAKGSN 121 (580)
Q Consensus 78 ~~~~P~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~----------------------------------~~~L~~l~l~~ 121 (580)
.+..|.. +.++++|++|+|++|++++.++. +.. +.+|+.|++++
T Consensus 142 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~ 221 (455)
T 3v47_A 142 KKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSG 221 (455)
T ss_dssp CSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTT
T ss_pred CccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCC
Confidence 9766776 88999999999999999887664 222 13455555555
Q ss_pred C---------------------------------------------------------------CCCCCCCCCchhHHHH
Q 008026 122 N---------------------------------------------------------------FCLPSPGACDPRLNAL 138 (580)
Q Consensus 122 n---------------------------------------------------------------~~~~~~~~~~~~l~~l 138 (580)
| .+...++..+..
T Consensus 222 n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~---- 297 (455)
T 3v47_A 222 NGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSH---- 297 (455)
T ss_dssp SCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTT----
T ss_pred CcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhccc----
Confidence 4 444444443332
Q ss_pred HHHHHhhCCccccccccCCCCCCCCc-cceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCc
Q 008026 139 LSVVKLMGYPQRFAENWKGNDPCSDW-IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 217 (580)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~ 217 (580)
+..+....+.++..... +..+..+++|+.|+|++|++.+..|..+.++++|++|+|++|++++..|.++.
T Consensus 298 ---------l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 368 (455)
T 3v47_A 298 ---------FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368 (455)
T ss_dssp ---------CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred ---------CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcc
Confidence 33444445555555543 44666778999999999999988899999999999999999999988899999
Q ss_pred CCCCCCEEEccCCcccccCCCCCC----CceeecCCCCCCCCCCC
Q 008026 218 VLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 218 ~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~~ 258 (580)
.+++|++|+|++|++++..+..+. ...+++++|++.|.|+.
T Consensus 369 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 999999999999999986665543 35699999999999863
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=216.89 Aligned_cols=226 Identities=18% Similarity=0.157 Sum_probs=155.1
Q ss_pred ccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCcccccCCc
Q 008026 5 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPD 83 (580)
Q Consensus 5 ~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~P~ 83 (580)
.+.+|..+. ..++.|+.+++++|.+....+..|.++++|++|+|++|.+++.+|. |.++++|++|+|++|++. .+|.
T Consensus 57 l~~l~~~~~-~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~ 134 (390)
T 3o6n_A 57 MRKLPAALL-DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR 134 (390)
T ss_dssp ESEECTHHH-HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred hhhCChhHh-cccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCH
Confidence 455676532 4567777888888877766667888999999999999999888775 788999999999999998 6776
Q ss_pred c-ccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHH----------------HHHHHh-
Q 008026 84 S-LVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL----------------LSVVKL- 144 (580)
Q Consensus 84 ~-~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l----------------~~~~~~- 144 (580)
. |.++++|+.|+|++|++++.++. +..+.+|+.|++++|.+..++...+..+..+ ..+...
T Consensus 135 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~ 214 (390)
T 3o6n_A 135 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASH 214 (390)
T ss_dssp TTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCS
T ss_pred HHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCC
Confidence 6 68899999999999999888775 7788889999999888877653322221110 000000
Q ss_pred -------hCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCc
Q 008026 145 -------MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 217 (580)
Q Consensus 145 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~ 217 (580)
......+....+.++..... ..+..+++|+.|++++|++.+..|..+..+++|++|+|++|+++ .+|..+.
T Consensus 215 n~l~~~~~~~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~ 292 (390)
T 3o6n_A 215 NSINVVRGPVNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ 292 (390)
T ss_dssp SCCCEEECCCCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSS
T ss_pred CeeeeccccccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccC
Confidence 00011223333334433332 34455667777777777777777777777777777777777776 4566666
Q ss_pred CCCCCCEEEccCCcccc
Q 008026 218 VLGALKELDVSNNQLYG 234 (580)
Q Consensus 218 ~l~~L~~l~ls~N~l~g 234 (580)
.+++|++|++++|++++
T Consensus 293 ~l~~L~~L~L~~n~l~~ 309 (390)
T 3o6n_A 293 PIPTLKVLDLSHNHLLH 309 (390)
T ss_dssp CCTTCCEEECCSSCCCC
T ss_pred CCCCCCEEECCCCccee
Confidence 67777777777777763
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=229.46 Aligned_cols=209 Identities=20% Similarity=0.097 Sum_probs=146.6
Q ss_pred hhcCcccCceEecccCcCcCCC--C-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCC--CCCcc
Q 008026 37 VIQNMTSLKEIWLHSNAFSGPL--P-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP--EFDRS 111 (580)
Q Consensus 37 ~~~~l~~L~~L~L~~N~l~~~~--p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~ 111 (580)
.+..+++|++|+|++|.+++.. | .+..+++|+.|+|++|++. .+|..+..+++|+.|++++|++++.+| .+..+
T Consensus 345 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 423 (606)
T 3vq2_A 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423 (606)
T ss_dssp CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTC
T ss_pred hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhcc
Confidence 3445566666666666665542 3 3555666666666666666 455666666666666666666666655 35566
Q ss_pred cccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC--ccceeccCCcEEEEEecCCcccccCc
Q 008026 112 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD--WIGVTCTKGNITVINFQKMNLTGTIS 189 (580)
Q Consensus 112 ~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~L~~L~ls~n~l~~~~p 189 (580)
.+|+.|++++|.+...++..+..+ ..+....+.++.... .+..+..+++|+.|+|++|++++..|
T Consensus 424 ~~L~~L~l~~n~l~~~~~~~~~~l-------------~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 490 (606)
T 3vq2_A 424 EKLLYLDISYTNTKIDFDGIFLGL-------------TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490 (606)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTC-------------TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred ccCCEEECcCCCCCccchhhhcCC-------------CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccCh
Confidence 666666666666655544433322 233334444444433 45566777899999999999999889
Q ss_pred ccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC-----CceeecCCCCCCCCCCCCC
Q 008026 190 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS-----NAIVNTDGNPDIGKEKSSS 260 (580)
Q Consensus 190 ~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~-----~~~~~~~~n~~~c~~~~~~ 260 (580)
..++++++|++|+|++|++++.+|..+..+++|++||+++|+++ .+|..+. ...+++++|||.|.|+...
T Consensus 491 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~ 565 (606)
T 3vq2_A 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQK 565 (606)
T ss_dssp TTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred hhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence 99999999999999999999888999999999999999999999 5555432 3568999999999987543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=198.66 Aligned_cols=184 Identities=19% Similarity=0.184 Sum_probs=125.1
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
.+..|+.+++++|.+.. .+.+..+++|++|+|++|.+++ ++.+..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 39 ~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 115 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHD-ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELV 115 (272)
T ss_dssp HHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCC-CGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCC-chhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEE
Confidence 45556666666664432 2346777777777777777775 34667777777777777777744444567777777777
Q ss_pred ccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 96 MTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 96 L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
|++|++++.++. +..+.+|+.|++++|.+..+++..+. .+++|
T Consensus 116 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~------------------------------------~l~~L 159 (272)
T 3rfs_A 116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFD------------------------------------KLTNL 159 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT------------------------------------TCTTC
T ss_pred CCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhc------------------------------------cCccC
Confidence 777777777665 56677777777777777666544321 22367
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~ 238 (580)
+.|++++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|++++|++.+..|.
T Consensus 160 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 160 TELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 7777777777765555567777777777777777765566667777777777777777766664
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=219.80 Aligned_cols=89 Identities=22% Similarity=0.216 Sum_probs=61.4
Q ss_pred eccCCcEEEEEecCCcccccCccc-ccCC----------------------CCCcEEeccCCcccccCCccCcCCCCCCE
Q 008026 168 TCTKGNITVINFQKMNLTGTISPE-FASF----------------------KSLQRLILADNNLSGMIPEGLSVLGALKE 224 (580)
Q Consensus 168 ~~~~~~L~~L~ls~n~l~~~~p~~-~~~l----------------------~~L~~L~ls~N~l~g~~p~~l~~l~~L~~ 224 (580)
+..+++|+.|++++|++.+.+|.. +..+ ++|+.|+|++|+|+ .+|..+..+++|++
T Consensus 399 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~ 477 (562)
T 3a79_B 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQE 477 (562)
T ss_dssp TTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSE
T ss_pred hcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCE
Confidence 455567777777777777545543 3333 56777777777776 77777778888888
Q ss_pred EEccCCcccccCCCC-CC----CceeecCCCCCCCCCCC
Q 008026 225 LDVSNNQLYGKIPSF-KS----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 225 l~ls~N~l~g~~p~~-~~----~~~~~~~~n~~~c~~~~ 258 (580)
|+|++|++++ +|.. +. ...+++++|+|.|.|+.
T Consensus 478 L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 478 LNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp EECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred EECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 8888888884 4543 32 23588889999988753
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.88 E-value=5e-23 Score=224.42 Aligned_cols=214 Identities=14% Similarity=0.098 Sum_probs=115.0
Q ss_pred cceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
+..++.+++++|.+....+..|.++++|++|+|++|.|++.+| .|..+++|++|+|++|.|++..|..|+++++|+.|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 3445555555554433333445666666666666666666555 466666666666666666644444566666666666
Q ss_pred ccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccc--------ccc-------------
Q 008026 96 MTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR--------FAE------------- 153 (580)
Q Consensus 96 L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~--------~~~------------- 153 (580)
|++|.++++++. |..+.+|+.|++++|.+..+++..+..+..|..+......+.. +..
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~ 209 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAI 209 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEEC
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccC
Confidence 666666666655 3566666666666666666665555444433322211111110 000
Q ss_pred ------ccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEc
Q 008026 154 ------NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 227 (580)
Q Consensus 154 ------~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~l 227 (580)
..+.++....+++.. ..+|+.|+|++|.+++ +..++.+++|+.|+|++|.+.+.+|..+..+++|+.|+|
T Consensus 210 ~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 285 (597)
T 3oja_B 210 PIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 285 (597)
T ss_dssp CTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEEC
T ss_pred CchhheeeccCCccccccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEEC
Confidence 001111111111111 1245566666666654 245666666666666666666666666666666666666
Q ss_pred cCCcccc
Q 008026 228 SNNQLYG 234 (580)
Q Consensus 228 s~N~l~g 234 (580)
++|++++
T Consensus 286 s~N~l~~ 292 (597)
T 3oja_B 286 SNNRLVA 292 (597)
T ss_dssp TTSCCCE
T ss_pred CCCCCCC
Confidence 6666665
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-22 Score=201.06 Aligned_cols=227 Identities=18% Similarity=0.135 Sum_probs=161.7
Q ss_pred eEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEcc
Q 008026 19 SLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97 (580)
Q Consensus 19 ~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~ 97 (580)
.|+.++++.+. ++.+|..+. +.|++|+|++|+|++.++ .|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 32 ~l~~l~~~~~~-l~~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLG-LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSC-CCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCC-ccccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 45555666554 445665553 689999999999999887 58999999999999999997779999999999999999
Q ss_pred CCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHh-------------hCCccccccccCCCCCCCCc
Q 008026 98 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL-------------MGYPQRFAENWKGNDPCSDW 164 (580)
Q Consensus 98 ~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~-------------~~~~~~~~~~~~~~~~~~~~ 164 (580)
+|+++.++..+. .+|+.|++++|.+..+++..+..+..+..+... ...+..+......++....+
T Consensus 109 ~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l 186 (330)
T 1xku_A 109 KNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 186 (330)
T ss_dssp SSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred CCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC
Confidence 999998777665 689999999999988775444333333221111 11122223333344444444
Q ss_pred cceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC---
Q 008026 165 IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS--- 241 (580)
Q Consensus 165 ~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~--- 241 (580)
+.... ++|+.|++++|++.+..|..+..+++|+.|+|++|++++..|..+..+++|++|++++|+++ .+|..+.
T Consensus 187 ~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~ 263 (330)
T 1xku_A 187 PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263 (330)
T ss_dssp CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCC
Confidence 43332 47778888888888777777888888888888888888666667888888888888888887 5565443
Q ss_pred -CceeecCCCCCC
Q 008026 242 -NAIVNTDGNPDI 253 (580)
Q Consensus 242 -~~~~~~~~n~~~ 253 (580)
...+++++|...
T Consensus 264 ~L~~L~l~~N~i~ 276 (330)
T 1xku_A 264 YIQVVYLHNNNIS 276 (330)
T ss_dssp SCCEEECCSSCCC
T ss_pred CcCEEECCCCcCC
Confidence 234677777643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=199.03 Aligned_cols=201 Identities=18% Similarity=0.110 Sum_probs=165.9
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++++..|..| .++..|+.+++++|.+.+..+..|.++++|++|+|++|.+++..+ .|.++++|++|++++|++.+.
T Consensus 38 n~l~~~~~~~~--~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 115 (276)
T 2z62_A 38 NPLRHLGSYSF--FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115 (276)
T ss_dssp CCCCEECTTTT--TTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCS
T ss_pred CcccccCHhHh--ccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCcccc
Confidence 56666666677 567888888999998877777789999999999999999998887 589999999999999999955
Q ss_pred CCccccCCCCCcEEEccCCccccc--CCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCC
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGP--VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 158 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~ 158 (580)
.+..+..+++|+.|+|++|++++. +..+..+.+|+.|++++|.+..+++..+..+..+
T Consensus 116 ~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-------------------- 175 (276)
T 2z62_A 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM-------------------- 175 (276)
T ss_dssp TTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTC--------------------
T ss_pred CchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhc--------------------
Confidence 555799999999999999999984 4468899999999999999988876555433311
Q ss_pred CCCCCccceeccCCcEE-EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 159 DPCSDWIGVTCTKGNIT-VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 159 ~~~~~~~~~~~~~~~L~-~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
..|. .|++++|++.+ +|.......+|++|+|++|++++..+..+..+++|+.|++++|++++..|
T Consensus 176 -------------~~l~l~L~ls~n~l~~-~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 176 -------------PLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp -------------TTCCEEEECCSSCCCE-ECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred -------------cccceeeecCCCcccc-cCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 1333 79999999995 44555556689999999999995555567899999999999999998776
Q ss_pred C
Q 008026 238 S 238 (580)
Q Consensus 238 ~ 238 (580)
.
T Consensus 242 ~ 242 (276)
T 2z62_A 242 R 242 (276)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=216.08 Aligned_cols=97 Identities=16% Similarity=0.111 Sum_probs=61.0
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccc-c
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTG-P 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~-~ 80 (580)
|++++..|..| .++..|+.+++++|++.+..|+.|.++++|++|+|++|+|+..++. .+++|++|+|++|++++ .
T Consensus 31 n~i~~~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~ 106 (520)
T 2z7x_B 31 NYISELWTSDI--LSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALP 106 (520)
T ss_dssp SCCCCCCHHHH--TTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSSCC
T ss_pred CcccccChhhc--cccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCcccccc
Confidence 44444444555 4456666666666666655566677777777777777776643323 56677777777777764 3
Q ss_pred CCccccCCCCCcEEEccCCccc
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQ 102 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~ 102 (580)
+|..|+++++|+.|+|++|+++
T Consensus 107 ~p~~~~~l~~L~~L~L~~n~l~ 128 (520)
T 2z7x_B 107 ICKEFGNMSQLKFLGLSTTHLE 128 (520)
T ss_dssp CCGGGGGCTTCCEEEEEESSCC
T ss_pred chhhhccCCcceEEEecCcccc
Confidence 5666777777777776666654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=220.25 Aligned_cols=238 Identities=20% Similarity=0.107 Sum_probs=145.6
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++++..|..| .+++.|+.+++++|++.+..|++|.++++|++|+|++|++++..| .|.++++|++|+|++|++++.
T Consensus 43 n~i~~~~~~~~--~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l 120 (606)
T 3t6q_A 43 NVLPTIQNTTF--SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120 (606)
T ss_dssp CCCSEECTTTS--TTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCG
T ss_pred CccCcCChhHh--ccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccC
Confidence 45555555566 446666666666666666556666666666666666666666555 466666666666666666643
Q ss_pred CCccccCCCCCcEEEccCCccccc-CCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCC
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGP-VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 159 (580)
.|..|+++++|++|+|++|++++. +|.+..+.+|+.|++++|.+..+++..+..+..+..+ .....++
T Consensus 121 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l-----------~L~l~~n 189 (606)
T 3t6q_A 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL-----------SLNLNGN 189 (606)
T ss_dssp GGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSE-----------EEECTTC
T ss_pred CcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhccccee-----------EEecCCC
Confidence 355566666666666666666663 3445556666666666666665543333222222100 0111111
Q ss_pred CCCCcc--------------------------------------------------ceeccC--CcEEEEEecCCccccc
Q 008026 160 PCSDWI--------------------------------------------------GVTCTK--GNITVINFQKMNLTGT 187 (580)
Q Consensus 160 ~~~~~~--------------------------------------------------~~~~~~--~~L~~L~ls~n~l~~~ 187 (580)
.....+ ..+..+ .+|+.|++++|++.+.
T Consensus 190 ~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~ 269 (606)
T 3t6q_A 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269 (606)
T ss_dssp CCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSC
T ss_pred ccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCcc
Confidence 111000 000001 1688888888888876
Q ss_pred CcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----CceeecCCCCCC
Q 008026 188 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGNPDI 253 (580)
Q Consensus 188 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~ 253 (580)
.+..|+.+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+. ...+.+.+|...
T Consensus 270 ~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~ 338 (606)
T 3t6q_A 270 SSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338 (606)
T ss_dssp CTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSC
T ss_pred CHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcc
Confidence 6667888888888888888888 7888888888888888888888877664432 234666666543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-23 Score=210.47 Aligned_cols=219 Identities=14% Similarity=0.120 Sum_probs=173.4
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++++..+..| .++..|+.+++++|++.+..++.|.++++|++|+|++|+|++.++. |.++++|++|+|++|++. .
T Consensus 62 n~i~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~ 138 (353)
T 2z80_A 62 NRITYISNSDL--QRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-T 138 (353)
T ss_dssp SCCCEECTTTT--TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-S
T ss_pred CcCcccCHHHh--ccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-c
Confidence 55665445577 5688888888888988877778899999999999999999987765 888999999999999999 6
Q ss_pred CCc--cccCCCCCcEEEccCC-cccccCC-CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccC
Q 008026 81 VPD--SLVKLESLKIVNMTNN-LLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 156 (580)
Q Consensus 81 ~P~--~~~~l~~L~~L~L~~N-~l~~~~~-~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~ 156 (580)
+|. .|.++++|+.|++++| .++..++ .+..+.+|+.|++++|.+...++..+..+ ..+....+
T Consensus 139 l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l-------------~~L~~L~l 205 (353)
T 2z80_A 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI-------------QNVSHLIL 205 (353)
T ss_dssp SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC-------------SEEEEEEE
T ss_pred cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhcc-------------ccCCeecC
Confidence 776 6899999999999999 5777766 48889999999999999888765554332 23333334
Q ss_pred CCCCCCCccceec-cCCcEEEEEecCCccccc-------------------------------CcccccCCCCCcEEecc
Q 008026 157 GNDPCSDWIGVTC-TKGNITVINFQKMNLTGT-------------------------------ISPEFASFKSLQRLILA 204 (580)
Q Consensus 157 ~~~~~~~~~~~~~-~~~~L~~L~ls~n~l~~~-------------------------------~p~~~~~l~~L~~L~ls 204 (580)
.++....++.... .+++|+.|++++|++++. +|..+..+++|++|+|+
T Consensus 206 ~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls 285 (353)
T 2z80_A 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFS 285 (353)
T ss_dssp ECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECC
T ss_pred CCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECC
Confidence 4444444443322 356788888888888752 56678899999999999
Q ss_pred CCcccccCCccC-cCCCCCCEEEccCCcccccCC
Q 008026 205 DNNLSGMIPEGL-SVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 205 ~N~l~g~~p~~l-~~l~~L~~l~ls~N~l~g~~p 237 (580)
+|+++ .+|..+ ..+++|++|++++|++++..|
T Consensus 286 ~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 286 RNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp SSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 99999 788775 899999999999999998776
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-22 Score=201.96 Aligned_cols=223 Identities=17% Similarity=0.154 Sum_probs=153.4
Q ss_pred CCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccc
Q 008026 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSL 85 (580)
Q Consensus 7 ~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~ 85 (580)
.+|..+. ..|+.+++++|.+.+..+..|.++++|++|+|++|++++..| .|.++++|++|+|++|++. .+|..+
T Consensus 47 ~ip~~~~----~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~ 121 (332)
T 2ft3_A 47 AVPKEIS----PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL 121 (332)
T ss_dssp SCCSCCC----TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSC
T ss_pred ccCCCCC----CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCccc
Confidence 4555542 234445555565555555567777777777777777776655 4666777777777777776 666665
Q ss_pred cCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCC--CCCCCchhHHHHHHHHHhhCCccccccccCCCCCCC
Q 008026 86 VKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLP--SPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 162 (580)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~--~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 162 (580)
. ++|++|+|++|++++.++. +..+.+|+.|++++|.+.. ..+..+.. + .+....+.++...
T Consensus 122 ~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-------------l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 122 P--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG-------------L-KLNYLRISEAKLT 185 (332)
T ss_dssp C--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCS-------------C-CCSCCBCCSSBCS
T ss_pred c--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccC-------------C-ccCEEECcCCCCC
Confidence 4 6677777777777766664 5666777777777776643 22222211 1 2333344445555
Q ss_pred CccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC-
Q 008026 163 DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS- 241 (580)
Q Consensus 163 ~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~- 241 (580)
.++.... ++|+.|++++|++.+..|..+..+++|+.|+|++|++.+..|..+..+++|++|++++|+++ .+|..+.
T Consensus 186 ~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 186 GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 5554443 58999999999999887889999999999999999999777778999999999999999999 6776543
Q ss_pred ---CceeecCCCCCC
Q 008026 242 ---NAIVNTDGNPDI 253 (580)
Q Consensus 242 ---~~~~~~~~n~~~ 253 (580)
...+++++|...
T Consensus 263 l~~L~~L~l~~N~l~ 277 (332)
T 2ft3_A 263 LKLLQVVYLHTNNIT 277 (332)
T ss_dssp CTTCCEEECCSSCCC
T ss_pred CccCCEEECCCCCCC
Confidence 345888888754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=210.05 Aligned_cols=234 Identities=14% Similarity=0.080 Sum_probs=158.4
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
.+..|+.+++++|.+....+..|.++++|++|+|++|.+++..+ .|..+++|++|+|++|++.+..|..|.++++|+.|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 35666666666665444444557888888888888888887776 58888888888888888886556668888888888
Q ss_pred EccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCcc--------ccc-------------
Q 008026 95 NMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ--------RFA------------- 152 (580)
Q Consensus 95 ~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~--------~~~------------- 152 (580)
+|++|+++.+++. +..+.+|+.|++++|.+..+++..+..+..|..+......+. .+.
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~ 202 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 202 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEE
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccC
Confidence 8888888887776 577888888888888888887766655554433322111111 111
Q ss_pred ------cccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEE
Q 008026 153 ------ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 226 (580)
Q Consensus 153 ------~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ 226 (580)
.....++....+++.. ..+|+.|++++|++++. +.+..+++|++|+|++|++.+..|..+..+++|+.|+
T Consensus 203 ~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 278 (390)
T 3o6n_A 203 IPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 278 (390)
T ss_dssp CCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred CCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEE
Confidence 1111111121122111 24677888888888742 4688888888888888888877788888888888888
Q ss_pred ccCCcccccCCCC---CCCceeecCCCCCC
Q 008026 227 VSNNQLYGKIPSF---KSNAIVNTDGNPDI 253 (580)
Q Consensus 227 ls~N~l~g~~p~~---~~~~~~~~~~n~~~ 253 (580)
+++|++++..+.. .....+++++|...
T Consensus 279 L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~ 308 (390)
T 3o6n_A 279 ISNNRLVALNLYGQPIPTLKVLDLSHNHLL 308 (390)
T ss_dssp CCSSCCCEEECSSSCCTTCCEEECCSSCCC
T ss_pred CCCCcCcccCcccCCCCCCCEEECCCCcce
Confidence 8888888643222 12345677777543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-23 Score=218.38 Aligned_cols=254 Identities=16% Similarity=0.071 Sum_probs=186.7
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++++..|..| .++..|+.+++++|++....+..|.++++|++|+|++|++++.+| .|..+++|+.|+|++|++.+.
T Consensus 66 n~i~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 143 (477)
T 2id5_A 66 NIVSAVEPGAF--NNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143 (477)
T ss_dssp SCCCEECTTTT--TTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEE
T ss_pred CccCEeChhhh--hCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCcccee
Confidence 66777778888 567888888888887766555678889999999999999988777 478888999999999988876
Q ss_pred CCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHH------------------
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSV------------------ 141 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~------------------ 141 (580)
.|..|.++++|+.|+|++|++++.++. +..+.+|+.|++++|.+..+++..+..+..|..+
T Consensus 144 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~ 223 (477)
T 2id5_A 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223 (477)
T ss_dssp CTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTT
T ss_pred ChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccC
Confidence 777888888888888888888877664 6666677777777776666555443332222110
Q ss_pred ----------------H-HhhCCccccccccCCCCCCCCccc-eeccCCcEEEEEecCCcccccCcccccCCCCCcEEec
Q 008026 142 ----------------V-KLMGYPQRFAENWKGNDPCSDWIG-VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 203 (580)
Q Consensus 142 ----------------~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l 203 (580)
+ .....+..+....+.++....++. .+..+.+|+.|+|++|++.+..|..|..+++|+.|+|
T Consensus 224 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 303 (477)
T 2id5_A 224 LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303 (477)
T ss_dssp CCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEEC
T ss_pred ccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEEC
Confidence 0 112334455555666666655433 4667789999999999999999999999999999999
Q ss_pred cCCcccccCCccCcCCCCCCEEEccCCcccccCCCC-C--CCceeecCCCCCCCCCC
Q 008026 204 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF-K--SNAIVNTDGNPDIGKEK 257 (580)
Q Consensus 204 s~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~-~--~~~~~~~~~n~~~c~~~ 257 (580)
++|+|++..+..+..+++|+.|+|++|++....+.. + ......+.++...|..+
T Consensus 304 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 304 SGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp CSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred CCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 999999655567889999999999999998543211 0 11124456666677543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.2e-24 Score=211.09 Aligned_cols=230 Identities=18% Similarity=0.147 Sum_probs=159.1
Q ss_pred cccccCCCCCccccccceEEecccCCCCCC-CCCchhhc-------CcccCceEecccCcCcCCCCC-C--CCCCCCcEE
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKL-GGGIDVIQ-------NMTSLKEIWLHSNAFSGPLPD-F--SGVKQLESL 70 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~-~--~~l~~L~~L 70 (580)
|++ .+|..+.. . |+.++++.|.+. ...|..+. ++++|++|+|++|++++..|. + ..+++|++|
T Consensus 53 n~l--~~p~~~~~-~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L 126 (312)
T 1wwl_A 53 DTE--ADLGQFTD-I---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126 (312)
T ss_dssp CTT--CCCHHHHH-H---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEE
T ss_pred ccc--ccHHHHHH-H---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEE
Confidence 444 66776631 1 555566666553 23444444 688888888888888877763 4 678888888
Q ss_pred eccCCcccccCCccccCC-----CCCcEEEccCCcccccCC-CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHh
Q 008026 71 SLRDNFFTGPVPDSLVKL-----ESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL 144 (580)
Q Consensus 71 ~L~~N~l~~~~P~~~~~l-----~~L~~L~L~~N~l~~~~~-~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~ 144 (580)
+|++|++++. |..++.+ ++|++|+|++|++++.+| .+..+.+|+.|++++|.+... ..+...
T Consensus 127 ~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----------~~~~~~ 194 (312)
T 1wwl_A 127 NLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE-----------RGLISA 194 (312)
T ss_dssp EEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHH-----------HHHHHH
T ss_pred EccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcc-----------hHHHHH
Confidence 8888888854 7777777 888888888888888875 477888888888888875321 011111
Q ss_pred h--CCccccccccCCCCCCCCccc----eeccCCcEEEEEecCCcccccCc-ccccCCCCCcEEeccCCcccccCCccCc
Q 008026 145 M--GYPQRFAENWKGNDPCSDWIG----VTCTKGNITVINFQKMNLTGTIS-PEFASFKSLQRLILADNNLSGMIPEGLS 217 (580)
Q Consensus 145 ~--~~~~~~~~~~~~~~~~~~~~~----~~~~~~~L~~L~ls~n~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~l~ 217 (580)
. ..+..+....+.++....++. .+..+++|+.|+|++|++.+.+| ..+..+++|+.|+|++|+|+ .+|..+.
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 1 334455555555555553322 22345688999999999987665 45667888999999999998 8888777
Q ss_pred CCCCCCEEEccCCcccccCCCCCC---CceeecCCCCCC
Q 008026 218 VLGALKELDVSNNQLYGKIPSFKS---NAIVNTDGNPDI 253 (580)
Q Consensus 218 ~l~~L~~l~ls~N~l~g~~p~~~~---~~~~~~~~n~~~ 253 (580)
++|++|||++|++++. |.+.. ...+++++|++.
T Consensus 274 --~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 274 --AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp --SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTT
T ss_pred --CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCC
Confidence 8899999999999876 55322 234778888764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-21 Score=189.16 Aligned_cols=176 Identities=20% Similarity=0.200 Sum_probs=145.0
Q ss_pred cccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcc
Q 008026 23 NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101 (580)
Q Consensus 23 ~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l 101 (580)
++++++ .++.+|..+. ++|++|+|++|.+++..+ .|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++
T Consensus 19 l~~~~~-~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 95 (251)
T 3m19_A 19 VDCQGK-SLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL 95 (251)
T ss_dssp EECTTC-CCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EecCCC-CccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcc
Confidence 444444 4455665554 589999999999998887 588899999999999999976666799999999999999999
Q ss_pred cccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEec
Q 008026 102 QGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 180 (580)
Q Consensus 102 ~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls 180 (580)
++.++. |..+.+|+.|++++|.+..+++..+. .+.+|+.|+|+
T Consensus 96 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~------------------------------------~l~~L~~L~Ls 139 (251)
T 3m19_A 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD------------------------------------RLTKLKELRLN 139 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT------------------------------------TCTTCCEEECC
T ss_pred cccChhHhcccCCCCEEEcCCCcCCCcChhHhc------------------------------------cCCcccEEECc
Confidence 988876 67888999999999998877765432 23489999999
Q ss_pred CCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 181 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 181 ~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
+|++++..|..|+.+++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..+
T Consensus 140 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 140 TNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 999996666678999999999999999996666788999999999999999987644
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-22 Score=218.90 Aligned_cols=135 Identities=19% Similarity=0.089 Sum_probs=92.0
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++++..|..| .+++.|+.+++++|.+.+..|.+|.++++|++|+|++|.+++..| .|.++++|++|+|++|++.+.
T Consensus 42 n~l~~~~~~~~--~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 119 (606)
T 3vq2_A 42 NPLKILKSYSF--SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119 (606)
T ss_dssp SCCCEECTTTT--TTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCS
T ss_pred CCcCEeChhhc--cCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccc
Confidence 55555555566 456677777777776666666677777777777777777777666 477777777777777777744
Q ss_pred CCccccCCCCCcEEEccCCcccc--cCCCCCcccccccccccCCCCCCCCCCCchhHHHH
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQG--PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 138 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l 138 (580)
.|..|+++++|+.|+|++|++++ .+..+..+.+|+.|++++|.+..+++..+..+..+
T Consensus 120 ~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 179 (606)
T 3vq2_A 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179 (606)
T ss_dssp SSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHC
T ss_pred cccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhcc
Confidence 44567777777777777777765 23346777777777777777777666555544433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=229.18 Aligned_cols=133 Identities=17% Similarity=0.092 Sum_probs=107.8
Q ss_pred CcccccCCCCCccccccceEEecccCCCCCCCCC-chhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccc
Q 008026 1 MLQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG-IDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFT 78 (580)
Q Consensus 1 ~~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~ 78 (580)
.|++++..|..| .++..|+.+++++|.....+ |.+|.++++|++|+|++|.|++..| .|.++++|++|+|++|++.
T Consensus 33 ~N~i~~i~~~~~--~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 110 (844)
T 3j0a_A 33 FNYIRTVTASSF--PFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110 (844)
T ss_dssp SCCCCEECSSSC--SSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCS
T ss_pred CCcCCccChhHC--cccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCC
Confidence 367777778888 56788888888888555544 6788999999999999999998877 5888999999999999998
Q ss_pred ccCCcc--ccCCCCCcEEEccCCcccccCC--CCCcccccccccccCCCCCCCCCCCchhH
Q 008026 79 GPVPDS--LVKLESLKIVNMTNNLLQGPVP--EFDRSVSLDMAKGSNNFCLPSPGACDPRL 135 (580)
Q Consensus 79 ~~~P~~--~~~l~~L~~L~L~~N~l~~~~~--~~~~~~~L~~l~l~~n~~~~~~~~~~~~l 135 (580)
+.+|.. |.++++|+.|+|++|.+++..+ .|..+.+|+.|++++|.+..+.+..+..+
T Consensus 111 ~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred cccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 777766 8899999999999999988765 47888899999999998877765554443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=200.79 Aligned_cols=218 Identities=17% Similarity=0.110 Sum_probs=166.7
Q ss_pred cccccCCCCC-ccccccceEEecccCCCCCCCC--CchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCccc
Q 008026 2 LQLIGGLPAS-FSGSQIQSLWVNGQNGNAKLGG--GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFT 78 (580)
Q Consensus 2 ~~~~~~~P~~-~~~~~l~~L~~~~~~~n~~~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~ 78 (580)
|++. .+|.. | .++..|+.+++++|.+... .+..+..+++|++|+|++|.+++.++.+..+++|+.|+|++|++.
T Consensus 38 n~l~-~i~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~ 114 (306)
T 2z66_A 38 NKLQ-SLPHGVF--DKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK 114 (306)
T ss_dssp SCCC-CCCTTTT--TTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEE
T ss_pred CccC-ccCHhHh--hccccCCEEECCCCccCcccCcccccccccccCEEECCCCccccChhhcCCCCCCCEEECCCCccc
Confidence 4454 56654 5 4577788888888866533 256677888899999999988866556788888999999988888
Q ss_pred ccCC-ccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCC-CCCCCchhHHHHHHHHHhhCCcccccccc
Q 008026 79 GPVP-DSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLP-SPGACDPRLNALLSVVKLMGYPQRFAENW 155 (580)
Q Consensus 79 ~~~P-~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~-~~~~~~~~l~~l~~~~~~~~~~~~~~~~~ 155 (580)
+..+ ..+..+++|+.|+|++|++++.++. +..+.+|+.|++++|.+.. ..+..+.. +..+....
T Consensus 115 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~-------------l~~L~~L~ 181 (306)
T 2z66_A 115 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE-------------LRNLTFLD 181 (306)
T ss_dssp SSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTT-------------CTTCCEEE
T ss_pred ccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhh-------------CcCCCEEE
Confidence 4333 4688888899999988888887775 6778888888888888765 22333222 23344444
Q ss_pred CCCCCCCCc-cceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCC-CCCEEEccCCccc
Q 008026 156 KGNDPCSDW-IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG-ALKELDVSNNQLY 233 (580)
Q Consensus 156 ~~~~~~~~~-~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~-~L~~l~ls~N~l~ 233 (580)
+.++..... +..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.+..|..+..++ +|++|+|++|+++
T Consensus 182 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~ 261 (306)
T 2z66_A 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261 (306)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred CCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence 555555443 44566678999999999999977777899999999999999999999999999995 9999999999998
Q ss_pred cc
Q 008026 234 GK 235 (580)
Q Consensus 234 g~ 235 (580)
+.
T Consensus 262 ~~ 263 (306)
T 2z66_A 262 CT 263 (306)
T ss_dssp CS
T ss_pred cc
Confidence 65
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=191.61 Aligned_cols=200 Identities=18% Similarity=0.156 Sum_probs=167.1
Q ss_pred cceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEc
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L 96 (580)
+..+..+++..+.+... ..+..+++|+.|++++|.++ .++.+..+++|++|+|++|++.+ + +.+..+++|++|+|
T Consensus 18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCTTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEEC
T ss_pred HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-cccccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEEC
Confidence 34455555555544332 34678999999999999998 45678889999999999999994 5 48999999999999
Q ss_pred cCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEE
Q 008026 97 TNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175 (580)
Q Consensus 97 ~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 175 (580)
++|.+++.++. +..+.+|+.|++++|.+..+++..+. .+++|+
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~------------------------------------~l~~L~ 136 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFD------------------------------------KLTNLT 136 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT------------------------------------TCTTCC
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhc------------------------------------cCCCCC
Confidence 99999999886 68899999999999999887765432 334899
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----CceeecCCCC
Q 008026 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGNP 251 (580)
Q Consensus 176 ~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~ 251 (580)
.|++++|++++..|..++.+++|+.|+|++|++++..|..+..+++|++|++++|++++..|..+. ...+++.+|+
T Consensus 137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 999999999977777789999999999999999976677789999999999999999988876543 3468999999
Q ss_pred CCCCCC
Q 008026 252 DIGKEK 257 (580)
Q Consensus 252 ~~c~~~ 257 (580)
+.|.++
T Consensus 217 ~~~~~~ 222 (272)
T 3rfs_A 217 WDCTCP 222 (272)
T ss_dssp BCCCTT
T ss_pred ccccCc
Confidence 998765
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-22 Score=209.72 Aligned_cols=217 Identities=17% Similarity=0.102 Sum_probs=184.5
Q ss_pred CcccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCcccc
Q 008026 1 MLQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTG 79 (580)
Q Consensus 1 ~~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~ 79 (580)
.|++++..|..| .++..|+.+++++|++....+..|.++++|++|+|++|+|++.++. |.++++|++|+|++|+|..
T Consensus 84 ~n~i~~~~~~~~--~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 161 (452)
T 3zyi_A 84 ENNIQMIQADTF--RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES 161 (452)
T ss_dssp SSCCCEECTTTT--TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCE
T ss_pred CCcCceECHHHc--CCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcce
Confidence 377888888889 6788999999999988888889999999999999999999988875 8889999999999999994
Q ss_pred cCCccccCCCCCcEEEccC-CcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCC
Q 008026 80 PVPDSLVKLESLKIVNMTN-NLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157 (580)
Q Consensus 80 ~~P~~~~~l~~L~~L~L~~-N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~ 157 (580)
..+..|.++++|+.|+|++ |.+..+++. |..+.+|+.|++++|.+..+|.. ..+..+....+.
T Consensus 162 ~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~---------------~~l~~L~~L~Ls 226 (452)
T 3zyi_A 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNL---------------TPLVGLEELEMS 226 (452)
T ss_dssp ECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCC---------------TTCTTCCEEECT
T ss_pred eCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccc---------------cccccccEEECc
Confidence 4445799999999999999 566666654 88999999999999999988631 223445555566
Q ss_pred CCCCCCc-cceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 158 NDPCSDW-IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 158 ~~~~~~~-~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
++....+ ++.+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++..
T Consensus 227 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp TSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 6666554 5667788899999999999999889999999999999999999996666778899999999999999873
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.2e-23 Score=204.20 Aligned_cols=205 Identities=13% Similarity=0.085 Sum_probs=153.9
Q ss_pred ccceEEecccCCCCCCCCCchhh--cCcccCceEecccCcCcCCCCCCCCC-----CCCcEEeccCCcccccCCccccCC
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVI--QNMTSLKEIWLHSNAFSGPLPDFSGV-----KQLESLSLRDNFFTGPVPDSLVKL 88 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~l-----~~L~~L~L~~N~l~~~~P~~~~~l 88 (580)
++..|+.+++++|.+.+..|..+ .++++|++|+|++|+|++.++.+..+ ++|++|+|++|++.+..|..|+.+
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 46677777777787777777765 88889999999999988873345555 888999999999886666788889
Q ss_pred CCCcEEEccCCccccc---CCCC--CcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC
Q 008026 89 ESLKIVNMTNNLLQGP---VPEF--DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 163 (580)
Q Consensus 89 ~~L~~L~L~~N~l~~~---~~~~--~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (580)
++|+.|+|++|++.+. ++.+ ..+.+|+.|++++|.+..++. +. ......+..+....++++....
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~--~~~~~~l~~L~~L~Ls~N~l~~ 242 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG--------VC--SALAAARVQLQGLDLSHNSLRD 242 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHH--------HH--HHHHHTTCCCSEEECTTSCCCS
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHH--------HH--HHHHhcCCCCCEEECCCCcCCc
Confidence 9999999999988764 3333 778888888998888763321 00 0111123344455555555554
Q ss_pred cc--ceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccccc
Q 008026 164 WI--GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 235 (580)
Q Consensus 164 ~~--~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~ 235 (580)
.+ .....+++|+.|+|++|+++ .+|..+. ++|++|+|++|+|++ +|. +..+++|++|++++|++++.
T Consensus 243 ~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~-~p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp SCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCS-CCC-TTTSCEEEEEECTTCTTTCC
T ss_pred ccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCC-Chh-HhhCCCCCEEeccCCCCCCC
Confidence 33 23334679999999999999 8998887 899999999999994 577 99999999999999999863
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.5e-22 Score=207.58 Aligned_cols=215 Identities=16% Similarity=0.096 Sum_probs=182.8
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++.+..|..| .++..|+.+++++|.+....+..|.++++|++|+|++|+|++.++ .|..+++|+.|+|++|+|...
T Consensus 74 n~i~~~~~~~~--~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 151 (440)
T 3zyj_A 74 NQIQIIKVNSF--KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESI 151 (440)
T ss_dssp CCCCEECTTTT--SSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEE
T ss_pred CcCCeeCHHHh--hCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCccccc
Confidence 67777777888 678899999999998888888999999999999999999998887 489999999999999999954
Q ss_pred CCccccCCCCCcEEEccCC-cccccCC-CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCC
Q 008026 81 VPDSLVKLESLKIVNMTNN-LLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 158 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N-~l~~~~~-~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~ 158 (580)
.+..|.++++|+.|+|++| .+..+++ .|..+.+|+.|++++|.+..+|.. ..+..+....+.+
T Consensus 152 ~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~---------------~~l~~L~~L~Ls~ 216 (440)
T 3zyj_A 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNL---------------TPLIKLDELDLSG 216 (440)
T ss_dssp CTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCC---------------TTCSSCCEEECTT
T ss_pred CHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccccc---------------CCCcccCEEECCC
Confidence 4557999999999999995 5665555 388999999999999999988731 2234455555666
Q ss_pred CCCCCc-cceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 159 DPCSDW-IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 159 ~~~~~~-~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
+....+ ++.+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++.
T Consensus 217 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 666554 556777889999999999999988999999999999999999999666677899999999999999987
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.1e-22 Score=212.21 Aligned_cols=215 Identities=15% Similarity=0.056 Sum_probs=163.4
Q ss_pred cceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEc
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L 96 (580)
...|+.+++++|.+....|..|.++++|++|+|++|.|++.+| |..+++|++|+|++|.|+ .+|. .++|+.|+|
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~-~l~~----~~~L~~L~L 106 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHA 106 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEE-EEEE----CTTCCEEEC
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCC-CCCC----CCCcCEEEC
Confidence 4478888888888888777899999999999999999998776 888999999999999998 4443 388999999
Q ss_pred cCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC-ccceec-cCCcE
Q 008026 97 TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD-WIGVTC-TKGNI 174 (580)
Q Consensus 97 ~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~L 174 (580)
++|.+++.++. .+.+|+.|++++|.+..+++..+..+ ..+....++++.... .+..++ .+++|
T Consensus 107 ~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l-------------~~L~~L~Ls~N~l~~~~~~~l~~~l~~L 171 (487)
T 3oja_A 107 ANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCR-------------SRVQYLDLKLNEIDTVNFAELAASSDTL 171 (487)
T ss_dssp CSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGG-------------SSEEEEECTTSCCCEEEGGGGGGGTTTC
T ss_pred cCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCC-------------CCCCEEECCCCCCCCcChHHHhhhCCcc
Confidence 99999988775 34678899999999888766554333 233444455555544 233343 56788
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----CceeecCCC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGN 250 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n 250 (580)
+.|+|++|.+++. |. +..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|++++ +|..+. ...+++++|
T Consensus 172 ~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N 247 (487)
T 3oja_A 172 EHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247 (487)
T ss_dssp CEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTC
T ss_pred cEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCC
Confidence 8888888888854 33 4468888899999998884 55568888889999999998886 454432 345788888
Q ss_pred CCCCCC
Q 008026 251 PDIGKE 256 (580)
Q Consensus 251 ~~~c~~ 256 (580)
++.|++
T Consensus 248 ~l~c~~ 253 (487)
T 3oja_A 248 GFHCGT 253 (487)
T ss_dssp CBCHHH
T ss_pred CCcCcc
Confidence 888754
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-21 Score=185.18 Aligned_cols=176 Identities=19% Similarity=0.140 Sum_probs=152.5
Q ss_pred ccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCC-CCccccccccccc
Q 008026 42 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGS 120 (580)
Q Consensus 42 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~ 120 (580)
.+.++++++++.++..++.+. ++|+.|+|++|++.+..|..|.++++|++|+|++|++++.++. +..+.+|+.|+++
T Consensus 14 ~~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 14 EGKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 467899999999997766654 6899999999999977777899999999999999999998886 7889999999999
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcE
Q 008026 121 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQR 200 (580)
Q Consensus 121 ~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~ 200 (580)
+|.+..+++..+. .+++|+.|+|++|++++..+..|..+++|+.
T Consensus 92 ~n~l~~~~~~~~~------------------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 135 (251)
T 3m19_A 92 NNQLASLPLGVFD------------------------------------HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKE 135 (251)
T ss_dssp TSCCCCCCTTTTT------------------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCcccccChhHhc------------------------------------ccCCCCEEEcCCCcCCCcChhHhccCCcccE
Confidence 9999988765542 2348999999999999666666899999999
Q ss_pred EeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----CceeecCCCCCCCC
Q 008026 201 LILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGNPDIGK 255 (580)
Q Consensus 201 L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c~ 255 (580)
|+|++|+|++..|..+..+++|++|+|++|++++..|..+. ...+++.+|++.|.
T Consensus 136 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 136 LRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred EECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999999966566899999999999999999987775543 34689999999987
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.3e-22 Score=189.34 Aligned_cols=191 Identities=16% Similarity=0.160 Sum_probs=151.0
Q ss_pred ccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCc-CcCCCC-CCCCCCCCcEEeccC-CcccccC
Q 008026 5 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA-FSGPLP-DFSGVKQLESLSLRD-NFFTGPV 81 (580)
Q Consensus 5 ~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~L~~-N~l~~~~ 81 (580)
...+|. +. . .|+.+++++|++.+..+..|.++++|++|+|++|+ +++..+ .|.++++|++|+|++ |++++..
T Consensus 23 l~~ip~-~~-~---~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~ 97 (239)
T 2xwt_C 23 IQRIPS-LP-P---STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97 (239)
T ss_dssp CSSCCC-CC-T---TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred ccccCC-CC-C---cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence 356777 63 2 45555666676666656689999999999999997 887776 588899999999998 9999544
Q ss_pred CccccCCCCCcEEEccCCcccccCCCCCcccccc---cccccCC-CCCCCCCCCchhHHHHHHHHHhhCCccccccccCC
Q 008026 82 PDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLD---MAKGSNN-FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157 (580)
Q Consensus 82 P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~---~l~l~~n-~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~ 157 (580)
|..|.++++|+.|+|++|++++.++ +..+.+|+ .|++++| .+..+++..+.
T Consensus 98 ~~~f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~------------------------ 152 (239)
T 2xwt_C 98 PDALKELPLLKFLGIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQ------------------------ 152 (239)
T ss_dssp TTSEECCTTCCEEEEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTT------------------------
T ss_pred HHHhCCCCCCCEEeCCCCCCccccc-cccccccccccEEECCCCcchhhcCccccc------------------------
Confidence 5679999999999999999998554 88888887 9999999 88877765442
Q ss_pred CCCCCCccceeccCCcEE-EEEecCCcccccCcccccCCCCCcEEeccCCc-ccccCCccCcCC-CCCCEEEccCCcccc
Q 008026 158 NDPCSDWIGVTCTKGNIT-VINFQKMNLTGTISPEFASFKSLQRLILADNN-LSGMIPEGLSVL-GALKELDVSNNQLYG 234 (580)
Q Consensus 158 ~~~~~~~~~~~~~~~~L~-~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~l~~l-~~L~~l~ls~N~l~g 234 (580)
.+++|+ .|++++|+++ .+|......++|+.|+|++|+ +++..+..+..+ ++|+.|++++|++++
T Consensus 153 ------------~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~ 219 (239)
T 2xwt_C 153 ------------GLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219 (239)
T ss_dssp ------------TTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC
T ss_pred ------------chhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc
Confidence 234899 9999999999 677765555899999999995 885556778888 999999999999986
Q ss_pred cCCC
Q 008026 235 KIPS 238 (580)
Q Consensus 235 ~~p~ 238 (580)
..+.
T Consensus 220 l~~~ 223 (239)
T 2xwt_C 220 LPSK 223 (239)
T ss_dssp CCCT
T ss_pred CChh
Confidence 5444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-21 Score=214.80 Aligned_cols=226 Identities=18% Similarity=0.091 Sum_probs=137.3
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++++..|..| .++..|+.+++++|.+.+..|+.|.++++|++|+|++|.+++.++ .|.++++|++|+|++|++.+.
T Consensus 35 n~l~~~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~ 112 (680)
T 1ziw_A 35 NQLRRLPAANF--TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKI 112 (680)
T ss_dssp SCCCCCCGGGG--GGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred CCCCCcCHHHH--hCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCcc
Confidence 44555444456 446666666666676666666677777777777777777776655 367777777777777777744
Q ss_pred CCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCC
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 159 (580)
.|..|+++++|+.|+|++|.+++.+|. +..+.+|+.|++++|.+..+++..+..+ ....+....+.++
T Consensus 113 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~-----------~~~~L~~L~L~~n 181 (680)
T 1ziw_A 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF-----------ANSSLKKLELSSN 181 (680)
T ss_dssp CSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGG-----------TTCEESEEECTTC
T ss_pred ChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhcc-----------ccccccEEECCCC
Confidence 445677777777777777777776654 5666777777777776665543211100 0112222222333
Q ss_pred CCCCcc-ceec---------------------------cCCcEEEEEecCCcccccCcccccCCCC--CcEEeccCCccc
Q 008026 160 PCSDWI-GVTC---------------------------TKGNITVINFQKMNLTGTISPEFASFKS--LQRLILADNNLS 209 (580)
Q Consensus 160 ~~~~~~-~~~~---------------------------~~~~L~~L~ls~n~l~~~~p~~~~~l~~--L~~L~ls~N~l~ 209 (580)
.....+ +.+. ...+|+.|++++|.+.+..|..+.+++. |+.|+|++|++.
T Consensus 182 ~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~ 261 (680)
T 1ziw_A 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261 (680)
T ss_dssp CCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCC
T ss_pred cccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcC
Confidence 222211 1111 1135666677777777666666666654 777777777777
Q ss_pred ccCCccCcCCCCCCEEEccCCcccccCCCCC
Q 008026 210 GMIPEGLSVLGALKELDVSNNQLYGKIPSFK 240 (580)
Q Consensus 210 g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~ 240 (580)
+..|..+..+++|++|++++|++++.+|..+
T Consensus 262 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 292 (680)
T 1ziw_A 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292 (680)
T ss_dssp EECTTTTTTCTTCCEEECCSCCBSEECTTTT
T ss_pred ccCcccccCcccccEeeCCCCccCccChhhh
Confidence 6666677777777777777777776666544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.3e-22 Score=215.43 Aligned_cols=238 Identities=14% Similarity=0.078 Sum_probs=170.9
Q ss_pred ccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCc---------------------CCCCCC
Q 008026 3 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS---------------------GPLPDF 61 (580)
Q Consensus 3 ~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~---------------------~~~p~~ 61 (580)
.+.+.+|+.| ..+..|+.++++.|.+. .+|+.+..+ +|++|++++|.+. +..+.
T Consensus 269 ~~~~~~~~~~--~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~- 343 (570)
T 2z63_A 269 YYLDDIIDLF--NCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE- 343 (570)
T ss_dssp EEESCSTTTT--GGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC-
T ss_pred hhhhhchhhh--cCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCcccccccCEEeCcCCcccccccc-
Confidence 4456666666 33444444444444333 355555544 5555555555544 33322
Q ss_pred CCCCCCcEEeccCCcccccC--CccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCC-CCchhHHHH
Q 008026 62 SGVKQLESLSLRDNFFTGPV--PDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG-ACDPRLNAL 138 (580)
Q Consensus 62 ~~l~~L~~L~L~~N~l~~~~--P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~-~~~~~l~~l 138 (580)
..+++|+.|+|++|++++.. |..+.++++|+.|+|++|.+++.++.+..+.+|+.|++++|.+...++ ..+..+
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l--- 420 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL--- 420 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTC---
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcC---
Confidence 45788888888888887433 677888888888888888888887778888888888888888776654 233222
Q ss_pred HHHHHhhCCccccccccCCCCCCCC-ccceeccCCcEEEEEecCCccc-ccCcccccCCCCCcEEeccCCcccccCCccC
Q 008026 139 LSVVKLMGYPQRFAENWKGNDPCSD-WIGVTCTKGNITVINFQKMNLT-GTISPEFASFKSLQRLILADNNLSGMIPEGL 216 (580)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~L~~L~ls~n~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l 216 (580)
..+....+.++.... .+..+..+++|+.|++++|++. +.+|..+..+++|++|+|++|++++..|..+
T Consensus 421 ----------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~ 490 (570)
T 2z63_A 421 ----------RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490 (570)
T ss_dssp ----------TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ----------CCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhh
Confidence 223333333333322 3445666789999999999998 6899999999999999999999998889999
Q ss_pred cCCCCCCEEEccCCcccccCCCCCC----CceeecCCCCCCCCCCC
Q 008026 217 SVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 217 ~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~~ 258 (580)
..+++|++|++++|++++.+|..+. ...+++.+|++.|.|+.
T Consensus 491 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred hcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 9999999999999999998887653 34689999999998764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.8e-22 Score=197.36 Aligned_cols=198 Identities=18% Similarity=0.164 Sum_probs=128.3
Q ss_pred EEecccCCCCCCCCCchhh--cCcccCceEecccCcCcCCCCC-----CCCCCCCcEEeccCCcccccCCccccCCCCCc
Q 008026 20 LWVNGQNGNAKLGGGIDVI--QNMTSLKEIWLHSNAFSGPLPD-----FSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 92 (580)
Q Consensus 20 L~~~~~~~n~~~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~-----~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~ 92 (580)
|+.+++++|.+.+..|..+ .++++|++|+|++|.+++..+. +..+++|++|+|++|++.+..|..|+.+++|+
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 172 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT 172 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence 4555555555555555555 5666666666666666654431 23456666666666666544445566666666
Q ss_pred EEEccCCcccc---cCCC--CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccce
Q 008026 93 IVNMTNNLLQG---PVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV 167 (580)
Q Consensus 93 ~L~L~~N~l~~---~~~~--~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (580)
.|+|++|++.+ .++. +..+.+|+.|++++|.+..+++.. .. .
T Consensus 173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~----~~-----------------------------l 219 (310)
T 4glp_A 173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVC----AA-----------------------------L 219 (310)
T ss_dssp EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHH----HH-----------------------------H
T ss_pred EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHH----HH-----------------------------H
Confidence 66666666544 2222 245556666666666553222100 00 1
Q ss_pred eccCCcEEEEEecCCcccccCcccccCC---CCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc-cCCCCCC-C
Q 008026 168 TCTKGNITVINFQKMNLTGTISPEFASF---KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG-KIPSFKS-N 242 (580)
Q Consensus 168 ~~~~~~L~~L~ls~n~l~~~~p~~~~~l---~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g-~~p~~~~-~ 242 (580)
+..+++|+.|+|++|++.+.+|+.++.+ ++|++|+|++|+|+ .+|..+. ++|++|||++|++++ +.+..+. .
T Consensus 220 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~~~l~~L 296 (310)
T 4glp_A 220 AAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQPDELPEV 296 (310)
T ss_dssp HHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCTTSCCCC
T ss_pred HhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchhhhCCCc
Confidence 2334689999999999998889888887 69999999999999 8898885 899999999999997 3444332 3
Q ss_pred ceeecCCCCCC
Q 008026 243 AIVNTDGNPDI 253 (580)
Q Consensus 243 ~~~~~~~n~~~ 253 (580)
..+++++|++.
T Consensus 297 ~~L~L~~N~l~ 307 (310)
T 4glp_A 297 DNLTLDGNPFL 307 (310)
T ss_dssp SCEECSSTTTS
T ss_pred cEEECcCCCCC
Confidence 46888899864
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.9e-21 Score=209.12 Aligned_cols=117 Identities=16% Similarity=0.085 Sum_probs=84.2
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|+|++ +|..+. ..|+.+++++|.+.+..+..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+ .
T Consensus 41 ~~L~~-ip~~~~----~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~ 114 (562)
T 3a79_B 41 RNLTH-VPKDLP----PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-N 114 (562)
T ss_dssp SCCCS-CCTTSC----TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-E
T ss_pred CCCcc-CCCCCC----CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-c
Confidence 44553 777662 455556666676666666778888888888888888887766 4777888888888888887 6
Q ss_pred CCccccCCCCCcEEEccCCcccccC--CCCCcccccccccccCCCCCC
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGPV--PEFDRSVSLDMAKGSNNFCLP 126 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~~~L~~l~l~~n~~~~ 126 (580)
+|.. .+++|++|+|++|++++.+ ..+..+.+|+.|++++|.+..
T Consensus 115 lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 115 ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc
Confidence 7766 7788888888888887744 247777777777777777654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.85 E-value=4e-22 Score=199.67 Aligned_cols=216 Identities=15% Similarity=0.060 Sum_probs=162.2
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
.+..|+.+++++|++....|..|.++++|++|+|++|.+++.+| +..+++|++|+|++|+++ .+| .+++|+.|+
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~-~l~----~~~~L~~L~ 105 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQ-ELL----VGPSIETLH 105 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEE-EEE----ECTTCCEEE
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCccc-ccc----CCCCcCEEE
Confidence 35577888888888877777889999999999999999987666 888999999999999998 444 348889999
Q ss_pred ccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCcc-cee-ccCCc
Q 008026 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI-GVT-CTKGN 173 (580)
Q Consensus 96 L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~ 173 (580)
+++|++++.++.. +.+|+.|++++|.+..+++..+..+. .+....+.++.....+ ..+ ..+++
T Consensus 106 l~~n~l~~~~~~~--~~~L~~L~l~~N~l~~~~~~~~~~l~-------------~L~~L~Ls~N~l~~~~~~~~~~~l~~ 170 (317)
T 3o53_A 106 AANNNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRS-------------RVQYLDLKLNEIDTVNFAELAASSDT 170 (317)
T ss_dssp CCSSCCSEEEECC--CSSCEEEECCSSCCCSGGGBCTGGGS-------------SEEEEECTTSCCCEEEGGGGGGGTTT
T ss_pred CCCCccCCcCccc--cCCCCEEECCCCCCCCccchhhhccC-------------CCCEEECCCCCCCcccHHHHhhccCc
Confidence 9999888877653 46788889999988887665544332 3344444555544432 222 24678
Q ss_pred EEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCC----CCceeecCC
Q 008026 174 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK----SNAIVNTDG 249 (580)
Q Consensus 174 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~----~~~~~~~~~ 249 (580)
|+.|+|++|++++ +|. ...+++|++|+|++|+++ .+|..+..+++|+.|++++|++++ +|..+ ....+++++
T Consensus 171 L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~ 246 (317)
T 3o53_A 171 LEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRG 246 (317)
T ss_dssp CCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTT
T ss_pred CCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccC
Confidence 9999999999884 443 345889999999999998 566678889999999999999985 45443 234588889
Q ss_pred CCCCCCC
Q 008026 250 NPDIGKE 256 (580)
Q Consensus 250 n~~~c~~ 256 (580)
|++.|.+
T Consensus 247 N~~~~~~ 253 (317)
T 3o53_A 247 NGFHCGT 253 (317)
T ss_dssp CCCBHHH
T ss_pred CCccCcC
Confidence 9888753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-22 Score=214.68 Aligned_cols=215 Identities=16% Similarity=0.106 Sum_probs=162.4
Q ss_pred CcccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCccccc
Q 008026 1 MLQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 1 ~~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~ 80 (580)
.|++++..|..| ..+..|+.+++++|.+.+..| |..+++|++|+|++|.|++.++. ++|+.|+|++|+|++.
T Consensus 43 ~n~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~L~~N~l~~~ 114 (487)
T 3oja_A 43 GNPLSQISAADL--APFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG----PSIETLHAANNNISRV 114 (487)
T ss_dssp SSCCCCCCGGGG--TTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC----TTCCEEECCSSCCCCE
T ss_pred CCcCCCCCHHHH--hCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC----CCcCEEECcCCcCCCC
Confidence 367788777888 668888999999997766544 99999999999999999976543 6788888888888743
Q ss_pred CCccccCCCCCcEEEccCCcccccCC-CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCC
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 159 (580)
.+. .+++|+.|+|++|.+++.+| .+..+.+|+.|++++|.+...++..+. ..+..+....+.++
T Consensus 115 ~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~------------~~l~~L~~L~Ls~N 179 (487)
T 3oja_A 115 SCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA------------ASSDTLEHLNLQYN 179 (487)
T ss_dssp EEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG------------GGTTTCCEEECTTS
T ss_pred Ccc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh------------hhCCcccEEecCCC
Confidence 332 35778888888888887766 467777888888888877765433321 01223344445555
Q ss_pred CCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc-ccCCC
Q 008026 160 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY-GKIPS 238 (580)
Q Consensus 160 ~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~-g~~p~ 238 (580)
.+...++. ..+++|+.|+|++|++++ +|+.++.+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ +.+|.
T Consensus 180 ~l~~~~~~-~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 180 FIYDVKGQ-VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CCCEEECC-CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred cccccccc-ccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 55444332 246799999999999995 5666999999999999999999 58999999999999999999998 66665
Q ss_pred CCC
Q 008026 239 FKS 241 (580)
Q Consensus 239 ~~~ 241 (580)
++.
T Consensus 257 ~~~ 259 (487)
T 3oja_A 257 FFS 259 (487)
T ss_dssp HHT
T ss_pred HHH
Confidence 543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.4e-22 Score=211.38 Aligned_cols=243 Identities=19% Similarity=0.113 Sum_probs=172.7
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|+|+ .+|..+. ..|+.+++++|.+.+..|+.|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+ .
T Consensus 10 n~l~-~ip~~~~----~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~ 83 (520)
T 2z7x_B 10 NGLI-HVPKDLS----QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-K 83 (520)
T ss_dssp SCCS-SCCCSCC----TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-E
T ss_pred CCcc-ccccccc----ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-e
Confidence 6666 6998883 567777788888777777899999999999999999999877 6899999999999999999 7
Q ss_pred CCccccCCCCCcEEEccCCccccc-C-CCCCcccccccccccCCCCCCC-------------------------CCCCch
Q 008026 81 VPDSLVKLESLKIVNMTNNLLQGP-V-PEFDRSVSLDMAKGSNNFCLPS-------------------------PGACDP 133 (580)
Q Consensus 81 ~P~~~~~l~~L~~L~L~~N~l~~~-~-~~~~~~~~L~~l~l~~n~~~~~-------------------------~~~~~~ 133 (580)
+|.. .+++|++|+|++|++++. . ..+..+.+|+.|++++|.+... .+..+.
T Consensus 84 lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~ 161 (520)
T 2z7x_B 84 ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ 161 (520)
T ss_dssp EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTT
T ss_pred cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeeccccccccccccccc
Confidence 8887 899999999999999984 3 4688888888888888876421 111111
Q ss_pred hHH-------------------------------------------HHHHHHHhhCCcc---------------------
Q 008026 134 RLN-------------------------------------------ALLSVVKLMGYPQ--------------------- 149 (580)
Q Consensus 134 ~l~-------------------------------------------~l~~~~~~~~~~~--------------------- 149 (580)
.+. .+.........+.
T Consensus 162 ~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~ 241 (520)
T 2z7x_B 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241 (520)
T ss_dssp TCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHH
T ss_pred ccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHH
Confidence 100 0000000000000
Q ss_pred ------ccccccCC------CCCCC----------------------Ccc------------------------ce--ec
Q 008026 150 ------RFAENWKG------NDPCS----------------------DWI------------------------GV--TC 169 (580)
Q Consensus 150 ------~~~~~~~~------~~~~~----------------------~~~------------------------~~--~~ 169 (580)
.+....+. ..|.. .+| +. ..
T Consensus 242 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 321 (520)
T 2z7x_B 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPS 321 (520)
T ss_dssp HHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCS
T ss_pred HHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchh
Confidence 00000000 00000 001 00 14
Q ss_pred cCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccc--cCCccCcCCCCCCEEEccCCcccccCCCC-C----CC
Q 008026 170 TKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG--MIPEGLSVLGALKELDVSNNQLYGKIPSF-K----SN 242 (580)
Q Consensus 170 ~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~l~~l~~L~~l~ls~N~l~g~~p~~-~----~~ 242 (580)
.+++|+.|++++|++++.+|..++++++|++|+|++|++.+ .+|..+..+++|++|++++|++++.+|.. + ..
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 56789999999999998899999999999999999999986 56678899999999999999999866643 2 23
Q ss_pred ceeecCCCCC
Q 008026 243 AIVNTDGNPD 252 (580)
Q Consensus 243 ~~~~~~~n~~ 252 (580)
..+++++|..
T Consensus 402 ~~L~Ls~N~l 411 (520)
T 2z7x_B 402 LSLNMSSNIL 411 (520)
T ss_dssp CEEECCSSCC
T ss_pred CEEECcCCCC
Confidence 4577777754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.5e-21 Score=184.63 Aligned_cols=186 Identities=18% Similarity=0.134 Sum_probs=157.6
Q ss_pred cccccCCCCCccccccceEEecccCCCC-CCCCCchhhcCcccCceEeccc-CcCcCCCC-CCCCCCCCcEEeccCCccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNA-KLGGGIDVIQNMTSLKEIWLHS-NAFSGPLP-DFSGVKQLESLSLRDNFFT 78 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~-~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~L~~N~l~ 78 (580)
|++++..|..| .++..|+.+++++|. +....+..|.++++|++|+|++ |+|++..+ .|.++++|+.|+|++|+++
T Consensus 41 n~l~~i~~~~~--~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~ 118 (239)
T 2xwt_C 41 THLRTIPSHAF--SNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118 (239)
T ss_dssp CCCSEECTTTT--TTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC
T ss_pred CcceEECHHHc--cCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc
Confidence 56666555677 567888888888887 5555556899999999999999 99998877 5889999999999999999
Q ss_pred ccCCccccCCCCCc---EEEccCC-cccccCCC-CCcccccc-cccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccc
Q 008026 79 GPVPDSLVKLESLK---IVNMTNN-LLQGPVPE-FDRSVSLD-MAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152 (580)
Q Consensus 79 ~~~P~~~~~l~~L~---~L~L~~N-~l~~~~~~-~~~~~~L~-~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~ 152 (580)
.+|. |..+++|+ .|++++| +++++++. |..+.+|+ .|++++|.+..+|...+.
T Consensus 119 -~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~------------------- 177 (239)
T 2xwt_C 119 -MFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFN------------------- 177 (239)
T ss_dssp -SCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTT-------------------
T ss_pred -cccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcC-------------------
Confidence 5887 89999998 9999999 99999886 88899999 999999999877765432
Q ss_pred cccCCCCCCCCccceeccCCcEEEEEecCCc-ccccCcccccCC-CCCcEEeccCCcccccCCccCcCCCCCCEEEccCC
Q 008026 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMN-LTGTISPEFASF-KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 230 (580)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~-l~~~~p~~~~~l-~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N 230 (580)
..+|+.|++++|+ +++..+..|..+ ++|+.|+|++|+++ .+|.. .+++|+.|+++++
T Consensus 178 ------------------~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 178 ------------------GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp ------------------TCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred ------------------CCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence 1389999999995 996666778999 99999999999998 77765 7889999999886
Q ss_pred c
Q 008026 231 Q 231 (580)
Q Consensus 231 ~ 231 (580)
.
T Consensus 237 ~ 237 (239)
T 2xwt_C 237 W 237 (239)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.2e-21 Score=207.38 Aligned_cols=191 Identities=16% Similarity=0.100 Sum_probs=149.7
Q ss_pred EEecccCCCCCCCCCchhh-cCcccCceEecccCcCcCCCC----CCCCCCCCcEEeccCCcccccCC---ccccCCCCC
Q 008026 20 LWVNGQNGNAKLGGGIDVI-QNMTSLKEIWLHSNAFSGPLP----DFSGVKQLESLSLRDNFFTGPVP---DSLVKLESL 91 (580)
Q Consensus 20 L~~~~~~~n~~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p----~~~~l~~L~~L~L~~N~l~~~~P---~~~~~l~~L 91 (580)
|+.+++++|.+ +.+|..+ .++++|++|+|++|++++..| .+..+++|+.|+|++|+++ .+| ..+..+++|
T Consensus 312 L~~L~l~~n~l-~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~~l~~L 389 (549)
T 2z81_A 312 VKRITVENSKV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNL 389 (549)
T ss_dssp CCEEEEESSCC-CCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCC-CHHHHHHHGGGCTTC
T ss_pred ceEEEeccCcc-ccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccc-ccccchhhhhcCCCC
Confidence 44455555643 4566555 578888899999988887553 2677888889999988888 444 348888889
Q ss_pred cEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccC
Q 008026 92 KIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 171 (580)
Q Consensus 92 ~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (580)
+.|+|++|+++.+++.+..+.+|+.|++++|.+..+++..+
T Consensus 390 ~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~--------------------------------------- 430 (549)
T 2z81_A 390 TSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIP--------------------------------------- 430 (549)
T ss_dssp CEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCCCTTSC---------------------------------------
T ss_pred CEEECCCCCCccCChhhcccccccEEECCCCCcccccchhc---------------------------------------
Confidence 99999999888777778888888888888888876654322
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----Cceeec
Q 008026 172 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNT 247 (580)
Q Consensus 172 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~ 247 (580)
.+|+.|++++|++++.+ ..+++|++|+|++|+|+ .+|. ...+++|++|||++|++++.+|..+. ...+++
T Consensus 431 ~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 504 (549)
T 2z81_A 431 QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504 (549)
T ss_dssp TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEEC
T ss_pred CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEe
Confidence 27899999999999643 57899999999999998 8887 57899999999999999988887543 346899
Q ss_pred CCCCCCCCCC
Q 008026 248 DGNPDIGKEK 257 (580)
Q Consensus 248 ~~n~~~c~~~ 257 (580)
++|+|.|.|+
T Consensus 505 ~~N~~~~~~~ 514 (549)
T 2z81_A 505 HTNPWDCSCP 514 (549)
T ss_dssp CSSCBCCCHH
T ss_pred cCCCccCCCc
Confidence 9999999875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-21 Score=194.98 Aligned_cols=213 Identities=16% Similarity=0.121 Sum_probs=164.8
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccC
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV 81 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~ 81 (580)
|++++..|..| .++..|+.+++++|.+.+..+ |..+++|++|+|++|.|++..+ +++|+.|++++|++++ +
T Consensus 44 n~l~~~~~~~~--~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~----~~~L~~L~l~~n~l~~-~ 114 (317)
T 3o53_A 44 NPLSQISAADL--APFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV----GPSIETLHAANNNISR-V 114 (317)
T ss_dssp SCCCCCCHHHH--TTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEE----CTTCCEEECCSSCCSE-E
T ss_pred CccCcCCHHHh--hCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccC----CCCcCEEECCCCccCC-c
Confidence 67777777788 568888888999997765443 8999999999999999997553 3788899999998884 4
Q ss_pred CccccCCCCCcEEEccCCcccccCC-CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCC
Q 008026 82 PDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 160 (580)
Q Consensus 82 P~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 160 (580)
|.. .+++|+.|+|++|++++.++ .+..+.+|+.|++++|.+..+++..+. ..+..+....+.++.
T Consensus 115 ~~~--~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------------~~l~~L~~L~L~~N~ 180 (317)
T 3o53_A 115 SCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA------------ASSDTLEHLNLQYNF 180 (317)
T ss_dssp EEC--CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGG------------GGTTTCCEEECTTSC
T ss_pred Ccc--ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHh------------hccCcCCEEECCCCc
Confidence 332 36778888999998888877 477788888888888888776543221 112233444455555
Q ss_pred CCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc-ccCCCC
Q 008026 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY-GKIPSF 239 (580)
Q Consensus 161 ~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~-g~~p~~ 239 (580)
...+++.. .+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ +.+|.+
T Consensus 181 l~~~~~~~-~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 257 (317)
T 3o53_A 181 IYDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (317)
T ss_dssp CCEEECCC-CCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHH
T ss_pred Cccccccc-ccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHH
Confidence 55544333 3679999999999999 56667999999999999999999 78999999999999999999999 666655
Q ss_pred C
Q 008026 240 K 240 (580)
Q Consensus 240 ~ 240 (580)
+
T Consensus 258 ~ 258 (317)
T 3o53_A 258 F 258 (317)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.8e-21 Score=191.93 Aligned_cols=195 Identities=16% Similarity=0.087 Sum_probs=156.8
Q ss_pred CcccccCCCCCccccccceEEecccCCCCCCCCCc----hhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCC
Q 008026 1 MLQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI----DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDN 75 (580)
Q Consensus 1 ~~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N 75 (580)
.|++++.+|..+....+..|+.+++++|.+....+ ..+..+++|++|+|++|++++.+| .|..+++|++|+|++|
T Consensus 100 ~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 179 (310)
T 4glp_A 100 DLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDN 179 (310)
T ss_dssp SCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSC
T ss_pred CCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCC
Confidence 47888999988731247778888888888776544 345689999999999999998887 5889999999999999
Q ss_pred ccccc--CC--ccccCCCCCcEEEccCCcccccCCC----CCcccccccccccCCCCCCC-CCCCchhHHHHHHHHHhhC
Q 008026 76 FFTGP--VP--DSLVKLESLKIVNMTNNLLQGPVPE----FDRSVSLDMAKGSNNFCLPS-PGACDPRLNALLSVVKLMG 146 (580)
Q Consensus 76 ~l~~~--~P--~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~~~L~~l~l~~n~~~~~-~~~~~~~l~~l~~~~~~~~ 146 (580)
++.+. +| ..+..+++|++|+|++|+++..++. +..+.+|+.|++++|.+... |+....
T Consensus 180 ~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~------------- 246 (310)
T 4glp_A 180 PGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR------------- 246 (310)
T ss_dssp TTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS-------------
T ss_pred CCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh-------------
Confidence 98753 33 3357899999999999999865542 45778999999999999877 332210
Q ss_pred CccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEE
Q 008026 147 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 226 (580)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ 226 (580)
...+++|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .+|. +..+++|+.|+
T Consensus 247 ---------------------~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~-~~~~-~~~l~~L~~L~ 300 (310)
T 4glp_A 247 ---------------------CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLN-RAPQ-PDELPEVDNLT 300 (310)
T ss_dssp ---------------------CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCC-SCCC-TTSCCCCSCEE
T ss_pred ---------------------ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCC-CCch-hhhCCCccEEE
Confidence 001248999999999999 7898875 89999999999999 4565 78899999999
Q ss_pred ccCCcccc
Q 008026 227 VSNNQLYG 234 (580)
Q Consensus 227 ls~N~l~g 234 (580)
|++|+++.
T Consensus 301 L~~N~l~~ 308 (310)
T 4glp_A 301 LDGNPFLV 308 (310)
T ss_dssp CSSTTTSC
T ss_pred CcCCCCCC
Confidence 99999984
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=1.9e-20 Score=186.55 Aligned_cols=190 Identities=19% Similarity=0.245 Sum_probs=131.7
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
.++..|+.+++++|.+.. .+ .+..+++|++|+|++|.+++..+ +..+++|+.|+|++|+++ .+| .+..+++|+.|
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L 112 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTL 112 (308)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEE
T ss_pred HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCC-Cch-hhcCCCCCCEE
Confidence 346667777777775544 44 68889999999999999987766 888999999999999998 555 68899999999
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
+|++|++++.++ +..+.+|+.|++++|.+..+++ +..+++|
T Consensus 113 ~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--------------------------------------l~~l~~L 153 (308)
T 1h6u_A 113 DLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--------------------------------------LAGLTNL 153 (308)
T ss_dssp ECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--------------------------------------GGGCTTC
T ss_pred ECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--------------------------------------ccCCCCc
Confidence 999999988654 8888899999999998876653 1122356
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC--CCCCCceeecCCCCC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--SFKSNAIVNTDGNPD 252 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p--~~~~~~~~~~~~n~~ 252 (580)
+.|++++|++++ ++. +..+++|+.|+|++|+++ .+|. +..+++|++|++++|++++..| .......+++++|++
T Consensus 154 ~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 154 QYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTI 229 (308)
T ss_dssp CEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEE
T ss_pred cEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccC-cChh-hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCee
Confidence 666666666663 333 666666666666666665 3332 5666666666666666664433 001123355555554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=181.26 Aligned_cols=141 Identities=20% Similarity=0.175 Sum_probs=107.9
Q ss_pred CCcccceeeccCcEEEEEEEE-cCCcE--EEEEEeeccccCh----------------------hhHHHHHHHHHHHHhc
Q 008026 396 NFSEENILGRGGFGTVYKGEL-HDGTK--IAVKRMEAGVISG----------------------KGLTEFKSEIAVLTKV 450 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 450 (580)
-|++.+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|++.+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 67888 9999875432110 1123688999999999
Q ss_pred CCCcc--cceeeEEEcCCeeEEEEEecCC-C----ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHH-hCCCCCc
Q 008026 451 RHRHL--VALLGHCLDGNEKLLVFEYMPQ-G----TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH-GLAHQSF 522 (580)
Q Consensus 451 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH-~~~~~~i 522 (580)
.|+++ +.++++ +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~gi 192 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AEL 192 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCE
Confidence 88764 334432 356899999942 4 55544311 234567789999999999999 7 899
Q ss_pred EecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 523 IHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 523 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|||||||+|||+++ .++|+|||+|.....
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 99999999999988 999999999987643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.6e-20 Score=185.53 Aligned_cols=215 Identities=18% Similarity=0.139 Sum_probs=139.9
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
.++..|+.+++++|.+.. .+. +.++++|++|++++|.....++.+..+++|++|++++|.+. .++. +..+++|+.|
T Consensus 107 ~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~-~~~~-~~~l~~L~~L 182 (347)
T 4fmz_A 107 QNLTNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVK-DVTP-IANLTDLYSL 182 (347)
T ss_dssp TTCTTCSEEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCSEE
T ss_pred cCCCcCCEEECcCCcccC-chh-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcC-Cchh-hccCCCCCEE
Confidence 456777777777776554 333 88888888888888876666667788888888888888887 4544 7888888888
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
++++|.+++..+ +..+.+|+.+++++|.+...++ +. .+..+....+.++.....+. +..+++|
T Consensus 183 ~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~-------------~~~~L~~L~l~~n~l~~~~~-~~~l~~L 245 (347)
T 4fmz_A 183 SLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP--VA-------------NMTRLNSLKIGNNKITDLSP-LANLSQL 245 (347)
T ss_dssp ECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GG-------------GCTTCCEEECCSSCCCCCGG-GTTCTTC
T ss_pred EccCCccccccc-ccCCCccceeecccCCCCCCch--hh-------------cCCcCCEEEccCCccCCCcc-hhcCCCC
Confidence 888888887665 6777777778887777766543 11 12223333344444444443 4455566
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCC----CCceeecCCC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK----SNAIVNTDGN 250 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~----~~~~~~~~~n 250 (580)
+.|++++|.+++ + +.+..+++|+.|++++|+++ .+| .+..+++|+.|++++|++++..|..+ ....+++++|
T Consensus 246 ~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~-~~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 321 (347)
T 4fmz_A 246 TWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321 (347)
T ss_dssp CEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSS
T ss_pred CEEECCCCccCC-C-hhHhcCCCcCEEEccCCccC-CCh-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCC
Confidence 666666666663 3 34666666666666666666 333 46666666666666666665554332 2234566666
Q ss_pred CCCC
Q 008026 251 PDIG 254 (580)
Q Consensus 251 ~~~c 254 (580)
+...
T Consensus 322 ~l~~ 325 (347)
T 4fmz_A 322 HITD 325 (347)
T ss_dssp SCCC
T ss_pred cccc
Confidence 5443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.4e-20 Score=193.22 Aligned_cols=187 Identities=19% Similarity=0.146 Sum_probs=124.0
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
.++..|+.+++++|.+.+ .| .|..+++|++|+|++|+|++. | +..+++|++|+|++|+|++ +| ++++++|++|
T Consensus 39 ~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L 111 (457)
T 3bz5_A 39 EQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYL 111 (457)
T ss_dssp HHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEE
T ss_pred hHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCce-ee--cCCCCcCCEE
Confidence 457777777888776554 44 688888899999999888875 3 7788888899998888884 55 8888888889
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCC-CCCccceeccCCc
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP-CSDWIGVTCTKGN 173 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 173 (580)
+|++|++++. | +..+.+|+.|++++|.+..++-. . +..+.......+. ...+ .+..+++
T Consensus 112 ~L~~N~l~~l-~-~~~l~~L~~L~l~~N~l~~l~l~---~-------------l~~L~~L~l~~n~~~~~~--~~~~l~~ 171 (457)
T 3bz5_A 112 NCDTNKLTKL-D-VSQNPLLTYLNCARNTLTEIDVS---H-------------NTQLTELDCHLNKKITKL--DVTPQTQ 171 (457)
T ss_dssp ECCSSCCSCC-C-CTTCTTCCEEECTTSCCSCCCCT---T-------------CTTCCEEECTTCSCCCCC--CCTTCTT
T ss_pred ECCCCcCCee-c-CCCCCcCCEEECCCCccceeccc---c-------------CCcCCEEECCCCCccccc--ccccCCc
Confidence 9988888885 3 78888888888888888776421 1 1122222222221 1111 1334456
Q ss_pred EEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 174 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 174 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
|+.|++++|++++ +| ++.+++|+.|++++|++++ + .+..+++|++|++++|++++
T Consensus 172 L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~-~--~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 172 LTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITK-L--DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp CCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSC-C--CCTTCTTCSEEECCSSCCSC
T ss_pred CCEEECCCCccce-ec--cccCCCCCEEECcCCcCCe-e--ccccCCCCCEEECcCCcccc
Confidence 6666666666663 44 5566666666666666653 2 25566666666666666665
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.7e-20 Score=172.13 Aligned_cols=172 Identities=19% Similarity=0.139 Sum_probs=136.4
Q ss_pred cCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccc
Q 008026 25 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 103 (580)
Q Consensus 25 ~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~ 103 (580)
++.+. +...|..+ .++|++|+|++|++++.++. |..+++|++|+|++|++++..+..|..+++|++|+|++|++++
T Consensus 14 c~~~~-l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 90 (208)
T 2o6s_A 14 CYSQG-RTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90 (208)
T ss_dssp CCSSC-CSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred ecCCC-ccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCc
Confidence 44443 33445433 45899999999999977774 7889999999999999994334457889999999999999998
Q ss_pred cCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCC
Q 008026 104 PVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM 182 (580)
Q Consensus 104 ~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n 182 (580)
.++. +..+.+|+.|++++|.+..+++..+. .+++|+.|+|++|
T Consensus 91 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~------------------------------------~l~~L~~L~l~~N 134 (208)
T 2o6s_A 91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFD------------------------------------KLTQLKDLRLYQN 134 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT------------------------------------TCTTCCEEECCSS
T ss_pred cCHhHhcCccCCCEEEcCCCcCcccCHhHhc------------------------------------cCCcCCEEECCCC
Confidence 8876 67888999999999988877655432 2348999999999
Q ss_pred cccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC
Q 008026 183 NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 242 (580)
Q Consensus 183 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~ 242 (580)
++++..+..+..+++|+.|+|++|.+.+ .+++|++|+++.|+++|.+|+.++.
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~ 187 (208)
T 2o6s_A 135 QLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGS 187 (208)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred ccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcc
Confidence 9996666668899999999999998874 4557899999999999999987654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.9e-20 Score=195.99 Aligned_cols=184 Identities=18% Similarity=0.142 Sum_probs=136.5
Q ss_pred eEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccC
Q 008026 19 SLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 98 (580)
Q Consensus 19 ~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~ 98 (580)
.|+.+++++|.+.+ +|..+. ++|++|+|++|+|+. +| ..+++|+.|+|++|+|++ +|. +.+ +|+.|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip--~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP--ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC--CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc--cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCC
Confidence 56666666665443 665453 678888888888884 44 446788888888888884 777 655 788888888
Q ss_pred CcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEE
Q 008026 99 NLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVIN 178 (580)
Q Consensus 99 N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ 178 (580)
|+|+++++ .+.+|+.|++++|.+..+|. . +..+....+.++.+..+|. ++ ++|+.|+
T Consensus 130 N~l~~lp~---~l~~L~~L~Ls~N~l~~lp~-~----------------l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~ 186 (571)
T 3cvr_A 130 NQLTMLPE---LPALLEYINADNNQLTMLPE-L----------------PTSLEVLSVRNNQLTFLPE-LP--ESLEALD 186 (571)
T ss_dssp SCCSCCCC---CCTTCCEEECCSSCCSCCCC-C----------------CTTCCEEECCSSCCSCCCC-CC--TTCCEEE
T ss_pred CcCCCCCC---cCccccEEeCCCCccCcCCC-c----------------CCCcCEEECCCCCCCCcch-hh--CCCCEEE
Confidence 88888554 56778888888888877665 1 1233444555565555555 43 6999999
Q ss_pred ecCCcccccCcccccCCCCC-------cEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCC
Q 008026 179 FQKMNLTGTISPEFASFKSL-------QRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK 240 (580)
Q Consensus 179 ls~n~l~~~~p~~~~~l~~L-------~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~ 240 (580)
|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+
T Consensus 187 Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l 250 (571)
T 3cvr_A 187 VSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250 (571)
T ss_dssp CCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHH
T ss_pred CcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHH
Confidence 9999999 7887 665 77 99999999999 899999999999999999999999887654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=184.12 Aligned_cols=215 Identities=19% Similarity=0.179 Sum_probs=169.9
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
..+..|+.+++++|...+..+ .+.++++|++|++++|.+.+..+ +..+++|+.|++++|++. .++. +..+++|+.|
T Consensus 129 ~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L 204 (347)
T 4fmz_A 129 ANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIE-DISP-LASLTSLHYF 204 (347)
T ss_dssp TTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCCC-CCGG-GGGCTTCCEE
T ss_pred ccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCccc-cccc-ccCCCcccee
Confidence 457778888888886666544 48999999999999999986655 788999999999999998 5665 8899999999
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
++++|.+++..+ +..+.+|+.|++++|.+..+++ + ..+..+....+.++....+ ..+..+++|
T Consensus 205 ~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~-------------~~l~~L~~L~l~~n~l~~~-~~~~~l~~L 267 (347)
T 4fmz_A 205 TAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--L-------------ANLSQLTWLEIGTNQISDI-NAVKDLTKL 267 (347)
T ss_dssp ECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--G-------------TTCTTCCEEECCSSCCCCC-GGGTTCTTC
T ss_pred ecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--h-------------hcCCCCCEEECCCCccCCC-hhHhcCCCc
Confidence 999999998776 7888899999999999887764 1 2233444445555555554 345667899
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC--CCCCCceeecCCCCC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--SFKSNAIVNTDGNPD 252 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p--~~~~~~~~~~~~n~~ 252 (580)
+.|++++|++++ + +.+..+++|+.|++++|++.+..|..+..+++|++|++++|++++..| .......+++.+|+.
T Consensus 268 ~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 268 KMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345 (347)
T ss_dssp CEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC--
T ss_pred CEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhcc
Confidence 999999999995 4 468899999999999999998888889999999999999999998766 112234577777763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=171.01 Aligned_cols=154 Identities=16% Similarity=0.167 Sum_probs=98.2
Q ss_pred ceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCc-cccCCCCCcEEEccCCcccccCC-CCCcccccccccccCC
Q 008026 45 KEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD-SLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNN 122 (580)
Q Consensus 45 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~-~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~l~l~~n 122 (580)
+++++++|.++..++.+. ..++.|+|++|+|++..|. .|..+++|+.|+|++|+++++++ .|..+.+|+.|++++|
T Consensus 14 ~~l~~s~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 14 TTVDCSNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEeEeCCCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 356666666654433332 2345666666666633332 25566666666666666665555 3555555555555555
Q ss_pred CCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEe
Q 008026 123 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLI 202 (580)
Q Consensus 123 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ 202 (580)
.+..+++..+ ..+++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 92 ~l~~~~~~~~------------------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 92 RLENVQHKMF------------------------------------KGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CCCCCCGGGG------------------------------------TTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred ccCccCHhHh------------------------------------cCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 5444433221 1233788888888888877788888888888888
Q ss_pred ccCCcccccCCccCcCCCCCCEEEccCCcccccC
Q 008026 203 LADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 236 (580)
Q Consensus 203 ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~ 236 (580)
|++|+|++..|..+..+++|+.|+|++|++++..
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 8888888777888888888888888888777543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=197.19 Aligned_cols=235 Identities=15% Similarity=0.087 Sum_probs=135.3
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|++++..|..| .++..|+.+++++|++.+..++.|.++++|++|+|++|.+++.+| .|.++++|++|+|++|+++ .
T Consensus 38 n~l~~~~~~~~--~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~ 114 (570)
T 2z63_A 38 NPLRHLGSYSF--FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-S 114 (570)
T ss_dssp CCCCEECTTTT--TTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCC-C
T ss_pred CccCccChhHh--hCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccc-c
Confidence 44445445555 445666666666665555555666666777777777776666555 3666667777777777666 3
Q ss_pred CCc-cccCCCCCcEEEccCCccccc--CCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCC
Q 008026 81 VPD-SLVKLESLKIVNMTNNLLQGP--VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157 (580)
Q Consensus 81 ~P~-~~~~l~~L~~L~L~~N~l~~~--~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~ 157 (580)
+|. .|+++++|++|+|++|.+++. +..+..+.+|+.|++++|.+..+++..+..+..+... .......
T Consensus 115 l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~---------~~~L~l~ 185 (570)
T 2z63_A 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL---------NLSLDLS 185 (570)
T ss_dssp STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTC---------CCEEECT
T ss_pred CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchh---------hhhcccC
Confidence 443 466677777777777766652 3346666677777777776666555444333322000 0011112
Q ss_pred CCCCCCccceeccCCcEEEEEecCC-------------------------------------------------------
Q 008026 158 NDPCSDWIGVTCTKGNITVINFQKM------------------------------------------------------- 182 (580)
Q Consensus 158 ~~~~~~~~~~~~~~~~L~~L~ls~n------------------------------------------------------- 182 (580)
++.....+.......+|+.|++++|
T Consensus 186 ~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 2222211111111123444444444
Q ss_pred ---cccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCC-C-CCceeecCCCC
Q 008026 183 ---NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF-K-SNAIVNTDGNP 251 (580)
Q Consensus 183 ---~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~-~-~~~~~~~~~n~ 251 (580)
.+.+.+|..+..+++|+.|++++|++. .+|..+..+ +|+.|++++|+++ .+|.. + ....+.+.+|.
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~ 336 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNK 336 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCB
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcccccccCEEeCcCCc
Confidence 455566677777888888888888887 678777777 8888888888877 55542 1 22335555554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.3e-20 Score=201.52 Aligned_cols=189 Identities=17% Similarity=0.167 Sum_probs=153.2
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCcc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 84 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~ 84 (580)
..+|..+. ..|+.+++++|.+....|..|.++++|++|+|++|+|++.+| .|.++++|++|+|++|++++..|..
T Consensus 18 ~~ip~~~~----~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 93 (549)
T 2z81_A 18 TSIPSGLT----AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSW 93 (549)
T ss_dssp SSCCSCCC----TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHH
T ss_pred ccccccCC----CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHH
Confidence 46888773 566777788888777777899999999999999999999887 5899999999999999999655556
Q ss_pred ccCCCCCcEEEccCCccccc--CCCCCcccccccccccCCC-CCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCC
Q 008026 85 LVKLESLKIVNMTNNLLQGP--VPEFDRSVSLDMAKGSNNF-CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 161 (580)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~--~~~~~~~~~L~~l~l~~n~-~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 161 (580)
|+++++|++|+|++|++++. ++.+..+.+|+.|++++|. +..+++..+
T Consensus 94 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~----------------------------- 144 (549)
T 2z81_A 94 FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF----------------------------- 144 (549)
T ss_dssp HTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTT-----------------------------
T ss_pred hccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhh-----------------------------
Confidence 99999999999999999964 4568999999999999997 554543322
Q ss_pred CCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccC-cCCCCCCEEEccCCccccc
Q 008026 162 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNNQLYGK 235 (580)
Q Consensus 162 ~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l-~~l~~L~~l~ls~N~l~g~ 235 (580)
..+++|+.|++++|++.+.+|..++.+++|+.|++++|.+. .+|..+ ..+++|++|++++|++++.
T Consensus 145 -------~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~ 211 (549)
T 2z81_A 145 -------AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARF 211 (549)
T ss_dssp -------TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTC
T ss_pred -------hcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccc
Confidence 23347888888888888888888888888888888888876 555544 4578888888888888864
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=190.86 Aligned_cols=217 Identities=20% Similarity=0.137 Sum_probs=113.2
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccC-------------ceEecccCcCcCCCCCC-------
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL-------------KEIWLHSNAFSGPLPDF------- 61 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L-------------~~L~L~~N~l~~~~p~~------- 61 (580)
|++ |.+|++| .+++.|+.+++++|.+.+..|..++++++| ++|++++|.+++.++..
T Consensus 21 n~l-~~iP~~i--~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~~~~L~~L~ 97 (454)
T 1jl5_A 21 SNL-TEMPVEA--ENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLV 97 (454)
T ss_dssp ----------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSCCTTCSEEE
T ss_pred Cch-hhCChhH--hcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCCcCCCCEEE
Confidence 444 6666666 456666666666666665666666655543 55555555555432210
Q ss_pred ----------CCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCC
Q 008026 62 ----------SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 131 (580)
Q Consensus 62 ----------~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~ 131 (580)
..+++|+.|++++|+++ .+|.. .++|++|+|++|+++++ |++..+.+|+.|++++|.+..+|...
T Consensus 98 l~~n~l~~lp~~~~~L~~L~l~~n~l~-~l~~~---~~~L~~L~L~~n~l~~l-p~~~~l~~L~~L~l~~N~l~~lp~~~ 172 (454)
T 1jl5_A 98 ASCNSLTELPELPQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLEKL-PELQNSSFLKIIDVDNNSLKKLPDLP 172 (454)
T ss_dssp CCSSCCSSCCCCCTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCSCCCCCC
T ss_pred ccCCcCCccccccCCCcEEECCCCccC-cccCC---CCCCCEEECcCCCCCCC-cccCCCCCCCEEECCCCcCcccCCCc
Confidence 01234444444444444 23321 14677777777777763 35777777777777777776655332
Q ss_pred chhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCccccc
Q 008026 132 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 211 (580)
Q Consensus 132 ~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 211 (580)
. .+....++++....++ .+..+++|+.|++++|++++ +|... ++|++|++++|++. .
T Consensus 173 ~-----------------~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~ 229 (454)
T 1jl5_A 173 P-----------------SLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-E 229 (454)
T ss_dssp T-----------------TCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-S
T ss_pred c-----------------cccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-c
Confidence 1 2233333444444444 35556667777777777663 44332 46667777777766 6
Q ss_pred CCccCcCCCCCCEEEccCCcccccCCCCC-CCceeecCCCC
Q 008026 212 IPEGLSVLGALKELDVSNNQLYGKIPSFK-SNAIVNTDGNP 251 (580)
Q Consensus 212 ~p~~l~~l~~L~~l~ls~N~l~g~~p~~~-~~~~~~~~~n~ 251 (580)
+|+ +..+++|++|++++|++++ +|... ....+++++|.
T Consensus 230 lp~-~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~N~ 268 (454)
T 1jl5_A 230 LPE-LQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNY 268 (454)
T ss_dssp CCC-CTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSC
T ss_pred ccc-cCCCCCCCEEECCCCcCCc-ccccccccCEEECCCCc
Confidence 663 6677777777777777765 34332 22345555554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=6.5e-20 Score=181.00 Aligned_cols=171 Identities=19% Similarity=0.232 Sum_probs=120.8
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
.+..|+.+++++|.+... + .+..+++|++|+|++|++++..+ +..+++|+.|+|++|+++ .+| .+..+++|+.|+
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L~ 118 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLS 118 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCC-CCh-hhccCCCCCEEE
Confidence 455566666666654432 2 36777777777777777776555 677777777777777777 344 377777777777
Q ss_pred ccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEE
Q 008026 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175 (580)
Q Consensus 96 L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 175 (580)
|++|++++. +.+..+.+|+.|++++|.+..++ .+..+++|+
T Consensus 119 L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~~--------------------------------------~l~~l~~L~ 159 (291)
T 1h6t_A 119 LEHNGISDI-NGLVHLPQLESLYLGNNKITDIT--------------------------------------VLSRLTKLD 159 (291)
T ss_dssp CTTSCCCCC-GGGGGCTTCCEEECCSSCCCCCG--------------------------------------GGGGCTTCS
T ss_pred CCCCcCCCC-hhhcCCCCCCEEEccCCcCCcch--------------------------------------hhccCCCCC
Confidence 777777765 55667777777777777665441 123345788
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 176 ~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
.|++++|++.+..| +..+++|+.|+|++|+++ .+|. +..+++|+.|++++|+++.
T Consensus 160 ~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~-~l~~-l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-BCGG-GTTCTTCSEEEEEEEEEEC
T ss_pred EEEccCCccccchh--hcCCCccCEEECCCCcCC-CChh-hccCCCCCEEECcCCcccC
Confidence 88888888885443 888888888888888887 4554 7888888888888888875
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.7e-20 Score=171.63 Aligned_cols=178 Identities=18% Similarity=0.160 Sum_probs=145.0
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCcccccCCcc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDS 84 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~P~~ 84 (580)
..+|..+. ..|+.+++++|++.+..+..|.++++|++|+|++|+|++.++. |..+++|++|+|++|++++..+..
T Consensus 20 ~~~p~~~~----~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 95 (208)
T 2o6s_A 20 TSVPTGIP----AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGV 95 (208)
T ss_dssp SSCCSCCC----TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred cCCCCCCC----CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhH
Confidence 35676662 4566677777877766667789999999999999999987775 788999999999999999444445
Q ss_pred ccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC
Q 008026 85 LVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 163 (580)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (580)
|.++++|+.|+|++|++++.++. +..+.+|+.|++++|.+..+++..+.
T Consensus 96 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~------------------------------ 145 (208)
T 2o6s_A 96 FDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD------------------------------ 145 (208)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT------------------------------
T ss_pred hcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhc------------------------------
Confidence 89999999999999999999886 68899999999999999887765432
Q ss_pred ccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 164 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 164 ~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
.+++|+.|++++|.+.+ .+++|+.|+++.|+++|.+|++++.++. ++..+...|
T Consensus 146 ------~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~----~~~~C~~~~ 199 (208)
T 2o6s_A 146 ------RLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP----DSAKCSGSG 199 (208)
T ss_dssp ------TCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT----TCSBBTTTC
T ss_pred ------cCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC----CccccccCC
Confidence 23489999999998774 4568999999999999999999988775 344444433
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.7e-19 Score=185.47 Aligned_cols=201 Identities=15% Similarity=0.056 Sum_probs=160.1
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccC
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV 81 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~ 81 (580)
|++++ +| .| ..+..|+.+++++|++.+ .| ++++++|++|+|++|+|++. | +..+++|++|+|++|++++ +
T Consensus 52 n~l~~-~~-~l--~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~-l 121 (457)
T 3bz5_A 52 SSITD-MT-GI--EKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTK-L 121 (457)
T ss_dssp SCCCC-CT-TG--GGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSC-C
T ss_pred CCccc-Ch-hh--cccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCe-e
Confidence 55665 46 56 567888888888887665 34 89999999999999999986 3 8899999999999999994 6
Q ss_pred CccccCCCCCcEEEccCCcccccCCCCCcccccccccccCC-CCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCC
Q 008026 82 PDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNN-FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 160 (580)
Q Consensus 82 P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n-~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 160 (580)
| ++.+++|+.|++++|+++++ .+..+.+|+.|++++| .+..++ + ..+..+....+.++.
T Consensus 122 ~--~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~~---~-------------~~l~~L~~L~ls~n~ 181 (457)
T 3bz5_A 122 D--VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKLD---V-------------TPQTQLTTLDCSFNK 181 (457)
T ss_dssp C--CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCCC---C-------------TTCTTCCEEECCSSC
T ss_pred c--CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCcccccc---c-------------ccCCcCCEEECCCCc
Confidence 6 99999999999999999996 3888999999999999 444442 1 122334444455555
Q ss_pred CCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCC
Q 008026 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK 240 (580)
Q Consensus 161 ~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~ 240 (580)
...++ +..+++|+.|++++|++++. .++.+++|+.|++++|++++ +| +..+++|+.|++++|++++..+..+
T Consensus 182 l~~l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l 253 (457)
T 3bz5_A 182 ITELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTL 253 (457)
T ss_dssp CCCCC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTC
T ss_pred cceec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHC
Confidence 55554 55667899999999999964 48899999999999999985 77 8889999999999999998765544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.2e-19 Score=168.39 Aligned_cols=133 Identities=21% Similarity=0.270 Sum_probs=87.7
Q ss_pred ccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCccccccccccc
Q 008026 42 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 120 (580)
Q Consensus 42 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~ 120 (580)
++|++|+|++|+|++.++ .|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|+.+++.
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~------------- 98 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKS------------- 98 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTT-------------
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHh-------------
Confidence 355555555555555544 355555555555555555544455555555555555555555544432
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcE
Q 008026 121 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQR 200 (580)
Q Consensus 121 ~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~ 200 (580)
.+. .+++|+.|+|++|++++..|..|..+++|+.
T Consensus 99 ----------~f~------------------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 132 (220)
T 2v9t_B 99 ----------LFE------------------------------------GLFSLQLLLLNANKINCLRVDAFQDLHNLNL 132 (220)
T ss_dssp ----------TTT------------------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ----------Hcc------------------------------------CCCCCCEEECCCCCCCEeCHHHcCCCCCCCE
Confidence 211 1237888888888888777788888888888
Q ss_pred EeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 201 LILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 201 L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
|+|++|+|++..+..+..+++|+.|+|++|++.
T Consensus 133 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred EECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 888888888666667888888888888777665
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.2e-19 Score=188.43 Aligned_cols=214 Identities=18% Similarity=0.184 Sum_probs=147.5
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
.+++.|+.+++++|.+.. . +.+.++++|++|++++|.+++..| +..+++|+.|+|++|++. .++ .+..+++|+.|
T Consensus 174 ~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L 248 (466)
T 1o6v_A 174 ANLTTLERLDISSNKVSD-I-SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLK-DIG-TLASLTNLTDL 248 (466)
T ss_dssp TTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred ccCCCCCEEECcCCcCCC-C-hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcc-cch-hhhcCCCCCEE
Confidence 345666666776665443 2 347777788888888887776655 566777888888888777 443 57778888888
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
++++|++++.++ +..+.+|+.|++++|.+..+++ + ..+..+....+.++....++. +..+++|
T Consensus 249 ~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~-------------~~l~~L~~L~L~~n~l~~~~~-~~~l~~L 311 (466)
T 1o6v_A 249 DLANNQISNLAP-LSGLTKLTELKLGANQISNISP--L-------------AGLTALTNLELNENQLEDISP-ISNLKNL 311 (466)
T ss_dssp ECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--G-------------TTCTTCSEEECCSSCCSCCGG-GGGCTTC
T ss_pred ECCCCccccchh-hhcCCCCCEEECCCCccCcccc--c-------------cCCCccCeEEcCCCcccCchh-hcCCCCC
Confidence 888888877766 7777778888888887776553 1 123334444455555555444 5566788
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCC--CCCceeecCCCCC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF--KSNAIVNTDGNPD 252 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~n~~ 252 (580)
+.|++++|++++..| +..+++|++|++++|++++. ..+..+++|+.|++++|++++.+|-. .....+.+.+|++
T Consensus 312 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAW 387 (466)
T ss_dssp SEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEE
T ss_pred CEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcc
Confidence 888888888886554 77888888888888888743 46788888888888888888777611 1223467777766
Q ss_pred CC
Q 008026 253 IG 254 (580)
Q Consensus 253 ~c 254 (580)
.+
T Consensus 388 ~~ 389 (466)
T 1o6v_A 388 TN 389 (466)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.9e-20 Score=186.76 Aligned_cols=155 Identities=21% Similarity=0.168 Sum_probs=103.7
Q ss_pred cCceEecccCcCcCCCCC-CC-CCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCccccccccccc
Q 008026 43 SLKEIWLHSNAFSGPLPD-FS-GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 120 (580)
Q Consensus 43 ~L~~L~L~~N~l~~~~p~-~~-~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~ 120 (580)
.|+.|+|++|+|++..+. |. ++++|+.|+|++|+|++..|..|.++++|++|+|++|+|+++++.
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~------------- 106 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEF------------- 106 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-------------
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHH-------------
Confidence 455666666666655553 44 566666666666666633334466666666666666666555442
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcE
Q 008026 121 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQR 200 (580)
Q Consensus 121 ~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~ 200 (580)
.+ ..+.+|+.|+|++|+|.+..|..|..+++|+.
T Consensus 107 ----------~~------------------------------------~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 140 (361)
T 2xot_A 107 ----------LF------------------------------------SDLQALEVLLLYNNHIVVVDRNAFEDMAQLQK 140 (361)
T ss_dssp ----------TT------------------------------------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred ----------Hh------------------------------------CCCcCCCEEECCCCcccEECHHHhCCcccCCE
Confidence 11 12237888888999998777888999999999
Q ss_pred EeccCCcccccCCccC----cCCCCCCEEEccCCcccccCCCCCC------CceeecCCCCCCCCCC
Q 008026 201 LILADNNLSGMIPEGL----SVLGALKELDVSNNQLYGKIPSFKS------NAIVNTDGNPDIGKEK 257 (580)
Q Consensus 201 L~ls~N~l~g~~p~~l----~~l~~L~~l~ls~N~l~g~~p~~~~------~~~~~~~~n~~~c~~~ 257 (580)
|+|++|+|+ .+|..+ ..+++|+.|||++|+|++..+..+. ...+.+.+|||.|+|.
T Consensus 141 L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 141 LYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp EECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred EECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 999999998 566654 5688999999999999854433221 1347889999999875
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.5e-19 Score=167.45 Aligned_cols=154 Identities=18% Similarity=0.130 Sum_probs=93.8
Q ss_pred ceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCC
Q 008026 45 KEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNF 123 (580)
Q Consensus 45 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~ 123 (580)
+.++.++++++..++.+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+.+++. |..+.+|+.|++++|.
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 345555555443333221 4455555555555543344455555555555555555444443 3344444444444444
Q ss_pred CCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEec
Q 008026 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 203 (580)
Q Consensus 124 ~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l 203 (580)
+..+++..+. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 100 l~~l~~~~~~------------------------------------~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 100 LTVLPSAVFD------------------------------------RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142 (229)
T ss_dssp CCCCCTTTTT------------------------------------TCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred CCccChhHhC------------------------------------cchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence 4444332221 2237888889999888 78888889999999999
Q ss_pred cCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 204 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 204 s~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
++|+|++..+..+..+++|+.|+|++|++.+..+
T Consensus 143 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 143 DQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999985555678889999999998888876544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5e-19 Score=191.39 Aligned_cols=175 Identities=19% Similarity=0.232 Sum_probs=133.2
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
..|..|+.++++.|.+.. ++ .|..|++|++|+|++|.|++.+| +..+++|+.|+|++|+|. .+| .+..+++|+.|
T Consensus 40 ~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L 114 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSL 114 (605)
T ss_dssp HHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCC-CCT-TSTTCTTCCEE
T ss_pred hcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCC-CCh-hhccCCCCCEE
Confidence 346667777777765443 33 47777788888888887776655 677777888888888777 444 67777788888
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
+|++|+++++ +.+..+.+|+.|++++|.+..+ ..++.+++|
T Consensus 115 ~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l--------------------------------------~~l~~l~~L 155 (605)
T 1m9s_A 115 SLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--------------------------------------TVLSRLTKL 155 (605)
T ss_dssp ECTTSCCCCC-GGGGGCTTCSEEECCSSCCCCC--------------------------------------GGGGSCTTC
T ss_pred EecCCCCCCC-ccccCCCccCEEECCCCccCCc--------------------------------------hhhcccCCC
Confidence 8888877764 5577777777777777776544 123445699
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
+.|+|++|+|.+..| +..|++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++...
T Consensus 156 ~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 156 DTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEECCCC
T ss_pred CEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcCCcc
Confidence 999999999997655 9999999999999999984 55 69999999999999999997543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.1e-19 Score=185.36 Aligned_cols=195 Identities=15% Similarity=0.160 Sum_probs=160.4
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
..+..|+.+++++|.+.+..| +..+++|++|+|++|.+++. +.+..+++|+.|+|++|++.+ ++. +..+++|+.|
T Consensus 196 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L 270 (466)
T 1o6v_A 196 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISN-LAP-LSGLTKLTEL 270 (466)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCSEE
T ss_pred ccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCcccc-chh-hhcCCCCCEE
Confidence 456777788888887665444 78899999999999999864 567889999999999999994 444 8899999999
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
+|++|++++.++ +..+.+|+.|++++|.+..+++ ...+..+....+.++...+.+. +..+++|
T Consensus 271 ~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~---------------~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L 333 (466)
T 1o6v_A 271 KLGANQISNISP-LAGLTALTNLELNENQLEDISP---------------ISNLKNLTYLTLYFNNISDISP-VSSLTKL 333 (466)
T ss_dssp ECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG---------------GGGCTTCSEEECCSSCCSCCGG-GGGCTTC
T ss_pred ECCCCccCcccc-ccCCCccCeEEcCCCcccCchh---------------hcCCCCCCEEECcCCcCCCchh-hccCccC
Confidence 999999998877 8888999999999999887653 1223445555566666666554 5677899
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccccc
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 235 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~ 235 (580)
+.|++++|++++. +.+.++++|+.|++++|++++..| +..+++|+.|++++|++++.
T Consensus 334 ~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 334 QRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp CEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred CEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 9999999999964 479999999999999999997776 89999999999999999974
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.3e-19 Score=173.18 Aligned_cols=173 Identities=13% Similarity=0.148 Sum_probs=145.5
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
.++..+..++++.+.+.. .+ .+..+++|++|++++|.|+.. |.+..+++|+.|+|++|+|+ .+|. +..+++|+.|
T Consensus 16 ~~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L 90 (263)
T 1xeu_A 16 PGLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEE
T ss_pred HHHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcccc-hHHhhCCCCCEEECCCCccC-CChh-hccCCCCCEE
Confidence 356777788888876544 34 688999999999999999954 57888999999999999999 5666 9999999999
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
+|++|++++.++ +.. .+|+.|++++|.+..++. +..+++|
T Consensus 91 ~L~~N~l~~l~~-~~~-~~L~~L~L~~N~l~~~~~--------------------------------------l~~l~~L 130 (263)
T 1xeu_A 91 SVNRNRLKNLNG-IPS-ACLSRLFLDNNELRDTDS--------------------------------------LIHLKNL 130 (263)
T ss_dssp ECCSSCCSCCTT-CCC-SSCCEEECCSSCCSBSGG--------------------------------------GTTCTTC
T ss_pred ECCCCccCCcCc-ccc-CcccEEEccCCccCCChh--------------------------------------hcCcccc
Confidence 999999998665 333 889999999998876531 2234589
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 236 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~ 236 (580)
+.|++++|++++ +| .++.+++|+.|+|++|++++. ..+..+++|+.|++++|++++..
T Consensus 131 ~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 131 EILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp CEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred cEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence 999999999995 55 799999999999999999954 67999999999999999999663
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.7e-19 Score=165.41 Aligned_cols=153 Identities=16% Similarity=0.134 Sum_probs=133.5
Q ss_pred CcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCC--CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHh
Q 008026 67 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL 144 (580)
Q Consensus 67 L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~ 144 (580)
-+.+++++|.++ .+|..+. ..++.|+|++|+|++.++. |..+.+|+.|++++|.+..+++..+.
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~----------- 78 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE----------- 78 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTT-----------
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhC-----------
Confidence 358999999999 7998774 4678999999999999764 78999999999999999887765442
Q ss_pred hCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCE
Q 008026 145 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKE 224 (580)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~ 224 (580)
.+.+|+.|+|++|++++..|..|..+++|++|+|++|+|++..|..+..+++|++
T Consensus 79 -------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 133 (220)
T 2v70_A 79 -------------------------GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRL 133 (220)
T ss_dssp -------------------------TCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSE
T ss_pred -------------------------CCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCE
Confidence 3348999999999999878888999999999999999999888999999999999
Q ss_pred EEccCCcccccCCCCCC----CceeecCCCCCCCCCCC
Q 008026 225 LDVSNNQLYGKIPSFKS----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 225 l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~~ 258 (580)
|+|++|++++..|..+. ...+++.+|+|.|.|..
T Consensus 134 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 134 LSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp EECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred EECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 99999999998887664 34689999999998764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=173.63 Aligned_cols=189 Identities=16% Similarity=0.197 Sum_probs=150.7
Q ss_pred cceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEc
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L 96 (580)
+..+....+..+..... ..+..+++|++|++++|.++. +|.+..+++|+.|+|++|++. .+|. +..+++|+.|+|
T Consensus 18 l~~~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-l~~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L 92 (308)
T 1h6u_A 18 LANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELEL 92 (308)
T ss_dssp HHHHHHHHTTCSSTTSE--ECHHHHHTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEEC
T ss_pred HHHHHHHHhCCCCcCce--ecHHHcCCcCEEEeeCCCccC-chhhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEc
Confidence 33343444544443332 235678999999999999986 467888999999999999999 6776 999999999999
Q ss_pred cCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEE
Q 008026 97 TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 176 (580)
Q Consensus 97 ~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ 176 (580)
++|++++. +.+..+.+|+.|++++|.+..+++ +..+++|+.
T Consensus 93 ~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~~~--------------------------------------l~~l~~L~~ 133 (308)
T 1h6u_A 93 SGNPLKNV-SAIAGLQSIKTLDLTSTQITDVTP--------------------------------------LAGLSNLQV 133 (308)
T ss_dssp CSCCCSCC-GGGTTCTTCCEEECTTSCCCCCGG--------------------------------------GTTCTTCCE
T ss_pred cCCcCCCc-hhhcCCCCCCEEECCCCCCCCchh--------------------------------------hcCCCCCCE
Confidence 99999986 578999999999999998876542 123458999
Q ss_pred EEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC--CCCCCceeecCCCCCC
Q 008026 177 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--SFKSNAIVNTDGNPDI 253 (580)
Q Consensus 177 L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p--~~~~~~~~~~~~n~~~ 253 (580)
|++++|++++ +|. ++.+++|+.|+|++|+++ .+|. +..+++|+.|++++|++++..| .......+++++|...
T Consensus 134 L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 134 LYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp EECCSSCCCC-CGG-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred EECCCCccCc-Ccc-ccCCCCccEEEccCCcCC-CChh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccC
Confidence 9999999995 444 999999999999999999 5555 9999999999999999996544 1123345788888654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.77 E-value=4e-19 Score=180.34 Aligned_cols=193 Identities=14% Similarity=0.039 Sum_probs=122.9
Q ss_pred CCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC--CCCCCCCCcE-EeccCCcccccCCc
Q 008026 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLES-LSLRDNFFTGPVPD 83 (580)
Q Consensus 7 ~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~-L~L~~N~l~~~~P~ 83 (580)
+||..+. .+++ .+++++|++.+..+++|.+|++|++|+|++|++.+.+| .|.++++|+. +.+++|+|....|.
T Consensus 23 ~iP~~l~-~~l~---~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~ 98 (350)
T 4ay9_X 23 EIPSDLP-RNAI---ELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPE 98 (350)
T ss_dssp SCCTTCC-TTCS---EEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTT
T ss_pred ccCcCcC-CCCC---EEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCch
Confidence 5666653 2333 34444555544444567777777777777777765554 2666666553 55566777744455
Q ss_pred cccCCCCCcEEEccCCcccccCCC-CCcccccccccccC-CCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCC
Q 008026 84 SLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSN-NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 161 (580)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~-n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 161 (580)
.|..+++|+.|++++|+++..++. +.....+..+++.+ +.+..++...+..+
T Consensus 99 ~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~-------------------------- 152 (350)
T 4ay9_X 99 AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL-------------------------- 152 (350)
T ss_dssp SBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTS--------------------------
T ss_pred hhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhc--------------------------
Confidence 677777777777777777766653 44455555565543 45555554433111
Q ss_pred CCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccC-CcccccCCc-cCcCCCCCCEEEccCCcccccCCCC
Q 008026 162 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILAD-NNLSGMIPE-GLSVLGALKELDVSNNQLYGKIPSF 239 (580)
Q Consensus 162 ~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~-N~l~g~~p~-~l~~l~~L~~l~ls~N~l~g~~p~~ 239 (580)
...++.|+|++|+|+ .+|.......+|++|++++ |++. .+|. .|..+++|++|||++|+|+...+..
T Consensus 153 ---------~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~ 221 (350)
T 4ay9_X 153 ---------SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYG 221 (350)
T ss_dssp ---------BSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSS
T ss_pred ---------chhhhhhcccccccc-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhh
Confidence 126888899999988 6777777778888898875 5665 6765 5688889999999999888544433
Q ss_pred C
Q 008026 240 K 240 (580)
Q Consensus 240 ~ 240 (580)
+
T Consensus 222 ~ 222 (350)
T 4ay9_X 222 L 222 (350)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.77 E-value=9.5e-18 Score=175.98 Aligned_cols=177 Identities=20% Similarity=0.236 Sum_probs=92.8
Q ss_pred ccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccC
Q 008026 42 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSN 121 (580)
Q Consensus 42 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~ 121 (580)
++|++|++++|++++... + .++|++|+|++|+++ .+| +|+++++|++|++++|++++++..+ .+|+.|++++
T Consensus 111 ~~L~~L~l~~n~l~~l~~-~--~~~L~~L~L~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~lp~~~---~~L~~L~L~~ 182 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGN 182 (454)
T ss_dssp TTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCS
T ss_pred CCCcEEECCCCccCcccC-C--CCCCCEEECcCCCCC-CCc-ccCCCCCCCEEECCCCcCcccCCCc---ccccEEECcC
Confidence 556666666666554321 1 145666666666665 355 3566666666666666665533222 2555555666
Q ss_pred CCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEE
Q 008026 122 NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL 201 (580)
Q Consensus 122 n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L 201 (580)
|.+..+|. +.. +..+......++....++... .+|+.|++++|++. .+| +++.+++|++|
T Consensus 183 n~l~~l~~--~~~-------------l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L 242 (454)
T 1jl5_A 183 NQLEELPE--LQN-------------LPFLTAIYADNNSLKKLPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTI 242 (454)
T ss_dssp SCCSSCCC--CTT-------------CTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEE
T ss_pred CcCCcCcc--ccC-------------CCCCCEEECCCCcCCcCCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEE
Confidence 65555431 111 112222223333332222211 36677777777776 566 36677777777
Q ss_pred eccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC-CceeecCCCC
Q 008026 202 ILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS-NAIVNTDGNP 251 (580)
Q Consensus 202 ~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~-~~~~~~~~n~ 251 (580)
++++|+++ .+|.. +++|+.|++++|++++ +|.... ...+++++|.
T Consensus 243 ~l~~N~l~-~l~~~---~~~L~~L~l~~N~l~~-l~~~~~~L~~L~ls~N~ 288 (454)
T 1jl5_A 243 YADNNLLK-TLPDL---PPSLEALNVRDNYLTD-LPELPQSLTFLDVSENI 288 (454)
T ss_dssp ECCSSCCS-SCCSC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSC
T ss_pred ECCCCcCC-ccccc---ccccCEEECCCCcccc-cCcccCcCCEEECcCCc
Confidence 77777776 45543 2566777777777665 444332 2335555554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.8e-19 Score=192.35 Aligned_cols=173 Identities=18% Similarity=0.115 Sum_probs=118.9
Q ss_pred CCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCC-
Q 008026 30 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE- 107 (580)
Q Consensus 30 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~- 107 (580)
.++.+|..+- +++++|||++|+|++++| +|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|+++++.
T Consensus 42 ~l~~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~ 119 (635)
T 4g8a_A 42 NFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA 119 (635)
T ss_dssp CCSSCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGG
T ss_pred CcCccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHH
Confidence 3444554331 367788888888877766 477788888888888888744445577788888888888888777765
Q ss_pred CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccc-
Q 008026 108 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG- 186 (580)
Q Consensus 108 ~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~- 186 (580)
|.++.+|+.|++++|.+..+++..+. .+++|+.|+|++|++.+
T Consensus 120 f~~L~~L~~L~Ls~N~l~~l~~~~~~------------------------------------~L~~L~~L~Ls~N~l~~~ 163 (635)
T 4g8a_A 120 FSGLSSLQKLVAVETNLASLENFPIG------------------------------------HLKTLKELNVAHNLIQSF 163 (635)
T ss_dssp GTTCTTCCEEECTTSCCCCSTTCCCT------------------------------------TCTTCCEEECCSSCCCCC
T ss_pred hcCCCCCCEEECCCCcCCCCChhhhh------------------------------------cCcccCeeccccCccccC
Confidence 67777788888888877766654432 23377777777777764
Q ss_pred cCcccccCCCCCcEEeccCCcccccCCccCcCCCCC----CEEEccCCcccccCCCCC
Q 008026 187 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGAL----KELDVSNNQLYGKIPSFK 240 (580)
Q Consensus 187 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L----~~l~ls~N~l~g~~p~~~ 240 (580)
.+|..++.+++|+.|+|++|+|++..|..+..++++ ..++++.|.++...|...
T Consensus 164 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~ 221 (635)
T 4g8a_A 164 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 221 (635)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT
T ss_pred CCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc
Confidence 356677777777777777777776666666655443 357777777776555443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-17 Score=180.36 Aligned_cols=103 Identities=17% Similarity=0.009 Sum_probs=54.1
Q ss_pred CCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCcccc
Q 008026 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLV 86 (580)
Q Consensus 7 ~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~ 86 (580)
.+|..+. ..|+.+++++|.+. .+|. .+++|++|+|++|+|++.++ .+++|++|+|++|+|+ .+|.
T Consensus 54 ~lp~~l~----~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~-~l~~--- 118 (622)
T 3g06_A 54 TLPDCLP----AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLT-HLPA--- 118 (622)
T ss_dssp CCCSCCC----TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCC-CCCC---
T ss_pred ccChhhC----CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCC-CCCC---
Confidence 6676663 33344444445433 3443 45677777777777764433 4566666666666666 4554
Q ss_pred CCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCC
Q 008026 87 KLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 127 (580)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~ 127 (580)
.+++|+.|+|++|+++++++. +.+|+.|++++|.+..+
T Consensus 119 ~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N~l~~l 156 (622)
T 3g06_A 119 LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLASL 156 (622)
T ss_dssp CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSCC
T ss_pred CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCCcCCCc
Confidence 344555555555555544332 13444444444444443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.7e-19 Score=179.45 Aligned_cols=163 Identities=19% Similarity=0.178 Sum_probs=121.1
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhc-CcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQ-NMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPD 83 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~ 83 (580)
..+|..+. ..|+.+++++|++....+..|. ++++|++|+|++|+|++..| .|.++++|+.|+|++|+|++..|.
T Consensus 31 ~~iP~~~~----~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 106 (361)
T 2xot_A 31 PNVPQSLP----SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEF 106 (361)
T ss_dssp SSCCSSCC----TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CccCccCC----CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHH
Confidence 45888773 2356677888877776667787 99999999999999999887 599999999999999999955556
Q ss_pred cccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCC
Q 008026 84 SLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 162 (580)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 162 (580)
.|.++++|+.|+|++|+|+++.|. |..+.
T Consensus 107 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-------------------------------------------------- 136 (361)
T 2xot_A 107 LFSDLQALEVLLLYNNHIVVVDRNAFEDMA-------------------------------------------------- 136 (361)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCT--------------------------------------------------
T ss_pred HhCCCcCCCEEECCCCcccEECHHHhCCcc--------------------------------------------------
Confidence 799999999999999999988764 44444
Q ss_pred CccceeccCCcEEEEEecCCcccccCcccc----cCCCCCcEEeccCCcccccCCccCcCCCC--CCEEEccCCccc
Q 008026 163 DWIGVTCTKGNITVINFQKMNLTGTISPEF----ASFKSLQRLILADNNLSGMIPEGLSVLGA--LKELDVSNNQLY 233 (580)
Q Consensus 163 ~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~----~~l~~L~~L~ls~N~l~g~~p~~l~~l~~--L~~l~ls~N~l~ 233 (580)
+|+.|+|++|+|++ +|..+ ..+++|+.|+|++|+|++..+..+..++. |+.|+|++|++.
T Consensus 137 ----------~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 137 ----------QLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp ----------TCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred ----------cCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 55666666666663 44333 45677777777777777333345566665 366777777775
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.1e-18 Score=161.89 Aligned_cols=151 Identities=21% Similarity=0.216 Sum_probs=131.7
Q ss_pred CcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhh
Q 008026 67 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLM 145 (580)
Q Consensus 67 L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~ 145 (580)
.+.++.+++++. .+|..+. ++|+.|+|++|++++.+|. |..+.+|+.|++++|.+..+++..+.
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~------------ 85 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD------------ 85 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT------------
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcc------------
Confidence 568999999999 8998774 8999999999999999775 78999999999999999888765542
Q ss_pred CCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEE
Q 008026 146 GYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 225 (580)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l 225 (580)
.+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|
T Consensus 86 ------------------------~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 140 (229)
T 3e6j_A 86 ------------------------SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140 (229)
T ss_dssp ------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE
T ss_pred ------------------------cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE
Confidence 2348999999999999766667899999999999999999 999999999999999
Q ss_pred EccCCcccccCCCCCC----CceeecCCCCCCCCCC
Q 008026 226 DVSNNQLYGKIPSFKS----NAIVNTDGNPDIGKEK 257 (580)
Q Consensus 226 ~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~ 257 (580)
+|++|++++..+..+. ...+.+.+|+|.|.|.
T Consensus 141 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 141 ALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999999977665443 3468999999999874
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-17 Score=181.05 Aligned_cols=111 Identities=21% Similarity=0.086 Sum_probs=67.6
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccC
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV 81 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~ 81 (580)
|+++ .+|..+ ..|+.+++++|++. .+|. .+++|++|+|++|.|++.++ .+++|+.|+|++|+|+ .+
T Consensus 71 N~l~-~lp~~l-----~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l~~---~l~~L~~L~L~~N~l~-~l 136 (622)
T 3g06_A 71 NNLT-SLPALP-----PELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHLPA---LPSGLCKLWIFGNQLT-SL 136 (622)
T ss_dssp CCCS-CCCCCC-----TTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCCCC---CCTTCCEEECCSSCCS-CC
T ss_pred CCCC-CCCCcC-----CCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCCCC---CCCCcCEEECCCCCCC-cC
Confidence 3443 566633 44455555556543 4554 66788888888888876544 4566777777777776 46
Q ss_pred CccccCCCCCcEEEccCCcccccCCCCCc-----------------ccccccccccCCCCCCCCC
Q 008026 82 PDSLVKLESLKIVNMTNNLLQGPVPEFDR-----------------SVSLDMAKGSNNFCLPSPG 129 (580)
Q Consensus 82 P~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----------------~~~L~~l~l~~n~~~~~~~ 129 (580)
|.. +++|+.|+|++|+++++++.+.. +.+|+.|++++|.+..+|.
T Consensus 137 p~~---l~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~l~~ 198 (622)
T 3g06_A 137 PVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPT 198 (622)
T ss_dssp CCC---CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCC
T ss_pred CCC---CCCCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCCCCC
Confidence 653 36666666666666654432211 2566777777777776664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.6e-18 Score=160.45 Aligned_cols=139 Identities=22% Similarity=0.291 Sum_probs=116.1
Q ss_pred cCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCcc
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 84 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~ 84 (580)
..+|..+. ..|+.+++++|++....+..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+ .+|..
T Consensus 24 ~~iP~~l~----~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~ 98 (220)
T 2v9t_B 24 TEIPTNLP----ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKS 98 (220)
T ss_dssp SSCCSSCC----TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTT
T ss_pred CcCCCccC----cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHh
Confidence 45787773 456666777787777666789999999999999999999877 5999999999999999999 67665
Q ss_pred -ccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCC
Q 008026 85 -LVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 162 (580)
Q Consensus 85 -~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 162 (580)
|..+++|+.|+|++|++++++|. |..+
T Consensus 99 ~f~~l~~L~~L~L~~N~l~~~~~~~~~~l--------------------------------------------------- 127 (220)
T 2v9t_B 99 LFEGLFSLQLLLLNANKINCLRVDAFQDL--------------------------------------------------- 127 (220)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTC---------------------------------------------------
T ss_pred HccCCCCCCEEECCCCCCCEeCHHHcCCC---------------------------------------------------
Confidence 78999999999999999988774 2222
Q ss_pred CccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCccc
Q 008026 163 DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 209 (580)
Q Consensus 163 ~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~ 209 (580)
++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 128 ---------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 128 ---------HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp ---------TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ---------CCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 37888888888888766667888999999999999886
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-18 Score=160.23 Aligned_cols=155 Identities=15% Similarity=0.155 Sum_probs=122.4
Q ss_pred hcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCccccc-CCCCCccccccc
Q 008026 38 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP-VPEFDRSVSLDM 116 (580)
Q Consensus 38 ~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~~~L~~ 116 (580)
...+++|++|++++|.|+. +|.+..+++|++|++++|.+. .+ ..+..+++|+.|+|++|++++. ++.+..+.+|+.
T Consensus 40 ~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHHTCCEEEEESSCCSC-CTTGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhhcCCccEEeccCCCccC-hHHHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 4778899999999999984 447888899999999999776 44 4788999999999999999874 456888889999
Q ss_pred ccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCC
Q 008026 117 AKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK 196 (580)
Q Consensus 117 l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~ 196 (580)
|++++|.+....+ ..+..+++|+.|++++|++.+.+| .+..++
T Consensus 117 L~Ls~n~i~~~~~------------------------------------~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~ 159 (197)
T 4ezg_A 117 LDISHSAHDDSIL------------------------------------TKINTLPKVNSIDLSYNGAITDIM-PLKTLP 159 (197)
T ss_dssp EECCSSBCBGGGH------------------------------------HHHTTCSSCCEEECCSCTBCCCCG-GGGGCS
T ss_pred EEecCCccCcHhH------------------------------------HHHhhCCCCCEEEccCCCCccccH-hhcCCC
Confidence 9999987754211 112234589999999998333676 699999
Q ss_pred CCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 197 SLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 197 ~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
+|+.|++++|+++ .++ .+..+++|++|++++|++.+
T Consensus 160 ~L~~L~l~~n~i~-~~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 160 ELKSLNIQFDGVH-DYR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SCCEEECTTBCCC-CCT-TGGGCSSCCEEEECBC----
T ss_pred CCCEEECCCCCCc-ChH-HhccCCCCCEEEeeCcccCC
Confidence 9999999999998 566 78999999999999999864
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.4e-18 Score=180.26 Aligned_cols=180 Identities=18% Similarity=0.177 Sum_probs=141.2
Q ss_pred hhcCcc-----cCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcc
Q 008026 37 VIQNMT-----SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 111 (580)
Q Consensus 37 ~~~~l~-----~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 111 (580)
.+..++ +|++|+|++|.|++.++.+ +++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|+++++ +..
T Consensus 49 ~~~~l~~C~~~~L~~L~Ls~n~L~~lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~ip~-l~~- 120 (571)
T 3cvr_A 49 AVSLLKECLINQFSELQLNRLNLSSLPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTLPE-LPA- 120 (571)
T ss_dssp HHHHHHHHHHTTCSEEECCSSCCSCCCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC-CCT-
T ss_pred hhhhccccccCCccEEEeCCCCCCccCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCcch-hhc-
Confidence 566665 9999999999999855555 389999999999999 899 558999999999999999665 655
Q ss_pred cccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCccc
Q 008026 112 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 191 (580)
Q Consensus 112 ~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~ 191 (580)
+|+.|++++|.+..+|. .. ..+....++++.+..++. .+++|+.|+|++|+|++ +|.
T Consensus 121 -~L~~L~Ls~N~l~~lp~-~l----------------~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~- 177 (571)
T 3cvr_A 121 -SLKHLDVDNNQLTMLPE-LP----------------ALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE- 177 (571)
T ss_dssp -TCCEEECCSSCCSCCCC-CC----------------TTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-
T ss_pred -CCCEEECCCCcCCCCCC-cC----------------ccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-cch-
Confidence 99999999999998876 21 234444555666655554 45689999999999995 887
Q ss_pred ccCCCCCcEEeccCCcccccCCccCcCCCCC-------CEEEccCCcccccCCCCCC----CceeecCCCCCCC
Q 008026 192 FASFKSLQRLILADNNLSGMIPEGLSVLGAL-------KELDVSNNQLYGKIPSFKS----NAIVNTDGNPDIG 254 (580)
Q Consensus 192 ~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L-------~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c 254 (580)
|. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+++ .+|..+. ...+++++|+..+
T Consensus 178 l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 178 LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 66 89999999999998 8888 665 77 99999999999 4665432 3458888888764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=2.3e-17 Score=152.12 Aligned_cols=131 Identities=20% Similarity=0.286 Sum_probs=85.2
Q ss_pred ceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCc-cccCCCCCcEEEccCCcccccCCC-CCcccccccccccCC
Q 008026 45 KEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD-SLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNN 122 (580)
Q Consensus 45 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~-~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n 122 (580)
+++++++|+++..+..+. .+|+.|+|++|+|++..|. .|..+++|+.|+|++|+|++.+|. |..+
T Consensus 11 ~~l~~s~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l----------- 77 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA----------- 77 (192)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC-----------
T ss_pred CEEEcCCCCcCcCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCc-----------
Confidence 567777777764443343 2677777777777743333 277777777777777777776553 2222
Q ss_pred CCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEe
Q 008026 123 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLI 202 (580)
Q Consensus 123 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ 202 (580)
.+|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 78 -------------------------------------------------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 78 -------------------------------------------------SHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp -------------------------------------------------TTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred -------------------------------------------------ccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 2566666666666666666666777777777
Q ss_pred ccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 203 LADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 203 ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
|++|+|++.+|..+..+++|++|+|++|++++..+
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 77777776667777777777777777777765544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.73 E-value=9e-18 Score=165.63 Aligned_cols=188 Identities=15% Similarity=0.175 Sum_probs=149.8
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
.+..+..+.+..+..... ..+..+++|++|++++|.++.. |.+..+++|+.|+|++|+++ .+|. +.++++|+.|+
T Consensus 22 ~l~~~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~-~~~~-l~~l~~L~~L~ 96 (291)
T 1h6t_A 22 AFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLF 96 (291)
T ss_dssp HHHHHHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEE
T ss_pred HHHHHHHHHhcCCCcccc--cchhhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccC-CCcc-cccCCCCCEEE
Confidence 345555555655544332 3457899999999999999865 66888999999999999999 5666 99999999999
Q ss_pred ccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEE
Q 008026 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175 (580)
Q Consensus 96 L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 175 (580)
|++|++++. +.+..+.+|+.|++++|.+..++. +..+++|+
T Consensus 97 l~~n~l~~~-~~l~~l~~L~~L~L~~n~i~~~~~--------------------------------------l~~l~~L~ 137 (291)
T 1h6t_A 97 LDENKVKDL-SSLKDLKKLKSLSLEHNGISDING--------------------------------------LVHLPQLE 137 (291)
T ss_dssp CCSSCCCCG-GGGTTCTTCCEEECTTSCCCCCGG--------------------------------------GGGCTTCC
T ss_pred CCCCcCCCC-hhhccCCCCCEEECCCCcCCCChh--------------------------------------hcCCCCCC
Confidence 999999985 458999999999999998876521 22345899
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCC---CCCceeecCCCCC
Q 008026 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF---KSNAIVNTDGNPD 252 (580)
Q Consensus 176 ~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~---~~~~~~~~~~n~~ 252 (580)
.|++++|++++ + +.++.+++|+.|+|++|++++ ++. +..+++|+.|++++|++++ +|.. .....+++.+|+.
T Consensus 138 ~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~N~l~~-~~~-l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~i 212 (291)
T 1h6t_A 138 SLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQEC 212 (291)
T ss_dssp EEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEEE
T ss_pred EEEccCCcCCc-c-hhhccCCCCCEEEccCCcccc-chh-hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCcc
Confidence 99999999995 4 579999999999999999995 444 9999999999999999986 3432 1233466677654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-18 Score=172.91 Aligned_cols=142 Identities=14% Similarity=0.136 Sum_probs=101.6
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccC------------hhhH--------HHHHHHHHHHHhcCCCc
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS------------GKGL--------TEFKSEIAVLTKVRHRH 454 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~--------~~~~~E~~~l~~l~h~n 454 (580)
.-|++.+.||+|++|.||+|...+|+.||||+++..... .... ....+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348999999999999999999889999999987542111 0001 12245666677665444
Q ss_pred ccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 455 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
+....-+.. ...++||||++|++|.++. .......++.|++.+|.|||. .+||||||||.|||+
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~-----------~~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVS-----------SVPDPASLYADLIALILRLAK---HGLIHGDFNEFNILI 238 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCC-----------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhc-----------ccHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEE
Confidence 432211111 2247999999998886543 112345678999999999997 899999999999999
Q ss_pred cCCC----------cEEEEeeccccccC
Q 008026 535 GDDM----------RAKVADFGLVRLAP 552 (580)
Q Consensus 535 ~~~~----------~~kl~Dfg~a~~~~ 552 (580)
++++ .+.|+||+-+....
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred eCCCCcccccccccceEEEEeCCcccCC
Confidence 8766 38999999776543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.72 E-value=7.9e-18 Score=181.99 Aligned_cols=188 Identities=15% Similarity=0.180 Sum_probs=152.9
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
.+..+..+.+..+.+.... .+..|++|+.|+|++|.|... |.+..|++|+.|+|++|+|+ .+|. +..|++|+.|+
T Consensus 19 ~l~~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~-~~~~-l~~l~~L~~L~ 93 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCC-CCGG-GGGCTTCCEEE
T ss_pred HHHHHHHHhccCCCccccc--chhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCC-CChh-hccCCCCCEEE
Confidence 4556666666666544432 367899999999999999854 57888999999999999999 5655 99999999999
Q ss_pred ccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEE
Q 008026 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175 (580)
Q Consensus 96 L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 175 (580)
|++|+|+++ |.+..+.+|+.|++++|.+..++. +..+++|+
T Consensus 94 Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l~~--------------------------------------l~~l~~L~ 134 (605)
T 1m9s_A 94 LDENKIKDL-SSLKDLKKLKSLSLEHNGISDING--------------------------------------LVHLPQLE 134 (605)
T ss_dssp CCSSCCCCC-TTSTTCTTCCEEECTTSCCCCCGG--------------------------------------GGGCTTCS
T ss_pred CcCCCCCCC-hhhccCCCCCEEEecCCCCCCCcc--------------------------------------ccCCCccC
Confidence 999999985 579999999999999998876431 22345899
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCC---CCCceeecCCCCC
Q 008026 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF---KSNAIVNTDGNPD 252 (580)
Q Consensus 176 ~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~---~~~~~~~~~~n~~ 252 (580)
.|+|++|++++. ..++.|++|+.|+|++|+|.+..| +..+++|+.|+|++|++++. |.. .....+.+.+|+.
T Consensus 135 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l 209 (605)
T 1m9s_A 135 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC 209 (605)
T ss_dssp EEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEE
T ss_pred EEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcC
Confidence 999999999954 689999999999999999996555 99999999999999999974 432 2234577777754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-19 Score=184.98 Aligned_cols=235 Identities=17% Similarity=0.115 Sum_probs=164.9
Q ss_pred CCCCccccccceEEecccCCCCCCCCCch----hhcCcccCceEecccC---cCcCCCC-CC-------CCCCCCcEEec
Q 008026 8 LPASFSGSQIQSLWVNGQNGNAKLGGGID----VIQNMTSLKEIWLHSN---AFSGPLP-DF-------SGVKQLESLSL 72 (580)
Q Consensus 8 ~P~~~~~~~l~~L~~~~~~~n~~~~~~~~----~~~~l~~L~~L~L~~N---~l~~~~p-~~-------~~l~~L~~L~L 72 (580)
++..+ ..+..|+.+++++|.+....+. .|.++++|++|+|++| ++++.+| .+ ..+++|++|+|
T Consensus 24 l~~~l--~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~L 101 (386)
T 2ca6_A 24 VFAVL--LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRL 101 (386)
T ss_dssp TSHHH--HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEEC
T ss_pred HHHHH--hcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEEC
Confidence 44444 4466788888888877665443 4678999999999986 4555555 23 67899999999
Q ss_pred cCCcccc----cCCccccCCCCCcEEEccCCcccccCCC-----CCcc---------cccccccccCCCCCCCCCCCchh
Q 008026 73 RDNFFTG----PVPDSLVKLESLKIVNMTNNLLQGPVPE-----FDRS---------VSLDMAKGSNNFCLPSPGACDPR 134 (580)
Q Consensus 73 ~~N~l~~----~~P~~~~~l~~L~~L~L~~N~l~~~~~~-----~~~~---------~~L~~l~l~~n~~~~~~~~~~~~ 134 (580)
++|++.+ .+|..+..+++|+.|+|++|.++...+. +..+ .+|+.|++++|.+... .
T Consensus 102 s~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~------~ 175 (386)
T 2ca6_A 102 SDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG------S 175 (386)
T ss_dssp CSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG------G
T ss_pred CCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcH------H
Confidence 9999986 4788899999999999999998755442 2333 7899999999987521 1
Q ss_pred HHHHHHHHHhhCCccccccccCCCCCCCC------ccceeccCCcEEEEEecCCccc----ccCcccccCCCCCcEEecc
Q 008026 135 LNALLSVVKLMGYPQRFAENWKGNDPCSD------WIGVTCTKGNITVINFQKMNLT----GTISPEFASFKSLQRLILA 204 (580)
Q Consensus 135 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~L~~L~ls~n~l~----~~~p~~~~~l~~L~~L~ls 204 (580)
+..+. ..+.....+....+.++...+ .+..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|+
T Consensus 176 ~~~l~---~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~ 252 (386)
T 2ca6_A 176 MKEWA---KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252 (386)
T ss_dssp HHHHH---HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred HHHHH---HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence 22111 111122234444455554431 1225566778999999999996 6788889999999999999
Q ss_pred CCccccc----CCccCc--CCCCCCEEEccCCcccc----cCCCCC-----CCceeecCCCCCC
Q 008026 205 DNNLSGM----IPEGLS--VLGALKELDVSNNQLYG----KIPSFK-----SNAIVNTDGNPDI 253 (580)
Q Consensus 205 ~N~l~g~----~p~~l~--~l~~L~~l~ls~N~l~g----~~p~~~-----~~~~~~~~~n~~~ 253 (580)
+|++++. +|..+. .+++|+.|+|++|++++ .+|..+ ....+++.+|+..
T Consensus 253 ~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 9999865 566663 48999999999999997 466543 2345777777643
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-19 Score=182.23 Aligned_cols=213 Identities=18% Similarity=0.139 Sum_probs=148.1
Q ss_pred ccceEEecccCCCCCCCCCchhh-------cCcccCceEecccCcCcC----CCC-CCCCCCCCcEEeccCCcccccCCc
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVI-------QNMTSLKEIWLHSNAFSG----PLP-DFSGVKQLESLSLRDNFFTGPVPD 83 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~-------~~l~~L~~L~L~~N~l~~----~~p-~~~~l~~L~~L~L~~N~l~~~~P~ 83 (580)
+|+.|.+.++..+++.+..|..+ .++++|++|+|++|.|++ .+| .+..+++|+.|+|++|++.+..+.
T Consensus 61 ~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~ 140 (386)
T 2ca6_A 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA 140 (386)
T ss_dssp TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH
T ss_pred CccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHH
Confidence 34444444443344555556444 688889999999998887 244 467788899999999988643333
Q ss_pred c----ccCC---------CCCcEEEccCCccc-ccCC----CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHH-h
Q 008026 84 S----LVKL---------ESLKIVNMTNNLLQ-GPVP----EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK-L 144 (580)
Q Consensus 84 ~----~~~l---------~~L~~L~L~~N~l~-~~~~----~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~-~ 144 (580)
. +..+ ++|+.|+|++|+++ +..+ .+..+.+|+.|++++|.+... .+..+.. .
T Consensus 141 ~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~---------g~~~l~~~~ 211 (386)
T 2ca6_A 141 KIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE---------GIEHLLLEG 211 (386)
T ss_dssp HHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH---------HHHHHHHTT
T ss_pred HHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh---------HHHHHHHHH
Confidence 3 3334 88999999999887 3333 355677888888888876511 1111111 2
Q ss_pred hCCccccccccCCCCCC-----CCccceeccCCcEEEEEecCCccccc----Ccccc--cCCCCCcEEeccCCcccc---
Q 008026 145 MGYPQRFAENWKGNDPC-----SDWIGVTCTKGNITVINFQKMNLTGT----ISPEF--ASFKSLQRLILADNNLSG--- 210 (580)
Q Consensus 145 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~L~~L~ls~n~l~~~----~p~~~--~~l~~L~~L~ls~N~l~g--- 210 (580)
+.....+....+.++.. ..++..+..+++|+.|+|++|++++. +|..+ +.+++|+.|+|++|++++
T Consensus 212 l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~ 291 (386)
T 2ca6_A 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 291 (386)
T ss_dssp GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH
T ss_pred hhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHH
Confidence 23334444555555554 23455566778999999999999976 67777 449999999999999996
Q ss_pred -cCCccC-cCCCCCCEEEccCCcccccCC
Q 008026 211 -MIPEGL-SVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 211 -~~p~~l-~~l~~L~~l~ls~N~l~g~~p 237 (580)
.+|..+ .++++|++|++++|++++..|
T Consensus 292 ~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 292 RTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 488888 668999999999999997664
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.4e-19 Score=182.90 Aligned_cols=124 Identities=15% Similarity=0.087 Sum_probs=96.5
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCc----hhhcCcc-cCceEecccCcCcCCCC-CCCCC-----CCCcEE
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI----DVIQNMT-SLKEIWLHSNAFSGPLP-DFSGV-----KQLESL 70 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p-~~~~l-----~~L~~L 70 (580)
|+++|.+|+.+ .....|+.+++++|.+....+ ..|.+++ +|++|+|++|.|++..+ .+..+ ++|+.|
T Consensus 8 n~~~~~~~~~~--~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L 85 (362)
T 3goz_A 8 HPGSNPVEEFT--SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSL 85 (362)
T ss_dssp CTTCCHHHHHH--TSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEE
T ss_pred ccchHHHHHHH--hCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEE
Confidence 67888888876 335557778888887777666 7788888 89999999999998766 34443 899999
Q ss_pred eccCCcccccCCccccCC-----CCCcEEEccCCcccccCCC-----CCc-ccccccccccCCCCCCC
Q 008026 71 SLRDNFFTGPVPDSLVKL-----ESLKIVNMTNNLLQGPVPE-----FDR-SVSLDMAKGSNNFCLPS 127 (580)
Q Consensus 71 ~L~~N~l~~~~P~~~~~l-----~~L~~L~L~~N~l~~~~~~-----~~~-~~~L~~l~l~~n~~~~~ 127 (580)
+|++|++++..+..+... ++|+.|+|++|++++..+. +.. ..+|+.|++++|.+...
T Consensus 86 ~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 153 (362)
T 3goz_A 86 NLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153 (362)
T ss_dssp ECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGS
T ss_pred ECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHH
Confidence 999999996666654443 8999999999999887763 223 36899999999987643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.1e-18 Score=164.76 Aligned_cols=167 Identities=13% Similarity=0.194 Sum_probs=142.1
Q ss_pred CcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccc
Q 008026 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 119 (580)
Q Consensus 40 ~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l 119 (580)
++..++.+++++|.++... .+..+++|+.|++++|+++ .+| .+..+++|+.|+|++|++++.++ +..+.+|+.|++
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L 92 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEEC
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEEC
Confidence 5778889999999999655 6778999999999999999 788 79999999999999999999888 999999999999
Q ss_pred cCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCc
Q 008026 120 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQ 199 (580)
Q Consensus 120 ~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~ 199 (580)
++|.+..+++... .+|+.|+|++|++++ +| .+..+++|+
T Consensus 93 ~~N~l~~l~~~~~---------------------------------------~~L~~L~L~~N~l~~-~~-~l~~l~~L~ 131 (263)
T 1xeu_A 93 NRNRLKNLNGIPS---------------------------------------ACLSRLFLDNNELRD-TD-SLIHLKNLE 131 (263)
T ss_dssp CSSCCSCCTTCCC---------------------------------------SSCCEEECCSSCCSB-SG-GGTTCTTCC
T ss_pred CCCccCCcCcccc---------------------------------------CcccEEEccCCccCC-Ch-hhcCccccc
Confidence 9999887654211 389999999999995 54 699999999
Q ss_pred EEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCC---CCceeecCCCCCCC
Q 008026 200 RLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK---SNAIVNTDGNPDIG 254 (580)
Q Consensus 200 ~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~---~~~~~~~~~n~~~c 254 (580)
.|+|++|+++ .+| .+..+++|+.|++++|++++. +... ....+++.+|++.|
T Consensus 132 ~L~Ls~N~i~-~~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 132 ILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp EEECTTSCCC-BCG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEEC
T ss_pred EEECCCCcCC-CCh-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccC
Confidence 9999999999 455 699999999999999999976 3221 23457777777544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-19 Score=194.49 Aligned_cols=180 Identities=14% Similarity=0.125 Sum_probs=142.4
Q ss_pred cceEEecccCCCCCCCCCchhhcCcccCceEecccCc-------------CcCCCC-CCCCCCCCcEEe-ccCCcccccC
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA-------------FSGPLP-DFSGVKQLESLS-LRDNFFTGPV 81 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~p-~~~~l~~L~~L~-L~~N~l~~~~ 81 (580)
++.|..++++.|++ +.+|+.+++|++|+.|++++|. +.+.+| .+..+++|+.|+ ++.|.+. .+
T Consensus 348 ~~~L~~L~Ls~n~L-~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-~L 425 (567)
T 1dce_A 348 DEQLFRCELSVEKS-TVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-DL 425 (567)
T ss_dssp TTTSSSCCCCHHHH-HHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-HH
T ss_pred CccceeccCChhhH-HhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-hh
Confidence 45666777877754 5778899999999999997775 556666 367788888888 6666544 33
Q ss_pred Cc------cccC--CCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCcccccc
Q 008026 82 PD------SLVK--LESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153 (580)
Q Consensus 82 P~------~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~ 153 (580)
+. .+.. ...|+.|+|++|+|++++ .+..+.+|+.|++++|.+..+|.
T Consensus 426 ~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp-~~~~l~~L~~L~Ls~N~l~~lp~------------------------ 480 (567)
T 1dce_A 426 RSKFLLENSVLKMEYADVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPP------------------------ 480 (567)
T ss_dssp HHHHHHHHHHHHHHHTTCSEEECTTSCCSSCC-CGGGGTTCCEEECCSSCCCCCCG------------------------
T ss_pred hhhhhhcccccccCccCceEEEecCCCCCCCc-CccccccCcEeecCcccccccch------------------------
Confidence 32 1111 125899999999999865 48999999999999998886653
Q ss_pred ccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccC-CccCcCCCCCCEEEccCCcc
Q 008026 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI-PEGLSVLGALKELDVSNNQL 232 (580)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~l~~l~~L~~l~ls~N~l 232 (580)
.++.+++|+.|+|++|+|++ +| .+++|++|+.|+|++|+|++.. |..++.+++|+.|+|++|++
T Consensus 481 -------------~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l 545 (567)
T 1dce_A 481 -------------ALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545 (567)
T ss_dssp -------------GGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred -------------hhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence 23345699999999999995 78 8999999999999999999766 99999999999999999999
Q ss_pred cccCCC
Q 008026 233 YGKIPS 238 (580)
Q Consensus 233 ~g~~p~ 238 (580)
++.+|.
T Consensus 546 ~~~~~~ 551 (567)
T 1dce_A 546 CQEEGI 551 (567)
T ss_dssp GGSSSC
T ss_pred CCCccH
Confidence 988764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.68 E-value=4.4e-18 Score=188.54 Aligned_cols=144 Identities=15% Similarity=0.104 Sum_probs=80.0
Q ss_pred CchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccc
Q 008026 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS 113 (580)
Q Consensus 34 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 113 (580)
.++.|..++.|++|+|++|.|..+++.+..+++|++|+|++|+|+ .+|..|++|++|+.|+|++|+|+.+++.|..+.+
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~ 294 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQ 294 (727)
T ss_dssp ------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTT
T ss_pred ChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCC
Confidence 345566666666666666666643334555666666666666666 6666666666666666666666655445666666
Q ss_pred cccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCccccc
Q 008026 114 LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA 193 (580)
Q Consensus 114 L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~ 193 (580)
|+.|++++|.+..+|.. +..+.+|+.|+|++|.|++.+|..+.
T Consensus 295 L~~L~L~~N~l~~lp~~-------------------------------------~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (727)
T 4b8c_D 295 LKYFYFFDNMVTTLPWE-------------------------------------FGNLCNLQFLGVEGNPLEKQFLKILT 337 (727)
T ss_dssp CSEEECCSSCCCCCCSS-------------------------------------TTSCTTCCCEECTTSCCCSHHHHHHH
T ss_pred CCEEECCCCCCCccChh-------------------------------------hhcCCCccEEeCCCCccCCCChHHHh
Confidence 66666666655544432 11233566666666666666665554
Q ss_pred CCCC-CcEEeccCCcccccCCcc
Q 008026 194 SFKS-LQRLILADNNLSGMIPEG 215 (580)
Q Consensus 194 ~l~~-L~~L~ls~N~l~g~~p~~ 215 (580)
.+.. +..|+|++|.++|.+|.+
T Consensus 338 ~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 338 EKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp HHHHHHHHHHHHHCCCCCCCCCC
T ss_pred hcchhhhHHhhccCcccCcCccc
Confidence 4322 123556666666655543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=162.47 Aligned_cols=209 Identities=15% Similarity=0.078 Sum_probs=156.8
Q ss_pred cccccCCCC-CccccccceEEecccCCCCCCCCCc-hhhcCcccCce-EecccCcCcCCCCC-CCCCCCCcEEeccCCcc
Q 008026 2 LQLIGGLPA-SFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKE-IWLHSNAFSGPLPD-FSGVKQLESLSLRDNFF 77 (580)
Q Consensus 2 ~~~~~~~P~-~~~~~~l~~L~~~~~~~n~~~~~~~-~~~~~l~~L~~-L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l 77 (580)
|+|+ .||. .| .++..|+.+++++|++.+.+| ++|.++++|++ ++++.|+|+...|+ |..+++|++|++++|+|
T Consensus 40 N~i~-~i~~~~f--~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l 116 (350)
T 4ay9_X 40 TKLR-VIQKGAF--SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 116 (350)
T ss_dssp CCCS-EECTTSS--TTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECC
T ss_pred CcCC-CcCHHHH--cCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccccc
Confidence 5555 5664 67 568888889999998877665 67899998775 67788999988884 88999999999999999
Q ss_pred cccCCccccCCCCCcEEEccC-CcccccCCC-CCccc-ccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccc
Q 008026 78 TGPVPDSLVKLESLKIVNMTN-NLLQGPVPE-FDRSV-SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154 (580)
Q Consensus 78 ~~~~P~~~~~l~~L~~L~L~~-N~l~~~~~~-~~~~~-~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~ 154 (580)
.+..+..+....++..|++.+ |++..+++. |..+. .++.|++++|.+..+++..+.
T Consensus 117 ~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~--------------------- 175 (350)
T 4ay9_X 117 KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFN--------------------- 175 (350)
T ss_dssp SSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSST---------------------
T ss_pred ccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhcc---------------------
Confidence 944444577888899999976 678877765 55554 588999999999988876552
Q ss_pred cCCCCCCCCccceeccCCcEEEEEecC-CcccccCcc-cccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcc
Q 008026 155 WKGNDPCSDWIGVTCTKGNITVINFQK-MNLTGTISP-EFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 232 (580)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~L~~L~ls~-n~l~~~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l 232 (580)
..+|+.|++++ |.+. .+|. .|..+++|+.|||++|+|+ .+|.. .+.+|+.|.+.++.-
T Consensus 176 ----------------~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~--~~~~L~~L~~l~~~~ 235 (350)
T 4ay9_X 176 ----------------GTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSY--GLENLKKLRARSTYN 235 (350)
T ss_dssp ----------------TEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCC-CCCSS--SCTTCCEEECTTCTT
T ss_pred ----------------ccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcC-ccChh--hhccchHhhhccCCC
Confidence 12799999986 5555 6765 5789999999999999999 77763 356677777666655
Q ss_pred cccCCCCCC---CceeecCCCCCCCC
Q 008026 233 YGKIPSFKS---NAIVNTDGNPDIGK 255 (580)
Q Consensus 233 ~g~~p~~~~---~~~~~~~~n~~~c~ 255 (580)
...+|+... ...+.+ .|++.|.
T Consensus 236 l~~lP~l~~l~~L~~l~l-~~~~~c~ 260 (350)
T 4ay9_X 236 LKKLPTLEKLVALMEASL-TYPSHCC 260 (350)
T ss_dssp CCCCCCTTTCCSCCEEEC-SCHHHHH
T ss_pred cCcCCCchhCcChhhCcC-CCCcccc
Confidence 557775422 223333 4666664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-18 Score=187.08 Aligned_cols=174 Identities=14% Similarity=0.073 Sum_probs=139.4
Q ss_pred cCCCCCccccccceEEecccCCCC-------------CCCCCchhhcCcccCceEe-cccCc-------------CcCCC
Q 008026 6 GGLPASFSGSQIQSLWVNGQNGNA-------------KLGGGIDVIQNMTSLKEIW-LHSNA-------------FSGPL 58 (580)
Q Consensus 6 ~~~P~~~~~~~l~~L~~~~~~~n~-------------~~~~~~~~~~~l~~L~~L~-L~~N~-------------l~~~~ 58 (580)
..+|++| .+++.|+.++++.|. ..+..|..+.+|++|+.|+ ++.|. |+..+
T Consensus 362 ~~Lp~~i--~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~ 439 (567)
T 1dce_A 362 TVLQSEL--ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKME 439 (567)
T ss_dssp HHHHHHH--HHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred HhhHHHH--HHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhhhhhcccccccC
Confidence 4688888 567788888876654 4556667888888888888 55553 33322
Q ss_pred CCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHH
Q 008026 59 PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 138 (580)
Q Consensus 59 p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l 138 (580)
+ ..|+.|+|++|+|+ .+|. |+.+++|+.|+|++|+|+.+|+.+..+.+|+.|++++|.+..+|
T Consensus 440 ~-----~~L~~L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~lp---------- 502 (567)
T 1dce_A 440 Y-----ADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD---------- 502 (567)
T ss_dssp H-----TTCSEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG----------
T ss_pred c-----cCceEEEecCCCCC-CCcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCCCc----------
Confidence 2 25899999999999 5887 99999999999999999977778999999999999999887654
Q ss_pred HHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccC-cccccCCCCCcEEeccCCcccccCCccC-
Q 008026 139 LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI-SPEFASFKSLQRLILADNNLSGMIPEGL- 216 (580)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~l- 216 (580)
.++.+++|+.|+|++|+|++.. |..++.|++|+.|+|++|+|++..| .+
T Consensus 503 ----------------------------~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~ 553 (567)
T 1dce_A 503 ----------------------------GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG-IQE 553 (567)
T ss_dssp ----------------------------GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS-CTT
T ss_pred ----------------------------ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc-HHH
Confidence 1233458999999999999776 9999999999999999999995544 33
Q ss_pred ---cCCCCCCEEEc
Q 008026 217 ---SVLGALKELDV 227 (580)
Q Consensus 217 ---~~l~~L~~l~l 227 (580)
..+++|+.||+
T Consensus 554 ~l~~~lp~L~~L~l 567 (567)
T 1dce_A 554 RLAEMLPSVSSILT 567 (567)
T ss_dssp HHHHHCTTCSEEEC
T ss_pred HHHHHCcccCccCC
Confidence 33889999975
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=4.9e-16 Score=143.19 Aligned_cols=126 Identities=22% Similarity=0.317 Sum_probs=103.1
Q ss_pred ceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCC
Q 008026 45 KEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNF 123 (580)
Q Consensus 45 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~ 123 (580)
+++++++|.++..++.+. ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|+++++. |..+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l------------ 77 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNM------------ 77 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTC------------
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCC------------
Confidence 678999999986654443 68999999999998 8998899999999999999999887764 2222
Q ss_pred CCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEec
Q 008026 124 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 203 (580)
Q Consensus 124 ~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l 203 (580)
.+|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 78 ------------------------------------------------~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 78 ------------------------------------------------TQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp ------------------------------------------------TTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred ------------------------------------------------CCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 37888889999999777778999999999999
Q ss_pred cCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 204 ADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 204 s~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
++|+|++..+..+..+++|+.|+|++|++.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 999999544456888999999988777665
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-17 Score=183.69 Aligned_cols=184 Identities=14% Similarity=0.034 Sum_probs=119.1
Q ss_pred CCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccC
Q 008026 8 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVK 87 (580)
Q Consensus 8 ~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~ 87 (580)
.|..| ..+..|+.|++++|.+. .+|..+.++++|++|+|++|.|+.+++.|.+|++|++|+|++|+|+ .+|..|++
T Consensus 216 ~~~~~--~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 216 PKDSK--YDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp --------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred Chhhh--ccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 35566 56788889999999765 6777788999999999999999944446999999999999999999 89999999
Q ss_pred CCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccce
Q 008026 88 LESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV 167 (580)
Q Consensus 88 l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (580)
|++|++|+|++|.|+.+++.|..+.+|+.|++++|.+...++..+..+..
T Consensus 292 l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~------------------------------ 341 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV------------------------------ 341 (727)
T ss_dssp GTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHH------------------------------
T ss_pred CCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcch------------------------------
Confidence 99999999999999988888999999999999999988665544332211
Q ss_pred eccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCC--------cccccCCccCcCCCCCCEEEccCCcccccC
Q 008026 168 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADN--------NLSGMIPEGLSVLGALKELDVSNNQLYGKI 236 (580)
Q Consensus 168 ~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N--------~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~ 236 (580)
.+..|+|++|.+++.+|.++ ..|++++| .|.+.++..+.++..+....+++|-+.+..
T Consensus 342 -----~~~~l~l~~N~l~~~~p~~l------~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~ 407 (727)
T 4b8c_D 342 -----TGLIFYLRDNRPEIPLPHER------RFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHY 407 (727)
T ss_dssp -----HHHHHHHHHCCCCCCCCCC-----------------------------------------------CCCGGG
T ss_pred -----hhhHHhhccCcccCcCcccc------ceeEeecccccccccCCccccccchhhcccccceeeeecccccccc
Confidence 11125677888888887654 44555555 444444555566777777788888776443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.7e-16 Score=144.95 Aligned_cols=130 Identities=16% Similarity=0.170 Sum_probs=110.7
Q ss_pred cEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCC
Q 008026 68 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 147 (580)
Q Consensus 68 ~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~ 147 (580)
+.+++++|++. .+|..+.. +|+.|+|++|+++++++.-
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~--------------------------------------- 48 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDG--------------------------------------- 48 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSC---------------------------------------
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCcc---------------------------------------
Confidence 78999999997 89987754 8999999999998877630
Q ss_pred ccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEc
Q 008026 148 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 227 (580)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~l 227 (580)
.+..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|++|+|
T Consensus 49 -------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 49 -------------------LFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp -------------------SGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred -------------------ccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 0112237999999999999888999999999999999999999888888999999999999
Q ss_pred cCCcccccCCCCCC----CceeecCCCCCCCCCCC
Q 008026 228 SNNQLYGKIPSFKS----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 228 s~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~~ 258 (580)
++|++++.+|..+. ...+++++|+|.|.++.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 99999999887764 34689999999998753
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-16 Score=146.50 Aligned_cols=148 Identities=11% Similarity=0.084 Sum_probs=122.2
Q ss_pred CCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHH
Q 008026 62 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSV 141 (580)
Q Consensus 62 ~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~ 141 (580)
..+++|+.|++++|++. .+| .+..+++|+.|++++|.++.. +.+..+.+|+.|++++|.+....+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~----------- 106 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIP----------- 106 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSC-----------
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccCh-----------
Confidence 55889999999999999 888 799999999999999977654 4688899999999999987642221
Q ss_pred HHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCc-ccccCCccCcCCC
Q 008026 142 VKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN-LSGMIPEGLSVLG 220 (580)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~l~~l~ 220 (580)
.+..+++|+.|++++|++++..|..++.+++|++|+|++|+ +. .+| .+..++
T Consensus 107 -------------------------~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~ 159 (197)
T 4ezg_A 107 -------------------------NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLP 159 (197)
T ss_dssp -------------------------CCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCS
T ss_pred -------------------------hhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCC
Confidence 22344599999999999998899999999999999999998 65 777 699999
Q ss_pred CCCEEEccCCcccccCCCC---CCCceeecCCCC
Q 008026 221 ALKELDVSNNQLYGKIPSF---KSNAIVNTDGNP 251 (580)
Q Consensus 221 ~L~~l~ls~N~l~g~~p~~---~~~~~~~~~~n~ 251 (580)
+|+.|++++|++++. +.. .....+++.+|+
T Consensus 160 ~L~~L~l~~n~i~~~-~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 160 ELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp SCCEEECTTBCCCCC-TTGGGCSSCCEEEECBC-
T ss_pred CCCEEECCCCCCcCh-HHhccCCCCCEEEeeCcc
Confidence 999999999999963 322 123457777775
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.67 E-value=4.3e-18 Score=173.60 Aligned_cols=125 Identities=15% Similarity=0.098 Sum_probs=94.5
Q ss_pred cccccCCC----CCccccccc-eEEecccCCCCCCCCCchhhcCc-----ccCceEecccCcCcCCCCC-----CCCC-C
Q 008026 2 LQLIGGLP----ASFSGSQIQ-SLWVNGQNGNAKLGGGIDVIQNM-----TSLKEIWLHSNAFSGPLPD-----FSGV-K 65 (580)
Q Consensus 2 ~~~~~~~P----~~~~~~~l~-~L~~~~~~~n~~~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~-----~~~l-~ 65 (580)
|++.+.-+ +.| .++. .|+.+++++|.+....+..|..+ ++|++|+|++|.+++..+. +..+ +
T Consensus 32 n~l~~~~~~~l~~~l--~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~ 109 (362)
T 3goz_A 32 NNLYSISTVELIQAF--ANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPF 109 (362)
T ss_dssp SCGGGSCHHHHHHHH--HTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred CCCChHHHHHHHHHH--HhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCC
Confidence 55555555 344 3455 78888899998888778777776 9999999999999987764 4445 8
Q ss_pred CCcEEeccCCcccccCCccccC-----CCCCcEEEccCCcccccCCC-----CCccc-ccccccccCCCCCCCC
Q 008026 66 QLESLSLRDNFFTGPVPDSLVK-----LESLKIVNMTNNLLQGPVPE-----FDRSV-SLDMAKGSNNFCLPSP 128 (580)
Q Consensus 66 ~L~~L~L~~N~l~~~~P~~~~~-----l~~L~~L~L~~N~l~~~~~~-----~~~~~-~L~~l~l~~n~~~~~~ 128 (580)
+|+.|+|++|+|++..+..+.. .++|++|+|++|+++..... +.... +|+.|++++|.+....
T Consensus 110 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~ 183 (362)
T 3goz_A 110 TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN 183 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC
T ss_pred CccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhh
Confidence 9999999999999655545443 36999999999999864432 23343 8999999999887654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-17 Score=166.09 Aligned_cols=195 Identities=16% Similarity=0.120 Sum_probs=123.0
Q ss_pred ecccCCCCCCCCCchhhcCc--ccCceEecccCcCcCCCCCCCCCCCCcEEeccCCccccc-CCccccCCCCCcEEEccC
Q 008026 22 VNGQNGNAKLGGGIDVIQNM--TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGP-VPDSLVKLESLKIVNMTN 98 (580)
Q Consensus 22 ~~~~~~n~~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~-~P~~~~~l~~L~~L~L~~ 98 (580)
.++++.+.+. +..+..+ +.++.|++++|.+++.++.+..+++|+.|+|++|.+++. +|..+..+++|+.|+|++
T Consensus 51 ~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~ 127 (336)
T 2ast_B 51 TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 127 (336)
T ss_dssp EEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred eeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcC
Confidence 3444444333 5566666 778888888888887777766778888888888887754 777778888888888888
Q ss_pred CcccccCC-CCCcccccccccccCC-CCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCC-CCCC--ccceeccCC-
Q 008026 99 NLLQGPVP-EFDRSVSLDMAKGSNN-FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND-PCSD--WIGVTCTKG- 172 (580)
Q Consensus 99 N~l~~~~~-~~~~~~~L~~l~l~~n-~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~- 172 (580)
|.+++..+ .+..+.+|+.|++++| .+... .+.. ....+..+....+.++ ...+ ++..+..++
T Consensus 128 ~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~------~l~~------~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~ 195 (336)
T 2ast_B 128 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF------ALQT------LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE 195 (336)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHH------HHHH------HHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCT
T ss_pred cccCHHHHHHHhcCCCCCEEECCCCCCCCHH------HHHH------HHhcCCCCCEEcCCCCCCcChHHHHHHHHhccc
Confidence 87775544 3666777888888877 33310 1111 1111222333333333 2221 233445556
Q ss_pred cEEEEEecCC--ccc-ccCcccccCCCCCcEEeccCCc-ccccCCccCcCCCCCCEEEccCCc
Q 008026 173 NITVINFQKM--NLT-GTISPEFASFKSLQRLILADNN-LSGMIPEGLSVLGALKELDVSNNQ 231 (580)
Q Consensus 173 ~L~~L~ls~n--~l~-~~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~l~~l~~L~~l~ls~N~ 231 (580)
+|+.|++++| .++ +.+|..+.++++|+.|+|++|. +++..+..+..+++|++|++++|.
T Consensus 196 ~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 196 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp TCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 7777777777 344 4566666677777777777777 555666677777777777777774
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.65 E-value=7.5e-18 Score=169.93 Aligned_cols=198 Identities=17% Similarity=0.090 Sum_probs=113.5
Q ss_pred ceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCC-CC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 18 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGP-LP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 18 ~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
..|+.++++.|.+.+..+ .+.++++|++|+|++|.+++. +| .+..+++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccch-hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 334444444443333322 244556666666666665543 33 245556666666666665555555566666666666
Q ss_pred ccCC-ccccc-CC-CCCcccccccccccCC-CCCCCCCCCchhHHHHHHHHHhhCCcc-ccccccCCCCC--C--CCccc
Q 008026 96 MTNN-LLQGP-VP-EFDRSVSLDMAKGSNN-FCLPSPGACDPRLNALLSVVKLMGYPQ-RFAENWKGNDP--C--SDWIG 166 (580)
Q Consensus 96 L~~N-~l~~~-~~-~~~~~~~L~~l~l~~n-~~~~~~~~~~~~l~~l~~~~~~~~~~~-~~~~~~~~~~~--~--~~~~~ 166 (580)
|++| .+++. ++ .+..+.+|+.|++++| .+... .+. .....++ .+....+.++. . ..++.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~------~~~------~~~~~l~~~L~~L~l~~~~~~~~~~~l~~ 216 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK------HVQ------VAVAHVSETITQLNLSGYRKNLQKSDLST 216 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH------HHH------HHHHHSCTTCCEEECCSCGGGSCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH------HHH------HHHHhcccCCCEEEeCCCcccCCHHHHHH
Confidence 6666 45431 22 2445555666666655 43310 000 0011111 22222233221 1 11233
Q ss_pred eeccCCcEEEEEecCCc-ccccCcccccCCCCCcEEeccCCcccccCCc---cCcCCCCCCEEEccCC
Q 008026 167 VTCTKGNITVINFQKMN-LTGTISPEFASFKSLQRLILADNNLSGMIPE---GLSVLGALKELDVSNN 230 (580)
Q Consensus 167 ~~~~~~~L~~L~ls~n~-l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~---~l~~l~~L~~l~ls~N 230 (580)
.+..+++|+.|++++|. +++..+..+.++++|+.|+|++|. +..|. .+..+++|+.|++++|
T Consensus 217 ~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 217 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp HHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS
T ss_pred HHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc
Confidence 44456799999999999 777888899999999999999996 23343 5888999999999999
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2e-16 Score=142.46 Aligned_cols=131 Identities=22% Similarity=0.255 Sum_probs=93.7
Q ss_pred CcccCceEecccCcCc-CCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccc
Q 008026 40 NMTSLKEIWLHSNAFS-GPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMA 117 (580)
Q Consensus 40 ~l~~L~~L~L~~N~l~-~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l 117 (580)
..++|++|+|++|.++ +.+| .+..+++|++|+|++|+++ .+ ..+..+++|+.|+|++|++++.+|.+..
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------- 92 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAE------- 92 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-CC-SSCCCCSSCCEEEEESCCCCSCCCHHHH-------
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-Ch-hhhccCCCCCEEECcCCcCchHHHHHHh-------
Confidence 3467888888888887 5555 4677888888888888888 44 6788888888888888888876553111
Q ss_pred cccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCc--ccccCC
Q 008026 118 KGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS--PEFASF 195 (580)
Q Consensus 118 ~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p--~~~~~l 195 (580)
.+++|+.|+|++|++++ +| ..+..+
T Consensus 93 ----------------------------------------------------~l~~L~~L~Ls~N~l~~-~~~~~~l~~l 119 (168)
T 2ell_A 93 ----------------------------------------------------KLPNLTHLNLSGNKLKD-ISTLEPLKKL 119 (168)
T ss_dssp ----------------------------------------------------HCTTCCEEECBSSSCCS-SGGGGGGSSC
T ss_pred ----------------------------------------------------hCCCCCEEeccCCccCc-chhHHHHhcC
Confidence 12366777777777763 33 567777
Q ss_pred CCCcEEeccCCcccccCCc----cCcCCCCCCEEEccCCccc
Q 008026 196 KSLQRLILADNNLSGMIPE----GLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 196 ~~L~~L~ls~N~l~g~~p~----~l~~l~~L~~l~ls~N~l~ 233 (580)
++|+.|++++|+++ .+|. .+..+++|++|++++|.+.
T Consensus 120 ~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 120 ECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp SCCCEEECCSSGGG-TSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred CCCCEEEeeCCcCc-chHHHHHHHHHhCccCcEecCCCCChh
Confidence 77777777777777 4443 6777777777777777776
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.8e-16 Score=140.68 Aligned_cols=112 Identities=19% Similarity=0.222 Sum_probs=96.9
Q ss_pred CCCCcEEeccCCccc-ccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHH
Q 008026 64 VKQLESLSLRDNFFT-GPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVV 142 (580)
Q Consensus 64 l~~L~~L~L~~N~l~-~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~ 142 (580)
.++|+.|+|++|+++ +.+|..+..+++|+.|+|++|.+++. +.+..
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~-------------------------------- 69 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPK-------------------------------- 69 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCC--------------------------------
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhcc--------------------------------
Confidence 478999999999998 78999899999999999999998876 33322
Q ss_pred HhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCC--ccCcCCC
Q 008026 143 KLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP--EGLSVLG 220 (580)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~l~~l~ 220 (580)
+++|+.|+|++|++.+.+|..+.++++|+.|+|++|+++ .+| ..+..++
T Consensus 70 ----------------------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~l~~l~ 120 (168)
T 2ell_A 70 ----------------------------LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLE 120 (168)
T ss_dssp ----------------------------CSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCC-SSGGGGGGSSCS
T ss_pred ----------------------------CCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccC-cchhHHHHhcCC
Confidence 237889999999999778888888999999999999998 554 7899999
Q ss_pred CCCEEEccCCcccccCC
Q 008026 221 ALKELDVSNNQLYGKIP 237 (580)
Q Consensus 221 ~L~~l~ls~N~l~g~~p 237 (580)
+|++|++++|++++..+
T Consensus 121 ~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 121 CLKSLDLFNCEVTNLND 137 (168)
T ss_dssp CCCEEECCSSGGGTSTT
T ss_pred CCCEEEeeCCcCcchHH
Confidence 99999999999997655
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-15 Score=138.16 Aligned_cols=133 Identities=19% Similarity=0.215 Sum_probs=100.6
Q ss_pred cCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCC-CcccccccccccC
Q 008026 43 SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF-DRSVSLDMAKGSN 121 (580)
Q Consensus 43 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~L~~l~l~~ 121 (580)
+.+.+++++|+++..+..+ .++|+.|+|++|++++..|..|..+++|+.|+|++|++++.++.. ..
T Consensus 8 ~~~~l~~~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~----------- 74 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDK----------- 74 (177)
T ss_dssp ETTEEECCSSCCSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT-----------
T ss_pred CCCEEEecCCCCccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccC-----------
Confidence 3567888888888655443 367888888888888444445788888888888888888766541 22
Q ss_pred CCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEE
Q 008026 122 NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL 201 (580)
Q Consensus 122 n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L 201 (580)
+.+|+.|+|++|++++..+..+..+++|+.|
T Consensus 75 -------------------------------------------------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 105 (177)
T 2o6r_A 75 -------------------------------------------------LTKLTILYLHENKLQSLPNGVFDKLTQLKEL 105 (177)
T ss_dssp -------------------------------------------------CTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred -------------------------------------------------CCccCEEECCCCCccccCHHHhhCCcccCEE
Confidence 2367888888888886666667889999999
Q ss_pred eccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 202 ILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 202 ~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
+|++|++++..+..+..+++|++|++++|++++..|
T Consensus 106 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 106 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999999984444456789999999999999987665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=140.28 Aligned_cols=128 Identities=15% Similarity=0.182 Sum_probs=106.1
Q ss_pred cEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCC
Q 008026 68 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 147 (580)
Q Consensus 68 ~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~ 147 (580)
+++++++|+++ .+|..+. ++|+.|+|++|+|+.+++.|..
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~------------------------------------- 52 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSN------------------------------------- 52 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGG-------------------------------------
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhc-------------------------------------
Confidence 67899999998 8887763 6889999999988855433222
Q ss_pred ccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEc
Q 008026 148 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 227 (580)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~l 227 (580)
+.+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus 53 -----------------------l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 53 -----------------------YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp -----------------------CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred -----------------------ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 237889999999999777788999999999999999999777788999999999999
Q ss_pred cCCcccccCCCCCC----CceeecCCCCCCCCCCC
Q 008026 228 SNNQLYGKIPSFKS----NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 228 s~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~~ 258 (580)
++|++++..+..+. ...+.+.+|+|.|+|..
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 99999976665443 35689999999998864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=5.4e-16 Score=136.66 Aligned_cols=129 Identities=21% Similarity=0.253 Sum_probs=102.5
Q ss_pred CcccCceEecccCcCc-CCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccc
Q 008026 40 NMTSLKEIWLHSNAFS-GPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMA 117 (580)
Q Consensus 40 ~l~~L~~L~L~~N~l~-~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l 117 (580)
..++|++|++++|.++ +.+| .+..+++|+.|+|++|++++ + ..+..+++|+.|+|++|++++.+|.+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~Ls~n~i~~~~~~~--------- 83 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-I-ANLPKLNKLKKLELSDNRVSGGLEVL--------- 83 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCC-C-TTCCCCTTCCEEECCSSCCCSCTHHH---------
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCC-c-hhhhcCCCCCEEECCCCcccchHHHH---------
Confidence 3478999999999998 5555 56889999999999999984 4 77889999999999999988755421
Q ss_pred cccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCccccc-CcccccCCC
Q 008026 118 KGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT-ISPEFASFK 196 (580)
Q Consensus 118 ~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~-~p~~~~~l~ 196 (580)
+..+++|+.|++++|++++. .|..++.++
T Consensus 84 --------------------------------------------------~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~ 113 (149)
T 2je0_A 84 --------------------------------------------------AEKCPNLTHLNLSGNKIKDLSTIEPLKKLE 113 (149)
T ss_dssp --------------------------------------------------HHHCTTCCEEECTTSCCCSHHHHGGGGGCT
T ss_pred --------------------------------------------------hhhCCCCCEEECCCCcCCChHHHHHHhhCC
Confidence 11123788899999999853 447899999
Q ss_pred CCcEEeccCCcccccCC---ccCcCCCCCCEEEccC
Q 008026 197 SLQRLILADNNLSGMIP---EGLSVLGALKELDVSN 229 (580)
Q Consensus 197 ~L~~L~ls~N~l~g~~p---~~l~~l~~L~~l~ls~ 229 (580)
+|+.|++++|++++..+ ..+..+++|++||+++
T Consensus 114 ~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 114 NLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999999999985444 4788899999999864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=5.8e-16 Score=140.61 Aligned_cols=134 Identities=18% Similarity=0.185 Sum_probs=105.8
Q ss_pred hhcCcccCceEecccCcCcCCCCCCCCCC-CCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccc
Q 008026 37 VIQNMTSLKEIWLHSNAFSGPLPDFSGVK-QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLD 115 (580)
Q Consensus 37 ~~~~l~~L~~L~L~~N~l~~~~p~~~~l~-~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~ 115 (580)
.+.++.+|++|+|++|+++.. |.+..+. +|+.|+|++|+|++ + ..|..+++|+.|+|++|+++++++.+
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~------- 83 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGL------- 83 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCH-------
T ss_pred hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcch-------
Confidence 456788888899999888854 6665544 88889998888884 4 57888888888888888888776542
Q ss_pred cccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcc--ccc
Q 008026 116 MAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISP--EFA 193 (580)
Q Consensus 116 ~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~--~~~ 193 (580)
+..+++|+.|++++|++. .+|. .+.
T Consensus 84 ----------------------------------------------------~~~l~~L~~L~L~~N~i~-~~~~~~~l~ 110 (176)
T 1a9n_A 84 ----------------------------------------------------DQALPDLTELILTNNSLV-ELGDLDPLA 110 (176)
T ss_dssp ----------------------------------------------------HHHCTTCCEEECCSCCCC-CGGGGGGGG
T ss_pred ----------------------------------------------------hhcCCCCCEEECCCCcCC-cchhhHhhh
Confidence 012237888888888886 6776 788
Q ss_pred CCCCCcEEeccCCcccccCCcc----CcCCCCCCEEEccCCcccc
Q 008026 194 SFKSLQRLILADNNLSGMIPEG----LSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 194 ~l~~L~~L~ls~N~l~g~~p~~----l~~l~~L~~l~ls~N~l~g 234 (580)
.+++|+.|++++|.+. .+|.. +..+++|+.||+++|....
T Consensus 111 ~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 111 SLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp GCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred cCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 8999999999999998 77775 8889999999999998763
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=8.5e-16 Score=135.35 Aligned_cols=128 Identities=14% Similarity=0.121 Sum_probs=106.5
Q ss_pred cceEEecccCCCCCC-CCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 17 IQSLWVNGQNGNAKL-GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 17 l~~L~~~~~~~n~~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
...|+.+++++|.+. +..|..+..+++|++|+|++|.+++. +.+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 355666777778776 57788889999999999999999987 7789999999999999999976898899999999999
Q ss_pred ccCCcccccC--CCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCc
Q 008026 96 MTNNLLQGPV--PEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN 173 (580)
Q Consensus 96 L~~N~l~~~~--~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (580)
|++|++++.+ +.+. .+++
T Consensus 95 ls~N~i~~~~~~~~~~------------------------------------------------------------~l~~ 114 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLK------------------------------------------------------------KLEN 114 (149)
T ss_dssp CTTSCCCSHHHHGGGG------------------------------------------------------------GCTT
T ss_pred CCCCcCCChHHHHHHh------------------------------------------------------------hCCC
Confidence 9999998753 2222 2347
Q ss_pred EEEEEecCCcccccCc---ccccCCCCCcEEeccC
Q 008026 174 ITVINFQKMNLTGTIS---PEFASFKSLQRLILAD 205 (580)
Q Consensus 174 L~~L~ls~n~l~~~~p---~~~~~l~~L~~L~ls~ 205 (580)
|+.|++++|++++..+ ..+..+++|+.|++++
T Consensus 115 L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 115 LKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8899999999986544 4788999999999874
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-17 Score=151.93 Aligned_cols=154 Identities=22% Similarity=0.230 Sum_probs=97.4
Q ss_pred hcCcccCceEecccCcCcCCCCC-------CCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCc
Q 008026 38 IQNMTSLKEIWLHSNAFSGPLPD-------FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDR 110 (580)
Q Consensus 38 ~~~l~~L~~L~L~~N~l~~~~p~-------~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 110 (580)
+.....++.++++.|.++|..|. +..+++|++|+|++|+++ .+| .+..+++|+.|+|++|+++.+++.+..
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~-~l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~ 91 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAV 91 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEES-CCC-CHHHHTTCCEEEEEEEEECSCSSHHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCc-ccc-ccccCCCCCEEECCCCCcccccchhhc
Confidence 44555666667777777666553 455667777777777776 366 667777777777777777654443444
Q ss_pred ccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCc-
Q 008026 111 SVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS- 189 (580)
Q Consensus 111 ~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p- 189 (580)
+.+|+.|++++|.+..++ .+. .+++|+.|++++|++++..+
T Consensus 92 ~~~L~~L~L~~N~l~~l~-----~~~---------------------------------~l~~L~~L~l~~N~i~~~~~~ 133 (198)
T 1ds9_A 92 ADTLEELWISYNQIASLS-----GIE---------------------------------KLVNLRVLYMSNNKITNWGEI 133 (198)
T ss_dssp HHHCSEEEEEEEECCCHH-----HHH---------------------------------HHHHSSEEEESEEECCCHHHH
T ss_pred CCcCCEEECcCCcCCcCC-----ccc---------------------------------cCCCCCEEECCCCcCCchhHH
Confidence 455566666665554332 011 11267778888888773222
Q ss_pred ccccCCCCCcEEeccCCcccccCCcc----------CcCCCCCCEEEccCCccc
Q 008026 190 PEFASFKSLQRLILADNNLSGMIPEG----------LSVLGALKELDVSNNQLY 233 (580)
Q Consensus 190 ~~~~~l~~L~~L~ls~N~l~g~~p~~----------l~~l~~L~~l~ls~N~l~ 233 (580)
..+..+++|+.|++++|++.+.+|.. +..+++|+.|| +|.++
T Consensus 134 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 134 DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred HHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 36777888888888888887666553 67778888776 56555
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.56 E-value=5.6e-17 Score=170.97 Aligned_cols=226 Identities=15% Similarity=0.062 Sum_probs=139.0
Q ss_pred ceEEecccCCCCCCCCC----chhhcCcccCceEecccCcCcCCCC-CCC-----CCCCCcEEeccCCccccc----CCc
Q 008026 18 QSLWVNGQNGNAKLGGG----IDVIQNMTSLKEIWLHSNAFSGPLP-DFS-----GVKQLESLSLRDNFFTGP----VPD 83 (580)
Q Consensus 18 ~~L~~~~~~~n~~~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p-~~~-----~l~~L~~L~L~~N~l~~~----~P~ 83 (580)
..|+.+++++|.+.... +..+..+++|++|+|++|.++...+ .+. .+++|+.|+|++|++++. +|.
T Consensus 142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 221 (461)
T 1z7x_W 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence 45777777777666543 4566778899999999998876433 222 256889999999988853 577
Q ss_pred cccCCCCCcEEEccCCcccccC-----CC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCC
Q 008026 84 SLVKLESLKIVNMTNNLLQGPV-----PE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 157 (580)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~-----~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~ 157 (580)
.+..+++|+.|+|++|+++... +. +..+.+|+.|++++|.+.... ...+...+.....+....++
T Consensus 222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~---------~~~l~~~l~~~~~L~~L~Ls 292 (461)
T 1z7x_W 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG---------CGDLCRVLRAKESLKELSLA 292 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH---------HHHHHHHHHHCTTCCEEECT
T ss_pred HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHH---------HHHHHHHHhhCCCcceEECC
Confidence 7888899999999999887642 22 235678888888888765321 11111111112233333334
Q ss_pred CCCCCCc-cceecc-----CCcEEEEEecCCccccc----CcccccCCCCCcEEeccCCcccccCCccCcC-----CCCC
Q 008026 158 NDPCSDW-IGVTCT-----KGNITVINFQKMNLTGT----ISPEFASFKSLQRLILADNNLSGMIPEGLSV-----LGAL 222 (580)
Q Consensus 158 ~~~~~~~-~~~~~~-----~~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~-----l~~L 222 (580)
++...+. +..++. .++|+.|++++|.+++. +|..+..+++|++|+|++|++.+..+..+.. .++|
T Consensus 293 ~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L 372 (461)
T 1z7x_W 293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372 (461)
T ss_dssp TCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCC
T ss_pred CCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCce
Confidence 3333210 001111 13677777777777754 4566667777777777777776544444432 5677
Q ss_pred CEEEccCCcccc----cCCCCC----CCceeecCCCCC
Q 008026 223 KELDVSNNQLYG----KIPSFK----SNAIVNTDGNPD 252 (580)
Q Consensus 223 ~~l~ls~N~l~g----~~p~~~----~~~~~~~~~n~~ 252 (580)
++|++++|++++ .+|..+ ....+++++|+.
T Consensus 373 ~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp CEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred EEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence 777777777774 444332 234466666653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.55 E-value=7.4e-17 Score=170.08 Aligned_cols=208 Identities=15% Similarity=0.107 Sum_probs=127.9
Q ss_pred eEEecccCCCCCCC----CCchhhcCcccCceEecccCcCcCCCC-C-----CCCCCCCcEEeccCCccccc----CCcc
Q 008026 19 SLWVNGQNGNAKLG----GGIDVIQNMTSLKEIWLHSNAFSGPLP-D-----FSGVKQLESLSLRDNFFTGP----VPDS 84 (580)
Q Consensus 19 ~L~~~~~~~n~~~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p-~-----~~~l~~L~~L~L~~N~l~~~----~P~~ 84 (580)
.|+.+++++|.+.. .++..+.++++|++|+|++|.++...+ . +...++|+.|+|++|++++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 57777888887664 447888999999999999999875433 1 23366899999999999863 4667
Q ss_pred ccCCCCCcEEEccCCcccccCCC-CC-----cccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCC
Q 008026 85 LVKLESLKIVNMTNNLLQGPVPE-FD-----RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 158 (580)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~~~-~~-----~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~ 158 (580)
+..+++|+.|+|++|.++...+. +. ...+|+.|++++|.+.... ...+ ...+.....+....+.+
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~------~~~l---~~~l~~~~~L~~L~Ls~ 236 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN------CRDL---CGIVASKASLRELALGS 236 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH------HHHH---HHHHHHCTTCCEEECCS
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH------HHHH---HHHHHhCCCccEEeccC
Confidence 78889999999999998765432 22 2447888899988776432 1111 11111122222223333
Q ss_pred CCCCCc------cceeccCCcEEEEEecCCccccc----CcccccCCCCCcEEeccCCcccccCCccCcC-----CCCCC
Q 008026 159 DPCSDW------IGVTCTKGNITVINFQKMNLTGT----ISPEFASFKSLQRLILADNNLSGMIPEGLSV-----LGALK 223 (580)
Q Consensus 159 ~~~~~~------~~~~~~~~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~-----l~~L~ 223 (580)
+...+. ++....+++|+.|++++|+++.. ++..+.++++|++|+|++|++.+..+..+.. .++|+
T Consensus 237 n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~ 316 (461)
T 1z7x_W 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 316 (461)
T ss_dssp SBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCC
T ss_pred CcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccce
Confidence 322211 11111234677777777776643 5566666677777777777665433333322 24666
Q ss_pred EEEccCCccccc
Q 008026 224 ELDVSNNQLYGK 235 (580)
Q Consensus 224 ~l~ls~N~l~g~ 235 (580)
+|++++|++++.
T Consensus 317 ~L~L~~n~l~~~ 328 (461)
T 1z7x_W 317 SLWVKSCSFTAA 328 (461)
T ss_dssp EEECTTSCCBGG
T ss_pred eeEcCCCCCchH
Confidence 666666666643
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=3.5e-15 Score=135.40 Aligned_cols=130 Identities=13% Similarity=0.064 Sum_probs=105.0
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcc-cCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCcc-ccCCCCCc
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMT-SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLK 92 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~-~~~l~~L~ 92 (580)
.++..|+.+++++|++.. .+. +..+. +|++|+|++|.|++. +.|..+++|++|+|++|+|+ .+|.. +..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCC
Confidence 356778888888886664 444 55555 999999999999986 78999999999999999999 56655 59999999
Q ss_pred EEEccCCcccccCC--CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceecc
Q 008026 93 IVNMTNNLLQGPVP--EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCT 170 (580)
Q Consensus 93 ~L~L~~N~l~~~~~--~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (580)
.|+|++|+++..++ .+. .
T Consensus 92 ~L~L~~N~i~~~~~~~~l~------------------------------------------------------------~ 111 (176)
T 1a9n_A 92 ELILTNNSLVELGDLDPLA------------------------------------------------------------S 111 (176)
T ss_dssp EEECCSCCCCCGGGGGGGG------------------------------------------------------------G
T ss_pred EEECCCCcCCcchhhHhhh------------------------------------------------------------c
Confidence 99999999976543 121 2
Q ss_pred CCcEEEEEecCCcccccCccc----ccCCCCCcEEeccCCccc
Q 008026 171 KGNITVINFQKMNLTGTISPE----FASFKSLQRLILADNNLS 209 (580)
Q Consensus 171 ~~~L~~L~ls~n~l~~~~p~~----~~~l~~L~~L~ls~N~l~ 209 (580)
+++|+.|++++|.+. .+|.. +..+++|+.||+++|.+.
T Consensus 112 l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 112 LKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 237888889999888 66764 888999999999999876
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.2e-14 Score=128.39 Aligned_cols=128 Identities=24% Similarity=0.243 Sum_probs=98.9
Q ss_pred cccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcc
Q 008026 23 NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101 (580)
Q Consensus 23 ~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l 101 (580)
+++++++ ++.+|..+ .++|++|+|++|++++.++. |..+++|++|+|++|+|++..|..|..+++|+.|+|++|++
T Consensus 12 l~~~~~~-l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 88 (177)
T 2o6r_A 12 IRCNSKG-LTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL 88 (177)
T ss_dssp EECCSSC-CSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCC-CccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCc
Confidence 4455554 44455433 36999999999999988774 78899999999999999944444589999999999999999
Q ss_pred cccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEec
Q 008026 102 QGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 180 (580)
Q Consensus 102 ~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls 180 (580)
++.++. +..+ ++|+.|+++
T Consensus 89 ~~~~~~~~~~l------------------------------------------------------------~~L~~L~l~ 108 (177)
T 2o6r_A 89 QSLPNGVFDKL------------------------------------------------------------TQLKELALD 108 (177)
T ss_dssp CCCCTTTTTTC------------------------------------------------------------TTCCEEECC
T ss_pred cccCHHHhhCC------------------------------------------------------------cccCEEECc
Confidence 988774 2222 267888888
Q ss_pred CCcccccCcccccCCCCCcEEeccCCcccccCC
Q 008026 181 KMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213 (580)
Q Consensus 181 ~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 213 (580)
+|++++..+..+..+++|+.|+|++|.+.+..|
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 888885444456788899999999998886544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.7e-16 Score=147.09 Aligned_cols=152 Identities=14% Similarity=0.132 Sum_probs=122.6
Q ss_pred ceEEecccCCCCCCCCCc------hhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCC
Q 008026 18 QSLWVNGQNGNAKLGGGI------DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESL 91 (580)
Q Consensus 18 ~~L~~~~~~~n~~~~~~~------~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L 91 (580)
..+..+++..+.+....| ..|.++++|++|+|++|.|++ +|.+..+++|+.|+|++|+++ .+|..+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 344445555554544444 489999999999999999998 558888999999999999999 899999999999
Q ss_pred cEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccC
Q 008026 92 KIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 171 (580)
Q Consensus 92 ~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (580)
+.|+|++|++++++ .+..+.+|+.|++++|.+..++. +. .+..+
T Consensus 96 ~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~--------~~---------------------------~l~~l 139 (198)
T 1ds9_A 96 EELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGE--------ID---------------------------KLAAL 139 (198)
T ss_dssp SEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHH--------HH---------------------------HHTTT
T ss_pred CEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhH--------HH---------------------------HHhcC
Confidence 99999999999864 68889999999999998865431 00 12234
Q ss_pred CcEEEEEecCCcccccCccc----------ccCCCCCcEEeccCCccc
Q 008026 172 GNITVINFQKMNLTGTISPE----------FASFKSLQRLILADNNLS 209 (580)
Q Consensus 172 ~~L~~L~ls~n~l~~~~p~~----------~~~l~~L~~L~ls~N~l~ 209 (580)
++|+.|++++|.+.+.+|.. +..+++|+.|| +|.++
T Consensus 140 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 140 DKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp TTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 58999999999999877753 88999999997 67665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-13 Score=123.67 Aligned_cols=62 Identities=23% Similarity=0.259 Sum_probs=31.7
Q ss_pred EEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccccc
Q 008026 174 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 235 (580)
Q Consensus 174 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~ 235 (580)
|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+++|++|+|++|+++..
T Consensus 56 L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 56 LTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 33333334444422223345555666666666666533333456666666666666665543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=3.6e-13 Score=121.22 Aligned_cols=107 Identities=20% Similarity=0.206 Sum_probs=84.1
Q ss_pred cCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCC-CcccccccccccC
Q 008026 43 SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF-DRSVSLDMAKGSN 121 (580)
Q Consensus 43 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~L~~l~l~~ 121 (580)
+.++|++++|+++..+..+ .++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+++++.. ..+
T Consensus 10 ~~~~l~~s~n~l~~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l---------- 77 (170)
T 3g39_A 10 SGTTVDCSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKL---------- 77 (170)
T ss_dssp ETTEEECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTC----------
T ss_pred CCCEEEeCCCCcCccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCC----------
Confidence 4578899999988755455 378889999999998666777889999999999999888877642 222
Q ss_pred CCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEE
Q 008026 122 NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL 201 (580)
Q Consensus 122 n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L 201 (580)
++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 78 --------------------------------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 107 (170)
T 3g39_A 78 --------------------------------------------------TQLTQLSLNDNQLKSIPRGAFDNLKSLTHI 107 (170)
T ss_dssp --------------------------------------------------TTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred --------------------------------------------------CCCCEEECCCCccCEeCHHHhcCCCCCCEE
Confidence 378888888888886555568899999999
Q ss_pred eccCCccccc
Q 008026 202 ILADNNLSGM 211 (580)
Q Consensus 202 ~ls~N~l~g~ 211 (580)
+|++|.+...
T Consensus 108 ~L~~N~~~c~ 117 (170)
T 3g39_A 108 WLLNNPWDCA 117 (170)
T ss_dssp ECCSSCBCTT
T ss_pred EeCCCCCCCC
Confidence 9999988743
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.7e-13 Score=121.62 Aligned_cols=59 Identities=15% Similarity=0.117 Sum_probs=29.2
Q ss_pred ceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccC
Q 008026 45 KEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 105 (580)
Q Consensus 45 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~ 105 (580)
+.+++++|+++..++.+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++++
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~ 73 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIP 73 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccC
Confidence 445555555543333332 45555555555555433444555555555555555554443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.4e-13 Score=121.84 Aligned_cols=107 Identities=21% Similarity=0.261 Sum_probs=81.5
Q ss_pred CcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhh
Q 008026 67 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLM 145 (580)
Q Consensus 67 L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~ 145 (580)
-+.+++++|++. .+|..+. ++|+.|+|++|+|++++|. |..+
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l---------------------------------- 56 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHL---------------------------------- 56 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTC----------------------------------
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCC----------------------------------
Confidence 378999999997 8998774 8899999999999988774 3332
Q ss_pred CCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEE
Q 008026 146 GYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 225 (580)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l 225 (580)
++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+..+++|++|
T Consensus 57 --------------------------~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 110 (174)
T 2r9u_A 57 --------------------------VNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHI 110 (174)
T ss_dssp --------------------------TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEE
T ss_pred --------------------------cCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEE
Confidence 267777888888885444446788888888888888884444458888888888
Q ss_pred EccCCcccccC
Q 008026 226 DVSNNQLYGKI 236 (580)
Q Consensus 226 ~ls~N~l~g~~ 236 (580)
+|++|++....
T Consensus 111 ~L~~N~~~c~~ 121 (174)
T 2r9u_A 111 YLYNNPWDCEC 121 (174)
T ss_dssp ECCSSCBCTTB
T ss_pred EeCCCCccccc
Confidence 88888887543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=3.3e-12 Score=123.71 Aligned_cols=147 Identities=14% Similarity=0.068 Sum_probs=113.9
Q ss_pred HHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeE
Q 008026 391 RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 391 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 469 (580)
......|++...++.|+.+.||++... +..+++|+...... .....+.+|+++++.+. +..++++++++...+..|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 445567888888999999999999754 68899999865321 12246889999999985 677889999999888999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA------------------------------- 518 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~------------------------------- 518 (580)
+||||++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 87 lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 9999999999876431 11223467889999999999721
Q ss_pred -------------------------CCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 519 -------------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 519 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998765567999998754
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.7e-12 Score=130.12 Aligned_cols=56 Identities=27% Similarity=0.300 Sum_probs=26.5
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCC-EEEccC
Q 008026 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK-ELDVSN 229 (580)
Q Consensus 173 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~-~l~ls~ 229 (580)
+|+.|+|++|+++..-+..|.+|++|++|+|.+| +...-+.+|.++++|+ .+++.+
T Consensus 227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~ 283 (329)
T 3sb4_A 227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA 283 (329)
T ss_dssp TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT
T ss_pred CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc
Confidence 4555555555555333334455555555555554 4322233445555555 555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.5e-12 Score=128.14 Aligned_cols=102 Identities=17% Similarity=0.135 Sum_probs=89.5
Q ss_pred ccCCCCCCCCCchhhcCcccCceEeccc-CcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcc
Q 008026 24 GQNGNAKLGGGIDVIQNMTSLKEIWLHS-NAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101 (580)
Q Consensus 24 ~~~~n~~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l 101 (580)
++++++.++.+|. |..+++|++|+|++ |.|++.+| .|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|
T Consensus 14 ~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 92 (347)
T 2ifg_A 14 RCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92 (347)
T ss_dssp ECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred EcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCcc
Confidence 5666634566888 99999999999996 99999887 599999999999999999987788899999999999999999
Q ss_pred cccCCCCCcccccccccccCCCCCC
Q 008026 102 QGPVPEFDRSVSLDMAKGSNNFCLP 126 (580)
Q Consensus 102 ~~~~~~~~~~~~L~~l~l~~n~~~~ 126 (580)
+++++.+.....|+.|++.+|.+.-
T Consensus 93 ~~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 93 ESLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp SCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred ceeCHHHcccCCceEEEeeCCCccC
Confidence 9999986665569999999998754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=8e-12 Score=126.27 Aligned_cols=60 Identities=27% Similarity=0.236 Sum_probs=35.1
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 173 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
+|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+..++ |+.|+|++|+|.
T Consensus 57 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 57 ELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 455555555555555555666666677777777776632233333333 777777777665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.25 E-value=6.9e-12 Score=125.74 Aligned_cols=63 Identities=11% Similarity=0.058 Sum_probs=35.4
Q ss_pred cEEEEEecCCcccccCcccccCCCCCc-EEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 173 NITVINFQKMNLTGTISPEFASFKSLQ-RLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 173 ~L~~L~ls~n~l~~~~p~~~~~l~~L~-~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
+|+.|+|++| +...-+..|.+|++|+ .|++.+ ++...-+.+|.++++|+.|++++|+++..-+
T Consensus 251 ~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~ 314 (329)
T 3sb4_A 251 YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGD 314 (329)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECT
T ss_pred CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccch
Confidence 5666666665 5434444566666666 666665 4542334556666666666666666654333
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.25 E-value=8.1e-12 Score=120.67 Aligned_cols=139 Identities=19% Similarity=0.157 Sum_probs=100.4
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCc--ccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~ 472 (580)
..|.+....+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 345554444466679999998777888999987543 2245788999999886444 556888888877889999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA---------------------------------- 518 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~---------------------------------- 518 (580)
||++|.++. .. ..+ ...++.+++..|..||+..
T Consensus 95 e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 95 GEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp ECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999998884 20 111 1245667777777777521
Q ss_pred ---------------------CCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 519 ---------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 519 ---------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
...++|+|++|.||++++++.+.|+||+.+...
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 112999999999999987766679999997653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=3e-13 Score=137.57 Aligned_cols=162 Identities=15% Similarity=0.148 Sum_probs=110.0
Q ss_pred cccCceEecccCcCcCCCC-C----CC-CCCCCcEEeccCCcccccCCcc-ccCCCCCcEEEccCCcccccCCC-C----
Q 008026 41 MTSLKEIWLHSNAFSGPLP-D----FS-GVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPE-F---- 108 (580)
Q Consensus 41 l~~L~~L~L~~N~l~~~~p-~----~~-~l~~L~~L~L~~N~l~~~~P~~-~~~l~~L~~L~L~~N~l~~~~~~-~---- 108 (580)
++.|++|+|++|.|+.... . +. ..++|+.|+|++|+|+..-... ...+++|+.|+|++|.++..... +
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4678888898888875332 1 22 2368888999988886433333 33467888899999888654332 2
Q ss_pred -CcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCccccc
Q 008026 109 -DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 187 (580)
Q Consensus 109 -~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~ 187 (580)
....+|+.|++++|.+... ....+.. .+...++|+.|+|++|.|...
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~------~~~~l~~--------------------------~L~~~~~L~~L~Ls~N~l~~~ 198 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAA------GVAVLME--------------------------GLAGNTSVTHLSLLHTGLGDE 198 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHH------HHHHHHH--------------------------HHHTCSSCCEEECTTSSCHHH
T ss_pred HhcCCccceeeCCCCCCChH------HHHHHHH--------------------------HHhcCCCcCEEeCCCCCCCcH
Confidence 2346788888888875421 1111111 011224799999999999853
Q ss_pred ----CcccccCCCCCcEEeccCCcccc----cCCccCcCCCCCCEEEccCCcccc
Q 008026 188 ----ISPEFASFKSLQRLILADNNLSG----MIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 188 ----~p~~~~~l~~L~~L~ls~N~l~g----~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
++..+..+++|+.|+|++|.|+. .++..+...+.|++|||++|++++
T Consensus 199 g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 199 GLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 46667788899999999999974 234455667899999999999874
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.16 E-value=3.9e-13 Score=146.22 Aligned_cols=201 Identities=12% Similarity=0.055 Sum_probs=114.7
Q ss_pred ccceEEecccCCCCCCCCCchhhcCc--ccCceEecccCc-CcC-CCCC-CCCCCCCcEEeccCCccccc----CCcccc
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNM--TSLKEIWLHSNA-FSG-PLPD-FSGVKQLESLSLRDNFFTGP----VPDSLV 86 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l--~~L~~L~L~~N~-l~~-~~p~-~~~l~~L~~L~L~~N~l~~~----~P~~~~ 86 (580)
++..|+.+++++|.+....+..+..+ .+|++|+|++|. ++. .++. ...+++|+.|+|++|.+.+. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 45566666666665555445556553 348888888776 221 1112 23577888888888887654 344466
Q ss_pred CCCCCcEEEccCCcccccCC-----CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccC-CCCC
Q 008026 87 KLESLKIVNMTNNLLQGPVP-----EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK-GNDP 160 (580)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~~-----~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~-~~~~ 160 (580)
.+++|+.|+|++|.+++... .+..+.+|+.|++++|.+..++ . .......+..+..... ....
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~--------~---~~~~~~~L~~L~l~~~~~~~~ 258 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV--------G---FFKAAANLEEFCGGSLNEDIG 258 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH--------H---HHHHCTTCCEEEECBCCCCTT
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH--------H---HHhhhhHHHhhcccccccccc
Confidence 77888888888888763322 2346677888888877654322 0 0011111111111100 1101
Q ss_pred CCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCC-ccCcCCCCCCEEEcc
Q 008026 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP-EGLSVLGALKELDVS 228 (580)
Q Consensus 161 ~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~l~~l~~L~~l~ls 228 (580)
.......+..+.+|+.|+++++... .+|..+..+++|++|+|++|.+.+... ..+..+++|+.|+++
T Consensus 259 ~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 259 MPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp CTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred hHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 1122233344457777777775433 667777777777777777777654333 335667777777777
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.9e-10 Score=114.36 Aligned_cols=143 Identities=15% Similarity=0.226 Sum_probs=105.5
Q ss_pred ccceeeccCcEEEEEEEEcCCcEEEEEEee--ccccChhhHHHHHHHHHHHHhcC--CCcccceeeEEEcC---CeeEEE
Q 008026 399 EENILGRGGFGTVYKGELHDGTKIAVKRME--AGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDG---NEKLLV 471 (580)
Q Consensus 399 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv 471 (580)
..+.++.|.++.||+.... +..+++|+.. .... ......+.+|+++++.+. +..+++++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4577899999999999775 4678888765 3221 122356888999999997 44578888888766 457999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--------------------------------- 518 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--------------------------------- 518 (580)
|||++|..+.+.. ...++..+...++.+++.+|..||+..
T Consensus 120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999998774321 124567778889999999999999731
Q ss_pred ----------------------CCCcEecCCCCCCeEecCCCc--EEEEeeccccc
Q 008026 519 ----------------------HQSFIHRDLKPSNILLGDDMR--AKVADFGLVRL 550 (580)
Q Consensus 519 ----------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 550 (580)
...++|||++|.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256899999999999987653 68999998864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.04 E-value=5.3e-12 Score=137.20 Aligned_cols=106 Identities=10% Similarity=-0.103 Sum_probs=75.7
Q ss_pred ccceEEecccCCCCCCCC----CchhhcCcccCceEecccCcCcCCC----CC-CCCCCCCcEEeccCCcccccCCcccc
Q 008026 16 QIQSLWVNGQNGNAKLGG----GIDVIQNMTSLKEIWLHSNAFSGPL----PD-FSGVKQLESLSLRDNFFTGPVPDSLV 86 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----p~-~~~l~~L~~L~L~~N~l~~~~P~~~~ 86 (580)
+++.|+.+++++|.+... ++..+.++++|++|+|++|.+++.. +. +.++++|+.|+|++|.+. .+|..+.
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~~~ 240 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFK 240 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHHHh
Confidence 456777777877866554 3345678899999999999998433 22 456899999999999998 5888899
Q ss_pred CCCCCcEEEccCCccc----ccCCCCCcccccccccccCC
Q 008026 87 KLESLKIVNMTNNLLQ----GPVPEFDRSVSLDMAKGSNN 122 (580)
Q Consensus 87 ~l~~L~~L~L~~N~l~----~~~~~~~~~~~L~~l~l~~n 122 (580)
++++|+.|+++.+... .....+..+.+|+.+.++++
T Consensus 241 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 280 (592)
T 3ogk_B 241 AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM 280 (592)
T ss_dssp HCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC
T ss_pred hhhHHHhhcccccccccchHHHHHHhhccccccccCcccc
Confidence 9999999999863322 11123555666666666554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.93 E-value=2e-11 Score=132.63 Aligned_cols=212 Identities=16% Similarity=0.062 Sum_probs=103.9
Q ss_pred cceEEecccCCCCCCCCCchhhc-CcccCceEecccC-cCcCC-CCCC-CCCCCCcEEeccCCcccccCCcccc----CC
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQ-NMTSLKEIWLHSN-AFSGP-LPDF-SGVKQLESLSLRDNFFTGPVPDSLV----KL 88 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~p~~-~~l~~L~~L~L~~N~l~~~~P~~~~----~l 88 (580)
+..|+.+++++|.+....+..+. .+++|++|+|++| .++.. ++.+ ..+++|+.|+|++|.+++..+..+. .+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 34455555555655544445554 5778888888877 44432 3333 3577888888888877654444333 55
Q ss_pred CCCcEEEccCCc--ccc-cCCC-CCcccccccccccCCCC-CC-------------CCCC-C--chhHHHHHHHHHhhCC
Q 008026 89 ESLKIVNMTNNL--LQG-PVPE-FDRSVSLDMAKGSNNFC-LP-------------SPGA-C--DPRLNALLSVVKLMGY 147 (580)
Q Consensus 89 ~~L~~L~L~~N~--l~~-~~~~-~~~~~~L~~l~l~~n~~-~~-------------~~~~-~--~~~l~~l~~~~~~~~~ 147 (580)
++|+.|+|++|. +.. .++. +..+.+|+.|++++|.. .. +.-. . ......+..+...+..
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~ 263 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence 678888887776 110 0111 23346677777776621 00 0000 0 0000111111111111
Q ss_pred ccccccc-cCCCCCCCCccceeccCCcEEEEEecCCcccccCc-ccccCCCCCcEEeccCCcccc-cCCccCcCCCCCCE
Q 008026 148 PQRFAEN-WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS-PEFASFKSLQRLILADNNLSG-MIPEGLSVLGALKE 224 (580)
Q Consensus 148 ~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p-~~~~~l~~L~~L~ls~N~l~g-~~p~~l~~l~~L~~ 224 (580)
...+... .........++.....+++|+.|+|++|.+++... ..+..+++|+.|++++| +.. .++.....+++|+.
T Consensus 264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~ 342 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE 342 (594)
T ss_dssp CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence 1111111 00111111122222234577777777777664322 23556777777777777 331 12222234677777
Q ss_pred EEccC
Q 008026 225 LDVSN 229 (580)
Q Consensus 225 l~ls~ 229 (580)
|++++
T Consensus 343 L~L~~ 347 (594)
T 2p1m_B 343 LRVFP 347 (594)
T ss_dssp EEEEC
T ss_pred EEEec
Confidence 77744
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.91 E-value=9.2e-12 Score=135.34 Aligned_cols=61 Identities=15% Similarity=0.141 Sum_probs=28.5
Q ss_pred CcEEEEEecCCcccccCcccccC-CCCCcEEeccCCcccccCCccC-cCCCCCCEEEccCCccc
Q 008026 172 GNITVINFQKMNLTGTISPEFAS-FKSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNNQLY 233 (580)
Q Consensus 172 ~~L~~L~ls~n~l~~~~p~~~~~-l~~L~~L~ls~N~l~g~~p~~l-~~l~~L~~l~ls~N~l~ 233 (580)
++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|+++
T Consensus 432 ~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 432 KDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp TTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred CCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 3455555544 444333333433 4555555555555543333222 33455555555555553
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.89 E-value=1.4e-11 Score=125.26 Aligned_cols=185 Identities=16% Similarity=0.056 Sum_probs=121.5
Q ss_pred cceEEecccCCCCCCCCCchhhcCc-----ccCceEecccCcCcCCCC-CC-CCCCCCcEEeccCCcccccCCccc----
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNM-----TSLKEIWLHSNAFSGPLP-DF-SGVKQLESLSLRDNFFTGPVPDSL---- 85 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p-~~-~~l~~L~~L~L~~N~l~~~~P~~~---- 85 (580)
+..|+.+++++|.+.......|..+ ++|++|+|++|.|+.... .+ ..+++|+.|+|++|+|+..-...+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3456677777777655444444443 799999999999875332 33 346789999999999974433334
Q ss_pred -cCCCCCcEEEccCCcccccCC-----CCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCC
Q 008026 86 -VKLESLKIVNMTNNLLQGPVP-----EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159 (580)
Q Consensus 86 -~~l~~L~~L~L~~N~l~~~~~-----~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 159 (580)
...++|+.|+|++|.|+.... .+..+.+|+.|++++|.+... ....+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~------g~~~L~~------------------- 205 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE------GLELLAA------------------- 205 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHH------HHHHHHH-------------------
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcH------HHHHHHH-------------------
Confidence 346889999999999975322 245677899999999986421 1111111
Q ss_pred CCCCccceeccCCcEEEEEecCCcccc----cCcccccCCCCCcEEeccCCcccccCCccCcCCCC-----CCEEE--cc
Q 008026 160 PCSDWIGVTCTKGNITVINFQKMNLTG----TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA-----LKELD--VS 228 (580)
Q Consensus 160 ~~~~~~~~~~~~~~L~~L~ls~n~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~-----L~~l~--ls 228 (580)
.+...++|+.|+|++|.|+. .++..+...++|++|+|++|.|+..-...+..+.. |+.+. +.
T Consensus 206 -------~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~ 278 (372)
T 3un9_A 206 -------QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTE 278 (372)
T ss_dssp -------HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC-
T ss_pred -------HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhc
Confidence 11122489999999999985 35556667899999999999997544444433321 55555 54
Q ss_pred CCccc
Q 008026 229 NNQLY 233 (580)
Q Consensus 229 ~N~l~ 233 (580)
.|.++
T Consensus 279 ~~~~~ 283 (372)
T 3un9_A 279 GTAVS 283 (372)
T ss_dssp ---CH
T ss_pred CCccC
Confidence 55444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.87 E-value=9.1e-09 Score=105.49 Aligned_cols=195 Identities=14% Similarity=0.073 Sum_probs=121.3
Q ss_pred CccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCC
Q 008026 11 SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLE 89 (580)
Q Consensus 11 ~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~ 89 (580)
.|.+.+|+.+. +..+ +......+|.++ +|+.+.|.+ .++.+.+ .|.++++|+.++|++|++. .+|.......
T Consensus 131 aF~~~~L~~i~---l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~ 203 (401)
T 4fdw_A 131 AFRNSQIAKVV---LNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYA 203 (401)
T ss_dssp TTTTCCCSEEE---CCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTC
T ss_pred hcccCCccEEE---eCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeec
Confidence 35333344444 4333 555556778884 799999986 6665555 5889999999999999998 7777644478
Q ss_pred CCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCc-cce
Q 008026 90 SLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW-IGV 167 (580)
Q Consensus 90 ~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 167 (580)
+|+.+.|.+| ++.+... |.++.+|+.+.+.+| +..++...|.. ..|..+ .+.+. ...+ ...
T Consensus 204 ~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i-------------~lp~~-i~~I~~~a 266 (401)
T 4fdw_A 204 GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTV-------------KLPNG-VTNIASRA 266 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEE-------------EEETT-CCEECTTT
T ss_pred ccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEE-------------EeCCC-ccEEChhH
Confidence 9999999855 6665553 888889999988775 56666665543 111100 00000 0011 122
Q ss_pred eccCCcEEEEEecCCccc-----ccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCC
Q 008026 168 TCTKGNITVINFQKMNLT-----GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 230 (580)
Q Consensus 168 ~~~~~~L~~L~ls~n~l~-----~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N 230 (580)
+..+.+|+.+++.+|.+. ..-+..|.+|++|+.++|.+ .+...-..+|.++++|+.++|.+|
T Consensus 267 F~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 267 FYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp TTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT
T ss_pred hhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc
Confidence 333456777777776654 23445666777777777773 355233446666777777777544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.86 E-value=9.6e-09 Score=105.33 Aligned_cols=204 Identities=13% Similarity=0.063 Sum_probs=134.6
Q ss_pred CccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCcccccCCc-cccCC
Q 008026 11 SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPD-SLVKL 88 (580)
Q Consensus 11 ~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~P~-~~~~l 88 (580)
.|.+.+|+.+.+-+ .+......+|.++++|+.++|++|+++.+... |. ..+|+.+.|..+ +. .|+. .|.++
T Consensus 153 aF~~~~L~~i~lp~----~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~ 225 (401)
T 4fdw_A 153 AFFNSTVQEIVFPS----TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKT 225 (401)
T ss_dssp TTTTCCCCEEECCT----TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTC
T ss_pred hcCCCCceEEEeCC----CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehhhHhhCC
Confidence 45444455554432 35555667899999999999999999876663 65 588999999754 66 4544 58899
Q ss_pred CCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC-ccce
Q 008026 89 ESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD-WIGV 167 (580)
Q Consensus 89 ~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 167 (580)
++|+.++|.+| ++.+....+...+|+.+.+ .+.+..++...|....+|..+.. ..+.....+... ....
T Consensus 226 ~~L~~l~l~~~-l~~I~~~aF~~~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l--------~~~~~~~~~~~~I~~~a 295 (401)
T 4fdw_A 226 SQLKTIEIPEN-VSTIGQEAFRESGITTVKL-PNGVTNIASRAFYYCPELAEVTT--------YGSTFNDDPEAMIHPYC 295 (401)
T ss_dssp TTCCCEECCTT-CCEECTTTTTTCCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE--------ESSCCCCCTTCEECTTT
T ss_pred CCCCEEecCCC-ccCccccccccCCccEEEe-CCCccEEChhHhhCCCCCCEEEe--------CCccccCCcccEECHHH
Confidence 99999999875 5555554333367777777 34466677666655443332210 011111011111 1223
Q ss_pred eccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 168 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 168 ~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
+..+.+|+.++|.+ .+...-...|.+|++|+.|+|.+| +...-+.+|.++ +|+.+++++|.+..
T Consensus 296 F~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 296 LEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ 359 (401)
T ss_dssp TTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred hhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence 44456899999994 577555678999999999999766 663446688889 99999999997763
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.70 E-value=1.2e-08 Score=102.71 Aligned_cols=63 Identities=13% Similarity=0.186 Sum_probs=50.0
Q ss_pred CcEEEEEecCCcccccCccccc---CCCCCcEEeccCCccccc----CCccCcCCCCCCEEEccCCcccc
Q 008026 172 GNITVINFQKMNLTGTISPEFA---SFKSLQRLILADNNLSGM----IPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 172 ~~L~~L~ls~n~l~~~~p~~~~---~l~~L~~L~ls~N~l~g~----~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
++|+.|+|++|.+....+..+. .+++|+.|+|+.|.|.+. ++..+..+++|+.|+|++|.++.
T Consensus 252 p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp TTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 4899999999998865544443 588999999999998753 45556678999999999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.67 E-value=7.2e-08 Score=95.11 Aligned_cols=137 Identities=19% Similarity=0.273 Sum_probs=97.2
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCc--ccceeeEEEcCC---eeEEEEE
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRH--LVALLGHCLDGN---EKLLVFE 473 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e 473 (580)
.+.++.|....||++. ..+++|+... ......+.+|.++++.+. +.. +.+++....... ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999863 5688887543 234567899999999884 433 344554443333 3489999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA----------------------------------- 518 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~----------------------------------- 518 (580)
+++|.++.+... ..++..+...++.+++..+..||+..
T Consensus 97 ~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999988865331 13556666777778888888877511
Q ss_pred --------------------CCCcEecCCCCCCeEecC--CCcEEEEeecccccc
Q 008026 519 --------------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVRLA 551 (580)
Q Consensus 519 --------------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~ 551 (580)
...++|+|++|.||++++ ...+.|+||+.+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 135799999999999987 456789999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=4.2e-07 Score=87.86 Aligned_cols=136 Identities=16% Similarity=0.154 Sum_probs=96.1
Q ss_pred eeeccCcE-EEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEEEEEecCCC
Q 008026 402 ILGRGGFG-TVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 402 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
.+..|..+ .||+.... ++..+++|+-.. .....+.+|...++.+. +--+.++++++.+.+..|+|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556554 68987655 466789997653 23457888999999885 334678889999899999999999998
Q ss_pred ChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 008026 479 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA---------------------------------------- 518 (580)
Q Consensus 479 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~---------------------------------------- 518 (580)
++.+.... .......++.+++..|..||+..
T Consensus 106 ~~~~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 106 TAFQVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EHHHHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 87665421 11122345566666666666410
Q ss_pred ---------------CCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 519 ---------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 519 ---------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
...++|+|+.+.|||+++++.+-|+||+.+...
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 112799999999999998776779999988643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=9.8e-07 Score=86.98 Aligned_cols=137 Identities=17% Similarity=0.175 Sum_probs=91.5
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCC---cccceeeEEE-cCCeeEEEEEec
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR---HLVALLGHCL-DGNEKLLVFEYM 475 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~ 475 (580)
.+.++.|....||+. +..+++|+-.. ......+.+|.++++.+.+. .+.+++.+.. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888998999987 56788887422 23456789999999999742 3566777664 445678999999
Q ss_pred CCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 008026 476 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-------------------------------------- 517 (580)
Q Consensus 476 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-------------------------------------- 517 (580)
+|..+.+... ..++..+...++.+++..|..||+.
T Consensus 96 ~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9988765311 1122233333334444444444421
Q ss_pred -------------------CCCCcEecCCCCCCeEecC---CCcE-EEEeecccccc
Q 008026 518 -------------------AHQSFIHRDLKPSNILLGD---DMRA-KVADFGLVRLA 551 (580)
Q Consensus 518 -------------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~Dfg~a~~~ 551 (580)
....++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1245799999999999987 4554 89999987653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.41 E-value=2.1e-08 Score=95.89 Aligned_cols=52 Identities=25% Similarity=0.355 Sum_probs=30.2
Q ss_pred cEEEEEecCCcccccCcccccCCC--CCcEEeccCCcccccCCc-------cCcCCCCCCEEE
Q 008026 173 NITVINFQKMNLTGTISPEFASFK--SLQRLILADNNLSGMIPE-------GLSVLGALKELD 226 (580)
Q Consensus 173 ~L~~L~ls~n~l~~~~p~~~~~l~--~L~~L~ls~N~l~g~~p~-------~l~~l~~L~~l~ 226 (580)
+|+.|+|++|+|.+. .++..++ +|++|+|++|.+.+.+|+ .+..+++|+.||
T Consensus 197 ~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 197 NLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp TCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 556666666666632 2333333 677777777777665552 255667777665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.31 E-value=2.4e-07 Score=84.02 Aligned_cols=61 Identities=18% Similarity=0.173 Sum_probs=30.5
Q ss_pred cEEEEEecCCccccc----CcccccCCCCCcEEec--cCCccccc----CCccCcCCCCCCEEEccCCccc
Q 008026 173 NITVINFQKMNLTGT----ISPEFASFKSLQRLIL--ADNNLSGM----IPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 173 ~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l--s~N~l~g~----~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
+|+.|+|++|.|... +...+...++|++|+| ++|.|... +...+...+.|++|+|++|.+.
T Consensus 94 ~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 94 TLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp SCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 344455555554422 3334445555666666 55555422 2233344456666666666554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.8e-06 Score=87.03 Aligned_cols=82 Identities=10% Similarity=-0.013 Sum_probs=55.3
Q ss_pred ccee-eccCcEEEEEEEEc-------CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcC-C--CcccceeeEEEcC--
Q 008026 400 ENIL-GRGGFGTVYKGELH-------DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-H--RHLVALLGHCLDG-- 465 (580)
Q Consensus 400 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~-- 465 (580)
.+.| +.|....+|+.... ++..+++|....... .......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 78888999998654 267889987654220 0001245678888888885 3 2466788777654
Q ss_pred -CeeEEEEEecCCCChh
Q 008026 466 -NEKLLVFEYMPQGTLS 481 (580)
Q Consensus 466 -~~~~lv~e~~~~g~L~ 481 (580)
+..|+||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.20 E-value=1.8e-07 Score=84.89 Aligned_cols=68 Identities=18% Similarity=0.251 Sum_probs=50.0
Q ss_pred hhhcCcccCceEecccC-cCcCCC-----CCCCCCCCCcEEeccCCcccc----cCCccccCCCCCcEEEccCCcccc
Q 008026 36 DVIQNMTSLKEIWLHSN-AFSGPL-----PDFSGVKQLESLSLRDNFFTG----PVPDSLVKLESLKIVNMTNNLLQG 103 (580)
Q Consensus 36 ~~~~~l~~L~~L~L~~N-~l~~~~-----p~~~~l~~L~~L~L~~N~l~~----~~P~~~~~l~~L~~L~L~~N~l~~ 103 (580)
..+...++|++|+|++| .|...- ..+...++|++|+|++|+|.. .+...+...++|+.|+|++|.|+.
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 35667888999999998 876421 125557889999999999863 244556667889999999888764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.17 E-value=1e-06 Score=84.09 Aligned_cols=66 Identities=21% Similarity=0.234 Sum_probs=56.4
Q ss_pred CCcEEEEEecCCcccc--cCcccccCCCCCcEEeccCCcccccCCccCcCCC--CCCEEEccCCcccccCCC
Q 008026 171 KGNITVINFQKMNLTG--TISPEFASFKSLQRLILADNNLSGMIPEGLSVLG--ALKELDVSNNQLYGKIPS 238 (580)
Q Consensus 171 ~~~L~~L~ls~n~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~--~L~~l~ls~N~l~g~~p~ 238 (580)
+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. .++..++ +|++|+|++|++++.+|.
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 3589999999999997 5667888999999999999999854 4456666 999999999999988773
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.14 E-value=3.2e-05 Score=77.23 Aligned_cols=143 Identities=16% Similarity=0.235 Sum_probs=79.8
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCC--Ccccceee------EEEcCCeeEEEE
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLG------HCLDGNEKLLVF 472 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~ 472 (580)
+.|+.|..+.||++...++ .+++|+.... ..++..|.++++.+.. -.+++++. +....+..+++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 4566677889999977644 5899988652 1233445555555431 12333332 123456789999
Q ss_pred EecCCCChh-----------HHHHHHhh--hCC--C--------CccHHH------------------------------
Q 008026 473 EYMPQGTLS-----------RHIFNWAE--EGL--K--------PLEWNR------------------------------ 499 (580)
Q Consensus 473 e~~~~g~L~-----------~~l~~~~~--~~~--~--------~~~~~~------------------------------ 499 (580)
||++|..+. +.+.+... ... . ...|..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 11111111 100 0 011211
Q ss_pred -HHHHHHHHHHHHHHHHh----------CCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 500 -RLTIALDVARGVEYLHG----------LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 500 -~~~i~~~i~~aL~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
...+..++..++++|+. .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 00111223445666652 0147899999999999998778899999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1e-05 Score=82.79 Aligned_cols=77 Identities=13% Similarity=0.128 Sum_probs=50.2
Q ss_pred cceeeccCcEEEEEEEEc-CCcEEEEEEeecccc--C---hhhHHHHHHHHHHHHhcCC--Cc-ccceeeEEEcCCeeEE
Q 008026 400 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI--S---GKGLTEFKSEIAVLTKVRH--RH-LVALLGHCLDGNEKLL 470 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~~~~l 470 (580)
.+.+|.|.++.||++... +++.|++|....... . .....++..|.++++.+.. +. +++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999654 468899998653211 0 1123456788888888742 33 4455543 3455689
Q ss_pred EEEecCCC
Q 008026 471 VFEYMPQG 478 (580)
Q Consensus 471 v~e~~~~g 478 (580)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=4.7e-06 Score=83.75 Aligned_cols=64 Identities=20% Similarity=0.262 Sum_probs=43.8
Q ss_pred CCcEEEEEecC--Ccccc-----cCcccc--cCCCCCcEEeccCCcccccCCccCc---CCCCCCEEEccCCcccc
Q 008026 171 KGNITVINFQK--MNLTG-----TISPEF--ASFKSLQRLILADNNLSGMIPEGLS---VLGALKELDVSNNQLYG 234 (580)
Q Consensus 171 ~~~L~~L~ls~--n~l~~-----~~p~~~--~~l~~L~~L~ls~N~l~g~~p~~l~---~l~~L~~l~ls~N~l~g 234 (580)
+++|+.|+|+. |...+ .+...+ ..+++|+.|+|++|.+....+..+. .+++|++|||+.|.+++
T Consensus 218 lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp CTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred CCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 34788888863 22111 112223 3589999999999998754443333 57899999999999986
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.90 E-value=8.1e-05 Score=73.01 Aligned_cols=141 Identities=16% Similarity=0.146 Sum_probs=92.0
Q ss_pred ccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC---CCcccceeeEEEcCCeeEEEEEec
Q 008026 399 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDGNEKLLVFEYM 475 (580)
Q Consensus 399 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~ 475 (580)
..+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+++++++....+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 356789999999999876 4678889976542 3467889999888884 356888898888888899999999
Q ss_pred CCCChh--------HHHHHHhhhCC-C-------------------CccHHHHH---HHH----------------HHHH
Q 008026 476 PQGTLS--------RHIFNWAEEGL-K-------------------PLEWNRRL---TIA----------------LDVA 508 (580)
Q Consensus 476 ~~g~L~--------~~l~~~~~~~~-~-------------------~~~~~~~~---~i~----------------~~i~ 508 (580)
++..+. +.+.+...... . .-+|.... ++. .+++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 987642 22222211111 0 01343221 111 1111
Q ss_pred HHH-HHHHh-CCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 509 RGV-EYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 509 ~aL-~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..+ ..|.. .....+||+|+.+.|++++.++ +.|+||.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 23321 1246799999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00011 Score=71.38 Aligned_cols=79 Identities=19% Similarity=0.199 Sum_probs=56.6
Q ss_pred CCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCC---cccceeeEEEcCCeeEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR---HLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~lv~ 472 (580)
...-.+.+|.|..+.||+.+..+|+.|++|+..... ......+..|++.|+.+.-. -+++++++. ..++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 344567899999999999999999999999865432 12234678899999988522 244555442 347999
Q ss_pred EecCCCCh
Q 008026 473 EYMPQGTL 480 (580)
Q Consensus 473 e~~~~g~L 480 (580)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00029 Score=72.47 Aligned_cols=75 Identities=15% Similarity=0.195 Sum_probs=45.8
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccc--cCh-----hhHHHHHHHHHHHH-hcCCCcccceeeEEEcCCeeEEE
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGV--ISG-----KGLTEFKSEIAVLT-KVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~-----~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.+.+|.|....||++.. ++..++||...... ... .....+..|+..+. ......+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 56789999999999964 46789999533210 011 02233444443322 22234566777665 5667999
Q ss_pred EEec-CC
Q 008026 472 FEYM-PQ 477 (580)
Q Consensus 472 ~e~~-~~ 477 (580)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00032 Score=69.29 Aligned_cols=158 Identities=13% Similarity=0.148 Sum_probs=85.2
Q ss_pred HHHHHhhcCCcc-----cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCc--ccceee
Q 008026 388 QVLRNVTNNFSE-----ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVALLG 460 (580)
Q Consensus 388 ~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~ 460 (580)
+++..+...|.+ .+.|+.|....+|+....++ .+++|...... ....+..|+.++..+.... +.+++.
T Consensus 10 ~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 10 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred HHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 344444444544 34566788889999977655 68889876521 1234566777777764212 233332
Q ss_pred E------EEcCCeeEEEEEecCCCChhH-----------HHHHHhhh--CCC-C-------ccHHHHHH-----------
Q 008026 461 H------CLDGNEKLLVFEYMPQGTLSR-----------HIFNWAEE--GLK-P-------LEWNRRLT----------- 502 (580)
Q Consensus 461 ~------~~~~~~~~lv~e~~~~g~L~~-----------~l~~~~~~--~~~-~-------~~~~~~~~----------- 502 (580)
. ....+..+++|+|++|..+.. .+.+.... ... . ..|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 123456789999998865421 11111111 000 0 11221100
Q ss_pred -HHHHHHHHHHHHHhC----CCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 503 -IALDVARGVEYLHGL----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 503 -i~~~i~~aL~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
+...+...+++++.. ....++|+|+++.||+++.+..+.++||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555531 135789999999999998775568999987753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00023 Score=72.53 Aligned_cols=151 Identities=16% Similarity=0.118 Sum_probs=104.2
Q ss_pred hhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccc
Q 008026 37 VIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLD 115 (580)
Q Consensus 37 ~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~ 115 (580)
......+|+.+.+.++. +.... .|.++..|+.+.+..+... .-...|..+..|+.+.+..+.+.. ..|..+.+|+
T Consensus 225 ~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~ 300 (394)
T 4fs7_A 225 FALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLT 300 (394)
T ss_dssp TTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCC
T ss_pred hhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc--cccccccccc
Confidence 34456788888887543 32323 4788889999999887665 455668889999988887764321 2377788888
Q ss_pred cccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCC
Q 008026 116 MAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF 195 (580)
Q Consensus 116 ~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l 195 (580)
.+.+.++ +..+....|. ...+|+.++|.++ ++..-..+|.+|
T Consensus 301 ~i~l~~~-i~~I~~~aF~------------------------------------~c~~L~~i~lp~~-v~~I~~~aF~~c 342 (394)
T 4fs7_A 301 EVKLLDS-VKFIGEEAFE------------------------------------SCTSLVSIDLPYL-VEEIGKRSFRGC 342 (394)
T ss_dssp EEEECTT-CCEECTTTTT------------------------------------TCTTCCEECCCTT-CCEECTTTTTTC
T ss_pred ccccccc-cceechhhhc------------------------------------CCCCCCEEEeCCc-ccEEhHHhccCC
Confidence 8877654 4444444432 2237888888754 664445678899
Q ss_pred CCCcEEeccCCcccccCCccCcCCCCCCEEEccCC
Q 008026 196 KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 230 (580)
Q Consensus 196 ~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N 230 (580)
++|+.+++..| +...-..+|.++++|+.+++..+
T Consensus 343 ~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 343 TSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred CCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 99999999877 66233557888999999988654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00027 Score=72.02 Aligned_cols=173 Identities=16% Similarity=0.070 Sum_probs=109.3
Q ss_pred cceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCc-------------------
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNF------------------- 76 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~------------------- 76 (580)
+..|+.+.+..+ .......+|.++.+|+.+++..| ++.+.. .|.++..|+.+.+..+.
T Consensus 161 c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip 238 (394)
T 4fs7_A 161 CESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGVKNIIIP 238 (394)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCEEEEC
T ss_pred cCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCCceEEEC
Confidence 334444444322 44444467888888888888766 332222 35555555555544322
Q ss_pred --ccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccc
Q 008026 77 --FTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154 (580)
Q Consensus 77 --l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~ 154 (580)
+...-...|.++.+|+.+.+..+..+-....|..+..++.+....+.+ +...+
T Consensus 239 ~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i---~~~~F---------------------- 293 (394)
T 4fs7_A 239 DSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV---PEKTF---------------------- 293 (394)
T ss_dssp TTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE---CTTTT----------------------
T ss_pred CCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee---ccccc----------------------
Confidence 121112347788999999998886654444577888887766555432 21111
Q ss_pred cCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
....+|+.+.+.++ +...-..+|.++.+|+.++|.++ +...-..+|.++++|+.+++..| ++
T Consensus 294 --------------~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~ 355 (394)
T 4fs7_A 294 --------------YGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR 355 (394)
T ss_dssp --------------TTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred --------------cccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc
Confidence 12247888888765 55445567899999999999765 66233568999999999999776 55
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00055 Score=69.73 Aligned_cols=110 Identities=16% Similarity=0.177 Sum_probs=69.9
Q ss_pred cccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC
Q 008026 84 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 163 (580)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (580)
.|.++++|+.+.+.++..+--.-.|.++..|+.+.+. +.+..++...|..
T Consensus 260 aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~----------------------------- 309 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAG----------------------------- 309 (394)
T ss_dssp TTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTT-----------------------------
T ss_pred eeeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecC-----------------------------
Confidence 4777888888888766544333347777888877775 3344555444421
Q ss_pred ccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccC-CccCcCCCCCCEEEccCCccc
Q 008026 164 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI-PEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 164 ~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~l~~l~~L~~l~ls~N~l~ 233 (580)
+.+|+.++|..+ ++..-..+|.+|++|+.+.|..+ +. .| ..+|.++++|+.+++.+|...
T Consensus 310 -------c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 310 -------CISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp -------CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHH
T ss_pred -------CCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceee
Confidence 236777777654 44344456777888888887654 55 44 346777788888887776543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00035 Score=68.33 Aligned_cols=72 Identities=13% Similarity=0.081 Sum_probs=45.1
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcc-cceeeEEEcCCeeEEEEEec-CC
Q 008026 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL-VALLGHCLDGNEKLLVFEYM-PQ 477 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~ 477 (580)
.+.|+.|....+|++ ..+++|+...... ......+|+.+++.+....+ .+++++. .+.-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 678999999999998 5588887754211 11123567777777642222 4565543 33457899999 66
Q ss_pred CChh
Q 008026 478 GTLS 481 (580)
Q Consensus 478 g~L~ 481 (580)
.++.
T Consensus 93 ~~l~ 96 (301)
T 3dxq_A 93 QTMS 96 (301)
T ss_dssp EECC
T ss_pred ccCC
Confidence 5553
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0005 Score=68.25 Aligned_cols=144 Identities=15% Similarity=0.114 Sum_probs=72.8
Q ss_pred ceeeccCcEE-EEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-C-CcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGT-VYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-H-RHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.++.|.... +|+....++..+++|...... ...+..|+.+++.+. + -.+.+++.+....+ +++||++++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 4465554444 667765446777777654321 023445667666664 2 23456666543333 789999977
Q ss_pred CChhHHHHHH------------------hhh---CCCCccHHHHH-------H-------------HHHHHHHHHHHHH-
Q 008026 478 GTLSRHIFNW------------------AEE---GLKPLEWNRRL-------T-------------IALDVARGVEYLH- 515 (580)
Q Consensus 478 g~L~~~l~~~------------------~~~---~~~~~~~~~~~-------~-------------i~~~i~~aL~~LH- 515 (580)
..+.+.+... ... ....++..... . ....+...++.+.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 6665433210 000 01111111100 0 0001112222221
Q ss_pred --hCCCCCcEecCCCCCCeEecCC----CcEEEEeecccccc
Q 008026 516 --GLAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRLA 551 (580)
Q Consensus 516 --~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~ 551 (580)
......++|||+.+.|||++.+ +.+.|+||+.+...
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123679999999999999874 67999999988654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0018 Score=65.84 Aligned_cols=59 Identities=14% Similarity=0.282 Sum_probs=44.7
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 172 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 172 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
.+|+.+.+. +.+...-...|.++.+|+.++|..+ ++..-..+|.++++|+.+.+..+ ++
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~ 346 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT 346 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC
Confidence 478888886 4566344567889999999999876 65233568999999999999654 54
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0025 Score=62.91 Aligned_cols=144 Identities=14% Similarity=0.055 Sum_probs=81.3
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCc--ccceeeE-----EEcCCeeEEEEE
Q 008026 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVALLGH-----CLDGNEKLLVFE 473 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e 473 (580)
+.++ |....||+....+|+.+++|....... ....+..|..+++.+.... +++++.. ....+..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 778899998776677899998864322 2346667888877774222 3444432 122456688999
Q ss_pred ecCCCChh-----------HHHHHHhh--hC-----CCCccHHHH----HH---------------HHHHHHHHHHHHHh
Q 008026 474 YMPQGTLS-----------RHIFNWAE--EG-----LKPLEWNRR----LT---------------IALDVARGVEYLHG 516 (580)
Q Consensus 474 ~~~~g~L~-----------~~l~~~~~--~~-----~~~~~~~~~----~~---------------i~~~i~~aL~~LH~ 516 (580)
|++|..+. +.+.+... .. ....++... .. +...+...++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875432 11111110 00 011121110 00 01111122333322
Q ss_pred C----CCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 517 L----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 517 ~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
. ....++|+|+++.||+++ + .+.++||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 135689999999999998 4 899999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00076 Score=69.40 Aligned_cols=73 Identities=18% Similarity=0.192 Sum_probs=49.3
Q ss_pred cceeeccCcEEEEEEEEcC--------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCc-ccceeeEEEcCCeeEE
Q 008026 400 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH-LVALLGHCLDGNEKLL 470 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~l 470 (580)
.+.|+.|-...||++...+ +..+++|+.... . ....+.+|..+++.+...+ .+++++.+.. .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4668888889999997653 478999987431 1 1144557888888885333 3567765532 38
Q ss_pred EEEecCCCCh
Q 008026 471 VFEYMPQGTL 480 (580)
Q Consensus 471 v~e~~~~g~L 480 (580)
|+||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0011 Score=66.70 Aligned_cols=144 Identities=15% Similarity=0.160 Sum_probs=83.8
Q ss_pred cceeeccCcEEEEEEEEc--------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEE
Q 008026 400 ENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 470 (580)
.+.+..|-...+|++... ++..|++|+.... ......+.+|.++++.+. +.-..++++++.. .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 356777888889998764 2478999985331 123456678999988885 3334567766543 29
Q ss_pred EEEecCCCChhH--------------HHHHHhhhC---CCCc--cHHHHHHHHHHHHH-------------------HHH
Q 008026 471 VFEYMPQGTLSR--------------HIFNWAEEG---LKPL--EWNRRLTIALDVAR-------------------GVE 512 (580)
Q Consensus 471 v~e~~~~g~L~~--------------~l~~~~~~~---~~~~--~~~~~~~i~~~i~~-------------------aL~ 512 (580)
||||++|..+.. .+.+..... .+.. -+.++.++..++.. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999865531 111111111 1111 24455555544322 233
Q ss_pred HHH----hC-CCCCcEecCCCCCCeEecCC----CcEEEEeeccccc
Q 008026 513 YLH----GL-AHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRL 550 (580)
Q Consensus 513 ~LH----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~ 550 (580)
.|. .. ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 11 13468999999999999876 7899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0027 Score=65.70 Aligned_cols=74 Identities=12% Similarity=0.067 Sum_probs=47.9
Q ss_pred cceeeccCcEEEEEEEEcC-CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcc-cceeeEEEcCCeeEEEEEecCC
Q 008026 400 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL-VALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 477 (580)
.+.|+.|-...+|++...+ +..+++|+..... . ......+|..+++.+...++ +++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D--EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C--SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4568888889999998764 4788899874321 1 11122578899998874444 56777662 2 259999987
Q ss_pred CCh
Q 008026 478 GTL 480 (580)
Q Consensus 478 g~L 480 (580)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0025 Score=64.32 Aligned_cols=55 Identities=16% Similarity=0.177 Sum_probs=32.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccC-CccCcCCCCCCEEEcc
Q 008026 172 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI-PEGLSVLGALKELDVS 228 (580)
Q Consensus 172 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~l~~l~~L~~l~ls 228 (580)
.+|+.+++.++.+...-...|.+|.+|+.+.|..+ +. .| ..+|.++++|+.+.+.
T Consensus 286 ~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 286 SNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp TTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCC
T ss_pred cccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEEC
Confidence 36666666666666444455666777777776544 44 33 3456666666666553
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.001 Score=55.84 Aligned_cols=55 Identities=18% Similarity=0.203 Sum_probs=41.9
Q ss_pred ceEecccCcCc--CCCCCCCCCCCCcEEeccCCcccccCCcc-ccCCCCCcEEEccCCccc
Q 008026 45 KEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQ 102 (580)
Q Consensus 45 ~~L~L~~N~l~--~~~p~~~~l~~L~~L~L~~N~l~~~~P~~-~~~l~~L~~L~L~~N~l~ 102 (580)
..++.+++.++ ..+..+ -++|+.|+|++|+|+ .+|.. |..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCC--CcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 47888888887 444333 246889999999998 67665 788999999999988653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00013 Score=64.58 Aligned_cols=80 Identities=11% Similarity=0.123 Sum_probs=41.8
Q ss_pred cCceEecccCcCcCC-CCCCCCCCCCcEEeccCCc-ccccCCccccCC----CCCcEEEccCC-ccccc-CCCCCccccc
Q 008026 43 SLKEIWLHSNAFSGP-LPDFSGVKQLESLSLRDNF-FTGPVPDSLVKL----ESLKIVNMTNN-LLQGP-VPEFDRSVSL 114 (580)
Q Consensus 43 ~L~~L~L~~N~l~~~-~p~~~~l~~L~~L~L~~N~-l~~~~P~~~~~l----~~L~~L~L~~N-~l~~~-~~~~~~~~~L 114 (580)
.|+.|||+++.|+.. +..+.++++|+.|+|++|. ++..-=..+..+ ++|+.|+|+++ +++.. +..+..+.+|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 566666666665532 2234556666666666664 442111223332 24666666665 35431 1234455666
Q ss_pred ccccccCC
Q 008026 115 DMAKGSNN 122 (580)
Q Consensus 115 ~~l~l~~n 122 (580)
+.|+++++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 66666665
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0014 Score=65.94 Aligned_cols=74 Identities=16% Similarity=0.138 Sum_probs=44.2
Q ss_pred cceeeccCcEEEEEEEEcC---------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCc-ccceeeEEEcCCeeE
Q 008026 400 ENILGRGGFGTVYKGELHD---------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH-LVALLGHCLDGNEKL 469 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~ 469 (580)
.+.++.|..-.+|++...+ +..+++|+..... ........|.++++.+...+ ..++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3567778888999997653 2688888765421 11112467888888775323 44666544 2 36
Q ss_pred EEEEecCCCCh
Q 008026 470 LVFEYMPQGTL 480 (580)
Q Consensus 470 lv~e~~~~g~L 480 (580)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0054 Score=61.88 Aligned_cols=141 Identities=15% Similarity=0.109 Sum_probs=93.3
Q ss_pred hhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCC-ccccCCCCCcEEEccCCcccccCC-CCCccc
Q 008026 36 DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVP-DSLVKLESLKIVNMTNNLLQGPVP-EFDRSV 112 (580)
Q Consensus 36 ~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P-~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~ 112 (580)
..+....+|+.+.+..+ +..... .|.++..|+.+.+..+ ++ .|. ..|.++.+|+.+.+..+ ++.+.. .|..+.
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceecccccccccc
Confidence 34556677777777655 332222 4777888888888765 55 343 45888888888888654 444443 377888
Q ss_pred ccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccc
Q 008026 113 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF 192 (580)
Q Consensus 113 ~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~ 192 (580)
+|+.+.+.++.+..++..+|.+ +.+|+.++|..+ ++..-..+|
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~------------------------------------c~~L~~i~lp~~-l~~I~~~aF 329 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMD------------------------------------CVKLSSVTLPTA-LKTIQVYAF 329 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTT------------------------------------CTTCCEEECCTT-CCEECTTTT
T ss_pred ccccccccccccceehhhhhcC------------------------------------CCCCCEEEcCcc-ccEEHHHHh
Confidence 8888888777777666665532 237888888765 653445679
Q ss_pred cCCCCCcEEeccCCcccccC-CccCcCC
Q 008026 193 ASFKSLQRLILADNNLSGMI-PEGLSVL 219 (580)
Q Consensus 193 ~~l~~L~~L~ls~N~l~g~~-p~~l~~l 219 (580)
.+|++|+++.+..+ +. .| ..+|.++
T Consensus 330 ~~C~~L~~i~ip~~-v~-~I~~~aF~~c 355 (379)
T 4h09_A 330 KNCKALSTISYPKS-IT-LIESGAFEGS 355 (379)
T ss_dssp TTCTTCCCCCCCTT-CC-EECTTTTTTS
T ss_pred hCCCCCCEEEECCc-cC-EEchhHhhCC
Confidence 99999999988655 54 34 3345443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0022 Score=53.82 Aligned_cols=51 Identities=25% Similarity=0.460 Sum_probs=35.8
Q ss_pred EEEecCCccc-ccCcccccCCCCCcEEeccCCcccccCC-ccCcCCCCCCEEEccC
Q 008026 176 VINFQKMNLT-GTISPEFASFKSLQRLILADNNLSGMIP-EGLSVLGALKELDVSN 229 (580)
Q Consensus 176 ~L~ls~n~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~l~~l~~L~~l~ls~ 229 (580)
.++-+++.|+ ..+|..+. ++|+.|+|++|+|+ .+| ..|..+++|+.|+|++
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~ 64 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGA 64 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCS
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecC
Confidence 6778888886 45775532 46888999999988 554 4567778888776543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0062 Score=60.45 Aligned_cols=31 Identities=23% Similarity=0.434 Sum_probs=27.6
Q ss_pred CCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 520 QSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 520 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5789999999999999878899999987754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.58 E-value=0.00064 Score=60.04 Aligned_cols=35 Identities=17% Similarity=0.231 Sum_probs=24.4
Q ss_pred cEEEEEecCCc-ccccCcccccCCCCCcEEeccCCc
Q 008026 173 NITVINFQKMN-LTGTISPEFASFKSLQRLILADNN 207 (580)
Q Consensus 173 ~L~~L~ls~n~-l~~~~p~~~~~l~~L~~L~ls~N~ 207 (580)
+|+.|+|++|. ++..-=..+.++++|+.|+|+++.
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 57888888874 664433456677888888887764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.42 E-value=0.00061 Score=61.39 Aligned_cols=59 Identities=14% Similarity=0.103 Sum_probs=26.4
Q ss_pred cEEEEEecCCccccc----CcccccCCCCCcEEeccCC---cccc----cCCccCcCCCCCCEEEccCCc
Q 008026 173 NITVINFQKMNLTGT----ISPEFASFKSLQRLILADN---NLSG----MIPEGLSVLGALKELDVSNNQ 231 (580)
Q Consensus 173 ~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~ls~N---~l~g----~~p~~l~~l~~L~~l~ls~N~ 231 (580)
.|+.|+|++|.|... +-+.+..-+.|++|+|++| ++.. .+-..+..-+.|+.|+++.|.
T Consensus 99 tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 99 SLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp SCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred ccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 445555555555421 2223333344566666543 2221 122334444556666665554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.19 E-value=0.00092 Score=60.22 Aligned_cols=87 Identities=21% Similarity=0.206 Sum_probs=61.2
Q ss_pred hcCcccCceEecccC-cCcCC----C-CCCCCCCCCcEEeccCCcccc----cCCccccCCCCCcEEEccCCcccccCC-
Q 008026 38 IQNMTSLKEIWLHSN-AFSGP----L-PDFSGVKQLESLSLRDNFFTG----PVPDSLVKLESLKIVNMTNNLLQGPVP- 106 (580)
Q Consensus 38 ~~~l~~L~~L~L~~N-~l~~~----~-p~~~~l~~L~~L~L~~N~l~~----~~P~~~~~l~~L~~L~L~~N~l~~~~~- 106 (580)
+.+-+.|++|+|++| .|... + ..+..-+.|+.|+|++|+|.. .|-+.+..-+.|+.|+|++|+|...-.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 445578999999986 66531 1 124456789999999999863 234456667889999999999875432
Q ss_pred ----CCCcccccccccccCCCC
Q 008026 107 ----EFDRSVSLDMAKGSNNFC 124 (580)
Q Consensus 107 ----~~~~~~~L~~l~l~~n~~ 124 (580)
.+.....|+.|++++|..
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~ 138 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQ 138 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSS
T ss_pred HHHHHHhhCCceeEEECCCCcC
Confidence 355667789999887643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.021 Score=58.19 Aligned_cols=143 Identities=13% Similarity=0.177 Sum_probs=84.0
Q ss_pred cceeeccCcEEEEEEEEcC--------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEE
Q 008026 400 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 470 (580)
.+.+..|-...+|+....+ +..|++|+..... .......+|.++++.+. +.-..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 4567778888999997653 5789999864421 11123457888888775 33345666533 2 278
Q ss_pred EEEecCCCChhH--------------HHHHHhh--h---------CCCCccHHHHHHHHHHH------------------
Q 008026 471 VFEYMPQGTLSR--------------HIFNWAE--E---------GLKPLEWNRRLTIALDV------------------ 507 (580)
Q Consensus 471 v~e~~~~g~L~~--------------~l~~~~~--~---------~~~~~~~~~~~~i~~~i------------------ 507 (580)
||||++|..|.. .+.+... . ...+.-+.++.++..++
T Consensus 148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 227 (424)
T 3mes_A 148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK 227 (424)
T ss_dssp EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence 999999865421 1111100 0 11112244444443322
Q ss_pred -HHHHHHHHhC---------------------CCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 508 -ARGVEYLHGL---------------------AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 508 -~~aL~~LH~~---------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
...+++|... ....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223333211 1245899999999999 7788999999998763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.04 E-value=0.2 Score=50.76 Aligned_cols=29 Identities=31% Similarity=0.529 Sum_probs=24.5
Q ss_pred cEecCCCCCCeEe------cCCCcEEEEeeccccc
Q 008026 522 FIHRDLKPSNILL------GDDMRAKVADFGLVRL 550 (580)
Q Consensus 522 ivH~Dlkp~NIll------~~~~~~kl~Dfg~a~~ 550 (580)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3456799999998754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.62 E-value=1.5 Score=39.66 Aligned_cols=86 Identities=10% Similarity=0.045 Sum_probs=60.7
Q ss_pred CCCcccceeeEEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHH-HHHhCCCCCcEecCCCC
Q 008026 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE-YLHGLAHQSFIHRDLKP 529 (580)
Q Consensus 451 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~-~LH~~~~~~ivH~Dlkp 529 (580)
.||++ -...-.+++.+.+.++.-+++.=...+ ..++...+++++.+|+.... +++. -+|--++|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 57777 334446667766666654332222222 24677888899988888766 5553 58889999
Q ss_pred CCeEecCCCcEEEEeecccccc
Q 008026 530 SNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 530 ~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
+||+++.++.+++.-.|+-..+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTB
T ss_pred ceEEEeCCCcEEEEEcCCcccC
Confidence 9999999999999999975544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.84 E-value=0.083 Score=54.59 Aligned_cols=63 Identities=10% Similarity=0.054 Sum_probs=18.0
Q ss_pred cccceeeccCcEEEEEEEEcC-CcEEEE------EEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEE
Q 008026 398 SEENILGRGGFGTVYKGELHD-GTKIAV------KRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL 463 (580)
Q Consensus 398 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 463 (580)
.+.+.+| ||.||+|.+.. ..+||+ |..............+.+|..+++..+|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3445666 99999997753 367888 766554444445567888999999999999999988765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.57 E-value=1.4 Score=39.75 Aligned_cols=87 Identities=13% Similarity=0.095 Sum_probs=62.5
Q ss_pred CCCcccceeeEEEcCCeeEEEEEecC-CCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 008026 451 RHRHLVALLGHCLDGNEKLLVFEYMP-QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 529 (580)
Q Consensus 451 ~h~niv~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp 529 (580)
.||+++.. .+-.+.+.+.+.++.-+ +-++.. + +..+...+++++.+|+...++++. =+|--++|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i--------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I--------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G--------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H--------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 57888866 45556666555555443 223322 2 346778889999999988866664 48889999
Q ss_pred CCeEecCCCcEEEEeeccccccC
Q 008026 530 SNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 530 ~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
+|++++.++.+++.-.|+-..+.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l~ 130 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVVD 130 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTBS
T ss_pred ceEEEcCCCCEEEEEccCccCCC
Confidence 99999999999999999755443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 580 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-52
Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 11/180 (6%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ +G G FGTVYKG+ H +AVK + + + L FK+E+ VL K RH +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
++ +G+ + +V ++ +L H+ E + + IA A+G++YL
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYL 120
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGYLAPEY 573
H +S IHRDLK +NI L +D+ K+ DFGL + GS + +++G+ ++APE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-49
Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 10/179 (5%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
LG G FG V+ G + TK+AVK ++ G +S F +E ++ +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
LV L ++ EYM G+L + L N+ L +A +A G+ ++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
+++IHRDL+ +NIL+ D + K+ADFGL RL + + + + APE
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 8e-49
Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 12/182 (6%)
Query: 394 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 452
++F + + LG G G V+K G +A K + I + E+ VL +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 63
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
++V G E + E+M G+L + + + +++ V +G+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLT 118
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
YL +HRD+KPSNIL+ K+ DFG+ + S+ GT Y++PE
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPE 173
Query: 573 YA 574
Sbjct: 174 RL 175
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (425), Expect = 5e-48
Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 15/184 (8%)
Query: 392 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTK 449
+ FS+ +G G FG VY + + +A+K+M +G S + + E+ L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+RH + + G L + LV EY + KPL+ + +
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQ 126
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
G+ YLH + IHRD+K NILL + K+ DFG + GT ++
Sbjct: 127 GLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWM 178
Query: 570 APEY 573
APE
Sbjct: 179 APEV 182
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-47
Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 10/179 (5%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ + LG G FG V G+ +A+K ++ G +S EF E V+ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEK 60
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
LV L G C ++ EYM G L ++ + + L + DV +EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYL 116
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
+ F+HRDL N L+ D KV+DFGL R + + + + PE
Sbjct: 117 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-47
Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ + +G G FG V+ G + K+A+K + G +S + +F E V+ K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 61
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
LV L G CL+ LVFE+M G LS ++ L + LDV G+ YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYL 117
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
IHRDL N L+G++ KV+DFG+ R + + + T + +PE
Sbjct: 118 E---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-46
Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 452
+F LG+G FG VY +A+K + + G+ + E+ + + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+++ L G+ D L+ EY P GT+ R + + R T ++A +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALS 120
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
Y H + IHRD+KP N+LLG K+ADFG AP + T + GT YL PE
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 174
Query: 573 Y 573
Sbjct: 175 M 175
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-46
Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 7/183 (3%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
++ +G G +G K DG + K ++ G ++ SE+ +L +++H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 455 LVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
+V +D L V EY G L+ I +E + L+ L + + ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALK 123
Query: 513 YLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 570
H + +HRDLKP+N+ L K+ DFGL R+ S GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182
Query: 571 PEY 573
PE
Sbjct: 183 PEQ 185
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-45
Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 10/182 (5%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ E LG+G FG V+ G + T++A+K ++ G +S + F E V+ K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
LV L +V EYM +G+L + E K L + + +A +A G+ Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
+++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 575 GN 576
Sbjct: 187 LY 188
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-45
Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 14/183 (7%)
Query: 399 EENILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 455
E+ LG G FGTV KG +AVK ++ E +E V+ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 456 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
V ++G C + +LV E G L++++ + ++ + + V+ G++YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE 124
Query: 516 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEY 573
+F+HRDL N+LL AK++DFGL + + + + + APE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 574 AGN 576
Sbjct: 182 INY 184
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-45
Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 16/181 (8%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+G+G FG V G+ + G K+AVK ++ + F +E +V+T++RH +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSN 61
Query: 455 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
LV LLG ++ L +V EYM +G+L ++ + G L + L +LDV +EY
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
L +F+HRDL N+L+ +D AKV+DFGL + A S + + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEA 171
Query: 574 A 574
Sbjct: 172 L 172
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-45
Identities = 48/184 (26%), Positives = 74/184 (40%), Gaps = 11/184 (5%)
Query: 392 NVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
N + + LG G FG VYK + + A K ++ S + L ++ EI +L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASC 66
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
H ++V LL N ++ E+ G + + +PL ++ +
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDA 122
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 570
+ YLH IHRDLK NIL D K+ADFG+ GT ++A
Sbjct: 123 LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMA 178
Query: 571 PEYA 574
PE
Sbjct: 179 PEVV 182
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-45
Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 400 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 458
+ +GRG F TVYKG + ++A ++ ++ FK E +L ++H ++V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 459 LGHCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+LV E M GTL ++ + K ++ + + +G+++L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFL 128
Query: 515 HGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
H IHRDLK NI + G K+ D GL L + S + GT ++APE
Sbjct: 129 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184
Query: 574 AGN 576
Sbjct: 185 YEE 187
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 2e-44
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 395 NNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
NN +G G FG V++ T +AVK ++ S +F+ E A++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 71
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-------------------WAE 489
+ + ++V LLG C G L+FEYM G L+ + + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 490 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
G PL +L IA VA G+ YL + F+HRDL N L+G++M K+ADFGL R
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 550 LAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580
+ A ++ PE +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYT 220
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (398), Expect = 2e-44
Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 10/183 (5%)
Query: 395 NNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+ + ++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 73
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
+LV LLG C ++ E+M G L ++ E + + L +A ++ +EY
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISSAMEY 130
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
L ++FIHRDL N L+G++ KVADFGL RL + + APE
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 574 AGN 576
Sbjct: 188 LAY 190
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-44
Identities = 47/181 (25%), Positives = 71/181 (39%), Gaps = 11/181 (6%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
++ LG G +G V +AVK ++ K EI + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHE 63
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
++V GH +GN + L EY G L I + + GV Y
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVY 118
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 572
LH HRD+KP N+LL + K++DFGL + + ++ GT Y+APE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 573 Y 573
Sbjct: 176 L 176
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-44
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 30/206 (14%)
Query: 395 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
N +LG G FG V + ++AVK ++ S + SE+ ++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMT 95
Query: 449 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN------------------WAE 489
++ H ++V LLG C L+FEY G L ++ + E
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 490 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
E L L + L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 550 LAPEGKG-SIETRIAGTFGYLAPEYA 574
+ ++APE
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESL 238
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 15/186 (8%)
Query: 394 TNNFSEENI-LGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
+N +I LG G FG+V +G +A+K ++ G E E ++ +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQ 65
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+ + ++V L+G C +LV E G L + + + + + + V+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSM 120
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFG 567
G++YL ++F+HRDL N+LL + AK++DFGL + R
Sbjct: 121 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 568 YLAPEY 573
+ APE
Sbjct: 178 WYAPEC 183
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 5e-43
Identities = 45/205 (21%), Positives = 86/205 (41%), Gaps = 25/205 (12%)
Query: 386 SIQVLRNVTNNFSEE---------NILGRGGFGTVYKGELHDGTK----IAVKRMEAGVI 432
+ + F++E ++G G FG V G L K +A+K +++G
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY- 66
Query: 433 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 492
+ K +F SE +++ + H +++ L G +++ E+M G+L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---- 122
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552
+ + + +A G++YL +++HRDL NIL+ ++ KV+DFGL R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 553 EGKGSIETR----IAGTFGYLAPEY 573
+ + APE
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEA 204
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-42
Identities = 53/203 (26%), Positives = 81/203 (39%), Gaps = 25/203 (12%)
Query: 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
N S LG G FG V + + +AVK ++ + SE+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLS 81
Query: 449 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-------------WAEEGLKP 494
+ H ++V LLG C G L++ EY G L + E+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 495 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554
L+ L+ + VA+G+ +L ++ IHRDL NILL K+ DFGL R
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 555 KGS-IETRIAGTFGYLAPEYAGN 576
++ ++APE N
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFN 221
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-42
Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 22/186 (11%)
Query: 400 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 459
+ +G+G FG V++G+ G ++AVK + + ++EI +RH +++ +
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 63
Query: 460 GHCLDGNEKL----LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 515
N LV +Y G+L ++ + + +AL A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLH 117
Query: 516 -----GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE---TRIAGTFG 567
+ HRDLK NIL+ + +AD GL +I+ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 568 YLAPEY 573
Y+APE
Sbjct: 178 YMAPEV 183
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 4e-42
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 396 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHR 453
+F ILG G F TV EL + A+K +E +I + E V++++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
V L D + Y G L ++I + ++ +EY
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEY 123
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APEGKGSIETRIAGTFGYLAPE 572
LH + IHRDLKP NILL +DM ++ DFG ++ +PE K + GT Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 573 Y 573
Sbjct: 181 L 181
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-42
Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 15/187 (8%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGT-----KIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
+ + + ++G G FG VYKG L + +A+K ++AG K +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQ 65
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
H +++ L G +++ EYM G L + + + + + +A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAA 121
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA--GTFG 567
G++YL + +++HRDL NIL+ ++ KV+DFGL R+ + + T
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 568 YLAPEYA 574
+ APE
Sbjct: 179 WTAPEAI 185
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 61/194 (31%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 450
N+ ++++G G FG V K + A+KRM+ S +F E+ VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 68
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNR 499
H +++ LLG C L EY P G L + F A L +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 500 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 559
L A DVARG++YL + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 560 TRIAGTFGYLAPEY 573
T ++A E
Sbjct: 184 TMGRLPVRWMAIES 197
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-41
Identities = 50/201 (24%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 374 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 432
D ++LE ++S+ + ++ +G+G GTVY ++ G ++A+++M
Sbjct: 2 DEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-- 56
Query: 433 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 492
+EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------ 110
Query: 493 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552
++ + + + + +E+LH IHRD+K NILLG D K+ DFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI- 166
Query: 553 EGKGSIETRIAGTFGYLAPEY 573
+ S + + GT ++APE
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEV 187
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-41
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 387 IQVLRNVTNNFSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFK 441
+++L+ F + +LG G FGTVYKG +A+K + S K E
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEIL 59
Query: 442 SEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 501
E V+ V + H+ LLG CL +L+ + MP G L ++ E + L
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL----LDYVREHKDNIGSQYLL 114
Query: 502 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIET 560
+ +A+G+ YL + +HRDL N+L+ K+ DFGL + L E K
Sbjct: 115 NWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 561 RIAGTFGYLAPEYA 574
++A E
Sbjct: 172 GGKVPIKWMALESI 185
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 16/191 (8%)
Query: 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
+ LG+G FG VY+G T++A+K + S + EF +E +V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK 78
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-----AEEGLKPLEWNRRLTI 503
+ H+V LLG G L++ E M +G L ++ + L P ++ + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRI 562
A ++A G+ YL+ F+HRDL N ++ +D K+ DFG+ R E + +
Sbjct: 139 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 563 AGTFGYLAPEY 573
+++PE
Sbjct: 196 LLPVRWMSPES 206
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 146 bits (370), Expect = 7e-40
Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 14/186 (7%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+V +++ LG G FG V++ E G A K + S K + EI ++ +
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVL 80
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
RH LV L D NE ++++E+M G L + + + + + V +G
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKG 136
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPEGKGSIETRIAGTFGY 568
+ ++H +++H DLKP NI+ K+ DFGL + T GT +
Sbjct: 137 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEF 191
Query: 569 LAPEYA 574
APE A
Sbjct: 192 AAPEVA 197
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-40
Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 395 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTK 449
+ LG G FG V +GE +AVK ++ V+S + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+ HR+L+ L G L K+ V E P G+L + + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS--IETRIAGTFG 567
G+ YL + FIHRDL N+LL K+ DFGL+R P+ ++ F
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 568 YLAPEYAGN 576
+ APE
Sbjct: 180 WCAPESLKT 188
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-38
Identities = 38/183 (20%), Positives = 70/183 (38%), Gaps = 13/183 (7%)
Query: 395 NNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+G G FG V++G +A+K + S +F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 65
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
H H+V L+G + ++ E G L + L+ + A ++
Sbjct: 66 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTA 120
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 570
+ YL + F+HRD+ N+L+ + K+ DFGL R + ++ ++A
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 571 PEY 573
PE
Sbjct: 178 PES 180
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-38
Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 18/193 (9%)
Query: 392 NVTNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVL 447
++ +F+E ++GRG FG VY G L D AVK + G+ +++F +E ++
Sbjct: 26 SLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIM 82
Query: 448 TKVRHRHLVALLGHCLDG-NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 506
H ++++LLG CL L+V YM G L I N + L
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQ 138
Query: 507 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG---SIETRIA 563
VA+G+++L + F+HRDL N +L + KVADFGL R + + +T
Sbjct: 139 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 564 GTFGYLAPEYAGN 576
++A E
Sbjct: 196 LPVKWMALESLQT 208
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (350), Expect = 8e-38
Identities = 52/187 (27%), Positives = 74/187 (39%), Gaps = 19/187 (10%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-------FKSEIAVL 447
N+ + ILGRG V + + AVK ++ E E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 448 TKVR-HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 506
KV H +++ L LVF+ M +G L ++ L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRA 118
Query: 507 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 566
+ + LH + +HRDLKP NILL DDM K+ DFG G+ + GT
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTP 173
Query: 567 GYLAPEY 573
YLAPE
Sbjct: 174 SYLAPEI 180
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (354), Expect = 1e-37
Identities = 43/186 (23%), Positives = 71/186 (38%), Gaps = 14/186 (7%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
+V + + LG G FG V++ E G K + K K+EI+++ +
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+ H L+ L D E +L+ E++ G L I + +
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACE 138
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 567
G++++H S +H D+KP NI+ K+ DFGL I T
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAE 193
Query: 568 YLAPEY 573
+ APE
Sbjct: 194 FAAPEI 199
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 140 bits (354), Expect = 1e-37
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 395 NNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGK-GLTEFKSE---IAVLTK 449
N+FS I+GRGGFG VY D G A+K ++ I K G T +E +++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
+V + ++ + + M G L H+ A ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 118
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 569
G+E++H ++ ++RDLKP+NILL + +++D GL + K GT GY+
Sbjct: 119 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYM 172
Query: 570 APEY 573
APE
Sbjct: 173 APEV 176
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 42/188 (22%), Positives = 78/188 (41%), Gaps = 9/188 (4%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+V ++ + +G G +G V + + ++A+K++ EI +L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLREIKILLRF 63
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
RH +++ + + + Y+ + ++ + L + + RG
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRG 121
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE--TRIAGTFGY 568
++Y+H + +HRDLKPSN+LL K+ DFGL R+A T T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 569 LAPEYAGN 576
APE N
Sbjct: 179 RAPEIMLN 186
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 5e-37
Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 15/189 (7%)
Query: 392 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
++ + + ++LG G F V E +A+K + + GK ++EIAVL K+
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKI 64
Query: 451 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
+H ++VAL G L+ + + G L I + V
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDA 119
Query: 511 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 567
V+YLH +HRDLKP N+L +D + ++DFGL ++ E GS+ + GT G
Sbjct: 120 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 174
Query: 568 YLAPEYAGN 576
Y+APE
Sbjct: 175 YVAPEVLAQ 183
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 135 bits (341), Expect = 1e-36
Identities = 48/191 (25%), Positives = 79/191 (41%), Gaps = 16/191 (8%)
Query: 392 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTK 449
++++ + ILG GG V+ L +AVK + A + F+ E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 450 VRHRHLVALLGHCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
+ H +VA+ G +V EY+ TL + P+ R + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIA 118
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE--TRIA 563
D + + + H IHRD+KP+NI++ KV DFG+ R + S+ +
Sbjct: 119 DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 564 GTFGYLAPEYA 574
GT YL+PE A
Sbjct: 176 GTAQYLSPEQA 186
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-36
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 25/200 (12%)
Query: 395 NNFSEENILGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAV 446
+ LG G FG V E + TK+AVK +++ K L++ SE+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 447 LTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL-----------KP 494
+ + +H++++ LLG C ++ EY +G L ++ GL +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 495 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554
L ++ A VARG+EYL + IHRDL N+L+ +D K+ADFGL R
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 555 KGSIET-RIAGTFGYLAPEY 573
+T ++APE
Sbjct: 189 DYYKKTTNGRLPVKWMAPEA 208
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (337), Expect = 9e-36
Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRH 452
+F LG G FG V+ H+G A+K ++ ++ K + E +L+ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
++ + G D + ++ +Y+ G L + + A +V +E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALE 118
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
YLH + I+RDLKP NILL + K+ DFG + P+ + + GT Y+APE
Sbjct: 119 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPE 171
Query: 573 Y 573
Sbjct: 172 V 172
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-35
Identities = 46/200 (23%), Positives = 76/200 (38%), Gaps = 24/200 (12%)
Query: 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 448
+ LGRG FG V + + +AVK ++ G + SE+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILI 71
Query: 449 KVRHRHLVALLGHCL--DGNEKLLVFEYMPQGTLSRHIFN-----------WAEEGLKPL 495
+ H V L G +++ E+ G LS ++ + + L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 496 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 555
+ + VA+G+E+L + IHRDL NILL + K+ DFGL R +
Sbjct: 132 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 556 GSIE-TRIAGTFGYLAPEYA 574
+ ++APE
Sbjct: 189 DYVRKGDARLPLKWMAPETI 208
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (329), Expect = 6e-35
Identities = 43/182 (23%), Positives = 73/182 (40%), Gaps = 8/182 (4%)
Query: 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
+ +G G +G VYK + + G A+K++ + EI++L +++H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V L +LVFE++ Q LE + L + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYC 116
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
H + +HRDLKP N+L+ + K+ADFGL R I +
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 575 GN 576
G+
Sbjct: 174 GS 175
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 49/182 (26%), Positives = 77/182 (42%), Gaps = 12/182 (6%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKV-R 451
+F +LG+G FG V+ E A+K ++ V+ + E VL+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 452 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 511
H L + V EY+ G L HI + + +R A ++ G+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGL 116
Query: 512 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 571
++LH + ++RDLK NILL D K+ADFG+ + G + GT Y+AP
Sbjct: 117 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAP 172
Query: 572 EY 573
E
Sbjct: 173 EI 174
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-34
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 9/178 (5%)
Query: 396 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 454
NF + +G G +G VYK G +A+K++ + + EI++L ++ H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 455 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 514
+V LL N+ LVFE++ Q + L + + + +G+ +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFC 118
Query: 515 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
H +HRDLKP N+L+ + K+ADFGL R T T Y APE
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 172
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 9e-34
Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 401 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLV 456
+ LG G F TVYK + +A+K+++ G S EI +L ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 457 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 516
LL + LVF++M N L + L +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH- 117
Query: 517 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 574
+HRDLKP+N+LL ++ K+ADFGL + + T T Y APE
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELL 172
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 4e-33
Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 18/187 (9%)
Query: 395 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKG----LTEFKSEIAVLTK 449
+ + +LG GGFG+VY G + D +A+K +E IS G T E+ +L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 450 VRHRH--LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 507
V ++ LL + +L+ E L+ + V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQV 119
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 566
V + H + +HRD+K NIL+ + K+ DFG L + ++ T GT
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTR 173
Query: 567 GYLAPEY 573
Y PE+
Sbjct: 174 VYSPPEW 180
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-33
Identities = 40/189 (21%), Positives = 72/189 (38%), Gaps = 15/189 (7%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
+ + + LGRG FG V++ E K ++ + G K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNI 57
Query: 450 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 509
RHR+++ L E +++FE++ + I L ++ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCE 113
Query: 510 GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 567
+++LH + H D++P NI+ K+ +FG R G +
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPE 168
Query: 568 YLAPEYAGN 576
Y APE +
Sbjct: 169 YYAPEVHQH 177
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 49/191 (25%), Positives = 78/191 (40%), Gaps = 19/191 (9%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI----SGKGLTEFKSEIAV 446
NV + + LG G F V K E G + A K ++ G + + E+++
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 447 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 506
L +++H +++ L + + +L+ E + G L + + L
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQ 121
Query: 507 VARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRLAPEGKGSIETRI 562
+ GV YLH H DLKP NI+L D R K+ DFGL G+ I
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNI 176
Query: 563 AGTFGYLAPEY 573
GT ++APE
Sbjct: 177 FGTPEFVAPEI 187
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 43/198 (21%), Positives = 77/198 (38%), Gaps = 20/198 (10%)
Query: 391 RNVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 449
R ++++ ++G G FG VY+ +L D G +A+K++ + E+ ++ K
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRK 69
Query: 450 VRHRHLVALLGHCLDGNEK------LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 503
+ H ++V L EK LV +Y+P+ + L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLY 127
Query: 504 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRI 562
+ R + Y+H HRD+KP N+LL D K+ DFG + G+ + I
Sbjct: 128 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYI 183
Query: 563 AGTFGYLAPEYAGNFGSS 580
+ G +
Sbjct: 184 CSRYYRAPELIFGATDYT 201
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 7e-32
Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 24/186 (12%)
Query: 400 ENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVA 457
+LG G G V + K A+K + + + + E+ + + + H+V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVR 69
Query: 458 LLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
++ + L+V E + G L I + G + I + ++Y
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 514 LHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 570
LH + HRD+KP N+L + K+ DFG + T Y+A
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVA 181
Query: 571 PEYAGN 576
PE G
Sbjct: 182 PEVLGP 187
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 52/181 (28%), Positives = 74/181 (40%), Gaps = 11/181 (6%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKVRH 452
N+F +LG+G FG V G A+K + VI K + +E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
L AL + V EY G L H+ + R ++ +E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
YLH + ++RD+K N++L D K+ DFGL + G+ GT YLAPE
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPE 175
Query: 573 Y 573
Sbjct: 176 V 176
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-31
Identities = 38/183 (20%), Positives = 73/183 (39%), Gaps = 9/183 (4%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+ + +G G +GTV+K + +A+KR+ + EI +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 454 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 513
++V L + LVFE+ Q L+ + + +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGF 116
Query: 514 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 573
H ++ +HRDLKP N+L+ + K+A+FGL R + +
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 574 AGN 576
G
Sbjct: 174 FGA 176
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 3e-31
Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 11/186 (5%)
Query: 394 TNNFSEENILGRGGFGTVYKGE--LHDGTKIAVKRMEAGVISGKGLTEFKSEIAV---LT 448
+ +G G +G V+K + G +A+KR+ E+AV L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 449 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP-LEWNRRLTIALDV 507
H ++V L C + + + + + ++ +P + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 567
RG+++LH +HRDLKP NIL+ + K+ADFGL R+ T + T
Sbjct: 126 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLW 180
Query: 568 YLAPEY 573
Y APE
Sbjct: 181 YRAPEV 186
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 44/191 (23%), Positives = 73/191 (38%), Gaps = 20/191 (10%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 453
+ + + +G+G FG V+K G K+A+K++ EI +L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 454 HLVALLGHCLDGNEK--------LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
++V L+ C LVF++ L + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQ 124
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS---IETRI 562
+ G L+ + +HRD+K +N+L+ D K+ADFGL R K S T
Sbjct: 125 MLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 563 AGTFGYLAPEY 573
T Y PE
Sbjct: 182 VVTLWYRPPEL 192
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 21/194 (10%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
V + + +G G +G V + G K+A+K++ S E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 451 RHRHLVALLGHCLDGN------EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 504
RH +++ LL + LV +M GT + + L +R +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH-----EKLGEDRIQFLV 127
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 564
+ +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A S T
Sbjct: 128 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVV 180
Query: 565 TFGYLAPEYAGNFG 578
T Y APE N+
Sbjct: 181 TRWYRAPEVILNWM 194
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 118 bits (296), Expect = 2e-30
Identities = 32/194 (16%), Positives = 67/194 (34%), Gaps = 25/194 (12%)
Query: 393 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 451
V ++ +G G FG +++G L + ++A+K + + E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLA 58
Query: 452 HR-HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
+ + +G +LV + + + A +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-----RKFSVKTVAMAAKQMLAR 113
Query: 511 VEYLHGLAHQSFIHRDLKPSNILLGDDM-----RAKVADFGLVRLAPEGKGSIE------ 559
V+ +H +S ++RD+KP N L+G V DFG+V+ +
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 560 TRIAGTFGYLAPEY 573
++GT Y++
Sbjct: 171 KNLSGTARYMSINT 184
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (296), Expect = 2e-30
Identities = 38/192 (19%), Positives = 70/192 (36%), Gaps = 23/192 (11%)
Query: 393 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 451
V N + +G G FG +Y G + G ++A+K + E + ++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQ 60
Query: 452 HRHLVALLGHCL-DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
+ + C +G+ ++V E + F + L +A +
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-----RKFSLKTVLLLADQMISR 115
Query: 511 VEYLHGLAHQSFIHRDLKPSNIL---LGDDMRAKVADFGLVRLAPEGKGSIE------TR 561
+EY+H ++FIHRD+KP N L + DFGL + + +
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 562 IAGTFGYLAPEY 573
+ GT Y +
Sbjct: 173 LTGTARYASINT 184
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-30
Identities = 46/196 (23%), Positives = 73/196 (37%), Gaps = 20/196 (10%)
Query: 392 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
V + +G G G V + +A+K++ + E+ ++ V
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 451 RHRHLVALLGHCL------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 504
H+++++LL + + LV E M E R +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--------RMSYLL 125
Query: 505 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 564
+ G+++LH IHRDLKPSNI++ D K+ DFGL R G + T
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV 180
Query: 565 TFGYLAPEYAGNFGSS 580
T Y APE G
Sbjct: 181 TRYYRAPEVILGMGYK 196
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (294), Expect = 2e-29
Identities = 47/181 (25%), Positives = 69/181 (38%), Gaps = 14/181 (7%)
Query: 395 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRH 452
+ F LG G FG V + G A+K ++ V+ K + +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 512
LV L D + +V EY+ G + H+ + A + E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFE 155
Query: 513 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 572
YLH I+RDLKP N+L+ +V DFG + + GT LAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPE 208
Query: 573 Y 573
Sbjct: 209 I 209
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (282), Expect = 4e-28
Identities = 34/187 (18%), Positives = 74/187 (39%), Gaps = 23/187 (12%)
Query: 392 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
+++ LGRG + V++ + + K+ VK ++ + K EI +L +
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENL 86
Query: 451 R-HRHLVALLGHCLDGNEKL--LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 507
R +++ L D + LVFE++ + + L ++
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEI 138
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETRIAGTF 566
+ ++Y H +HRD+KP N+++ + + ++ D+GL G+ +
Sbjct: 139 LKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASR 193
Query: 567 GYLAPEY 573
+ PE
Sbjct: 194 YFKGPEL 200
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 44/186 (23%), Positives = 72/186 (38%), Gaps = 15/186 (8%)
Query: 395 NNFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVISG--KGLTEFKSEIAVLT 448
NF +LG G +G V+ G A+K ++ I K ++E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 449 KVRHR-HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 507
+R LV L + L+ +Y+ G L H+ + + ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEI 138
Query: 508 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 567
+E+LH I+RD+K NILL + + DFGL + + GT
Sbjct: 139 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 568 YLAPEY 573
Y+AP+
Sbjct: 196 YMAPDI 201
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 8e-26
Identities = 38/195 (19%), Positives = 75/195 (38%), Gaps = 18/195 (9%)
Query: 392 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 450
V + + +G G +G+V G ++AVK++ S E+ +L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 451 RHRHLVALLGHCLDGN-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 505
+H +++ LL + + ++ L+ + + L + +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIY 128
Query: 506 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 565
+ RG++Y+H IHRDLKPSN+ + +D K+ DFG LA + +A
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG---LARHTDDEMTGYVATR 182
Query: 566 FGYLAPEYAGNFGSS 580
+ +
Sbjct: 183 WYRAPEIMLNWMHYN 197
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (251), Expect = 3e-25
Identities = 27/161 (16%), Positives = 46/161 (28%), Gaps = 28/161 (17%)
Query: 401 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK--------GLTEFKSEIAVLTKVRH 452
++G G V+ + VK + G S K G F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 453 RHLVALLG----HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 508
R L L G ++ E + L R +E + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE------------VLDMIL 113
Query: 509 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549
V + H+ +H DL N+L+ + + DF
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 91.6 bits (226), Expect = 1e-20
Identities = 35/185 (18%), Positives = 67/185 (36%), Gaps = 19/185 (10%)
Query: 403 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--------- 452
LG G F TV+ + + + T +A+K + + + + EI +L +V
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDSM 77
Query: 453 --RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 510
H++ LL H + + + + + + + I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 511 VEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGK-GSIETRIAGTFGY 568
++Y+H IH D+KP N+L+ D + + L T T Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 569 LAPEY 573
+PE
Sbjct: 196 RSPEV 200
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.8 bits (172), Expect = 1e-13
Identities = 39/198 (19%), Positives = 66/198 (33%), Gaps = 24/198 (12%)
Query: 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
+T+L+ + +N S P + L+ LSL N +L L +L +++ NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGI-LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 251
Query: 100 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159
+ P L K N + ++ L G N
Sbjct: 252 QISNLAP-LSGLTKLTELKLGANQ--------------ISNISPLAGLTALTNLELNENQ 296
Query: 160 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 219
N+T + N++ +S LQRL A+N +S L+ L
Sbjct: 297 LEDISPISNLK--NLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 220 GALKELDVSNNQLYGKIP 237
+ L +NQ+ P
Sbjct: 351 TNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.3 bits (168), Expect = 3e-13
Identities = 33/198 (16%), Positives = 65/198 (32%), Gaps = 26/198 (13%)
Query: 34 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 93
I + +T+L E+ L+ N + + L L L +N + P L L L
Sbjct: 211 DITPLGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267
Query: 94 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFA 152
+ + N + P + ++ N SP + L L L +
Sbjct: 268 LKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS---- 323
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
P S + + F ++ A+ ++ L N +S +
Sbjct: 324 -------PVSSL-------TKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLT 367
Query: 213 PEGLSVLGALKELDVSNN 230
P L+ L + +L +++
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 29/223 (13%), Positives = 74/223 (33%), Gaps = 8/223 (3%)
Query: 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD 74
Q+ +L + G + G ++ + +L +I +N + + + +L + + +
Sbjct: 44 DQVTTLQADR-LGIKSIDG----VEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNN 97
Query: 75 NFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPR 134
N P + + + + P+ L+++ + + G +
Sbjct: 98 NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157
Query: 135 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFAS 194
+ + V + + + + ++ + + N +
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI 217
Query: 195 FKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237
+L L L N L L+ L L +LD++NNQ+ P
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 258
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 15/60 (25%), Positives = 25/60 (41%), Gaps = 4/60 (6%)
Query: 178 NFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237
K N+T T+S + L + + +G+ L L +++ SNNQL P
Sbjct: 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP 83
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 5e-11
Identities = 31/199 (15%), Positives = 62/199 (31%), Gaps = 16/199 (8%)
Query: 42 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100
+ L +N + DF +K L +L L +N + P + L L+ + ++ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 101 LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 160
L+ + +++ + + ++ +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL------------GTNPLKS 138
Query: 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 220
G ++ I N+T TI SL L L N ++ + L L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195
Query: 221 ALKELDVSNNQLYGKIPSF 239
L +L +S N +
Sbjct: 196 NLAKLGLSFNSISAVDNGS 214
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 2e-10
Identities = 32/205 (15%), Positives = 61/205 (29%), Gaps = 13/205 (6%)
Query: 38 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 97
+ + S E+ + PD K L L +N +L+ L +N+
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 98 NN----------LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 147
L + + + + L + L G
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 148 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 207
+ KGN+ + G+ + ++ NLT + ++L L+L +N+
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 208 LSGMIPEGLSVLGALKELDVSNNQL 232
L IP+G L + N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 15/65 (23%), Positives = 26/65 (40%), Gaps = 4/65 (6%)
Query: 168 TCTK-GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 226
+K + +N K NLT + P+ K L L++N L L L +L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 227 VSNNQ 231
+ +
Sbjct: 62 LDRAE 66
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 3e-10
Identities = 55/242 (22%), Positives = 85/242 (35%), Gaps = 14/242 (5%)
Query: 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLPD 60
L L P S + + L G L G I I +T L +++ SG +PD
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 61 -FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 119
S +K L +L N +G +P S+ L +L + N + G +P+
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD------------ 167
Query: 120 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 179
S + N L + A + V T
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 180 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 239
N + K+L L L +N + G +P+GL+ L L L+VS N L G+IP
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 240 KS 241
+
Sbjct: 288 GN 289
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.6 bits (140), Expect = 6e-10
Identities = 28/110 (25%), Positives = 46/110 (41%), Gaps = 9/110 (8%)
Query: 131 CDPR-LNALLSVVKLMGYPQRFAENWKGNDPCSD-WIGVTCTKGN----ITVINFQKMNL 184
C+P+ ALL + K +G P + D C+ W+GV C + ++ +NL
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 185 TG--TISPEFASFKSLQRLILADN-NLSGMIPEGLSVLGALKELDVSNNQ 231
I A+ L L + NL G IP ++ L L L +++
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.8 bits (125), Expect = 4e-08
Identities = 23/69 (33%), Positives = 35/69 (50%), Gaps = 2/69 (2%)
Query: 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFC 124
K L L LR+N G +P L +L+ L +N++ N L G +P+ D++ +NN C
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 125 L--PSPGAC 131
L AC
Sbjct: 304 LCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.1 bits (105), Expect = 1e-05
Identities = 9/68 (13%), Positives = 24/68 (35%), Gaps = 3/68 (4%)
Query: 18 QSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNF 76
N ++ G + + + L + + N G +P +++ + + +N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 77 FT--GPVP 82
P+P
Sbjct: 303 CLCGSPLP 310
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 8e-09
Identities = 28/195 (14%), Positives = 59/195 (30%), Gaps = 12/195 (6%)
Query: 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
++ + + + + + L L L+DN T P L + + ++ N
Sbjct: 39 DLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGN 95
Query: 100 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159
L+ + S +P A L L + + A
Sbjct: 96 PLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQY 155
Query: 160 PCSDWIGVTCT-----KGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
V+ +T + ++ AS +L + L +N +S + P
Sbjct: 156 LSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP- 212
Query: 215 GLSVLGALKELDVSN 229
L+ L + ++N
Sbjct: 213 -LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 4e-07
Identities = 27/201 (13%), Positives = 63/201 (31%), Gaps = 8/201 (3%)
Query: 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
+ + +I + + + + + + +LS T + + L +L + + +N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 100 LLQGPVPE---FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 156
+ P + N + L+ + + + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 157 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 216
+ ++ G + N + A+ L L DN +S + P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 217 SVLGALKELDVSNNQLYGKIP 237
+ L L E+ + NNQ+ P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 9e-07
Identities = 17/65 (26%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 173 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGM----IPEGLSVLGALKELDV 227
+I ++ Q L+ E + Q + L D L+ I L V AL EL++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 228 SNNQL 232
+N+L
Sbjct: 63 RSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 2e-04
Identities = 13/103 (12%), Positives = 34/103 (33%), Gaps = 15/103 (14%)
Query: 149 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT----ISPEFASFKSLQRLILA 204
Q + G+ + V+ +++ + ++ + SL+ L L+
Sbjct: 346 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 405
Query: 205 DNNLSGMIPEGLSVLG--------ALKELDVSNNQLYGKIPSF 239
+N L G+ L L++L + + ++
Sbjct: 406 NNCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.001
Identities = 16/83 (19%), Positives = 28/83 (33%), Gaps = 4/83 (4%)
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM-- 211
+ + I+ + + L+ L LAD ++S
Sbjct: 327 ACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC 386
Query: 212 --IPEGLSVLGALKELDVSNNQL 232
+ L +L+ELD+SNN L
Sbjct: 387 SSLAATLLANHSLRELDLSNNCL 409
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 3e-06
Identities = 24/197 (12%), Positives = 60/197 (30%), Gaps = 16/197 (8%)
Query: 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
+ L + + + + + ++ + ++ + L ++ + + N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 100 LLQG-------PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 152
L + + S+ L + N + + L+ PQ +
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 153 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 212
N + TK + + + A LQ L L+ N++S +
Sbjct: 139 LYLGNNKITDITVLSRLTKLDT----LSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL- 193
Query: 213 PEGLSVLGALKELDVSN 229
L+ L L L++ +
Sbjct: 194 -RALAGLKNLDVLELFS 209
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 7e-06
Identities = 20/98 (20%), Positives = 38/98 (38%), Gaps = 9/98 (9%)
Query: 145 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 204
G + + N ++ + ++ +N L + A L+RLI +
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIAS 312
Query: 205 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 242
N+L+ +PE + LK+L V N L + P +
Sbjct: 313 FNHLAE-VPE---LPQNLKQLHVEYNPLR-EFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 6/108 (5%)
Query: 145 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 204
Y E + + + + + I SL+ L ++
Sbjct: 233 DNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS 292
Query: 205 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-AIVNTDGNP 251
+N L +P L+ L S N L ++P N ++ + NP
Sbjct: 293 NNKLIE-LPAL---PPRLERLIASFNHL-AEVPELPQNLKQLHVEYNP 335
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 23/200 (11%), Positives = 51/200 (25%), Gaps = 40/200 (20%)
Query: 36 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94
+ + + +L+ ++L NA D F + L L L N + + L SL +
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 154
+ N + P +
Sbjct: 183 LLHQNRVAHVHPHA-----------------------------------FRDLGRLMTLY 207
Query: 155 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 214
N+ + + + + LQ+ + + + +P+
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQ 266
Query: 215 GLSVLGALKELDVSNNQLYG 234
L+ ++ N L G
Sbjct: 267 RLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 3e-04
Identities = 41/237 (17%), Positives = 78/237 (32%), Gaps = 17/237 (7%)
Query: 5 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FS 62
I +PA+ S ++L + + N + L+++ L NA + F
Sbjct: 44 ISHVPAA-SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
Query: 63 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSN 121
G+ +L +L L P L +L+ + + +N LQ + F +L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 122 NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 181
N P L++L N G + +
Sbjct: 163 NRISSVPERAFRGLHSLDR------------LLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 182 MNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 238
NL+ + A ++LQ L L DN + L++ S++++ +P
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ 266
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 3e-05
Identities = 31/189 (16%), Positives = 65/189 (34%), Gaps = 8/189 (4%)
Query: 40 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
+ + L + + + + Q+ +L D + L +L +N +NN
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 100 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159
L P + + +D+ +N +P A L L + N
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 160 PCSDWIGVTCTKGNITVINFQKMNLTG---TISPEFASFKSLQRLILADNNLSGMIPEGL 216
++ + + Q++N + T A+ +L+RL ++ N +S L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 217 SVLGALKEL 225
+ L L+ L
Sbjct: 191 AKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 3e-05
Identities = 12/85 (14%), Positives = 22/85 (25%), Gaps = 3/85 (3%)
Query: 154 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 213
N + NL + F L ++ + +
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218
Query: 214 EGLSVLGALKELDVSNNQLYGKIPS 238
GL L L+ N + K+P+
Sbjct: 219 YGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.003
Identities = 11/54 (20%), Positives = 16/54 (29%), Gaps = 2/54 (3%)
Query: 48 WLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99
L N LP+ F G L + L L+ L+ + N
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 37/262 (14%), Positives = 69/262 (26%), Gaps = 34/262 (12%)
Query: 36 DVIQNMTSLKEIWLH--SNAFSGPLPDFSGVKQLESLSLRDNFFTG-PVPDSLVKLESLK 92
DV + S I + PL + +++ + L ++ + L + L+
Sbjct: 15 DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQ 74
Query: 93 IVNMTNNLLQGPVPE----FDRSVSLDMAKGSNNFCLPSPGACDPRLN------------ 136
+++ L P+ V L+++ S
Sbjct: 75 NLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF 134
Query: 137 ------ALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISP 190
++ V + K V + + + L
Sbjct: 135 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194
Query: 191 EFASFKSLQRLILAD-NNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNA------ 243
EF LQ L L+ ++ L + LK L V G + K
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQIN 254
Query: 244 --IVNTDGNPDIGKEKSSSFQG 263
T P IG +K+ G
Sbjct: 255 CSHFTTIARPTIGNKKNQEIWG 276
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 7e-04
Identities = 9/55 (16%), Positives = 23/55 (41%), Gaps = 4/55 (7%)
Query: 182 MNLTGTI---SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233
+ LT + + ++ + + L L + +I + L +D S+N++
Sbjct: 1 VKLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR 54
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 9e-04
Identities = 14/103 (13%), Positives = 30/103 (29%), Gaps = 23/103 (22%)
Query: 35 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL----------------------ESLSL 72
+ ++ + + + L N P + ++ L + L L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLL 72
Query: 73 RDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL 114
+N LV L ++N+ N L +R +
Sbjct: 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.002
Identities = 19/157 (12%), Positives = 41/157 (26%), Gaps = 41/157 (26%)
Query: 70 LSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG 129
L L T V L +L + +++++N L+ P L++
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEV------------- 47
Query: 130 ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 189
+ +D + + + + L + +
Sbjct: 48 -------------------------LQASDNALENVDGVANLPRLQELLLCNNRLQQSAA 82
Query: 190 PE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 225
+ S L L L N+L + L +
Sbjct: 83 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.5 bits (81), Expect = 0.004
Identities = 12/41 (29%), Positives = 21/41 (51%), Gaps = 2/41 (4%)
Query: 199 QRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 239
+ L LA +L+ + L L + LD+S+N+L P+
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPAL 39
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 580 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.98 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.98 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.98 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.98 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.98 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.98 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.98 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.92 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.88 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.84 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.83 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.65 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.62 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.48 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.22 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.18 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.84 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.82 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.7 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.26 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.85 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.74 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.32 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.27 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.8 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.64 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.05 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.71 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-39 Score=308.91 Aligned_cols=177 Identities=27% Similarity=0.407 Sum_probs=151.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 467999999999999999999875 789999999976432 223467899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 83 Ey~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp ECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 99999999998832 3478999999999999999999998 899999999999999999999999999998764
Q ss_pred CCC-CCccccccccCCccCccccCCCCC
Q 008026 553 EGK-GSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 553 ~~~-~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... .......+||+.|||||++.+.++
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 182 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREF 182 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSB
T ss_pred cCCccccccceeeCcCccCHhHhcCCCC
Confidence 332 122345689999999999987664
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-38 Score=305.36 Aligned_cols=174 Identities=26% Similarity=0.434 Sum_probs=153.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 47999999999999999999764 799999999976432 235678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++.+ ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 98 y~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999987643 368999999999999999999998 8999999999999999999999999999987754
Q ss_pred CCCCccccccccCCccCccccCCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... .....+||+.|||||++.+.+|+
T Consensus 169 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~ 194 (293)
T d1yhwa1 169 EQS-KRSTMVGTPYWMAPEVVTRKAYG 194 (293)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHSSSCBC
T ss_pred ccc-cccccccCCCccChhhhcCCCCC
Confidence 332 33456799999999999988764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=305.71 Aligned_cols=184 Identities=23% Similarity=0.408 Sum_probs=145.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--CCeeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 471 (580)
++|++.+.||+|+||+||+|+.. +|+.||+|++..........+.+.+|++++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999765 78999999998766666667889999999999999999999999865 4567999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
|||+++|+|.+++.+.... ...+++..++.++.||+.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999998654433 357899999999999999999999731 1349999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
....... .....+||+.|||||++.+.+|+
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~ 192 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYN 192 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCC
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCC
Confidence 8754332 33456899999999999988764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-38 Score=302.10 Aligned_cols=175 Identities=30% Similarity=0.525 Sum_probs=154.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 6899999999764332 334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999998854 2468999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... .....||+.|||||++.+.+|+
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~ 182 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHD 182 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCC
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCC
Confidence 432 3446799999999999988764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=300.57 Aligned_cols=176 Identities=31% Similarity=0.458 Sum_probs=144.2
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||+||+|++.+++.||||+++... ...+++.+|++++++++||||++++|++...+..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 5789999999999999999999888999999997643 2346799999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++|+|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 ~~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 82 MEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred cCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence 999999998743 23568899999999999999999998 89999999999999999999999999999877554
Q ss_pred CCCccccccccCCccCccccCCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.........||+.|||||++.+.+|+
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~ 180 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYS 180 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCC
T ss_pred CceeecceecCcccCChHHhcCCCCC
Confidence 43333446799999999999988764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=303.52 Aligned_cols=178 Identities=27% Similarity=0.438 Sum_probs=152.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||+||+|+.. +++.||||++.+... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 789999999976432 2334577999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999988743 2468999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCC-CccccccccCCccCccccCCCCCC
Q 008026 553 EGKG-SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~-~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... ......+||+.|||||++.+.+|+
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ 188 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSAC 188 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCC
T ss_pred cCCcccccccccCCccccCceeeccCCCC
Confidence 4322 223446799999999999888764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-37 Score=304.02 Aligned_cols=177 Identities=30% Similarity=0.452 Sum_probs=155.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||+||+|.+. +++.||||+++... ...+++.+|++++++++||||+++++++.+++..++|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 57888999999999999999876 68899999987643 345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++.. .....+++..++.|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 94 ~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 94 FMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred cccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999998854 334578999999999999999999998 8999999999999999999999999999997765
Q ss_pred CCCCccccccccCCccCccccCCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..........||+.|||||++.+.+|+
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~ 194 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFS 194 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCS
T ss_pred CCceeeccccccccccChHHHcCCCCC
Confidence 444344445689999999999887764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-38 Score=311.42 Aligned_cols=176 Identities=24% Similarity=0.362 Sum_probs=153.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... ......++.+|+.++++++|||||++++++.+.+..|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999875 78999999997642 3445678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+ +++|+||||||+|||+++++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999998541 368999999999999999999997 2489999999999999999999999999998764
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... ....+||+.|||||++.+.+|+
T Consensus 157 ~~~---~~~~~GT~~Y~APEvl~~~~y~ 181 (322)
T d1s9ja_ 157 DSM---ANSFVGTRSYMSPERLQGTHYS 181 (322)
T ss_dssp HHT---C---CCSSCCCCHHHHHCSCCC
T ss_pred CCc---cccccCCccccCchHHcCCCCC
Confidence 322 2346899999999999988774
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-37 Score=304.59 Aligned_cols=178 Identities=28% Similarity=0.391 Sum_probs=156.2
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999874 799999999986533 233467789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+..
T Consensus 84 ~ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eeccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 999999999988754 2468899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... ......+||+.|||||++.+.+|+
T Consensus 156 ~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~ 183 (337)
T d1o6la_ 156 ISDG-ATMKTFCGTPEYLAPEVLEDNDYG 183 (337)
T ss_dssp CCTT-CCBCCCEECGGGCCGGGGSSSCBC
T ss_pred ccCC-cccccceeCHHHhhhhhccCCCCC
Confidence 4433 234457899999999999998874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-37 Score=298.32 Aligned_cols=176 Identities=28% Similarity=0.465 Sum_probs=151.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||.||+|+++++..||||+++... ...+.+.+|++++++++|||||++++++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 35788999999999999999999888999999997643 234679999999999999999999998754 56799999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++..... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 y~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999988754322 258999999999999999999998 8999999999999999999999999999998765
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
..........||+.|||||++.+..|
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~ 187 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTF 187 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEE
T ss_pred CccccccccCCcccccChHHHhCCCC
Confidence 44333444678999999999876654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-37 Score=296.84 Aligned_cols=174 Identities=32% Similarity=0.537 Sum_probs=145.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.++|++.+.||+|+||+||+|+++ ..||||+++.........+.+.+|++++++++||||+++++++.. +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367999999999999999999864 469999998766566677899999999999999999999998754 56899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++.. ....+++.+++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999998843 23468999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCC-CccccccccCCccCccccCCC
Q 008026 554 GKG-SIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 554 ~~~-~~~~~~~Gt~~y~APE~~~~~ 577 (580)
... .......||+.|||||++.+.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~ 181 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQ 181 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTC
T ss_pred cCCcccccccccCcccCCHHHHhcc
Confidence 322 223446799999999999754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-36 Score=292.01 Aligned_cols=169 Identities=27% Similarity=0.418 Sum_probs=145.6
Q ss_pred CcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc----CCeeEEE
Q 008026 397 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLV 471 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 471 (580)
|++.+.||+|+||+||+|.+. ++..||+|++..........+.+.+|++++++++||||+++++++.+ ....|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999775 68899999998766666667889999999999999999999999875 3457999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeEec-CCCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a 548 (580)
|||+++|+|.+++.+. ..+++..++.++.||+.||+|||+ ++ ||||||||+|||++ +++.+||+|||+|
T Consensus 91 mE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 9999999999988542 468899999999999999999997 55 99999999999996 5789999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
+..... .....+||+.|||||++.+
T Consensus 163 ~~~~~~---~~~~~~GT~~Y~aPE~~~~ 187 (270)
T d1t4ha_ 163 TLKRAS---FAKAVIGTPEFMAPEMYEE 187 (270)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGGT
T ss_pred eeccCC---ccCCcccCccccCHHHhCC
Confidence 865432 2345689999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-37 Score=298.66 Aligned_cols=172 Identities=27% Similarity=0.415 Sum_probs=149.3
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
+.|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46899999999999999999875 7899999999764 33455778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++.+. ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 90 y~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 90 FCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred cCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999887442 2468999999999999999999998 8999999999999999999999999999976533
Q ss_pred CCCCccccccccCCccCccccCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
.. .......||+.|||||++.+
T Consensus 163 ~~-~~~~~~~Gt~~y~APE~l~~ 184 (288)
T d2jfla1 163 TI-QRRDSFIGTPYWMAPEVVMC 184 (288)
T ss_dssp HH-HHHTCCCSCCTTCCHHHHTT
T ss_pred Cc-ccccccccccccCCHHHHhh
Confidence 21 12234679999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-37 Score=300.91 Aligned_cols=177 Identities=28% Similarity=0.451 Sum_probs=137.8
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.+.|++.+.||+|+||+||+|+.. +++.||||++.+.... .....+.+|++++++++||||+++++++.+++..|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4567999999999999999999875 6899999999865433 2345688999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec---CCCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a 548 (580)
|||++||+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||+. +++.+||+|||+|
T Consensus 86 mE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp ECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEecccee
Confidence 999999999999843 3579999999999999999999998 8999999999999995 5789999999999
Q ss_pred cccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 549 RLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+...... .....+||+.|||||++.+.+|+
T Consensus 158 ~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~ 187 (307)
T d1a06a_ 158 KMEDPGS--VLSTACGTPGYVAPEVLAQKPYS 187 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCC
T ss_pred EEccCCC--eeeeeeeCccccCcHHHcCCCCC
Confidence 8764432 23446799999999999988774
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=290.58 Aligned_cols=176 Identities=28% Similarity=0.418 Sum_probs=154.7
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||+||+|++++++.||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57999999999999999999998889999999986433 346799999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++|+|.+++.. ....+++..+.+++.||++||+|||+ ++|+||||||+||++++++.+||+|||+|+.....
T Consensus 81 ~~~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 81 MANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CTTEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred cCCCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999888643 22367889999999999999999998 89999999999999999999999999999876554
Q ss_pred CCCccccccccCCccCccccCCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.........||+.|+|||++.+.+|+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~ 179 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFS 179 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCC
T ss_pred CceeecccCCCCCcCCcHHhcCCCCC
Confidence 43344446799999999999877764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-36 Score=299.49 Aligned_cols=174 Identities=27% Similarity=0.438 Sum_probs=153.0
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||+||+|+.+ +|+.||||++++... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999875 799999999976432 2344678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||++||+|..++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999887743 2457888899999999999999997 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.. ....+||+.|||||++.+.+|+
T Consensus 156 ~~----~~~~~Gt~~Y~APE~l~~~~y~ 179 (316)
T d1fota_ 156 DV----TYTLCGTPDYIAPEVVSTKPYN 179 (316)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBC
T ss_pred cc----cccccCcccccCHHHHcCCCCC
Confidence 43 2346899999999999988764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-36 Score=300.15 Aligned_cols=176 Identities=25% Similarity=0.397 Sum_probs=153.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999875 7999999999764 2344578899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec--CCCcEEEEeeccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRL 550 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~ 550 (580)
||+++|+|.+++.+ ....+++..+..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 103 E~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 103 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999988743 23469999999999999999999998 8999999999999996 357899999999987
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ......||+.|||||++.+.+|+
T Consensus 176 ~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~ 203 (350)
T d1koaa2 176 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVG 203 (350)
T ss_dssp CCTTS--CEEEECSCTTTCCHHHHHTCCBC
T ss_pred ccccc--ccceecCcccccCHHHHcCCCCC
Confidence 65433 23446899999999999887764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-36 Score=296.36 Aligned_cols=168 Identities=28% Similarity=0.421 Sum_probs=147.1
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
.|+..+.||+|+||+||+|+.. +++.||||++...... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4899999999999999999764 7899999999865433 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
||++|+|..++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999988765532 2468999999999999999999998 8999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccCccccCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
. ....||+.|||||++.+
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILA 185 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTT
T ss_pred C-----CccccCccccCHHHHhc
Confidence 2 33579999999999865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=292.12 Aligned_cols=178 Identities=26% Similarity=0.373 Sum_probs=154.2
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh----hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
+.++|++.+.||+|+||+||+|+.. +|+.||||++.+..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4468999999999999999999875 78999999997654322 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC----cEEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 543 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 543 (580)
.|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+||||||||+|||++.++ .+|++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 99999999999999998541 368999999999999999999998 8999999999999998766 49999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+|+...... ......||+.|||||++.+..|+
T Consensus 160 DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~ 194 (293)
T d1jksa_ 160 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLG 194 (293)
T ss_dssp CCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBC
T ss_pred chhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCC
Confidence 999998765433 23345799999999999887654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-35 Score=297.68 Aligned_cols=176 Identities=23% Similarity=0.330 Sum_probs=153.4
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.+++..|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467999999999999999999764 79999999997643 334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEec--CCCcEEEEeeccccc
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRL 550 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~ 550 (580)
||+++|+|.+++.. ....+++.+++.|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 106 E~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 106 EFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp ECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeeccccee
Confidence 99999999887632 23468999999999999999999998 8999999999999998 578999999999988
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
..... ......||+.|||||++.+.+|+
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 206 (352)
T d1koba_ 179 LNPDE--IVKVTTATAEFAAPEIVDREPVG 206 (352)
T ss_dssp CCTTS--CEEEECSSGGGCCHHHHTTCCBC
T ss_pred cCCCC--ceeeccCcccccCHHHHcCCCCC
Confidence 75543 23446799999999999988764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-36 Score=295.04 Aligned_cols=178 Identities=25% Similarity=0.429 Sum_probs=140.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CC---cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||+||+|+++ ++ ..||||++... ......+++.+|++++++++|||||++++++..++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999875 23 35889988653 344556789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++|+|.+++.. ....+++.+++.++.||+.||+|||+ ++||||||||+|||++.++++||+|||+|+.
T Consensus 105 v~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999987743 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCCc----cccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSI----ETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~----~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
........ .....||+.|||||++.+..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 211 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCC
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCC
Confidence 65432211 1224579999999999887764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-36 Score=290.85 Aligned_cols=176 Identities=31% Similarity=0.483 Sum_probs=145.0
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||+||+|+++++..||||+++... ...+.+.+|+.++++++|||||++++++. .+..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 5799999999999999999999888899999997543 23467999999999999999999999985 4568999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++|+|..++..... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+.....
T Consensus 93 ~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999988755322 368999999999999999999998 89999999999999999999999999999876554
Q ss_pred CCCccccccccCCccCccccCCCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.........||+.|+|||++.++.++
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~ 192 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFT 192 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCC
T ss_pred CceeeccccccccccChHHHhCCCCC
Confidence 43344446799999999999877654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=288.80 Aligned_cols=178 Identities=25% Similarity=0.455 Sum_probs=144.0
Q ss_pred cCCcccceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
+.|+..++||+|+||.||+|.+++. ..||||++... .......++.+|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4688899999999999999977632 47999999753 34445667999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+.++++.+++.. ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999887643 33578999999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCC--ccccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGS--IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
........ ......||+.|||||++.+..++
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 191 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 191 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCC
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCC
Confidence 76543221 22335689999999999887764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-35 Score=297.88 Aligned_cols=174 Identities=27% Similarity=0.362 Sum_probs=153.9
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 472 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 472 (580)
++|++.+.||+|+||.||+|+.+ +|+.||||++.+... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 799999999976432 2344577899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccC
Q 008026 473 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 552 (580)
Q Consensus 473 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 552 (580)
||+.+|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999888442 368999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccCccccCCCCCC
Q 008026 553 EGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 553 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.. .....||+.|||||++.+.+|+
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~ 216 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYN 216 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBC
T ss_pred cc----cccccCccccCCHHHHcCCCCC
Confidence 32 2346799999999999988764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-35 Score=289.12 Aligned_cols=170 Identities=26% Similarity=0.399 Sum_probs=140.2
Q ss_pred ceeeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEecCC
Q 008026 401 NILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 477 (580)
Q Consensus 401 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 477 (580)
+.||+|+||+||+|.++ +++.||||+++....+....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999764 35689999997655555566789999999999999999999999865 457899999999
Q ss_pred CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCCCCC
Q 008026 478 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 557 (580)
Q Consensus 478 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 557 (580)
|+|.+++.. ...+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999998843 2468999999999999999999998 89999999999999999999999999999876544322
Q ss_pred c--cccccccCCccCccccCCCCC
Q 008026 558 I--ETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 558 ~--~~~~~Gt~~y~APE~~~~~~~ 579 (580)
. .....||+.|||||++.+.+|
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~ 187 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKF 187 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEE
T ss_pred cccccccCCCceecCchhhcCCCC
Confidence 2 223568999999999876654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-35 Score=287.05 Aligned_cols=176 Identities=25% Similarity=0.419 Sum_probs=146.9
Q ss_pred cCCcccce-eeccCcEEEEEEEEc---CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENI-LGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|.+.+. ||+|+||+||+|.++ ++..||||+++.. ......+++.+|++++++++|||||++++++.+ +..|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45666774 999999999999764 3557999999764 344566789999999999999999999999875 46899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++|+|.+++.. ....+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 86 vmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999988732 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCC--ccccccccCCccCccccCCCCC
Q 008026 551 APEGKGS--IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 551 ~~~~~~~--~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
....... ......||+.|||||++.+.++
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 189 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKF 189 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred ccccccccccccccccCccccChHHHhCCCC
Confidence 6543321 1223568999999999876654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-35 Score=293.56 Aligned_cols=182 Identities=29% Similarity=0.425 Sum_probs=148.6
Q ss_pred cCCcccceeeccCcEEEEEEEEcC-C-----cEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD-G-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 467 (580)
++|++.+.||+|+||+||+|++.. + ..||+|.+.... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 578999999999999999997652 2 369999886532 334557889999999998 79999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhh------------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAE------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 529 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp 529 (580)
.++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+ ++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999865321 112458899999999999999999998 8999999999
Q ss_pred CCeEecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 530 SNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 530 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+|||++.++.+||+|||+|+........ ......||+.|||||++.++.|+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 244 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence 9999999999999999999876544322 22346789999999999877764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=287.67 Aligned_cols=177 Identities=28% Similarity=0.448 Sum_probs=151.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-ChhhHHHHHHHHHHHH-hcCCCcccceeeEEEcCCeeEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLT-KVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv 471 (580)
++|++.+.||+|+||+||+|+.. +++.||||++++... .....+.+.+|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999775 799999999976432 2334556677777665 68999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 551 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 551 (580)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+..
T Consensus 82 mEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence 999999999999854 1357889999999999999999998 89999999999999999999999999999866
Q ss_pred CCCCCCccccccccCCccCccccCCCCCC
Q 008026 552 PEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 552 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.... .......||+.|+|||++.+.+|+
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 181 (320)
T d1xjda_ 154 MLGD-AKTNTFCGTPDYIAPEILLGQKYN 181 (320)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred cccc-ccccccCCCCCcCCHHHHcCCCCC
Confidence 5433 233446799999999999998874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-34 Score=279.74 Aligned_cols=173 Identities=29% Similarity=0.376 Sum_probs=151.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh-------hhHHHHHHHHHHHHhcC-CCcccceeeEEEc
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-------KGLTEFKSEIAVLTKVR-HRHLVALLGHCLD 464 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 464 (580)
.++|++.+.||+|+||+||+|+.. +++.||||++.+..... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999764 78999999997654321 12346889999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEe
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 544 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 544 (580)
++..|+||||+++|+|.+++.. . ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~--~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---K--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---H--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHh---c--CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEcc
Confidence 9999999999999999999853 2 368999999999999999999998 8999999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGN 576 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 576 (580)
||+|+...... .....+||+.|+|||++.+
T Consensus 154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~ 183 (277)
T d1phka_ 154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIEC 183 (277)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHH
T ss_pred chheeEccCCC--ceeeeeccCCCCCHHHhhc
Confidence 99998775433 2344679999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-34 Score=282.20 Aligned_cols=179 Identities=25% Similarity=0.382 Sum_probs=145.5
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC----e
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----E 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 467 (580)
.++|++.+.||+|+||.||+|+.. +++.||||+++..... ......+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999764 7999999999865443 344567999999999999999999999987654 3
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.|+||||+++++|.+++.. ...+++.+++.++.||+.||+|||+ ++||||||||+|||++.++..+++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhh
Confidence 7899999999999987743 2468999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCC--CccccccccCCccCccccCCCCCC
Q 008026 548 VRLAPEGKG--SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 548 a~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++....... ......+||+.|||||++.+.+|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~ 192 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 192 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCC
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCC
Confidence 876543321 223446799999999999988764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-34 Score=285.57 Aligned_cols=175 Identities=22% Similarity=0.293 Sum_probs=151.4
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEE
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 471 (580)
+.++|++.+.||+|+||+||+|... +++.||||+++... .....+.+|+++++.++||||+++++++.+++..|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999775 78999999997642 3345688999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCC--CcEEEEeecccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFGLVR 549 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~ 549 (580)
||||+||+|.+++.. ....+++.++..|+.||+.||+|||+ ++|+||||||+|||++.+ ..+||+|||+++
T Consensus 80 mE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 80 FEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhh
Confidence 999999999998843 22368999999999999999999998 899999999999999854 579999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
...... ......||+.|+|||...+..|
T Consensus 153 ~~~~~~--~~~~~~~t~~y~ape~~~~~~~ 180 (321)
T d1tkia_ 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEE
T ss_pred ccccCC--cccccccccccccchhccCCCC
Confidence 765432 2344679999999999987765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-34 Score=292.25 Aligned_cols=172 Identities=27% Similarity=0.394 Sum_probs=145.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh-hhHHHHHH---HHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKS---EIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|+.. +|+.||||++.+..... .....+.+ |+++++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999875 79999999997543221 12233334 466777778999999999999999999
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999998854 1467889999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
...... ....+||+.|||||++.++
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~ 180 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKG 180 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTT
T ss_pred ecCCCc---ccccccccccchhHHhhcC
Confidence 765432 2345799999999998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-34 Score=282.54 Aligned_cols=177 Identities=28% Similarity=0.407 Sum_probs=147.0
Q ss_pred cCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||+||+|+. .+++.||||+++.........+++.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999977 478999999997654444456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+.++ +.+++.. .....+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~~-~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSEE-HHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCCc-hhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence 99764 4444422 234568999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
... ......||+.|+|||++...++
T Consensus 155 ~~~-~~~~~~gt~~y~apE~~~~~~~ 179 (298)
T d1gz8a_ 155 PVR-TYTHEVVTLWYRAPEILLGCKY 179 (298)
T ss_dssp CSB-CTTCCBCCCTTCCHHHHTTCSS
T ss_pred Ccc-cceeecccceeeehhhhccccC
Confidence 432 3344579999999999876653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-34 Score=284.14 Aligned_cols=188 Identities=31% Similarity=0.471 Sum_probs=155.2
Q ss_pred HHHHhhcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEE
Q 008026 389 VLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 462 (580)
Q Consensus 389 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 462 (580)
.++...++|++.+.||+|+||+||+|+.+ +++.||||+++.. ......+++.+|++++++++||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 34445678999999999999999999864 3578999998753 3444567899999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCChhHHHHHHhh-------------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 008026 463 LDGNEKLLVFEYMPQGTLSRHIFNWAE-------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 523 (580)
Q Consensus 463 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iv 523 (580)
.+.+..++||||+++|+|.+++..... .....+++.+++.|+.|++.||+|||+ ++||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence 999999999999999999999864211 122358899999999999999999998 8999
Q ss_pred ecCCCCCCeEecCCCcEEEEeeccccccCCCCC-CccccccccCCccCccccCCCCCC
Q 008026 524 HRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 524 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
||||||+|||++.++.+||+|||+|+....... .......||+.|||||++.+..|+
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t 220 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 220 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC
Confidence 999999999999999999999999986543321 223345789999999999887764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-34 Score=283.76 Aligned_cols=172 Identities=23% Similarity=0.335 Sum_probs=144.9
Q ss_pred hcCCcccc-eeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEc----CC
Q 008026 394 TNNFSEEN-ILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD----GN 466 (580)
Q Consensus 394 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~ 466 (580)
.++|++.+ .||+|+||.||+|+. .+++.||||+++.. ..+.+|++++.++ +||||++++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46898764 699999999999976 47899999998642 4577899987665 79999999999875 35
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEE
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 543 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 543 (580)
..|+|||||+||+|.+++.+ .+...+++.++..|+.||+.||+|||+ .+|+||||||+|||+++ .+.+||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccc
Confidence 68999999999999999853 233579999999999999999999998 89999999999999985 4679999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+|+....... ....+||+.|||||++.+.+|+
T Consensus 157 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~ 191 (335)
T d2ozaa1 157 DFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYD 191 (335)
T ss_dssp CCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGS
T ss_pred ccceeeeccCCCc--cccccCCcccCCcHHHcCCCCC
Confidence 9999987655432 3446799999999999887664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-34 Score=279.09 Aligned_cols=177 Identities=22% Similarity=0.344 Sum_probs=138.0
Q ss_pred cCCcccceeeccCcEEEEEEEEcC----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|.+.. +..||||+++.. ......+.+.+|++++++++||||+++++++. .+..++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 579999999999999999997642 356889988653 34445678999999999999999999999985 467899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
||||+++|+|.+++.. ....+++.+++.++.||+.||+|||+ ++||||||||+||++++++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999887643 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCccCccccCCCCCC
Q 008026 551 APEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.............||+.|+|||++.+.+|+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~ 187 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFT 187 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCS
T ss_pred ccCCcceeccceecCcccchhhHhccCCCC
Confidence 655443334456789999999999877664
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-34 Score=282.44 Aligned_cols=177 Identities=28% Similarity=0.445 Sum_probs=143.2
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCc----EEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
.+|++.+.||+|+||+||+|.+. +|+ +||+|+++.. ......+++.+|++++++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46999999999999999999764 444 5888888653 2344567899999999999999999999999865 567
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+++||+.+++|.+++.. ....+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 88899999999887643 34578999999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCCc-cccccccCCccCccccCCCCCC
Q 008026 550 LAPEGKGSI-ETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 550 ~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
......... .....||+.|||||++.++.|+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 191 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCC
T ss_pred ecccccccccccccccCccccChHHHhcCCCC
Confidence 765443222 2335689999999999887764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-34 Score=281.36 Aligned_cols=170 Identities=29% Similarity=0.356 Sum_probs=140.2
Q ss_pred ccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh---hhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 399 EENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG---KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 399 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
..++||+|+||+||+|+.. +|+.||||+++...... ...+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999875 68999999997643221 1235688999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+.++++..+. .....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~-----~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIK-----DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHT-----TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhh-----hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC
Confidence 9887766544 233568889999999999999999998 89999999999999999999999999999876544
Q ss_pred CCCccccccccCCccCccccCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
.. .....+||+.|||||++.+.
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~ 175 (299)
T d1ua2a_ 154 NR-AYTHQVVTRWYRAPELLFGA 175 (299)
T ss_dssp CC-CCCCSCCCCTTCCHHHHTTC
T ss_pred cc-cccceecChhhccHHHHccC
Confidence 32 23345799999999998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-33 Score=277.21 Aligned_cols=175 Identities=26% Similarity=0.338 Sum_probs=148.7
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEEe
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 474 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 474 (580)
++|++.+.||+|+||+||+|++++++.||||++..........+++.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999998999999999977654555567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+.++.+..+. .....+++.++..++.||+.||+|||+ .+||||||||+|||++.++.+|++|||.|......
T Consensus 82 ~~~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH-----TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH-----hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9876665554 233579999999999999999999998 89999999999999999999999999999876543
Q ss_pred CCCccccccccCCccCccccCCCC
Q 008026 555 KGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 555 ~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.. ......|++.|+|||.+.+..
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~ 176 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSK 176 (286)
T ss_dssp ---------CCCTTCCHHHHTTCC
T ss_pred cc-ccceecccchhhhHHHHhCCC
Confidence 32 223356899999999987654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-34 Score=277.20 Aligned_cols=175 Identities=27% Similarity=0.354 Sum_probs=146.7
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccCh----hhHHHHHHHHHHHHhcC--CCcccceeeEEEcCC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 466 (580)
.++|++.+.||+|+||+||+|+.. +++.||||++.+..... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999765 78999999997654322 12244678999999997 899999999999999
Q ss_pred eeEEEEEecCC-CChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-CCcEEEEe
Q 008026 467 EKLLVFEYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVAD 544 (580)
Q Consensus 467 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~D 544 (580)
..++||||+.+ +++.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 577766643 2468999999999999999999998 89999999999999985 57999999
Q ss_pred eccccccCCCCCCccccccccCCccCccccCCCCC
Q 008026 545 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 545 fg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
||+|+..... ......||+.|||||++.+.++
T Consensus 155 FG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~ 186 (273)
T d1xwsa_ 155 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRY 186 (273)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCB
T ss_pred cccceecccc---cccccccCCCcCCHHHHcCCCC
Confidence 9999875433 2345689999999999876553
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-33 Score=278.11 Aligned_cols=184 Identities=27% Similarity=0.403 Sum_probs=142.5
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcC
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 465 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 465 (580)
..++|++.+.||+|+||.||+|++. +++.||||+++... .....+.+.+|...+.++ +|+||+.+++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3468999999999999999999764 24689999987533 344556788888888887 589999999988765
Q ss_pred -CeeEEEEEecCCCChhHHHHHHhhh-----------CCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeE
Q 008026 466 -NEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533 (580)
Q Consensus 466 -~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 533 (580)
...++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ ++||||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcccee
Confidence 4689999999999999999654321 12358899999999999999999998 89999999999999
Q ss_pred ecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 534 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 534 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+++++.+||+|||+|+........ ......||+.|||||++.+..|+
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 214 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence 999999999999999876543322 23346799999999999887764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-33 Score=272.34 Aligned_cols=171 Identities=33% Similarity=0.516 Sum_probs=139.8
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-CCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 473 (580)
++|++.+.||+|+||.||+|+++ |..||||+++.. ...+.+.+|++++++++||||++++|++.+ .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 57888999999999999999885 789999999653 234678999999999999999999999865 456899999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
|+++|+|.+++..... ..+++..+++|+.||+.||+|||+ .+||||||||+||+++.++.+|++|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999865332 257899999999999999999998 8999999999999999999999999999987543
Q ss_pred CCCCccccccccCCccCccccCCCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
. .....+|+.|+|||++.+++++
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t 178 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFS 178 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCC
T ss_pred C----CccccccccCCChHHHhCCCCC
Confidence 2 2234689999999999877764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-33 Score=274.91 Aligned_cols=173 Identities=25% Similarity=0.378 Sum_probs=139.7
Q ss_pred cCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC----eeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----EKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l 470 (580)
++|.+.+.||+|+||.||+|++ +|+.||||++.... ......+.|+..+..++||||+++++++.+.+ ..|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5688899999999999999986 58999999986421 11222334555566789999999999998654 5789
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhC-----CCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
||||+++|+|.+++.+ ..++|.+++.++.|++.||+|+|+. ..++||||||||+|||+++++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999954 3689999999999999999999963 1369999999999999999999999999
Q ss_pred ccccccCCCCCC---ccccccccCCccCccccCCC
Q 008026 546 GLVRLAPEGKGS---IETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 546 g~a~~~~~~~~~---~~~~~~Gt~~y~APE~~~~~ 577 (580)
|+++........ ......||++|||||++.+.
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred CccccccCCCcceeccccceecccCcCChhhcccc
Confidence 999876544321 22346799999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.6e-33 Score=274.91 Aligned_cols=182 Identities=29% Similarity=0.418 Sum_probs=153.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCe
Q 008026 395 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 467 (580)
++|++.+.||+|+||.||+|++. +++.||||+++... ......++.+|+.+++++ +||||+++++++.+.+.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 57889999999999999999753 45789999997643 344566799999999999 59999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhh-------------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEe
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAE-------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 534 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll 534 (580)
.++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+ ++||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 9999999999999999865432 123468899999999999999999998 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 535 GDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 535 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+.++.+|++|||.++........ ......||+.|+|||++.++.++
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 225 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC
Confidence 99999999999999876544332 23346799999999999877654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.1e-33 Score=276.47 Aligned_cols=180 Identities=34% Similarity=0.511 Sum_probs=146.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCc--EEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEcCCeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 470 (580)
++|++.+.||+|+||.||+|.++ ++. .||||++.... .....+++.+|+++++++ +||||+++++++.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 57899999999999999999775 444 47788876432 334556799999999999 69999999999999999999
Q ss_pred EEEecCCCChhHHHHHHh-----------hhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCc
Q 008026 471 VFEYMPQGTLSRHIFNWA-----------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 539 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 539 (580)
||||+++|+|.+++.... ......+++.++++++.||+.||.|+|+ ++||||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 999999999999986431 1234578999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 540 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 540 ~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+||+|||+|+....... .....||..|+|||.+.+.+|+
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~ 204 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYT 204 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEEC
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCC
Confidence 99999999986543322 2234689999999999876653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.3e-33 Score=273.97 Aligned_cols=183 Identities=27% Similarity=0.447 Sum_probs=154.1
Q ss_pred hcCCcccceeeccCcEEEEEEEEc------CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCe
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 467 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 467 (580)
.++|++.+.||+|+||.||+|.+. ++..||||+++.. ........+.+|++++++++||||+++++++...+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 367889999999999999999764 3578999999753 344556679999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhh-----hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEE
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAE-----EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 542 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 542 (580)
.++||||+++|+|.+++..... .....+++.++.+++.|++.||.|||+ ++|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence 9999999999999999865432 123457889999999999999999998 79999999999999999999999
Q ss_pred EeeccccccCCCCC-CccccccccCCccCccccCCCCCC
Q 008026 543 ADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 543 ~Dfg~a~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+|||+|+....... .......||+.|+|||.+.+..++
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~ 213 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 213 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCC
Confidence 99999987644322 222335689999999999877654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.4e-33 Score=270.63 Aligned_cols=177 Identities=29% Similarity=0.486 Sum_probs=137.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc--CC--cEEEEEEeecccc-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH--DG--TKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 469 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 469 (580)
++|++.+.||+|+||.||+|++. ++ ..||||++.+... .....+++.+|++++++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56999999999999999999764 22 3789999876543 23445789999999999999999999999976 4678
Q ss_pred EEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 470 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 470 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
+||||+++|++.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999887542 2358999999999999999999998 899999999999999999999999999999
Q ss_pred ccCCCCCC--ccccccccCCccCccccCCCCC
Q 008026 550 LAPEGKGS--IETRIAGTFGYLAPEYAGNFGS 579 (580)
Q Consensus 550 ~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~~ 579 (580)
........ ......||+.|+|||++.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 191 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCC
Confidence 77544322 1223467889999999876554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=7e-33 Score=272.59 Aligned_cols=183 Identities=29% Similarity=0.421 Sum_probs=148.3
Q ss_pred hcCCcccceeeccCcEEEEEEEEcC--------CcEEEEEEeeccccChhhHHHHHHHHHHHHhc-CCCcccceeeEEEc
Q 008026 394 TNNFSEENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 464 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 464 (580)
.++|++.+.||+|+||.||+|+... +..||||+++.+. ......++.+|...+.++ +||||+++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3578999999999999999997542 2479999997643 445567888999999888 79999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHHHHhh-----------hCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeE
Q 008026 465 GNEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 533 (580)
Q Consensus 465 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl 533 (580)
++..++||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+ .+||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccccee
Confidence 9999999999999999999964321 123468999999999999999999998 89999999999999
Q ss_pred ecCCCcEEEEeeccccccCCCCCC-ccccccccCCccCccccCCCCCC
Q 008026 534 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 534 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
++.++.+||+|||+++........ ......||+.|+|||++.++.|+
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~ 215 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC
Confidence 999999999999999876543322 22345789999999999887764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.3e-32 Score=272.16 Aligned_cols=178 Identities=27% Similarity=0.366 Sum_probs=144.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-C-CcEEEEEEeeccccChhhHHHHHHHHHHHHhc---CCCcccceeeEEEc----
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-D-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLD---- 464 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 464 (580)
.++|++.+.||+|+||+||+|++. + ++.||||+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999874 4 66799999976544443444566787777665 79999999999853
Q ss_pred -CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEE
Q 008026 465 -GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 543 (580)
Q Consensus 465 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 543 (580)
....+++|||++++.+.... ......+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~----~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD----KVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH----HSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhh----hccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence 34678999999887665433 2334568899999999999999999998 899999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 544 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 544 Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
|||+++..... .......||+.|||||++.+.+|+
T Consensus 159 dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~ 193 (305)
T d1blxa_ 159 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYA 193 (305)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCC
T ss_pred chhhhhhhccc--ccCCCcccChhhcCcchhcCCCCC
Confidence 99998865432 233456899999999999988875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.1e-32 Score=268.82 Aligned_cols=173 Identities=30% Similarity=0.475 Sum_probs=144.3
Q ss_pred cceeeccCcEEEEEEEEcC----CcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc-CCeeEEEEEe
Q 008026 400 ENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLLVFEY 474 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 474 (580)
.++||+|+||+||+|++.. ...||||+++.. ......+++.+|++++++++||||++++|++.. ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 5789999999999998753 236899998752 345567889999999999999999999999875 4688999999
Q ss_pred cCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCCC
Q 008026 475 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 554 (580)
Q Consensus 475 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 554 (580)
+++|+|.+++.. .....++..+++++.|++.||.|+|+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999988743 33467788899999999999999998 89999999999999999999999999999876543
Q ss_pred CCC---ccccccccCCccCccccCCCCCC
Q 008026 555 KGS---IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 555 ~~~---~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
... ......||+.|+|||.+.+..++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 212 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFT 212 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCC
T ss_pred ccccceecccccccccccChHHHhcCCCC
Confidence 221 22335689999999998876653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-32 Score=274.83 Aligned_cols=172 Identities=28% Similarity=0.419 Sum_probs=142.5
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC-----
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 466 (580)
+.++|++.+.||+|+||+||+|... +|+.||||+++.........+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4578999999999999999999765 6999999999876555666778999999999999999999999997654
Q ss_pred -eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 467 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 467 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
..|+||||+ +.+|...... ..+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+|++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccc
Confidence 469999999 5677666532 468999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCccCccccCCCC
Q 008026 546 GLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 546 g~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|+|+..... .+...||+.|+|||++.+..
T Consensus 166 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~ 194 (346)
T d1cm8a_ 166 GLARQADSE----MTGYVVTRWYRAPEVILNWM 194 (346)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTT
T ss_pred cceeccCCc----cccccccccccCHHHHcCCC
Confidence 999876543 23457999999999987643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.5e-32 Score=267.82 Aligned_cols=175 Identities=25% Similarity=0.359 Sum_probs=142.7
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc--------C
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--------G 465 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 465 (580)
++|++.+.||+|+||+||+|+.. +|+.||||++...........++.+|++++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999874 79999999997665555566788999999999999999999998865 3
Q ss_pred CeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEee
Q 008026 466 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 545 (580)
Q Consensus 466 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 545 (580)
+..|+||||++++.+.... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 4579999999877665433 334568889999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCC---CccccccccCCccCccccCCC
Q 008026 546 GLVRLAPEGKG---SIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 546 g~a~~~~~~~~---~~~~~~~Gt~~y~APE~~~~~ 577 (580)
|+|+....... ......+||+.|+|||++.+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCC
Confidence 99976653221 122335799999999998765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=269.54 Aligned_cols=174 Identities=24% Similarity=0.369 Sum_probs=141.7
Q ss_pred hcCCcccceeeccCcEEEEEEEE-cCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCC----ee
Q 008026 394 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----EK 468 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 468 (580)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+.. .....+++.+|+++|++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46799999999999999999976 489999999997532 3445668899999999999999999999987643 23
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 548 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 548 (580)
+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|
T Consensus 86 ~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 555666779999998843 368999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCC--CccccccccCCccCccccCCC
Q 008026 549 RLAPEGKG--SIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 549 ~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~ 577 (580)
+....... ......+||+.|+|||++...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 187 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTB
T ss_pred eeccCCCccceeeccccccceechHHHhhcC
Confidence 86543221 122346799999999998554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=1.7e-31 Score=266.81 Aligned_cols=166 Identities=20% Similarity=0.374 Sum_probs=142.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcC--CeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDG--NEKLL 470 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~l 470 (580)
++|++.+.||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 57999999999999999999874 7899999998652 2467889999999996 99999999999754 56899
Q ss_pred EEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC-cEEEEeecccc
Q 008026 471 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 549 (580)
Q Consensus 471 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~ 549 (580)
||||+++++|..+. +.+++..+..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccce
Confidence 99999999997654 368999999999999999999998 8999999999999998654 68999999998
Q ss_pred ccCCCCCCccccccccCCccCccccCCCC
Q 008026 550 LAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
...... .....+||+.|+|||.+.+..
T Consensus 179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~ 205 (328)
T d3bqca1 179 FYHPGQ--EYNVRVASRYFKGPELLVDYQ 205 (328)
T ss_dssp ECCTTC--CCCSCCSCGGGCCHHHHTTCC
T ss_pred eccCCC--cccccccCccccCcccccCCC
Confidence 765443 234457899999999987654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=2.3e-31 Score=260.90 Aligned_cols=175 Identities=18% Similarity=0.283 Sum_probs=146.6
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCC-CcccceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+|++.++.++| +|++.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 368999999999999999999865 78999999886532 22357789999999975 8999999999999999999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC-----CCcEEEEeec
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFG 546 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg 546 (580)
|||+ +++|.+++.. ....+++.++..++.|++.||+|||+ ++||||||||+|||++. ++.+||+|||
T Consensus 80 me~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccc
Confidence 9999 6899887743 22468899999999999999999997 89999999999999974 5789999999
Q ss_pred cccccCCCCCC------ccccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGKGS------IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~~~------~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+|+........ .....+||+.|||||++.+.+++
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~ 191 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS 191 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC
Confidence 99876543211 12346799999999999988764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-31 Score=261.42 Aligned_cols=175 Identities=23% Similarity=0.312 Sum_probs=152.6
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcCCeeEEEEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 473 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 473 (580)
++|++.+.||+|+||+||+|++. +++.||||+++..........++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999874 78999999998765555667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeeccccccCC
Q 008026 474 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 553 (580)
Q Consensus 474 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 553 (580)
++.++++..++. ....+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccc-----cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 999988877653 23567889999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccCCCC
Q 008026 554 GKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 554 ~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
... ......+++.|+|||++.+.+
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~ 177 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCS
T ss_pred CCc-cceeeccccchhhhhHhccCC
Confidence 432 223346788999999987654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.5e-31 Score=265.73 Aligned_cols=169 Identities=25% Similarity=0.401 Sum_probs=137.6
Q ss_pred CCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC------Cee
Q 008026 396 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------NEK 468 (580)
Q Consensus 396 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 468 (580)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5888899999999999999875 799999999976432 234799999999999999999998643 346
Q ss_pred EEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC-cEEEEeecc
Q 008026 469 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGL 547 (580)
Q Consensus 469 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~ 547 (580)
|+||||++++ +.+.+.... .....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~-~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPET-VYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEE-HHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCc-cHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence 8999999765 444443322 233578999999999999999999997 8999999999999999765 899999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNF 577 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~ 577 (580)
|+...... .....+||+.|+|||.+.+.
T Consensus 170 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 197 (350)
T d1q5ka_ 170 AKQLVRGE--PNVSYICSRYYRAPELIFGA 197 (350)
T ss_dssp CEECCTTS--CCCSCCSCTTSCCHHHHTTC
T ss_pred hhhccCCc--ccccccccccccChHHhhcc
Confidence 98765443 23345799999999987653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-31 Score=267.79 Aligned_cols=174 Identities=26% Similarity=0.346 Sum_probs=138.8
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEc------CC
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------GN 466 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 466 (580)
.++|++.+.||+|+||+||+|++. +|+.||||++...........++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999875 79999999998766666667789999999999999999999999964 36
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..|+||||+.++.+ +.+. ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eeEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechh
Confidence 78999999976544 3331 358899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+++...... .....+||+.|+|||++.+..++
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~ 196 (355)
T d2b1pa1 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 196 (355)
T ss_dssp C-----------------CCTTCCHHHHTTCCCC
T ss_pred hhhcccccc--ccccccccccccChhhhcCCCCC
Confidence 988665433 33446799999999999987764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.8e-32 Score=266.93 Aligned_cols=176 Identities=25% Similarity=0.357 Sum_probs=150.5
Q ss_pred cCCcccceeeccCcEEEEEEEEc----CCcEEEEEEeecccc--ChhhHHHHHHHHHHHHhcCC-CcccceeeEEEcCCe
Q 008026 395 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNE 467 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 467 (580)
++|++.+.||+|+||+||+|+.. +|+.||||++++... +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999752 578999999976432 22345678899999999976 899999999999999
Q ss_pred eEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeecc
Q 008026 468 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 547 (580)
Q Consensus 468 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 547 (580)
.++||||+.+|+|.+++... ..+.+..+..++.||+.||+|+|+ .+||||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999988542 356788899999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCccCccccCCCC
Q 008026 548 VRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
|+..............|++.|+|||.+.+.+
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~ 206 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGD 206 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC
T ss_pred hhhhcccccccccccccccccchhHHhhcCC
Confidence 9876554433444567999999999997654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.6e-31 Score=265.36 Aligned_cols=173 Identities=25% Similarity=0.387 Sum_probs=144.5
Q ss_pred hhcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCcccceeeEEEcC-----C
Q 008026 393 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 466 (580)
Q Consensus 393 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 466 (580)
+.++|++.+.||+|+||+||+|+.. +|+.||||++.+........+++.+|++++++++||||+++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3568999999999999999999764 799999999987655556667889999999999999999999998643 3
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcEEEEeec
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 546 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 546 (580)
..+++|+|+.+|+|.+++.. +.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccc
Confidence 44677788889999988732 468999999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCccCccccCCCC
Q 008026 547 LVRLAPEGKGSIETRIAGTFGYLAPEYAGNFG 578 (580)
Q Consensus 547 ~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 578 (580)
.|..... ......||+.|+|||.+.+..
T Consensus 167 ~a~~~~~----~~~~~~g~~~y~apE~~~~~~ 194 (348)
T d2gfsa1 167 LARHTDD----EMTGYVATRWYRAPEIMLNWM 194 (348)
T ss_dssp ---CCTG----GGSSSCHHHHTSCHHHHTTCS
T ss_pred hhcccCc----ccccccccccccCchhhcCCc
Confidence 9875532 233457899999999977654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=4e-30 Score=253.23 Aligned_cols=175 Identities=22% Similarity=0.341 Sum_probs=140.9
Q ss_pred hcCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCccc-ceeeEEEcCCeeEEE
Q 008026 394 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV-ALLGHCLDGNEKLLV 471 (580)
Q Consensus 394 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv 471 (580)
.++|++.+.||+|+||.||+|++. +++.||||++..... ..++.+|+++++.++|++++ .+.+++.+.+..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 357999999999999999999764 689999998876422 23578899999999877655 555666778889999
Q ss_pred EEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecC---CCcEEEEeeccc
Q 008026 472 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 548 (580)
Q Consensus 472 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a 548 (580)
|||+ ++++.+.+.. ....+++..+..++.|++.||+|||+ ++||||||||+|||++. +..+||+|||+|
T Consensus 82 me~~-~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 82 MELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEc-CCchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 9999 5566665532 23568999999999999999999998 89999999999999863 457999999999
Q ss_pred cccCCCCCC------ccccccccCCccCccccCCCCCC
Q 008026 549 RLAPEGKGS------IETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 549 ~~~~~~~~~------~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
+........ ......||+.|||||++.+.+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 191 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCC
Confidence 877543321 12346799999999999988764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=4.3e-28 Score=240.42 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=183.2
Q ss_pred ccccc--CCCCCccccccceEEecccCC-CCCCCCCchhhcCcccCceEecccCcCcCCCCC-CCCCCCCcEEeccCCcc
Q 008026 2 LQLIG--GLPASFSGSQIQSLWVNGQNG-NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFF 77 (580)
Q Consensus 2 ~~~~~--~~P~~~~~~~l~~L~~~~~~~-n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l 77 (580)
|+++| .+|++| .+|+.|+.+++++ |++.+.+|..|++|++|++|+|++|+|.+.+|. +..+..|+.++++.|++
T Consensus 60 ~~l~g~~~lp~~l--~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~ 137 (313)
T d1ogqa_ 60 LNLPKPYPIPSSL--ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137 (313)
T ss_dssp CCCSSCEECCGGG--GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEE
T ss_pred CCCCCCCCCChHH--hcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccc
Confidence 55666 478888 5677777777765 666667888888888888888888888887774 67788888888888888
Q ss_pred cccCCccccCCCCCcEEEccCCcccccCCC-CCccccc-ccccccCCCCCCCCCCCchhHHHHHHHHHhhCCcccccccc
Q 008026 78 TGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSL-DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 155 (580)
Q Consensus 78 ~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L-~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~ 155 (580)
.+.+|..++++++|+.+++++|.+++.+|. +..+..+ +.+.++.|.+....+..+..+. ......
T Consensus 138 ~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~-------------~~~l~l 204 (313)
T d1ogqa_ 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-------------LAFVDL 204 (313)
T ss_dssp ESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-------------CSEEEC
T ss_pred cccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccc-------------cccccc
Confidence 888888888888888888888888877764 5566554 6777888877655543332111 000001
Q ss_pred CCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccccc
Q 008026 156 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 235 (580)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~ 235 (580)
..+......+.....+.+|+.|++++|.+.+.+| .++.+++|+.|+|++|+|+|.+|++|+++++|++|||++|+|+|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~ 283 (313)
T d1ogqa_ 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred cccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccccc
Confidence 1111111234455566799999999999997665 799999999999999999999999999999999999999999999
Q ss_pred CCCCCC---CceeecCCCCCCCCCCCC
Q 008026 236 IPSFKS---NAIVNTDGNPDIGKEKSS 259 (580)
Q Consensus 236 ~p~~~~---~~~~~~~~n~~~c~~~~~ 259 (580)
+|+... ...+.+.+|+.+|+.|.+
T Consensus 284 iP~~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 284 IPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp CCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred CCCcccCCCCCHHHhCCCccccCCCCC
Confidence 998632 235788999999987643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.92 E-value=9.6e-26 Score=228.09 Aligned_cols=175 Identities=23% Similarity=0.271 Sum_probs=137.1
Q ss_pred cCCcccceeeccCcEEEEEEEEc-CCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-----------CCcccceeeEE
Q 008026 395 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----------HRHLVALLGHC 462 (580)
Q Consensus 395 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~ 462 (580)
++|++.+.||+|+||+||+|+.. +|+.||||++++. ....+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 35999999999999999999874 7999999999753 233456788998888775 57899999887
Q ss_pred Ec--CCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCC--
Q 008026 463 LD--GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 538 (580)
Q Consensus 463 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 538 (580)
.. ....+++|+++..+........ ......+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred eeccccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcc
Confidence 64 3566777777766554333322 2334578889999999999999999997 47899999999999998654
Q ss_pred ----cEEEEeeccccccCCCCCCccccccccCCccCccccCCCCCC
Q 008026 539 ----RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAGNFGSS 580 (580)
Q Consensus 539 ----~~kl~Dfg~a~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 580 (580)
.++++|||.|...... ....+||+.|+|||++.+.+|+
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCC
T ss_pred cccceeeEeecccccccccc----cccccccccccChhhccccCCC
Confidence 3999999999765432 2335799999999999887664
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.91 E-value=1e-25 Score=223.16 Aligned_cols=221 Identities=21% Similarity=0.304 Sum_probs=181.6
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCccccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~ 80 (580)
|+++|.||++| .+|+.|+.+++++|++.+..+..+.++..|++++++.|.+.+.+| .+..++.|+.+++++|.+.|.
T Consensus 87 N~l~g~iP~~i--~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ 164 (313)
T d1ogqa_ 87 NNLVGPIPPAI--AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164 (313)
T ss_dssp TTEESCCCGGG--GGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEE
T ss_pred ccccccccccc--ccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccccc
Confidence 78999999999 678999999999999888888889999999999999999999888 589999999999999999999
Q ss_pred CCccccCCCCC-cEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCC
Q 008026 81 VPDSLVKLESL-KIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 159 (580)
Q Consensus 81 ~P~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 159 (580)
+|..+..+.+| +.++++.|++++..|.......+..+++.++......+.... ....+......++
T Consensus 165 ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~-------------~~~~l~~l~~~~~ 231 (313)
T d1ogqa_ 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG-------------SDKNTQKIHLAKN 231 (313)
T ss_dssp CCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCC-------------TTSCCSEEECCSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-------------ccccccccccccc
Confidence 99999999886 899999999999888644444455677777765544332221 1222223333334
Q ss_pred CCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCc-cccc-CC
Q 008026 160 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ-LYGK-IP 237 (580)
Q Consensus 160 ~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~-l~g~-~p 237 (580)
.....+..++.+++|+.|+|++|+++|.+|+.|++|++|++|+|++|+|+|.+|. ++++++|+.+++++|+ +.|. +|
T Consensus 232 ~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp EECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTTSS
T ss_pred cccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCCCC
Confidence 4444455566678999999999999999999999999999999999999999994 7899999999999998 6664 66
Q ss_pred C
Q 008026 238 S 238 (580)
Q Consensus 238 ~ 238 (580)
+
T Consensus 311 ~ 311 (313)
T d1ogqa_ 311 A 311 (313)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=5.5e-24 Score=205.22 Aligned_cols=194 Identities=19% Similarity=0.091 Sum_probs=150.1
Q ss_pred cccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcc
Q 008026 23 NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 101 (580)
Q Consensus 23 ~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l 101 (580)
.+++++.+. .+|+.+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+|+ .+|. ++.+++|+.|+|++|++
T Consensus 15 v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l 89 (266)
T d1p9ag_ 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQL 89 (266)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCC
T ss_pred EEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccccccccc
Confidence 366666544 4665553 478888888888887766 4788888888888888888 6663 57788888888888888
Q ss_pred cccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecC
Q 008026 102 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 181 (580)
Q Consensus 102 ~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~ 181 (580)
+..++.+..+.+|+.|++++|.+..++...+. .+.+++.|++++
T Consensus 90 ~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~------------------------------------~l~~l~~L~l~~ 133 (266)
T d1p9ag_ 90 QSLPLLGQTLPALTVLDVSFNRLTSLPLGALR------------------------------------GLGELQELYLKG 133 (266)
T ss_dssp SSCCCCTTTCTTCCEEECCSSCCCCCCSSTTT------------------------------------TCTTCCEEECTT
T ss_pred cccccccccccccccccccccccceeeccccc------------------------------------cccccccccccc
Confidence 88877788888888888888887776654432 223788899999
Q ss_pred CcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----CceeecCCCCCCCCCC
Q 008026 182 MNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----NAIVNTDGNPDIGKEK 257 (580)
Q Consensus 182 n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~~~~~~~~n~~~c~~~ 257 (580)
|.+....+..+..++.|+.|++++|+|++..|..+..+++|++|||++|+|+ .+|..+. ...+.+.||||.|+|.
T Consensus 134 n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 9988666666778889999999999998666677888999999999999988 6665432 2458889999999985
Q ss_pred C
Q 008026 258 S 258 (580)
Q Consensus 258 ~ 258 (580)
.
T Consensus 213 ~ 213 (266)
T d1p9ag_ 213 I 213 (266)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.5e-23 Score=202.16 Aligned_cols=188 Identities=18% Similarity=0.145 Sum_probs=163.0
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccC
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV 81 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~ 81 (580)
++|+ .||+.|. ..|+.+++++|++.+..+++|.++++|++|+|++|+|+. +|.+..+++|++|+|++|+++ .+
T Consensus 20 ~~L~-~iP~~lp----~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~-~~ 92 (266)
T d1p9ag_ 20 RNLT-ALPPDLP----KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ-SL 92 (266)
T ss_dssp SCCS-SCCSCCC----TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCS-SC
T ss_pred CCCC-eeCcCcC----cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-ccccccccccccccccccccc-cc
Confidence 3455 5898884 345566777887766656889999999999999999985 456788999999999999999 78
Q ss_pred CccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCC
Q 008026 82 PDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 160 (580)
Q Consensus 82 P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 160 (580)
|..+.++++|+.|++++|.+.+..+. +..+.+++.|++.+|.+..+++..+.
T Consensus 93 ~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~--------------------------- 145 (266)
T d1p9ag_ 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT--------------------------- 145 (266)
T ss_dssp CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTT---------------------------
T ss_pred ccccccccccccccccccccceeeccccccccccccccccccccceecccccc---------------------------
Confidence 88999999999999999999988775 67888999999999999988866543
Q ss_pred CCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 161 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 161 ~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
.+.+|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|+++..+++|+.|+|++|++.
T Consensus 146 ---------~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 146 ---------PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ---------TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ---------ccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 2238999999999999877788999999999999999999 99999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=7e-23 Score=186.89 Aligned_cols=137 Identities=16% Similarity=0.168 Sum_probs=107.3
Q ss_pred CcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccC----------------hhhHHHHHHHHHHHHhcCCCcccceee
Q 008026 397 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS----------------GKGLTEFKSEIAVLTKVRHRHLVALLG 460 (580)
Q Consensus 397 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~~~~ 460 (580)
+.+.+.||+|+||.||+|+..+|+.||||+++..... ........+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3467899999999999999888999999987532111 011234567889999999999998876
Q ss_pred EEEcCCeeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeEecCCCcE
Q 008026 461 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 540 (580)
Q Consensus 461 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 540 (580)
+. ..+++|||+++..+.+ ++...+..++.|++.|++|||+ ++|+||||||+|||++++ .+
T Consensus 82 ~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EE
T ss_pred ec----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CE
Confidence 53 2379999998765532 3334466789999999999998 899999999999999865 58
Q ss_pred EEEeeccccccCC
Q 008026 541 KVADFGLVRLAPE 553 (580)
Q Consensus 541 kl~Dfg~a~~~~~ 553 (580)
+|+|||.|+....
T Consensus 142 ~liDFG~a~~~~~ 154 (191)
T d1zara2 142 WIIDFPQSVEVGE 154 (191)
T ss_dssp EECCCTTCEETTS
T ss_pred EEEECCCcccCCC
Confidence 9999999977643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=5.5e-23 Score=200.24 Aligned_cols=212 Identities=21% Similarity=0.246 Sum_probs=172.0
Q ss_pred CCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEecc-CCcccccCCcc
Q 008026 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLR-DNFFTGPVPDS 84 (580)
Q Consensus 7 ~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~-~N~l~~~~P~~ 84 (580)
++|..+. ++ ++.|++++|++.+..+.+|.++++|++|++++|+|....+ .+.++..++.++.. .|.+....|..
T Consensus 25 ~iP~~ip-~~---~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~ 100 (284)
T d1ozna_ 25 AVPVGIP-AA---SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPAT 100 (284)
T ss_dssp SCCTTCC-TT---CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTT
T ss_pred ccCCCCC-CC---CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 6777774 23 4556677777766555779999999999999999988776 46778888888764 56676444667
Q ss_pred ccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCC
Q 008026 85 LVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 163 (580)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (580)
|.++++|+.|++++|.+....+. +....+|+.+++++|.+..+++..+.
T Consensus 101 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~------------------------------ 150 (284)
T d1ozna_ 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR------------------------------ 150 (284)
T ss_dssp TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT------------------------------
T ss_pred hcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhc------------------------------
Confidence 99999999999999998877665 66777889999999998888765442
Q ss_pred ccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC--
Q 008026 164 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS-- 241 (580)
Q Consensus 164 ~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~-- 241 (580)
...+|+.|++++|++.+..|..|.++++|+.+++++|++++..|..|..+++|++||+++|++++..|..+.
T Consensus 151 ------~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~ 224 (284)
T d1ozna_ 151 ------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224 (284)
T ss_dssp ------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred ------cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccc
Confidence 223899999999999987888899999999999999999988899999999999999999999987765443
Q ss_pred --CceeecCCCCCCCCCCC
Q 008026 242 --NAIVNTDGNPDIGKEKS 258 (580)
Q Consensus 242 --~~~~~~~~n~~~c~~~~ 258 (580)
...+++++|||.|.|..
T Consensus 225 ~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 225 RALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp TTCCEEECCSSCEECSGGG
T ss_pred cccCEEEecCCCCCCCccc
Confidence 45689999999998753
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.84 E-value=7.7e-21 Score=186.88 Aligned_cols=224 Identities=17% Similarity=0.167 Sum_probs=167.4
Q ss_pred CCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccc
Q 008026 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSL 85 (580)
Q Consensus 7 ~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~ 85 (580)
++|..+. +.|+.+++++|++....+.+|.++++|++|++++|.+....| .|.++++|+.|++++|+++ .+|..+
T Consensus 24 ~lP~~l~----~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~ 98 (305)
T d1xkua_ 24 KVPKDLP----PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM 98 (305)
T ss_dssp SCCCSCC----TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC
T ss_pred ccCCCCC----CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch
Confidence 6788873 346666788886665555689999999999999999998877 4889999999999999999 788764
Q ss_pred cCCCCCcEEEccCCcccccCC---------------------------CCCcccccccccccCCCCCCCCCCCchhHHHH
Q 008026 86 VKLESLKIVNMTNNLLQGPVP---------------------------EFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 138 (580)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~~---------------------------~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l 138 (580)
...|..|++++|.+.++.+ .+..+.+|+.+++++|.+..++...+..+.
T Consensus 99 --~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~-- 174 (305)
T d1xkua_ 99 --PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT-- 174 (305)
T ss_dssp --CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCS--
T ss_pred --hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccC--
Confidence 4578888888888887653 123345667777888877777655443222
Q ss_pred HHHHHhhCCccccccccCCCCCCCC-ccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCc
Q 008026 139 LSVVKLMGYPQRFAENWKGNDPCSD-WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 217 (580)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~ 217 (580)
...+.++.... .+..+..+..++.|++++|.+.+..|..+.++++|++|+|++|+|+ .+|+++.
T Consensus 175 --------------~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~ 239 (305)
T d1xkua_ 175 --------------ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239 (305)
T ss_dssp --------------EEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred --------------EEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccc
Confidence 12222222222 2344555678999999999999888888999999999999999998 8899999
Q ss_pred CCCCCCEEEccCCcccccCCCCC----------CCceeecCCCCCCC
Q 008026 218 VLGALKELDVSNNQLYGKIPSFK----------SNAIVNTDGNPDIG 254 (580)
Q Consensus 218 ~l~~L~~l~ls~N~l~g~~p~~~----------~~~~~~~~~n~~~c 254 (580)
.+++|++|+|++|+++..-...+ ....+.++||||.+
T Consensus 240 ~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp TCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 99999999999999985322221 12347889999865
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.5e-20 Score=182.80 Aligned_cols=198 Identities=19% Similarity=0.171 Sum_probs=169.4
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecc-cCcCcCCCC-CCCCCCCCcEEeccCCcccc
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH-SNAFSGPLP-DFSGVKQLESLSLRDNFFTG 79 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~-~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~ 79 (580)
|+++..-|..| .++..|+.+++++|++....+..+.++..++.++.. .|.++...| .|.++++|++|+|++|.+..
T Consensus 42 N~i~~i~~~~f--~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~ 119 (284)
T d1ozna_ 42 NRISHVPAASF--RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE 119 (284)
T ss_dssp SCCCEECTTTT--TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC
T ss_pred CcCCCCCHHHh--hccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCccccc
Confidence 56654444568 568888999999998888888889999999998775 566776666 58999999999999999985
Q ss_pred cCCccccCCCCCcEEEccCCcccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCC
Q 008026 80 PVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 158 (580)
Q Consensus 80 ~~P~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~ 158 (580)
..+..+..+.+|+.+++++|+++++++. |..+..|+.|++++|.+..+++..+.
T Consensus 120 ~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~------------------------- 174 (284)
T d1ozna_ 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR------------------------- 174 (284)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT-------------------------
T ss_pred ccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhc-------------------------
Confidence 5566699999999999999999998876 67788999999999999888766553
Q ss_pred CCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 159 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 159 ~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
.+++|+.+++++|++++..|..|.++++|++|++++|++.+..|..+..+++|++|++++|++.+.-+
T Consensus 175 -----------~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 175 -----------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp -----------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred -----------cccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 23489999999999999999999999999999999999997777889999999999999999986543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.5e-18 Score=158.72 Aligned_cols=165 Identities=18% Similarity=0.226 Sum_probs=80.7
Q ss_pred cccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCccccccccccc
Q 008026 41 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 120 (580)
Q Consensus 41 l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~ 120 (580)
|.+|++|++++|.++.. +.+..+++|+.|+|++|+|+ .+| .++.+++|+.|++++|++++++ .+..+.+|+.|+++
T Consensus 45 L~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~L~~n~i~-~l~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp HHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEECT
T ss_pred hcCccEEECcCCCCCCc-hhHhhCCCCCEEeCCCcccc-Ccc-ccccCccccccccccccccccc-cccccccccccccc
Confidence 44455555555555432 22444455555555555554 233 2444555555555555554432 34444455555555
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcE
Q 008026 121 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQR 200 (580)
Q Consensus 121 ~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~ 200 (580)
+|.+..+++- . .+..+.......+...+. .....+++|+.+++++|++++ ++ .++++++|++
T Consensus 121 ~~~~~~~~~l--~-------------~l~~l~~l~~~~n~l~~~-~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~ 182 (210)
T d1h6ta2 121 HNGISDINGL--V-------------HLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQN 182 (210)
T ss_dssp TSCCCCCGGG--G-------------GCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCE
T ss_pred cccccccccc--c-------------cccccccccccccccccc-ccccccccccccccccccccc-cc-cccCCCCCCE
Confidence 5444332110 0 000000111111111111 112234477777777777773 43 3777777777
Q ss_pred EeccCCcccccCCccCcCCCCCCEEEccC
Q 008026 201 LILADNNLSGMIPEGLSVLGALKELDVSN 229 (580)
Q Consensus 201 L~ls~N~l~g~~p~~l~~l~~L~~l~ls~ 229 (580)
|+|++|+|+ .+| .+..+++|++|+|++
T Consensus 183 L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 183 LYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp EECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred EECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 777777776 555 477777777777753
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.1e-18 Score=158.66 Aligned_cols=85 Identities=14% Similarity=0.105 Sum_probs=49.6
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCCC-ceeecCCCC
Q 008026 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-AIVNTDGNP 251 (580)
Q Consensus 173 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~~-~~~~~~~n~ 251 (580)
+|+.|+|++|+|++..|..|..+++|++|+|++|.+... +....-...++.+.+..|.++...|..+.. .+.++..|.
T Consensus 103 ~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~-~~~~~~~~~l~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~ 181 (192)
T d1w8aa_ 103 QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN-CHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSE 181 (192)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS-GGGHHHHHHHHHHCCSGGGCBBCSSTTTTTSBGGGSCTTT
T ss_pred cccccccCCccccccCHHHhcCCcccccccccccccccc-cchHHHhhhhhhhcccCCCeEeCCChhhcCCEeeecCHhh
Confidence 666777777777755556667777777777777776532 221111223455556666666555555433 446667777
Q ss_pred CCCCCCC
Q 008026 252 DIGKEKS 258 (580)
Q Consensus 252 ~~c~~~~ 258 (580)
..|..+.
T Consensus 182 l~C~~~~ 188 (192)
T d1w8aa_ 182 FKCSSEN 188 (192)
T ss_dssp CCCCCC-
T ss_pred CcCCCCC
Confidence 7776543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.73 E-value=7.6e-18 Score=165.13 Aligned_cols=224 Identities=17% Similarity=0.143 Sum_probs=158.2
Q ss_pred EecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCC
Q 008026 21 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 99 (580)
Q Consensus 21 ~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N 99 (580)
+.++++++. ++.+|..+. ++|++|+|++|+|+..++ +|.++++|++|++++|.+....|..|.++++|+.|++++|
T Consensus 13 ~~~~C~~~~-L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 13 RVVQCSDLG-LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TEEECTTSC-CCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCC-CCccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 345666554 455676553 689999999999998887 5999999999999999999656778999999999999999
Q ss_pred cccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHH-------------HhhCCccccccccCCCCCCCCccc
Q 008026 100 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVV-------------KLMGYPQRFAENWKGNDPCSDWIG 166 (580)
Q Consensus 100 ~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~ 166 (580)
+++.++..+. ..+..|....|.+..++...+........+. .....+..+......++....++.
T Consensus 90 ~l~~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~ 167 (305)
T d1xkua_ 90 QLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 167 (305)
T ss_dssp CCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS
T ss_pred ccCcCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCc
Confidence 9998876543 3567777788877766532211110000000 000001111122223333333433
Q ss_pred eeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccCCCCCC----C
Q 008026 167 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS----N 242 (580)
Q Consensus 167 ~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p~~~~----~ 242 (580)
.. .++|+.|++++|.+.+..+..+..++.++.|++++|++.+..|..+..+++|++|+|++|+|+ .+|..+. .
T Consensus 168 ~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L 244 (305)
T d1xkua_ 168 GL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 244 (305)
T ss_dssp SC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSC
T ss_pred cc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCC
Confidence 32 358899999999999888889999999999999999999777888899999999999999998 4565543 2
Q ss_pred ceeecCCCCC
Q 008026 243 AIVNTDGNPD 252 (580)
Q Consensus 243 ~~~~~~~n~~ 252 (580)
..+++++|.-
T Consensus 245 ~~L~Ls~N~i 254 (305)
T d1xkua_ 245 QVVYLHNNNI 254 (305)
T ss_dssp CEEECCSSCC
T ss_pred CEEECCCCcc
Confidence 3577777753
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=3.8e-17 Score=149.30 Aligned_cols=170 Identities=16% Similarity=0.174 Sum_probs=130.0
Q ss_pred cceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEc
Q 008026 17 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 96 (580)
Q Consensus 17 l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L 96 (580)
+..+....++.+...... ....+.+|++|++++|.++. ++.+..+++|++|+|++|+++ .++. ++++++|+.|++
T Consensus 17 l~~~i~~~l~~~~~~~~~--~~~~l~~l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~-~~~~-l~~l~~L~~L~l 91 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILM 91 (199)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEEC
T ss_pred HHHHHHHHhCCCCCCCcc--CHHHhcCCCEEECCCCCCCC-ccccccCCCcCcCcccccccc-Cccc-ccCCcccccccc
Confidence 444444555555444322 23567889999999999884 456777899999999999998 4554 889999999999
Q ss_pred cCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEE
Q 008026 97 TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 176 (580)
Q Consensus 97 ~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ 176 (580)
++|.+...+ .+..+..|+.+++++|.+...++ +..+++|+.
T Consensus 92 ~~n~~~~~~-~l~~l~~L~~L~l~~~~~~~~~~--------------------------------------~~~l~~L~~ 132 (199)
T d2omxa2 92 NNNQIADIT-PLANLTNLTGLTLFNNQITDIDP--------------------------------------LKNLTNLNR 132 (199)
T ss_dssp CSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGG--------------------------------------GTTCTTCSE
T ss_pred ccccccccc-ccccccccccccccccccccccc--------------------------------------cchhhhhHH
Confidence 999887655 47788889999988887654321 123458999
Q ss_pred EEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccc
Q 008026 177 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 177 L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
|++++|++. .+| .+..+++|++|++++|+++ .++ .++.+++|++|++++|++++
T Consensus 133 L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~-~l~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 133 LELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVT-DLK-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp EECCSSCCC-CCG-GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCC
T ss_pred hhhhhhhhc-ccc-ccccccccccccccccccc-CCc-cccCCCCCCEEECCCCCCCC
Confidence 999999987 454 5888999999999999998 454 48889999999999999885
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.2e-16 Score=149.38 Aligned_cols=195 Identities=14% Similarity=0.146 Sum_probs=124.3
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
.|..+...+++.++..+. ..++.|.+|+.|++++|.|+.. +.+..+++|++|+|++|++.+ ++ .+..+++|+.|+
T Consensus 17 ~l~~~~~~~l~~~~~~d~--~~~~~l~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~-~~-~l~~l~~l~~l~ 91 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITD-LA-PLKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHHTTCSSTTSE--ECHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCCSCCEEE
T ss_pred HHHHHHHHHhCCCCcCCc--CCHHHcCCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeec-cc-cccccccccccc
Confidence 344444555555544432 2345667777777777777754 556677777777777777773 33 277777777777
Q ss_pred ccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEE
Q 008026 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175 (580)
Q Consensus 96 L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 175 (580)
+++|.++. ++.+..+.+|+.+.++++......+.. ...........+....... .+....+|+
T Consensus 92 ~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~~~~~---------------~~~~~~~l~~~~~~~~~~~-~~~~~~~L~ 154 (227)
T d1h6ua2 92 LSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTPLA---------------GLSNLQVLYLDLNQITNIS-PLAGLTNLQ 154 (227)
T ss_dssp CCSCCCSC-CGGGTTCTTCCEEECTTSCCCCCGGGT---------------TCTTCCEEECCSSCCCCCG-GGGGCTTCC
T ss_pred cccccccc-cccccccccccccccccccccccchhc---------------cccchhhhhchhhhhchhh-hhccccccc
Confidence 77777764 345666777777777777655443210 0111111112222222221 234456899
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCcccccC
Q 008026 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 236 (580)
Q Consensus 176 ~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~ 236 (580)
.|++++|.+.. ++ .++++++|++|+|++|++. .+|. +..+++|++|+|++|++++..
T Consensus 155 ~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~i~ 211 (227)
T d1h6ua2 155 YLSIGNAQVSD-LT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVS 211 (227)
T ss_dssp EEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCBCG
T ss_pred ccccccccccc-ch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCCCCc
Confidence 99999998884 33 3888999999999999998 5554 888999999999999988543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=4.4e-17 Score=148.93 Aligned_cols=162 Identities=18% Similarity=0.242 Sum_probs=133.0
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
.+..|+.+++++|.+.+ + +.+..+++|++|+|++|+|++..| +.++++|+.|++++|.+. .+| .+.++++|+.|+
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-ccc-cccccccccccc
Confidence 35566667777776554 2 458899999999999999997654 889999999999999998 666 489999999999
Q ss_pred ccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEE
Q 008026 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175 (580)
Q Consensus 96 L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 175 (580)
+++|.+.... .+..+.+|+.+++++|.+..++. +..+.+|+
T Consensus 113 l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~--------------------------------------l~~~~~L~ 153 (199)
T d2omxa2 113 LFNNQITDID-PLKNLTNLNRLELSSNTISDISA--------------------------------------LSGLTSLQ 153 (199)
T ss_dssp CCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGG--------------------------------------GTTCTTCS
T ss_pred cccccccccc-ccchhhhhHHhhhhhhhhccccc--------------------------------------cccccccc
Confidence 9999988754 47788999999999998765431 11234899
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEE
Q 008026 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 225 (580)
Q Consensus 176 ~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l 225 (580)
.|++++|++++ ++ .++++++|++|++++|+++ .+| .++.+++|+.|
T Consensus 154 ~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L 199 (199)
T d2omxa2 154 QLNFSSNQVTD-LK-PLANLTTLERLDISSNKVS-DIS-VLAKLTNLESL 199 (199)
T ss_dssp EEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred ccccccccccC-Cc-cccCCCCCCEEECCCCCCC-CCc-cccCCCCCCcC
Confidence 99999999994 54 4899999999999999998 565 58899999876
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=1.3e-17 Score=151.55 Aligned_cols=170 Identities=14% Similarity=0.093 Sum_probs=129.1
Q ss_pred cccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC--CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCc
Q 008026 23 NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100 (580)
Q Consensus 23 ~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~ 100 (580)
.+++++++ +.+|..+. +++++|+|++|+|++.++ .|.++++|+.|+|++|++.+..+..|..+++|++|+|++|+
T Consensus 13 v~Cs~~~L-~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGL-KEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCC-SSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEeCCCc-CccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 45666644 45665543 588999999999987554 47889999999999999997777789999999999999999
Q ss_pred ccccCCC-CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEe
Q 008026 101 LQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 179 (580)
Q Consensus 101 l~~~~~~-~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l 179 (580)
|+.+++. |.++.+|+.|++++|.+..+++..|.. +++|+.|+|
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~------------------------------------l~~L~~l~L 133 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH------------------------------------LNSLTSLNL 133 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTT------------------------------------CTTCCEEEC
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcC------------------------------------Ccccccccc
Confidence 9998886 778899999999999998888766532 238999999
Q ss_pred cCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccccc
Q 008026 180 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 235 (580)
Q Consensus 180 s~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~ 235 (580)
++|.+....+..+ -...++.+.+..|.+....|.. +..++.+||+.|.|.-.
T Consensus 134 ~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 134 ASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCCC
T ss_pred cccccccccchHH-HhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCcCC
Confidence 9999884333222 1234666778888888777765 45677888999988743
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=2.3e-16 Score=159.41 Aligned_cols=163 Identities=22% Similarity=0.213 Sum_probs=96.8
Q ss_pred CCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHh
Q 008026 65 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL 144 (580)
Q Consensus 65 ~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~ 144 (580)
++++.|++++|.+++..| +..+++|+.|++++|+++.. +.+..+.+|+.+++++|.+..+++. ..+..+..+...
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~~--~~~~~L~~L~l~ 271 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLG 271 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGGG--TTCTTCSEEECC
T ss_pred cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc-chhhcccccchhccccCccCCCCcc--cccccCCEeecc
Confidence 344445556666663222 44556666666666666653 3455555666666666665554321 111111111000
Q ss_pred ---------hCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCcc
Q 008026 145 ---------MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 215 (580)
Q Consensus 145 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 215 (580)
......+.......+..... ..+..+.+++.|++++|++++ ++ .+..+++|++|++++|+|+ .+| +
T Consensus 272 ~~~l~~~~~~~~~~~l~~l~~~~n~l~~~-~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~ 346 (384)
T d2omza2 272 ANQISNISPLAGLTALTNLELNENQLEDI-SPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-S 346 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCCSCC-GGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-G
T ss_pred CcccCCCCccccccccccccccccccccc-cccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-h
Confidence 00011111111222222222 235556789999999999995 44 3889999999999999998 565 6
Q ss_pred CcCCCCCCEEEccCCcccccCC
Q 008026 216 LSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 216 l~~l~~L~~l~ls~N~l~g~~p 237 (580)
+..+++|++|++++|++++.+|
T Consensus 347 l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 347 LANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp GGGCTTCCEEECCSSCCCBCGG
T ss_pred HcCCCCCCEEECCCCcCCCChh
Confidence 9999999999999999997655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=9.4e-17 Score=150.03 Aligned_cols=189 Identities=17% Similarity=0.205 Sum_probs=147.0
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 94 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L 94 (580)
..+..|+.+++.+|.+.+ + +.+.+|++|++|+|++|++++..| +..+++|++|++++|.++ .++ .+..+++|+.+
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l 112 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTL 112 (227)
T ss_dssp HHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEE
T ss_pred HHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc-cccccccccccccccccc-ccc-ccccccccccc
Confidence 346677777787786654 4 458999999999999999997654 888999999999999998 665 58899999999
Q ss_pred EccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcE
Q 008026 95 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 174 (580)
Q Consensus 95 ~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 174 (580)
++++|...+..+ +.....+..+.++++.+....+- .....+......++....+.+ +..+++|
T Consensus 113 ~l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~---------------~~~~~L~~L~l~~n~~~~~~~-l~~l~~L 175 (227)
T d1h6ua2 113 DLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISPL---------------AGLTNLQYLSIGNAQVSDLTP-LANLSKL 175 (227)
T ss_dssp ECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGGG---------------GGCTTCCEEECCSSCCCCCGG-GTTCTTC
T ss_pred ccccccccccch-hccccchhhhhchhhhhchhhhh---------------ccccccccccccccccccchh-hcccccc
Confidence 999999887644 56667778888888877654321 112233344445555544444 5667899
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccC
Q 008026 175 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN 229 (580)
Q Consensus 175 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~ 229 (580)
+.|+|++|++++ +| .++++++|++|+|++|+++ .+|. +.++++|+.|++++
T Consensus 176 ~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 176 TTLKADDNKISD-IS-PLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEEEE
T ss_pred eecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEEeeC
Confidence 999999999994 55 4899999999999999999 5663 89999999999974
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=1.6e-16 Score=160.67 Aligned_cols=189 Identities=16% Similarity=0.179 Sum_probs=126.7
Q ss_pred ccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEE
Q 008026 16 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 95 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~ 95 (580)
.+..+..++++.|.+....| +..+++|++|++++|.++. +|.+..+++|+.|++++|++++ ++ .+..+++|+.|+
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~-~~-~~~~~~~L~~L~ 269 (384)
T d2omza2 195 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISN-LA-PLSGLTKLTELK 269 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred cccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-cchhhcccccchhccccCccCC-CC-cccccccCCEee
Confidence 34555555555564444322 4556777777777777774 3456667777777777777773 43 267777777777
Q ss_pred ccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEE
Q 008026 96 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 175 (580)
Q Consensus 96 L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 175 (580)
+++|++++.++ +..+..++.+.+..|.+..++. + .....+....+.++...+++. +..+++|+
T Consensus 270 l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~~~--~-------------~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~ 332 (384)
T d2omza2 270 LGANQISNISP-LAGLTALTNLELNENQLEDISP--I-------------SNLKNLTYLTLYFNNISDISP-VSSLTKLQ 332 (384)
T ss_dssp CCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--G-------------GGCTTCSEEECCSSCCSCCGG-GGGCTTCC
T ss_pred ccCcccCCCCc-cccccccccccccccccccccc--c-------------chhcccCeEECCCCCCCCCcc-cccCCCCC
Confidence 77777776543 5556666666777766654321 0 111112222233333334332 45667999
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCC
Q 008026 176 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 230 (580)
Q Consensus 176 ~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N 230 (580)
.|++++|+|+ .+| .+++|++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 333 ~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 333 RLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp EEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred EEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 9999999999 465 69999999999999999995544 899999999999998
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=2.2e-16 Score=149.01 Aligned_cols=188 Identities=13% Similarity=0.076 Sum_probs=122.5
Q ss_pred CCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCC--CCCCCCCCcEEecc-CCcccccCCc
Q 008026 7 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLR-DNFFTGPVPD 83 (580)
Q Consensus 7 ~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~-~N~l~~~~P~ 83 (580)
.+|+.+. .+++ .+++++|.+.+..+.+|.++++|++|+|++|.+...+| .|.++++++.|++. .|++....|.
T Consensus 22 ~iP~~l~-~~l~---~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~ 97 (242)
T d1xwdc1 22 EIPSDLP-RNAI---ELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPE 97 (242)
T ss_dssp SCCSCSC-SCCS---EEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTT
T ss_pred CcCCCCC-CCCC---EEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccc
Confidence 6776663 2344 44455555544444567788888888888887776544 36777788877765 4666655566
Q ss_pred cccCCCCCcEEEccCCcccccCCC--CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCC
Q 008026 84 SLVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 161 (580)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 161 (580)
.|.++++|+.|++++|++...++. +..+..+..+...++.+..++...+..+
T Consensus 98 ~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~-------------------------- 151 (242)
T d1xwdc1 98 AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL-------------------------- 151 (242)
T ss_dssp SEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS--------------------------
T ss_pred cccccccccccccchhhhcccccccccccccccccccccccccccccccccccc--------------------------
Confidence 678888888888888877755442 2334445555556666655554433210
Q ss_pred CCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEE-eccCCcccccCCc-cCcCCCCCCEEEccCCccccc
Q 008026 162 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL-ILADNNLSGMIPE-GLSVLGALKELDVSNNQLYGK 235 (580)
Q Consensus 162 ~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L-~ls~N~l~g~~p~-~l~~l~~L~~l~ls~N~l~g~ 235 (580)
...++.|++++|+++ .++....+..++.++ ++++|+|+ .+|. .|..+++|++|||++|+++..
T Consensus 152 ---------~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l 216 (242)
T d1xwdc1 152 ---------SFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL 216 (242)
T ss_dssp ---------BSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCC
T ss_pred ---------cccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCcc
Confidence 126888889999888 455555556665554 56778887 6654 578889999999999998843
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.62 E-value=9.3e-16 Score=141.17 Aligned_cols=172 Identities=13% Similarity=0.114 Sum_probs=128.8
Q ss_pred cccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCccccccccccc
Q 008026 41 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 120 (580)
Q Consensus 41 l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~ 120 (580)
+.++...+++.+.+++.++. ..+.+|+.|++++|++. .++ .+..+++|++|+|++|++++++ .+..+.+|+.|+++
T Consensus 23 l~~~i~~~l~~~~~~~~~~~-~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 23 FAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLD 98 (210)
T ss_dssp HHHHHHHHTTCSCTTSEECH-HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECC
T ss_pred HHHHHHHHhCcCccCCccCH-HHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccc
Confidence 34455567888888876642 34678999999999999 565 4899999999999999999866 47889999999999
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcE
Q 008026 121 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQR 200 (580)
Q Consensus 121 ~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~ 200 (580)
+|.+..+++- ..+..+......++....++ .+..+++|+.+++++|.+++ +..+..+++|+.
T Consensus 99 ~n~i~~l~~l---------------~~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~ 160 (210)
T d1h6ta2 99 ENKVKDLSSL---------------KDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDT 160 (210)
T ss_dssp SSCCCCGGGG---------------TTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSE
T ss_pred cccccccccc---------------cccccccccccccccccccc-cccccccccccccccccccc--cccccccccccc
Confidence 9998876421 12233334444444444433 34556788999999998884 335778899999
Q ss_pred EeccCCcccccCCccCcCCCCCCEEEccCCcccccCC
Q 008026 201 LILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 237 (580)
Q Consensus 201 L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~g~~p 237 (580)
+++++|+++ .+++ +.++++|+.|+|++|+++. +|
T Consensus 161 l~l~~n~l~-~i~~-l~~l~~L~~L~Ls~N~i~~-l~ 194 (210)
T d1h6ta2 161 LSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-LR 194 (210)
T ss_dssp EECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCB-CG
T ss_pred ccccccccc-cccc-ccCCCCCCEEECCCCCCCC-Ch
Confidence 999999998 4553 8889999999999998874 44
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=5.5e-16 Score=136.01 Aligned_cols=126 Identities=18% Similarity=0.163 Sum_probs=89.1
Q ss_pred hcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccc
Q 008026 38 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMA 117 (580)
Q Consensus 38 ~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l 117 (580)
+.++..|++|+|++|+|+.+...+..+++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+++.+++.+.
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~-------- 83 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLD-------- 83 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHH--------
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccc--------
Confidence 55667788888888888765333456778888888888887 564 47778888888888888877665421
Q ss_pred cccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCc--ccccCC
Q 008026 118 KGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS--PEFASF 195 (580)
Q Consensus 118 ~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p--~~~~~l 195 (580)
..+++|+.|++++|++. .++ ..+..+
T Consensus 84 ---------------------------------------------------~~l~~L~~L~L~~N~i~-~~~~l~~l~~l 111 (162)
T d1a9na_ 84 ---------------------------------------------------QALPDLTELILTNNSLV-ELGDLDPLASL 111 (162)
T ss_dssp ---------------------------------------------------HHCTTCCEEECCSCCCC-CGGGGGGGGGC
T ss_pred ---------------------------------------------------ccccccccceecccccc-ccccccccccc
Confidence 11236777777777777 343 357778
Q ss_pred CCCcEEeccCCcccccCCc----cCcCCCCCCEEE
Q 008026 196 KSLQRLILADNNLSGMIPE----GLSVLGALKELD 226 (580)
Q Consensus 196 ~~L~~L~ls~N~l~g~~p~----~l~~l~~L~~l~ 226 (580)
++|+.|++++|.++ ..|. .+..+++|++||
T Consensus 112 ~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 112 KSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 88888888888887 5664 467788888876
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=4.7e-15 Score=123.62 Aligned_cols=58 Identities=19% Similarity=0.339 Sum_probs=42.8
Q ss_pred ceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCccccc
Q 008026 45 KEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 104 (580)
Q Consensus 45 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~ 104 (580)
++|+|++|+|+. ++.+..+++|++|+|++|+|+ .+|+.|+.+++|+.|++++|+|+.+
T Consensus 1 R~L~Ls~n~l~~-l~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l 58 (124)
T d1dcea3 1 RVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV 58 (124)
T ss_dssp SEEECTTSCCSS-CCCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred CEEEcCCCCCCC-CcccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc
Confidence 467778887773 345677777788888888877 6777777777777777777777654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1.4e-14 Score=120.75 Aligned_cols=102 Identities=22% Similarity=0.261 Sum_probs=77.7
Q ss_pred cEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCC
Q 008026 68 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 147 (580)
Q Consensus 68 ~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~ 147 (580)
++|+|++|+|+ .+| .+..+++|++|+|++|+|+.+++.+..+.
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~----------------------------------- 43 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALR----------------------------------- 43 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCT-----------------------------------
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhh-----------------------------------
Confidence 57999999999 776 48999999999999999988766554444
Q ss_pred ccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCC--ccCcCCCCCCEE
Q 008026 148 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP--EGLSVLGALKEL 225 (580)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~l~~l~~L~~l 225 (580)
+|+.|++++|+|+ .+| .+..+++|+.|++++|+|+ .+| ..+..+++|++|
T Consensus 44 -------------------------~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 44 -------------------------CLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp -------------------------TCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEE
T ss_pred -------------------------ccccccccccccc-ccC-ccccccccCeEECCCCccC-CCCCchhhcCCCCCCEE
Confidence 5667777777777 454 4777788888888888877 444 357777788888
Q ss_pred EccCCcccc
Q 008026 226 DVSNNQLYG 234 (580)
Q Consensus 226 ~ls~N~l~g 234 (580)
++++|+++.
T Consensus 96 ~l~~N~i~~ 104 (124)
T d1dcea3 96 NLQGNSLCQ 104 (124)
T ss_dssp ECTTSGGGG
T ss_pred ECCCCcCCc
Confidence 888887774
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.48 E-value=9.1e-13 Score=130.67 Aligned_cols=90 Identities=27% Similarity=0.323 Sum_probs=61.4
Q ss_pred cccccCCCCCccccccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccC
Q 008026 2 LQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV 81 (580)
Q Consensus 2 ~~~~~~~P~~~~~~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~ 81 (580)
|.|+ ++|+.+ ++|+.| +++.|++. .+|+. +.+|++|++++|+++.. +.+ .+.|++|+|++|++. .+
T Consensus 48 ~~L~-~lp~~~--~~L~~L---~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~~l--p~~L~~L~L~~n~l~-~l 113 (353)
T d1jl5a_ 48 LGLS-SLPELP--PHLESL---VASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-SDL--PPLLEYLGVSNNQLE-KL 113 (353)
T ss_dssp SCCS-CCCSCC--TTCSEE---ECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-CSC--CTTCCEEECCSSCCS-SC
T ss_pred CCCC-CCCCCC--CCCCEE---ECCCCCCc-ccccc---hhhhhhhhhhhcccchh-hhh--ccccccccccccccc-cc
Confidence 3443 578765 445544 56667554 55654 45788888888888743 332 246888888888888 77
Q ss_pred CccccCCCCCcEEEccCCcccccCC
Q 008026 82 PDSLVKLESLKIVNMTNNLLQGPVP 106 (580)
Q Consensus 82 P~~~~~l~~L~~L~L~~N~l~~~~~ 106 (580)
|. ++.+++|+.|++++|.+...+.
T Consensus 114 p~-~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 114 PE-LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp CC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred cc-hhhhccceeecccccccccccc
Confidence 74 6788888888888888776554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.6e-14 Score=136.00 Aligned_cols=185 Identities=18% Similarity=0.138 Sum_probs=137.9
Q ss_pred cccccCCCC-CccccccceEEecccCCCCCCCCC-chhhcCcccCceEeccc-CcCcCCCCC-CCCCCCCcEEeccCCcc
Q 008026 2 LQLIGGLPA-SFSGSQIQSLWVNGQNGNAKLGGG-IDVIQNMTSLKEIWLHS-NAFSGPLPD-FSGVKQLESLSLRDNFF 77 (580)
Q Consensus 2 ~~~~~~~P~-~~~~~~l~~L~~~~~~~n~~~~~~-~~~~~~l~~L~~L~L~~-N~l~~~~p~-~~~l~~L~~L~L~~N~l 77 (580)
|+++ .+|. .| .++..|+.+++++|...... +..|.+++.+++|++.. |.+....+. |.++++|+.|++++|++
T Consensus 39 n~i~-~l~~~~f--~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l 115 (242)
T d1xwdc1 39 TKLR-VIQKGAF--SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 115 (242)
T ss_dssp CCCC-EECTTTT--TTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCC
T ss_pred CcCC-ccChhHh--hccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhh
Confidence 4444 5655 57 45777888888888777644 46789999999998764 678777774 78899999999999999
Q ss_pred cccCCc--cccCCCCCcEEEccCCcccccCCC-CCccc-ccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCcccccc
Q 008026 78 TGPVPD--SLVKLESLKIVNMTNNLLQGPVPE-FDRSV-SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 153 (580)
Q Consensus 78 ~~~~P~--~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~-~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~ 153 (580)
. .+|. .+..+..|..+..+++++..+.+. +..+. .+..+++.+|.+..++...+.
T Consensus 116 ~-~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-------------------- 174 (242)
T d1xwdc1 116 K-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-------------------- 174 (242)
T ss_dssp C-SCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT--------------------
T ss_pred c-ccccccccccccccccccccccccccccccccccccccceeeeccccccccccccccc--------------------
Confidence 8 4544 356677888888888899887765 55544 678899999988877655431
Q ss_pred ccCCCCCCCCccceeccCCcEE-EEEecCCcccccCcc-cccCCCCCcEEeccCCcccccCCc-cCcCCCCCCEEEccC
Q 008026 154 NWKGNDPCSDWIGVTCTKGNIT-VINFQKMNLTGTISP-EFASFKSLQRLILADNNLSGMIPE-GLSVLGALKELDVSN 229 (580)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~L~-~L~ls~n~l~~~~p~-~~~~l~~L~~L~ls~N~l~g~~p~-~l~~l~~L~~l~ls~ 229 (580)
..++. .+++++|+++ .+|. .|.++++|++|+|++|+|+ .+|. .+.++++|+.+++.+
T Consensus 175 -----------------~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 175 -----------------GTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp -----------------TCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEESSSEES
T ss_pred -----------------chhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcccccCcCCC
Confidence 12454 4457888898 5655 5789999999999999999 6654 577777777766644
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=9.6e-15 Score=127.94 Aligned_cols=88 Identities=15% Similarity=0.067 Sum_probs=74.7
Q ss_pred cccceEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCcc-ccCCCCCcE
Q 008026 15 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKI 93 (580)
Q Consensus 15 ~~l~~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~-~~~l~~L~~ 93 (580)
.+...|+.+++++|++... ++.+..+++|+.|+|++|.|+.. +.|..+++|++|+|++|+++ .+|.. +..+++|+.
T Consensus 15 ~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCcccccccccccc
Confidence 3566788889999976654 66678899999999999999954 67899999999999999999 66655 678999999
Q ss_pred EEccCCcccccC
Q 008026 94 VNMTNNLLQGPV 105 (580)
Q Consensus 94 L~L~~N~l~~~~ 105 (580)
|+|++|+++...
T Consensus 92 L~L~~N~i~~~~ 103 (162)
T d1a9na_ 92 LILTNNSLVELG 103 (162)
T ss_dssp EECCSCCCCCGG
T ss_pred ceeccccccccc
Confidence 999999998653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.43 E-value=4.5e-12 Score=125.53 Aligned_cols=99 Identities=19% Similarity=0.189 Sum_probs=76.7
Q ss_pred eEEecccCCCCCCCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccC
Q 008026 19 SLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 98 (580)
Q Consensus 19 ~L~~~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~ 98 (580)
.|..++++++.+ +.+|+. +++|++|+|++|+|+.. |+. +.+|+.|++++|+++ .++.- .++|++|+|++
T Consensus 39 ~l~~LdLs~~~L-~~lp~~---~~~L~~L~Ls~N~l~~l-p~~--~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGL-SSLPEL---PPHLESLVASCNSLTEL-PEL--PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCC-SCCCSC---CTTCSEEECCSSCCSSC-CCC--CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCCEEEeCCCCC-CCCCCC---CCCCCEEECCCCCCccc-ccc--hhhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 355667777754 457753 57899999999999954 532 468999999999998 67642 25699999999
Q ss_pred CcccccCCCCCcccccccccccCCCCCCCCC
Q 008026 99 NLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG 129 (580)
Q Consensus 99 N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 129 (580)
|+++.++ .+..+.+|+.+++++|.+...+.
T Consensus 108 n~l~~lp-~~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 108 NQLEKLP-ELQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp SCCSSCC-CCTTCTTCCEEECCSSCCSCCCC
T ss_pred ccccccc-chhhhccceeecccccccccccc
Confidence 9998765 57888999999999988776654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=1.9e-15 Score=137.35 Aligned_cols=132 Identities=21% Similarity=0.306 Sum_probs=86.8
Q ss_pred CCCCchhhcCcccCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCc
Q 008026 31 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDR 110 (580)
Q Consensus 31 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 110 (580)
++.++..|..|++|++|+|++|+|+. ++.+.++++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++.+. .+..
T Consensus 37 i~~l~~sl~~L~~L~~L~Ls~n~I~~-i~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l~-~~~~ 113 (198)
T d1m9la_ 37 IEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLS-GIEK 113 (198)
T ss_dssp CCCCHHHHHHTTTCCEEECSEEEESC-CCCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCHH-HHHH
T ss_pred hhhhhhHHhcccccceeECcccCCCC-cccccCCccccChhhcccccc-cccccccccccccccccccccccccc-cccc
Confidence 34455667777777777777777764 345666777777777777776 66665555666777777777766431 1111
Q ss_pred ccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCc-
Q 008026 111 SVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS- 189 (580)
Q Consensus 111 ~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p- 189 (580)
+ ++|+.|++++|+++ .++
T Consensus 114 l------------------------------------------------------------~~L~~L~L~~N~i~-~~~~ 132 (198)
T d1m9la_ 114 L------------------------------------------------------------VNLRVLYMSNNKIT-NWGE 132 (198)
T ss_dssp H------------------------------------------------------------HHSSEEEESEEECC-CHHH
T ss_pred c------------------------------------------------------------ccccccccccchhc-cccc
Confidence 1 26777788888777 333
Q ss_pred -ccccCCCCCcEEeccCCcccccCCcc----------CcCCCCCCEEE
Q 008026 190 -PEFASFKSLQRLILADNNLSGMIPEG----------LSVLGALKELD 226 (580)
Q Consensus 190 -~~~~~l~~L~~L~ls~N~l~g~~p~~----------l~~l~~L~~l~ 226 (580)
..+..|++|+.|+|++|.+....+.. +..+++|+.||
T Consensus 133 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 133 IDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 35778888888888888876444432 45677888876
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=6e-12 Score=109.02 Aligned_cols=60 Identities=25% Similarity=0.155 Sum_probs=41.8
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCCccCcCCCCCCEEEccCCccc
Q 008026 173 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 173 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
+|+.|+|++|+|+...|.+|..+++|+.|+|++|+|+ .+|..+.....|+.|+|++|++.
T Consensus 57 ~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 57 ELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 5666666666666555666777888888888888887 66666555556777777776653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.22 E-value=1.8e-13 Score=124.00 Aligned_cols=113 Identities=21% Similarity=0.349 Sum_probs=86.4
Q ss_pred CCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHHHHHH
Q 008026 61 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLS 140 (580)
Q Consensus 61 ~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~ 140 (580)
+..|++|+.|+|++|+|+ .++ .+..+++|+.|+|++|+++.+++. .
T Consensus 44 l~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~-~------------------------------- 89 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENL-D------------------------------- 89 (198)
T ss_dssp HHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSH-H-------------------------------
T ss_pred HhcccccceeECcccCCC-Ccc-cccCCccccChhhccccccccccc-c-------------------------------
Confidence 566777888888888877 665 477788888888888877644321 0
Q ss_pred HHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcccccCC--ccCcC
Q 008026 141 VVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP--EGLSV 218 (580)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~l~~ 218 (580)
..+++|+.|++++|+++ .++ .+..+++|+.|+|++|+++ .++ ..+..
T Consensus 90 ----------------------------~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~ 138 (198)
T d1m9la_ 90 ----------------------------AVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAA 138 (198)
T ss_dssp ----------------------------HHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECC-CHHHHHHHTT
T ss_pred ----------------------------ccccccccccccccccc-ccc-cccccccccccccccchhc-cccccccccC
Confidence 00126889999999998 454 5889999999999999998 555 46899
Q ss_pred CCCCCEEEccCCcccccCCC
Q 008026 219 LGALKELDVSNNQLYGKIPS 238 (580)
Q Consensus 219 l~~L~~l~ls~N~l~g~~p~ 238 (580)
+++|+.|++++|+++...+.
T Consensus 139 l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 139 LDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp TTTCSEEEECSSHHHHHHCT
T ss_pred CCccceeecCCCccccCccc
Confidence 99999999999999866554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=3.2e-11 Score=104.35 Aligned_cols=101 Identities=16% Similarity=0.132 Sum_probs=84.6
Q ss_pred cccCCCCCCCCCchhhcCcccCceEecccC-cCcCCCC-CCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCc
Q 008026 23 NGQNGNAKLGGGIDVIQNMTSLKEIWLHSN-AFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 100 (580)
Q Consensus 23 ~~~~~n~~~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~ 100 (580)
+++.++ .....|..+..+++|++|+|++| .|+.+.+ +|.++++|+.|+|++|+|+..-|..|..+++|+.|+|++|+
T Consensus 13 l~c~~~-~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRD-GALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSS-CCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCC-CCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 445555 34456777889999999999866 5887665 59999999999999999995556779999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCC
Q 008026 101 LQGPVPEFDRSVSLDMAKGSNNFC 124 (580)
Q Consensus 101 l~~~~~~~~~~~~L~~l~l~~n~~ 124 (580)
|+.++++.....+|+.|++++|.+
T Consensus 92 l~~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 92 LESLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp CSCCCSTTTCSCCCCEEECCSSCC
T ss_pred CcccChhhhccccccccccCCCcc
Confidence 999999877777899999999966
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=5.2e-12 Score=121.31 Aligned_cols=182 Identities=16% Similarity=0.130 Sum_probs=102.9
Q ss_pred cCcccCceEecccCcCcCCC-CC-CCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCC-ccccc-CCC-CCcccc
Q 008026 39 QNMTSLKEIWLHSNAFSGPL-PD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN-LLQGP-VPE-FDRSVS 113 (580)
Q Consensus 39 ~~l~~L~~L~L~~N~l~~~~-p~-~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N-~l~~~-~~~-~~~~~~ 113 (580)
....+|++|||+++.++... +. +..+++|++|+|++|.+++..+..+..+++|+.|+|+++ .++.. ... ...+.+
T Consensus 43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~ 122 (284)
T d2astb2 43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122 (284)
T ss_dssp CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence 34556777777777765432 22 456777777777777776666666777777777777774 44421 111 234566
Q ss_pred cccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCC--CC--CCccceeccCCcEEEEEecCC-cccccC
Q 008026 114 LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND--PC--SDWIGVTCTKGNITVINFQKM-NLTGTI 188 (580)
Q Consensus 114 L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~L~~L~ls~n-~l~~~~ 188 (580)
|+.|+++++.... ...+..+. ......+.. ..+.+. .. ..+......+++|+.|++++| .+++..
T Consensus 123 L~~L~ls~c~~~~-----~~~~~~~~--~~~~~~L~~---L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~ 192 (284)
T d2astb2 123 LDELNLSWCFDFT-----EKHVQVAV--AHVSETITQ---LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192 (284)
T ss_dssp CCEEECCCCTTCC-----HHHHHHHH--HHSCTTCCE---EECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGG
T ss_pred ccccccccccccc-----cccchhhh--cccccccch---hhhcccccccccccccccccccccccccccccccCCCchh
Confidence 7777776652110 11111110 000011111 111100 00 001112223457888888876 466667
Q ss_pred cccccCCCCCcEEeccC-CcccccCCccCcCCCCCCEEEccCC
Q 008026 189 SPEFASFKSLQRLILAD-NNLSGMIPEGLSVLGALKELDVSNN 230 (580)
Q Consensus 189 p~~~~~l~~L~~L~ls~-N~l~g~~p~~l~~l~~L~~l~ls~N 230 (580)
...+.++++|++|+|++ +.++......++++++|+.|+++++
T Consensus 193 ~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred hhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 77788888888888888 4666566667778888888888776
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.84 E-value=1.5e-10 Score=114.29 Aligned_cols=196 Identities=19% Similarity=0.235 Sum_probs=98.0
Q ss_pred hhhcCcccCceEecccCcCcCCC-----CCCCCCCCCcEEeccCCcccc---c-------CCccccCCCCCcEEEccCCc
Q 008026 36 DVIQNMTSLKEIWLHSNAFSGPL-----PDFSGVKQLESLSLRDNFFTG---P-------VPDSLVKLESLKIVNMTNNL 100 (580)
Q Consensus 36 ~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~l~~L~~L~L~~N~l~~---~-------~P~~~~~l~~L~~L~L~~N~ 100 (580)
.++.+...|++|+|++|.|...- ..+...++|+.|+++++.+.. . +...+..+++|+.|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 44555666777777777664311 124556667777776654321 1 11224445667777777776
Q ss_pred ccccCC-----CCCcccccccccccCCCCCCCCCCCchhHH-HHHHHH--HhhCCccccccccCCCCCCCC-----ccce
Q 008026 101 LQGPVP-----EFDRSVSLDMAKGSNNFCLPSPGACDPRLN-ALLSVV--KLMGYPQRFAENWKGNDPCSD-----WIGV 167 (580)
Q Consensus 101 l~~~~~-----~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~-~l~~~~--~~~~~~~~~~~~~~~~~~~~~-----~~~~ 167 (580)
++..-. .+..+.+|+.|++++|.+.... ...+. .+..+. ........+.....+.+...+ +...
T Consensus 105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~---~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~ 181 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQA---GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181 (344)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHH---HHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred cccccccchhhhhcccccchheecccccccccc---cccccccccccccccccccCcccceeecccccccccccccccch
Confidence 654311 1234456666777666543110 00000 011110 000111111111222222110 1111
Q ss_pred eccCCcEEEEEecCCccccc-----CcccccCCCCCcEEeccCCccccc----CCccCcCCCCCCEEEccCCcccc
Q 008026 168 TCTKGNITVINFQKMNLTGT-----ISPEFASFKSLQRLILADNNLSGM----IPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 168 ~~~~~~L~~L~ls~n~l~~~-----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
+.....|+.|+|++|++... +...+..+++|+.|+|++|++... +...+..+++|++|+|++|.+++
T Consensus 182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 22335677778877777631 334466677777888887776522 34456677777888888777763
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.82 E-value=2.3e-10 Score=112.91 Aligned_cols=210 Identities=16% Similarity=0.065 Sum_probs=128.6
Q ss_pred ccceEEecccCCCCCCCCCc----hhhcCcccCceEecccCcCcCCC---C--------CCCCCCCCcEEeccCCccccc
Q 008026 16 QIQSLWVNGQNGNAKLGGGI----DVIQNMTSLKEIWLHSNAFSGPL---P--------DFSGVKQLESLSLRDNFFTGP 80 (580)
Q Consensus 16 ~l~~L~~~~~~~n~~~~~~~----~~~~~l~~L~~L~L~~N~l~~~~---p--------~~~~l~~L~~L~L~~N~l~~~ 80 (580)
+...|+.+++++|.+..... ..+...++|+.|+++++.+.... | .+...++|+.|+|++|.+...
T Consensus 29 ~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 108 (344)
T d2ca6a1 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108 (344)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred hCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccc
Confidence 34556667777775533222 34667788999999887654322 1 144578899999999988743
Q ss_pred ----CCccccCCCCCcEEEccCCcccccCCC--------------CCcccccccccccCCCCCCCCCCCchhHHHHHHHH
Q 008026 81 ----VPDSLVKLESLKIVNMTNNLLQGPVPE--------------FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVV 142 (580)
Q Consensus 81 ----~P~~~~~l~~L~~L~L~~N~l~~~~~~--------------~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~ 142 (580)
+...+...++|+.|++++|.+...-.. ......|+.+.+++|.+.. .....+....
T Consensus 109 ~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~------~~~~~l~~~l 182 (344)
T d2ca6a1 109 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN------GSMKEWAKTF 182 (344)
T ss_dssp THHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG------GGHHHHHHHH
T ss_pred cccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc------cccccccchh
Confidence 344566788899999998877432110 1123456677777775532 1222222222
Q ss_pred HhhCCccccccccCCCCCCCC------ccceeccCCcEEEEEecCCccccc----CcccccCCCCCcEEeccCCcccccC
Q 008026 143 KLMGYPQRFAENWKGNDPCSD------WIGVTCTKGNITVINFQKMNLTGT----ISPEFASFKSLQRLILADNNLSGMI 212 (580)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~~ 212 (580)
.....+.. ..+..+...+ ....+...++|+.|+|++|.+... +...+..+++|++|+|++|.|.+.-
T Consensus 183 ~~~~~L~~---L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g 259 (344)
T d2ca6a1 183 QSHRLLHT---VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 259 (344)
T ss_dssp HHCTTCCE---EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH
T ss_pred hhhhhhcc---cccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchh
Confidence 22222222 2222222221 112344557899999999998743 5566788999999999999987542
Q ss_pred Ccc----Cc--CCCCCCEEEccCCcccc
Q 008026 213 PEG----LS--VLGALKELDVSNNQLYG 234 (580)
Q Consensus 213 p~~----l~--~l~~L~~l~ls~N~l~g 234 (580)
... +. ..+.|++||+++|+++.
T Consensus 260 ~~~l~~~l~~~~~~~L~~L~ls~N~i~~ 287 (344)
T d2ca6a1 260 AAAVVDAFSKLENIGLQTLRLQYNEIEL 287 (344)
T ss_dssp HHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred hHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence 222 22 24679999999999873
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.70 E-value=3.2e-09 Score=101.39 Aligned_cols=197 Identities=14% Similarity=0.109 Sum_probs=125.0
Q ss_pred cccCCCCCCCCCchhhcCcc--cCceEecccCcCcCCCCCCCCCCCCcEEeccCCccccc-CCccccCCCCCcEEEccCC
Q 008026 23 NGQNGNAKLGGGIDVIQNMT--SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGP-VPDSLVKLESLKIVNMTNN 99 (580)
Q Consensus 23 ~~~~~n~~~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~-~P~~~~~l~~L~~L~L~~N 99 (580)
+|++++.+. |+.+..+. .+..+.++...+...........+|++|+|++|.+.+. ++.-+..+++|++|+|+++
T Consensus 5 lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EECCCCCCC---chHHHHHHhccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 455555443 44444332 35667777776665444445567999999999998744 4555889999999999999
Q ss_pred cccccCC-CCCcccccccccccCCC-CCCCCCCCchhHHHHHHHHHhhCCccccccccCCC-CCCCC--ccceecc-CCc
Q 008026 100 LLQGPVP-EFDRSVSLDMAKGSNNF-CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN-DPCSD--WIGVTCT-KGN 173 (580)
Q Consensus 100 ~l~~~~~-~~~~~~~L~~l~l~~n~-~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~-~~~ 173 (580)
.++...+ .+..+.+|+.|+++++. ++ +..+..+ ......+..+ .+++ ....+ +...... .++
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~it------d~~l~~l---~~~~~~L~~L---~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFS------EFALQTL---LSSCSRLDEL---NLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCC------HHHHHHH---HHHCTTCCEE---ECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCCcHHHHHHhcCCCCcCcccccccccc------ccccchh---hHHHHhcccc---ccccccccccccchhhhcccccc
Confidence 9876443 47788899999999863 32 1222222 1222222222 2221 11111 1111222 257
Q ss_pred EEEEEecCCc--ccc-cCcccccCCCCCcEEeccCC-cccccCCccCcCCCCCCEEEccCC-cccc
Q 008026 174 ITVINFQKMN--LTG-TISPEFASFKSLQRLILADN-NLSGMIPEGLSVLGALKELDVSNN-QLYG 234 (580)
Q Consensus 174 L~~L~ls~n~--l~~-~~p~~~~~l~~L~~L~ls~N-~l~g~~p~~l~~l~~L~~l~ls~N-~l~g 234 (580)
|+.|+++++. ++. .+..-+.++++|++|++++| .+++..+..+..+++|++|++++| .+++
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~ 215 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCCh
Confidence 9999998753 432 24334467899999999986 577777788899999999999985 5654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=7.5e-08 Score=90.37 Aligned_cols=150 Identities=15% Similarity=0.075 Sum_probs=100.7
Q ss_pred HHHHHhhcCCcccceeeccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCC
Q 008026 388 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN 466 (580)
Q Consensus 388 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 466 (580)
.++......|+..+..+.++.+.||+... ++..+++|+...... .....+.+|...+..+. +--+.+++++...++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 35566667788777665566679998865 466778887764321 22335678888888775 434677888888888
Q ss_pred eeEEEEEecCCCChhHHHHHHhhhCCCCccHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 008026 467 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA---------------------------- 518 (580)
Q Consensus 467 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~---------------------------- 518 (580)
..++||++++|.++.+.... ......++.+++..+..||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ceEEEEEecccccccccccc----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 89999999999877543310 0112233445555555555310
Q ss_pred ----------------------------CCCcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 519 ----------------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 519 ----------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11378999999999998776667999998764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=9.5e-09 Score=89.01 Aligned_cols=59 Identities=19% Similarity=0.100 Sum_probs=37.6
Q ss_pred cCceEecccCcCcCCCCCCCCCCCCcEEeccCCcccccCCccccCCCCCcEEEccCCcccccC
Q 008026 43 SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 105 (580)
Q Consensus 43 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~P~~~~~l~~L~~L~L~~N~l~~~~ 105 (580)
+.+.|+++++... +.+..+..+..|++.+|... .++..+..+++|+.|+|++|+|+.+.
T Consensus 23 ~~~~Ldls~l~~~---~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~ 81 (162)
T d1koha1 23 SQQALDLKGLRSD---PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLD 81 (162)
T ss_dssp SSCCBCCCCCSSC---TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCS
T ss_pred hhCeeecccCCCC---chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCc
Confidence 4556677665432 34444555556666666554 55555667888888888888887654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=3.5e-08 Score=100.32 Aligned_cols=168 Identities=14% Similarity=0.105 Sum_probs=109.2
Q ss_pred hhcCcccCceEecccCcCcCCCC-----CCCCCCCCcEEeccCCcccccCCccc-----cCCCCCcEEEccCCcccccCC
Q 008026 37 VIQNMTSLKEIWLHSNAFSGPLP-----DFSGVKQLESLSLRDNFFTGPVPDSL-----VKLESLKIVNMTNNLLQGPVP 106 (580)
Q Consensus 37 ~~~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~L~~N~l~~~~P~~~-----~~l~~L~~L~L~~N~l~~~~~ 106 (580)
.......|+.|++++|.+..... .+...+.++.+++++|.+...-...+ .....|+.+++++|.++....
T Consensus 250 ~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~ 329 (460)
T d1z7xw1 250 LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACC 329 (460)
T ss_dssp HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhh
Confidence 34556789999999998875432 13457889999999999863222211 234679999999998875432
Q ss_pred C-----CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecC
Q 008026 107 E-----FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 181 (580)
Q Consensus 107 ~-----~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~ 181 (580)
. +..+.+|++|++++|.+... . +..+...+.. ....|+.|+|++
T Consensus 330 ~~l~~~~~~~~~L~~L~Ls~N~i~~~------g---~~~l~~~l~~----------------------~~~~L~~L~Ls~ 378 (460)
T d1z7xw1 330 SHFSSVLAQNRFLLELQISNNRLEDA------G---VRELCQGLGQ----------------------PGSVLRVLWLAD 378 (460)
T ss_dssp HHHHHHHHHCSSCCEEECCSSBCHHH------H---HHHHHHHHTS----------------------TTCCCCEEECTT
T ss_pred hhcccccccccchhhhheeeecccCc------c---cchhhhhhhc----------------------ccCCCCEEECCC
Confidence 1 23445788888888876321 1 1111111100 012688999999
Q ss_pred Ccccc----cCcccccCCCCCcEEeccCCcccccCCccC----c-CCCCCCEEEccCCccccc
Q 008026 182 MNLTG----TISPEFASFKSLQRLILADNNLSGMIPEGL----S-VLGALKELDVSNNQLYGK 235 (580)
Q Consensus 182 n~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l----~-~l~~L~~l~ls~N~l~g~ 235 (580)
|+|+. .++..+..+++|++|+|++|+|+......+ . +...|+.|++++|.+...
T Consensus 379 n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 379 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 99874 355667778899999999998874322222 2 344789999999888753
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=4.8e-08 Score=99.31 Aligned_cols=166 Identities=22% Similarity=0.214 Sum_probs=108.6
Q ss_pred hhcCcccCceEecccCcCcCC-----CCC-CCCCCCCcEEeccCCccccc----CCccccCCCCCcEEEccCCcccccCC
Q 008026 37 VIQNMTSLKEIWLHSNAFSGP-----LPD-FSGVKQLESLSLRDNFFTGP----VPDSLVKLESLKIVNMTNNLLQGPVP 106 (580)
Q Consensus 37 ~~~~l~~L~~L~L~~N~l~~~-----~p~-~~~l~~L~~L~L~~N~l~~~----~P~~~~~l~~L~~L~L~~N~l~~~~~ 106 (580)
.+...+.++.+++++|.+... .+. +.....|+.|++++|.+... +...+...+.++.+++++|.++....
T Consensus 221 ~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~ 300 (460)
T d1z7xw1 221 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 300 (460)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred cccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 345667788888888876432 111 34467788888888877532 23345667888888888888764221
Q ss_pred C------CCcccccccccccCCCCCCCCCCCchhHHHHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEec
Q 008026 107 E------FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 180 (580)
Q Consensus 107 ~------~~~~~~L~~l~l~~n~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls 180 (580)
. ......|+.+++++|.+... ....+..+ .....+|+.|+|+
T Consensus 301 ~~l~~~l~~~~~~L~~l~l~~~~l~~~------~~~~l~~~--------------------------~~~~~~L~~L~Ls 348 (460)
T d1z7xw1 301 RLLCETLLEPGCQLESLWVKSCSFTAA------CCSHFSSV--------------------------LAQNRFLLELQIS 348 (460)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGG------GHHHHHHH--------------------------HHHCSSCCEEECC
T ss_pred chhhccccccccccccccccccchhhh------hhhhcccc--------------------------cccccchhhhhee
Confidence 1 12234577777777755422 11111111 1122479999999
Q ss_pred CCccccc----Cccccc-CCCCCcEEeccCCcccc----cCCccCcCCCCCCEEEccCCcccc
Q 008026 181 KMNLTGT----ISPEFA-SFKSLQRLILADNNLSG----MIPEGLSVLGALKELDVSNNQLYG 234 (580)
Q Consensus 181 ~n~l~~~----~p~~~~-~l~~L~~L~ls~N~l~g----~~p~~l~~l~~L~~l~ls~N~l~g 234 (580)
+|++... ++..+. ..+.|+.|+|++|+|+. .+++.+..+++|++|||++|+++.
T Consensus 349 ~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp SSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred eecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 9999753 444554 46789999999999973 245567778999999999999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=2.1e-06 Score=79.70 Aligned_cols=75 Identities=20% Similarity=0.195 Sum_probs=53.8
Q ss_pred eeeccC-cEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCC--CcccceeeEEEcCCeeEEEEEecCCC
Q 008026 402 ILGRGG-FGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGNEKLLVFEYMPQG 478 (580)
Q Consensus 402 ~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 478 (580)
.+..|. .+.||+....++..+++|...... ...+..|.+.++.+.. -.+.+++++..+++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344554 368999988878888999765432 2346778887777743 23567788888888899999999886
Q ss_pred Chh
Q 008026 479 TLS 481 (580)
Q Consensus 479 ~L~ 481 (580)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=4.7e-07 Score=77.98 Aligned_cols=84 Identities=18% Similarity=0.128 Sum_probs=65.2
Q ss_pred chhhcCcccCceEecccCcCcCCCC--C-CCCCCCCcEEeccCCcccccCCc-cccCCCCCcEEEccCCcccccCCC---
Q 008026 35 IDVIQNMTSLKEIWLHSNAFSGPLP--D-FSGVKQLESLSLRDNFFTGPVPD-SLVKLESLKIVNMTNNLLQGPVPE--- 107 (580)
Q Consensus 35 ~~~~~~l~~L~~L~L~~N~l~~~~p--~-~~~l~~L~~L~L~~N~l~~~~P~-~~~~l~~L~~L~L~~N~l~~~~~~--- 107 (580)
+..+.++++|++|+|++|+|+...+ . +..+++|+.|+|++|+|+ .+++ .+....+|+.|+|++|.+......
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~ 136 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQST 136 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchh
Confidence 3445689999999999999997643 2 566899999999999999 6766 355556899999999999876552
Q ss_pred -----CCcccccccccc
Q 008026 108 -----FDRSVSLDMAKG 119 (580)
Q Consensus 108 -----~~~~~~L~~l~l 119 (580)
+..+.+|+.|+.
T Consensus 137 y~~~i~~~~P~L~~LDg 153 (162)
T d1koha1 137 YISAIRERFPKLLRLDG 153 (162)
T ss_dssp HHHHHHTTSTTCCEETT
T ss_pred HHHHHHHHCCCCCEECc
Confidence 345667777763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.74 E-value=4.9e-05 Score=75.01 Aligned_cols=78 Identities=13% Similarity=0.129 Sum_probs=49.5
Q ss_pred cceeeccCcEEEEEEEEc-CCcEEEEEEeeccc-c----ChhhHHHHHHHHHHHHhcC-C--CcccceeeEEEcCCeeEE
Q 008026 400 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-I----SGKGLTEFKSEIAVLTKVR-H--RHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~----~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~l 470 (580)
.+.||.|..-.||++... +++.|+||.-.... . ......+...|.+.++.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 356899999999999765 46789999654311 0 0112345667888887763 3 345556544 4556689
Q ss_pred EEEecCCCC
Q 008026 471 VFEYMPQGT 479 (580)
Q Consensus 471 v~e~~~~g~ 479 (580)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.32 E-value=0.00035 Score=66.72 Aligned_cols=137 Identities=13% Similarity=0.051 Sum_probs=77.5
Q ss_pred EEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCccc--cee-----eEEEcCCeeEEEEEecCCCChh
Q 008026 409 GTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV--ALL-----GHCLDGNEKLLVFEYMPQGTLS 481 (580)
Q Consensus 409 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~~-----~~~~~~~~~~lv~e~~~~g~L~ 481 (580)
-.||+++.++|..|++|+...... ..+++..|...+..+....+. ... ..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 479999998999999999865432 345677888888777532222 111 1233456678999999764331
Q ss_pred H-----------HHHHHhh---h----CCCCccHH-------------------HHHHHHHHHHHHHHHHHh----CCCC
Q 008026 482 R-----------HIFNWAE---E----GLKPLEWN-------------------RRLTIALDVARGVEYLHG----LAHQ 520 (580)
Q Consensus 482 ~-----------~l~~~~~---~----~~~~~~~~-------------------~~~~i~~~i~~aL~~LH~----~~~~ 520 (580)
. .+.+... . .....+.. ....+...+...++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 1111000 0 00111111 111122222223333322 1235
Q ss_pred CcEecCCCCCCeEecCCCcEEEEeeccccc
Q 008026 521 SFIHRDLKPSNILLGDDMRAKVADFGLVRL 550 (580)
Q Consensus 521 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 550 (580)
++||+|+.+.|||++++ ..++||+-|..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999743 46899998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.27 E-value=3.3e-05 Score=66.34 Aligned_cols=40 Identities=10% Similarity=-0.014 Sum_probs=17.9
Q ss_pred ccCCCCCcEEeccCCcccc-------cCCccCcCCCCCCEEEccCCc
Q 008026 192 FASFKSLQRLILADNNLSG-------MIPEGLSVLGALKELDVSNNQ 231 (580)
Q Consensus 192 ~~~l~~L~~L~ls~N~l~g-------~~p~~l~~l~~L~~l~ls~N~ 231 (580)
+...++|++|+|++|++.. .+...+...+.|+.|+++.+.
T Consensus 96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3344455555555554331 012223334555556555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.11 E-value=6.3e-05 Score=64.47 Aligned_cols=88 Identities=19% Similarity=0.179 Sum_probs=51.5
Q ss_pred CcccCceEecccC-cCcCC-C----CCCCCCCCCcEEeccCCcccc----cCCccccCCCCCcEEEccCCcccccCC---
Q 008026 40 NMTSLKEIWLHSN-AFSGP-L----PDFSGVKQLESLSLRDNFFTG----PVPDSLVKLESLKIVNMTNNLLQGPVP--- 106 (580)
Q Consensus 40 ~l~~L~~L~L~~N-~l~~~-~----p~~~~l~~L~~L~L~~N~l~~----~~P~~~~~l~~L~~L~L~~N~l~~~~~--- 106 (580)
+.++|++|+|+++ .++.. . ..+...+.|+.|+|++|.+.. .+...+...+.|+.|+|++|.++..-.
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4466777777753 34421 1 124445667777777777652 122334556677777777777664321
Q ss_pred --CCCcccccccccccCCCCCCC
Q 008026 107 --EFDRSVSLDMAKGSNNFCLPS 127 (580)
Q Consensus 107 --~~~~~~~L~~l~l~~n~~~~~ 127 (580)
.+....+|+.|++++|.+..+
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~ 115 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVL 115 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCc
Confidence 355566777777777765544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.80 E-value=0.0026 Score=60.12 Aligned_cols=159 Identities=11% Similarity=0.002 Sum_probs=82.1
Q ss_pred eHHHHHHhhcCCcccceee-----ccCcEEEEEEEEcCCcEEEEEEeeccccChhhHHHHHHHHHHHHhcCCCccc--ce
Q 008026 386 SIQVLRNVTNNFSEENILG-----RGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV--AL 458 (580)
Q Consensus 386 ~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~ 458 (580)
+.+++..+..+|.+.+... .|---+.|+.+..+| .+++|+..... ...++..|++++..+...++. ..
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC----CHHHHHHHHHHHHhhhhcccccccc
Confidence 4567777777887754443 455567899877655 48999876531 223455667777766432221 11
Q ss_pred ee------EEEcCCeeEEEEEecCCCChhH-----------HHHHHhh---hCC-----CC-----------------cc
Q 008026 459 LG------HCLDGNEKLLVFEYMPQGTLSR-----------HIFNWAE---EGL-----KP-----------------LE 496 (580)
Q Consensus 459 ~~------~~~~~~~~~lv~e~~~~g~L~~-----------~l~~~~~---~~~-----~~-----------------~~ 496 (580)
.. +.........++.+..+..... .+..... ... .. ..
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11 1222445566777766543211 0000000 000 00 00
Q ss_pred HHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeEecCCCcEEEEeecccc
Q 008026 497 WNRRLTIALDVARGVEYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 549 (580)
Q Consensus 497 ~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 549 (580)
.......+..+...+.-.+. .-..++||+|+.+.||+++.+...-++||+.|.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00111222222222222221 124689999999999999988767899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.64 E-value=0.0034 Score=61.37 Aligned_cols=73 Identities=15% Similarity=0.142 Sum_probs=48.9
Q ss_pred cceeeccCcEEEEEEEEcC--------CcEEEEEEeeccccChhhHHHHHHHHHHHHhcC-CCcccceeeEEEcCCeeEE
Q 008026 400 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 470 (580)
Q Consensus 400 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 470 (580)
.+.|+.|-.=.+|++...+ .+.|++++.-. . .......+|..+++.+. +.-..++++++.. .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 3578888888999997653 34566666542 1 12335568888888885 4444577777643 58
Q ss_pred EEEecCCCCh
Q 008026 471 VFEYMPQGTL 480 (580)
Q Consensus 471 v~e~~~~g~L 480 (580)
|+||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.05 E-value=0.0016 Score=55.09 Aligned_cols=39 Identities=15% Similarity=0.157 Sum_probs=17.3
Q ss_pred CcccCceEeccc-CcCcCCC--C---CCCCCCCCcEEeccCCccc
Q 008026 40 NMTSLKEIWLHS-NAFSGPL--P---DFSGVKQLESLSLRDNFFT 78 (580)
Q Consensus 40 ~l~~L~~L~L~~-N~l~~~~--p---~~~~l~~L~~L~L~~N~l~ 78 (580)
+.+.|++|+|++ +.++... + .+...++|+.|+|++|.+.
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 445555555554 2333111 0 1333445555555555543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.71 E-value=0.00036 Score=59.41 Aligned_cols=117 Identities=18% Similarity=0.187 Sum_probs=67.4
Q ss_pred CCCCCCcEEeccC-Cccccc----CCccccCCCCCcEEEccCCcccccCCCCCcccccccccccCCCCCCCCCCCchhHH
Q 008026 62 SGVKQLESLSLRD-NFFTGP----VPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLN 136 (580)
Q Consensus 62 ~~l~~L~~L~L~~-N~l~~~----~P~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~l~ 136 (580)
.+.+.|+.|+|++ |.++.. +-..+...++|+.|+|++|.++.... .
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~-----------------------------~ 64 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVA-----------------------------F 64 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHH-----------------------------H
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHH-----------------------------H
Confidence 3467888999987 456421 33345678889999999987753211 1
Q ss_pred HHHHHHHhhCCccccccccCCCCCCCCccceeccCCcEEEEEecCCccccc----CcccccCCCCCcEEec--cCCcccc
Q 008026 137 ALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT----ISPEFASFKSLQRLIL--ADNNLSG 210 (580)
Q Consensus 137 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l--s~N~l~g 210 (580)
.+... +....+++.|++++|.+... +-..+...++|+.++| ++|.+..
T Consensus 65 ~L~~~--------------------------l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~ 118 (166)
T d1io0a_ 65 ALAEM--------------------------LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN 118 (166)
T ss_dssp HHHHH--------------------------HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHH--------------------------HhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcH
Confidence 11000 00112566777777776532 3345566677776544 4555532
Q ss_pred ----cCCccCcCCCCCCEEEccCCccc
Q 008026 211 ----MIPEGLSVLGALKELDVSNNQLY 233 (580)
Q Consensus 211 ----~~p~~l~~l~~L~~l~ls~N~l~ 233 (580)
.+...+...+.|+.|+++.+...
T Consensus 119 ~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 119 NVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 23344556777888877766543
|